data_1lwr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1lwr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.7 Cg_exo -56.53 173.7 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.509 2.14 . . . . 0.0 113.095 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m -95.15 159.51 14.98 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.536 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.91 144.4 98.99 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.129 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.9 Cg_endo -66.02 163.63 30.52 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.417 1.411 . . . . 0.0 110.822 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 128.1 48.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -102.91 115.72 31.15 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.45 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.42 141.68 30.2 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.92 125.66 8.15 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.448 -1.358 . . . . 0.0 112.51 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -121.27 119.68 32.95 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.0 ttm -105.89 132.2 52.28 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.727 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.31 147.49 22.41 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.458 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.07 13.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.907 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.88 -22.76 42.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.828 175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -40.65 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.102 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -137.65 49.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.278 0.561 . . . . 0.0 109.876 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -121.12 112.95 19.33 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.9 127.92 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.751 -170.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -114.18 127.25 55.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -107.83 113.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.81 131.88 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.544 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.33 107.07 18.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.787 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.56 132.59 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.095 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HZ3' ' CB ' ' A' ' 31' ' ' SER . 36.4 mtpt -99.1 155.29 17.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.845 0.715 . . . . 0.0 109.729 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.493 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.99 -48.2 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.02 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -143.89 109.11 5.04 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.134 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.0 m-20 -130.77 -37.59 1.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.035 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.82 54.71 0.39 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.42 33.16 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.609 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 11.4 m 43.62 61.3 10.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -88.75 40.0 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.418 1.412 . . . . 0.0 108.943 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.24 150.21 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.897 0.856 . . . . 0.0 111.336 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.1 mtt180 -130.95 116.67 18.17 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.793 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 35.66 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.498 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 82.7 m-85 -139.16 151.3 46.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.792 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.89 109.83 21.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.92 122.9 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.035 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.74 135.43 46.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.614 1.196 . . . . 0.0 107.927 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.51 161.6 37.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.876 -1.53 . . . . 0.0 112.063 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 7.8 ptm180 -144.35 170.1 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.763 -1.562 . . . . 0.0 110.166 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.541 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -122.63 179.65 4.54 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.714 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 tp -82.43 42.68 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.102 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.56 -56.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.344 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.3 m -124.31 151.95 43.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.409 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -98.07 175.03 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.606 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.8 m95 10.5 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.581 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 27.7 mmmt -80.53 163.0 58.77 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.049 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.4 Cg_exo -44.89 102.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.907 1.738 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.45 175.09 4.26 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.577 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.52 153.12 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.014 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -114.39 127.51 55.88 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.019 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -73.26 164.77 58.56 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.263 -177.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.77 169.99 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.749 1.633 . . . . 0.0 110.272 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.5 t -76.9 77.55 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.554 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.09 64.67 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 t -96.99 -174.47 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.14 -25.33 4.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -160.22 167.68 27.06 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.778 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -129.56 153.66 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.125 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ptp -139.81 154.54 47.38 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.37 -1.332 . . . . 0.0 113.157 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -140.38 139.77 35.4 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.563 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -135.78 136.55 40.8 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.616 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 86.97 51.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.0 170.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.1 mm? -97.96 -177.85 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.923 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.449 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 47.4 m-20 -74.3 134.73 42.58 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.685 0.755 . . . . 0.0 111.328 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -73.21 155.32 39.69 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.207 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.14 49.12 7.64 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.869 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 153.8 49.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.732 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -95.14 150.26 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.888 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 15.4 m-85 -134.23 143.4 47.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.451 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.7 123.06 43.98 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.891 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.51 121.82 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 35.2 m-85 -110.39 125.43 53.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -120.76 122.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.87 0.732 . . . . 0.0 110.835 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 86' ' ' ALA . 2.2 t -107.11 157.99 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.51 155.53 43.6 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.43 -1.308 . . . . 0.0 109.534 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.35 158.84 18.58 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.838 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.7 t-20 -144.58 151.34 38.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.716 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -35.7 -44.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.585 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.14 38.14 2.5 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.74 -155.06 23.49 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.317 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -121.76 159.32 26.91 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.794 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -121.86 125.59 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -41.38 165.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.718 1.886 . . . . 0.0 113.737 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 76' ' ' VAL . . . -88.09 136.08 33.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.19 147.01 27.56 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.56 129.66 56.6 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.702 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -115.09 128.58 56.31 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.986 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.455 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -125.85 138.66 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.421 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 39.6 p90 -158.09 178.19 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.028 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -129.7 147.07 51.45 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.912 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -79.85 171.7 14.76 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.67 -171.07 3.36 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.051 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.65 141.24 36.4 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.068 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 116.245 -1.836 . . . . 0.0 110.431 -179.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.526 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -55.22 170.09 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.699 2.266 . . . . 0.0 113.748 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -94.27 174.17 7.27 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.191 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.36 142.2 58.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.744 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -69.55 169.53 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.588 1.525 . . . . 0.0 110.289 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HB2' HE22 ' A' ' 26' ' ' GLN . 34.0 ttpt -99.23 137.61 37.5 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 172.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 mt -108.38 109.32 20.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.834 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.07 145.38 24.57 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.94 127.96 7.91 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.68 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.39 126.81 48.77 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.491 ' CE ' HD13 ' A' ' 19' ' ' ILE . 47.5 tpp -104.46 129.7 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.913 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -82.82 150.17 27.65 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.31 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.73 12.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.061 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.3 m-20 -79.86 -23.31 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.967 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.27 -41.99 2.03 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.883 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -136.53 48.31 2.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.131 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 m -121.22 116.03 24.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.545 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -116.19 128.59 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.469 -170.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.5 124.42 52.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.071 0.857 . . . . 0.0 108.961 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -109.12 120.62 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -94.19 130.7 40.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.283 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CD1' ' CD2' ' A' ' 36' ' ' TYR . 31.2 mt -99.33 98.54 9.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mm -89.42 107.88 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.242 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -68.69 170.03 10.13 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.441 HE22 ' HB2' ' A' ' 7' ' ' LYS . 3.5 pt20 -170.31 -67.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.652 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.4 m-20 -117.94 86.52 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.218 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.4 m-20 -129.31 -17.41 3.79 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.57 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.82 23.43 49.75 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.557 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.1 m 43.84 64.9 6.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.763 -0.718 . . . . 0.0 112.797 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -86.93 46.44 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 N-CA-C 107.26 -1.862 . . . . 0.0 107.26 170.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.02 152.11 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.008 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -127.63 113.91 16.68 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.221 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.8 p-80 36.86 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 90.9 m-85 -137.25 152.09 49.43 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.461 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.8 109.26 21.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -113.12 121.15 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.797 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.82 137.54 48.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 124.69 1.244 . . . . 0.0 107.874 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 155.16 44.87 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.906 -1.518 . . . . 0.0 112.173 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.2 ptm180 -131.23 164.66 25.07 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.018 -1.447 . . . . 0.0 110.098 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.548 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -120.61 170.48 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.02 43.09 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.506 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.73 -58.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.074 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.3 m -127.21 154.81 44.36 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.194 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -101.41 163.6 12.19 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.144 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 24.81 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.258 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 39.9 mmtm -71.49 165.93 44.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.116 174.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -49.17 96.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.723 1.615 . . . . 0.0 110.046 175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.01 174.34 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.534 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.91 154.4 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.368 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -113.99 130.12 56.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.789 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.1 mt -78.18 164.02 58.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.798 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.8 Cg_exo -60.33 168.08 6.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.666 1.577 . . . . 0.0 110.318 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.2 t -75.92 78.1 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.724 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 63.66 0.36 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.1 t -97.09 -172.12 2.37 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.689 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -131.96 -15.82 2.95 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.214 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.414 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.2 p-80 -159.71 165.39 32.65 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.556 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.543 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.3 p -135.0 152.18 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.66 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptp -137.78 150.58 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.418 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.491 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -139.6 138.21 35.99 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.954 174.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 53.1 mtmt -142.41 141.7 32.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.849 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.2 t 93.32 44.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.291 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.0 mm? -94.96 -178.65 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.028 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.469 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.4 m-20 -73.72 135.17 43.62 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 0.0 111.241 -173.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -74.19 156.49 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.291 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 45.24 47.07 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.729 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.48 154.95 47.24 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.002 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -97.24 149.04 22.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 14.8 m-85 -133.8 144.47 49.02 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.614 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.72 121.0 37.29 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.619 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.73 123.38 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.16 127.12 55.84 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.48 120.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 123.914 0.759 . . . . 0.0 110.731 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.428 HG21 ' HB1' ' A' ' 86' ' ' ALA . 2.3 t -104.08 158.88 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.58 45.26 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.219 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.97 157.48 21.44 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.317 -1.353 . . . . 0.0 107.9 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.526 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.5 t-20 -144.37 153.29 41.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.527 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -37.21 -41.95 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.496 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -107.64 36.38 2.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.79 -153.51 21.11 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.041 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -120.08 158.92 25.85 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 t -124.04 128.02 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.97 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -42.09 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 125.751 1.907 . . . . 0.0 113.303 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 76' ' ' VAL . . . -90.17 140.89 29.24 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.443 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.8 145.08 29.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.6 t-160 -115.25 129.87 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.418 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 78.1 t80 -117.73 130.1 56.11 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.095 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.423 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.61 139.7 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.541 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.545 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.7 p90 -157.38 177.43 11.45 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.154 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.52 146.57 51.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.951 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.31 164.98 19.7 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.539 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -81.61 -169.84 2.52 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.1 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.94 141.7 36.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.154 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.708 -179.524 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.453 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.523 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 28.2 Cg_endo -71.33 179.99 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.849 2.366 . . . . 0.0 112.737 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -103.95 160.32 14.91 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.177 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.69 148.99 98.56 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.812 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -71.85 171.85 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.307 1.338 . . . . 0.0 110.335 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HG3' HE22 ' A' ' 26' ' ' GLN . 32.9 mtmt -100.16 146.57 26.68 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 171.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.9 mt -115.09 114.04 24.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.195 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -95.42 144.81 25.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.79 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -111.33 127.09 8.03 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.48 -1.343 . . . . 0.0 112.554 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -122.73 124.58 43.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 47.9 ttm -105.25 133.13 50.52 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.595 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.94 153.88 25.09 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.543 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.07 10.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.082 -0.559 . . . . 0.0 112.234 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -80.0 -23.17 41.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.878 176.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.57 -37.03 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.36 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -132.53 2.46 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.123 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -75.67 116.5 16.45 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.974 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.503 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.4 mm -117.0 127.67 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.182 -172.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.85 125.45 54.08 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.582 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.2 t -108.91 119.78 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -97.28 128.72 44.38 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.102 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 47.3 mt -96.72 110.34 22.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 123.855 0.722 . . . . 0.0 109.695 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -97.42 108.18 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.686 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -72.4 168.43 18.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.753 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.425 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.6 pt20 -166.27 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.555 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 18.7 t70 -111.8 89.87 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.075 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 18.1 m-20 -131.97 -17.81 2.73 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.255 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.18 54.03 1.31 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.42 31.65 58.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 t 36.8 79.07 0.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 114.637 -0.782 . . . . 0.0 112.949 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HG2' HD22 ' A' ' 79' ' ' ASN . 6.0 Cg_endo -87.55 35.46 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 N-CA-C 107.169 -1.896 . . . . 0.0 107.169 165.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.99 144.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 122.091 0.948 . . . . 0.0 111.863 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 27.6 mtt180 -128.19 128.65 45.15 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.109 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 11.9 p-80 34.44 -173.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -139.93 153.5 46.97 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.555 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -106.29 112.16 25.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG13 HG21 ' A' ' 60' ' ' VAL . 45.9 t -114.11 128.22 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.928 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -134.43 140.25 46.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 125.039 1.462 . . . . 0.0 108.011 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.62 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.99 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 24.5 ptt85 -126.41 158.8 35.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.354 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -120.78 169.43 10.43 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.551 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.95 43.6 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.868 173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.49 -57.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.826 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.3 m -130.95 152.28 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.003 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 38.2 mt-10 -105.89 142.02 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.655 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.2 m95 58.81 84.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.837 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mptp? -70.67 161.89 74.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.123 173.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.66 105.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.88 1.72 . . . . 0.0 111.073 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.81 161.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.842 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.5 tt -134.12 149.91 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.459 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -114.29 132.41 56.17 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD11 ' HB ' ' A' ' 60' ' ' VAL . 1.5 mt -82.79 165.25 42.75 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.129 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.1 156.13 56.92 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.784 1.656 . . . . 0.0 110.324 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -73.66 83.26 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.183 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.62 47.61 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.63 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -97.13 167.44 11.05 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.04 -2.62 9.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.643 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.05 163.5 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.191 -1.403 . . . . 0.0 112.86 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.582 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -135.43 152.29 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.867 173.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptp -137.67 150.63 47.51 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.641 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -141.74 140.78 33.19 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.24 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.41 162.1 35.84 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.011 -1.075 . . . . 0.0 111.728 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 m 65.96 54.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.705 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.8 mm? -100.18 -175.43 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.046 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.7 m-20 -78.51 136.64 37.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.084 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -75.16 155.72 36.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 43.28 48.61 5.77 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.567 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.47 152.83 47.79 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.128 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -91.63 146.14 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 17.1 m-85 -134.45 138.72 44.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.245 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.61 118.3 28.88 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.457 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -112.29 126.85 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 51.5 m-85 -115.69 125.76 53.24 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.44 121.88 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 123.96 0.787 . . . . 0.0 110.708 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.81 156.26 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -126.38 155.74 41.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.955 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -110.08 149.13 30.47 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.126 -1.43 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.523 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -129.34 141.68 51.02 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.806 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -42.59 -33.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.229 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -126.61 50.44 1.93 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -160.36 27.06 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.097 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -125.97 159.18 33.35 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.827 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -113.18 111.32 21.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -39.59 159.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 125.442 1.714 . . . . 0.0 112.527 -176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.0 128.75 35.07 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.951 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.58 145.06 25.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.7 t-160 -116.12 130.94 57.04 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.781 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.6 t80 -120.07 128.86 53.88 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.314 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -126.23 135.67 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.627 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.502 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.7 p90 -157.49 177.65 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.169 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -128.25 147.9 50.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.425 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.8 p -79.87 170.59 16.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.178 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -84.48 -171.29 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.222 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 140.88 36.92 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.092 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.386 -179.074 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.0 Cg_exo -58.05 172.23 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.561 2.174 . . . . 0.0 113.34 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -98.66 163.35 12.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.567 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.75 143.7 98.21 Favored Pre-proline 0 N--CA 1.491 1.594 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.372 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -71.63 172.51 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.66 1.573 . . . . 0.0 110.582 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' N ' ' NE2' ' A' ' 26' ' ' GLN . 28.1 mtmt -99.06 142.21 30.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -112.29 111.37 22.2 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.037 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -92.05 144.03 25.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.0 131.45 10.46 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.22 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -128.07 125.83 40.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.1 ttm -107.65 131.52 54.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.89 151.97 28.09 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.429 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.18 10.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.157 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -79.97 -22.46 42.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.123 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.74 -37.16 3.84 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.051 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.1 p-10 -138.56 46.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -121.48 113.25 19.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.536 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 mm -116.35 129.16 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.688 -169.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -114.21 127.38 55.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.8 t -110.69 118.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -95.75 130.63 42.6 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.62 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 55.6 mt -99.6 109.43 21.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 123.678 0.611 . . . . 0.0 109.978 -174.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -94.69 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.74 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -79.01 140.41 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' N ' ' A' ' 7' ' ' LYS . 2.2 pt20 -136.87 -70.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.329 -171.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -115.88 101.29 8.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.004 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.02 -34.54 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.31 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.94 52.1 0.35 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.19 18.78 35.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.597 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 68.6 m 40.75 61.85 6.73 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.9 Cg_endo -87.08 51.36 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.709 1.606 . . . . 0.0 108.694 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.6 mm -88.2 149.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 122.046 0.927 . . . . 0.0 111.446 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.546 HH11 ' HG ' ' A' ' 55' ' ' SER . 45.9 mtp85 -132.05 123.61 27.58 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.943 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.532 ' H ' ' N ' ' A' ' 56' ' ' GLY . 6.0 p-80 33.65 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.6 m-85 -142.02 156.46 45.43 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.862 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.57 109.91 21.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 60' ' ' VAL . 46.8 t -114.11 123.67 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.068 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.23 137.87 46.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.804 1.315 . . . . 0.0 108.057 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.39 157.53 44.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 117.966 -1.494 . . . . 0.0 112.294 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.3 ptm180 -134.23 166.54 22.55 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.941 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.02 -170.72 2.01 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.91 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.83 40.17 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.089 172.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.44 -58.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.597 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.596 ' HG ' ' HZ1' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -125.72 157.55 37.1 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.417 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.6 pt-20 -101.3 162.57 12.8 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.282 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 25.24 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.838 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.596 ' HZ1' ' HG ' ' A' ' 45' ' ' SER . 70.6 mmtt -75.83 162.99 69.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -44.28 100.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.747 1.632 . . . . 0.0 110.869 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.66 175.65 4.07 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.42 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.34 155.64 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.384 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -113.96 135.36 54.08 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.861 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 2.1 mt -85.18 167.06 27.9 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.415 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.4 Cg_exo -65.12 154.65 72.47 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.729 1.619 . . . . 0.0 109.91 172.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.546 ' HG ' HH11 ' A' ' 34' ' ' ARG . 9.0 t -65.62 85.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.588 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 113.4 61.9 0.42 Allowed Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.327 -0.939 . . . . 0.0 110.94 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 t -97.08 164.78 12.37 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.582 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.3 -18.69 14.76 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.87 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.435 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.0 p-80 -160.03 172.86 16.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.898 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.2 p -134.8 155.0 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.232 171.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -139.06 151.46 46.77 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.863 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -139.37 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.574 173.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -134.85 137.56 43.38 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.764 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 90.07 48.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.843 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.2 mm? -96.72 -177.47 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.986 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 133.5 40.88 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.752 0.787 . . . . 0.0 111.46 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.66 156.13 39.72 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.254 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.3 t30 46.37 46.04 13.63 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.199 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.8 154.65 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.077 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.61 147.58 24.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.528 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 18.2 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.476 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -120.24 119.78 34.19 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.956 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.69 121.41 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 32.9 m-85 -110.92 124.27 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.9 t -121.08 122.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.856 0.722 . . . . 0.0 110.725 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.27 155.41 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -125.52 157.28 37.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.408 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 29.9 tt0 -111.79 156.33 22.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.712 -1.195 . . . . 0.0 107.801 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.9 t-20 -137.04 150.03 47.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -37.69 -35.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.145 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -125.73 48.35 2.08 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.732 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.25 -162.18 27.22 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.323 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -119.08 159.15 24.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.85 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 26.6 t -121.02 119.35 32.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -40.75 164.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.639 1.837 . . . . 0.0 113.231 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.92 140.09 31.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.519 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.6 146.63 28.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.457 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.64 129.85 56.39 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.021 -1.071 . . . . 0.0 111.469 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -117.97 130.63 56.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.163 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.457 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -127.64 141.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.75 -176.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.536 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 40.0 p90 -160.09 178.11 10.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.971 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -127.86 147.74 50.45 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.775 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -80.04 170.31 16.64 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.133 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -80.43 -179.63 7.25 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.892 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.67 144.1 28.32 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.382 -179.263 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.1 Cg_exo -61.22 172.43 3.23 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.566 2.177 . . . . 0.0 112.936 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -97.56 152.49 18.98 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.548 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.74 144.73 72.91 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.49 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.19 164.27 30.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.251 1.301 . . . . 0.0 110.212 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -102.35 129.29 48.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.3 mt -102.79 110.86 22.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.073 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -89.73 139.6 30.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.16 118.37 6.16 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.488 -1.339 . . . . 0.0 112.033 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 75.6 mt-30 -112.73 105.63 13.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.443 ' CE ' HD11 ' A' ' 19' ' ' ILE . 23.6 mtp -103.8 127.66 51.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.016 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -79.91 118.03 4.63 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.845 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.45 13.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.786 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.7 m-20 -79.85 -24.25 41.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.984 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 156.58 -69.96 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.493 -1.813 . . . . 0.0 112.891 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -143.46 18.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.736 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -75.81 115.12 15.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.981 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.501 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 15.6 mm -117.03 123.84 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.716 -173.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.4 124.48 52.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.903 0.752 . . . . 0.0 109.345 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.566 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.8 t -104.37 109.41 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.0 t-20 -88.87 128.59 35.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.563 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.12 102.37 14.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.434 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.73 132.55 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -107.01 148.25 28.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.283 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -130.61 -63.76 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.055 -173.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 5.1 m-20 -132.86 116.52 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.162 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.1 m-20 -133.42 -35.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.04 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.4 53.65 0.42 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 20.81 37.09 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.1 t 44.08 61.15 11.18 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.83 -176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -87.86 44.24 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.518 1.478 . . . . 0.0 109.013 172.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.78 148.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.398 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.5 mtt180 -130.82 126.04 35.26 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.185 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.3 p-80 31.95 169.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 54.1 m-85 -123.5 138.88 54.48 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.32 172.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.409 HD13 ' HB ' ' A' ' 76' ' ' VAL . 10.4 mt -100.27 100.6 11.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 51' ' ' ILE . 48.2 t -109.1 121.97 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.4 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -133.33 140.54 47.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.727 1.267 . . . . 0.0 107.749 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.49 155.42 43.09 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 8.8 ptt180 -131.48 163.08 28.76 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.404 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.14 169.52 11.15 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.458 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -74.13 43.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.733 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.98 -57.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.186 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -128.44 156.42 43.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -104.78 160.59 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.774 -1.171 . . . . 0.0 112.21 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.507 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.5 m95 28.36 89.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.101 -1.409 . . . . 0.0 113.749 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 61.5 mttm -76.24 163.4 66.62 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.323 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.31 105.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.832 1.688 . . . . 0.0 110.551 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -78.17 174.49 11.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.849 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.92 136.25 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.099 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 18.5 ttp85 -105.52 110.62 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.895 169.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 2.8 mt -69.09 162.14 67.54 Favored Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.606 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -79.18 147.53 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.12 1.88 . . . . 0.0 109.173 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 m -61.47 127.33 30.97 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.671 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.91 43.17 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -97.03 167.04 11.31 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.939 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.58 -47.22 3.0 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.654 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -148.17 167.62 24.59 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.962 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.1 p -119.36 145.06 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.479 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -131.31 148.69 52.71 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.831 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.2 pp -140.7 136.72 32.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.425 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -142.7 158.61 43.48 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.846 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t 75.9 45.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -92.9 -175.02 3.77 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.483 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 35.3 t70 -82.45 141.46 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.128 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.546 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.8 m95 -77.89 153.42 32.64 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.376 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.2 47.22 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.342 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.78 153.07 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.26 149.07 22.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.531 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 20.7 m-85 -133.45 141.7 47.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.393 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -119.76 118.1 29.97 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.576 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.98 123.67 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 56.6 m-85 -111.96 126.34 55.03 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.67 119.38 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 124.021 0.826 . . . . 0.0 110.462 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 86' ' ' ALA . 2.5 t -110.22 157.42 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.35 158.1 40.74 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.37 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.54 160.62 17.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.53 -1.268 . . . . 0.0 107.924 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.485 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -144.76 151.46 38.88 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.08 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -37.28 -44.03 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.315 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.99 41.79 1.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.42 -154.15 22.32 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.325 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -123.35 162.02 23.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.868 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 5.7 t -119.67 115.42 23.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -40.34 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 125.646 1.841 . . . . 0.0 113.458 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 76' ' ' VAL . . . -83.37 131.65 35.04 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.944 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.24 143.0 30.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.48 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -113.74 129.08 56.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.45 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -114.89 123.88 50.28 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.669 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -122.71 134.05 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.11 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.501 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 43.3 p90 -156.41 178.68 10.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.501 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.94 51.71 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.137 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 p -84.98 165.26 17.73 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -80.18 -172.78 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.158 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.33 140.51 39.15 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.01 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 116.586 -1.673 . . . . 0.0 110.707 -178.699 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -59.86 172.41 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.541 2.161 . . . . 0.0 112.984 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 m -93.8 159.58 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.603 172.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.79 146.72 90.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.5 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.5 169.0 18.16 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.428 1.419 . . . . 0.0 110.642 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -104.38 130.94 52.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -105.8 113.46 27.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.396 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -95.55 139.41 31.85 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.562 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.44 123.34 7.83 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.442 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.55 119.75 33.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.77 131.04 51.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.477 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.61 153.16 24.73 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.718 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 8.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-20 -79.84 -22.34 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.969 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.39 -36.38 4.43 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.318 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -131.35 -1.36 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.984 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -68.05 113.39 5.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.321 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.8 mm -115.75 127.17 73.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.1 -175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -115.74 124.63 51.28 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 63.3 t -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 114.446 -1.252 . . . . 0.0 107.941 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -88.27 128.47 35.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.091 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.51 106.43 18.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.908 0.755 . . . . 0.0 109.704 -171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.07 131.04 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.637 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -102.0 145.86 28.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.946 0.779 . . . . 0.0 109.586 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.453 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.4 -90.26 0.38 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.934 -175.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 24.1 m-20 -104.46 111.36 23.99 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.799 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -134.35 -33.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.196 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.81 51.94 0.33 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.11 19.62 38.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.593 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 43.46 60.78 10.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 114.781 -0.71 . . . . 0.0 112.802 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -87.8 43.65 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.594 1.529 . . . . 0.0 108.815 172.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mm -76.58 152.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.272 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.3 mtt180 -127.74 114.43 17.27 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.2 p-80 31.83 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.401 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 77.8 m-85 -135.43 152.14 51.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.551 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -111.17 112.02 23.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.95 129.59 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.054 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HD3' ' CG ' ' A' ' 47' ' ' TRP . 40.2 ttmt -134.58 134.6 41.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.895 1.372 . . . . 0.0 108.086 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.76 159.83 41.81 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.791 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 12.6 ptt180 -142.99 172.32 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -126.65 169.55 13.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.989 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.9 44.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.734 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.16 -54.33 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.94 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 p -133.6 156.63 47.49 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.53 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -86.63 -163.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.982 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.43 ' CG ' ' HD3' ' A' ' 39' ' ' LYS . 9.7 m95 -23.22 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.2 mptp? -77.9 167.01 39.42 Favored Pre-proline 0 N--CA 1.489 1.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.687 170.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 11.5 Cg_exo -50.62 108.57 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.843 1.695 . . . . 0.0 110.528 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -53.25 161.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.755 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.79 149.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.078 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -114.32 131.38 56.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.233 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -79.64 167.88 30.67 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.817 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.43 154.85 55.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.79 1.66 . . . . 0.0 108.867 169.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -80.18 113.31 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.973 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 46.51 3.7 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.3 p -96.8 -178.01 4.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.892 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.35 -56.77 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.315 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -146.04 164.87 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.669 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 7.1 p -109.88 144.01 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.66 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.13 147.22 50.96 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.019 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.9 OUTLIER -138.76 138.28 37.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.001 173.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -137.17 163.18 31.49 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.494 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m 63.59 53.41 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.664 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.8 mm? -96.21 -176.25 3.61 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.849 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.478 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.6 m-20 -76.94 132.47 39.07 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.639 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -72.98 154.52 40.49 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.013 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 46.32 47.92 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.657 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.78 153.45 48.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.935 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.74 145.93 25.87 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.227 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.2 m-85 -132.14 145.14 51.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 123.918 0.761 . . . . 0.0 112.526 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.37 122.83 40.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.433 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.1 125.49 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.0 m-85 -112.85 127.23 56.12 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.63 124.19 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.3 t -109.27 157.21 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.83 44.31 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.467 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.0 tt0 -110.6 164.62 12.55 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.782 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.3 t-20 -146.27 149.68 34.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.021 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.401 ' HA ' ' NE ' ' A' ' 34' ' ' ARG . 32.3 tt0 -38.22 -42.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.447 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -115.54 43.01 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.533 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.67 -158.49 27.68 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.986 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 157.92 40.78 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -123.32 119.25 29.55 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.586 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -43.39 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.602 1.814 . . . . 0.0 113.23 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -87.66 140.45 29.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.804 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.57 29.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.447 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -114.68 131.61 56.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.545 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -118.56 129.62 55.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.897 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.447 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.75 139.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.496 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.4 p90 -158.84 175.9 13.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.167 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.44 147.19 49.83 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.654 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -79.91 169.64 17.61 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.238 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -80.51 -176.37 5.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.154 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.22 147.74 25.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.107 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.69 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.8 Cg_exo -68.3 170.79 13.96 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.4 m -82.69 -157.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.824 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.35 35.86 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 9.7 Cg_endo -67.52 160.75 46.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.188 1.258 . . . . 0.0 110.661 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 126.05 47.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -100.72 113.63 26.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.317 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -98.42 144.22 28.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.427 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.47 132.31 10.38 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.14 -171.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.443 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.7 mt-30 -125.13 128.67 48.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.06 133.84 51.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.678 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.55 150.6 21.31 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.785 -1.198 . . . . 0.0 111.789 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.79 10.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.973 -0.613 . . . . 0.0 112.429 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.2 m-20 -79.8 -21.83 43.83 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.996 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.0 -43.02 1.76 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.194 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.09 40.02 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.981 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -112.34 116.71 30.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.543 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.7 mm -120.47 127.87 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 120.091 -0.643 . . . . 0.0 110.648 -170.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -112.8 125.4 54.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.152 0.907 . . . . 0.0 108.599 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.8 t -109.09 117.88 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.443 ' ND2' HE21 ' A' ' 11' ' ' GLN . 6.3 m-80 -98.3 129.34 45.0 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.379 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -98.58 102.56 14.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.274 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.1 mm -90.74 129.99 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.013 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HZ2' ' HG ' ' A' ' 31' ' ' SER . 30.6 mtpt -97.86 156.6 16.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.787 0.68 . . . . 0.0 109.723 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -144.61 -50.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.356 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.9 m-20 -141.51 109.15 5.64 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.211 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.6 m-20 -131.06 -31.72 1.67 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.66 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.38 50.99 0.59 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.83 27.29 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 8.4 m 45.77 59.1 15.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.2 Cg_endo -89.01 42.41 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.438 1.425 . . . . 0.0 109.547 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.405 HD12 HD21 ' A' ' 79' ' ' ASN . 22.7 mm -82.42 151.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.916 0.865 . . . . 0.0 111.255 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -130.25 115.06 16.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.677 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.5 p-80 37.38 -172.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 86.2 m-85 -139.94 154.05 47.1 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.187 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.92 109.9 20.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.73 121.26 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.88 -173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -132.42 140.24 48.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.607 1.192 . . . . 0.0 108.132 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.36 156.22 43.65 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.808 -1.557 . . . . 0.0 112.389 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 5.0 ptm180 -129.17 160.34 33.2 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.598 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.532 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -114.14 -172.88 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.146 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.5 tp -91.31 41.69 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.448 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.48 -58.86 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -120.02 151.29 39.21 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.387 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -106.68 153.77 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.825 -176.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.544 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 38.83 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.652 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 65.2 mttm -77.28 162.75 68.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.255 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.2 Cg_exo -43.39 99.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.946 1.764 . . . . 0.0 110.814 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.67 175.71 6.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.268 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.96 153.91 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.301 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -113.49 135.85 53.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.929 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.4 mt -84.71 162.68 49.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.824 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -69.16 145.7 61.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.716 1.611 . . . . 0.0 109.755 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.4 m -59.8 102.6 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 123.934 0.771 . . . . 0.0 111.479 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 52.68 0.56 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -97.13 -179.49 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.563 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.98 -34.59 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.515 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -148.51 167.7 24.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.204 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.1 p -133.4 153.97 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.746 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -138.76 151.68 47.3 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.568 -1.253 . . . . 0.0 112.515 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.25 142.7 42.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.74 173.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -142.94 153.14 42.76 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.081 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t 72.25 42.98 0.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.589 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.62 -172.31 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.666 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 4.6 m-20 -85.29 143.33 28.77 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.637 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -76.46 154.69 34.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.744 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.59 49.41 6.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.768 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.92 49.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.575 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.51 147.91 23.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.407 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.532 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 30.8 m-85 -133.0 142.72 48.99 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.515 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 4.6 mp0 -119.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.78 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.91 122.7 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.0 m-85 -111.1 124.2 51.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.34 120.8 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.863 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.76 158.05 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.17 164.9 22.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.658 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.2 tt0 -118.71 162.48 18.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.222 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.532 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.5 t-20 -151.16 154.47 36.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.356 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -41.99 -34.02 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.61 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -79.41 -45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.891 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.76 -118.71 0.51 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -118.46 163.2 17.11 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.613 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.92 116.03 22.93 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.869 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -39.05 158.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.297 1.623 . . . . 0.0 112.784 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.04 139.71 32.33 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.544 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.37 146.29 30.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.3 t-160 -116.47 130.87 56.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.785 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 74.6 t80 -118.01 130.22 56.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.21 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.58 140.52 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.971 -176.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.543 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 36.6 p90 -161.57 179.04 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -130.63 148.48 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.836 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -79.91 172.3 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.522 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -85.54 -171.22 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.099 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.96 142.77 35.1 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.081 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 116.199 -1.858 . . . . 0.0 110.443 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.448 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.1 Cg_endo -63.77 166.65 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.36 2.04 . . . . 0.0 112.586 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.15 165.79 15.47 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.468 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.79 142.85 88.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.11 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.42 167.22 23.0 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.412 1.408 . . . . 0.0 110.54 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -101.7 131.83 47.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.02 113.74 27.52 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.844 -1.142 . . . . 0.0 110.277 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.36 142.29 32.04 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.257 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -118.51 136.46 12.21 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 118.877 -1.63 . . . . 0.0 113.82 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -128.43 137.91 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.647 -0.777 . . . . 0.0 109.464 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.406 ' CE ' HD13 ' A' ' 19' ' ' ILE . 36.5 ttm -109.33 134.42 51.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.502 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.62 146.15 22.26 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.855 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.87 8.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.89 -30.11 40.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.783 175.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.54 -39.43 2.06 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.407 -1.378 . . . . 0.0 113.174 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -130.27 -14.75 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.697 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -54.17 113.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.214 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.544 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.3 mm -116.78 130.71 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.076 -174.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -116.98 124.77 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.859 0.724 . . . . 0.0 109.084 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -110.23 120.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -97.09 133.22 42.04 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.343 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 41.0 mt -101.55 101.45 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -93.78 131.01 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HZ2' ' CB ' ' A' ' 31' ' ' SER . 32.0 mtmt -101.74 157.66 16.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.738 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -51.44 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.649 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -145.4 103.93 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.428 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.6 m-20 -117.25 -40.21 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.738 0.649 . . . . 0.0 109.714 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.57 52.95 0.21 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.29 20.56 29.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.599 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 19.5 m 42.16 60.84 9.12 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.9 Cg_endo -90.44 42.85 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.553 1.502 . . . . 0.0 109.112 172.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mm -81.44 151.42 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.989 0.899 . . . . 0.0 111.367 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.4 mtt180 -130.52 114.37 15.41 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.835 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.7 p-80 35.77 -170.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.484 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.4 m-85 -139.99 150.64 44.71 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.006 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.07 110.86 23.26 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.52 127.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.812 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -132.49 140.7 48.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.012 1.445 . . . . 0.0 107.834 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.17 157.01 43.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.56 -1.656 . . . . 0.0 112.591 177.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.8 ptm180 -134.41 165.3 25.48 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.354 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -127.53 177.74 6.56 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.303 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.56 40.96 0.53 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.838 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -142.34 -62.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.904 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -129.7 171.23 12.87 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.267 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -116.46 160.87 19.96 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.211 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.9 m95 28.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.347 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 52.0 mttp -72.63 160.08 83.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.351 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.7 Cg_exo -41.77 107.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.1 1.866 . . . . 0.0 111.579 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.16 160.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.623 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -131.35 147.95 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.156 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -113.71 125.03 53.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -69.88 164.23 53.4 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.271 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.63 172.21 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.804 1.669 . . . . 0.0 110.635 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -74.5 76.92 1.95 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.974 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.47 64.78 0.59 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.526 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -89.63 -176.99 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.851 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -126.63 -14.11 5.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.503 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.433 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 42.2 p-80 -159.18 170.34 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.753 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p -136.87 150.81 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 124.864 1.353 . . . . 0.0 108.582 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -133.72 150.0 51.5 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.152 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -143.85 144.88 31.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.539 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -140.27 172.17 13.12 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.789 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.7 m 57.84 59.66 3.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.631 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 19.6 mt -95.21 177.9 5.71 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.353 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.51 124.15 22.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.252 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.489 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 77.1 m95 -70.74 148.49 47.9 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 50.77 49.77 20.32 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.671 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.27 152.27 50.69 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.27 151.78 22.41 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 1.7 m-85 -137.04 141.28 42.47 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.6 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.65 121.08 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.721 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.26 123.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.438 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 43.9 m-85 -113.03 125.51 54.48 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.46 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.534 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 86' ' ' ALA . 2.0 t -107.2 159.41 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.07 155.38 44.46 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.548 -1.261 . . . . 0.0 109.805 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.8 tt0 -110.81 163.85 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.86 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -153.69 154.21 33.7 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.577 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -40.45 -43.48 1.82 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.327 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -101.84 37.05 1.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.33 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.23 -134.02 8.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.22 -179.99 6.86 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.585 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -130.05 124.31 32.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -45.79 171.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 125.516 1.76 . . . . 0.0 111.686 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -88.55 145.96 25.42 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.605 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.72 147.96 27.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.908 -1.497 . . . . 0.0 106.982 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.471 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.8 t-160 -116.14 130.96 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.592 -173.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.4 t80 -118.65 130.56 55.92 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.737 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.95 140.44 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.854 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 48.3 p90 -157.44 -178.76 7.58 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.849 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -128.97 145.07 51.34 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.353 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.93 168.42 19.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.901 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.1 m -81.78 -176.47 6.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.291 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.23 144.16 30.43 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.321 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.219 -1.848 . . . . 0.0 110.505 -178.088 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.6 Cg_exo -57.93 171.85 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.417 2.078 . . . . 0.0 113.011 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -95.43 159.66 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.682 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.32 141.86 98.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.896 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.09 167.52 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.28 1.32 . . . . 0.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -100.64 127.77 46.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.38 109.79 21.54 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.922 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.13 137.81 37.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.49 142.87 16.16 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.489 -1.815 . . . . 0.0 113.791 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -129.4 138.79 51.68 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.093 -1.053 . . . . 0.0 109.361 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 19' ' ' ILE . 52.2 tpp -104.72 131.52 52.07 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.42 150.31 23.43 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.525 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.72 8.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.0 m-20 -79.87 -23.03 42.2 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.125 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.8 -50.87 0.76 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.649 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 9.8 p30 -123.87 1.36 8.7 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.33 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.6 m -69.56 116.75 10.32 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.301 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.508 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -115.41 127.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.776 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -115.07 124.78 52.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.023 0.827 . . . . 0.0 109.072 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.5 t -112.45 120.69 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -98.2 130.48 44.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.04 100.88 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.27 130.7 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.868 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -104.16 153.04 21.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.842 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.05 -49.89 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.915 -174.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.6 m-20 -139.76 111.63 7.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.008 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -130.02 -37.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.123 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.51 55.05 0.36 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 20.42 35.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.619 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.7 t 44.15 60.61 11.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 114.8 -0.7 . . . . 0.0 112.728 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.619 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -89.42 43.39 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.393 1.395 . . . . 0.0 109.214 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mm -88.54 149.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.877 0.846 . . . . 0.0 111.266 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 69.2 mtt85 -131.46 123.55 28.34 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.867 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.9 p-80 36.69 -173.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.7 m-85 -139.74 153.57 47.22 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.784 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.49 109.42 21.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.32 125.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.204 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -136.45 141.1 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.56 158.06 43.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.069 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 9.0 ptm85 -133.96 159.36 40.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.645 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -116.81 -177.8 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.92 41.58 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.792 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.65 -61.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.335 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -118.99 149.68 41.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.528 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 23.9 pt-20 -117.53 144.73 44.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.588 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.558 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 56.87 77.48 0.26 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.027 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 25.9 mmmt -72.57 163.27 69.15 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.541 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -46.57 99.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.823 1.682 . . . . 0.0 110.444 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.32 172.7 2.99 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.529 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.17 153.81 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.951 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -112.84 131.77 55.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.949 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.8 mt -81.84 163.76 52.06 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.861 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.26 152.43 76.46 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.771 1.647 . . . . 0.0 110.438 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.422 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 33.7 m -68.61 93.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.885 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.91 52.71 0.46 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -97.22 170.13 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.394 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.93 -36.66 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.996 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -146.56 169.48 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.579 -1.248 . . . . 0.0 112.124 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -132.76 151.79 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.885 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ptp -135.65 148.31 48.91 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.894 -1.123 . . . . 0.0 112.022 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.32 144.2 34.46 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.458 174.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -140.16 170.36 15.98 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.663 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 m 61.19 57.03 2.56 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.042 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 17' ' ' ASN . 10.6 mp -94.95 178.52 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -71.99 133.06 45.1 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.248 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -72.93 151.47 41.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.837 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 46.97 49.08 15.05 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.54 152.08 48.7 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.051 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -92.66 148.72 21.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 11.1 m-85 -136.05 143.33 44.62 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.692 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 3.7 mp0 -119.2 122.66 42.49 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.139 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.96 123.4 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.7 m-85 -112.57 125.98 54.85 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.6 t -122.45 121.8 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 124.047 0.842 . . . . 0.0 110.677 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.412 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.1 t -106.33 159.07 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.34 156.68 42.7 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.751 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.41 153.82 25.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.392 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.507 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.2 t-20 -141.25 150.83 43.13 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.143 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -36.12 -43.82 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.846 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -108.33 35.9 3.0 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -152.31 21.5 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.072 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -120.97 158.15 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -118.32 120.43 37.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -40.05 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 125.81 1.944 . . . . 0.0 113.492 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -84.0 136.41 34.06 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.051 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.94 145.68 28.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.49 129.43 56.54 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.574 -174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 71.6 t80 -117.5 129.75 56.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.34 140.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.749 -176.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.505 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.2 p90 -158.63 -179.34 7.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.071 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -129.55 147.63 51.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.568 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.4 p -79.88 166.83 21.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -82.44 -172.01 3.78 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.66 148.28 24.51 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.325 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 116.474 -1.727 . . . . 0.0 110.652 -178.799 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.493 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.9 Cg_exo -61.3 172.84 2.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.6 2.2 . . . . 0.0 112.99 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -97.06 163.45 12.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.479 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.0 99.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.164 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.91 172.14 12.31 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.451 1.434 . . . . 0.0 110.463 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -107.04 133.48 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.1 mt -106.46 115.9 31.01 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.262 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.39 140.49 31.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.45 129.05 9.37 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.656 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -124.53 124.73 42.9 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.9 ttm -106.96 133.76 51.13 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.8 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.25 150.55 22.83 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.596 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.35 14.01 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.074 -0.563 . . . . 0.0 111.936 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.86 -24.31 41.33 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.684 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 -40.53 2.45 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.706 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 9.4 p30 -138.18 48.68 1.96 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.92 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -120.82 115.11 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.542 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.05 129.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -114.01 125.16 53.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.3 t -107.7 115.0 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -96.73 130.41 43.98 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.313 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.84 109.66 22.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.637 -173.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.29 132.5 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -104.4 148.0 26.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.82 0.7 . . . . 0.0 109.408 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.56 -66.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.135 -174.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -127.77 110.92 13.09 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.27 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.7 m-20 -128.83 -37.09 1.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.986 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 56.87 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 18.65 43.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.609 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 45.16 60.15 13.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.791 -0.704 . . . . 0.0 112.87 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -88.89 42.52 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.458 1.438 . . . . 0.0 109.365 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.43 151.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.878 0.847 . . . . 0.0 111.446 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 78.4 mtt-85 -131.05 117.31 18.95 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.886 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.57 -173.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.45 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 82.2 m-85 -137.85 154.26 49.51 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.052 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mt -110.33 111.49 22.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 123.98 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.146 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -132.35 138.56 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.688 1.242 . . . . 0.0 107.938 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.2 p90 -144.05 158.43 43.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.916 -1.514 . . . . 0.0 112.45 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.4 ptm180 -141.88 169.79 16.94 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.442 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.59 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -128.14 168.87 14.8 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.767 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.92 43.53 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.724 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -153.4 -51.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.931 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 p -125.87 148.06 49.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.111 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -103.1 167.23 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.865 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.7 m95 18.33 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.952 -1.476 . . . . 0.0 114.226 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.7 mttp -77.18 163.55 64.17 Favored Pre-proline 0 N--CA 1.49 1.525 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.072 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.7 Cg_exo -44.68 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.803 1.668 . . . . 0.0 110.908 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.02 175.27 3.84 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.394 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.04 154.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.362 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.95 134.06 55.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.812 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.2 mt -82.42 162.99 54.33 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.027 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.88 169.86 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.773 1.649 . . . . 0.0 110.633 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -74.64 77.82 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.935 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.5 65.82 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 t -97.01 -174.54 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.71 -23.02 4.43 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.618 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.421 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.6 p-80 -160.23 168.31 25.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.994 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.5 p -131.87 151.4 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.268 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -137.3 152.07 49.36 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.827 -176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.14 139.1 33.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.43 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 64' ' ' SER . 51.8 mtmt -142.5 141.43 32.11 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.85 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.5 t 93.51 45.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.345 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 mm? -96.56 178.51 5.31 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.391 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -68.17 133.44 48.9 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.612 0.72 . . . . 0.0 111.493 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.73 154.25 39.69 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.227 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.42 48.9 8.23 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.565 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.63 49.82 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.802 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.37 144.05 26.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.59 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 6.0 m-85 -129.74 144.84 51.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.912 0.758 . . . . 0.0 112.463 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -119.79 124.01 45.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.409 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.2 t -116.07 123.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 38.9 m-85 -111.49 124.92 53.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -120.02 122.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 123.876 0.735 . . . . 0.0 110.567 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -106.94 157.8 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 155.63 42.86 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.58 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.67 158.87 18.78 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.233 -1.387 . . . . 0.0 107.73 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.6 t-20 -146.45 153.28 40.26 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.543 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -42.4 -37.68 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.466 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -103.01 29.77 5.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.5 -148.04 19.35 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.849 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -122.23 158.82 28.62 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.967 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.7 t -121.86 124.13 43.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.35 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -40.92 165.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.735 1.897 . . . . 0.0 113.59 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 76' ' ' VAL . . . -88.45 140.97 28.92 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.45 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.53 30.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.448 ' CE1' HG23 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.19 129.45 56.65 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.408 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -116.87 130.23 56.57 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.033 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.448 HG23 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.63 140.74 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.593 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.31 178.09 10.72 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.777 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -128.12 145.21 51.08 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.894 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.8 p -79.88 171.37 15.2 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.154 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -86.53 -170.47 3.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.134 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.72 141.19 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.242 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.536 -1.697 . . . . 0.0 110.672 -179.366 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.46 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 12.4 Cg_exo -56.89 173.26 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.601 2.201 . . . . 0.0 113.1 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -95.76 163.04 13.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.239 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.73 142.07 95.53 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.173 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.48 171.21 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.606 1.538 . . . . 0.0 110.686 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' CG ' HE22 ' A' ' 26' ' ' GLN . 38.1 mtpt -98.03 139.92 33.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.4 mt -111.29 110.21 20.59 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.15 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.04 141.51 28.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.793 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.8 123.32 7.29 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.17 -173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -120.88 123.09 41.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.3 ttm -104.14 131.86 50.99 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.19 146.25 23.75 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.719 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.14 9.53 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.76 -30.25 40.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.858 175.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.29 -41.47 1.68 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.062 177.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.91 -15.05 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.676 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.0 m -55.37 116.5 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.552 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.0 mm -117.55 130.35 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.552 -173.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.1 125.68 52.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.939 0.774 . . . . 0.0 108.996 172.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.572 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 60.2 t -107.33 113.47 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 126.69 37.0 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.212 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.11 107.22 19.54 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.899 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.2 mm -92.44 106.27 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.524 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.73 140.89 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.469 HE22 ' CG ' ' A' ' 7' ' ' LYS . 2.4 pt20 -138.17 -78.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.355 -172.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.1 m-20 -106.14 100.82 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.962 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -132.36 -35.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.277 -179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 51.45 0.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.01 17.75 36.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.594 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 41.39 61.09 7.99 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -86.48 51.58 2.6 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.685 1.59 . . . . 0.0 108.73 172.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.5 mm -87.41 150.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.031 0.92 . . . . 0.0 111.622 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.8 mtt180 -129.94 119.38 23.14 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.413 -1.722 . . . . 0.0 108.543 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 34.73 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.46 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.2 m-85 -139.52 151.18 45.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.009 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mt -107.48 110.78 22.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.2 128.2 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.913 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.73 140.23 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 125.036 1.46 . . . . 0.0 107.979 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.56 156.52 43.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.726 -1.59 . . . . 0.0 112.657 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -131.58 156.99 44.8 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.073 -177.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -119.33 168.56 10.8 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 tp -73.59 42.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.795 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.93 -57.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.083 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.3 m -128.62 153.06 47.65 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.141 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -104.99 165.49 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.044 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.428 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.62 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.448 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.9 mttm -77.03 159.99 77.2 Favored Pre-proline 0 N--CA 1.491 1.618 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.334 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 24.3 Cg_exo -40.45 111.65 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.188 1.926 . . . . 0.0 111.895 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.71 164.87 4.29 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.809 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -136.4 151.18 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.365 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -117.34 132.24 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.241 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -79.07 165.13 51.02 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.508 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.33 159.79 29.72 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.808 1.672 . . . . 0.0 110.682 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 95.34 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.94 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.455 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 96.92 65.35 0.92 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -97.14 -172.57 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.469 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -122.16 -43.81 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.741 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -147.13 167.44 24.13 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.061 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.572 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.5 p -122.48 149.54 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.375 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -132.87 147.12 52.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.606 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -139.48 137.76 35.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.991 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -139.55 158.16 44.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.463 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t 71.88 49.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.203 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.82 -174.22 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.233 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.6 133.51 38.44 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.666 0.746 . . . . 0.0 111.081 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.5 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 72.1 m95 -75.17 156.95 35.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.074 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 45.53 46.3 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.769 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.7 154.66 46.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.11 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -96.69 147.65 23.69 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.5 m-85 -134.0 140.85 46.98 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.471 -178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 119.48 34.26 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.205 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.6 t -113.77 127.65 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 55.0 m-85 -114.82 126.58 54.98 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.58 121.54 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.627 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.408 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.2 t -105.84 156.06 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.91 156.01 42.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.523 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -109.96 156.24 20.72 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.821 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 13.2 t-20 -140.53 149.88 43.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.958 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -34.14 -45.34 0.21 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.758 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -113.97 40.15 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.82 -156.85 26.11 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.378 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -120.33 159.6 24.71 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.725 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 24.8 t -120.59 120.64 36.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -41.0 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.633 1.833 . . . . 0.0 113.189 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -83.95 136.16 34.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.338 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.93 144.42 29.01 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.8 t-160 -114.81 130.08 56.8 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.284 -174.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.192 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.86 137.98 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.571 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.6 p90 -156.04 177.47 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.163 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.27 146.17 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.623 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -83.76 164.59 19.48 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -80.48 -171.13 2.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.273 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.15 139.18 39.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.208 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.461 -1.733 . . . . 0.0 110.801 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.2 Cg_exo -58.04 172.83 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.621 2.214 . . . . 0.0 113.31 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -101.6 162.54 12.82 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.407 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.92 142.27 85.26 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.364 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.82 154.12 67.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.501 1.468 . . . . 0.0 109.962 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -83.39 139.66 32.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 mt -109.03 108.98 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.313 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -93.89 144.71 25.19 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.462 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 130.58 9.57 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.302 -1.427 . . . . 0.0 112.889 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -125.37 129.87 50.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.0 ttm -107.28 134.49 50.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.55 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -90.52 151.53 21.42 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.679 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.91 9.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.11 -0.545 . . . . 0.0 112.353 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.92 -20.55 45.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.009 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 108.54 -41.98 2.07 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.633 -1.27 . . . . 0.0 111.163 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -127.86 2.15 6.01 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.915 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -65.42 111.92 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.248 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 8.5 mm -116.34 126.36 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.968 -176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -114.71 124.93 53.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 123.933 0.771 . . . . 0.0 108.949 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.4 t -108.87 118.58 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.7 128.42 42.56 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.6 mt -97.95 102.27 13.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 123.914 0.759 . . . . 0.0 109.079 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.31 103.04 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.715 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -77.6 149.95 34.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.75 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -147.31 -51.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.946 -1.101 . . . . 0.0 112.406 -172.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 106.11 7.06 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.098 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.4 m-20 -129.42 -39.33 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.22 57.16 0.38 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.65 18.42 41.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.618 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.8 t 44.76 60.47 12.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -89.15 43.98 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.476 1.451 . . . . 0.0 109.071 172.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.67 150.95 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.883 0.849 . . . . 0.0 111.543 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.8 mtt85 -129.22 117.56 20.93 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.07 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.9 p-80 32.02 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 69.4 m-85 -134.62 152.35 51.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.173 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.62 113.36 26.28 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.79 128.55 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.209 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -135.41 139.68 44.35 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.24 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.35 154.54 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.161 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.6 ptm180 -126.49 160.74 29.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.671 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -108.64 -169.27 1.47 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.97 41.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.587 172.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.22 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 p -121.65 150.02 42.35 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.999 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -113.27 150.04 33.01 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.22 -172.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.5 m95 47.79 83.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.562 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 46.1 mmtm -66.29 161.49 56.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.368 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -47.22 105.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.77 1.647 . . . . 0.0 110.81 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.25 154.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.464 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -129.55 148.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.269 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -114.26 128.59 56.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.753 -0.779 . . . . 0.0 108.899 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.58 163.97 63.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.712 -176.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -78.23 132.39 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.879 1.719 . . . . 0.0 107.74 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -56.58 131.95 50.24 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.44 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.26 34.26 5.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 m -96.98 152.47 18.69 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.961 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.07 -28.08 10.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.033 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -145.49 165.72 27.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.36 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 10.6 p -128.58 150.12 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.269 174.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -134.74 149.85 50.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.741 -1.184 . . . . 0.0 112.509 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -141.61 146.48 36.28 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.765 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -139.2 178.57 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.867 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.1 m 54.34 55.24 8.35 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.733 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 25.1 mt -91.49 176.55 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.867 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -73.45 128.22 34.89 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.828 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.408 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 81.7 m95 -71.06 149.92 46.06 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.951 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 48.05 50.33 16.12 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.604 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.43 154.51 47.65 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.792 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.94 147.83 23.27 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.285 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 65' ' ' LEU . 13.5 m-85 -133.23 143.88 49.43 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.521 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.04 119.24 29.76 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.16 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.39 124.57 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 53.8 m-85 -114.21 125.78 54.31 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.36 123.46 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 123.991 0.807 . . . . 0.0 110.416 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 86' ' ' ALA . 2.1 t -109.72 157.18 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.26 156.4 40.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.079 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -110.12 160.25 16.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.823 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -146.46 151.81 38.0 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.372 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -34.89 -46.15 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.644 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -109.19 38.81 2.2 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.99 -150.55 20.65 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.147 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -123.23 159.58 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.04 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -118.99 118.06 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -39.32 163.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.849 1.968 . . . . 0.0 113.725 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -85.44 137.49 32.88 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.15 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.34 29.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.03 130.39 56.93 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.534 -174.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -118.33 130.56 56.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.117 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.61 139.11 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.647 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.52 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 37.5 p90 -159.88 179.36 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.266 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -128.04 147.46 50.51 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.642 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.4 p -79.92 168.39 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.81 -170.45 3.0 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.172 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.25 141.61 36.47 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.16 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 116.143 -1.884 . . . . 0.0 110.398 -178.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.0 Cg_exo -59.15 169.85 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.372 2.048 . . . . 0.0 113.639 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -94.89 177.51 5.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.16 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.34 144.97 58.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.139 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -71.68 164.99 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.691 1.594 . . . . 0.0 110.531 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' CB ' HE22 ' A' ' 26' ' ' GLN . 10.3 mtpp -93.43 132.62 37.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.04 108.83 20.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.795 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.49 135.28 42.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.75 143.59 16.44 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.455 -1.831 . . . . 0.0 113.151 -171.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -131.14 139.56 49.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 108.942 172.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -108.88 132.77 53.72 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.708 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.39 150.74 27.47 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.326 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.19 13.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.931 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.94 -25.28 40.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.664 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.01 -44.63 1.46 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.066 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.481 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 10.8 p30 -134.41 44.8 2.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.321 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -112.9 110.63 20.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.7 mm -114.13 128.48 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.421 -170.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.38 124.82 51.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.3 t -111.84 120.13 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -96.65 130.7 43.82 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.524 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD12 ' CD2' ' A' ' 36' ' ' TYR . 40.2 mt -99.99 103.43 14.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.943 0.777 . . . . 0.0 109.114 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.67 108.4 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.554 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HZ2' ' HH ' ' A' ' 36' ' ' TYR . 16.6 mttm -70.13 169.43 13.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.2 pt20 -170.25 -69.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.689 -1.204 . . . . 0.0 111.399 -175.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 16.9 t70 -115.23 89.39 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.019 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -130.85 -17.63 3.14 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.776 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.34 52.35 1.6 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.417 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.27 22.75 50.71 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 44.26 64.37 7.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 114.78 -0.71 . . . . 0.0 112.736 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.7 Cg_endo -88.13 46.22 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 171.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 mm -92.55 151.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.197 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -128.19 115.19 17.99 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.05 -1.886 . . . . 0.0 108.098 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.1 p-80 35.69 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.509 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.3 m-85 -142.86 137.95 29.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.013 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -88.19 111.07 21.22 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.22 126.8 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.306 -175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -132.55 138.8 47.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 125.08 1.488 . . . . 0.0 107.632 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.17 156.31 43.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.715 -1.594 . . . . 0.0 112.223 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.2 ptm180 -134.88 163.54 29.6 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.892 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -120.71 -168.25 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.773 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -93.28 40.54 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.825 170.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.8 -61.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.572 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.59 157.78 30.0 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.231 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -109.69 156.21 20.54 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.594 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.487 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.1 m95 34.42 83.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.108 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.2 mmtt -70.45 161.54 75.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.203 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.8 Cg_exo -43.2 107.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.982 1.788 . . . . 0.0 111.556 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -55.18 161.27 1.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.729 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.281 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttp85 -112.43 118.06 34.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.2 mm? -60.12 165.9 4.43 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.036 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.1 Cg_exo -61.47 141.67 92.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.37 1.38 . . . . 0.0 109.483 172.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -59.15 88.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.568 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . 106.52 58.9 0.6 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -97.12 -173.49 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.449 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.97 -25.48 3.59 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.536 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -160.07 167.51 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.394 -1.323 . . . . 0.0 112.574 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.564 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -130.73 150.27 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.671 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -134.92 147.74 49.89 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.777 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -140.46 142.86 35.31 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.226 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 178.68 6.68 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.536 -175.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m 49.06 56.89 7.1 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.687 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 10.2 mt -91.99 164.34 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.527 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.36 129.78 42.9 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.832 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -71.8 147.84 46.84 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 47.16 51.09 13.54 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.623 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.52 151.62 49.94 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.264 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -89.2 146.74 24.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 65' ' ' LEU . 1.5 m-85 -133.97 140.84 47.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.531 -176.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -122.11 123.4 41.46 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.585 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -113.79 122.57 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 39.7 m-85 -112.29 124.06 51.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.49 120.6 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.86 0.725 . . . . 0.0 110.702 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 86' ' ' ALA . 1.9 t -103.78 164.45 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 154.08 49.85 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.679 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.79 156.37 22.98 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.789 -1.165 . . . . 0.0 107.88 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -144.97 152.33 40.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -40.83 -40.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.144 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.65 35.83 2.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.91 -151.32 20.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.98 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -128.41 161.59 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.573 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -126.76 128.24 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.881 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -46.14 173.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 125.608 1.817 . . . . 0.0 112.906 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 76' ' ' VAL . . . -93.63 145.34 24.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.31 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.81 146.61 28.38 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 171.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.472 ' CE1' HG23 ' A' ' 90' ' ' VAL . 11.0 t-160 -115.69 129.8 56.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.457 -174.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 51.7 t80 -119.95 131.95 55.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.472 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.6 t -129.69 144.18 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.209 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 47.6 p90 -159.83 -177.97 6.72 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.977 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -129.64 145.66 51.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.471 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 169.22 18.23 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -84.43 -169.94 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.305 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.53 142.02 36.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.008 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 116.542 -1.694 . . . . 0.0 110.685 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HG3' HD21 ' A' ' 79' ' ' ASN . 3.1 Cg_exo -61.77 169.25 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.824 . . . . 0.0 112.169 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 m -91.09 152.95 20.42 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.66 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 143.53 93.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.165 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.88 167.63 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.329 1.353 . . . . 0.0 110.45 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -103.4 132.69 49.45 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.1 mt -104.6 113.85 27.7 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.158 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -95.66 143.18 27.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 127.38 8.76 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.586 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -123.3 121.12 35.04 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.1 ttm -105.14 132.55 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.658 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.37 149.73 21.45 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.318 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -65.75 14.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.907 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.1 m-20 -80.01 -24.59 40.72 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.549 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.16 -42.73 1.87 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.41 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -131.84 10.02 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.18 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -77.98 112.81 15.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.256 -0.977 . . . . 0.0 108.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.504 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 9.5 mm -116.34 126.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.972 -172.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.38 127.11 56.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.4 t -108.01 116.55 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -97.28 129.4 44.58 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.424 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.2 106.39 18.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.758 0.661 . . . . 0.0 109.491 -173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -96.29 129.82 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -105.55 153.33 21.9 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.506 -177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.68 0.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.191 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.93 116.47 10.74 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.724 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.3 m-20 -126.66 -44.6 1.66 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.872 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.8 65.28 0.26 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.33 64.15 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -174.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.4 t 44.03 60.63 11.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 114.58 -0.81 . . . . 0.0 113.008 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 19.6 Cg_endo -91.24 52.28 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.782 1.655 . . . . 0.0 109.337 174.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.67 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.842 0.829 . . . . 0.0 111.423 -174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -131.41 118.91 20.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.034 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.4 p-80 36.1 -172.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.471 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.4 m-85 -140.26 151.07 44.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.754 176.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.96 111.61 23.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.8 t -114.8 124.45 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.324 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.7 141.33 46.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.789 1.306 . . . . 0.0 107.911 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.34 157.7 43.69 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.731 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -132.01 162.87 29.7 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.032 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . . . -113.2 -169.13 1.43 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.22 40.76 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.263 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.81 -59.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.504 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.512 ' CB ' ' HZ3' ' A' ' 48' ' ' LYS . 73.7 m -114.02 147.94 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.197 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.5 pt-20 -107.83 157.53 18.09 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.762 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.469 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.7 m95 31.51 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.185 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HZ3' ' CB ' ' A' ' 45' ' ' SER . 69.3 mmtt -72.57 162.04 76.11 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.111 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.4 Cg_exo -45.13 100.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.837 1.691 . . . . 0.0 110.614 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.34 173.06 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.617 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 tt -138.52 155.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.133 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -114.15 127.41 55.89 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.03 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -73.36 166.46 43.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.562 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.62 165.69 11.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.836 1.691 . . . . 0.0 110.635 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -75.43 79.5 2.48 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.071 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.69 57.96 0.34 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -97.04 170.19 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.546 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -120.32 -3.5 9.98 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.606 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -160.16 164.2 33.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.83 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.2 p -138.76 154.27 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.732 172.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptp -138.2 152.74 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.738 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -144.64 146.35 32.22 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.783 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -141.87 173.29 11.65 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.532 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t 58.65 60.77 2.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.455 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 14.6 mt -98.76 178.58 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.442 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.3 128.52 36.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.147 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.78 151.31 43.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.459 -1.296 . . . . 0.0 109.999 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.86 50.37 11.21 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.687 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.92 151.57 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.024 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -89.73 145.29 25.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 42' ' ' ALA . 1.9 m-85 -132.68 141.52 48.64 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.568 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.6 119.39 29.74 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.54 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -112.59 124.81 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.7 m-85 -112.71 125.49 54.37 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.74 121.99 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.406 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.4 158.26 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -127.5 158.42 37.45 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.634 -1.226 . . . . 0.0 109.235 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -112.86 157.41 21.44 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.289 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.465 HD21 ' HG3' ' A' ' 3' ' ' PRO . 15.3 t-20 -139.42 148.03 42.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.696 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -35.61 -44.06 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.796 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -114.89 41.87 2.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.575 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.51 -155.15 25.95 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.563 -1.303 . . . . 0.0 111.188 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -122.28 167.44 13.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.671 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 2.2 t -123.93 116.97 23.75 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -40.71 162.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.554 1.784 . . . . 0.0 113.284 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.87 136.33 35.36 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.356 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.58 146.28 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.54 130.56 56.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.596 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -116.57 126.81 53.83 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.961 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -124.37 136.68 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.561 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 40.4 p90 -157.33 -178.93 7.72 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.012 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -129.55 146.48 51.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.486 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -79.92 168.97 18.55 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.734 -0.787 . . . . 0.0 108.885 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.93 -169.97 2.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.656 -0.817 . . . . 0.0 110.184 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.89 140.57 39.5 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 116.551 -1.69 . . . . 0.0 110.808 -178.606 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 4.2 Cg_exo -59.86 165.28 10.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.427 2.085 . . . . 0.0 113.269 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -86.29 169.77 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.559 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.41 139.02 63.51 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.746 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -69.58 169.04 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.561 1.507 . . . . 0.0 110.411 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HB2' HE22 ' A' ' 26' ' ' GLN . 1.1 tmmt? -96.12 138.44 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.3 107.18 17.98 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.789 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.71 140.8 29.42 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.455 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.52 119.56 6.3 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.89 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -120.31 117.54 28.07 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.475 ' CE ' HD13 ' A' ' 19' ' ' ILE . 55.4 tpp -100.44 132.33 45.88 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.156 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.08 149.01 20.52 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.456 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -65.38 13.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.08 -0.56 . . . . 0.0 112.047 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.91 -25.21 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.448 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.08 -48.8 0.91 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.575 -1.298 . . . . 0.0 111.388 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -128.44 0.08 5.63 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.104 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.415 ' HG ' ' CB ' ' A' ' 15' ' ' ASP . 32.9 m -67.84 117.98 10.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.339 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.512 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.03 128.71 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.307 -172.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -114.26 127.3 55.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 123.981 0.801 . . . . 0.0 108.926 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 53.9 t -107.95 117.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -90.9 124.55 35.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.899 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -98.51 96.89 8.29 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.91 106.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.612 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -77.06 151.43 35.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.443 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.8 pt20 -148.06 -63.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.296 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.21 93.51 3.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.344 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.08 -34.51 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.054 0.846 . . . . 0.0 109.944 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.48 55.16 0.33 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.62 46.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -175.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.571 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 66.2 m 41.95 61.9 7.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.5 Cg_endo -86.7 46.6 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.715 1.61 . . . . 0.0 108.503 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.7 mm -82.58 152.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.468 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 35' ' ' HIS . 49.9 mtt180 -129.6 114.26 15.83 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.544 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.499 ' H ' ' H ' ' A' ' 56' ' ' GLY . 9.1 p-80 35.46 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.518 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.0 m-85 -142.2 151.74 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.744 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.78 109.56 21.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.31 123.32 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.341 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.84 140.37 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.613 1.196 . . . . 0.0 108.028 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.36 154.06 41.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.971 -1.492 . . . . 0.0 112.492 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.2 ptm180 -131.52 165.0 24.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.916 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -121.48 174.64 6.64 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.153 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -79.45 42.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.045 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.52 -59.02 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.288 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.8 m -124.7 152.99 43.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.056 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -101.98 162.68 12.72 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.808 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 25.16 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.575 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HZ3' ' HH ' ' A' ' 71' ' ' TYR . 50.5 mttp -74.91 163.37 68.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.843 175.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.95 99.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.916 1.744 . . . . 0.0 110.917 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.55 175.97 3.17 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.352 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.74 154.99 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.207 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -116.68 129.79 56.35 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.842 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -75.25 163.49 67.48 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.09 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.79 144.34 48.27 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.775 1.65 . . . . 0.0 109.677 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -51.95 110.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.935 0.772 . . . . 0.0 111.842 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 94.33 58.99 1.18 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.865 -1.16 . . . . 0.0 110.581 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -97.19 -177.27 3.79 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.135 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -134.4 -33.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.918 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -143.96 163.17 34.22 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.811 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -131.3 152.05 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.279 173.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.418 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -137.73 156.03 48.44 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.086 -176.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -144.22 140.98 29.61 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.121 174.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -140.61 158.62 43.72 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.276 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t 72.01 51.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.443 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 65' ' ' LEU . 3.7 mm? -100.6 -176.8 3.3 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.626 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.47 131.17 40.81 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -73.3 155.77 39.12 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.985 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 48.37 45.68 20.47 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.55 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.01 152.9 49.82 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.357 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -95.22 148.7 22.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.8 m-85 -133.44 143.8 49.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.706 -178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.63 119.64 34.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.521 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.72 124.28 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.8 m-85 -111.75 125.33 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.14 120.53 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.909 0.756 . . . . 0.0 110.595 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.37 155.68 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.01 154.67 40.88 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.335 -1.346 . . . . 0.0 109.513 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.08 161.02 16.33 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.33 -1.348 . . . . 0.0 107.652 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.509 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.1 t-20 -148.84 153.36 37.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.125 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -39.5 -39.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.61 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.7 -44.89 19.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.59 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.77 -127.1 0.89 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.676 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -124.41 159.07 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.07 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.0 t -124.44 124.39 42.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.37 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -41.49 163.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 125.629 1.831 . . . . 0.0 113.304 -175.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.83 141.05 30.74 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.65 -174.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.89 144.88 30.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 171.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -114.58 129.15 56.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.114 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.59 127.99 54.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.163 -1.381 . . . . 0.0 108.141 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 HG23 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.67 136.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.149 -177.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.9 p90 -153.58 177.22 11.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.98 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.31 144.06 51.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.814 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.2 p -82.8 163.48 21.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -174.14 4.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.142 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 149.81 21.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.205 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.546 -178.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.6 Cg_exo -58.86 171.37 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 113.299 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 m -98.53 166.59 11.28 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.61 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 141.91 83.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.122 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.84 171.39 15.74 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.596 1.53 . . . . 0.0 110.6 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' N ' ' NE2' ' A' ' 26' ' ' GLN . 30.2 mtmt -97.82 140.03 32.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -109.61 110.86 22.04 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.202 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.8 142.69 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.44 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.94 136.79 11.51 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 118.912 -1.613 . . . . 0.0 113.468 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.01 136.46 52.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.397 -0.902 . . . . 0.0 109.185 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.2 ttm -108.1 130.96 55.07 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.462 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.59 152.16 27.32 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.14 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.89 12.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.248 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.95 -23.9 41.35 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.57 175.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.24 -39.28 2.96 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.755 -1.212 . . . . 0.0 111.315 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.55 9.49 3.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.468 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 m -78.92 113.47 17.05 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.776 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.9 mm -114.92 126.94 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -172.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -113.94 123.61 50.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.087 0.867 . . . . 0.0 108.885 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.8 t -111.25 122.58 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -98.04 132.27 43.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.634 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -100.46 101.8 12.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 124.091 0.869 . . . . 0.0 108.805 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.7 mm -87.11 105.43 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.666 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HZ2' ' HG ' ' A' ' 31' ' ' SER . 24.1 mtmt -74.77 149.79 39.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' NE2' ' N ' ' A' ' 7' ' ' LYS . 2.8 pt20 -147.36 -56.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.19 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.2 100.75 5.51 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.557 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.5 m-20 -129.73 -36.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.087 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.81 53.45 0.37 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 21.35 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.582 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.1 t 41.6 62.65 7.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 114.784 -0.708 . . . . 0.0 112.823 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 31' ' ' SER . 7.4 Cg_endo -86.02 43.46 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.603 1.535 . . . . 0.0 108.392 171.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.24 150.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.581 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.8 mtt180 -129.71 116.0 18.15 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.634 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.69 -172.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.498 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.7 m-85 -139.5 148.88 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.671 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.77 110.08 22.28 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -111.98 126.33 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.651 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.85 140.75 47.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 125.056 1.472 . . . . 0.0 107.767 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 151.86 35.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.592 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.8 ptt180 -125.62 162.31 25.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.247 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -125.45 174.44 8.19 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.391 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.05 43.92 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.993 171.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -150.41 -61.65 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.5 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -129.28 163.0 26.61 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.562 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 21.2 mt-10 -109.73 156.78 19.85 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.945 -1.102 . . . . 0.0 113.197 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.432 ' CE3' ' HB3' ' A' ' 41' ' ' ARG . 3.6 m95 34.72 79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.795 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 73.7 mmtt -62.53 160.74 31.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.193 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.71 101.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.884 1.722 . . . . 0.0 111.06 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -49.13 158.58 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.957 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.3 147.22 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.196 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -114.75 123.91 50.44 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -70.34 165.42 44.59 Favored Pre-proline 0 N--CA 1.488 1.462 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.237 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.98 164.55 9.88 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.823 1.682 . . . . 0.0 110.451 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -73.65 79.88 1.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.67 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.63 60.67 0.43 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -96.98 -174.69 3.04 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.856 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.66 -12.05 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.512 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -154.16 163.64 39.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.275 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -136.92 151.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.946 173.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.5 ptp -135.22 148.06 49.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.106 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.52 143.24 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.354 173.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -141.63 173.04 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.716 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 t 59.43 57.21 3.42 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.433 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 15.0 mt -94.35 179.95 5.12 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.62 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.471 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 13.1 t70 -78.11 135.28 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.037 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.419 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 75.6 m95 -76.17 152.33 36.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.593 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.21 49.29 15.45 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.521 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 153.71 47.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.33 147.75 22.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.213 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 65' ' ' LEU . 15.6 m-85 -133.94 137.29 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 123.947 0.779 . . . . 0.0 111.865 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -118.5 115.82 25.38 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.908 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.15 122.97 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.494 ' HH ' ' CE1' ' A' ' 88' ' ' HIS . 39.2 m-85 -112.53 124.74 53.19 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.38 121.22 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.666 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.12 157.27 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 118.422 -1.311 . . . . 0.0 109.686 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.57 160.28 17.34 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.49 -1.284 . . . . 0.0 107.795 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -145.79 151.47 37.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.852 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -36.77 -43.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.649 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -109.1 37.41 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.79 -152.45 22.16 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.771 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -129.04 163.71 24.81 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.734 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -126.18 125.93 43.26 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.964 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -43.27 167.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.707 1.879 . . . . 0.0 113.378 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB2' HG23 ' A' ' 76' ' ' VAL . . . -88.85 141.03 28.84 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.793 -173.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.68 147.13 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.494 ' CE1' ' HH ' ' A' ' 74' ' ' TYR . 11.0 t-160 -116.71 130.3 56.65 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.544 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 81.3 t80 -117.95 127.64 54.04 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.239 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.405 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -123.87 134.39 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.611 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.0 p90 -156.29 176.78 12.24 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.263 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.74 147.39 49.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.511 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -79.9 168.49 19.18 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.92 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.11 -170.91 3.12 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.223 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.78 141.41 36.55 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.017 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.531 -178.643 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -58.76 170.91 2.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.518 2.146 . . . . 0.0 112.797 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 t -93.63 171.04 9.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.64 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.29 141.3 73.63 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.685 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.16 168.16 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 121.47 1.446 . . . . 0.0 110.904 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -101.63 130.81 48.05 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 mt -104.71 111.52 24.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.118 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -95.45 142.79 27.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -113.71 133.17 11.04 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.23 -1.462 . . . . 0.0 112.978 -170.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -127.75 129.3 46.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.6 ttm -107.66 134.08 51.16 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.699 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.33 153.73 24.58 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.779 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.56 10.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.985 -0.607 . . . . 0.0 112.292 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.92 -22.39 42.78 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.866 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.14 -37.47 3.54 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.559 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.5 p30 -137.48 46.82 2.11 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -120.58 114.93 22.46 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.537 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -118.56 128.34 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.501 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HZ2' ' CD2' ' A' ' 59' ' ' HIS . 38.1 tttm -113.6 125.34 54.06 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.1 t -109.86 118.5 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -98.73 128.5 45.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.48 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.7 mt -100.38 105.18 16.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mm -94.65 128.58 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.876 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -103.54 147.64 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.311 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.42 -54.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.197 -174.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 18.9 m-20 -132.82 107.34 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.627 -175.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.6 m-20 -131.98 -35.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.035 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.91 52.22 0.35 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.19 20.96 34.05 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.596 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 67.1 m 41.92 61.34 8.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.5 Cg_endo -87.74 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.631 1.554 . . . . 0.0 108.787 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.81 151.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.449 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.0 mtt180 -130.67 115.1 16.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.69 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.476 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.8 p-80 37.43 -171.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.528 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -141.17 151.49 43.89 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.021 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.19 108.81 20.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -114.42 122.37 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.95 -172.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.64 142.23 46.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 124.536 1.147 . . . . 0.0 108.222 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.82 153.3 40.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.994 -1.482 . . . . 0.0 112.575 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.3 ptm180 -129.0 164.53 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.563 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.56 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -118.25 -169.17 1.65 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.314 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.32 41.27 1.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.403 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.93 -59.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.719 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -121.97 156.54 33.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.544 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -105.48 157.26 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.839 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 32.83 88.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.495 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -71.84 166.01 44.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.002 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.4 Cg_exo -46.38 96.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.816 1.677 . . . . 0.0 110.578 177.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.73 174.97 4.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.244 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.83 155.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.642 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -115.83 127.94 55.44 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.034 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -74.57 164.71 59.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.091 -177.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -71.21 143.89 45.1 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.747 1.631 . . . . 0.0 109.461 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.5 m -56.69 105.33 0.2 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.931 0.769 . . . . 0.0 111.906 -176.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.476 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 107.22 52.15 0.74 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -97.15 169.24 9.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.844 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.18 -32.25 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.391 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CD2' ' HZ2' ' A' ' 20' ' ' LYS . 24.9 p-80 -148.05 167.3 25.3 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.523 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.4 p -134.22 153.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.865 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 ptp -136.54 152.69 50.78 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.513 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -137.59 141.7 41.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.728 172.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 64' ' ' SER . 10.0 ttpp -144.51 135.39 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.891 -173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 91.49 46.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.332 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.0 mm? -93.62 -178.98 4.87 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.829 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.464 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 30.1 t70 -75.73 135.46 40.34 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.401 -173.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.59 156.4 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.297 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.48 48.77 10.87 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.888 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.12 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.086 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.44 146.18 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.954 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 11.8 m-85 -131.04 140.48 50.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.31 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.86 117.29 28.45 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.195 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.05 121.89 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 37.7 m-85 -110.81 123.73 50.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.5 t -120.21 121.07 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.946 0.778 . . . . 0.0 110.349 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 86' ' ' ALA . 2.1 t -106.37 158.34 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.63 156.21 42.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.606 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -111.69 160.68 17.04 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.463 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.2 t-20 -145.37 151.15 37.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.839 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -36.42 -43.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.719 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -110.5 38.03 2.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.17 -153.53 23.44 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.839 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -128.09 163.36 24.78 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.765 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.6 t -126.54 125.19 41.61 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.037 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -43.14 167.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 125.582 1.801 . . . . 0.0 113.513 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -88.76 141.27 28.64 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.679 -174.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.83 147.0 28.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.447 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.04 129.35 56.32 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.609 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.6 t80 -117.25 127.83 54.48 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.239 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.447 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -125.43 139.12 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.921 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 42.2 p90 -157.91 178.31 10.37 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.733 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -129.12 146.56 51.04 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.957 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.2 p -79.94 171.58 14.92 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.419 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -84.36 -176.04 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.092 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.85 147.99 24.92 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.08 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.436 -1.745 . . . . 0.0 110.568 -178.529 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 37.6 Cg_endo -73.01 179.46 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.919 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -98.34 159.42 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.182 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.87 147.95 92.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.617 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.59 169.47 15.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.296 1.331 . . . . 0.0 110.626 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -104.06 134.6 47.05 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.99 110.86 21.92 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.405 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.34 148.22 22.3 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.487 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -115.49 128.91 8.27 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.959 -172.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.77 128.1 50.03 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.513 ' CE ' HD12 ' A' ' 19' ' ' ILE . 52.8 tpp -103.62 128.99 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.21 151.14 25.45 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.256 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.87 8.92 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -80.0 -21.13 43.97 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.246 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.9 -35.19 5.19 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.573 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 6.1 p30 -133.12 0.47 3.43 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.17 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -72.97 113.83 10.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.227 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.518 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.3 mm -114.97 126.17 72.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.831 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.69 125.36 54.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.928 0.767 . . . . 0.0 109.227 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.4 t -109.43 122.3 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.73 129.04 41.8 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.324 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.06 98.52 9.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.96 133.43 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.648 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HZ3' ' HG ' ' A' ' 31' ' ' SER . 40.9 mtmt -92.32 171.38 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.865 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -64.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.757 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.99 91.23 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.2 m-20 -128.43 -16.11 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.061 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.65 49.82 2.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.52 47.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.558 ' HG ' ' HZ3' ' A' ' 25' ' ' LYS . 42.6 t 44.2 68.04 3.45 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.379 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -89.49 43.91 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.764 1.642 . . . . 0.0 107.956 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.27 146.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.853 -171.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 89.8 mtt-85 -126.04 123.78 39.18 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.464 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.4 p-80 37.16 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -138.08 156.07 48.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.026 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.52 110.82 22.02 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 60' ' ' VAL . 49.0 t -114.35 123.56 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.024 -1.07 . . . . 0.0 109.94 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -136.01 139.22 42.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.682 1.239 . . . . 0.0 107.927 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.06 155.2 43.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.933 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.0 ptt85 -130.63 164.34 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.016 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -124.88 169.85 11.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.683 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.68 43.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.9 -56.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.041 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.5 m -130.54 157.18 43.4 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.197 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -101.65 165.25 11.32 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.82 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.462 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.8 m95 21.9 91.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.047 -1.433 . . . . 0.0 114.019 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.0 mptm? -74.45 165.23 55.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.109 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.3 Cg_exo -45.13 99.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.856 1.704 . . . . 0.0 110.716 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 175.24 3.5 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.451 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.1 tt -140.18 154.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -115.29 136.42 53.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.0 mt -87.99 164.64 32.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.32 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.3 Cg_exo -62.24 165.68 14.42 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.812 1.674 . . . . 0.0 110.389 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -74.93 80.89 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.13 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.04 58.2 0.26 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.721 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -97.06 167.16 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.375 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.24 -8.94 12.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.651 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -160.09 165.23 32.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.053 -1.459 . . . . 0.0 112.943 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.548 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.6 p -137.72 153.52 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.978 172.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 ptp -136.53 151.02 48.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.341 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.46 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.84 146.14 35.49 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.366 173.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -141.52 -177.25 5.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.416 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.4 t 55.19 51.87 12.54 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.449 ' H ' ' HB2' ' A' ' 17' ' ' ASN . 31.6 mt -85.49 165.68 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.812 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -78.31 8.19 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.412 -171.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 60.52 162.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.167 0.508 . . . . 0.0 111.861 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 36.23 43.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.03 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.77 156.16 48.88 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.061 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -98.23 147.86 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.144 0.903 . . . . 0.0 108.629 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 91' ' ' PHE . 33.2 m-85 -131.95 142.92 49.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.972 0.795 . . . . 0.0 111.783 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -118.55 118.15 30.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.646 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -110.52 122.75 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 54.2 m-85 -111.45 125.88 54.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.1 t -121.0 122.29 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.626 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -109.35 155.51 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.15 159.2 35.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.955 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -109.37 149.77 29.02 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.469 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.517 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -130.88 143.96 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.267 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -43.39 -37.17 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.81 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -117.07 46.26 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.793 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -153.72 22.62 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.371 174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -125.17 160.59 28.8 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.882 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.8 t -113.13 109.64 19.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -39.25 158.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 125.497 1.748 . . . . 0.0 112.698 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.56 127.88 33.23 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.828 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.76 145.21 26.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.53 129.26 56.65 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.608 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.5 t80 -115.84 127.22 54.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.37 134.55 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.358 -175.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 39.7 p90 -155.74 174.75 14.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.473 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.52 148.46 48.88 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.803 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -79.88 172.58 13.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 m -87.14 -172.94 4.19 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.727 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.23 144.21 27.26 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.283 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.566 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.9 Cg_exo -60.3 168.08 6.86 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.551 2.167 . . . . 0.0 113.046 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.82 158.46 18.74 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.828 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.06 146.2 92.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.173 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.32 167.93 19.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.458 1.439 . . . . 0.0 110.749 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -103.59 128.75 50.81 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.6 114.34 28.5 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.494 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -103.18 140.74 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 89' ' ' PHE . . . -123.31 140.8 13.27 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.724 -170.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -131.39 143.3 50.37 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.2 -1.0 . . . . 0.0 109.645 170.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.661 -0.816 . . . . 0.0 108.969 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -81.89 153.8 33.15 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.808 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.27 8.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.374 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 13' ' ' GLY . 17.5 m-20 -79.92 -25.16 40.62 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.533 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.1 -37.03 4.03 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.727 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.44 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 13.4 m-20 -123.08 -12.0 7.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.9 m -65.73 112.04 3.51 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.638 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.521 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.8 mm -112.21 126.7 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -114.7 121.35 43.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 124.044 0.84 . . . . 0.0 108.865 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.5 t -109.98 118.02 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -95.44 133.78 39.02 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.341 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 52.0 mt -102.58 101.12 11.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 124.049 0.843 . . . . 0.0 108.885 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.51 134.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.025 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -101.52 148.61 25.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.006 0.816 . . . . 0.0 109.333 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.448 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.66 -72.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.81 -175.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 29.9 m-20 -130.34 107.29 9.15 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.931 -176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.0 m-20 -126.44 -35.73 2.35 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.655 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.43 54.6 0.26 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.412 ' C ' ' HD3' ' A' ' 32' ' ' PRO . . . 89.06 28.63 20.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 77.8 p 32.21 63.37 1.26 Allowed Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -87.39 46.31 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.758 1.638 . . . . 0.0 108.755 173.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.08 149.87 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.462 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' HIS . 62.1 mtt85 -130.45 117.59 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.13 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.8 p-80 36.1 -175.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.483 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.1 m-85 -137.55 142.84 41.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.944 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.28 105.7 17.74 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.81 125.57 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.088 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -131.8 134.02 45.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 125.0 1.438 . . . . 0.0 107.681 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.59 158.63 43.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 117.711 -1.595 . . . . 0.0 112.185 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 22.5 ptt85 -142.71 168.37 19.89 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.458 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.577 ' C ' ' H ' ' A' ' 44' ' ' ALA . . . -131.43 171.63 13.15 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.38 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -71.06 26.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.153 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -131.22 -59.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -124.82 154.91 40.27 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -108.98 166.74 10.6 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.314 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.432 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 22.67 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.188 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 79.8 mttt -69.81 165.67 39.66 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.085 173.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 14.0 Cg_exo -48.81 107.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.867 1.711 . . . . 0.0 110.711 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.81 159.59 2.22 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.86 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -130.09 147.82 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.018 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -114.77 113.33 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.334 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -58.55 167.44 1.78 Allowed Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.604 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.62 171.37 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.736 1.624 . . . . 0.0 110.502 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.3 m -76.29 77.29 3.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.736 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 70.1 0.68 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -93.31 -171.94 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.187 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.89 -20.22 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.006 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.415 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 20.4 p-80 -160.0 173.46 15.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.025 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.549 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -135.23 150.8 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 124.856 1.347 . . . . 0.0 108.416 173.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptp -134.12 147.59 50.85 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.002 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -142.13 147.35 36.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.885 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -141.09 175.44 9.63 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.942 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t 49.36 66.94 0.97 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.226 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 12.3 mt -100.0 -174.69 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.075 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.0 126.42 29.63 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.761 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -76.38 151.4 36.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.177 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 47.04 49.06 15.26 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.032 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . . . -127.45 150.72 49.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.45 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -91.8 140.64 29.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -129.9 143.38 50.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.002 0.814 . . . . 0.0 112.431 -173.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.46 125.18 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.804 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.88 125.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 49.1 m-85 -114.49 127.66 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.54 119.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.59 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.408 HG21 ' HB1' ' A' ' 86' ' ' ALA . 2.3 t -104.34 156.98 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.42 155.4 43.73 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.185 -1.406 . . . . 0.0 109.862 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -111.25 157.93 19.56 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.869 175.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.6 t-20 -145.43 152.87 40.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.09 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -33.61 -45.82 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.908 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -109.85 37.68 2.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.56 -153.52 22.09 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.227 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -120.25 158.76 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.835 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -121.79 124.76 44.93 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.29 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -40.85 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 125.75 1.906 . . . . 0.0 113.505 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 76' ' ' VAL . . . -85.83 137.93 32.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.223 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.81 145.94 28.48 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.476 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.6 t-160 -117.03 131.85 56.84 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.648 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 76.9 t80 -121.5 134.39 55.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.236 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -131.07 142.8 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.818 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 19' ' ' ILE . 49.0 p90 -158.97 -178.78 7.49 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.282 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -129.32 144.41 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.661 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -79.82 169.38 18.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -85.75 -168.11 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.076 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.13 140.55 37.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.433 -178.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.2 Cg_endo -62.8 176.79 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.476 2.117 . . . . 0.0 112.767 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -96.81 162.1 13.57 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.906 173.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 145.63 99.02 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.316 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.11 170.27 12.12 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.391 1.394 . . . . 0.0 111.177 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -104.59 132.92 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.09 111.84 23.68 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.254 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.92 145.19 24.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.95 130.3 9.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.332 -1.413 . . . . 0.0 112.868 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.41 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.5 mt-30 -123.09 125.82 45.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 170.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 ttm -107.13 128.93 54.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.468 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.04 150.55 24.02 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.811 -1.185 . . . . 0.0 111.472 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.46 13.97 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.833 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 13' ' ' GLY . 13.5 m-20 -79.96 -23.14 41.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.669 174.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.51 -39.63 2.83 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.397 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.6 12.78 4.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.94 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -80.0 109.89 14.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.532 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.2 mm -115.14 126.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.272 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -113.28 126.5 55.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 123.943 0.777 . . . . 0.0 109.058 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 55.7 t -108.74 115.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.41 ' ND2' HE21 ' A' ' 11' ' ' GLN . 3.5 m-80 -95.96 128.58 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.459 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.52 107.62 19.84 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.772 -172.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.1 mm -100.71 135.22 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.458 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -101.71 152.1 21.24 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.652 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.95 -50.41 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.129 -176.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 12.7 m-20 -141.15 106.78 5.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.9 m-20 -132.06 -34.26 1.28 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.234 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.63 53.85 0.37 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.05 21.01 34.3 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.568 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 39.52 64.15 4.28 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 114.927 -0.637 . . . . 0.0 112.64 -176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.6 Cg_endo -86.28 44.41 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.621 1.547 . . . . 0.0 108.556 172.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -86.66 148.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.468 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 47.1 mtt180 -129.68 120.09 24.59 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.616 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 36.89 -174.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.1 m-85 -139.2 151.65 46.72 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.036 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.21 109.73 21.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.7 t -114.39 123.12 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.055 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -134.48 140.92 46.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.552 1.158 . . . . 0.0 107.922 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HH ' ' HZ2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -146.04 156.15 43.28 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.694 -1.602 . . . . 0.0 112.378 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -125.89 160.49 29.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.49 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -108.55 -169.63 1.53 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.19 39.91 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.116 171.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.45 -59.41 0.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.2 m -118.41 148.6 42.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.009 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.0 pt-20 -107.05 151.62 25.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.816 -1.153 . . . . 0.0 112.181 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 42.0 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.41 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HZ3' ' HH ' ' A' ' 71' ' ' TYR . 71.3 mttt -73.54 165.17 55.38 Favored Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.483 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.89 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.767 1.645 . . . . 0.0 110.479 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.12 174.38 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.675 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -137.76 154.23 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.043 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.74 128.69 56.05 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.093 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.17 165.13 56.39 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.149 -177.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.75 166.58 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.858 1.705 . . . . 0.0 110.237 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.3 m -76.27 79.67 3.05 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.874 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.69 60.75 0.41 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -97.08 -175.61 3.3 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.769 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -117.82 -39.89 3.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.571 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -148.22 168.44 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.21 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -128.07 152.09 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.289 174.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptp -136.44 154.11 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.528 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.7 OUTLIER -137.9 142.79 40.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.552 173.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -131.6 165.72 23.02 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.455 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m 53.58 62.56 2.58 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.189 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 19.3 mt -92.36 178.19 5.91 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.029 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -73.59 128.98 37.0 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.188 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.51 150.1 45.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.584 -1.246 . . . . 0.0 109.883 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 48.61 49.15 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.478 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.55 153.1 48.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.963 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -94.04 147.96 22.63 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.009 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' HH ' ' HZ3' ' A' ' 48' ' ' LYS . 10.9 m-85 -132.67 140.88 48.34 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.419 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.95 116.24 24.73 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.024 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.53 123.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 40.5 m-85 -112.18 125.56 54.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.29 121.84 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 124.035 0.834 . . . . 0.0 110.188 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.7 158.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -129.69 160.98 31.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.333 -1.347 . . . . 0.0 109.106 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -112.22 157.46 20.87 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.091 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -139.92 147.99 41.36 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.105 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -36.83 -43.39 0.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.41 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -114.41 42.73 2.04 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.669 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.9 -154.25 24.27 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.192 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -121.33 161.34 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.961 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t -116.0 115.45 26.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -40.44 160.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 125.512 1.757 . . . . 0.0 112.661 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.65 138.35 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.532 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.21 146.27 29.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.463 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.2 t-160 -116.97 130.86 56.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.465 -173.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -118.49 128.44 54.59 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.116 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.39 138.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.818 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.48 -179.78 8.22 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.973 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.08 147.48 50.94 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.768 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -80.02 170.06 16.99 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.784 -0.767 . . . . 0.0 109.292 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.7 m -81.41 -175.98 5.77 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.154 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.42 147.38 26.41 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.123 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.521 -1.704 . . . . 0.0 110.692 -178.203 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.0 Cg_endo -64.24 174.29 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.548 2.165 . . . . 0.0 112.603 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -87.92 145.59 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.286 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.77 78.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.571 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.41 165.74 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.218 1.279 . . . . 0.0 110.569 -176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -103.42 133.29 48.72 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.3 112.24 25.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.959 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -93.4 141.89 27.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.29 131.28 10.55 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.341 -1.409 . . . . 0.0 112.587 -171.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -128.85 126.97 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 ttm -106.2 132.69 51.96 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.77 152.42 23.95 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.571 -176.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.99 12.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.311 -0.556 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.95 -24.26 41.12 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.645 175.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.06 -40.77 2.43 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.434 177.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -132.15 10.06 4.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.076 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -81.78 116.25 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.953 176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.513 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.3 mm -116.97 128.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.324 -172.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -113.47 126.3 55.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.988 0.805 . . . . 0.0 108.982 173.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -108.78 113.27 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -95.05 129.83 41.98 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.401 -176.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -98.71 106.45 18.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.715 -173.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.3 mm -97.66 131.76 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.994 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -107.49 156.26 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.366 -177.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.32 -65.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.516 -174.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -135.23 128.4 31.86 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.325 177.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -133.53 -36.27 0.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 123.901 0.751 . . . . 0.0 109.899 177.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.63 54.22 0.3 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.44 18.86 37.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -175.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.594 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 42.56 61.27 9.25 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 114.907 -0.646 . . . . 0.0 112.648 -176.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.0 Cg_endo -88.46 37.99 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.558 1.506 . . . . 0.0 109.583 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -77.54 150.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.901 0.858 . . . . 0.0 111.78 -172.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 9.0 mmt180 -127.85 113.32 15.77 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.367 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.2 p-80 36.2 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 174.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.0 m-85 -137.98 152.3 48.78 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.115 177.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -108.56 110.72 22.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.45 124.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.289 -174.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -135.52 140.15 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.62 1.2 . . . . 0.0 108.291 177.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.78 155.98 44.34 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.202 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.3 ptm180 -129.56 164.67 23.32 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.988 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -113.83 -177.95 3.26 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 tp -87.03 41.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.111 173.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.11 -60.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.522 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 p -119.11 151.3 38.53 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.439 177.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.8 pt-20 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.858 -173.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 42.29 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.35 175.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -69.83 168.3 18.55 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.695 173.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -52.26 95.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.656 1.57 . . . . 0.0 109.819 174.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.65 172.61 2.05 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.486 -173.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.11 154.63 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.392 -177.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -114.74 129.24 56.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.09 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -76.1 165.93 49.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.133 -177.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.45 168.24 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.787 1.658 . . . . 0.0 110.211 172.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.4 t -77.87 78.97 4.35 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.566 -177.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.0 60.72 0.34 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -97.18 -174.51 2.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.688 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -119.5 -40.52 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.707 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -148.06 169.12 20.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.11 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.0 p -127.46 152.48 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.422 173.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.8 ptp -136.25 150.42 48.95 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.599 -1.241 . . . . 0.0 112.908 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.492 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -140.47 139.21 35.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.097 172.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -140.39 162.76 34.54 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.606 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t 66.93 50.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.605 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.9 mm? -96.43 -174.52 3.07 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.665 176.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -83.3 142.6 30.97 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.095 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.403 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 74.3 m95 -77.75 155.17 31.37 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.366 -178.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.35 48.66 10.49 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.604 -176.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.09 47.33 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.837 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -97.94 149.92 21.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.532 177.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.547 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 31.6 m-85 -135.47 145.27 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.423 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -121.08 118.56 30.08 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.347 -1.751 . . . . 0.0 108.328 177.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.68 124.55 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 45.0 m-85 -112.69 126.18 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -121.29 122.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.13 158.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 156.54 41.41 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.261 176.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -111.97 159.77 18.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.585 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.417 HD22 ' HG2' ' A' ' 32' ' ' PRO . 19.0 t-20 -144.88 148.94 34.5 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.985 178.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -37.91 -42.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.481 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -112.32 42.12 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.465 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.45 -153.97 22.76 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.46 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -125.35 162.52 24.59 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.877 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 117.13 27.39 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -40.96 163.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 125.482 1.739 . . . . 0.0 113.206 -174.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.15 134.72 34.98 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.126 -176.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.87 145.58 29.58 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.465 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.2 t-160 -115.25 131.06 57.05 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.627 -173.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -118.13 127.27 53.61 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.008 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -125.32 139.31 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.64 -176.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 38.5 p90 -159.17 176.98 11.55 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.24 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -127.63 147.9 50.37 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.756 175.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.3 p -79.84 170.83 15.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.248 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.57 -170.81 3.24 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.143 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.19 141.88 36.81 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.156 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.54 -1.695 . . . . 0.0 110.741 -179.193 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -60.99 173.83 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.493 2.129 . . . . 0.0 112.917 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -95.39 155.51 16.71 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.036 174.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.26 143.09 97.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.075 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.65 165.9 23.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.343 1.362 . . . . 0.0 110.75 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.61 132.53 48.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.6 mt -104.72 113.78 27.58 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.224 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.02 138.78 31.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.441 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.75 124.56 7.91 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.492 -1.337 . . . . 0.0 112.469 -172.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.81 120.88 35.85 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.4 ttm -106.39 131.69 53.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.73 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.73 149.27 23.26 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.689 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.84 11.63 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.074 -0.563 . . . . 0.0 112.255 -177.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.5 m-20 -79.93 -22.36 42.8 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.876 176.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.8 -37.8 3.61 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.957 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.0 p-10 -140.27 47.52 1.79 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m -120.57 114.33 21.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.519 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.9 mm -117.41 128.54 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.633 -170.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -114.94 126.6 54.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.562 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.9 t -109.01 111.5 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -94.33 130.9 40.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.623 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' CD1' ' CD2' ' A' ' 36' ' ' TYR . 19.6 mt -100.05 108.51 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.949 -172.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.79 127.12 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -104.06 156.16 18.09 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.471 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 -53.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.146 -172.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.15 118.91 16.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.294 -178.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.27 -41.43 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 177.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.13 54.54 0.25 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -177.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.53 42.88 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 14.4 t 42.3 60.38 9.59 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -88.65 46.87 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.658 1.572 . . . . 0.0 108.962 173.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.67 152.32 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.602 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 35' ' ' HIS . 11.0 mtt180 -130.37 119.9 23.47 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.331 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.544 ' H ' ' HA ' ' A' ' 55' ' ' SER . 7.2 p-80 31.87 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.129 -1.851 . . . . 0.0 115.988 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.447 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 81.9 m-85 -137.47 153.1 50.13 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.9 175.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.402 HD13 ' HB ' ' A' ' 76' ' ' VAL . 4.9 mt -110.82 112.2 23.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.86 128.16 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.215 -174.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.3 139.4 46.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.905 1.378 . . . . 0.0 108.104 175.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.438 ' CD2' HD23 ' A' ' 62' ' ' LEU . 1.9 p90 -147.38 154.57 41.04 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.581 177.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -133.39 160.81 36.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.47 -172.75 2.12 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -93.43 39.34 1.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.585 171.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.66 -60.67 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.348 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.5 m -118.94 141.12 48.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.8 pt-20 -105.02 171.93 7.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.093 -171.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 7.4 m95 18.28 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.591 -1.641 . . . . 0.0 114.123 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 42' ' ' ALA . 9.4 mptt -67.57 164.34 39.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.689 174.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -47.17 104.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.844 1.696 . . . . 0.0 110.881 177.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 156.66 0.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.261 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 tt -131.12 146.92 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.359 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -115.21 132.14 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.4 mt -82.69 164.69 45.84 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.875 -177.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.25 155.58 68.84 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.599 1.533 . . . . 0.0 109.454 172.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.544 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.5 t -73.36 103.1 3.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.373 -177.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.25 0.74 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.07 172.84 7.58 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.155 -175.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.3 -43.7 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.565 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.5 p-80 -148.86 168.4 23.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.614 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.562 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -123.15 150.74 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.035 174.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -135.92 149.19 48.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.506 -1.277 . . . . 0.0 112.833 -175.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -138.65 135.31 34.73 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.68 173.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' SER . 84.1 mttt -142.9 142.11 31.66 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.778 -178.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.9 m 91.07 43.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.892 176.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.9 mm? -95.37 -176.47 3.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.369 -177.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.0 m-20 -71.43 130.95 42.6 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.877 -172.078 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.6 155.99 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 43.3 48.42 5.8 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.792 -177.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.9 151.88 49.98 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.802 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.86 149.54 21.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.642 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 7.6 m-85 -133.74 140.92 47.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.657 -177.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.17 119.72 34.1 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.518 -1.673 . . . . 0.0 108.234 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.62 125.41 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m-85 -113.52 125.39 54.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.2 123.75 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.893 0.746 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -108.72 158.01 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.72 157.02 41.46 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.413 -1.315 . . . . 0.0 109.547 178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -112.15 161.88 16.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.731 -1.188 . . . . 0.0 108.009 175.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.9 t-20 -143.78 149.8 37.6 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.546 177.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -41.21 -39.47 1.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.172 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -113.05 39.06 2.64 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.92 -150.88 22.39 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.681 175.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -134.31 168.52 18.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.227 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 t -127.97 123.06 33.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.215 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.15 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 125.557 1.786 . . . . 0.0 113.253 -174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.423 ' HB2' HG21 ' A' ' 76' ' ' VAL . . . -87.02 138.84 31.15 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.63 -174.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.79 145.8 29.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.453 ' CE1' HG23 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.04 130.72 57.0 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.6 -173.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -118.5 129.26 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.017 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.453 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.7 140.64 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.936 -176.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.2 p90 -158.84 -178.65 7.41 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.739 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -130.85 146.76 52.38 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.91 175.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -79.88 171.5 15.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.332 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.86 -170.88 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.072 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.07 140.85 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.052 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.459 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 10.9 Cg_endo -68.23 174.34 8.22 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.658 2.239 . . . . 0.0 112.427 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -101.54 158.78 15.83 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.925 172.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.31 149.58 68.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.349 -174.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -71.82 172.02 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.589 1.526 . . . . 0.0 110.766 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -106.07 134.1 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.47 112.43 24.82 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.399 -176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 23.1 tt0 -92.48 141.45 28.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.76 121.83 7.29 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.869 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -122.16 121.58 37.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.4 ttm -104.76 134.2 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.701 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.63 150.86 22.01 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.735 -176.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.76 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.085 -0.557 . . . . 0.0 112.294 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 13' ' ' GLY . 15.5 m-20 -79.82 -22.2 43.31 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.017 176.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.97 -50.97 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.541 176.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -128.15 7.62 6.02 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.807 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.5 t -73.11 117.32 14.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.865 176.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.52 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.4 mm -117.04 128.63 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.869 -171.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -113.8 125.85 54.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.008 0.817 . . . . 0.0 108.976 171.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 59.4 t -105.9 110.19 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 11.5 t-20 -88.03 129.06 35.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.95 -175.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -99.69 100.95 11.99 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.265 -175.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -93.05 128.84 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -101.17 147.57 26.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 123.951 0.782 . . . . 0.0 109.672 -176.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.444 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.18 -86.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.937 -175.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -107.59 109.5 21.16 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.659 -174.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.1 m-20 -133.62 -34.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.127 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.92 53.51 0.36 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.72 21.04 35.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -175.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.568 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.0 m 42.85 61.47 9.4 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.745 -176.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 31' ' ' SER . 14.3 Cg_endo -86.54 45.61 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.792 1.662 . . . . 0.0 108.75 173.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.35 148.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.278 -173.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.0 mtt180 -125.35 111.43 15.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.89 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 33.97 -171.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.07 156.23 49.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.83 176.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 76' ' ' VAL . 5.2 mt -112.82 111.45 22.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.82 124.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.447 -174.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -136.75 138.1 40.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.487 1.117 . . . . 0.0 108.328 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.85 156.88 45.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.0 -1.48 . . . . 0.0 112.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 27.0 ptt180 -134.69 168.81 18.33 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.39 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.25 172.17 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.797 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -71.8 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.952 174.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -136.53 -58.75 0.73 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.742 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.7 m -126.48 158.79 35.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.581 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.7 pt-20 -101.43 166.98 10.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.751 -177.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.441 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.9 m95 17.94 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.966 -1.47 . . . . 0.0 114.514 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 14.1 mptt -73.68 167.27 36.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.322 173.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -48.06 98.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.76 1.64 . . . . 0.0 110.39 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.77 174.44 5.16 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.349 -173.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -139.19 154.89 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.499 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.35 137.06 52.07 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.783 173.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.5 mt -87.49 166.45 25.28 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.306 -177.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -81.33 140.04 11.94 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.92 1.747 . . . . 0.0 108.063 167.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -62.53 135.31 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.742 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.61 41.81 4.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -97.03 168.62 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.505 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -114.59 -45.81 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.44 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -147.86 167.43 24.8 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.361 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.0 p -119.07 149.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.778 173.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -132.55 148.41 52.37 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.874 -174.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.98 140.41 38.21 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.202 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -140.59 162.35 35.57 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.357 -177.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 m 71.69 46.4 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.403 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -95.27 -176.06 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 177.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -84.98 146.33 27.27 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.816 -175.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.441 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 71.0 m95 -80.25 155.33 27.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.545 -177.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 44.91 46.77 9.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.458 -175.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 149.94 47.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.712 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -98.83 143.09 29.55 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.327 178.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 39.4 m-85 -131.51 144.32 51.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 123.995 0.809 . . . . 0.0 112.057 -177.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.12 119.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.428 -1.715 . . . . 0.0 108.06 176.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.55 124.53 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 59.8 m-85 -111.35 126.96 55.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.8 t -120.92 121.82 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.944 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' HB ' HD13 ' A' ' 37' ' ' LEU . 2.5 t -109.5 158.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.72 160.21 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.516 -1.274 . . . . 0.0 109.36 177.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -111.1 164.76 12.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.435 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 20.1 t-20 -152.19 151.89 31.57 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -41.63 -41.41 2.2 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.327 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -79.7 -47.62 15.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.503 -177.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.63 -108.79 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.995 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -140.72 173.23 11.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.895 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.77 119.27 27.47 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -42.49 162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.307 1.629 . . . . 0.0 112.664 -176.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.51 134.49 35.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.202 -176.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.3 143.07 32.54 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.462 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.6 t-160 -113.21 130.74 56.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.397 -174.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -116.88 126.85 53.61 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.984 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.43 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -123.63 135.44 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.298 -176.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 p90 -156.93 174.03 16.12 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.34 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -127.3 148.2 50.23 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.544 175.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -79.83 168.5 19.19 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.002 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 m -81.25 -173.17 4.18 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.356 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.04 150.55 21.28 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.109 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 116.247 -1.835 . . . . 0.0 110.392 -178.802 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 7.2 Cg_exo -59.35 176.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.634 2.223 . . . . 0.0 112.909 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -93.0 161.53 14.41 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.224 171.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.36 143.73 92.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.422 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.37 172.8 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.484 1.456 . . . . 0.0 110.915 -177.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -106.6 132.25 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.1 mt -109.04 112.12 24.13 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.352 -176.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.33 144.2 25.62 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.41 131.52 10.56 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.422 -173.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -129.16 129.4 45.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.407 ' CE ' HD11 ' A' ' 19' ' ' ILE . 37.8 ttm -106.86 134.64 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.41 144.03 21.29 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.591 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.48 9.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.95 -27.22 39.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.858 175.566 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.26 -40.05 1.95 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.931 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -130.64 -15.1 3.56 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.801 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -52.88 115.72 1.98 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.332 174.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.9 mm -117.33 128.79 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.122 -175.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -114.94 126.66 55.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 47.6 t -109.27 118.94 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.77 124.02 39.6 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.81 -178.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.62 104.29 15.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -173.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -97.96 133.06 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.204 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -101.1 146.58 27.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.896 0.747 . . . . 0.0 109.434 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.46 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.07 -89.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.413 -175.781 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 20.8 t70 -95.45 105.69 17.68 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.125 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.75 -35.12 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.66 51.27 0.42 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.96 17.61 40.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -175.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.603 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 64.3 m 43.35 59.84 11.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.4 Cg_endo -88.53 50.9 1.67 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.842 1.695 . . . . 0.0 108.513 172.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mm -78.86 151.34 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.027 0.918 . . . . 0.0 111.68 -172.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 32.8 mmm-85 -126.13 108.01 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.536 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.0 p-80 36.17 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.484 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 76.5 m-85 -138.73 151.92 47.54 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.131 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.87 108.78 20.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.7 t -114.08 122.23 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.02 -173.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -132.58 135.65 46.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.664 1.228 . . . . 0.0 108.1 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.8 158.69 43.6 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 117.941 -1.504 . . . . 0.0 112.162 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.6 ptm180 -138.32 170.36 16.15 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.305 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.62 179.5 4.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.514 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 40.83 0.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.535 172.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.28 -60.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.426 ' CB ' ' HZ3' ' A' ' 48' ' ' LYS . 2.8 m -116.45 149.5 39.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.104 177.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -100.11 160.84 14.01 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.175 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.424 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 24.8 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.402 -1.272 . . . . 0.0 114.028 178.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 67.5 mmtt -76.19 162.16 72.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.8 Cg_exo -45.12 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.765 1.643 . . . . 0.0 110.611 177.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.87 175.45 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.571 -173.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -137.97 155.19 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.354 -177.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -115.89 130.25 56.75 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.214 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -78.33 165.09 52.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.239 -177.472 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.12 161.0 27.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.832 1.688 . . . . 0.0 110.87 172.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 t -68.24 95.55 0.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 95.57 65.38 0.97 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -97.14 -169.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.231 -176.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -129.54 -38.88 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.646 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -144.69 164.65 30.35 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.569 -1.252 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -131.77 153.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.492 174.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptp -137.45 152.13 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.981 -174.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -142.04 138.61 31.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.172 172.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -137.94 161.23 37.22 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.745 -177.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t 66.51 49.91 1.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.543 177.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.96 -174.63 3.31 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.653 177.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 32.7 t70 -80.55 137.32 36.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.708 -175.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.508 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 73.1 m95 -75.62 156.04 35.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.168 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 49.53 44.82 24.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.111 -178.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.71 156.06 44.89 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.546 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.76 149.33 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 19.8 m-85 -135.22 144.63 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.78 -178.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.58 121.45 38.4 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.273 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.0 t -114.06 123.11 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.9 m-85 -110.92 125.64 53.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.67 121.21 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 123.881 0.738 . . . . 0.0 110.446 -178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -106.54 158.04 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.81 157.53 41.24 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.381 -1.327 . . . . 0.0 109.868 178.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.9 tt0 -112.11 164.27 13.35 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.454 HD22 ' HG2' ' A' ' 32' ' ' PRO . 11.3 t-20 -148.24 151.99 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.949 178.127 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -34.14 -45.81 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.757 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.95 39.78 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.5 -152.81 23.66 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.636 174.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -129.86 166.25 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.779 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.1 t -128.71 125.68 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.957 -176.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -43.39 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.52 1.762 . . . . 0.0 113.298 -175.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.406 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.25 139.7 30.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.61 -175.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.52 145.54 30.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.462 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.2 130.11 56.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.382 -174.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -117.86 129.72 55.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.883 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -127.38 141.1 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.694 -176.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.5 p90 -157.99 177.92 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.066 178.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 146.5 50.78 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.69 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.0 p -83.34 163.36 20.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.379 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 m -74.86 178.75 5.31 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.164 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.5 144.79 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 116.252 -1.832 . . . . 0.0 110.328 -178.926 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 8.3 Cg_exo -59.4 177.26 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.798 2.332 . . . . 0.0 112.944 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -80.17 -154.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.23 150.18 39.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.97 166.28 28.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.377 1.385 . . . . 0.0 110.755 -177.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.48 128.94 52.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 mt -102.91 110.73 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.018 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -91.49 143.09 26.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.431 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.27 125.17 7.76 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.337 -1.411 . . . . 0.0 112.486 -173.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.444 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 77.9 mt-30 -121.55 122.47 39.76 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.5 ttm -107.17 130.9 54.65 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.745 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.8 149.09 24.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.307 -177.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.55 16.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.85 -24.48 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.332 174.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -40.61 2.45 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.715 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.9 p30 -137.49 49.1 2.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.139 0.495 . . . . 0.0 110.0 177.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.2 m -122.16 113.5 19.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.542 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.07 128.53 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.604 -169.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.94 125.75 53.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.082 0.864 . . . . 0.0 108.748 173.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.5 t -107.12 116.47 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.6 m-20 -93.88 129.01 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.913 -177.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 39.4 mt -100.56 99.41 10.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -175.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.9 mm -95.99 130.36 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -104.15 150.85 23.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.711 0.632 . . . . 0.0 109.803 -175.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -79.64 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.037 -174.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.55 102.43 11.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.177 -175.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -131.91 -35.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 178.535 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.07 51.04 0.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.77 22.48 25.86 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -175.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.0 m 39.09 62.44 4.86 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -88.25 50.69 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.729 1.62 . . . . 0.0 108.722 173.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.45 151.59 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.7 mtt85 -131.69 121.69 24.69 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.821 178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.544 ' H ' ' N ' ' A' ' 56' ' ' GLY . 9.2 p-80 35.44 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.19 158.37 43.81 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.972 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -112.45 109.86 19.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG12 HG23 ' A' ' 60' ' ' VAL . 48.0 t -115.48 124.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.652 -173.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -134.72 140.57 46.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.683 1.24 . . . . 0.0 108.422 177.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -144.07 154.83 43.62 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.924 -1.51 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 12.0 ptm180 -126.14 163.68 22.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.556 179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.81 -168.08 1.3 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 tp -95.9 41.49 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.447 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.77 -56.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.611 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.511 ' CB ' ' HZ2' ' A' ' 48' ' ' LYS . 46.8 m -106.76 142.83 35.76 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.269 177.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.6 pt-20 -107.87 144.06 35.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.792 -176.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.6 m95 47.45 84.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.454 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HZ2' ' CB ' ' A' ' 45' ' ' SER . 72.0 mmtt -77.54 161.17 73.11 Favored Pre-proline 0 N--CA 1.491 1.603 0 CA-C-N 114.346 -1.297 . . . . 0.0 107.824 174.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.4 Cg_exo -43.37 103.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.909 1.739 . . . . 0.0 110.838 179.211 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.76 175.87 6.82 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.503 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.7 157.54 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.757 -177.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -114.39 140.98 48.23 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.911 172.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD12 ' HB ' ' A' ' 60' ' ' VAL . 2.0 mt -90.18 165.56 23.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.667 -176.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.9 Cg_exo -61.58 157.91 39.45 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.71 1.607 . . . . 0.0 110.39 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -64.58 86.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.171 -176.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.544 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 106.15 62.91 0.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -93.84 179.59 5.3 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.24 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -18.91 7.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.236 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.431 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 19.1 p-80 -160.16 168.94 24.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.435 -1.306 . . . . 0.0 112.245 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.5 p -134.6 153.64 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.924 172.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.2 ptp -138.34 153.69 48.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.314 -1.354 . . . . 0.0 112.763 -176.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.97 140.17 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.142 173.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.9 tppt? -137.98 137.82 38.29 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.821 -174.177 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 8.2 m 85.86 50.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.784 171.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.2 mm? -95.2 -177.55 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.833 -179.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.2 134.21 39.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.687 0.756 . . . . 0.0 111.079 -172.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -72.34 154.65 40.82 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 47.5 47.37 17.36 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.911 -177.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.07 50.11 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.821 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.61 149.96 22.24 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.278 177.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.529 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -133.29 144.25 49.59 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.62 -176.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.35 118.25 28.0 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.82 123.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 39.3 m-85 -111.64 125.16 53.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.32 122.14 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 123.935 0.772 . . . . 0.0 110.314 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.32 155.4 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.4 163.81 22.48 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.5 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -117.59 156.34 28.27 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.461 -1.295 . . . . 0.0 107.961 172.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 6.5 t-20 -141.76 152.12 43.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.665 178.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 34.3 tt0 -29.34 -47.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.501 179.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -111.85 36.09 3.44 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.5 -161.27 27.37 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.786 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -110.3 158.76 18.06 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.031 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.49 114.47 24.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.569 -175.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -39.98 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.368 1.668 . . . . 0.0 112.794 -176.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.53 140.06 36.04 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.769 -174.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.46 147.27 29.53 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 172.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -116.93 131.48 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.667 -173.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -118.22 131.53 56.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.372 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.25 140.16 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.897 -176.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.75 178.79 9.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.016 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.5 52.06 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.279 177.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.4 p -81.0 165.9 21.3 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.711 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 m -79.9 -175.78 5.11 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.096 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.49 149.28 23.38 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.106 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 116.488 -1.72 . . . . 0.0 110.63 -178.685 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 1.6 Cg_endo -62.32 170.96 5.86 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.471 2.114 . . . . 0.0 112.924 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.6 p -87.42 150.36 23.84 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.909 171.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.45 160.12 1.42 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.173 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.5 162.47 27.66 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.206 1.27 . . . . 0.0 110.193 176.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 132.54 48.47 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.65 113.45 27.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.577 -174.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -92.7 141.19 28.74 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.597 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.42 121.37 7.08 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.129 -174.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 79.4 mt-30 -117.55 114.57 23.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.46 ' CE ' HD13 ' A' ' 19' ' ' ILE . 50.9 tpp -101.87 130.14 48.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.148 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.01 146.36 21.19 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.481 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.23 14.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.916 -177.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.8 -25.56 40.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.572 175.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.54 -48.34 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.924 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -131.92 51.38 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.167 0.508 . . . . 0.0 109.967 176.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -121.69 112.21 18.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 173.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.542 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -116.27 128.54 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.656 -171.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -114.98 126.07 54.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.05 0.844 . . . . 0.0 108.859 171.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.1 t -105.6 111.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 1.4 t-20 -89.0 127.83 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.5 -175.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.31 103.54 15.49 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.352 -174.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.7 mm -96.52 134.78 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HZ2' ' HG ' ' A' ' 31' ' ' SER . 31.8 mtmt -104.48 154.53 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.257 -176.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -66.56 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.627 -175.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -131.41 117.79 19.35 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 5.0 m-20 -130.06 -35.25 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.98 177.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.51 52.76 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.94 23.25 28.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -175.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.608 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 24.7 m 43.51 61.38 10.25 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -88.9 39.58 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.464 1.443 . . . . 0.0 109.058 173.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.1 151.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.927 0.87 . . . . 0.0 111.258 -174.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.8 mtt180 -128.75 115.52 18.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.825 -179.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 31.9 -174.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.495 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 71.7 m-85 -132.57 153.34 51.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.077 174.254 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.86 113.27 25.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.89 128.98 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.043 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.82 138.03 45.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.839 1.337 . . . . 0.0 108.122 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.63 157.15 44.33 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.805 -1.558 . . . . 0.0 112.007 176.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -134.73 163.93 28.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.448 -177.081 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.33 166.18 15.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.727 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.04 43.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.966 172.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -147.69 -56.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.742 176.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.543 ' HG ' ' HZ3' ' A' ' 48' ' ' LYS . 15.8 p -132.05 157.99 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.198 175.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 16.0 pt-20 -105.09 165.34 11.16 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.711 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.8 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.614 178.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HZ3' ' HG ' ' A' ' 45' ' ' SER . 72.6 mmtt -69.52 163.44 58.96 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.45 172.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.0 Cg_exo -49.59 105.72 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.726 1.618 . . . . 0.0 110.622 176.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.36 160.67 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -175.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.27 148.84 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.181 174.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -115.07 135.56 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -88.1 164.19 34.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.159 -177.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.26 161.19 41.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.694 1.596 . . . . 0.0 109.08 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -84.38 99.65 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.188 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.38 48.75 0.51 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -177.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -97.05 178.3 5.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.551 -177.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.21 -42.02 3.09 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.058 -179.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -150.72 168.32 24.72 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.106 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.556 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.6 p -120.73 148.19 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.719 172.141 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 ptp -133.09 149.95 52.1 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.604 -1.238 . . . . 0.0 112.79 -174.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -139.15 134.84 33.36 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.402 173.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -133.96 138.56 45.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.42 -176.025 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 5.9 t 88.81 49.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.836 172.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.0 mm? -96.32 -179.88 4.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.852 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -71.62 133.45 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.587 0.708 . . . . 0.0 111.127 -174.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -73.76 155.72 38.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 45.18 47.1 10.02 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.859 -177.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.27 156.04 45.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.014 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.29 148.94 22.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 12.2 m-85 -134.02 144.38 48.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.525 -178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.52 123.33 42.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.421 176.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.05 124.76 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 40.3 m-85 -113.43 125.66 54.48 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -120.63 124.36 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.536 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -110.99 157.05 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.54 158.84 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.459 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.8 tt0 -113.22 163.91 14.2 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.627 -1.229 . . . . 0.0 107.786 174.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.8 t-20 -148.93 152.37 36.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.987 177.217 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -36.81 -44.08 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.516 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -109.99 40.21 1.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.59 -153.78 22.23 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.271 172.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -122.29 161.81 22.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.733 179.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 t -120.94 117.64 27.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -40.95 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 125.592 1.808 . . . . 0.0 113.378 -174.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 76' ' ' VAL . . . -84.18 136.51 33.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.194 -176.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.03 145.45 30.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.449 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.83 131.02 56.96 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.718 -173.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -118.58 130.48 55.91 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.019 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.55 141.01 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.386 -177.169 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.47 177.28 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.068 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 147.01 50.73 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.927 176.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.92 163.45 20.01 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.586 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -80.77 -168.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.213 -179.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.57 143.16 33.43 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.044 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.235 -1.84 . . . . 0.0 110.463 -179.361 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 9.3 Cg_endo -67.41 174.39 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.573 2.182 . . . . 0.0 113.054 -178.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -94.36 -178.01 4.45 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.706 172.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.65 149.34 64.06 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.988 177.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.83 174.68 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.377 1.385 . . . . 0.0 109.954 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HB2' HE22 ' A' ' 26' ' ' GLN . 20.9 ttpt -105.78 141.0 37.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.75 115.16 29.35 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.29 -177.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.04 138.41 39.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -126.64 143.65 14.5 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.277 -1.916 . . . . 0.0 113.815 -171.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -128.14 138.53 52.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.084 171.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.476 ' CE ' HD12 ' A' ' 19' ' ' ILE . 21.5 mtp -108.31 128.2 54.54 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.9 178.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -80.88 151.46 32.04 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.81 -175.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.87 11.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.037 -0.581 . . . . 0.0 112.311 -178.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.8 -24.62 41.29 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.727 176.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.29 -41.65 2.16 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.86 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.6 p30 -138.87 50.44 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.116 177.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.3 m -122.31 114.65 21.07 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.5 mm -116.2 128.86 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.684 -170.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 123.04 47.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.12 0.887 . . . . 0.0 109.214 175.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 44.4 t -112.79 120.28 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -176.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -97.42 134.2 40.99 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.772 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -101.4 105.9 16.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.048 0.843 . . . . 0.0 109.039 -175.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.18 107.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.165 -176.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -76.92 156.84 31.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.422 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.7 pt20 -154.57 -83.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.389 -173.083 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.42 98.65 8.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.66 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -131.62 -34.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.498 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.79 56.72 0.43 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.86 19.07 41.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.571 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.8 m 42.1 61.56 8.45 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.744 -176.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -86.92 45.51 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.727 1.618 . . . . 0.0 108.701 173.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.4 mm -82.15 150.8 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.203 -173.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' HIS . 63.4 mtp85 -128.26 112.41 14.46 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.799 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.4 p-80 38.66 -173.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 175.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.45 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.53 153.88 51.57 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.28 177.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.89 110.51 21.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 175.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.55 124.92 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.281 -173.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -135.56 139.97 44.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.647 1.217 . . . . 0.0 108.151 177.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.38 154.87 42.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.299 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 16.0 ptt180 -132.23 164.87 25.41 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.381 -178.058 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.53 169.77 13.33 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.272 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -74.16 42.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.783 173.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -145.49 -56.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.731 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.43 ' HG ' ' HZ2' ' A' ' 48' ' ' LYS . 12.9 p -137.05 164.25 28.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.521 175.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -100.98 169.13 9.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.398 -174.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 6.5 m95 17.81 95.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.788 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.5 mmtt -69.0 165.48 37.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.99 172.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 13.1 Cg_exo -50.71 97.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.538 1.492 . . . . 0.0 109.849 175.063 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.0 172.23 1.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.566 -173.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.3 tt -138.24 154.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.956 -179.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -115.5 135.57 53.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.94 174.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -85.41 165.1 37.73 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.002 -177.383 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 9.9 Cg_endo -73.31 146.41 40.17 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.725 1.616 . . . . 0.0 109.783 172.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.3 p -58.17 113.85 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.931 0.769 . . . . 0.0 111.285 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.41 56.29 1.05 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -97.04 177.04 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 -45.48 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.813 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -144.27 170.22 16.4 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.128 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.5 p -129.03 151.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.348 175.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ptp -138.09 150.91 47.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.67 -1.212 . . . . 0.0 112.193 -177.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.52 140.51 41.15 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.983 174.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.8 ttpt -140.47 136.42 32.96 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.811 -173.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.3 t 90.31 48.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.763 172.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.8 mm? -95.4 179.49 5.14 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.321 -178.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.03 134.69 48.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.661 0.743 . . . . 0.0 111.441 -173.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -74.47 154.21 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 45.86 48.06 12.1 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.618 -177.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.29 151.86 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.2 148.77 21.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 65' ' ' LEU . 8.6 m-85 -133.62 141.25 47.56 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.398 -178.16 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.47 117.83 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.753 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.07 122.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 41.8 m-85 -112.21 125.88 54.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.33 122.71 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.888 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.15 158.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.99 159.67 33.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.049 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -112.74 164.66 13.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.448 -1.301 . . . . 0.0 107.582 174.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -149.6 153.2 36.72 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.872 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -40.74 -40.89 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.318 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -79.75 -52.5 7.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.01 -119.37 0.57 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.114 -177.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -125.34 163.93 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.427 -179.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.66 119.35 30.47 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -40.59 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 125.357 1.661 . . . . 0.0 113.447 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.62 139.24 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.387 -176.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.87 144.78 34.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.448 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.4 t-160 -116.39 131.59 56.9 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.633 -173.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 85.6 t80 -117.72 128.16 54.62 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.083 -179.175 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.436 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -124.89 137.89 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.58 -176.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.1 p90 -157.8 178.3 10.4 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.276 178.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.13 145.98 51.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.78 175.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -80.0 172.6 13.55 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.283 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -86.28 -174.96 5.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.166 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.91 147.51 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.312 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.471 -1.728 . . . . 0.0 110.551 -179.09 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 14.9 Cg_endo -71.2 178.02 5.92 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -84.93 152.71 23.32 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.479 170.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 162.7 0.92 Allowed Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.335 174.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.71 167.38 20.69 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.219 1.28 . . . . 0.0 110.522 176.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -104.24 127.42 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -98.31 112.32 24.35 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.983 -177.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.62 93.99 4.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -104.46 152.24 17.51 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.946 -172.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.64 157.82 43.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.953 -1.124 . . . . 0.0 109.232 178.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.3 ttm -111.12 139.45 46.47 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.359 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.15 154.85 25.76 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.121 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.45 11.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.267 -176.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 20.4 m-20 -79.89 -22.87 42.29 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.152 175.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.58 -37.09 3.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.939 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 10.1 p-10 -140.12 46.22 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.112 177.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.4 m -120.77 115.23 22.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.0 mm -116.08 130.85 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.132 -170.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.77 122.48 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.8 t -108.88 116.44 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -93.44 134.34 35.78 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.17 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 32.7 mt -101.41 103.74 14.68 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.286 -176.138 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mm -95.2 136.71 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.13 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -104.36 152.6 22.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.45 -69.88 0.54 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.916 -175.636 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 25.7 m-20 -127.45 110.78 13.11 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.3 m-20 -131.48 -33.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.399 178.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.12 52.09 0.5 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.22 24.81 25.77 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.559 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 39.26 64.34 4.0 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.853 -0.674 . . . . 0.0 112.489 -176.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.9 44.61 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.665 1.577 . . . . 0.0 108.705 173.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 mm -90.69 148.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.163 -174.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' HIS . 74.6 mtm-85 -131.8 125.6 32.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.829 175.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.7 p-80 36.34 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 176.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 94.7 m-85 -138.57 150.56 46.45 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.518 178.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -105.27 110.32 22.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.47 126.31 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 118.959 -1.097 . . . . 0.0 110.607 -174.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -132.41 135.31 46.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 125.035 1.46 . . . . 0.0 107.804 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.47 151.69 41.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.659 -1.616 . . . . 0.0 112.128 176.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.3 ptm180 -124.15 160.53 27.64 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.433 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -109.17 -168.84 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.85 39.78 1.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.54 -60.97 0.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.506 ' HG ' ' HZ2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -118.03 150.26 39.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.505 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.9 pt-20 -106.79 144.02 34.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.746 -177.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.48 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.4 m95 48.45 82.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.107 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HZ2' ' HG ' ' A' ' 45' ' ' SER . 72.6 mmtt -68.71 161.26 72.48 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.926 174.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.6 Cg_exo -43.63 104.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.96 1.773 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -52.21 161.63 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.902 -175.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.3 147.7 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.412 174.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -114.04 129.69 56.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.4 mt -78.35 164.68 54.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.663 -178.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 6.0 Cg_exo -63.03 149.84 90.4 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.646 1.564 . . . . 0.0 110.009 174.192 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.4 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 20.5 m -64.23 87.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.68 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.7 56.61 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.7 t -97.02 -175.07 3.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.162 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.86 -24.01 3.01 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.974 -178.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p-80 -160.26 167.52 27.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.988 -177.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.8 p -130.4 152.32 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.579 174.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ptp -137.86 148.91 45.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.235 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -138.58 135.75 35.31 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.719 174.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.9 mtmt -141.63 143.07 33.45 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.871 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.5 m 90.82 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.999 175.036 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.2 mm? -92.6 -177.81 4.69 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.813 -178.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.29 133.94 41.19 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.635 0.731 . . . . 0.0 111.229 -172.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.59 155.8 39.66 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.125 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.6 t30 44.63 47.02 8.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.084 -177.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.41 154.58 46.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.824 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.42 148.31 23.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.684 177.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.534 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 21.4 m-85 -133.76 142.1 47.78 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.502 -177.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -122.86 118.42 27.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.184 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.68 123.42 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 50.3 m-85 -112.2 126.04 54.79 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.08 122.42 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.925 0.766 . . . . 0.0 110.705 -178.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.23 159.71 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.61 159.93 35.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.016 177.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.14 151.99 30.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.361 -1.336 . . . . 0.0 108.283 175.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.454 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -142.55 150.77 40.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.62 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -37.81 -39.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.711 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.63 -49.86 11.53 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.085 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 -125.2 0.75 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.513 -179.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -119.78 157.87 27.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.088 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.68 118.05 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -41.53 162.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 125.538 1.774 . . . . 0.0 112.873 -175.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.78 135.36 34.57 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.235 -175.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.99 148.05 25.83 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.48 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -117.4 130.64 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.783 -172.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.3 t80 -119.17 130.37 55.48 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.939 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.48 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.7 t -128.48 142.85 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.311 -175.307 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 49.6 p90 -162.52 179.08 8.03 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.334 177.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -129.28 147.91 51.16 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.49 175.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.6 p -79.87 170.95 15.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.344 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -83.23 -173.02 4.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.967 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 138.9 39.83 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.02 -178.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 116.447 -1.739 . . . . 0.0 110.654 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.503 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.3 Cg_exo -60.09 173.26 1.92 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.549 2.166 . . . . 0.0 113.177 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -98.62 162.61 13.04 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 144.27 94.98 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.168 -177.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.54 174.01 8.02 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.392 1.395 . . . . 0.0 110.495 -178.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -109.09 132.08 54.45 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.37 114.68 29.0 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.876 -1.129 . . . . 0.0 110.035 -176.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -95.09 141.27 28.92 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.73 127.44 8.97 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.634 -171.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -121.82 113.28 19.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 19' ' ' ILE . 25.0 mtp -103.63 127.2 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.348 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.79 147.16 21.0 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.722 -1.228 . . . . 0.0 112.25 -174.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.27 13.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.918 -0.641 . . . . 0.0 112.141 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.554 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.23 41.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.449 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.67 -46.18 1.21 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.55 176.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -134.54 35.37 3.18 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.315 177.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -104.59 113.88 27.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.519 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 12.1 mm -118.43 126.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.492 -171.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -113.66 127.38 56.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.006 0.816 . . . . 0.0 108.822 172.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.1 t -108.53 116.31 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -97.65 129.64 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.54 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.2 mt -99.37 109.64 22.22 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.756 -172.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.9 mm -100.6 135.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.94 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HZ3' ' HG ' ' A' ' 31' ' ' SER . 30.1 mtmt -101.58 150.42 23.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.828 0.705 . . . . 0.0 109.265 -179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 -49.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.744 -175.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -140.01 104.27 4.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.69 -177.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -132.57 -33.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.256 178.695 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.64 51.66 0.49 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.64 23.94 29.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.589 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.6 t 42.76 62.13 8.64 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.734 -0.733 . . . . 0.0 112.816 -176.026 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.83 41.68 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.582 1.521 . . . . 0.0 108.813 171.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.65 150.83 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.488 -173.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 53.4 mtt-85 -130.69 117.52 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.47 -1.695 . . . . 0.0 108.598 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.3 p-80 36.76 -175.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 176.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.45 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 91.7 m-85 -137.21 153.96 50.29 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.012 176.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -108.65 110.21 21.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 60' ' ' VAL . 44.7 t -114.17 123.81 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.137 -173.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -134.49 137.85 44.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.661 1.225 . . . . 0.0 108.113 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.21 158.71 43.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.968 -1.493 . . . . 0.0 112.505 179.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.0 ptm180 -138.28 170.72 15.52 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.983 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -120.09 -168.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.155 -175.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.24 41.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.484 174.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.23 -57.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.701 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -122.95 157.61 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.926 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.1 pt-20 -97.68 178.22 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.462 -177.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.5 m95 3.38 100.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -77.42 167.87 32.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.307 172.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 14.2 Cg_exo -48.61 98.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.711 1.607 . . . . 0.0 110.365 176.169 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.37 174.32 4.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.353 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.12 155.51 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.389 -177.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -113.68 134.08 54.95 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.974 173.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -82.28 163.55 52.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.933 -177.64 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.7 Cg_exo -59.59 167.29 6.76 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.84 1.693 . . . . 0.0 110.51 174.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -74.76 79.82 2.07 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.657 -176.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 63.02 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -97.05 -175.81 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.808 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.03 -16.53 3.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.274 -179.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.9 p-80 -160.07 164.52 33.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.496 -176.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -134.9 152.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.614 173.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -137.42 152.86 50.06 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.708 -176.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -138.88 140.57 38.45 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.52 173.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.32 156.2 47.01 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.617 -174.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.1 t 62.68 59.13 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.378 175.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.68 -175.14 2.81 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.653 176.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.461 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.8 m-20 -79.84 140.33 36.85 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.677 0.751 . . . . 0.0 111.462 -174.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 80.4 m95 -76.73 154.15 34.37 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.602 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 44.49 48.34 8.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 -177.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.34 152.79 47.75 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.676 179.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.58 147.66 24.57 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.601 176.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.556 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 23.1 m-85 -132.2 143.39 49.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.36 -176.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -120.82 118.26 29.52 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.785 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -112.91 120.63 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 47.6 m-85 -110.08 125.4 52.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.83 120.69 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.429 -178.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 86' ' ' ALA . 2.2 t -104.98 158.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.98 156.48 43.71 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.612 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.24 159.24 18.1 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.742 174.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 20.0 t-20 -143.64 151.87 40.66 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.512 178.228 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -40.03 -39.1 0.81 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.006 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -107.99 35.43 3.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.01 -151.44 20.45 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.942 173.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -121.79 160.08 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.933 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -122.54 122.85 39.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -41.88 165.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.664 1.852 . . . . 0.0 113.468 -174.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.41 ' HB3' HG21 ' A' ' 76' ' ' VAL . . . -85.57 137.23 33.01 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.34 146.01 28.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.462 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.09 128.16 55.45 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.687 -174.039 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 82.7 t80 -112.73 124.97 53.78 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.88 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG21 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -124.29 137.46 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.324 -176.475 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 46.3 p90 -161.34 179.09 8.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.821 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -128.53 153.36 47.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.364 173.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.1 p -79.92 177.72 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.074 177.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -90.45 -174.01 3.98 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.333 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.46 149.18 23.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.083 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.538 -1.696 . . . . 0.0 110.621 -178.571 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.468 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.4 Cg_exo -60.62 169.48 5.46 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.407 2.072 . . . . 0.0 113.08 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -98.0 163.39 12.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.347 172.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.44 142.28 91.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.269 -176.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -70.65 163.24 39.7 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.551 1.501 . . . . 0.0 110.087 -178.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -91.98 137.05 32.68 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.7 mt -105.77 109.81 21.9 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.56 -179.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -94.34 137.92 32.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.34 -178.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.85 125.85 8.48 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.593 -1.289 . . . . 0.0 112.384 -171.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -120.84 117.74 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.462 ' CE ' HD11 ' A' ' 19' ' ' ILE . 51.2 tpp -99.92 127.43 46.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.78 150.34 24.12 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.191 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 4.8 mp0 -66.69 14.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.798 -176.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.75 41.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.461 174.559 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.21 -43.5 1.7 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.337 177.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -130.81 6.89 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.205 178.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -75.06 112.27 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.819 176.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 9.4 mm -114.36 125.04 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.862 -173.356 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.63 125.85 54.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.0 t -108.38 113.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -178.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -93.46 129.26 39.7 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.353 -177.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -97.37 106.14 18.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.393 -173.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.94 105.55 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.803 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -76.23 148.04 37.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -146.01 -55.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.26 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.68 101.58 5.54 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.682 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.1 m-20 -129.07 -37.41 1.69 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.109 178.252 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.02 54.69 0.38 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.54 20.24 38.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -175.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.586 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.1 m 42.47 61.87 8.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -86.68 43.0 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.695 1.597 . . . . 0.0 108.493 172.058 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -80.79 151.09 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.536 -172.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.1 mtt180 -127.85 111.7 13.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.696 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.8 p-80 37.46 -176.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 175.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.448 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 80.9 m-85 -134.34 151.35 51.18 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.847 175.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 76' ' ' VAL . 5.9 mt -107.68 110.68 22.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG11 HG23 ' A' ' 60' ' ' VAL . 43.4 t -115.7 125.98 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.413 -174.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -137.53 142.2 41.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.637 1.21 . . . . 0.0 107.924 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.19 157.78 43.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.802 -1.559 . . . . 0.0 112.187 179.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -132.32 163.19 29.22 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.305 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -120.98 175.65 5.95 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.62 42.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.125 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.97 -59.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.244 178.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -125.41 154.89 41.24 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.156 176.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -106.47 158.16 17.11 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.992 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 33.03 86.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.204 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.8 mmtt -72.52 164.16 62.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.387 175.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.46 98.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.83 1.687 . . . . 0.0 110.537 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.64 173.6 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.506 -174.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.02 155.0 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.09 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -115.96 133.45 56.01 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.884 173.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.6 mt -82.63 162.94 54.03 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.294 -176.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.7 Cg_exo -60.33 168.85 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.932 1.755 . . . . 0.0 111.016 173.123 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 p -80.9 81.44 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.956 -177.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 58.47 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 m -97.13 178.94 5.09 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.898 -178.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.75 -37.68 2.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.545 -178.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -148.93 168.43 23.07 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.018 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -126.89 150.49 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.48 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ptp -134.39 148.12 50.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.52 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.85 141.74 33.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.008 173.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -141.51 174.06 10.91 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.901 -1.119 . . . . 0.0 111.309 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 m 59.02 56.79 3.81 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.424 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 17.2 mt -94.33 -178.1 4.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.18 131.95 38.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.229 175.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.402 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.3 m95 -72.71 152.61 41.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.556 -1.258 . . . . 0.0 110.251 -178.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.77 46.79 18.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.853 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.88 154.28 45.68 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.889 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.28 149.9 20.83 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.216 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 16.3 m-85 -135.5 141.9 45.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.269 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.14 118.28 30.96 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.422 177.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.64 124.2 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.59 125.71 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.5 t -121.49 122.51 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.023 0.827 . . . . 0.0 110.482 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.2 t -109.16 158.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.09 156.77 43.35 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.408 -1.317 . . . . 0.0 109.797 177.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.4 tt0 -112.05 162.52 15.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -147.26 150.86 35.67 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.099 177.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -39.05 -43.04 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.307 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -111.52 40.37 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.599 -175.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.12 -152.12 22.58 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.82 174.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -132.67 167.88 19.29 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.701 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.34 121.01 29.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.3 -178.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -43.41 166.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 125.5 1.75 . . . . 0.0 112.987 -175.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -83.82 135.87 34.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.37 -175.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.9 144.32 29.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.472 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -113.96 129.25 56.62 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.336 -174.265 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -116.8 125.05 51.02 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.785 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.468 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -124.28 137.73 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.501 -176.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 44.1 p90 -156.85 177.93 10.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.07 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -126.31 147.72 49.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.475 174.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.88 167.97 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 m -78.16 -177.25 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.362 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.22 146.65 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.891 179.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 116.466 -1.731 . . . . 0.0 110.531 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.79 -176.35 17.11 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.489 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.7 Cg_exo -56.53 173.7 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.509 2.14 . . . . 0.0 113.095 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m -95.15 159.51 14.98 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.536 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.91 144.4 98.99 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.129 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.9 Cg_endo -66.02 163.63 30.52 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.417 1.411 . . . . 0.0 110.822 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 128.1 48.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -102.91 115.72 31.15 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.45 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.42 141.68 30.2 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.92 125.66 8.15 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.448 -1.358 . . . . 0.0 112.51 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -121.27 119.68 32.95 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.0 ttm -105.89 132.2 52.28 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.727 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.31 147.49 22.41 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.458 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.07 13.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.907 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.88 -22.76 42.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.828 175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -40.65 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.102 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -137.65 49.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.278 0.561 . . . . 0.0 109.876 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -121.12 112.95 19.33 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.9 127.92 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.751 -170.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -114.18 127.25 55.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -107.83 113.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.81 131.88 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.544 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.33 107.07 18.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.787 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.56 132.59 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.095 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HZ3' ' CB ' ' A' ' 31' ' ' SER . 36.4 mtpt -99.1 155.29 17.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.845 0.715 . . . . 0.0 109.729 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.493 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.99 -48.2 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.02 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -143.89 109.11 5.04 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.134 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.0 m-20 -130.77 -37.59 1.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.035 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.82 54.71 0.39 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.42 33.16 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.609 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 11.4 m 43.62 61.3 10.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -88.75 40.0 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.418 1.412 . . . . 0.0 108.943 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.24 150.21 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.897 0.856 . . . . 0.0 111.336 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.1 mtt180 -130.95 116.67 18.17 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.793 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 35.66 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.498 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 82.7 m-85 -139.16 151.3 46.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.792 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.89 109.83 21.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -113.92 122.9 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.035 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.74 135.43 46.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.614 1.196 . . . . 0.0 107.927 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.51 161.6 37.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.876 -1.53 . . . . 0.0 112.063 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 7.8 ptm180 -144.35 170.1 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.763 -1.562 . . . . 0.0 110.166 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.541 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -122.63 179.65 4.54 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.714 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 tp -82.43 42.68 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.102 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.56 -56.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.344 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.3 m -124.31 151.95 43.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.409 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -98.07 175.03 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.606 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.8 m95 10.5 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.581 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 27.7 mmmt -80.53 163.0 58.77 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.049 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.4 Cg_exo -44.89 102.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.907 1.738 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.45 175.09 4.26 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.577 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.52 153.12 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.014 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -114.39 127.51 55.88 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.019 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -73.26 164.77 58.56 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.263 -177.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.77 169.99 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.749 1.633 . . . . 0.0 110.272 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.5 t -76.9 77.55 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.554 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.09 64.67 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 t -96.99 -174.47 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.14 -25.33 4.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -160.22 167.68 27.06 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.778 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -129.56 153.66 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.125 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ptp -139.81 154.54 47.38 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.37 -1.332 . . . . 0.0 113.157 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -140.38 139.77 35.4 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.563 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -135.78 136.55 40.8 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.616 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 86.97 51.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.0 170.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.1 mm? -97.96 -177.85 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.923 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.449 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 47.4 m-20 -74.3 134.73 42.58 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.685 0.755 . . . . 0.0 111.328 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -73.21 155.32 39.69 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.207 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.14 49.12 7.64 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.869 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 153.8 49.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.732 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -95.14 150.26 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.888 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 15.4 m-85 -134.23 143.4 47.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.451 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.7 123.06 43.98 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.891 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.51 121.82 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 35.2 m-85 -110.39 125.43 53.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -120.76 122.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.87 0.732 . . . . 0.0 110.835 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 86' ' ' ALA . 2.2 t -107.11 157.99 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.51 155.53 43.6 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.43 -1.308 . . . . 0.0 109.534 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.35 158.84 18.58 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.838 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.7 t-20 -144.58 151.34 38.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.716 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -35.7 -44.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.585 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.14 38.14 2.5 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.74 -155.06 23.49 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.317 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -121.76 159.32 26.91 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.794 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -121.86 125.59 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -41.38 165.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.718 1.886 . . . . 0.0 113.737 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 76' ' ' VAL . . . -88.09 136.08 33.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.19 147.01 27.56 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.56 129.66 56.6 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.702 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -115.09 128.58 56.31 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.986 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -125.85 138.66 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.421 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 39.6 p90 -158.09 178.19 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.028 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -129.7 147.07 51.45 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.912 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -79.85 171.7 14.76 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.67 -171.07 3.36 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.051 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.65 141.24 36.4 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.068 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 116.245 -1.836 . . . . 0.0 110.431 -179.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.017 0.437 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.27 176.5 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.557 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -55.22 170.09 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.699 2.266 . . . . 0.0 113.748 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -94.27 174.17 7.27 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.191 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.36 142.2 58.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.744 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -69.55 169.53 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.588 1.525 . . . . 0.0 110.289 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HB2' HE22 ' A' ' 26' ' ' GLN . 34.0 ttpt -99.23 137.61 37.5 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 172.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 mt -108.38 109.32 20.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.834 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.07 145.38 24.57 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.94 127.96 7.91 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.68 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.39 126.81 48.77 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.491 ' CE ' HD13 ' A' ' 19' ' ' ILE . 47.5 tpp -104.46 129.7 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.913 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -82.82 150.17 27.65 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.31 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.73 12.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.061 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.3 m-20 -79.86 -23.31 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.967 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.27 -41.99 2.03 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.883 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -136.53 48.31 2.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.131 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 m -121.22 116.03 24.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.545 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -116.19 128.59 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.469 -170.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.5 124.42 52.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.071 0.857 . . . . 0.0 108.961 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.543 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -109.12 120.62 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -94.19 130.7 40.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.283 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CD1' ' CD2' ' A' ' 36' ' ' TYR . 31.2 mt -99.33 98.54 9.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mm -89.42 107.88 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.242 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -68.69 170.03 10.13 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.441 HE22 ' HB2' ' A' ' 7' ' ' LYS . 3.5 pt20 -170.31 -67.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.652 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.4 m-20 -117.94 86.52 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.218 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.4 m-20 -129.31 -17.41 3.79 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.57 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.82 23.43 49.75 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.557 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.1 m 43.84 64.9 6.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.763 -0.718 . . . . 0.0 112.797 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -86.93 46.44 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 N-CA-C 107.26 -1.862 . . . . 0.0 107.26 170.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.02 152.11 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.008 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -127.63 113.91 16.68 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.221 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.8 p-80 36.86 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 90.9 m-85 -137.25 152.09 49.43 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.461 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.8 109.26 21.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -113.12 121.15 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.797 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.82 137.54 48.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 124.69 1.244 . . . . 0.0 107.874 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 155.16 44.87 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.906 -1.518 . . . . 0.0 112.173 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.2 ptm180 -131.23 164.66 25.07 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.018 -1.447 . . . . 0.0 110.098 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.548 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -120.61 170.48 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.02 43.09 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.506 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.73 -58.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.074 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.3 m -127.21 154.81 44.36 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.194 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -101.41 163.6 12.19 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.144 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 24.81 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.258 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 39.9 mmtm -71.49 165.93 44.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.116 174.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -49.17 96.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.723 1.615 . . . . 0.0 110.046 175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.01 174.34 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.534 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.91 154.4 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.368 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -113.99 130.12 56.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.789 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.1 mt -78.18 164.02 58.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.798 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.8 Cg_exo -60.33 168.08 6.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.666 1.577 . . . . 0.0 110.318 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.2 t -75.92 78.1 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.724 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 63.66 0.36 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.1 t -97.09 -172.12 2.37 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.689 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -131.96 -15.82 2.95 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.214 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.414 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.2 p-80 -159.71 165.39 32.65 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.556 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.543 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.3 p -135.0 152.18 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.66 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptp -137.78 150.58 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.418 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.491 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -139.6 138.21 35.99 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.954 174.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 53.1 mtmt -142.41 141.7 32.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.849 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.2 t 93.32 44.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.291 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.0 mm? -94.96 -178.65 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.028 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.469 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.4 m-20 -73.72 135.17 43.62 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 0.0 111.241 -173.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -74.19 156.49 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.291 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 45.24 47.07 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.729 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.48 154.95 47.24 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.002 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -97.24 149.04 22.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 14.8 m-85 -133.8 144.47 49.02 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.614 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.72 121.0 37.29 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.619 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.73 123.38 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.16 127.12 55.84 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.48 120.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 123.914 0.759 . . . . 0.0 110.731 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.428 HG21 ' HB1' ' A' ' 86' ' ' ALA . 2.3 t -104.08 158.88 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.58 45.26 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.219 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.97 157.48 21.44 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.317 -1.353 . . . . 0.0 107.9 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.526 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.5 t-20 -144.37 153.29 41.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.527 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -37.21 -41.95 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.496 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -107.64 36.38 2.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.79 -153.51 21.11 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.041 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -120.08 158.92 25.85 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 t -124.04 128.02 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.97 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -42.09 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 125.751 1.907 . . . . 0.0 113.303 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 76' ' ' VAL . . . -90.17 140.89 29.24 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.443 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.8 145.08 29.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.6 t-160 -115.25 129.87 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.418 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 78.1 t80 -117.73 130.1 56.11 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.095 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.423 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.61 139.7 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.541 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.545 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.7 p90 -157.38 177.43 11.45 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.154 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.52 146.57 51.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.951 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.31 164.98 19.7 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.539 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -81.61 -169.84 2.52 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.1 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.94 141.7 36.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.154 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.708 -179.524 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -113.91 172.35 14.31 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.539 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.523 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 28.2 Cg_endo -71.33 179.99 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.849 2.366 . . . . 0.0 112.737 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -103.95 160.32 14.91 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.177 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.69 148.99 98.56 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.812 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -71.85 171.85 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.307 1.338 . . . . 0.0 110.335 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HG3' HE22 ' A' ' 26' ' ' GLN . 32.9 mtmt -100.16 146.57 26.68 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 171.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.9 mt -115.09 114.04 24.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.195 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -95.42 144.81 25.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.79 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -111.33 127.09 8.03 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.48 -1.343 . . . . 0.0 112.554 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -122.73 124.58 43.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 47.9 ttm -105.25 133.13 50.52 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.595 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.94 153.88 25.09 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.543 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.07 10.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.082 -0.559 . . . . 0.0 112.234 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -80.0 -23.17 41.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.878 176.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.57 -37.03 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.36 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -132.53 2.46 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.123 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -75.67 116.5 16.45 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.974 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.503 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.4 mm -117.0 127.67 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.182 -172.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.85 125.45 54.08 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.582 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.2 t -108.91 119.78 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -97.28 128.72 44.38 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.102 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 47.3 mt -96.72 110.34 22.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 123.855 0.722 . . . . 0.0 109.695 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -97.42 108.18 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.686 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -72.4 168.43 18.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.753 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.425 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.6 pt20 -166.27 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.555 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 18.7 t70 -111.8 89.87 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.075 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 18.1 m-20 -131.97 -17.81 2.73 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.255 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.18 54.03 1.31 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.42 31.65 58.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 t 36.8 79.07 0.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 114.637 -0.782 . . . . 0.0 112.949 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HG2' HD22 ' A' ' 79' ' ' ASN . 6.0 Cg_endo -87.55 35.46 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 N-CA-C 107.169 -1.896 . . . . 0.0 107.169 165.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.99 144.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 122.091 0.948 . . . . 0.0 111.863 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 27.6 mtt180 -128.19 128.65 45.15 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.109 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 11.9 p-80 34.44 -173.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -139.93 153.5 46.97 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.555 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -106.29 112.16 25.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG13 HG21 ' A' ' 60' ' ' VAL . 45.9 t -114.11 128.22 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.928 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -134.43 140.25 46.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 125.039 1.462 . . . . 0.0 108.011 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.62 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.99 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 24.5 ptt85 -126.41 158.8 35.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.354 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -120.78 169.43 10.43 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.551 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.95 43.6 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.868 173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.49 -57.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.826 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.3 m -130.95 152.28 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.003 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 38.2 mt-10 -105.89 142.02 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.655 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.2 m95 58.81 84.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.837 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mptp? -70.67 161.89 74.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.123 173.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.66 105.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.88 1.72 . . . . 0.0 111.073 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.81 161.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.842 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.5 tt -134.12 149.91 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.459 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -114.29 132.41 56.17 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD11 ' HB ' ' A' ' 60' ' ' VAL . 1.5 mt -82.79 165.25 42.75 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.129 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.1 156.13 56.92 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.784 1.656 . . . . 0.0 110.324 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -73.66 83.26 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.183 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.62 47.61 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.63 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -97.13 167.44 11.05 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.04 -2.62 9.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.643 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.05 163.5 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.191 -1.403 . . . . 0.0 112.86 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.582 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -135.43 152.29 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.867 173.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptp -137.67 150.63 47.51 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.641 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -141.74 140.78 33.19 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.24 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.41 162.1 35.84 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.011 -1.075 . . . . 0.0 111.728 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 m 65.96 54.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.705 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.8 mm? -100.18 -175.43 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.046 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.7 m-20 -78.51 136.64 37.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.084 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -75.16 155.72 36.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 43.28 48.61 5.77 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.567 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.47 152.83 47.79 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.128 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -91.63 146.14 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 17.1 m-85 -134.45 138.72 44.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.245 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.61 118.3 28.88 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.457 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -112.29 126.85 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 51.5 m-85 -115.69 125.76 53.24 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.44 121.88 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 123.96 0.787 . . . . 0.0 110.708 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.81 156.26 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -126.38 155.74 41.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.955 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -110.08 149.13 30.47 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.126 -1.43 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.523 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -129.34 141.68 51.02 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.806 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -42.59 -33.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.229 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -126.61 50.44 1.93 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -160.36 27.06 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.097 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -125.97 159.18 33.35 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.827 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -113.18 111.32 21.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -39.59 159.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 125.442 1.714 . . . . 0.0 112.527 -176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.0 128.75 35.07 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.951 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.58 145.06 25.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.7 t-160 -116.12 130.94 57.04 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.781 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.6 t80 -120.07 128.86 53.88 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.314 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -126.23 135.67 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.627 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.502 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.7 p90 -157.49 177.65 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.169 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -128.25 147.9 50.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.425 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.8 p -79.87 170.59 16.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.178 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -84.48 -171.29 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.222 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 140.88 36.92 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.092 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.386 -179.074 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.72 169.87 15.22 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.569 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.0 Cg_exo -58.05 172.23 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.561 2.174 . . . . 0.0 113.34 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -98.66 163.35 12.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.567 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.75 143.7 98.21 Favored Pre-proline 0 N--CA 1.491 1.594 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.372 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -71.63 172.51 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.66 1.573 . . . . 0.0 110.582 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' N ' ' NE2' ' A' ' 26' ' ' GLN . 28.1 mtmt -99.06 142.21 30.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -112.29 111.37 22.2 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.037 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -92.05 144.03 25.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.0 131.45 10.46 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.22 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -128.07 125.83 40.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.1 ttm -107.65 131.52 54.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.89 151.97 28.09 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.429 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.18 10.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.157 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -79.97 -22.46 42.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.123 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.74 -37.16 3.84 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.051 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.1 p-10 -138.56 46.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -121.48 113.25 19.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.536 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 mm -116.35 129.16 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.688 -169.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -114.21 127.38 55.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.8 t -110.69 118.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -95.75 130.63 42.6 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.62 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 55.6 mt -99.6 109.43 21.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 123.678 0.611 . . . . 0.0 109.978 -174.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -94.69 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.74 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -79.01 140.41 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' N ' ' A' ' 7' ' ' LYS . 2.2 pt20 -136.87 -70.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.329 -171.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -115.88 101.29 8.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.004 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.02 -34.54 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.31 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.94 52.1 0.35 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.19 18.78 35.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.597 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 68.6 m 40.75 61.85 6.73 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.9 Cg_endo -87.08 51.36 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.709 1.606 . . . . 0.0 108.694 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.6 mm -88.2 149.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 122.046 0.927 . . . . 0.0 111.446 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.546 HH11 ' HG ' ' A' ' 55' ' ' SER . 45.9 mtp85 -132.05 123.61 27.58 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.943 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.532 ' H ' ' N ' ' A' ' 56' ' ' GLY . 6.0 p-80 33.65 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.6 m-85 -142.02 156.46 45.43 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.862 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.57 109.91 21.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 60' ' ' VAL . 46.8 t -114.11 123.67 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.068 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.23 137.87 46.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.804 1.315 . . . . 0.0 108.057 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.39 157.53 44.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 117.966 -1.494 . . . . 0.0 112.294 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.3 ptm180 -134.23 166.54 22.55 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.941 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.02 -170.72 2.01 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.91 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.83 40.17 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.089 172.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.44 -58.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.597 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.596 ' HG ' ' HZ1' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -125.72 157.55 37.1 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.417 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.6 pt-20 -101.3 162.57 12.8 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.282 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 25.24 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.838 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.596 ' HZ1' ' HG ' ' A' ' 45' ' ' SER . 70.6 mmtt -75.83 162.99 69.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -44.28 100.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.747 1.632 . . . . 0.0 110.869 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.66 175.65 4.07 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.42 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.34 155.64 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.384 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -113.96 135.36 54.08 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.861 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 2.1 mt -85.18 167.06 27.9 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.415 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.4 Cg_exo -65.12 154.65 72.47 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.729 1.619 . . . . 0.0 109.91 172.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.546 ' HG ' HH11 ' A' ' 34' ' ' ARG . 9.0 t -65.62 85.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.588 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 113.4 61.9 0.42 Allowed Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.327 -0.939 . . . . 0.0 110.94 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 t -97.08 164.78 12.37 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.582 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.3 -18.69 14.76 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.87 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.435 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.0 p-80 -160.03 172.86 16.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.898 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.2 p -134.8 155.0 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.232 171.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -139.06 151.46 46.77 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.863 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -139.37 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.574 173.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -134.85 137.56 43.38 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.764 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 90.07 48.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.843 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.2 mm? -96.72 -177.47 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.986 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 133.5 40.88 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.752 0.787 . . . . 0.0 111.46 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.66 156.13 39.72 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.254 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.3 t30 46.37 46.04 13.63 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.199 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.8 154.65 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.077 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.61 147.58 24.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.528 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 18.2 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.476 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -120.24 119.78 34.19 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.956 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.69 121.41 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 32.9 m-85 -110.92 124.27 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.9 t -121.08 122.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.856 0.722 . . . . 0.0 110.725 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.27 155.41 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -125.52 157.28 37.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.408 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 29.9 tt0 -111.79 156.33 22.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.712 -1.195 . . . . 0.0 107.801 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.9 t-20 -137.04 150.03 47.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -37.69 -35.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.145 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -125.73 48.35 2.08 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.732 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.25 -162.18 27.22 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.323 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -119.08 159.15 24.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.85 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 26.6 t -121.02 119.35 32.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -40.75 164.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.639 1.837 . . . . 0.0 113.231 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.92 140.09 31.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.519 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.6 146.63 28.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.457 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.64 129.85 56.39 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.021 -1.071 . . . . 0.0 111.469 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -117.97 130.63 56.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.163 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.457 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -127.64 141.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.75 -176.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.536 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 40.0 p90 -160.09 178.11 10.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.971 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -127.86 147.74 50.45 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.775 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -80.04 170.31 16.64 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.133 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -80.43 -179.63 7.25 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.892 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.67 144.1 28.32 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.382 -179.263 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.9 172.32 15.86 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.603 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.1 Cg_exo -61.22 172.43 3.23 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.566 2.177 . . . . 0.0 112.936 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -97.56 152.49 18.98 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.548 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.74 144.73 72.91 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.49 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.19 164.27 30.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.251 1.301 . . . . 0.0 110.212 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -102.35 129.29 48.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.3 mt -102.79 110.86 22.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.073 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -89.73 139.6 30.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.16 118.37 6.16 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.488 -1.339 . . . . 0.0 112.033 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 75.6 mt-30 -112.73 105.63 13.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.443 ' CE ' HD11 ' A' ' 19' ' ' ILE . 23.6 mtp -103.8 127.66 51.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.016 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -79.91 118.03 4.63 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.845 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.45 13.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.786 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.7 m-20 -79.85 -24.25 41.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.984 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 156.58 -69.96 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.493 -1.813 . . . . 0.0 112.891 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -143.46 18.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.736 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -75.81 115.12 15.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.981 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.501 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 15.6 mm -117.03 123.84 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.716 -173.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.4 124.48 52.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.903 0.752 . . . . 0.0 109.345 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.566 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.8 t -104.37 109.41 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.0 t-20 -88.87 128.59 35.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.563 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.12 102.37 14.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.434 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.73 132.55 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -107.01 148.25 28.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.283 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -130.61 -63.76 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.055 -173.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 5.1 m-20 -132.86 116.52 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.162 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.1 m-20 -133.42 -35.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.04 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.4 53.65 0.42 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 20.81 37.09 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.1 t 44.08 61.15 11.18 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.83 -176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -87.86 44.24 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.518 1.478 . . . . 0.0 109.013 172.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.78 148.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.398 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.5 mtt180 -130.82 126.04 35.26 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.185 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.3 p-80 31.95 169.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 54.1 m-85 -123.5 138.88 54.48 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.32 172.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.409 HD13 ' HB ' ' A' ' 76' ' ' VAL . 10.4 mt -100.27 100.6 11.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 51' ' ' ILE . 48.2 t -109.1 121.97 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.4 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -133.33 140.54 47.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.727 1.267 . . . . 0.0 107.749 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.49 155.42 43.09 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 8.8 ptt180 -131.48 163.08 28.76 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.404 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.14 169.52 11.15 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.458 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -74.13 43.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.733 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.98 -57.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.186 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -128.44 156.42 43.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -104.78 160.59 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.774 -1.171 . . . . 0.0 112.21 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.507 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.5 m95 28.36 89.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.101 -1.409 . . . . 0.0 113.749 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 61.5 mttm -76.24 163.4 66.62 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.323 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.31 105.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.832 1.688 . . . . 0.0 110.551 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -78.17 174.49 11.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.849 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.92 136.25 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.099 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 18.5 ttp85 -105.52 110.62 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.895 169.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 2.8 mt -69.09 162.14 67.54 Favored Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.606 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -79.18 147.53 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.12 1.88 . . . . 0.0 109.173 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 m -61.47 127.33 30.97 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.671 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.91 43.17 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -97.03 167.04 11.31 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.939 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.58 -47.22 3.0 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.654 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -148.17 167.62 24.59 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.962 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.1 p -119.36 145.06 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.479 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -131.31 148.69 52.71 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.831 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.2 pp -140.7 136.72 32.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.425 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -142.7 158.61 43.48 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.846 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t 75.9 45.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -92.9 -175.02 3.77 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.483 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 35.3 t70 -82.45 141.46 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.128 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.546 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.8 m95 -77.89 153.42 32.64 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.376 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.2 47.22 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.342 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.78 153.07 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.26 149.07 22.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.531 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 20.7 m-85 -133.45 141.7 47.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.393 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -119.76 118.1 29.97 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.576 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.98 123.67 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 56.6 m-85 -111.96 126.34 55.03 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.67 119.38 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 124.021 0.826 . . . . 0.0 110.462 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 86' ' ' ALA . 2.5 t -110.22 157.42 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.35 158.1 40.74 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.37 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.54 160.62 17.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.53 -1.268 . . . . 0.0 107.924 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.485 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -144.76 151.46 38.88 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.08 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -37.28 -44.03 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.315 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.99 41.79 1.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.42 -154.15 22.32 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.325 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -123.35 162.02 23.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.868 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 5.7 t -119.67 115.42 23.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -40.34 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 125.646 1.841 . . . . 0.0 113.458 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 76' ' ' VAL . . . -83.37 131.65 35.04 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.944 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.24 143.0 30.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.48 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -113.74 129.08 56.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.45 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -114.89 123.88 50.28 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.669 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -122.71 134.05 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.11 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.501 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 43.3 p90 -156.41 178.68 10.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.501 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.94 51.71 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.137 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 p -84.98 165.26 17.73 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -80.18 -172.78 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.158 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.33 140.51 39.15 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.01 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 116.586 -1.673 . . . . 0.0 110.707 -178.699 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.024 0.44 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.41 173.87 15.22 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.452 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -59.86 172.41 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.541 2.161 . . . . 0.0 112.984 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 m -93.8 159.58 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.603 172.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.79 146.72 90.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.5 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.5 169.0 18.16 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.428 1.419 . . . . 0.0 110.642 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -104.38 130.94 52.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -105.8 113.46 27.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.396 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -95.55 139.41 31.85 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.562 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.44 123.34 7.83 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.442 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.55 119.75 33.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.77 131.04 51.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.477 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.61 153.16 24.73 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.718 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 8.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-20 -79.84 -22.34 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.969 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.39 -36.38 4.43 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.318 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -131.35 -1.36 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.984 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -68.05 113.39 5.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.321 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.8 mm -115.75 127.17 73.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.1 -175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -115.74 124.63 51.28 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 63.3 t -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 114.446 -1.252 . . . . 0.0 107.941 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -88.27 128.47 35.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.091 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.51 106.43 18.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.908 0.755 . . . . 0.0 109.704 -171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.07 131.04 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.637 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -102.0 145.86 28.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.946 0.779 . . . . 0.0 109.586 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.453 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.4 -90.26 0.38 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.934 -175.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 24.1 m-20 -104.46 111.36 23.99 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.799 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -134.35 -33.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.196 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.81 51.94 0.33 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.11 19.62 38.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.593 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 43.46 60.78 10.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 114.781 -0.71 . . . . 0.0 112.802 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -87.8 43.65 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.594 1.529 . . . . 0.0 108.815 172.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mm -76.58 152.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.272 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.3 mtt180 -127.74 114.43 17.27 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.2 p-80 31.83 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.401 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 77.8 m-85 -135.43 152.14 51.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.551 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -111.17 112.02 23.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.1 t -114.95 129.59 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.054 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HD3' ' CG ' ' A' ' 47' ' ' TRP . 40.2 ttmt -134.58 134.6 41.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.895 1.372 . . . . 0.0 108.086 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.76 159.83 41.81 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.791 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 12.6 ptt180 -142.99 172.32 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -126.65 169.55 13.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.989 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.9 44.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.734 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.16 -54.33 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.94 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 p -133.6 156.63 47.49 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.53 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -86.63 -163.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.982 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.43 ' CG ' ' HD3' ' A' ' 39' ' ' LYS . 9.7 m95 -23.22 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.2 mptp? -77.9 167.01 39.42 Favored Pre-proline 0 N--CA 1.489 1.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.687 170.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 11.5 Cg_exo -50.62 108.57 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.843 1.695 . . . . 0.0 110.528 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -53.25 161.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.755 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.79 149.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.078 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -114.32 131.38 56.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.233 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -79.64 167.88 30.67 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.817 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.43 154.85 55.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.79 1.66 . . . . 0.0 108.867 169.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -80.18 113.31 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.973 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 46.51 3.7 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.3 p -96.8 -178.01 4.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.892 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.35 -56.77 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.315 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -146.04 164.87 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.669 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 7.1 p -109.88 144.01 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.66 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.13 147.22 50.96 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.019 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.9 OUTLIER -138.76 138.28 37.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.001 173.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -137.17 163.18 31.49 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.494 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m 63.59 53.41 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.664 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.8 mm? -96.21 -176.25 3.61 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.849 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.478 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.6 m-20 -76.94 132.47 39.07 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.639 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -72.98 154.52 40.49 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.013 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 46.32 47.92 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.657 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.78 153.45 48.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.935 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.74 145.93 25.87 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.227 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.2 m-85 -132.14 145.14 51.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 123.918 0.761 . . . . 0.0 112.526 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.37 122.83 40.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.433 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.1 125.49 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.0 m-85 -112.85 127.23 56.12 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.63 124.19 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.3 t -109.27 157.21 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.83 44.31 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.467 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.0 tt0 -110.6 164.62 12.55 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.782 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.3 t-20 -146.27 149.68 34.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.021 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.401 ' HA ' ' NE ' ' A' ' 34' ' ' ARG . 32.3 tt0 -38.22 -42.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.447 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -115.54 43.01 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.533 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.67 -158.49 27.68 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.986 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 157.92 40.78 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -123.32 119.25 29.55 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.586 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -43.39 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.602 1.814 . . . . 0.0 113.23 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -87.66 140.45 29.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.804 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.57 29.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.447 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -114.68 131.61 56.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.545 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -118.56 129.62 55.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.897 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.447 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.75 139.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.496 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.4 p90 -158.84 175.9 13.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.167 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.44 147.19 49.83 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.654 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -79.91 169.64 17.61 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.238 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -80.51 -176.37 5.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.154 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.22 147.74 25.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.107 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.69 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.51 155.03 6.36 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.8 Cg_exo -68.3 170.79 13.96 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.4 m -82.69 -157.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.824 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.35 35.86 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 9.7 Cg_endo -67.52 160.75 46.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.188 1.258 . . . . 0.0 110.661 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 126.05 47.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -100.72 113.63 26.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.317 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -98.42 144.22 28.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.427 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.47 132.31 10.38 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.14 -171.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.443 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.7 mt-30 -125.13 128.67 48.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.06 133.84 51.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.678 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.55 150.6 21.31 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.785 -1.198 . . . . 0.0 111.789 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.79 10.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.973 -0.613 . . . . 0.0 112.429 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.2 m-20 -79.8 -21.83 43.83 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.996 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.0 -43.02 1.76 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.194 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.09 40.02 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.981 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -112.34 116.71 30.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.543 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.7 mm -120.47 127.87 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 120.091 -0.643 . . . . 0.0 110.648 -170.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -112.8 125.4 54.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.152 0.907 . . . . 0.0 108.599 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.8 t -109.09 117.88 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.443 ' ND2' HE21 ' A' ' 11' ' ' GLN . 6.3 m-80 -98.3 129.34 45.0 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.379 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -98.58 102.56 14.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.274 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.1 mm -90.74 129.99 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.013 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HZ2' ' HG ' ' A' ' 31' ' ' SER . 30.6 mtpt -97.86 156.6 16.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.787 0.68 . . . . 0.0 109.723 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -144.61 -50.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.356 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.9 m-20 -141.51 109.15 5.64 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.211 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.6 m-20 -131.06 -31.72 1.67 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.66 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.38 50.99 0.59 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.83 27.29 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.601 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 8.4 m 45.77 59.1 15.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.2 Cg_endo -89.01 42.41 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.438 1.425 . . . . 0.0 109.547 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.405 HD12 HD21 ' A' ' 79' ' ' ASN . 22.7 mm -82.42 151.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.916 0.865 . . . . 0.0 111.255 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -130.25 115.06 16.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.677 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.5 p-80 37.38 -172.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 86.2 m-85 -139.94 154.05 47.1 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.187 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.92 109.9 20.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.73 121.26 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.88 -173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -132.42 140.24 48.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.607 1.192 . . . . 0.0 108.132 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.36 156.22 43.65 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.808 -1.557 . . . . 0.0 112.389 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 5.0 ptm180 -129.17 160.34 33.2 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.598 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -114.14 -172.88 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.146 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.5 tp -91.31 41.69 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.448 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.48 -58.86 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -120.02 151.29 39.21 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.387 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -106.68 153.77 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.825 -176.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.544 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 38.83 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.652 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 65.2 mttm -77.28 162.75 68.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.255 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.2 Cg_exo -43.39 99.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.946 1.764 . . . . 0.0 110.814 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.67 175.71 6.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.268 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.96 153.91 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.301 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -113.49 135.85 53.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.929 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.4 mt -84.71 162.68 49.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.824 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -69.16 145.7 61.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.716 1.611 . . . . 0.0 109.755 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.4 m -59.8 102.6 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 123.934 0.771 . . . . 0.0 111.479 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 52.68 0.56 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -97.13 -179.49 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.563 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.98 -34.59 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.515 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -148.51 167.7 24.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.204 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.1 p -133.4 153.97 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.746 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -138.76 151.68 47.3 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.568 -1.253 . . . . 0.0 112.515 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.25 142.7 42.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.74 173.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -142.94 153.14 42.76 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.081 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t 72.25 42.98 0.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.589 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.62 -172.31 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.666 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 4.6 m-20 -85.29 143.33 28.77 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.637 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -76.46 154.69 34.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.744 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.59 49.41 6.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.768 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.92 49.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.575 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.51 147.91 23.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.407 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.532 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 30.8 m-85 -133.0 142.72 48.99 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.515 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 4.6 mp0 -119.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.78 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.91 122.7 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.0 m-85 -111.1 124.2 51.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.34 120.8 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.863 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.76 158.05 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.17 164.9 22.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.658 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.2 tt0 -118.71 162.48 18.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.222 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.532 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.5 t-20 -151.16 154.47 36.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.356 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -41.99 -34.02 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.61 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -79.41 -45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.891 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.76 -118.71 0.51 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -118.46 163.2 17.11 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.613 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.92 116.03 22.93 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.869 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -39.05 158.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.297 1.623 . . . . 0.0 112.784 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.04 139.71 32.33 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.544 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.37 146.29 30.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.3 t-160 -116.47 130.87 56.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.785 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 74.6 t80 -118.01 130.22 56.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.21 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.58 140.52 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.971 -176.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.543 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 36.6 p90 -161.57 179.04 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -130.63 148.48 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.836 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -79.91 172.3 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.522 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -85.54 -171.22 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.099 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.96 142.77 35.1 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.081 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 116.199 -1.858 . . . . 0.0 110.443 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.33 13.57 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.434 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.448 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.1 Cg_endo -63.77 166.65 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.36 2.04 . . . . 0.0 112.586 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.15 165.79 15.47 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.468 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.79 142.85 88.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.11 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.42 167.22 23.0 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.412 1.408 . . . . 0.0 110.54 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -101.7 131.83 47.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.02 113.74 27.52 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.844 -1.142 . . . . 0.0 110.277 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.36 142.29 32.04 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.257 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -118.51 136.46 12.21 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 118.877 -1.63 . . . . 0.0 113.82 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -128.43 137.91 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.647 -0.777 . . . . 0.0 109.464 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.406 ' CE ' HD13 ' A' ' 19' ' ' ILE . 36.5 ttm -109.33 134.42 51.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.502 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.62 146.15 22.26 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.855 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.87 8.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.89 -30.11 40.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.783 175.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.54 -39.43 2.06 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.407 -1.378 . . . . 0.0 113.174 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -130.27 -14.75 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.697 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -54.17 113.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.214 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.544 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.3 mm -116.78 130.71 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.076 -174.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -116.98 124.77 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.859 0.724 . . . . 0.0 109.084 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -110.23 120.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -97.09 133.22 42.04 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.343 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 41.0 mt -101.55 101.45 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -93.78 131.01 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HZ2' ' CB ' ' A' ' 31' ' ' SER . 32.0 mtmt -101.74 157.66 16.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.738 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -51.44 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.649 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -145.4 103.93 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.428 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.6 m-20 -117.25 -40.21 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.738 0.649 . . . . 0.0 109.714 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.57 52.95 0.21 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.29 20.56 29.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.599 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 19.5 m 42.16 60.84 9.12 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.9 Cg_endo -90.44 42.85 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.553 1.502 . . . . 0.0 109.112 172.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mm -81.44 151.42 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.989 0.899 . . . . 0.0 111.367 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.4 mtt180 -130.52 114.37 15.41 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.835 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.7 p-80 35.77 -170.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.484 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.4 m-85 -139.99 150.64 44.71 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.006 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.07 110.86 23.26 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.52 127.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.812 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -132.49 140.7 48.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.012 1.445 . . . . 0.0 107.834 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.17 157.01 43.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.56 -1.656 . . . . 0.0 112.591 177.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.8 ptm180 -134.41 165.3 25.48 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.354 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -127.53 177.74 6.56 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.303 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.56 40.96 0.53 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.838 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -142.34 -62.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.904 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -129.7 171.23 12.87 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.267 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -116.46 160.87 19.96 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.211 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.9 m95 28.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.347 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 52.0 mttp -72.63 160.08 83.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.351 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.7 Cg_exo -41.77 107.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.1 1.866 . . . . 0.0 111.579 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.16 160.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.623 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -131.35 147.95 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.156 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -113.71 125.03 53.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -69.88 164.23 53.4 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.271 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.63 172.21 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.804 1.669 . . . . 0.0 110.635 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -74.5 76.92 1.95 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.974 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.47 64.78 0.59 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.526 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -89.63 -176.99 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.851 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -126.63 -14.11 5.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.503 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.433 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 42.2 p-80 -159.18 170.34 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.753 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p -136.87 150.81 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 124.864 1.353 . . . . 0.0 108.582 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -133.72 150.0 51.5 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.152 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -143.85 144.88 31.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.539 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -140.27 172.17 13.12 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.789 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.7 m 57.84 59.66 3.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.631 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 19.6 mt -95.21 177.9 5.71 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.353 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.51 124.15 22.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.252 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.489 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 77.1 m95 -70.74 148.49 47.9 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 50.77 49.77 20.32 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.671 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.27 152.27 50.69 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.27 151.78 22.41 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 1.7 m-85 -137.04 141.28 42.47 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.6 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.65 121.08 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.721 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.26 123.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.438 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 43.9 m-85 -113.03 125.51 54.48 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.46 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.534 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 86' ' ' ALA . 2.0 t -107.2 159.41 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.07 155.38 44.46 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.548 -1.261 . . . . 0.0 109.805 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.8 tt0 -110.81 163.85 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.86 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -153.69 154.21 33.7 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.577 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -40.45 -43.48 1.82 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.327 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -101.84 37.05 1.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.33 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.23 -134.02 8.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.22 -179.99 6.86 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.585 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -130.05 124.31 32.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -45.79 171.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 125.516 1.76 . . . . 0.0 111.686 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -88.55 145.96 25.42 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.605 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.72 147.96 27.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.908 -1.497 . . . . 0.0 106.982 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.471 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.8 t-160 -116.14 130.96 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.592 -173.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.4 t80 -118.65 130.56 55.92 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.737 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.95 140.44 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.854 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.476 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 48.3 p90 -157.44 -178.76 7.58 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.849 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -128.97 145.07 51.34 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.353 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.93 168.42 19.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.901 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.1 m -81.78 -176.47 6.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.291 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.23 144.16 30.43 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.321 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.219 -1.848 . . . . 0.0 110.505 -178.088 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.032 0.444 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.4 178.54 29.95 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.402 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.6 Cg_exo -57.93 171.85 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.417 2.078 . . . . 0.0 113.011 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -95.43 159.66 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.682 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.32 141.86 98.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.896 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.09 167.52 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.28 1.32 . . . . 0.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -100.64 127.77 46.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.38 109.79 21.54 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.922 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.13 137.81 37.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.49 142.87 16.16 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.489 -1.815 . . . . 0.0 113.791 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -129.4 138.79 51.68 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.093 -1.053 . . . . 0.0 109.361 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 19' ' ' ILE . 52.2 tpp -104.72 131.52 52.07 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.42 150.31 23.43 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.525 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.72 8.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.0 m-20 -79.87 -23.03 42.2 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.125 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.8 -50.87 0.76 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.649 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 9.8 p30 -123.87 1.36 8.7 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.33 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.6 m -69.56 116.75 10.32 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.301 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.508 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -115.41 127.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.776 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -115.07 124.78 52.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.023 0.827 . . . . 0.0 109.072 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.5 t -112.45 120.69 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -98.2 130.48 44.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.04 100.88 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.27 130.7 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.868 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -104.16 153.04 21.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.842 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.05 -49.89 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.915 -174.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.6 m-20 -139.76 111.63 7.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.008 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -130.02 -37.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.123 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.51 55.05 0.36 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 20.42 35.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.619 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.7 t 44.15 60.61 11.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 114.8 -0.7 . . . . 0.0 112.728 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.619 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -89.42 43.39 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.393 1.395 . . . . 0.0 109.214 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mm -88.54 149.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.877 0.846 . . . . 0.0 111.266 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 69.2 mtt85 -131.46 123.55 28.34 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.867 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.9 p-80 36.69 -173.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.7 m-85 -139.74 153.57 47.22 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.784 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.49 109.42 21.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.32 125.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.204 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -136.45 141.1 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.56 158.06 43.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.069 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 9.0 ptm85 -133.96 159.36 40.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.645 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -116.81 -177.8 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.92 41.58 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.792 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.65 -61.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.335 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -118.99 149.68 41.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.528 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 23.9 pt-20 -117.53 144.73 44.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.588 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.558 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 56.87 77.48 0.26 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.027 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 25.9 mmmt -72.57 163.27 69.15 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.541 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -46.57 99.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.823 1.682 . . . . 0.0 110.444 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.32 172.7 2.99 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.529 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.17 153.81 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.951 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -112.84 131.77 55.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.949 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.8 mt -81.84 163.76 52.06 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.861 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.26 152.43 76.46 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.771 1.647 . . . . 0.0 110.438 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.422 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 33.7 m -68.61 93.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.885 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.91 52.71 0.46 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -97.22 170.13 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.394 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.93 -36.66 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.996 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -146.56 169.48 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.579 -1.248 . . . . 0.0 112.124 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -132.76 151.79 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.885 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ptp -135.65 148.31 48.91 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.894 -1.123 . . . . 0.0 112.022 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.32 144.2 34.46 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.458 174.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -140.16 170.36 15.98 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.663 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 m 61.19 57.03 2.56 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.042 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 17' ' ' ASN . 10.6 mp -94.95 178.52 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -71.99 133.06 45.1 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.248 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -72.93 151.47 41.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.837 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 46.97 49.08 15.05 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.54 152.08 48.7 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.051 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -92.66 148.72 21.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 11.1 m-85 -136.05 143.33 44.62 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.692 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 3.7 mp0 -119.2 122.66 42.49 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.139 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.96 123.4 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.7 m-85 -112.57 125.98 54.85 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.6 t -122.45 121.8 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 124.047 0.842 . . . . 0.0 110.677 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.412 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.1 t -106.33 159.07 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.34 156.68 42.7 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.751 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.41 153.82 25.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.392 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.507 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.2 t-20 -141.25 150.83 43.13 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.143 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -36.12 -43.82 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.846 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -108.33 35.9 3.0 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -152.31 21.5 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.072 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -120.97 158.15 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -118.32 120.43 37.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -40.05 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 125.81 1.944 . . . . 0.0 113.492 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -84.0 136.41 34.06 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.051 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.94 145.68 28.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.49 129.43 56.54 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.574 -174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 71.6 t80 -117.5 129.75 56.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.34 140.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.749 -176.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.505 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.2 p90 -158.63 -179.34 7.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.071 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -129.55 147.63 51.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.568 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.4 p -79.88 166.83 21.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -82.44 -172.01 3.78 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.66 148.28 24.51 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.325 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 116.474 -1.727 . . . . 0.0 110.652 -178.799 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.54 169.53 14.14 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.493 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.9 Cg_exo -61.3 172.84 2.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.6 2.2 . . . . 0.0 112.99 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -97.06 163.45 12.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.479 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.0 99.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.164 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.91 172.14 12.31 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.451 1.434 . . . . 0.0 110.463 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -107.04 133.48 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.1 mt -106.46 115.9 31.01 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.262 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.39 140.49 31.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.45 129.05 9.37 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.656 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -124.53 124.73 42.9 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.9 ttm -106.96 133.76 51.13 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.8 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.25 150.55 22.83 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.596 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.35 14.01 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.074 -0.563 . . . . 0.0 111.936 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.86 -24.31 41.33 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.684 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 -40.53 2.45 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.706 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 9.4 p30 -138.18 48.68 1.96 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.92 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -120.82 115.11 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.542 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.05 129.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -114.01 125.16 53.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.3 t -107.7 115.0 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -96.73 130.41 43.98 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.313 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.84 109.66 22.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.637 -173.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.29 132.5 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -104.4 148.0 26.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.82 0.7 . . . . 0.0 109.408 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.56 -66.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.135 -174.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -127.77 110.92 13.09 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.27 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.7 m-20 -128.83 -37.09 1.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.986 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 56.87 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 18.65 43.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.609 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 45.16 60.15 13.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.791 -0.704 . . . . 0.0 112.87 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -88.89 42.52 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.458 1.438 . . . . 0.0 109.365 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.43 151.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.878 0.847 . . . . 0.0 111.446 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 78.4 mtt-85 -131.05 117.31 18.95 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.886 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.57 -173.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.45 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 82.2 m-85 -137.85 154.26 49.51 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.052 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mt -110.33 111.49 22.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 123.98 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.146 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -132.35 138.56 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.688 1.242 . . . . 0.0 107.938 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.2 p90 -144.05 158.43 43.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.916 -1.514 . . . . 0.0 112.45 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.4 ptm180 -141.88 169.79 16.94 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.442 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.59 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -128.14 168.87 14.8 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.767 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.92 43.53 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.724 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -153.4 -51.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.931 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 p -125.87 148.06 49.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.111 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -103.1 167.23 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.865 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.7 m95 18.33 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.952 -1.476 . . . . 0.0 114.226 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.7 mttp -77.18 163.55 64.17 Favored Pre-proline 0 N--CA 1.49 1.525 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.072 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.7 Cg_exo -44.68 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.803 1.668 . . . . 0.0 110.908 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.02 175.27 3.84 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.394 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.04 154.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.362 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.95 134.06 55.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.812 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.2 mt -82.42 162.99 54.33 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.027 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.88 169.86 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.773 1.649 . . . . 0.0 110.633 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -74.64 77.82 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.935 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.5 65.82 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 t -97.01 -174.54 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.71 -23.02 4.43 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.618 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.421 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.6 p-80 -160.23 168.31 25.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.994 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.5 p -131.87 151.4 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.268 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -137.3 152.07 49.36 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.827 -176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.14 139.1 33.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.43 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 64' ' ' SER . 51.8 mtmt -142.5 141.43 32.11 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.85 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.5 t 93.51 45.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.345 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.7 mm? -96.56 178.51 5.31 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.391 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -68.17 133.44 48.9 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.612 0.72 . . . . 0.0 111.493 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.73 154.25 39.69 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.227 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.42 48.9 8.23 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.565 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.63 49.82 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.802 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.37 144.05 26.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.59 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 6.0 m-85 -129.74 144.84 51.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.912 0.758 . . . . 0.0 112.463 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -119.79 124.01 45.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.409 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.2 t -116.07 123.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 38.9 m-85 -111.49 124.92 53.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -120.02 122.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 123.876 0.735 . . . . 0.0 110.567 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -106.94 157.8 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 155.63 42.86 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.58 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.67 158.87 18.78 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.233 -1.387 . . . . 0.0 107.73 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.6 t-20 -146.45 153.28 40.26 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.543 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -42.4 -37.68 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.466 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -103.01 29.77 5.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.5 -148.04 19.35 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.849 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -122.23 158.82 28.62 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.967 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.7 t -121.86 124.13 43.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.35 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -40.92 165.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.735 1.897 . . . . 0.0 113.59 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 76' ' ' VAL . . . -88.45 140.97 28.92 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.45 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.53 30.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.448 ' CE1' HG23 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.19 129.45 56.65 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.408 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -116.87 130.23 56.57 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.033 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.448 HG23 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.63 140.74 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.593 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.31 178.09 10.72 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.777 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -128.12 145.21 51.08 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.894 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.8 p -79.88 171.37 15.2 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.154 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -86.53 -170.47 3.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.134 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.72 141.19 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.242 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.536 -1.697 . . . . 0.0 110.672 -179.366 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.08 0.467 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.42 179.82 15.87 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 12.4 Cg_exo -56.89 173.26 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.601 2.201 . . . . 0.0 113.1 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -95.76 163.04 13.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.239 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.73 142.07 95.53 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.173 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.48 171.21 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.606 1.538 . . . . 0.0 110.686 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' CG ' HE22 ' A' ' 26' ' ' GLN . 38.1 mtpt -98.03 139.92 33.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.4 mt -111.29 110.21 20.59 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.15 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.04 141.51 28.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.793 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.8 123.32 7.29 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.17 -173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -120.88 123.09 41.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.3 ttm -104.14 131.86 50.99 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.19 146.25 23.75 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.719 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.14 9.53 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.76 -30.25 40.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.858 175.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.29 -41.47 1.68 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.062 177.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.91 -15.05 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.676 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.0 m -55.37 116.5 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.552 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.0 mm -117.55 130.35 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.552 -173.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.1 125.68 52.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.939 0.774 . . . . 0.0 108.996 172.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.572 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 60.2 t -107.33 113.47 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 126.69 37.0 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.212 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.11 107.22 19.54 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.899 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.2 mm -92.44 106.27 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.524 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.73 140.89 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.469 HE22 ' CG ' ' A' ' 7' ' ' LYS . 2.4 pt20 -138.17 -78.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.355 -172.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.1 m-20 -106.14 100.82 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.962 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -132.36 -35.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.277 -179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 51.45 0.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.01 17.75 36.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.594 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 41.39 61.09 7.99 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -86.48 51.58 2.6 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.685 1.59 . . . . 0.0 108.73 172.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.5 mm -87.41 150.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.031 0.92 . . . . 0.0 111.622 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.8 mtt180 -129.94 119.38 23.14 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.413 -1.722 . . . . 0.0 108.543 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 34.73 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.46 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.2 m-85 -139.52 151.18 45.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.009 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mt -107.48 110.78 22.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.2 128.2 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.913 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.73 140.23 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 125.036 1.46 . . . . 0.0 107.979 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.56 156.52 43.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.726 -1.59 . . . . 0.0 112.657 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -131.58 156.99 44.8 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.073 -177.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -119.33 168.56 10.8 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 tp -73.59 42.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.795 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.93 -57.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.083 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.3 m -128.62 153.06 47.65 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.141 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -104.99 165.49 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.044 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.428 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.62 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.448 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.9 mttm -77.03 159.99 77.2 Favored Pre-proline 0 N--CA 1.491 1.618 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.334 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 24.3 Cg_exo -40.45 111.65 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.188 1.926 . . . . 0.0 111.895 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.71 164.87 4.29 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.809 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -136.4 151.18 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.365 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -117.34 132.24 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.241 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -79.07 165.13 51.02 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.508 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.33 159.79 29.72 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.808 1.672 . . . . 0.0 110.682 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 95.34 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.94 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.455 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 96.92 65.35 0.92 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -97.14 -172.57 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.469 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -122.16 -43.81 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.741 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -147.13 167.44 24.13 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.061 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.572 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.5 p -122.48 149.54 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.375 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -132.87 147.12 52.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.606 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -139.48 137.76 35.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.991 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -139.55 158.16 44.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.463 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t 71.88 49.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.203 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.82 -174.22 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.233 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.6 133.51 38.44 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.666 0.746 . . . . 0.0 111.081 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.5 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 72.1 m95 -75.17 156.95 35.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.074 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 45.53 46.3 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.769 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.7 154.66 46.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.11 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -96.69 147.65 23.69 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.5 m-85 -134.0 140.85 46.98 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.471 -178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 119.48 34.26 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.205 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.6 t -113.77 127.65 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 55.0 m-85 -114.82 126.58 54.98 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.58 121.54 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.627 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.408 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.2 t -105.84 156.06 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.91 156.01 42.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.523 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -109.96 156.24 20.72 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.821 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 13.2 t-20 -140.53 149.88 43.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.958 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -34.14 -45.34 0.21 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.758 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -113.97 40.15 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.82 -156.85 26.11 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.378 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -120.33 159.6 24.71 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.725 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 24.8 t -120.59 120.64 36.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -41.0 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.633 1.833 . . . . 0.0 113.189 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -83.95 136.16 34.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.338 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.93 144.42 29.01 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.8 t-160 -114.81 130.08 56.8 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.284 -174.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.192 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.86 137.98 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.571 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.6 p90 -156.04 177.47 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.163 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.27 146.17 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.623 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -83.76 164.59 19.48 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -80.48 -171.13 2.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.273 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.15 139.18 39.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.208 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.461 -1.733 . . . . 0.0 110.801 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.48 175.42 18.74 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.2 Cg_exo -58.04 172.83 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.621 2.214 . . . . 0.0 113.31 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -101.6 162.54 12.82 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.407 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.92 142.27 85.26 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.364 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.82 154.12 67.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.501 1.468 . . . . 0.0 109.962 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -83.39 139.66 32.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 mt -109.03 108.98 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.313 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -93.89 144.71 25.19 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.462 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 130.58 9.57 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.302 -1.427 . . . . 0.0 112.889 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -125.37 129.87 50.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.0 ttm -107.28 134.49 50.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.55 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -90.52 151.53 21.42 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.679 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.91 9.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.11 -0.545 . . . . 0.0 112.353 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.92 -20.55 45.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.009 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 108.54 -41.98 2.07 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.633 -1.27 . . . . 0.0 111.163 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -127.86 2.15 6.01 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.915 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -65.42 111.92 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.248 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 8.5 mm -116.34 126.36 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.968 -176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -114.71 124.93 53.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 123.933 0.771 . . . . 0.0 108.949 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.4 t -108.87 118.58 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.7 128.42 42.56 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.6 mt -97.95 102.27 13.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 123.914 0.759 . . . . 0.0 109.079 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.31 103.04 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.715 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -77.6 149.95 34.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.75 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -147.31 -51.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.946 -1.101 . . . . 0.0 112.406 -172.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 106.11 7.06 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.098 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.4 m-20 -129.42 -39.33 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.22 57.16 0.38 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.65 18.42 41.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.618 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.8 t 44.76 60.47 12.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -89.15 43.98 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.476 1.451 . . . . 0.0 109.071 172.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.67 150.95 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.883 0.849 . . . . 0.0 111.543 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.8 mtt85 -129.22 117.56 20.93 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.07 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.9 p-80 32.02 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 69.4 m-85 -134.62 152.35 51.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.173 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.62 113.36 26.28 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.79 128.55 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.209 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -135.41 139.68 44.35 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.24 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.35 154.54 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.161 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.6 ptm180 -126.49 160.74 29.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.671 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -108.64 -169.27 1.47 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.97 41.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.587 172.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.22 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 p -121.65 150.02 42.35 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.999 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -113.27 150.04 33.01 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.22 -172.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.5 m95 47.79 83.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.562 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 46.1 mmtm -66.29 161.49 56.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.368 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -47.22 105.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.77 1.647 . . . . 0.0 110.81 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.25 154.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.464 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -129.55 148.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.269 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -114.26 128.59 56.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.753 -0.779 . . . . 0.0 108.899 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.58 163.97 63.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.712 -176.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -78.23 132.39 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.879 1.719 . . . . 0.0 107.74 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -56.58 131.95 50.24 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.44 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.26 34.26 5.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 m -96.98 152.47 18.69 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.961 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.07 -28.08 10.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.033 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -145.49 165.72 27.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.36 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 10.6 p -128.58 150.12 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.269 174.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -134.74 149.85 50.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.741 -1.184 . . . . 0.0 112.509 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -141.61 146.48 36.28 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.765 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -139.2 178.57 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.867 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.1 m 54.34 55.24 8.35 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.733 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 25.1 mt -91.49 176.55 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.867 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -73.45 128.22 34.89 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.828 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.408 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 81.7 m95 -71.06 149.92 46.06 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.951 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 48.05 50.33 16.12 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.604 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.43 154.51 47.65 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.792 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.94 147.83 23.27 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.285 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 65' ' ' LEU . 13.5 m-85 -133.23 143.88 49.43 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.521 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.04 119.24 29.76 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.16 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.39 124.57 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 53.8 m-85 -114.21 125.78 54.31 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.36 123.46 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 123.991 0.807 . . . . 0.0 110.416 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 86' ' ' ALA . 2.1 t -109.72 157.18 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.26 156.4 40.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.079 176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -110.12 160.25 16.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.823 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -146.46 151.81 38.0 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.372 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -34.89 -46.15 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.644 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -109.19 38.81 2.2 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.99 -150.55 20.65 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.147 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -123.23 159.58 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.04 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -118.99 118.06 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -39.32 163.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.849 1.968 . . . . 0.0 113.725 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -85.44 137.49 32.88 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.15 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.34 29.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.03 130.39 56.93 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.534 -174.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -118.33 130.56 56.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.117 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.61 139.11 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.647 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.52 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 37.5 p90 -159.88 179.36 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.266 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -128.04 147.46 50.51 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.642 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.4 p -79.92 168.39 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.81 -170.45 3.0 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.172 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.25 141.61 36.47 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.16 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 116.143 -1.884 . . . . 0.0 110.398 -178.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.992 0.425 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.25 169.07 12.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.0 Cg_exo -59.15 169.85 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.372 2.048 . . . . 0.0 113.639 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -94.89 177.51 5.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.16 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.34 144.97 58.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.139 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -71.68 164.99 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.691 1.594 . . . . 0.0 110.531 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' CB ' HE22 ' A' ' 26' ' ' GLN . 10.3 mtpp -93.43 132.62 37.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.04 108.83 20.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.795 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.49 135.28 42.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.75 143.59 16.44 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.455 -1.831 . . . . 0.0 113.151 -171.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -131.14 139.56 49.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 108.942 172.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -108.88 132.77 53.72 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.708 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.39 150.74 27.47 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.326 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.19 13.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.931 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.94 -25.28 40.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.664 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.01 -44.63 1.46 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.066 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.481 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 10.8 p30 -134.41 44.8 2.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.321 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -112.9 110.63 20.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.558 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.7 mm -114.13 128.48 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.421 -170.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.38 124.82 51.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.3 t -111.84 120.13 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -96.65 130.7 43.82 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.524 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD12 ' CD2' ' A' ' 36' ' ' TYR . 40.2 mt -99.99 103.43 14.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.943 0.777 . . . . 0.0 109.114 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.67 108.4 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.554 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HZ2' ' HH ' ' A' ' 36' ' ' TYR . 16.6 mttm -70.13 169.43 13.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.2 pt20 -170.25 -69.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.689 -1.204 . . . . 0.0 111.399 -175.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 16.9 t70 -115.23 89.39 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.019 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -130.85 -17.63 3.14 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.776 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.34 52.35 1.6 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.417 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.27 22.75 50.71 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 44.26 64.37 7.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 114.78 -0.71 . . . . 0.0 112.736 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.7 Cg_endo -88.13 46.22 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 171.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 mm -92.55 151.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.197 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -128.19 115.19 17.99 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.05 -1.886 . . . . 0.0 108.098 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.1 p-80 35.69 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.509 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.3 m-85 -142.86 137.95 29.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.013 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -88.19 111.07 21.22 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.22 126.8 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.306 -175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -132.55 138.8 47.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 125.08 1.488 . . . . 0.0 107.632 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.17 156.31 43.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.715 -1.594 . . . . 0.0 112.223 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.2 ptm180 -134.88 163.54 29.6 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.892 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 71' ' ' TYR . . . -120.71 -168.25 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.773 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -93.28 40.54 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.825 170.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.8 -61.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.572 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.59 157.78 30.0 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.231 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -109.69 156.21 20.54 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.594 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.487 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.1 m95 34.42 83.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.108 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.2 mmtt -70.45 161.54 75.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.203 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.8 Cg_exo -43.2 107.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.982 1.788 . . . . 0.0 111.556 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -55.18 161.27 1.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.729 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.281 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttp85 -112.43 118.06 34.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.2 mm? -60.12 165.9 4.43 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.036 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.1 Cg_exo -61.47 141.67 92.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.37 1.38 . . . . 0.0 109.483 172.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -59.15 88.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.568 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . 106.52 58.9 0.6 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -97.12 -173.49 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.449 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.97 -25.48 3.59 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.536 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -160.07 167.51 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.394 -1.323 . . . . 0.0 112.574 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.564 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -130.73 150.27 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.671 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -134.92 147.74 49.89 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.777 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.558 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -140.46 142.86 35.31 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.226 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 178.68 6.68 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.536 -175.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m 49.06 56.89 7.1 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.687 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 10.2 mt -91.99 164.34 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.527 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.36 129.78 42.9 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.832 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -71.8 147.84 46.84 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 47.16 51.09 13.54 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.623 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.52 151.62 49.94 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.264 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -89.2 146.74 24.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 65' ' ' LEU . 1.5 m-85 -133.97 140.84 47.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.531 -176.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -122.11 123.4 41.46 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.585 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -113.79 122.57 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 39.7 m-85 -112.29 124.06 51.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.49 120.6 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.86 0.725 . . . . 0.0 110.702 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 86' ' ' ALA . 1.9 t -103.78 164.45 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 154.08 49.85 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.679 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.79 156.37 22.98 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.789 -1.165 . . . . 0.0 107.88 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -144.97 152.33 40.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -40.83 -40.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.144 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.65 35.83 2.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.91 -151.32 20.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.98 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -128.41 161.59 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.573 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -126.76 128.24 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.881 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -46.14 173.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 125.608 1.817 . . . . 0.0 112.906 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 76' ' ' VAL . . . -93.63 145.34 24.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.31 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.81 146.61 28.38 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 171.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.472 ' CE1' HG23 ' A' ' 90' ' ' VAL . 11.0 t-160 -115.69 129.8 56.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.457 -174.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 51.7 t80 -119.95 131.95 55.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.472 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.6 t -129.69 144.18 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.209 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 47.6 p90 -159.83 -177.97 6.72 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.977 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -129.64 145.66 51.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.471 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 169.22 18.23 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -84.43 -169.94 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.305 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.53 142.02 36.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.008 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 116.542 -1.694 . . . . 0.0 110.685 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.995 0.426 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.85 -87.85 1.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HG3' HD21 ' A' ' 79' ' ' ASN . 3.1 Cg_exo -61.77 169.25 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.824 . . . . 0.0 112.169 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 m -91.09 152.95 20.42 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.66 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 143.53 93.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.165 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.88 167.63 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.329 1.353 . . . . 0.0 110.45 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -103.4 132.69 49.45 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.1 mt -104.6 113.85 27.7 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.158 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -95.66 143.18 27.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 127.38 8.76 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.586 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -123.3 121.12 35.04 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.1 ttm -105.14 132.55 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.658 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.37 149.73 21.45 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.318 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -65.75 14.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.907 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.1 m-20 -80.01 -24.59 40.72 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.549 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.16 -42.73 1.87 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.41 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -131.84 10.02 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.18 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -77.98 112.81 15.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.256 -0.977 . . . . 0.0 108.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.504 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 9.5 mm -116.34 126.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.972 -172.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.38 127.11 56.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.4 t -108.01 116.55 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -97.28 129.4 44.58 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.424 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.2 106.39 18.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.758 0.661 . . . . 0.0 109.491 -173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -96.29 129.82 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -105.55 153.33 21.9 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.506 -177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.68 0.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.191 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.93 116.47 10.74 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.724 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.3 m-20 -126.66 -44.6 1.66 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.872 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.8 65.28 0.26 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.33 64.15 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -174.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.4 t 44.03 60.63 11.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 114.58 -0.81 . . . . 0.0 113.008 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 19.6 Cg_endo -91.24 52.28 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.782 1.655 . . . . 0.0 109.337 174.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.67 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.842 0.829 . . . . 0.0 111.423 -174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -131.41 118.91 20.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.034 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.4 p-80 36.1 -172.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.471 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.4 m-85 -140.26 151.07 44.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.754 176.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.96 111.61 23.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.8 t -114.8 124.45 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.324 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.7 141.33 46.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.789 1.306 . . . . 0.0 107.911 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.34 157.7 43.69 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.731 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -132.01 162.87 29.7 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.032 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . . . -113.2 -169.13 1.43 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.22 40.76 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.263 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.81 -59.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.504 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.512 ' CB ' ' HZ3' ' A' ' 48' ' ' LYS . 73.7 m -114.02 147.94 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.197 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.5 pt-20 -107.83 157.53 18.09 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.762 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.469 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.7 m95 31.51 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.185 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HZ3' ' CB ' ' A' ' 45' ' ' SER . 69.3 mmtt -72.57 162.04 76.11 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.111 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.4 Cg_exo -45.13 100.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.837 1.691 . . . . 0.0 110.614 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.34 173.06 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.617 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 tt -138.52 155.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.133 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -114.15 127.41 55.89 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.03 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -73.36 166.46 43.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.562 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.62 165.69 11.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.836 1.691 . . . . 0.0 110.635 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -75.43 79.5 2.48 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.071 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.69 57.96 0.34 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -97.04 170.19 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.546 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -120.32 -3.5 9.98 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.606 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -160.16 164.2 33.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.83 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.2 p -138.76 154.27 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.732 172.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptp -138.2 152.74 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.738 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -144.64 146.35 32.22 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.783 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -141.87 173.29 11.65 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.532 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t 58.65 60.77 2.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.455 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 14.6 mt -98.76 178.58 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.442 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.3 128.52 36.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.147 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.78 151.31 43.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.459 -1.296 . . . . 0.0 109.999 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.86 50.37 11.21 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.687 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.92 151.57 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.024 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -89.73 145.29 25.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 42' ' ' ALA . 1.9 m-85 -132.68 141.52 48.64 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.568 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.6 119.39 29.74 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.54 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -112.59 124.81 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.7 m-85 -112.71 125.49 54.37 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.74 121.99 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.406 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.4 158.26 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -127.5 158.42 37.45 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.634 -1.226 . . . . 0.0 109.235 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -112.86 157.41 21.44 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.289 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.465 HD21 ' HG3' ' A' ' 3' ' ' PRO . 15.3 t-20 -139.42 148.03 42.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.696 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -35.61 -44.06 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.796 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -114.89 41.87 2.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.575 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.51 -155.15 25.95 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.563 -1.303 . . . . 0.0 111.188 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -122.28 167.44 13.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.671 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 2.2 t -123.93 116.97 23.75 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -40.71 162.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.554 1.784 . . . . 0.0 113.284 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.87 136.33 35.36 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.356 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.58 146.28 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.54 130.56 56.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.596 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -116.57 126.81 53.83 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.961 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -124.37 136.68 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.561 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 40.4 p90 -157.33 -178.93 7.72 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.012 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -129.55 146.48 51.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.486 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -79.92 168.97 18.55 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.734 -0.787 . . . . 0.0 108.885 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.93 -169.97 2.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.656 -0.817 . . . . 0.0 110.184 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.89 140.57 39.5 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 116.551 -1.69 . . . . 0.0 110.808 -178.606 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.977 0.418 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.71 173.06 15.19 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 4.2 Cg_exo -59.86 165.28 10.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.427 2.085 . . . . 0.0 113.269 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -86.29 169.77 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.559 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.41 139.02 63.51 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.746 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -69.58 169.04 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.561 1.507 . . . . 0.0 110.411 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HB2' HE22 ' A' ' 26' ' ' GLN . 1.1 tmmt? -96.12 138.44 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.3 107.18 17.98 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.789 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -86.71 140.8 29.42 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.455 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.52 119.56 6.3 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.89 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -120.31 117.54 28.07 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.475 ' CE ' HD13 ' A' ' 19' ' ' ILE . 55.4 tpp -100.44 132.33 45.88 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.156 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.08 149.01 20.52 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.456 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -65.38 13.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.08 -0.56 . . . . 0.0 112.047 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.91 -25.21 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.448 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.08 -48.8 0.91 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.575 -1.298 . . . . 0.0 111.388 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -128.44 0.08 5.63 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.104 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.415 ' HG ' ' CB ' ' A' ' 15' ' ' ASP . 32.9 m -67.84 117.98 10.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.339 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.512 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.03 128.71 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.307 -172.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -114.26 127.3 55.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 123.981 0.801 . . . . 0.0 108.926 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 53.9 t -107.95 117.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -90.9 124.55 35.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.899 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -98.51 96.89 8.29 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.91 106.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.612 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -77.06 151.43 35.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.443 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.8 pt20 -148.06 -63.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.296 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.21 93.51 3.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.344 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.08 -34.51 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.054 0.846 . . . . 0.0 109.944 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.48 55.16 0.33 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.62 46.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -175.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.571 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 66.2 m 41.95 61.9 7.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.5 Cg_endo -86.7 46.6 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.715 1.61 . . . . 0.0 108.503 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.7 mm -82.58 152.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.468 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 35' ' ' HIS . 49.9 mtt180 -129.6 114.26 15.83 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.544 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.499 ' H ' ' H ' ' A' ' 56' ' ' GLY . 9.1 p-80 35.46 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.518 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.0 m-85 -142.2 151.74 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.744 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.78 109.56 21.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.3 t -115.31 123.32 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.341 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.84 140.37 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.613 1.196 . . . . 0.0 108.028 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.36 154.06 41.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.971 -1.492 . . . . 0.0 112.492 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.2 ptm180 -131.52 165.0 24.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.916 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -121.48 174.64 6.64 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.153 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -79.45 42.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.045 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.52 -59.02 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.288 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.8 m -124.7 152.99 43.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.056 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -101.98 162.68 12.72 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.808 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 25.16 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.575 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HZ3' ' HH ' ' A' ' 71' ' ' TYR . 50.5 mttp -74.91 163.37 68.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.843 175.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.95 99.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.916 1.744 . . . . 0.0 110.917 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.55 175.97 3.17 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.352 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.74 154.99 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.207 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -116.68 129.79 56.35 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.842 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -75.25 163.49 67.48 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.09 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.79 144.34 48.27 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.775 1.65 . . . . 0.0 109.677 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -51.95 110.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.935 0.772 . . . . 0.0 111.842 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 94.33 58.99 1.18 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.865 -1.16 . . . . 0.0 110.581 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -97.19 -177.27 3.79 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.135 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -134.4 -33.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.918 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -143.96 163.17 34.22 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.811 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -131.3 152.05 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.279 173.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.418 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -137.73 156.03 48.44 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.086 -176.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -144.22 140.98 29.61 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.121 174.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -140.61 158.62 43.72 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.276 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t 72.01 51.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.443 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 65' ' ' LEU . 3.7 mm? -100.6 -176.8 3.3 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.626 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.47 131.17 40.81 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -73.3 155.77 39.12 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.985 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 48.37 45.68 20.47 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.55 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.01 152.9 49.82 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.357 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -95.22 148.7 22.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.8 m-85 -133.44 143.8 49.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.706 -178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.63 119.64 34.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.521 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.72 124.28 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.8 m-85 -111.75 125.33 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.14 120.53 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.909 0.756 . . . . 0.0 110.595 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.37 155.68 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.01 154.67 40.88 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.335 -1.346 . . . . 0.0 109.513 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.08 161.02 16.33 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.33 -1.348 . . . . 0.0 107.652 174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.509 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.1 t-20 -148.84 153.36 37.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.125 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -39.5 -39.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.61 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.7 -44.89 19.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.59 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.77 -127.1 0.89 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.676 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -124.41 159.07 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.07 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.0 t -124.44 124.39 42.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.37 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -41.49 163.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 125.629 1.831 . . . . 0.0 113.304 -175.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.83 141.05 30.74 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.65 -174.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.89 144.88 30.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 171.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -114.58 129.15 56.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.114 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.59 127.99 54.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.163 -1.381 . . . . 0.0 108.141 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 HG23 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.67 136.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.149 -177.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.9 p90 -153.58 177.22 11.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.98 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.31 144.06 51.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.814 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.2 p -82.8 163.48 21.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -174.14 4.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.142 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 149.81 21.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.205 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.546 -178.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.034 0.445 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.1 173.2 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.455 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.6 Cg_exo -58.86 171.37 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 113.299 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 m -98.53 166.59 11.28 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.61 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 141.91 83.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.122 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.84 171.39 15.74 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.596 1.53 . . . . 0.0 110.6 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' N ' ' NE2' ' A' ' 26' ' ' GLN . 30.2 mtmt -97.82 140.03 32.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -109.61 110.86 22.04 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.202 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.8 142.69 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.44 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.94 136.79 11.51 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 118.912 -1.613 . . . . 0.0 113.468 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.01 136.46 52.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.397 -0.902 . . . . 0.0 109.185 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.2 ttm -108.1 130.96 55.07 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.462 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.59 152.16 27.32 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.14 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.89 12.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.248 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.95 -23.9 41.35 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.57 175.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.24 -39.28 2.96 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.755 -1.212 . . . . 0.0 111.315 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.55 9.49 3.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.468 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 m -78.92 113.47 17.05 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.776 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.9 mm -114.92 126.94 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -172.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -113.94 123.61 50.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.087 0.867 . . . . 0.0 108.885 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.8 t -111.25 122.58 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -98.04 132.27 43.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.634 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -100.46 101.8 12.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 124.091 0.869 . . . . 0.0 108.805 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.7 mm -87.11 105.43 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.666 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HZ2' ' HG ' ' A' ' 31' ' ' SER . 24.1 mtmt -74.77 149.79 39.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' NE2' ' N ' ' A' ' 7' ' ' LYS . 2.8 pt20 -147.36 -56.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.19 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.2 100.75 5.51 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.557 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.5 m-20 -129.73 -36.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.087 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.81 53.45 0.37 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 21.35 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.582 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.1 t 41.6 62.65 7.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 114.784 -0.708 . . . . 0.0 112.823 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 31' ' ' SER . 7.4 Cg_endo -86.02 43.46 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.603 1.535 . . . . 0.0 108.392 171.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.24 150.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.581 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.8 mtt180 -129.71 116.0 18.15 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.634 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.69 -172.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.498 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.7 m-85 -139.5 148.88 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.671 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.8 mt -104.77 110.08 22.28 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -111.98 126.33 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.651 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.85 140.75 47.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 125.056 1.472 . . . . 0.0 107.767 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 151.86 35.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.592 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.8 ptt180 -125.62 162.31 25.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.247 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -125.45 174.44 8.19 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.391 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.05 43.92 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.993 171.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -150.41 -61.65 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.5 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -129.28 163.0 26.61 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.562 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 21.2 mt-10 -109.73 156.78 19.85 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.945 -1.102 . . . . 0.0 113.197 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.432 ' CE3' ' HB3' ' A' ' 41' ' ' ARG . 3.6 m95 34.72 79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.795 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 73.7 mmtt -62.53 160.74 31.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.193 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.71 101.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.884 1.722 . . . . 0.0 111.06 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -49.13 158.58 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.957 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.3 147.22 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.196 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -114.75 123.91 50.44 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -70.34 165.42 44.59 Favored Pre-proline 0 N--CA 1.488 1.462 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.237 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.98 164.55 9.88 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.823 1.682 . . . . 0.0 110.451 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -73.65 79.88 1.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.67 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.63 60.67 0.43 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -96.98 -174.69 3.04 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.856 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.66 -12.05 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.512 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -154.16 163.64 39.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.275 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -136.92 151.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.946 173.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.5 ptp -135.22 148.06 49.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.106 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.52 143.24 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.354 173.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -141.63 173.04 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.716 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 t 59.43 57.21 3.42 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.433 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 15.0 mt -94.35 179.95 5.12 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.62 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.471 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 13.1 t70 -78.11 135.28 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.037 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.419 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 75.6 m95 -76.17 152.33 36.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.593 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.21 49.29 15.45 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.521 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 153.71 47.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.33 147.75 22.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.213 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 65' ' ' LEU . 15.6 m-85 -133.94 137.29 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 123.947 0.779 . . . . 0.0 111.865 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -118.5 115.82 25.38 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.908 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.15 122.97 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' HH ' ' CE1' ' A' ' 88' ' ' HIS . 39.2 m-85 -112.53 124.74 53.19 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.38 121.22 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.666 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.12 157.27 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 118.422 -1.311 . . . . 0.0 109.686 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -111.57 160.28 17.34 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.49 -1.284 . . . . 0.0 107.795 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -145.79 151.47 37.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.852 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -36.77 -43.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.649 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -109.1 37.41 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.79 -152.45 22.16 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.771 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -129.04 163.71 24.81 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.734 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -126.18 125.93 43.26 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.964 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -43.27 167.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.707 1.879 . . . . 0.0 113.378 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB2' HG23 ' A' ' 76' ' ' VAL . . . -88.85 141.03 28.84 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.793 -173.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.68 147.13 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.494 ' CE1' ' HH ' ' A' ' 74' ' ' TYR . 11.0 t-160 -116.71 130.3 56.65 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.544 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 81.3 t80 -117.95 127.64 54.04 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.239 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.405 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -123.87 134.39 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.611 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.0 p90 -156.29 176.78 12.24 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.263 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.74 147.39 49.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.511 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -79.9 168.49 19.18 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.92 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.11 -170.91 3.12 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.223 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.78 141.41 36.55 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.017 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.531 -178.643 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.64 177.66 15.87 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -58.76 170.91 2.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.518 2.146 . . . . 0.0 112.797 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 t -93.63 171.04 9.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.64 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.29 141.3 73.63 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.685 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.16 168.16 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 121.47 1.446 . . . . 0.0 110.904 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -101.63 130.81 48.05 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 mt -104.71 111.52 24.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.118 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -95.45 142.79 27.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -113.71 133.17 11.04 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.23 -1.462 . . . . 0.0 112.978 -170.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -127.75 129.3 46.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.6 ttm -107.66 134.08 51.16 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.699 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.33 153.73 24.58 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.779 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.56 10.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.985 -0.607 . . . . 0.0 112.292 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.92 -22.39 42.78 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.866 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.14 -37.47 3.54 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.559 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.5 p30 -137.48 46.82 2.11 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -120.58 114.93 22.46 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.537 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -118.56 128.34 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.501 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HZ2' ' CD2' ' A' ' 59' ' ' HIS . 38.1 tttm -113.6 125.34 54.06 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.1 t -109.86 118.5 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -98.73 128.5 45.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.48 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.7 mt -100.38 105.18 16.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mm -94.65 128.58 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.876 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -103.54 147.64 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.311 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.42 -54.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.197 -174.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 18.9 m-20 -132.82 107.34 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.627 -175.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.6 m-20 -131.98 -35.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.035 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.91 52.22 0.35 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.19 20.96 34.05 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.596 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 67.1 m 41.92 61.34 8.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.5 Cg_endo -87.74 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.631 1.554 . . . . 0.0 108.787 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.81 151.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.449 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.0 mtt180 -130.67 115.1 16.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.69 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.476 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.8 p-80 37.43 -171.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.528 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -141.17 151.49 43.89 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.021 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -105.19 108.81 20.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -114.42 122.37 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.95 -172.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.64 142.23 46.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 124.536 1.147 . . . . 0.0 108.222 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.82 153.3 40.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.994 -1.482 . . . . 0.0 112.575 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.3 ptm180 -129.0 164.53 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.563 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.56 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -118.25 -169.17 1.65 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.314 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.7 tp -93.32 41.27 1.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.403 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.93 -59.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.719 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -121.97 156.54 33.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.544 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -105.48 157.26 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.839 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 32.83 88.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.495 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -71.84 166.01 44.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.002 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.4 Cg_exo -46.38 96.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.816 1.677 . . . . 0.0 110.578 177.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.73 174.97 4.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.244 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.83 155.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.642 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -115.83 127.94 55.44 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.034 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -74.57 164.71 59.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.091 -177.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -71.21 143.89 45.1 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.747 1.631 . . . . 0.0 109.461 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.5 m -56.69 105.33 0.2 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.931 0.769 . . . . 0.0 111.906 -176.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.476 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 107.22 52.15 0.74 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -97.15 169.24 9.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.844 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.18 -32.25 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.391 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CD2' ' HZ2' ' A' ' 20' ' ' LYS . 24.9 p-80 -148.05 167.3 25.3 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.523 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.4 p -134.22 153.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.865 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 ptp -136.54 152.69 50.78 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.513 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -137.59 141.7 41.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.728 172.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 64' ' ' SER . 10.0 ttpp -144.51 135.39 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.891 -173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 91.49 46.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.332 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.0 mm? -93.62 -178.98 4.87 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.829 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.464 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 30.1 t70 -75.73 135.46 40.34 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.401 -173.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.59 156.4 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.297 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.48 48.77 10.87 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.888 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.12 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.086 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.44 146.18 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.954 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 11.8 m-85 -131.04 140.48 50.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.31 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.86 117.29 28.45 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.195 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.05 121.89 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 37.7 m-85 -110.81 123.73 50.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.5 t -120.21 121.07 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.946 0.778 . . . . 0.0 110.349 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 86' ' ' ALA . 2.1 t -106.37 158.34 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.63 156.21 42.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.606 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -111.69 160.68 17.04 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.463 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.2 t-20 -145.37 151.15 37.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.839 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -36.42 -43.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.719 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -110.5 38.03 2.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.17 -153.53 23.44 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.839 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -128.09 163.36 24.78 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.765 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.6 t -126.54 125.19 41.61 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.037 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -43.14 167.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 125.582 1.801 . . . . 0.0 113.513 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -88.76 141.27 28.64 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.679 -174.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.83 147.0 28.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.447 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.04 129.35 56.32 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.609 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.6 t80 -117.25 127.83 54.48 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.239 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.447 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -125.43 139.12 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.921 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 42.2 p90 -157.91 178.31 10.37 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.733 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -129.12 146.56 51.04 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.957 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.2 p -79.94 171.58 14.92 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.419 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -84.36 -176.04 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.092 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.85 147.99 24.92 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.08 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.436 -1.745 . . . . 0.0 110.568 -178.529 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.69 179.95 19.01 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.498 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 37.6 Cg_endo -73.01 179.46 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.919 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -98.34 159.42 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.182 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.87 147.95 92.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.617 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.59 169.47 15.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.296 1.331 . . . . 0.0 110.626 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -104.06 134.6 47.05 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.99 110.86 21.92 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.405 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.34 148.22 22.3 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.487 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -115.49 128.91 8.27 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.959 -172.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.77 128.1 50.03 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.513 ' CE ' HD12 ' A' ' 19' ' ' ILE . 52.8 tpp -103.62 128.99 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.21 151.14 25.45 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.256 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.87 8.92 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -80.0 -21.13 43.97 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.246 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.9 -35.19 5.19 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.573 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 6.1 p30 -133.12 0.47 3.43 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.17 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -72.97 113.83 10.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.227 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.518 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.3 mm -114.97 126.17 72.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.831 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.69 125.36 54.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.928 0.767 . . . . 0.0 109.227 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.4 t -109.43 122.3 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.73 129.04 41.8 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.324 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.06 98.52 9.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.96 133.43 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.648 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HZ3' ' HG ' ' A' ' 31' ' ' SER . 40.9 mtmt -92.32 171.38 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.865 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -64.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.757 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.99 91.23 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.2 m-20 -128.43 -16.11 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.061 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.65 49.82 2.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.52 47.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.558 ' HG ' ' HZ3' ' A' ' 25' ' ' LYS . 42.6 t 44.2 68.04 3.45 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.379 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -89.49 43.91 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.764 1.642 . . . . 0.0 107.956 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.27 146.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.853 -171.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 89.8 mtt-85 -126.04 123.78 39.18 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.464 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.4 p-80 37.16 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -138.08 156.07 48.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.026 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.52 110.82 22.02 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 60' ' ' VAL . 49.0 t -114.35 123.56 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.024 -1.07 . . . . 0.0 109.94 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -136.01 139.22 42.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.682 1.239 . . . . 0.0 107.927 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.06 155.2 43.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.933 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.0 ptt85 -130.63 164.34 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.016 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -124.88 169.85 11.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.683 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.68 43.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.9 -56.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.041 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.5 m -130.54 157.18 43.4 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.197 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -101.65 165.25 11.32 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.82 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.462 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.8 m95 21.9 91.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.047 -1.433 . . . . 0.0 114.019 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.0 mptm? -74.45 165.23 55.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.109 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.3 Cg_exo -45.13 99.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.856 1.704 . . . . 0.0 110.716 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 175.24 3.5 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.451 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.1 tt -140.18 154.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -115.29 136.42 53.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.0 mt -87.99 164.64 32.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.32 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.3 Cg_exo -62.24 165.68 14.42 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.812 1.674 . . . . 0.0 110.389 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -74.93 80.89 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.13 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.04 58.2 0.26 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.721 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -97.06 167.16 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.375 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.24 -8.94 12.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.651 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -160.09 165.23 32.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.053 -1.459 . . . . 0.0 112.943 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.548 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.6 p -137.72 153.52 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.978 172.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 ptp -136.53 151.02 48.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.341 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.46 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.84 146.14 35.49 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.366 173.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -141.52 -177.25 5.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.416 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.4 t 55.19 51.87 12.54 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' H ' ' HB2' ' A' ' 17' ' ' ASN . 31.6 mt -85.49 165.68 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.812 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -78.31 8.19 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.412 -171.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 60.52 162.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.167 0.508 . . . . 0.0 111.861 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 36.23 43.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.03 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.77 156.16 48.88 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.061 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -98.23 147.86 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.144 0.903 . . . . 0.0 108.629 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 91' ' ' PHE . 33.2 m-85 -131.95 142.92 49.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.972 0.795 . . . . 0.0 111.783 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -118.55 118.15 30.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.646 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -110.52 122.75 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 54.2 m-85 -111.45 125.88 54.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.1 t -121.0 122.29 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.626 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -109.35 155.51 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.15 159.2 35.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.955 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -109.37 149.77 29.02 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.469 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.517 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -130.88 143.96 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.267 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -43.39 -37.17 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.81 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -117.07 46.26 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.793 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -153.72 22.62 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.371 174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -125.17 160.59 28.8 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.882 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.8 t -113.13 109.64 19.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -39.25 158.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 125.497 1.748 . . . . 0.0 112.698 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.56 127.88 33.23 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.828 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.76 145.21 26.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.53 129.26 56.65 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.608 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.5 t80 -115.84 127.22 54.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.37 134.55 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.358 -175.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 39.7 p90 -155.74 174.75 14.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.473 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.52 148.46 48.88 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.803 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -79.88 172.58 13.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 m -87.14 -172.94 4.19 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.727 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.23 144.21 27.26 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.283 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.566 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.2 173.83 14.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.9 Cg_exo -60.3 168.08 6.86 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.551 2.167 . . . . 0.0 113.046 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.82 158.46 18.74 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.828 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.06 146.2 92.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.173 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.32 167.93 19.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.458 1.439 . . . . 0.0 110.749 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -103.59 128.75 50.81 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.6 114.34 28.5 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.494 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -103.18 140.74 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 89' ' ' PHE . . . -123.31 140.8 13.27 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.724 -170.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -131.39 143.3 50.37 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.2 -1.0 . . . . 0.0 109.645 170.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.661 -0.816 . . . . 0.0 108.969 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -81.89 153.8 33.15 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.808 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.27 8.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.374 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 13' ' ' GLY . 17.5 m-20 -79.92 -25.16 40.62 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.533 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.1 -37.03 4.03 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.727 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.44 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 13.4 m-20 -123.08 -12.0 7.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.9 m -65.73 112.04 3.51 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.638 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.521 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.8 mm -112.21 126.7 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -114.7 121.35 43.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 124.044 0.84 . . . . 0.0 108.865 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.5 t -109.98 118.02 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -95.44 133.78 39.02 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.341 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 52.0 mt -102.58 101.12 11.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 124.049 0.843 . . . . 0.0 108.885 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.51 134.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.025 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -101.52 148.61 25.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.006 0.816 . . . . 0.0 109.333 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.448 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.66 -72.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.81 -175.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 29.9 m-20 -130.34 107.29 9.15 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.931 -176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.0 m-20 -126.44 -35.73 2.35 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.655 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.43 54.6 0.26 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' C ' ' HD3' ' A' ' 32' ' ' PRO . . . 89.06 28.63 20.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.573 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 77.8 p 32.21 63.37 1.26 Allowed Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -87.39 46.31 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.758 1.638 . . . . 0.0 108.755 173.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.08 149.87 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.462 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' HIS . 62.1 mtt85 -130.45 117.59 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.13 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.8 p-80 36.1 -175.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.483 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.1 m-85 -137.55 142.84 41.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.944 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.28 105.7 17.74 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.81 125.57 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.088 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -131.8 134.02 45.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 125.0 1.438 . . . . 0.0 107.681 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.59 158.63 43.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 117.711 -1.595 . . . . 0.0 112.185 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 22.5 ptt85 -142.71 168.37 19.89 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.458 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' C ' ' H ' ' A' ' 44' ' ' ALA . . . -131.43 171.63 13.15 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.38 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -71.06 26.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.153 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -131.22 -59.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -124.82 154.91 40.27 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -108.98 166.74 10.6 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.314 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.432 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 22.67 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.188 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 79.8 mttt -69.81 165.67 39.66 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.085 173.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 14.0 Cg_exo -48.81 107.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.867 1.711 . . . . 0.0 110.711 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.81 159.59 2.22 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.86 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -130.09 147.82 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.018 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -114.77 113.33 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.334 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -58.55 167.44 1.78 Allowed Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.604 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.62 171.37 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.736 1.624 . . . . 0.0 110.502 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.3 m -76.29 77.29 3.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.736 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 70.1 0.68 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -93.31 -171.94 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.187 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.89 -20.22 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.006 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 20.4 p-80 -160.0 173.46 15.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.025 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.549 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -135.23 150.8 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 124.856 1.347 . . . . 0.0 108.416 173.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptp -134.12 147.59 50.85 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.002 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -142.13 147.35 36.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.885 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -141.09 175.44 9.63 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.942 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t 49.36 66.94 0.97 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.226 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 12.3 mt -100.0 -174.69 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.075 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.0 126.42 29.63 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.761 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -76.38 151.4 36.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.177 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 47.04 49.06 15.26 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.032 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . . . -127.45 150.72 49.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.45 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -91.8 140.64 29.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -129.9 143.38 50.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.002 0.814 . . . . 0.0 112.431 -173.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.46 125.18 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.804 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.88 125.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 49.1 m-85 -114.49 127.66 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.54 119.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.59 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.408 HG21 ' HB1' ' A' ' 86' ' ' ALA . 2.3 t -104.34 156.98 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.42 155.4 43.73 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.185 -1.406 . . . . 0.0 109.862 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -111.25 157.93 19.56 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.869 175.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.6 t-20 -145.43 152.87 40.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.09 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -33.61 -45.82 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.908 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -109.85 37.68 2.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.56 -153.52 22.09 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.227 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -120.25 158.76 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.835 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -121.79 124.76 44.93 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.29 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -40.85 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 125.75 1.906 . . . . 0.0 113.505 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 76' ' ' VAL . . . -85.83 137.93 32.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.223 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.81 145.94 28.48 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.476 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.6 t-160 -117.03 131.85 56.84 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.648 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 76.9 t80 -121.5 134.39 55.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.236 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -131.07 142.8 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.818 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 19' ' ' ILE . 49.0 p90 -158.97 -178.78 7.49 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.282 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -129.32 144.41 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.661 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -79.82 169.38 18.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -85.75 -168.11 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.076 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.13 140.55 37.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.433 -178.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.063 0.459 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.48 173.31 14.22 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.2 Cg_endo -62.8 176.79 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.476 2.117 . . . . 0.0 112.767 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -96.81 162.1 13.57 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.906 173.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 145.63 99.02 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.316 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.11 170.27 12.12 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.391 1.394 . . . . 0.0 111.177 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -104.59 132.92 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.09 111.84 23.68 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.254 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.92 145.19 24.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.95 130.3 9.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.332 -1.413 . . . . 0.0 112.868 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.41 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.5 mt-30 -123.09 125.82 45.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 170.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 ttm -107.13 128.93 54.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.468 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.04 150.55 24.02 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.811 -1.185 . . . . 0.0 111.472 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.46 13.97 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.833 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 13' ' ' GLY . 13.5 m-20 -79.96 -23.14 41.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.669 174.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.51 -39.63 2.83 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.397 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.6 12.78 4.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.94 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -80.0 109.89 14.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.532 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.2 mm -115.14 126.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.272 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -113.28 126.5 55.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 123.943 0.777 . . . . 0.0 109.058 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 55.7 t -108.74 115.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.41 ' ND2' HE21 ' A' ' 11' ' ' GLN . 3.5 m-80 -95.96 128.58 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.459 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.52 107.62 19.84 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.772 -172.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.1 mm -100.71 135.22 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.458 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -101.71 152.1 21.24 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.652 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.95 -50.41 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.129 -176.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 12.7 m-20 -141.15 106.78 5.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.9 m-20 -132.06 -34.26 1.28 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.234 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.63 53.85 0.37 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.05 21.01 34.3 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.568 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 39.52 64.15 4.28 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 114.927 -0.637 . . . . 0.0 112.64 -176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.6 Cg_endo -86.28 44.41 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.621 1.547 . . . . 0.0 108.556 172.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -86.66 148.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.468 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 47.1 mtt180 -129.68 120.09 24.59 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.616 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 36.89 -174.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.1 m-85 -139.2 151.65 46.72 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.036 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.21 109.73 21.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.7 t -114.39 123.12 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.055 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -134.48 140.92 46.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.552 1.158 . . . . 0.0 107.922 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HH ' ' HZ2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -146.04 156.15 43.28 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.694 -1.602 . . . . 0.0 112.378 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -125.89 160.49 29.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.49 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -108.55 -169.63 1.53 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.19 39.91 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.116 171.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.45 -59.41 0.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.2 m -118.41 148.6 42.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.009 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.0 pt-20 -107.05 151.62 25.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.816 -1.153 . . . . 0.0 112.181 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 42.0 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.41 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HZ3' ' HH ' ' A' ' 71' ' ' TYR . 71.3 mttt -73.54 165.17 55.38 Favored Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.483 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.89 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.767 1.645 . . . . 0.0 110.479 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.12 174.38 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.675 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -137.76 154.23 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.043 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.74 128.69 56.05 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.093 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.17 165.13 56.39 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.149 -177.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.75 166.58 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.858 1.705 . . . . 0.0 110.237 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.3 m -76.27 79.67 3.05 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.874 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.69 60.75 0.41 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -97.08 -175.61 3.3 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.769 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -117.82 -39.89 3.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.571 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -148.22 168.44 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.21 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -128.07 152.09 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.289 174.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptp -136.44 154.11 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.528 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.7 OUTLIER -137.9 142.79 40.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.552 173.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -131.6 165.72 23.02 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.455 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m 53.58 62.56 2.58 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.189 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 19.3 mt -92.36 178.19 5.91 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.029 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -73.59 128.98 37.0 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.188 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.51 150.1 45.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.584 -1.246 . . . . 0.0 109.883 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 48.61 49.15 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.478 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.55 153.1 48.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.963 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -94.04 147.96 22.63 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.009 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' HH ' ' HZ3' ' A' ' 48' ' ' LYS . 10.9 m-85 -132.67 140.88 48.34 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.419 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.95 116.24 24.73 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.024 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.53 123.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 40.5 m-85 -112.18 125.56 54.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.29 121.84 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 124.035 0.834 . . . . 0.0 110.188 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.7 158.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 84' ' ' SER . . . -129.69 160.98 31.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.333 -1.347 . . . . 0.0 109.106 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -112.22 157.46 20.87 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.091 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -139.92 147.99 41.36 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.105 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -36.83 -43.39 0.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.41 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -114.41 42.73 2.04 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.669 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.9 -154.25 24.27 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.192 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -121.33 161.34 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.961 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t -116.0 115.45 26.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -40.44 160.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 125.512 1.757 . . . . 0.0 112.661 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.65 138.35 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.532 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.21 146.27 29.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.463 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.2 t-160 -116.97 130.86 56.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.465 -173.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -118.49 128.44 54.59 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.116 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.39 138.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.818 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.48 -179.78 8.22 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.973 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.08 147.48 50.94 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.768 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -80.02 170.06 16.99 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.784 -0.767 . . . . 0.0 109.292 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.7 m -81.41 -175.98 5.77 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.154 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.42 147.38 26.41 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.123 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.521 -1.704 . . . . 0.0 110.692 -178.203 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.913 0.387 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.74 176.05 16.79 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.598 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.0 Cg_endo -64.24 174.29 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.548 2.165 . . . . 0.0 112.603 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -87.92 145.59 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.286 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.77 78.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.571 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.41 165.74 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.218 1.279 . . . . 0.0 110.569 -176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -103.42 133.29 48.72 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.3 112.24 25.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.959 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -93.4 141.89 27.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.29 131.28 10.55 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.341 -1.409 . . . . 0.0 112.587 -171.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -128.85 126.97 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 ttm -106.2 132.69 51.96 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.77 152.42 23.95 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.571 -176.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.99 12.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.311 -0.556 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.95 -24.26 41.12 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.645 175.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.06 -40.77 2.43 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.434 177.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -132.15 10.06 4.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.076 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -81.78 116.25 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.953 176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.513 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.3 mm -116.97 128.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.324 -172.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -113.47 126.3 55.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.988 0.805 . . . . 0.0 108.982 173.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -108.78 113.27 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -95.05 129.83 41.98 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.401 -176.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -98.71 106.45 18.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.715 -173.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.3 mm -97.66 131.76 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.994 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -107.49 156.26 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.366 -177.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.32 -65.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.516 -174.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -135.23 128.4 31.86 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.325 177.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -133.53 -36.27 0.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 123.901 0.751 . . . . 0.0 109.899 177.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.63 54.22 0.3 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.44 18.86 37.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -175.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.594 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 42.56 61.27 9.25 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 114.907 -0.646 . . . . 0.0 112.648 -176.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.0 Cg_endo -88.46 37.99 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.558 1.506 . . . . 0.0 109.583 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -77.54 150.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.901 0.858 . . . . 0.0 111.78 -172.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 9.0 mmt180 -127.85 113.32 15.77 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.367 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.2 p-80 36.2 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 174.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.0 m-85 -137.98 152.3 48.78 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.115 177.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -108.56 110.72 22.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.45 124.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.289 -174.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -135.52 140.15 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.62 1.2 . . . . 0.0 108.291 177.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.78 155.98 44.34 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.202 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.3 ptm180 -129.56 164.67 23.32 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.988 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -113.83 -177.95 3.26 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 tp -87.03 41.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.111 173.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.11 -60.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.522 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 p -119.11 151.3 38.53 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.439 177.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.8 pt-20 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.858 -173.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 42.29 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.35 175.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -69.83 168.3 18.55 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.695 173.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -52.26 95.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.656 1.57 . . . . 0.0 109.819 174.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.65 172.61 2.05 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.486 -173.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.11 154.63 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.392 -177.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -114.74 129.24 56.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.09 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -76.1 165.93 49.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.133 -177.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.45 168.24 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.787 1.658 . . . . 0.0 110.211 172.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.4 t -77.87 78.97 4.35 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.566 -177.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.0 60.72 0.34 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -97.18 -174.51 2.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.688 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -119.5 -40.52 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.707 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -148.06 169.12 20.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.11 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.0 p -127.46 152.48 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.422 173.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.8 ptp -136.25 150.42 48.95 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.599 -1.241 . . . . 0.0 112.908 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.492 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -140.47 139.21 35.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.097 172.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -140.39 162.76 34.54 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.606 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t 66.93 50.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.605 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.9 mm? -96.43 -174.52 3.07 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.665 176.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -83.3 142.6 30.97 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.095 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.403 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 74.3 m95 -77.75 155.17 31.37 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.366 -178.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.35 48.66 10.49 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.604 -176.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.09 47.33 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.837 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -97.94 149.92 21.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.532 177.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.547 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 31.6 m-85 -135.47 145.27 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.423 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -121.08 118.56 30.08 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.347 -1.751 . . . . 0.0 108.328 177.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.68 124.55 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 45.0 m-85 -112.69 126.18 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -121.29 122.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.13 158.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 156.54 41.41 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.261 176.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -111.97 159.77 18.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.585 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.417 HD22 ' HG2' ' A' ' 32' ' ' PRO . 19.0 t-20 -144.88 148.94 34.5 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.985 178.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -37.91 -42.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.481 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -112.32 42.12 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.465 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.45 -153.97 22.76 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.46 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -125.35 162.52 24.59 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.877 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 117.13 27.39 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -40.96 163.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 125.482 1.739 . . . . 0.0 113.206 -174.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.15 134.72 34.98 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.126 -176.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.87 145.58 29.58 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.465 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.2 t-160 -115.25 131.06 57.05 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.627 -173.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -118.13 127.27 53.61 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.008 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -125.32 139.31 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.64 -176.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 38.5 p90 -159.17 176.98 11.55 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.24 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -127.63 147.9 50.37 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.756 175.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.3 p -79.84 170.83 15.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.248 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.57 -170.81 3.24 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.143 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.19 141.88 36.81 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.156 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.54 -1.695 . . . . 0.0 110.741 -179.193 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.003 0.43 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.8 170.83 14.56 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.97 -1.109 . . . . 0.0 110.556 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -60.99 173.83 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.493 2.129 . . . . 0.0 112.917 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -95.39 155.51 16.71 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.036 174.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.26 143.09 97.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.075 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.65 165.9 23.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.343 1.362 . . . . 0.0 110.75 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.61 132.53 48.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.6 mt -104.72 113.78 27.58 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.224 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.02 138.78 31.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.441 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.75 124.56 7.91 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.492 -1.337 . . . . 0.0 112.469 -172.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.81 120.88 35.85 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.4 ttm -106.39 131.69 53.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.73 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.73 149.27 23.26 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.689 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.84 11.63 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.074 -0.563 . . . . 0.0 112.255 -177.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.5 m-20 -79.93 -22.36 42.8 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.876 176.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.8 -37.8 3.61 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.957 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.0 p-10 -140.27 47.52 1.79 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m -120.57 114.33 21.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.519 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.9 mm -117.41 128.54 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.633 -170.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -114.94 126.6 54.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.562 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.9 t -109.01 111.5 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -94.33 130.9 40.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.623 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' CD1' ' CD2' ' A' ' 36' ' ' TYR . 19.6 mt -100.05 108.51 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.949 -172.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.79 127.12 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -104.06 156.16 18.09 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.471 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 -53.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.146 -172.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.15 118.91 16.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.294 -178.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.27 -41.43 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 177.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.13 54.54 0.25 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -177.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.53 42.88 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 14.4 t 42.3 60.38 9.59 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -88.65 46.87 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.658 1.572 . . . . 0.0 108.962 173.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.67 152.32 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.602 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 35' ' ' HIS . 11.0 mtt180 -130.37 119.9 23.47 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.331 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.544 ' H ' ' HA ' ' A' ' 55' ' ' SER . 7.2 p-80 31.87 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.129 -1.851 . . . . 0.0 115.988 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.447 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 81.9 m-85 -137.47 153.1 50.13 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.9 175.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.402 HD13 ' HB ' ' A' ' 76' ' ' VAL . 4.9 mt -110.82 112.2 23.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.86 128.16 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.215 -174.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.3 139.4 46.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.905 1.378 . . . . 0.0 108.104 175.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.438 ' CD2' HD23 ' A' ' 62' ' ' LEU . 1.9 p90 -147.38 154.57 41.04 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.581 177.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -133.39 160.81 36.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.47 -172.75 2.12 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -93.43 39.34 1.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.585 171.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.66 -60.67 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.348 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.5 m -118.94 141.12 48.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.8 pt-20 -105.02 171.93 7.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.093 -171.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 7.4 m95 18.28 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.591 -1.641 . . . . 0.0 114.123 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 42' ' ' ALA . 9.4 mptt -67.57 164.34 39.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.689 174.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -47.17 104.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.844 1.696 . . . . 0.0 110.881 177.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 156.66 0.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.261 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 tt -131.12 146.92 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.359 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -115.21 132.14 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.4 mt -82.69 164.69 45.84 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.875 -177.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.25 155.58 68.84 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.599 1.533 . . . . 0.0 109.454 172.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.544 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.5 t -73.36 103.1 3.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.373 -177.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.25 0.74 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.07 172.84 7.58 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.155 -175.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.3 -43.7 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.565 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.5 p-80 -148.86 168.4 23.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.614 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.562 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -123.15 150.74 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.035 174.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -135.92 149.19 48.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.506 -1.277 . . . . 0.0 112.833 -175.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -138.65 135.31 34.73 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.68 173.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' SER . 84.1 mttt -142.9 142.11 31.66 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.778 -178.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.9 m 91.07 43.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.892 176.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.9 mm? -95.37 -176.47 3.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.369 -177.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.0 m-20 -71.43 130.95 42.6 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.877 -172.078 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.6 155.99 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 43.3 48.42 5.8 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.792 -177.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.9 151.88 49.98 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.802 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.86 149.54 21.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.642 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 7.6 m-85 -133.74 140.92 47.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.657 -177.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.17 119.72 34.1 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.518 -1.673 . . . . 0.0 108.234 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.62 125.41 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m-85 -113.52 125.39 54.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.2 123.75 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.893 0.746 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -108.72 158.01 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.72 157.02 41.46 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.413 -1.315 . . . . 0.0 109.547 178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -112.15 161.88 16.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.731 -1.188 . . . . 0.0 108.009 175.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.9 t-20 -143.78 149.8 37.6 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.546 177.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -41.21 -39.47 1.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.172 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -113.05 39.06 2.64 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.92 -150.88 22.39 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.681 175.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -134.31 168.52 18.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.227 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 t -127.97 123.06 33.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.215 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.15 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 125.557 1.786 . . . . 0.0 113.253 -174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.423 ' HB2' HG21 ' A' ' 76' ' ' VAL . . . -87.02 138.84 31.15 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.63 -174.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.79 145.8 29.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.453 ' CE1' HG23 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.04 130.72 57.0 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.6 -173.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -118.5 129.26 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.017 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.453 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.7 140.64 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.936 -176.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.2 p90 -158.84 -178.65 7.41 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.739 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -130.85 146.76 52.38 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.91 175.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -79.88 171.5 15.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.332 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.86 -170.88 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.072 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.07 140.85 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.052 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.459 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -113.66 172.89 14.65 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.657 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 10.9 Cg_endo -68.23 174.34 8.22 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.658 2.239 . . . . 0.0 112.427 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -101.54 158.78 15.83 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.925 172.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.31 149.58 68.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.349 -174.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -71.82 172.02 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.589 1.526 . . . . 0.0 110.766 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -106.07 134.1 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.47 112.43 24.82 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.399 -176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 23.1 tt0 -92.48 141.45 28.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.76 121.83 7.29 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.869 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -122.16 121.58 37.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.4 ttm -104.76 134.2 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.701 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.63 150.86 22.01 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.735 -176.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.76 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.085 -0.557 . . . . 0.0 112.294 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 13' ' ' GLY . 15.5 m-20 -79.82 -22.2 43.31 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.017 176.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.97 -50.97 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.541 176.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -128.15 7.62 6.02 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.807 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.5 t -73.11 117.32 14.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.865 176.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.52 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.4 mm -117.04 128.63 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.869 -171.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -113.8 125.85 54.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.008 0.817 . . . . 0.0 108.976 171.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 59.4 t -105.9 110.19 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 11.5 t-20 -88.03 129.06 35.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.95 -175.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -99.69 100.95 11.99 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.265 -175.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -93.05 128.84 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -101.17 147.57 26.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 123.951 0.782 . . . . 0.0 109.672 -176.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.444 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.18 -86.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.937 -175.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -107.59 109.5 21.16 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.659 -174.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.1 m-20 -133.62 -34.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.127 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.92 53.51 0.36 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.72 21.04 35.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -175.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.568 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.0 m 42.85 61.47 9.4 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.745 -176.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 31' ' ' SER . 14.3 Cg_endo -86.54 45.61 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.792 1.662 . . . . 0.0 108.75 173.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.35 148.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.278 -173.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.0 mtt180 -125.35 111.43 15.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.89 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 33.97 -171.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.07 156.23 49.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.83 176.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 76' ' ' VAL . 5.2 mt -112.82 111.45 22.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.82 124.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.447 -174.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -136.75 138.1 40.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.487 1.117 . . . . 0.0 108.328 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.85 156.88 45.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.0 -1.48 . . . . 0.0 112.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 27.0 ptt180 -134.69 168.81 18.33 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.39 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.25 172.17 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.797 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -71.8 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.952 174.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -136.53 -58.75 0.73 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.742 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.7 m -126.48 158.79 35.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.581 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.7 pt-20 -101.43 166.98 10.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.751 -177.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.441 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.9 m95 17.94 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.966 -1.47 . . . . 0.0 114.514 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 14.1 mptt -73.68 167.27 36.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.322 173.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -48.06 98.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.76 1.64 . . . . 0.0 110.39 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.77 174.44 5.16 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.349 -173.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -139.19 154.89 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.499 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.35 137.06 52.07 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.783 173.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.5 mt -87.49 166.45 25.28 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.306 -177.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -81.33 140.04 11.94 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.92 1.747 . . . . 0.0 108.063 167.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -62.53 135.31 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.742 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.61 41.81 4.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -97.03 168.62 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.505 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -114.59 -45.81 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.44 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -147.86 167.43 24.8 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.361 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.0 p -119.07 149.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.778 173.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -132.55 148.41 52.37 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.874 -174.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.98 140.41 38.21 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.202 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -140.59 162.35 35.57 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.357 -177.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 m 71.69 46.4 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.403 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -95.27 -176.06 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 177.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -84.98 146.33 27.27 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.816 -175.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.441 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 71.0 m95 -80.25 155.33 27.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.545 -177.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 44.91 46.77 9.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.458 -175.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 149.94 47.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.712 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -98.83 143.09 29.55 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.327 178.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 39.4 m-85 -131.51 144.32 51.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 123.995 0.809 . . . . 0.0 112.057 -177.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.12 119.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.428 -1.715 . . . . 0.0 108.06 176.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.55 124.53 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 59.8 m-85 -111.35 126.96 55.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.8 t -120.92 121.82 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.944 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' HB ' HD13 ' A' ' 37' ' ' LEU . 2.5 t -109.5 158.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.72 160.21 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.516 -1.274 . . . . 0.0 109.36 177.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -111.1 164.76 12.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.435 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 20.1 t-20 -152.19 151.89 31.57 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -41.63 -41.41 2.2 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.327 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -79.7 -47.62 15.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.503 -177.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.63 -108.79 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.995 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -140.72 173.23 11.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.895 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.77 119.27 27.47 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -42.49 162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.307 1.629 . . . . 0.0 112.664 -176.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.51 134.49 35.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.202 -176.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.3 143.07 32.54 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.462 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.6 t-160 -113.21 130.74 56.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.397 -174.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -116.88 126.85 53.61 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.984 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.43 HG23 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -123.63 135.44 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.298 -176.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 p90 -156.93 174.03 16.12 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.34 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -127.3 148.2 50.23 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.544 175.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -79.83 168.5 19.19 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.002 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 m -81.25 -173.17 4.18 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.356 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.04 150.55 21.28 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.109 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 116.247 -1.835 . . . . 0.0 110.392 -178.802 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.37 174.9 15.6 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 7.2 Cg_exo -59.35 176.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.634 2.223 . . . . 0.0 112.909 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -93.0 161.53 14.41 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.224 171.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.36 143.73 92.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.422 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.37 172.8 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.484 1.456 . . . . 0.0 110.915 -177.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -106.6 132.25 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.1 mt -109.04 112.12 24.13 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.352 -176.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.33 144.2 25.62 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.41 131.52 10.56 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.422 -173.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -129.16 129.4 45.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.407 ' CE ' HD11 ' A' ' 19' ' ' ILE . 37.8 ttm -106.86 134.64 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.41 144.03 21.29 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.591 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.48 9.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.95 -27.22 39.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.858 175.566 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.26 -40.05 1.95 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.931 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -130.64 -15.1 3.56 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.801 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -52.88 115.72 1.98 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.332 174.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.9 mm -117.33 128.79 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.122 -175.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -114.94 126.66 55.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 47.6 t -109.27 118.94 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.77 124.02 39.6 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.81 -178.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.62 104.29 15.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -173.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -97.96 133.06 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.204 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -101.1 146.58 27.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.896 0.747 . . . . 0.0 109.434 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.07 -89.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.413 -175.781 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 20.8 t70 -95.45 105.69 17.68 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.125 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.75 -35.12 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.66 51.27 0.42 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.96 17.61 40.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -175.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.603 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 64.3 m 43.35 59.84 11.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.4 Cg_endo -88.53 50.9 1.67 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.842 1.695 . . . . 0.0 108.513 172.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mm -78.86 151.34 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.027 0.918 . . . . 0.0 111.68 -172.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 32.8 mmm-85 -126.13 108.01 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.536 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.0 p-80 36.17 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.484 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 76.5 m-85 -138.73 151.92 47.54 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.131 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.87 108.78 20.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.7 t -114.08 122.23 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.02 -173.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -132.58 135.65 46.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.664 1.228 . . . . 0.0 108.1 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.8 158.69 43.6 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 117.941 -1.504 . . . . 0.0 112.162 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.6 ptm180 -138.32 170.36 16.15 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.305 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.62 179.5 4.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.514 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 40.83 0.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.535 172.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.28 -60.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.426 ' CB ' ' HZ3' ' A' ' 48' ' ' LYS . 2.8 m -116.45 149.5 39.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.104 177.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -100.11 160.84 14.01 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.175 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.424 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 24.8 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.402 -1.272 . . . . 0.0 114.028 178.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 67.5 mmtt -76.19 162.16 72.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.8 Cg_exo -45.12 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.765 1.643 . . . . 0.0 110.611 177.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.87 175.45 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.571 -173.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -137.97 155.19 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.354 -177.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -115.89 130.25 56.75 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.214 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -78.33 165.09 52.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.239 -177.472 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.12 161.0 27.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.832 1.688 . . . . 0.0 110.87 172.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 t -68.24 95.55 0.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 95.57 65.38 0.97 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -97.14 -169.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.231 -176.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -129.54 -38.88 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.646 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -144.69 164.65 30.35 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.569 -1.252 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -131.77 153.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.492 174.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptp -137.45 152.13 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.981 -174.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -142.04 138.61 31.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.172 172.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -137.94 161.23 37.22 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.745 -177.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t 66.51 49.91 1.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.543 177.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.96 -174.63 3.31 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.653 177.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 32.7 t70 -80.55 137.32 36.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.708 -175.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.508 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 73.1 m95 -75.62 156.04 35.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.168 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 49.53 44.82 24.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.111 -178.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.71 156.06 44.89 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.546 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.76 149.33 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 19.8 m-85 -135.22 144.63 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.78 -178.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.58 121.45 38.4 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.273 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.0 t -114.06 123.11 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.9 m-85 -110.92 125.64 53.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.67 121.21 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 123.881 0.738 . . . . 0.0 110.446 -178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -106.54 158.04 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.81 157.53 41.24 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.381 -1.327 . . . . 0.0 109.868 178.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.9 tt0 -112.11 164.27 13.35 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.454 HD22 ' HG2' ' A' ' 32' ' ' PRO . 11.3 t-20 -148.24 151.99 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.949 178.127 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -34.14 -45.81 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.757 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.95 39.78 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.5 -152.81 23.66 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.636 174.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -129.86 166.25 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.779 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.1 t -128.71 125.68 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.957 -176.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -43.39 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.52 1.762 . . . . 0.0 113.298 -175.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.406 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.25 139.7 30.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.61 -175.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.52 145.54 30.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.462 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.2 130.11 56.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.382 -174.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -117.86 129.72 55.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.883 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -127.38 141.1 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.694 -176.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.5 p90 -157.99 177.92 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.066 178.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 146.5 50.78 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.69 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.0 p -83.34 163.36 20.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.379 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 m -74.86 178.75 5.31 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.164 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.5 144.79 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 116.252 -1.832 . . . . 0.0 110.328 -178.926 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.01 179.03 18.26 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.937 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 8.3 Cg_exo -59.4 177.26 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.798 2.332 . . . . 0.0 112.944 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -80.17 -154.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.23 150.18 39.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.97 166.28 28.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.377 1.385 . . . . 0.0 110.755 -177.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.48 128.94 52.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 mt -102.91 110.73 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.018 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -91.49 143.09 26.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.431 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.27 125.17 7.76 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.337 -1.411 . . . . 0.0 112.486 -173.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.444 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 77.9 mt-30 -121.55 122.47 39.76 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.5 ttm -107.17 130.9 54.65 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.745 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.8 149.09 24.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.307 -177.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.55 16.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.85 -24.48 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.332 174.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -40.61 2.45 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.715 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.9 p30 -137.49 49.1 2.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.139 0.495 . . . . 0.0 110.0 177.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.2 m -122.16 113.5 19.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.542 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.07 128.53 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.604 -169.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.94 125.75 53.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.082 0.864 . . . . 0.0 108.748 173.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.5 t -107.12 116.47 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.6 m-20 -93.88 129.01 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.913 -177.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 39.4 mt -100.56 99.41 10.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -175.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.9 mm -95.99 130.36 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -104.15 150.85 23.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.711 0.632 . . . . 0.0 109.803 -175.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -79.64 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.037 -174.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.55 102.43 11.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.177 -175.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -131.91 -35.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 178.535 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.07 51.04 0.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.77 22.48 25.86 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -175.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.583 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.0 m 39.09 62.44 4.86 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -88.25 50.69 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.729 1.62 . . . . 0.0 108.722 173.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.45 151.59 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.7 mtt85 -131.69 121.69 24.69 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.821 178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.544 ' H ' ' N ' ' A' ' 56' ' ' GLY . 9.2 p-80 35.44 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.19 158.37 43.81 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.972 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -112.45 109.86 19.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG12 HG23 ' A' ' 60' ' ' VAL . 48.0 t -115.48 124.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.652 -173.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -134.72 140.57 46.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.683 1.24 . . . . 0.0 108.422 177.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -144.07 154.83 43.62 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.924 -1.51 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 12.0 ptm180 -126.14 163.68 22.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.556 179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.81 -168.08 1.3 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 tp -95.9 41.49 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.447 173.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.77 -56.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.611 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.511 ' CB ' ' HZ2' ' A' ' 48' ' ' LYS . 46.8 m -106.76 142.83 35.76 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.269 177.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.6 pt-20 -107.87 144.06 35.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.792 -176.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.6 m95 47.45 84.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.454 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HZ2' ' CB ' ' A' ' 45' ' ' SER . 72.0 mmtt -77.54 161.17 73.11 Favored Pre-proline 0 N--CA 1.491 1.603 0 CA-C-N 114.346 -1.297 . . . . 0.0 107.824 174.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.4 Cg_exo -43.37 103.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.909 1.739 . . . . 0.0 110.838 179.211 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.76 175.87 6.82 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.503 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.7 157.54 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.757 -177.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -114.39 140.98 48.23 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.911 172.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD12 ' HB ' ' A' ' 60' ' ' VAL . 2.0 mt -90.18 165.56 23.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.667 -176.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.9 Cg_exo -61.58 157.91 39.45 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.71 1.607 . . . . 0.0 110.39 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -64.58 86.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.171 -176.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.544 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 106.15 62.91 0.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -93.84 179.59 5.3 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.24 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -18.91 7.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.236 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.431 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 19.1 p-80 -160.16 168.94 24.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.435 -1.306 . . . . 0.0 112.245 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.5 p -134.6 153.64 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.924 172.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.2 ptp -138.34 153.69 48.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.314 -1.354 . . . . 0.0 112.763 -176.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.97 140.17 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.142 173.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.9 tppt? -137.98 137.82 38.29 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.821 -174.177 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 8.2 m 85.86 50.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.784 171.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.2 mm? -95.2 -177.55 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.833 -179.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.2 134.21 39.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.687 0.756 . . . . 0.0 111.079 -172.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -72.34 154.65 40.82 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 47.5 47.37 17.36 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.911 -177.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.07 50.11 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.821 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.61 149.96 22.24 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.278 177.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.529 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -133.29 144.25 49.59 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.62 -176.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.35 118.25 28.0 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.82 123.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 39.3 m-85 -111.64 125.16 53.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.32 122.14 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 123.935 0.772 . . . . 0.0 110.314 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.32 155.4 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.4 163.81 22.48 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.5 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -117.59 156.34 28.27 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.461 -1.295 . . . . 0.0 107.961 172.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 6.5 t-20 -141.76 152.12 43.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.665 178.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 34.3 tt0 -29.34 -47.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.501 179.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -111.85 36.09 3.44 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.5 -161.27 27.37 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.786 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -110.3 158.76 18.06 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.031 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.49 114.47 24.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.569 -175.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -39.98 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.368 1.668 . . . . 0.0 112.794 -176.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.53 140.06 36.04 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.769 -174.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.46 147.27 29.53 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 172.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -116.93 131.48 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.667 -173.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -118.22 131.53 56.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.372 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.25 140.16 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.897 -176.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.75 178.79 9.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.016 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.5 52.06 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.279 177.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.4 p -81.0 165.9 21.3 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.711 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 m -79.9 -175.78 5.11 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.096 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.49 149.28 23.38 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.106 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 116.488 -1.72 . . . . 0.0 110.63 -178.685 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.973 0.415 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.23 172.95 16.87 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.501 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 1.6 Cg_endo -62.32 170.96 5.86 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.471 2.114 . . . . 0.0 112.924 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.6 p -87.42 150.36 23.84 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.909 171.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.45 160.12 1.42 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.173 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.5 162.47 27.66 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.206 1.27 . . . . 0.0 110.193 176.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 132.54 48.47 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.65 113.45 27.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.577 -174.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -92.7 141.19 28.74 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.597 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.42 121.37 7.08 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.129 -174.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 79.4 mt-30 -117.55 114.57 23.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.46 ' CE ' HD13 ' A' ' 19' ' ' ILE . 50.9 tpp -101.87 130.14 48.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.148 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.01 146.36 21.19 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.481 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.23 14.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.916 -177.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.8 -25.56 40.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.572 175.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.54 -48.34 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.924 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -131.92 51.38 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.167 0.508 . . . . 0.0 109.967 176.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -121.69 112.21 18.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 173.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.542 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -116.27 128.54 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.656 -171.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -114.98 126.07 54.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.05 0.844 . . . . 0.0 108.859 171.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.1 t -105.6 111.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 1.4 t-20 -89.0 127.83 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.5 -175.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.31 103.54 15.49 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.352 -174.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.7 mm -96.52 134.78 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HZ2' ' HG ' ' A' ' 31' ' ' SER . 31.8 mtmt -104.48 154.53 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.257 -176.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -66.56 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.627 -175.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -131.41 117.79 19.35 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 5.0 m-20 -130.06 -35.25 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.98 177.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.51 52.76 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.94 23.25 28.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -175.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.608 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 24.7 m 43.51 61.38 10.25 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -88.9 39.58 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.464 1.443 . . . . 0.0 109.058 173.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.1 151.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.927 0.87 . . . . 0.0 111.258 -174.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.8 mtt180 -128.75 115.52 18.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.825 -179.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 31.9 -174.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.495 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 71.7 m-85 -132.57 153.34 51.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.077 174.254 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.86 113.27 25.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.89 128.98 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.043 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.82 138.03 45.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.839 1.337 . . . . 0.0 108.122 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.63 157.15 44.33 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.805 -1.558 . . . . 0.0 112.007 176.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -134.73 163.93 28.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.448 -177.081 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.33 166.18 15.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.727 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.04 43.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.966 172.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -147.69 -56.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.742 176.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.543 ' HG ' ' HZ3' ' A' ' 48' ' ' LYS . 15.8 p -132.05 157.99 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.198 175.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 16.0 pt-20 -105.09 165.34 11.16 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.711 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.8 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.614 178.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HZ3' ' HG ' ' A' ' 45' ' ' SER . 72.6 mmtt -69.52 163.44 58.96 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.45 172.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.0 Cg_exo -49.59 105.72 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.726 1.618 . . . . 0.0 110.622 176.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.36 160.67 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -175.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.27 148.84 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.181 174.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -115.07 135.56 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -88.1 164.19 34.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.159 -177.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.26 161.19 41.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.694 1.596 . . . . 0.0 109.08 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -84.38 99.65 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.188 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.38 48.75 0.51 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -177.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -97.05 178.3 5.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.551 -177.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.21 -42.02 3.09 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.058 -179.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -150.72 168.32 24.72 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.106 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.556 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.6 p -120.73 148.19 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.719 172.141 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 ptp -133.09 149.95 52.1 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.604 -1.238 . . . . 0.0 112.79 -174.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -139.15 134.84 33.36 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.402 173.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -133.96 138.56 45.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.42 -176.025 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 5.9 t 88.81 49.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.836 172.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.0 mm? -96.32 -179.88 4.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.852 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -71.62 133.45 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.587 0.708 . . . . 0.0 111.127 -174.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -73.76 155.72 38.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 45.18 47.1 10.02 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.859 -177.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.27 156.04 45.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.014 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.29 148.94 22.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 12.2 m-85 -134.02 144.38 48.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.525 -178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -120.52 123.33 42.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.421 176.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.05 124.76 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 40.3 m-85 -113.43 125.66 54.48 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -120.63 124.36 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.536 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -110.99 157.05 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.54 158.84 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.459 177.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.8 tt0 -113.22 163.91 14.2 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.627 -1.229 . . . . 0.0 107.786 174.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.8 t-20 -148.93 152.37 36.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.987 177.217 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -36.81 -44.08 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.516 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -109.99 40.21 1.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.59 -153.78 22.23 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.271 172.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -122.29 161.81 22.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.733 179.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 t -120.94 117.64 27.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -40.95 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 125.592 1.808 . . . . 0.0 113.378 -174.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 76' ' ' VAL . . . -84.18 136.51 33.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.194 -176.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.03 145.45 30.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.449 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.83 131.02 56.96 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.718 -173.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -118.58 130.48 55.91 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.019 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.55 141.01 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.386 -177.169 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.47 177.28 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.068 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 147.01 50.73 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.927 176.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.92 163.45 20.01 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.586 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -80.77 -168.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.213 -179.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.57 143.16 33.43 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.044 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.235 -1.84 . . . . 0.0 110.463 -179.361 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.907 0.384 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.18 171.84 13.53 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.644 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 9.3 Cg_endo -67.41 174.39 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.573 2.182 . . . . 0.0 113.054 -178.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -94.36 -178.01 4.45 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.706 172.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.65 149.34 64.06 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.988 177.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.83 174.68 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.377 1.385 . . . . 0.0 109.954 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HB2' HE22 ' A' ' 26' ' ' GLN . 20.9 ttpt -105.78 141.0 37.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.75 115.16 29.35 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.29 -177.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.04 138.41 39.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -126.64 143.65 14.5 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.277 -1.916 . . . . 0.0 113.815 -171.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -128.14 138.53 52.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.084 171.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.476 ' CE ' HD12 ' A' ' 19' ' ' ILE . 21.5 mtp -108.31 128.2 54.54 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.9 178.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -80.88 151.46 32.04 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.81 -175.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.87 11.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.037 -0.581 . . . . 0.0 112.311 -178.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.8 -24.62 41.29 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.727 176.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.29 -41.65 2.16 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.86 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.6 p30 -138.87 50.44 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.116 177.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.3 m -122.31 114.65 21.07 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.5 mm -116.2 128.86 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.684 -170.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 123.04 47.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.12 0.887 . . . . 0.0 109.214 175.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 44.4 t -112.79 120.28 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -176.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -97.42 134.2 40.99 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.772 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -101.4 105.9 16.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.048 0.843 . . . . 0.0 109.039 -175.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.18 107.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.165 -176.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -76.92 156.84 31.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.422 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.7 pt20 -154.57 -83.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.389 -173.083 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.42 98.65 8.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.66 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -131.62 -34.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.498 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.79 56.72 0.43 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.86 19.07 41.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.571 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.8 m 42.1 61.56 8.45 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.744 -176.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -86.92 45.51 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.727 1.618 . . . . 0.0 108.701 173.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.4 mm -82.15 150.8 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.203 -173.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' HIS . 63.4 mtp85 -128.26 112.41 14.46 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.799 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.4 p-80 38.66 -173.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 175.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.45 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.53 153.88 51.57 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.28 177.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.89 110.51 21.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 175.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.55 124.92 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.281 -173.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -135.56 139.97 44.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.647 1.217 . . . . 0.0 108.151 177.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.38 154.87 42.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.299 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 16.0 ptt180 -132.23 164.87 25.41 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.381 -178.058 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.53 169.77 13.33 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.272 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -74.16 42.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.783 173.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -145.49 -56.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.731 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.43 ' HG ' ' HZ2' ' A' ' 48' ' ' LYS . 12.9 p -137.05 164.25 28.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.521 175.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -100.98 169.13 9.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.398 -174.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 6.5 m95 17.81 95.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.788 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.5 mmtt -69.0 165.48 37.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.99 172.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 13.1 Cg_exo -50.71 97.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.538 1.492 . . . . 0.0 109.849 175.063 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.0 172.23 1.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.566 -173.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.3 tt -138.24 154.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.956 -179.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -115.5 135.57 53.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.94 174.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -85.41 165.1 37.73 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.002 -177.383 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 9.9 Cg_endo -73.31 146.41 40.17 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.725 1.616 . . . . 0.0 109.783 172.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.3 p -58.17 113.85 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.931 0.769 . . . . 0.0 111.285 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.41 56.29 1.05 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -97.04 177.04 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 -45.48 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.813 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -144.27 170.22 16.4 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.128 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.5 p -129.03 151.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.348 175.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ptp -138.09 150.91 47.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.67 -1.212 . . . . 0.0 112.193 -177.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.52 140.51 41.15 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.983 174.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.8 ttpt -140.47 136.42 32.96 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.811 -173.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.3 t 90.31 48.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.763 172.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 3.8 mm? -95.4 179.49 5.14 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.321 -178.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.03 134.69 48.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.661 0.743 . . . . 0.0 111.441 -173.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -74.47 154.21 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 45.86 48.06 12.1 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.618 -177.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.29 151.86 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.2 148.77 21.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 65' ' ' LEU . 8.6 m-85 -133.62 141.25 47.56 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.398 -178.16 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.47 117.83 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.753 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.07 122.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 41.8 m-85 -112.21 125.88 54.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.33 122.71 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.888 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.15 158.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.99 159.67 33.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.049 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -112.74 164.66 13.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.448 -1.301 . . . . 0.0 107.582 174.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -149.6 153.2 36.72 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.872 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -40.74 -40.89 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.318 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -79.75 -52.5 7.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.01 -119.37 0.57 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.114 -177.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -125.34 163.93 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.427 -179.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.66 119.35 30.47 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -40.59 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 125.357 1.661 . . . . 0.0 113.447 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.62 139.24 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.387 -176.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.87 144.78 34.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.448 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.4 t-160 -116.39 131.59 56.9 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.633 -173.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 85.6 t80 -117.72 128.16 54.62 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.083 -179.175 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -124.89 137.89 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.58 -176.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.1 p90 -157.8 178.3 10.4 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.276 178.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.13 145.98 51.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.78 175.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -80.0 172.6 13.55 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.283 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -86.28 -174.96 5.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.166 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.91 147.51 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.312 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.471 -1.728 . . . . 0.0 110.551 -179.09 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.78 172.97 13.4 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.692 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 14.9 Cg_endo -71.2 178.02 5.92 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -84.93 152.71 23.32 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.479 170.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 162.7 0.92 Allowed Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.335 174.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.71 167.38 20.69 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.219 1.28 . . . . 0.0 110.522 176.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -104.24 127.42 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -98.31 112.32 24.35 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.983 -177.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.62 93.99 4.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -104.46 152.24 17.51 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.946 -172.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.64 157.82 43.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.953 -1.124 . . . . 0.0 109.232 178.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.3 ttm -111.12 139.45 46.47 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.359 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.15 154.85 25.76 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.121 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.45 11.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.267 -176.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 20.4 m-20 -79.89 -22.87 42.29 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.152 175.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.58 -37.09 3.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.939 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 10.1 p-10 -140.12 46.22 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.112 177.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.4 m -120.77 115.23 22.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.501 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.0 mm -116.08 130.85 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.132 -170.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.77 122.48 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.8 t -108.88 116.44 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -93.44 134.34 35.78 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.17 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 32.7 mt -101.41 103.74 14.68 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.286 -176.138 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mm -95.2 136.71 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.13 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -104.36 152.6 22.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.45 -69.88 0.54 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.916 -175.636 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 25.7 m-20 -127.45 110.78 13.11 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.3 m-20 -131.48 -33.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.399 178.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.12 52.09 0.5 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.22 24.81 25.77 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.559 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 39.26 64.34 4.0 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.853 -0.674 . . . . 0.0 112.489 -176.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.9 44.61 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.665 1.577 . . . . 0.0 108.705 173.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 mm -90.69 148.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.163 -174.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' HIS . 74.6 mtm-85 -131.8 125.6 32.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.829 175.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.7 p-80 36.34 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 176.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 94.7 m-85 -138.57 150.56 46.45 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.518 178.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -105.27 110.32 22.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.47 126.31 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 118.959 -1.097 . . . . 0.0 110.607 -174.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -132.41 135.31 46.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 125.035 1.46 . . . . 0.0 107.804 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.47 151.69 41.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.659 -1.616 . . . . 0.0 112.128 176.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.3 ptm180 -124.15 160.53 27.64 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.433 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -109.17 -168.84 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.85 39.78 1.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.54 -60.97 0.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.506 ' HG ' ' HZ2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -118.03 150.26 39.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.505 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.9 pt-20 -106.79 144.02 34.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.746 -177.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.48 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.4 m95 48.45 82.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.107 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HZ2' ' HG ' ' A' ' 45' ' ' SER . 72.6 mmtt -68.71 161.26 72.48 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.926 174.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.6 Cg_exo -43.63 104.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.96 1.773 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -52.21 161.63 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.902 -175.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.3 147.7 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.412 174.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -114.04 129.69 56.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.4 mt -78.35 164.68 54.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.663 -178.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 6.0 Cg_exo -63.03 149.84 90.4 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.646 1.564 . . . . 0.0 110.009 174.192 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.4 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 20.5 m -64.23 87.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.68 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.7 56.61 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.7 t -97.02 -175.07 3.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.162 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.86 -24.01 3.01 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.974 -178.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p-80 -160.26 167.52 27.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.988 -177.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.8 p -130.4 152.32 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.579 174.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ptp -137.86 148.91 45.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.235 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -138.58 135.75 35.31 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.719 174.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.9 mtmt -141.63 143.07 33.45 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.871 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.5 m 90.82 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.999 175.036 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 4.2 mm? -92.6 -177.81 4.69 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.813 -178.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.29 133.94 41.19 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.635 0.731 . . . . 0.0 111.229 -172.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.59 155.8 39.66 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.125 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.6 t30 44.63 47.02 8.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.084 -177.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.41 154.58 46.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.824 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.42 148.31 23.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.684 177.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.534 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 21.4 m-85 -133.76 142.1 47.78 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.502 -177.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -122.86 118.42 27.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.184 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.68 123.42 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 50.3 m-85 -112.2 126.04 54.79 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.08 122.42 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.925 0.766 . . . . 0.0 110.705 -178.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.23 159.71 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.61 159.93 35.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.016 177.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.14 151.99 30.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.361 -1.336 . . . . 0.0 108.283 175.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.454 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -142.55 150.77 40.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.62 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -37.81 -39.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.711 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.63 -49.86 11.53 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.085 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 -125.2 0.75 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.513 -179.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -119.78 157.87 27.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.088 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.68 118.05 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -41.53 162.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 125.538 1.774 . . . . 0.0 112.873 -175.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.78 135.36 34.57 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.235 -175.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.99 148.05 25.83 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.48 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -117.4 130.64 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.783 -172.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.3 t80 -119.17 130.37 55.48 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.939 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.48 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.7 t -128.48 142.85 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.311 -175.307 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 49.6 p90 -162.52 179.08 8.03 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.334 177.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -129.28 147.91 51.16 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.49 175.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.6 p -79.87 170.95 15.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.344 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -83.23 -173.02 4.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.967 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 138.9 39.83 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.02 -178.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 116.447 -1.739 . . . . 0.0 110.654 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.965 0.412 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.69 176.59 14.54 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.044 -1.074 . . . . 0.0 110.588 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.3 Cg_exo -60.09 173.26 1.92 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.549 2.166 . . . . 0.0 113.177 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -98.62 162.61 13.04 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 144.27 94.98 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.168 -177.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.54 174.01 8.02 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.392 1.395 . . . . 0.0 110.495 -178.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -109.09 132.08 54.45 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.37 114.68 29.0 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.876 -1.129 . . . . 0.0 110.035 -176.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -95.09 141.27 28.92 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.73 127.44 8.97 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.634 -171.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -121.82 113.28 19.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 19' ' ' ILE . 25.0 mtp -103.63 127.2 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.348 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.79 147.16 21.0 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.722 -1.228 . . . . 0.0 112.25 -174.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.27 13.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.918 -0.641 . . . . 0.0 112.141 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.554 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.23 41.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.449 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.67 -46.18 1.21 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.55 176.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -134.54 35.37 3.18 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.315 177.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -104.59 113.88 27.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.519 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 12.1 mm -118.43 126.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.492 -171.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -113.66 127.38 56.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.006 0.816 . . . . 0.0 108.822 172.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.1 t -108.53 116.31 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -97.65 129.64 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.54 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.2 mt -99.37 109.64 22.22 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.756 -172.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.9 mm -100.6 135.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.94 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HZ3' ' HG ' ' A' ' 31' ' ' SER . 30.1 mtmt -101.58 150.42 23.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.828 0.705 . . . . 0.0 109.265 -179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 -49.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.744 -175.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -140.01 104.27 4.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.69 -177.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -132.57 -33.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.256 178.695 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.64 51.66 0.49 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.64 23.94 29.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.589 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.6 t 42.76 62.13 8.64 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.734 -0.733 . . . . 0.0 112.816 -176.026 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.83 41.68 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.582 1.521 . . . . 0.0 108.813 171.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.65 150.83 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.488 -173.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 53.4 mtt-85 -130.69 117.52 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.47 -1.695 . . . . 0.0 108.598 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.3 p-80 36.76 -175.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 176.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.45 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 91.7 m-85 -137.21 153.96 50.29 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.012 176.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -108.65 110.21 21.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 60' ' ' VAL . 44.7 t -114.17 123.81 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.137 -173.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -134.49 137.85 44.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.661 1.225 . . . . 0.0 108.113 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.21 158.71 43.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.968 -1.493 . . . . 0.0 112.505 179.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.0 ptm180 -138.28 170.72 15.52 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.983 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 71' ' ' TYR . . . -120.09 -168.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.155 -175.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.24 41.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.484 174.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.23 -57.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.701 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -122.95 157.61 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.926 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.1 pt-20 -97.68 178.22 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.462 -177.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.5 m95 3.38 100.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -77.42 167.87 32.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.307 172.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 14.2 Cg_exo -48.61 98.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.711 1.607 . . . . 0.0 110.365 176.169 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.37 174.32 4.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.353 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.12 155.51 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.389 -177.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -113.68 134.08 54.95 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.974 173.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -82.28 163.55 52.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.933 -177.64 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.7 Cg_exo -59.59 167.29 6.76 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.84 1.693 . . . . 0.0 110.51 174.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -74.76 79.82 2.07 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.657 -176.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 63.02 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -97.05 -175.81 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.808 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.03 -16.53 3.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.274 -179.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.9 p-80 -160.07 164.52 33.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.496 -176.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -134.9 152.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.614 173.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -137.42 152.86 50.06 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.708 -176.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -138.88 140.57 38.45 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.52 173.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.32 156.2 47.01 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.617 -174.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.1 t 62.68 59.13 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.378 175.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.68 -175.14 2.81 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.653 176.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' H ' ' HH ' ' A' ' 71' ' ' TYR . 3.8 m-20 -79.84 140.33 36.85 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.677 0.751 . . . . 0.0 111.462 -174.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 80.4 m95 -76.73 154.15 34.37 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.602 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 44.49 48.34 8.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 -177.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.34 152.79 47.75 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.676 179.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.58 147.66 24.57 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.601 176.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.556 ' CE2' ' HB1' ' A' ' 42' ' ' ALA . 23.1 m-85 -132.2 143.39 49.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.36 -176.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -120.82 118.26 29.52 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.785 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -112.91 120.63 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 47.6 m-85 -110.08 125.4 52.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.83 120.69 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.429 -178.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 86' ' ' ALA . 2.2 t -104.98 158.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.98 156.48 43.71 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.612 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.24 159.24 18.1 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.742 174.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 20.0 t-20 -143.64 151.87 40.66 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.512 178.228 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -40.03 -39.1 0.81 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.006 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -107.99 35.43 3.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.01 -151.44 20.45 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.942 173.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -121.79 160.08 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.933 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -122.54 122.85 39.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -41.88 165.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.664 1.852 . . . . 0.0 113.468 -174.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.41 ' HB3' HG21 ' A' ' 76' ' ' VAL . . . -85.57 137.23 33.01 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.34 146.01 28.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.462 ' CE1' HG21 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.09 128.16 55.45 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.687 -174.039 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 82.7 t80 -112.73 124.97 53.78 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.88 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG21 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -124.29 137.46 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.324 -176.475 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 46.3 p90 -161.34 179.09 8.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.821 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -128.53 153.36 47.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.364 173.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.1 p -79.92 177.72 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.074 177.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -90.45 -174.01 3.98 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.333 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.46 149.18 23.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.083 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.538 -1.696 . . . . 0.0 110.621 -178.571 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.56 169.45 17.5 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.467 179.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.468 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.4 Cg_exo -60.62 169.48 5.46 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.407 2.072 . . . . 0.0 113.08 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -98.0 163.39 12.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.347 172.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.44 142.28 91.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.269 -176.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -70.65 163.24 39.7 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.551 1.501 . . . . 0.0 110.087 -178.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -91.98 137.05 32.68 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.7 mt -105.77 109.81 21.9 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.56 -179.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -94.34 137.92 32.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.34 -178.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.85 125.85 8.48 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.593 -1.289 . . . . 0.0 112.384 -171.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -120.84 117.74 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.462 ' CE ' HD11 ' A' ' 19' ' ' ILE . 51.2 tpp -99.92 127.43 46.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.78 150.34 24.12 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.191 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 4.8 mp0 -66.69 14.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.798 -176.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.75 41.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.461 174.559 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.21 -43.5 1.7 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.337 177.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -130.81 6.89 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.205 178.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -75.06 112.27 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.819 176.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 9.4 mm -114.36 125.04 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.862 -173.356 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.63 125.85 54.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.0 t -108.38 113.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -178.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -93.46 129.26 39.7 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.353 -177.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -97.37 106.14 18.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.393 -173.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.94 105.55 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.803 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -76.23 148.04 37.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -146.01 -55.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.26 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.68 101.58 5.54 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.682 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.1 m-20 -129.07 -37.41 1.69 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.109 178.252 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.02 54.69 0.38 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.54 20.24 38.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -175.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.586 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.1 m 42.47 61.87 8.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -86.68 43.0 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.695 1.597 . . . . 0.0 108.493 172.058 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -80.79 151.09 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.536 -172.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.1 mtt180 -127.85 111.7 13.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.696 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.8 p-80 37.46 -176.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 175.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 80.9 m-85 -134.34 151.35 51.18 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.847 175.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 76' ' ' VAL . 5.9 mt -107.68 110.68 22.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG11 HG23 ' A' ' 60' ' ' VAL . 43.4 t -115.7 125.98 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.413 -174.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -137.53 142.2 41.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.637 1.21 . . . . 0.0 107.924 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.19 157.78 43.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.802 -1.559 . . . . 0.0 112.187 179.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -132.32 163.19 29.22 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.305 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . . . -120.98 175.65 5.95 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.62 42.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.125 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.97 -59.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.244 178.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -125.41 154.89 41.24 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.156 176.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -106.47 158.16 17.11 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.992 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 33.03 86.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.204 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.8 mmtt -72.52 164.16 62.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.387 175.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.46 98.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.83 1.687 . . . . 0.0 110.537 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.64 173.6 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.506 -174.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.02 155.0 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.09 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -115.96 133.45 56.01 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.884 173.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.6 mt -82.63 162.94 54.03 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.294 -176.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.7 Cg_exo -60.33 168.85 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.932 1.755 . . . . 0.0 111.016 173.123 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 p -80.9 81.44 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.956 -177.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 58.47 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 m -97.13 178.94 5.09 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.898 -178.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.75 -37.68 2.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.545 -178.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -148.93 168.43 23.07 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.018 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -126.89 150.49 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.48 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ptp -134.39 148.12 50.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.52 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.85 141.74 33.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.008 173.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -141.51 174.06 10.91 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.901 -1.119 . . . . 0.0 111.309 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 m 59.02 56.79 3.81 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.424 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 17.2 mt -94.33 -178.1 4.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.18 131.95 38.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.229 175.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.402 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.3 m95 -72.71 152.61 41.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.556 -1.258 . . . . 0.0 110.251 -178.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.77 46.79 18.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.853 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.88 154.28 45.68 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.889 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.28 149.9 20.83 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.216 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 42' ' ' ALA . 16.3 m-85 -135.5 141.9 45.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.269 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.14 118.28 30.96 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.422 177.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.64 124.2 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.59 125.71 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.5 t -121.49 122.51 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.023 0.827 . . . . 0.0 110.482 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 HG23 ' HB1' ' A' ' 86' ' ' ALA . 2.2 t -109.16 158.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.09 156.77 43.35 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.408 -1.317 . . . . 0.0 109.797 177.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.4 tt0 -112.05 162.52 15.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -147.26 150.86 35.67 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.099 177.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -39.05 -43.04 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.307 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -111.52 40.37 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.599 -175.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.12 -152.12 22.58 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.82 174.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -132.67 167.88 19.29 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.701 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.34 121.01 29.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.3 -178.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -43.41 166.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 125.5 1.75 . . . . 0.0 112.987 -175.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 76' ' ' VAL . . . -83.82 135.87 34.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.37 -175.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.9 144.32 29.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.472 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -113.96 129.25 56.62 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.336 -174.265 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -116.8 125.05 51.02 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.785 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.468 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -124.28 137.73 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.501 -176.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 44.1 p90 -156.85 177.93 10.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.07 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -126.31 147.72 49.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.475 174.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.88 167.97 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 m -78.16 -177.25 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.362 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.22 146.65 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.891 179.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 116.466 -1.731 . . . . 0.0 110.531 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.49 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.7 Cg_exo -56.53 173.7 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.509 2.14 . . . . 0.0 113.095 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m -95.15 159.51 14.98 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.536 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.91 144.4 98.99 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.129 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.9 Cg_endo -66.02 163.63 30.52 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.417 1.411 . . . . 0.0 110.822 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 128.1 48.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -102.91 115.72 31.15 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.45 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.42 141.68 30.2 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -106.92 125.66 8.15 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.448 -1.358 . . . . 0.0 112.51 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -121.27 119.68 32.95 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.0 ttm -105.89 132.2 52.28 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.727 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.31 147.49 22.41 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.458 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.07 13.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.907 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.88 -22.76 42.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.828 175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -40.65 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.102 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.409 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 8.4 p30 -137.65 49.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.278 0.561 . . . . 0.0 109.876 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -121.12 112.95 19.33 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.9 127.92 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.751 -170.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -114.18 127.25 55.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -107.83 113.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.81 131.88 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.544 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 30.3 mt -101.33 107.07 18.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.787 -172.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.56 132.59 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.095 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -99.1 155.29 17.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.845 0.715 . . . . 0.0 109.729 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.493 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.99 -48.2 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.02 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -143.89 109.11 5.04 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.134 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.0 m-20 -130.77 -37.59 1.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.035 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.82 54.71 0.39 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.42 33.16 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 11.4 m 43.62 61.3 10.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -88.75 40.0 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.418 1.412 . . . . 0.0 108.943 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.24 150.21 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.897 0.856 . . . . 0.0 111.336 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.1 mtt180 -130.95 116.67 18.17 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.793 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 35.66 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.566 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 82.7 m-85 -139.16 151.3 46.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.792 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.8 mt -106.89 109.83 21.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 54.9 t -113.92 122.9 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.035 -174.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.74 135.43 46.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.614 1.196 . . . . 0.0 107.927 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -141.51 161.6 37.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.876 -1.53 . . . . 0.0 112.063 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 7.8 ptm180 -144.35 170.1 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.763 -1.562 . . . . 0.0 110.166 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -122.63 179.65 4.54 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.714 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 tp -82.43 42.68 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.102 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.56 -56.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.344 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.3 m -124.31 151.95 43.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.409 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -98.07 175.03 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.606 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.8 m95 10.5 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.581 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 27.7 mmmt -80.53 163.0 58.77 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.049 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.4 Cg_exo -44.89 102.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.907 1.738 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.45 175.09 4.26 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.577 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.52 153.12 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.014 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 39.1 ttm105 -114.39 127.51 55.88 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.019 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -73.26 164.77 58.56 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.263 -177.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.77 169.99 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.749 1.633 . . . . 0.0 110.272 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.5 t -76.9 77.55 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.554 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.09 64.67 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 t -96.99 -174.47 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.14 -25.33 4.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 12.3 p-80 -160.22 167.68 27.06 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.778 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -129.56 153.66 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.125 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ptp -139.81 154.54 47.38 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.37 -1.332 . . . . 0.0 113.157 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -140.38 139.77 35.4 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.563 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -135.78 136.55 40.8 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.616 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 86.97 51.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.0 170.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -97.96 -177.85 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.923 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 134.73 42.58 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.685 0.755 . . . . 0.0 111.328 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -73.21 155.32 39.69 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.207 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.14 49.12 7.64 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.869 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 153.8 49.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.732 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -95.14 150.26 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.888 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.4 m-85 -134.23 143.4 47.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.451 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.7 123.06 43.98 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.891 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.51 121.82 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 35.2 m-85 -110.39 125.43 53.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -120.76 122.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.87 0.732 . . . . 0.0 110.835 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -107.11 157.99 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.51 155.53 43.6 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.43 -1.308 . . . . 0.0 109.534 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.7 tt0 -111.35 158.84 18.58 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.838 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.7 t-20 -144.58 151.34 38.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.716 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -35.7 -44.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.585 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.14 38.14 2.5 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.74 -155.06 23.49 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.317 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -121.76 159.32 26.91 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.794 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.5 t -121.86 125.59 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.294 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -41.38 165.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.718 1.886 . . . . 0.0 113.737 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.09 136.08 33.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.19 147.01 27.56 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.56 129.66 56.6 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.702 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 80.3 t80 -115.09 128.58 56.31 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.986 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -125.85 138.66 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.421 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 39.6 p90 -158.09 178.19 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.028 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -129.7 147.07 51.45 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.912 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -79.85 171.7 14.76 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.67 -171.07 3.36 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.051 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.65 141.24 36.4 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.068 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 116.245 -1.836 . . . . 0.0 110.431 -179.226 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -55.22 170.09 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.699 2.266 . . . . 0.0 113.748 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -94.27 174.17 7.27 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.191 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.36 142.2 58.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.744 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -69.55 169.53 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.588 1.525 . . . . 0.0 110.289 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -99.23 137.61 37.5 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 mt -108.38 109.32 20.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.834 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.07 145.38 24.57 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.94 127.96 7.91 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.68 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.39 126.81 48.77 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.484 ' CE ' HD11 ' A' ' 19' ' ' ILE . 47.5 tpp -104.46 129.7 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.913 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -82.82 150.17 27.65 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.31 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.73 12.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.061 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.3 m-20 -79.86 -23.31 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.967 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.27 -41.99 2.03 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.883 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -136.53 48.31 2.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.131 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 m -121.22 116.03 24.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -116.19 128.59 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.469 -170.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.5 124.42 52.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.071 0.857 . . . . 0.0 108.961 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -109.12 120.62 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -94.19 130.7 40.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.283 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.33 98.54 9.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mm -89.42 107.88 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.242 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -68.69 170.03 10.13 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 4.5 pt20 -170.31 -67.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.652 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.4 m-20 -117.94 86.52 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.218 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.4 m-20 -129.31 -17.41 3.79 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.57 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.82 23.43 49.75 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.1 m 43.84 64.9 6.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.763 -0.718 . . . . 0.0 112.797 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -86.93 46.44 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 N-CA-C 107.26 -1.862 . . . . 0.0 107.26 170.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.02 152.11 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.008 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -127.63 113.91 16.68 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.221 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.8 p-80 36.86 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.9 m-85 -137.25 152.09 49.43 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.461 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.8 109.26 21.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 60' ' ' VAL . 49.7 t -113.12 121.15 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.797 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.82 137.54 48.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 124.69 1.244 . . . . 0.0 107.874 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 155.16 44.87 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.906 -1.518 . . . . 0.0 112.173 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.2 ptm180 -131.23 164.66 25.07 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.018 -1.447 . . . . 0.0 110.098 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.61 170.48 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.02 43.09 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.506 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.73 -58.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.074 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.3 m -127.21 154.81 44.36 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.194 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -101.41 163.6 12.19 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.144 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.469 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 24.81 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.258 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 39.9 mmtm -71.49 165.93 44.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.116 174.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -49.17 96.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.723 1.615 . . . . 0.0 110.046 175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.01 174.34 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.534 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.91 154.4 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.368 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -113.99 130.12 56.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.789 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mt -78.18 164.02 58.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.798 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.8 Cg_exo -60.33 168.08 6.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.666 1.577 . . . . 0.0 110.318 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.2 t -75.92 78.1 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.724 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 63.66 0.36 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.1 t -97.09 -172.12 2.37 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.689 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -131.96 -15.82 2.95 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.214 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.2 p-80 -159.71 165.39 32.65 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.556 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.3 p -135.0 152.18 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.66 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptp -137.78 150.58 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.418 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -139.6 138.21 35.99 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.954 174.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 53.1 mtmt -142.41 141.7 32.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.849 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.2 t 93.32 44.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.291 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -178.65 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.028 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.72 135.17 43.62 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 0.0 111.241 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -74.19 156.49 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.291 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 45.24 47.07 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.729 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.48 154.95 47.24 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.002 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -97.24 149.04 22.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.8 m-85 -133.8 144.47 49.02 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.614 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.72 121.0 37.29 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.619 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.73 123.38 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.16 127.12 55.84 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.48 120.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 123.914 0.759 . . . . 0.0 110.731 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.08 158.88 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.58 45.26 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.219 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.97 157.48 21.44 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.317 -1.353 . . . . 0.0 107.9 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.5 t-20 -144.37 153.29 41.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.527 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -37.21 -41.95 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.496 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -107.64 36.38 2.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.79 -153.51 21.11 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.041 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -120.08 158.92 25.85 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 t -124.04 128.02 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.97 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -42.09 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 125.751 1.907 . . . . 0.0 113.303 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -90.17 140.89 29.24 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.443 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.8 145.08 29.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.466 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -115.25 129.87 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.418 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 78.1 t80 -117.73 130.1 56.11 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.095 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.61 139.7 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.541 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.7 p90 -157.38 177.43 11.45 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.154 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.52 146.57 51.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.951 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.31 164.98 19.7 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.539 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -81.61 -169.84 2.52 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.1 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.94 141.7 36.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.154 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.708 -179.524 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.453 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 28.2 Cg_endo -71.33 179.99 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.849 2.366 . . . . 0.0 112.737 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -103.95 160.32 14.91 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.177 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.69 148.99 98.56 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.812 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -71.85 171.85 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.307 1.338 . . . . 0.0 110.335 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.16 146.57 26.68 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.9 mt -115.09 114.04 24.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.195 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -95.42 144.81 25.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.79 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -111.33 127.09 8.03 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.48 -1.343 . . . . 0.0 112.554 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -122.73 124.58 43.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 47.9 ttm -105.25 133.13 50.52 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.595 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.94 153.88 25.09 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.543 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.07 10.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.082 -0.559 . . . . 0.0 112.234 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -80.0 -23.17 41.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.878 176.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.57 -37.03 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.36 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -132.53 2.46 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.123 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -75.67 116.5 16.45 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.974 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.0 127.67 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.182 -172.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.85 125.45 54.08 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.2 t -108.91 119.78 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -97.28 128.72 44.38 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.102 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 47.3 mt -96.72 110.34 22.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 123.855 0.722 . . . . 0.0 109.695 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -97.42 108.18 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.686 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -72.4 168.43 18.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.753 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.458 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.6 pt20 -166.27 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.555 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 18.7 t70 -111.8 89.87 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.075 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 18.1 m-20 -131.97 -17.81 2.73 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.255 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.18 54.03 1.31 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.42 31.65 58.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 t 36.8 79.07 0.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 114.637 -0.782 . . . . 0.0 112.949 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 79' ' ' ASN . 6.0 Cg_endo -87.55 35.46 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 N-CA-C 107.169 -1.896 . . . . 0.0 107.169 165.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.99 144.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 122.091 0.948 . . . . 0.0 111.863 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 27.6 mtt180 -128.19 128.65 45.15 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.109 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 11.9 p-80 34.44 -173.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.475 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -139.93 153.5 46.97 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.555 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -106.29 112.16 25.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 60' ' ' VAL . 45.9 t -114.11 128.22 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.928 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -134.43 140.25 46.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 125.039 1.462 . . . . 0.0 108.011 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.62 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.99 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.477 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 24.5 ptt85 -126.41 158.8 35.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.354 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.78 169.43 10.43 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.551 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.95 43.6 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.868 173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.49 -57.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.826 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.3 m -130.95 152.28 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.003 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 38.2 mt-10 -105.89 142.02 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.655 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.2 m95 58.81 84.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.837 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mptp? -70.67 161.89 74.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.123 173.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.66 105.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.88 1.72 . . . . 0.0 111.073 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.81 161.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.842 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.5 tt -134.12 149.91 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.459 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -114.29 132.41 56.17 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 60' ' ' VAL . 1.5 mt -82.79 165.25 42.75 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.129 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.5 Cg_exo -63.1 156.13 56.92 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.784 1.656 . . . . 0.0 110.324 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -73.66 83.26 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.183 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.62 47.61 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.63 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -97.13 167.44 11.05 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.04 -2.62 9.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.643 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.459 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.05 163.5 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.191 -1.403 . . . . 0.0 112.86 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -135.43 152.29 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.867 173.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptp -137.67 150.63 47.51 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.641 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -141.74 140.78 33.19 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.24 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.41 162.1 35.84 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.011 -1.075 . . . . 0.0 111.728 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 m 65.96 54.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.705 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -100.18 -175.43 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.046 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.51 136.64 37.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.084 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -75.16 155.72 36.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 43.28 48.61 5.77 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.567 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.47 152.83 47.79 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.128 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -91.63 146.14 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 17.1 m-85 -134.45 138.72 44.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.245 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.61 118.3 28.88 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.457 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -112.29 126.85 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 51.5 m-85 -115.69 125.76 53.24 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.44 121.88 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 123.96 0.787 . . . . 0.0 110.708 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -106.81 156.26 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.38 155.74 41.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.955 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -110.08 149.13 30.47 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.126 -1.43 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.56 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -129.34 141.68 51.02 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.806 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -42.59 -33.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.229 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -126.61 50.44 1.93 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -160.36 27.06 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.097 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -125.97 159.18 33.35 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.827 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -113.18 111.32 21.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -39.59 159.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 125.442 1.714 . . . . 0.0 112.527 -176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.0 128.75 35.07 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.951 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.58 145.06 25.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.7 t-160 -116.12 130.94 57.04 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.781 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.6 t80 -120.07 128.86 53.88 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.314 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -126.23 135.67 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.627 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 19' ' ' ILE . 38.7 p90 -157.49 177.65 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.169 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -128.25 147.9 50.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.425 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.8 p -79.87 170.59 16.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.178 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -84.48 -171.29 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.222 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 140.88 36.92 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.092 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.386 -179.074 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.492 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.0 Cg_exo -58.05 172.23 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.561 2.174 . . . . 0.0 113.34 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -98.66 163.35 12.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.567 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.75 143.7 98.21 Favored Pre-proline 0 N--CA 1.491 1.594 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.372 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -71.63 172.51 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.66 1.573 . . . . 0.0 110.582 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -99.06 142.21 30.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -112.29 111.37 22.2 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.037 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -92.05 144.03 25.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.0 131.45 10.46 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.22 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -128.07 125.83 40.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.1 ttm -107.65 131.52 54.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.89 151.97 28.09 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.429 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.18 10.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.157 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -79.97 -22.46 42.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.123 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.74 -37.16 3.84 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.051 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.1 p-10 -138.56 46.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -121.48 113.25 19.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 mm -116.35 129.16 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.688 -169.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -114.21 127.38 55.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.8 t -110.69 118.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -95.75 130.63 42.6 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.62 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 55.6 mt -99.6 109.43 21.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 123.678 0.611 . . . . 0.0 109.978 -174.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -94.69 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.74 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -79.01 140.41 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -136.87 -70.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.329 -171.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -115.88 101.29 8.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.004 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.02 -34.54 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.31 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.94 52.1 0.35 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.19 18.78 35.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.604 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 68.6 m 40.75 61.85 6.73 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.9 Cg_endo -87.08 51.36 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.709 1.606 . . . . 0.0 108.694 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.6 mm -88.2 149.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 122.046 0.927 . . . . 0.0 111.446 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.9 mtp85 -132.05 123.61 27.58 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.943 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.59 ' H ' ' N ' ' A' ' 56' ' ' GLY . 6.0 p-80 33.65 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.6 m-85 -142.02 156.46 45.43 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.862 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.57 109.91 21.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 60' ' ' VAL . 46.8 t -114.11 123.67 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.068 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.23 137.87 46.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.804 1.315 . . . . 0.0 108.057 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.39 157.53 44.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 117.966 -1.494 . . . . 0.0 112.294 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.3 ptm180 -134.23 166.54 22.55 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.941 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.02 -170.72 2.01 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.91 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.0 tp -91.83 40.17 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.089 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.44 -58.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.597 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.55 37.1 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.417 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.6 pt-20 -101.3 162.57 12.8 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.282 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.467 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 25.24 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.838 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 70.6 mmtt -75.83 162.99 69.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -44.28 100.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.747 1.632 . . . . 0.0 110.869 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.66 175.65 4.07 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.42 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.34 155.64 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.384 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -113.96 135.36 54.08 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.861 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.1 mt -85.18 167.06 27.9 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.415 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.4 Cg_exo -65.12 154.65 72.47 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.729 1.619 . . . . 0.0 109.91 172.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.453 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 9.0 t -65.62 85.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.588 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 113.4 61.9 0.42 Allowed Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.327 -0.939 . . . . 0.0 110.94 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 t -97.08 164.78 12.37 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.582 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.3 -18.69 14.76 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.87 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.0 p-80 -160.03 172.86 16.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.898 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.2 p -134.8 155.0 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.232 171.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -139.06 151.46 46.77 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.863 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -139.37 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.574 173.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -134.85 137.56 43.38 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.764 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 90.07 48.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.843 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -96.72 -177.47 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.986 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 133.5 40.88 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.752 0.787 . . . . 0.0 111.46 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.66 156.13 39.72 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.254 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.3 t30 46.37 46.04 13.63 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.199 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.8 154.65 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.077 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 45.0 mt-10 -97.61 147.58 24.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.528 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 18.2 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.476 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -120.24 119.78 34.19 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.956 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.69 121.41 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 32.9 m-85 -110.92 124.27 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.9 t -121.08 122.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.856 0.722 . . . . 0.0 110.725 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.27 155.41 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -125.52 157.28 37.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.408 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 29.9 tt0 -111.79 156.33 22.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.712 -1.195 . . . . 0.0 107.801 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.5 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.9 t-20 -137.04 150.03 47.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -37.69 -35.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.145 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -125.73 48.35 2.08 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.732 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.25 -162.18 27.22 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.323 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -119.08 159.15 24.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.85 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.6 t -121.02 119.35 32.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -40.75 164.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.639 1.837 . . . . 0.0 113.231 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.92 140.09 31.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.519 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.6 146.63 28.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.64 129.85 56.39 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.021 -1.071 . . . . 0.0 111.469 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -117.97 130.63 56.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.163 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -127.64 141.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.75 -176.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 40.0 p90 -160.09 178.11 10.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.971 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -127.86 147.74 50.45 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.775 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -80.04 170.31 16.64 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.133 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -80.43 -179.63 7.25 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.892 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.67 144.1 28.32 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.382 -179.263 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.1 Cg_exo -61.22 172.43 3.23 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.566 2.177 . . . . 0.0 112.936 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -97.56 152.49 18.98 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.548 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.74 144.73 72.91 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.49 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.19 164.27 30.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.251 1.301 . . . . 0.0 110.212 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -102.35 129.29 48.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.3 mt -102.79 110.86 22.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.073 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -89.73 139.6 30.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.16 118.37 6.16 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.488 -1.339 . . . . 0.0 112.033 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.73 105.63 13.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.438 ' CE ' HD11 ' A' ' 19' ' ' ILE . 23.6 mtp -103.8 127.66 51.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.016 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -79.91 118.03 4.63 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.845 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.45 13.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.786 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.7 m-20 -79.85 -24.25 41.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.984 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 156.58 -69.96 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.493 -1.813 . . . . 0.0 112.891 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -143.46 18.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.736 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -75.81 115.12 15.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.981 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.501 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 15.6 mm -117.03 123.84 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.716 -173.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.4 124.48 52.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.903 0.752 . . . . 0.0 109.345 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.8 t -104.37 109.41 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -88.87 128.59 35.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.563 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.12 102.37 14.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.434 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.73 132.55 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -107.01 148.25 28.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.283 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -130.61 -63.76 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.055 -173.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 5.1 m-20 -132.86 116.52 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.162 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.1 m-20 -133.42 -35.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.04 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.4 53.65 0.42 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 20.81 37.09 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.612 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.1 t 44.08 61.15 11.18 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.83 -176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -87.86 44.24 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.518 1.478 . . . . 0.0 109.013 172.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.78 148.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.398 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.5 mtt180 -130.82 126.04 35.26 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.185 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.3 p-80 31.95 169.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 54.1 m-85 -123.5 138.88 54.48 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.32 172.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.4 mt -100.27 100.6 11.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 51' ' ' ILE . 48.2 t -109.1 121.97 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.4 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -133.33 140.54 47.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.727 1.267 . . . . 0.0 107.749 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.49 155.42 43.09 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 8.8 ptt180 -131.48 163.08 28.76 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.404 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.14 169.52 11.15 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.458 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -74.13 43.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.733 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.98 -57.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.186 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -128.44 156.42 43.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -104.78 160.59 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.774 -1.171 . . . . 0.0 112.21 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.5 m95 28.36 89.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.101 -1.409 . . . . 0.0 113.749 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 61.5 mttm -76.24 163.4 66.62 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.323 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.31 105.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.832 1.688 . . . . 0.0 110.551 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -78.17 174.49 11.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.849 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.92 136.25 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.099 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.656 ' N ' HD13 ' A' ' 51' ' ' ILE . 18.5 ttp85 -105.52 110.62 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.895 169.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 51' ' ' ILE . 2.8 mt -69.09 162.14 67.54 Favored Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.606 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -79.18 147.53 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.12 1.88 . . . . 0.0 109.173 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 m -61.47 127.33 30.97 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.671 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.91 43.17 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -97.03 167.04 11.31 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.939 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.58 -47.22 3.0 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.654 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -148.17 167.62 24.59 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.962 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.1 p -119.36 145.06 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.479 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -131.31 148.69 52.71 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.831 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.2 pp -140.7 136.72 32.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.425 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -142.7 158.61 43.48 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.846 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t 75.9 45.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -92.9 -175.02 3.77 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.45 141.46 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.128 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.578 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.8 m95 -77.89 153.42 32.64 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.376 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.2 47.22 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.342 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.78 153.07 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.26 149.07 22.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 20.7 m-85 -133.45 141.7 47.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.393 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -119.76 118.1 29.97 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.576 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.98 123.67 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 56.6 m-85 -111.96 126.34 55.03 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.67 119.38 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 124.021 0.826 . . . . 0.0 110.462 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -110.22 157.42 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.35 158.1 40.74 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.37 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.8 tt0 -112.54 160.62 17.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.53 -1.268 . . . . 0.0 107.924 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -144.76 151.46 38.88 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.08 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -37.28 -44.03 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.315 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.99 41.79 1.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.42 -154.15 22.32 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.325 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -123.35 162.02 23.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.868 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 5.7 t -119.67 115.42 23.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -40.34 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 125.646 1.841 . . . . 0.0 113.458 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.37 131.65 35.04 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.944 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.24 143.0 30.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.74 129.08 56.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.45 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -114.89 123.88 50.28 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.669 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -122.71 134.05 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.11 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 43.3 p90 -156.41 178.68 10.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.501 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.94 51.71 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.137 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 p -84.98 165.26 17.73 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -80.18 -172.78 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.158 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.33 140.51 39.15 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.01 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 116.586 -1.673 . . . . 0.0 110.707 -178.699 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -59.86 172.41 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.541 2.161 . . . . 0.0 112.984 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 m -93.8 159.58 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.603 172.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.79 146.72 90.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.5 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.5 169.0 18.16 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.428 1.419 . . . . 0.0 110.642 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -104.38 130.94 52.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -105.8 113.46 27.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.396 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -95.55 139.41 31.85 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.562 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.44 123.34 7.83 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.442 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.55 119.75 33.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.77 131.04 51.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.477 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.61 153.16 24.73 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.718 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 8.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-20 -79.84 -22.34 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.969 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.39 -36.38 4.43 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.318 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -131.35 -1.36 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.984 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -68.05 113.39 5.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.321 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.541 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.8 mm -115.75 127.17 73.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.1 -175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -115.74 124.63 51.28 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 63.3 t -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 114.446 -1.252 . . . . 0.0 107.941 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -88.27 128.47 35.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.091 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.51 106.43 18.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.908 0.755 . . . . 0.0 109.704 -171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.07 131.04 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.637 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -102.0 145.86 28.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.946 0.779 . . . . 0.0 109.586 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.4 -90.26 0.38 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.934 -175.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 24.1 m-20 -104.46 111.36 23.99 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.799 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -134.35 -33.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.196 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.81 51.94 0.33 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.11 19.62 38.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.603 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 43.46 60.78 10.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 114.781 -0.71 . . . . 0.0 112.802 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -87.8 43.65 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.594 1.529 . . . . 0.0 108.815 172.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mm -76.58 152.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.272 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.3 mtt180 -127.74 114.43 17.27 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.2 p-80 31.83 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 77.8 m-85 -135.43 152.14 51.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.551 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.5 mt -111.17 112.02 23.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 60' ' ' VAL . 49.1 t -114.95 129.59 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.054 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HD3' ' CG ' ' A' ' 47' ' ' TRP . 40.2 ttmt -134.58 134.6 41.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.895 1.372 . . . . 0.0 108.086 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.76 159.83 41.81 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.791 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 12.6 ptt180 -142.99 172.32 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -126.65 169.55 13.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.989 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.9 44.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.734 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.16 -54.33 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.94 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 p -133.6 156.63 47.49 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.53 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -86.63 -163.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.982 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.443 ' CG ' ' HD3' ' A' ' 39' ' ' LYS . 9.7 m95 -23.22 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -77.9 167.01 39.42 Favored Pre-proline 0 N--CA 1.489 1.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.687 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -50.62 108.57 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.843 1.695 . . . . 0.0 110.528 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -53.25 161.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.755 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.79 149.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.078 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -114.32 131.38 56.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.233 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -79.64 167.88 30.67 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.817 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.43 154.85 55.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.79 1.66 . . . . 0.0 108.867 169.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -80.18 113.31 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.973 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 46.51 3.7 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.3 p -96.8 -178.01 4.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.892 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.35 -56.77 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.315 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -146.04 164.87 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.669 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 7.1 p -109.88 144.01 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.66 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.13 147.22 50.96 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.019 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.9 OUTLIER -138.76 138.28 37.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.001 173.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -137.17 163.18 31.49 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.494 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m 63.59 53.41 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.664 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -96.21 -176.25 3.61 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.849 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.94 132.47 39.07 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.639 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -72.98 154.52 40.49 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.013 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 46.32 47.92 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.657 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.78 153.45 48.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.935 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.74 145.93 25.87 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.227 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.2 m-85 -132.14 145.14 51.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 123.918 0.761 . . . . 0.0 112.526 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.37 122.83 40.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.433 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.1 125.49 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.0 m-85 -112.85 127.23 56.12 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.63 124.19 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -109.27 157.21 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.59 155.83 44.31 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.467 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.0 tt0 -110.6 164.62 12.55 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.782 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 32' ' ' PRO . 16.3 t-20 -146.27 149.68 34.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.021 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -38.22 -42.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.447 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -115.54 43.01 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.533 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.67 -158.49 27.68 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.986 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 157.92 40.78 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 28.4 t -123.32 119.25 29.55 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.586 -175.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -43.39 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.602 1.814 . . . . 0.0 113.23 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.66 140.45 29.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.804 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.57 29.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -114.68 131.61 56.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.545 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -118.56 129.62 55.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.897 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.75 139.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.496 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.541 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.4 p90 -158.84 175.9 13.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.167 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.44 147.19 49.83 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.654 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -79.91 169.64 17.61 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.238 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -80.51 -176.37 5.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.154 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.22 147.74 25.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.107 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.69 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.548 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.8 Cg_exo -68.3 170.79 13.96 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.4 m -82.69 -157.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.824 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.35 35.86 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 9.7 Cg_endo -67.52 160.75 46.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.188 1.258 . . . . 0.0 110.661 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.77 126.05 47.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -100.72 113.63 26.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.317 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -98.42 144.22 28.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.427 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.47 132.31 10.38 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.14 -171.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -125.13 128.67 48.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.06 133.84 51.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.678 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.55 150.6 21.31 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.785 -1.198 . . . . 0.0 111.789 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.79 10.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.973 -0.613 . . . . 0.0 112.429 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.2 m-20 -79.8 -21.83 43.83 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.996 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.0 -43.02 1.76 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.194 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.09 40.02 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.981 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -112.34 116.71 30.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.557 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.7 mm -120.47 127.87 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 120.091 -0.643 . . . . 0.0 110.648 -170.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -112.8 125.4 54.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.152 0.907 . . . . 0.0 108.599 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.8 t -109.09 117.88 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.3 129.34 45.0 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.379 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -98.58 102.56 14.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.274 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 7' ' ' LYS . 29.1 mm -90.74 129.99 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.013 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -97.86 156.6 16.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.787 0.68 . . . . 0.0 109.723 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -144.61 -50.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.356 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.9 m-20 -141.51 109.15 5.64 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.211 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.6 m-20 -131.06 -31.72 1.67 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.66 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.38 50.99 0.59 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.83 27.29 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.616 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 8.4 m 45.77 59.1 15.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.2 Cg_endo -89.01 42.41 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.438 1.425 . . . . 0.0 109.547 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.54 HD13 HD22 ' A' ' 79' ' ' ASN . 22.7 mm -82.42 151.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.916 0.865 . . . . 0.0 111.255 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -130.25 115.06 16.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.677 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.5 p-80 37.38 -172.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.2 m-85 -139.94 154.05 47.1 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.187 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.92 109.9 20.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' VAL . 47.7 t -113.73 121.26 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.88 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -132.42 140.24 48.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.607 1.192 . . . . 0.0 108.132 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.409 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -145.36 156.22 43.65 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.808 -1.557 . . . . 0.0 112.389 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.603 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 5.0 ptm180 -129.17 160.34 33.2 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.598 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -114.14 -172.88 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.146 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 11.5 tp -91.31 41.69 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.448 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.48 -58.86 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -120.02 151.29 39.21 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.387 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -106.68 153.77 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.825 -176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.603 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 38.83 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.652 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 65.2 mttm -77.28 162.75 68.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.255 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.2 Cg_exo -43.39 99.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.946 1.764 . . . . 0.0 110.814 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.67 175.71 6.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.268 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.96 153.91 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.301 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -113.49 135.85 53.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.929 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -84.71 162.68 49.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.824 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -69.16 145.7 61.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.716 1.611 . . . . 0.0 109.755 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.428 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.4 m -59.8 102.6 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 123.934 0.771 . . . . 0.0 111.479 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 52.68 0.56 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -97.13 -179.49 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.563 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.98 -34.59 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.515 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -148.51 167.7 24.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.204 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.1 p -133.4 153.97 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.746 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -138.76 151.68 47.3 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.568 -1.253 . . . . 0.0 112.515 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.25 142.7 42.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.74 173.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -142.94 153.14 42.76 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.081 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t 72.25 42.98 0.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.589 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.2 mm? -87.62 -172.31 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.666 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.29 143.33 28.77 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.637 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -76.46 154.69 34.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.744 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 43.59 49.41 6.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.768 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.92 49.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.575 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 29.2 tt0 -97.51 147.91 23.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.407 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 30.8 m-85 -133.0 142.72 48.99 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.515 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 4.6 mp0 -119.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.78 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.91 122.7 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.0 m-85 -111.1 124.2 51.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.34 120.8 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.863 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.4 t -105.76 158.05 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.17 164.9 22.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.658 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.2 tt0 -118.71 162.48 18.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.222 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.548 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.5 t-20 -151.16 154.47 36.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.356 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -41.99 -34.02 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.61 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -79.41 -45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.891 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.76 -118.71 0.51 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -118.46 163.2 17.11 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.613 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.92 116.03 22.93 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.869 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -39.05 158.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.297 1.623 . . . . 0.0 112.784 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.04 139.71 32.33 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.544 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.37 146.29 30.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -116.47 130.87 56.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.785 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 74.6 t80 -118.01 130.22 56.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.21 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.58 140.52 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.971 -176.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.557 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 36.6 p90 -161.57 179.04 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -130.63 148.48 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.836 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -79.91 172.3 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.522 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -85.54 -171.22 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.099 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.96 142.77 35.1 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.081 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 116.199 -1.858 . . . . 0.0 110.443 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.1 Cg_endo -63.77 166.65 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.36 2.04 . . . . 0.0 112.586 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.15 165.79 15.47 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.468 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.79 142.85 88.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.11 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.42 167.22 23.0 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.412 1.408 . . . . 0.0 110.54 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -101.7 131.83 47.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.02 113.74 27.52 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.844 -1.142 . . . . 0.0 110.277 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.36 142.29 32.04 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.257 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -118.51 136.46 12.21 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 118.877 -1.63 . . . . 0.0 113.82 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -128.43 137.91 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.647 -0.777 . . . . 0.0 109.464 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.5 ttm -109.33 134.42 51.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.502 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.62 146.15 22.26 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.855 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.87 8.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.89 -30.11 40.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.783 175.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.54 -39.43 2.06 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.407 -1.378 . . . . 0.0 113.174 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -130.27 -14.75 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.697 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -54.17 113.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.214 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.3 mm -116.78 130.71 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.076 -174.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -116.98 124.77 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.859 0.724 . . . . 0.0 109.084 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -110.23 120.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -97.09 133.22 42.04 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.343 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 41.0 mt -101.55 101.45 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -93.78 131.01 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -101.74 157.66 16.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.738 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -51.44 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.649 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -145.4 103.93 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.428 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.6 m-20 -117.25 -40.21 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.738 0.649 . . . . 0.0 109.714 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.57 52.95 0.21 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.29 20.56 29.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 19.5 m 42.16 60.84 9.12 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.9 Cg_endo -90.44 42.85 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.553 1.502 . . . . 0.0 109.112 172.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 79' ' ' ASN . 23.2 mm -81.44 151.42 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.989 0.899 . . . . 0.0 111.367 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.4 mtt180 -130.52 114.37 15.41 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.835 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.7 p-80 35.77 -170.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.4 m-85 -139.99 150.64 44.71 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.006 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.07 110.86 23.26 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.52 127.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.812 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -132.49 140.7 48.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.012 1.445 . . . . 0.0 107.834 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.17 157.01 43.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.56 -1.656 . . . . 0.0 112.591 177.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.8 ptm180 -134.41 165.3 25.48 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.354 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -127.53 177.74 6.56 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.303 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.56 40.96 0.53 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.838 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -142.34 -62.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.904 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -129.7 171.23 12.87 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.267 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -116.46 160.87 19.96 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.211 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.9 m95 28.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.347 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 52.0 mttp -72.63 160.08 83.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.351 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.7 Cg_exo -41.77 107.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.1 1.866 . . . . 0.0 111.579 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.16 160.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.623 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -131.35 147.95 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.156 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -113.71 125.03 53.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -69.88 164.23 53.4 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.271 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.63 172.21 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.804 1.669 . . . . 0.0 110.635 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -74.5 76.92 1.95 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.974 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.47 64.78 0.59 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.526 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -89.63 -176.99 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.851 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -126.63 -14.11 5.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.503 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 42.2 p-80 -159.18 170.34 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.753 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p -136.87 150.81 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 124.864 1.353 . . . . 0.0 108.582 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -133.72 150.0 51.5 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.152 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.584 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.3 pp -143.85 144.88 31.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.539 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -140.27 172.17 13.12 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.789 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.7 m 57.84 59.66 3.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.631 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.6 mt -95.21 177.9 5.71 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.353 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.51 124.15 22.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.252 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 77.1 m95 -70.74 148.49 47.9 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.77 49.77 20.32 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.671 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.27 152.27 50.69 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.27 151.78 22.41 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.698 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.7 m-85 -137.04 141.28 42.47 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.6 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.65 121.08 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.721 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.26 123.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.438 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 43.9 m-85 -113.03 125.51 54.48 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.46 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.534 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.2 159.41 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.07 155.38 44.46 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.548 -1.261 . . . . 0.0 109.805 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.8 tt0 -110.81 163.85 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.86 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.483 HD22 HD13 ' A' ' 33' ' ' ILE . 18.6 t-20 -153.69 154.21 33.7 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.577 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -40.45 -43.48 1.82 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.327 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -101.84 37.05 1.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.33 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.23 -134.02 8.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.22 -179.99 6.86 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.585 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -130.05 124.31 32.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -45.79 171.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 125.516 1.76 . . . . 0.0 111.686 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.55 145.96 25.42 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.605 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.72 147.96 27.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.908 -1.497 . . . . 0.0 106.982 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.522 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.8 t-160 -116.14 130.96 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.592 -173.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.4 t80 -118.65 130.56 55.92 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.737 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.522 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.95 140.44 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.854 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 19' ' ' ILE . 48.3 p90 -157.44 -178.76 7.58 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.849 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -128.97 145.07 51.34 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.353 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.93 168.42 19.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.901 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.1 m -81.78 -176.47 6.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.291 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.23 144.16 30.43 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.321 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.219 -1.848 . . . . 0.0 110.505 -178.088 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.6 Cg_exo -57.93 171.85 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.417 2.078 . . . . 0.0 113.011 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -95.43 159.66 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.682 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.32 141.86 98.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.896 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.09 167.52 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.28 1.32 . . . . 0.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -100.64 127.77 46.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.38 109.79 21.54 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.922 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.13 137.81 37.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.49 142.87 16.16 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.489 -1.815 . . . . 0.0 113.791 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -129.4 138.79 51.68 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.093 -1.053 . . . . 0.0 109.361 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.487 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.2 tpp -104.72 131.52 52.07 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.42 150.31 23.43 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.525 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.72 8.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.0 m-20 -79.87 -23.03 42.2 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.125 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.8 -50.87 0.76 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.649 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 9.8 p30 -123.87 1.36 8.7 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.33 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.6 m -69.56 116.75 10.32 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.301 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -115.41 127.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.776 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -115.07 124.78 52.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.023 0.827 . . . . 0.0 109.072 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.5 t -112.45 120.69 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -98.2 130.48 44.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.04 100.88 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.27 130.7 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.868 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -104.16 153.04 21.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.842 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.05 -49.89 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.915 -174.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.6 m-20 -139.76 111.63 7.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.008 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -130.02 -37.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.123 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.51 55.05 0.36 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 20.42 35.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.628 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.7 t 44.15 60.61 11.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 114.8 -0.7 . . . . 0.0 112.728 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -89.42 43.39 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.393 1.395 . . . . 0.0 109.214 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mm -88.54 149.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.877 0.846 . . . . 0.0 111.266 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 69.2 mtt85 -131.46 123.55 28.34 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.867 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.9 p-80 36.69 -173.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.7 m-85 -139.74 153.57 47.22 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.784 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.49 109.42 21.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 48.2 t -113.32 125.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.204 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -136.45 141.1 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.56 158.06 43.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.069 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.614 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 9.0 ptm85 -133.96 159.36 40.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.645 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -116.81 -177.8 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.92 41.58 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.792 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.65 -61.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.335 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -118.99 149.68 41.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.528 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 23.9 pt-20 -117.53 144.73 44.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.588 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.614 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 56.87 77.48 0.26 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.027 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 25.9 mmmt -72.57 163.27 69.15 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.541 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -46.57 99.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.823 1.682 . . . . 0.0 110.444 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.32 172.7 2.99 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.529 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.17 153.81 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.951 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -112.84 131.77 55.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.949 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.455 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.8 mt -81.84 163.76 52.06 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.861 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.26 152.43 76.46 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.771 1.647 . . . . 0.0 110.438 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 33.7 m -68.61 93.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.885 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.91 52.71 0.46 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -97.22 170.13 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.394 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.93 -36.66 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.996 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -146.56 169.48 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.579 -1.248 . . . . 0.0 112.124 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -132.76 151.79 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.885 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ptp -135.65 148.31 48.91 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.894 -1.123 . . . . 0.0 112.022 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 65' ' ' LEU . 1.5 pp -141.32 144.2 34.46 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.458 174.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -140.16 170.36 15.98 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.663 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 m 61.19 57.03 2.56 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.042 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 62' ' ' LEU . 10.6 mp -94.95 178.52 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -71.99 133.06 45.1 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.248 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.403 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.4 m95 -72.93 151.47 41.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.837 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.97 49.08 15.05 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.54 152.08 48.7 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.051 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -92.66 148.72 21.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.1 m-85 -136.05 143.33 44.62 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.692 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 3.7 mp0 -119.2 122.66 42.49 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.139 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.96 123.4 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.7 m-85 -112.57 125.98 54.85 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.6 t -122.45 121.8 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 124.047 0.842 . . . . 0.0 110.677 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.33 159.07 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.34 156.68 42.7 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.751 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.41 153.82 25.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.392 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.2 t-20 -141.25 150.83 43.13 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.143 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -36.12 -43.82 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.846 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -108.33 35.9 3.0 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -152.31 21.5 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.072 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -120.97 158.15 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.32 120.43 37.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -40.05 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 125.81 1.944 . . . . 0.0 113.492 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.0 136.41 34.06 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.051 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.94 145.68 28.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.486 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.49 129.43 56.54 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.574 -174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 71.6 t80 -117.5 129.75 56.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.34 140.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.749 -176.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.2 p90 -158.63 -179.34 7.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.071 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -129.55 147.63 51.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.568 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.4 p -79.88 166.83 21.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -82.44 -172.01 3.78 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.66 148.28 24.51 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.325 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 116.474 -1.727 . . . . 0.0 110.652 -178.799 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.9 Cg_exo -61.3 172.84 2.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.6 2.2 . . . . 0.0 112.99 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -97.06 163.45 12.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.479 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.0 99.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.164 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.91 172.14 12.31 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.451 1.434 . . . . 0.0 110.463 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -107.04 133.48 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.1 mt -106.46 115.9 31.01 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.262 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.39 140.49 31.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.45 129.05 9.37 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.656 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -124.53 124.73 42.9 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.9 ttm -106.96 133.76 51.13 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.8 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.25 150.55 22.83 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.596 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.35 14.01 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.074 -0.563 . . . . 0.0 111.936 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.86 -24.31 41.33 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.684 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 -40.53 2.45 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.706 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 9.4 p30 -138.18 48.68 1.96 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.92 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -120.82 115.11 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.552 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.05 129.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -114.01 125.16 53.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.3 t -107.7 115.0 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -96.73 130.41 43.98 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.313 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.84 109.66 22.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.637 -173.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.29 132.5 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -104.4 148.0 26.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.82 0.7 . . . . 0.0 109.408 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.56 -66.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.135 -174.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.7 m-20 -127.77 110.92 13.09 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.27 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.7 m-20 -128.83 -37.09 1.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.986 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 56.87 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 18.65 43.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 45.16 60.15 13.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.791 -0.704 . . . . 0.0 112.87 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -88.89 42.52 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.458 1.438 . . . . 0.0 109.365 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 79' ' ' ASN . 22.6 mm -83.43 151.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.878 0.847 . . . . 0.0 111.446 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 78.4 mtt-85 -131.05 117.31 18.95 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.886 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.57 -173.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 82.2 m-85 -137.85 154.26 49.51 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.052 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.5 mt -110.33 111.49 22.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 60' ' ' VAL . 46.4 t -115.12 123.98 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.146 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -132.35 138.56 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.688 1.242 . . . . 0.0 107.938 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.2 p90 -144.05 158.43 43.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.916 -1.514 . . . . 0.0 112.45 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.4 ptm180 -141.88 169.79 16.94 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.442 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -128.14 168.87 14.8 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.767 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.92 43.53 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.724 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -153.4 -51.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.931 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 p -125.87 148.06 49.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.111 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -103.1 167.23 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.865 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.7 m95 18.33 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.952 -1.476 . . . . 0.0 114.226 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.7 mttp -77.18 163.55 64.17 Favored Pre-proline 0 N--CA 1.49 1.525 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.072 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.7 Cg_exo -44.68 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.803 1.668 . . . . 0.0 110.908 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.02 175.27 3.84 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.394 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.04 154.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.362 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 42.7 ttm180 -114.95 134.06 55.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.812 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.2 mt -82.42 162.99 54.33 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.027 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 3.9 Cg_exo -59.88 169.86 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.773 1.649 . . . . 0.0 110.633 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -74.64 77.82 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.935 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.5 65.82 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 t -97.01 -174.54 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.71 -23.02 4.43 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.618 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.6 p-80 -160.23 168.31 25.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.994 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.5 p -131.87 151.4 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.268 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -137.3 152.07 49.36 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.827 -176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.14 139.1 33.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.43 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 64' ' ' SER . 51.8 mtmt -142.5 141.43 32.11 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.85 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.5 t 93.51 45.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.345 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.7 mm? -96.56 178.51 5.31 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.391 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -68.17 133.44 48.9 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.612 0.72 . . . . 0.0 111.493 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.73 154.25 39.69 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.227 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.42 48.9 8.23 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.565 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.63 49.82 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.802 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.37 144.05 26.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 6.0 m-85 -129.74 144.84 51.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.912 0.758 . . . . 0.0 112.463 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -119.79 124.01 45.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.409 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.2 t -116.07 123.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 38.9 m-85 -111.49 124.92 53.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -120.02 122.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 123.876 0.735 . . . . 0.0 110.567 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -106.94 157.8 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 155.63 42.86 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.58 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.67 158.87 18.78 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.233 -1.387 . . . . 0.0 107.73 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.6 t-20 -146.45 153.28 40.26 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.543 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -42.4 -37.68 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.466 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -103.01 29.77 5.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.5 -148.04 19.35 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.849 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -122.23 158.82 28.62 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.967 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.7 t -121.86 124.13 43.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.35 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -40.92 165.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.735 1.897 . . . . 0.0 113.59 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.45 140.97 28.92 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.45 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.53 30.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.19 129.45 56.65 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.408 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 67.5 t80 -116.87 130.23 56.57 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.033 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.63 140.74 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.593 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.31 178.09 10.72 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.777 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -128.12 145.21 51.08 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.894 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.8 p -79.88 171.37 15.2 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.154 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -86.53 -170.47 3.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.134 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.72 141.19 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.242 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.536 -1.697 . . . . 0.0 110.672 -179.366 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.46 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 12.4 Cg_exo -56.89 173.26 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.601 2.201 . . . . 0.0 113.1 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -95.76 163.04 13.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.239 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.73 142.07 95.53 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.173 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.48 171.21 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.606 1.538 . . . . 0.0 110.686 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -98.03 139.92 33.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.4 mt -111.29 110.21 20.59 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.15 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.04 141.51 28.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.793 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.8 123.32 7.29 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.17 -173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -120.88 123.09 41.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.3 ttm -104.14 131.86 50.99 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.19 146.25 23.75 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.719 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.14 9.53 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.76 -30.25 40.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.858 175.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.29 -41.47 1.68 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.062 177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.91 -15.05 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.676 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.0 m -55.37 116.5 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.552 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.0 mm -117.55 130.35 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.552 -173.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.1 125.68 52.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.939 0.774 . . . . 0.0 108.996 172.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.584 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 60.2 t -107.33 113.47 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 126.69 37.0 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.212 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.7 mt -99.11 107.22 19.54 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.899 -172.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.2 mm -92.44 106.27 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.524 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.73 140.89 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.446 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.2 pt20 -138.17 -78.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.355 -172.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.1 m-20 -106.14 100.82 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.962 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -132.36 -35.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.277 -179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 51.45 0.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.01 17.75 36.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.602 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 41.39 61.09 7.99 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -86.48 51.58 2.6 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.685 1.59 . . . . 0.0 108.73 172.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.5 mm -87.41 150.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.031 0.92 . . . . 0.0 111.622 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.8 mtt180 -129.94 119.38 23.14 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.413 -1.722 . . . . 0.0 108.543 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.53 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.7 p-80 34.73 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.516 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.2 m-85 -139.52 151.18 45.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.009 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mt -107.48 110.78 22.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.2 128.2 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.913 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.73 140.23 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 125.036 1.46 . . . . 0.0 107.979 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.56 156.52 43.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.726 -1.59 . . . . 0.0 112.657 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -131.58 156.99 44.8 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.073 -177.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.629 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -119.33 168.56 10.8 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 tp -73.59 42.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.795 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.93 -57.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.083 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.3 m -128.62 153.06 47.65 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.141 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -104.99 165.49 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.044 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.62 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.448 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.9 mttm -77.03 159.99 77.2 Favored Pre-proline 0 N--CA 1.491 1.618 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.334 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 24.3 Cg_exo -40.45 111.65 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.188 1.926 . . . . 0.0 111.895 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.71 164.87 4.29 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.809 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -136.4 151.18 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.365 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -117.34 132.24 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.241 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -79.07 165.13 51.02 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.508 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.33 159.79 29.72 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.808 1.672 . . . . 0.0 110.682 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 95.34 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.94 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 96.92 65.35 0.92 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -97.14 -172.57 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.469 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -122.16 -43.81 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.741 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 22.6 p-80 -147.13 167.44 24.13 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.061 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.5 p -122.48 149.54 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.375 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -132.87 147.12 52.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.606 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -139.48 137.76 35.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.991 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -139.55 158.16 44.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.463 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t 71.88 49.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.203 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -97.82 -174.22 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.233 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.6 133.51 38.44 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.666 0.746 . . . . 0.0 111.081 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.51 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 72.1 m95 -75.17 156.95 35.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.074 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 45.53 46.3 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.769 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.7 154.66 46.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.11 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -96.69 147.65 23.69 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.629 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.5 m-85 -134.0 140.85 46.98 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.471 -178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 119.48 34.26 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.205 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.6 t -113.77 127.65 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 55.0 m-85 -114.82 126.58 54.98 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.58 121.54 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.627 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -105.84 156.06 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.91 156.01 42.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.523 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -109.96 156.24 20.72 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.821 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 13.2 t-20 -140.53 149.88 43.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.958 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -34.14 -45.34 0.21 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.758 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -113.97 40.15 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.82 -156.85 26.11 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.378 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -120.33 159.6 24.71 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.725 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 24.8 t -120.59 120.64 36.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -41.0 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.633 1.833 . . . . 0.0 113.189 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.95 136.16 34.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.338 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.93 144.42 29.01 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.8 t-160 -114.81 130.08 56.8 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.284 -174.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.192 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.86 137.98 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.571 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.6 p90 -156.04 177.47 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.163 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.27 146.17 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.623 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -83.76 164.59 19.48 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -80.48 -171.13 2.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.273 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.15 139.18 39.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.208 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.461 -1.733 . . . . 0.0 110.801 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.2 Cg_exo -58.04 172.83 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.621 2.214 . . . . 0.0 113.31 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -101.6 162.54 12.82 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.407 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.92 142.27 85.26 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.364 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.82 154.12 67.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.501 1.468 . . . . 0.0 109.962 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -83.39 139.66 32.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 mt -109.03 108.98 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.313 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -93.89 144.71 25.19 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.462 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -112.93 130.58 9.57 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.302 -1.427 . . . . 0.0 112.889 -171.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -125.37 129.87 50.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.0 ttm -107.28 134.49 50.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.55 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -90.52 151.53 21.42 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.679 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.91 9.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.11 -0.545 . . . . 0.0 112.353 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.92 -20.55 45.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.009 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 108.54 -41.98 2.07 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.633 -1.27 . . . . 0.0 111.163 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 12.9 p30 -127.86 2.15 6.01 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.915 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -65.42 111.92 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.248 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.56 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.5 mm -116.34 126.36 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.968 -176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -114.71 124.93 53.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 123.933 0.771 . . . . 0.0 108.949 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.4 t -108.87 118.58 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.7 128.42 42.56 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.6 mt -97.95 102.27 13.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 123.914 0.759 . . . . 0.0 109.079 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.31 103.04 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.715 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -77.6 149.95 34.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.75 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -147.31 -51.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.946 -1.101 . . . . 0.0 112.406 -172.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 106.11 7.06 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.098 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.4 m-20 -129.42 -39.33 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.22 57.16 0.38 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.65 18.42 41.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.627 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.8 t 44.76 60.47 12.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -89.15 43.98 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.476 1.451 . . . . 0.0 109.071 172.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.67 150.95 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.883 0.849 . . . . 0.0 111.543 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.8 mtt85 -129.22 117.56 20.93 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.07 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.9 p-80 32.02 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.506 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 69.4 m-85 -134.62 152.35 51.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.173 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.62 113.36 26.28 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 60' ' ' VAL . 52.9 t -115.79 128.55 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.209 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -135.41 139.68 44.35 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.24 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.35 154.54 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.161 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.6 ptm180 -126.49 160.74 29.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.671 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.64 -169.27 1.47 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.8 tp -96.97 41.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.587 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.22 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 p -121.65 150.02 42.35 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.999 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -113.27 150.04 33.01 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.22 -172.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.5 m95 47.79 83.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.562 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 46.1 mmtm -66.29 161.49 56.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.368 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -47.22 105.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.77 1.647 . . . . 0.0 110.81 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.25 154.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.464 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -129.55 148.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.269 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -114.26 128.59 56.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.753 -0.779 . . . . 0.0 108.899 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.58 163.97 63.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.712 -176.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -78.23 132.39 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.879 1.719 . . . . 0.0 107.74 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -56.58 131.95 50.24 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.44 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.26 34.26 5.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 m -96.98 152.47 18.69 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.961 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.07 -28.08 10.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.033 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -145.49 165.72 27.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.36 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 10.6 p -128.58 150.12 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.269 174.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -134.74 149.85 50.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.741 -1.184 . . . . 0.0 112.509 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.1 pp -141.61 146.48 36.28 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.765 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -139.2 178.57 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.867 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.1 m 54.34 55.24 8.35 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.733 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 62' ' ' LEU . 25.1 mt -91.49 176.55 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.867 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -73.45 128.22 34.89 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.828 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.416 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 81.7 m95 -71.06 149.92 46.06 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.951 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.05 50.33 16.12 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.604 -175.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.43 154.51 47.65 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.792 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.94 147.83 23.27 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.285 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 13.5 m-85 -133.23 143.88 49.43 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.521 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.04 119.24 29.76 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.16 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.39 124.57 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 53.8 m-85 -114.21 125.78 54.31 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.36 123.46 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 123.991 0.807 . . . . 0.0 110.416 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.72 157.18 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.26 156.4 40.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.079 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -110.12 160.25 16.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.823 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.529 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -146.46 151.81 38.0 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.372 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -34.89 -46.15 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.644 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -109.19 38.81 2.2 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.99 -150.55 20.65 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.147 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -123.23 159.58 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.04 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.99 118.06 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -39.32 163.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.849 1.968 . . . . 0.0 113.725 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.44 137.49 32.88 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.15 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.34 29.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.03 130.39 56.93 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.534 -174.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.9 t80 -118.33 130.56 56.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.117 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.61 139.11 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.647 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.5 p90 -159.88 179.36 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.266 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -128.04 147.46 50.51 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.642 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.4 p -79.92 168.39 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.81 -170.45 3.0 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.172 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.25 141.61 36.47 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.16 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 116.143 -1.884 . . . . 0.0 110.398 -178.742 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.0 Cg_exo -59.15 169.85 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.372 2.048 . . . . 0.0 113.639 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -94.89 177.51 5.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.16 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.34 144.97 58.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.139 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -71.68 164.99 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.691 1.594 . . . . 0.0 110.531 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -93.43 132.62 37.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.04 108.83 20.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.795 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.49 135.28 42.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.75 143.59 16.44 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.455 -1.831 . . . . 0.0 113.151 -171.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -131.14 139.56 49.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 108.942 172.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -108.88 132.77 53.72 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.708 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.39 150.74 27.47 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.326 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.19 13.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.931 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.94 -25.28 40.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.664 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.01 -44.63 1.46 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.066 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.568 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 10.8 p30 -134.41 44.8 2.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.321 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -112.9 110.63 20.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.7 mm -114.13 128.48 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.421 -170.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.38 124.82 51.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.3 t -111.84 120.13 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -96.65 130.7 43.82 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.524 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 36' ' ' TYR . 40.2 mt -99.99 103.43 14.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.943 0.777 . . . . 0.0 109.114 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.67 108.4 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.554 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -70.13 169.43 13.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 4.3 pt20 -170.25 -69.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.689 -1.204 . . . . 0.0 111.399 -175.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 16.9 t70 -115.23 89.39 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.019 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -130.85 -17.63 3.14 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.776 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.34 52.35 1.6 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.417 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.27 22.75 50.71 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 44.26 64.37 7.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 114.78 -0.71 . . . . 0.0 112.736 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.7 Cg_endo -88.13 46.22 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 171.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 mm -92.55 151.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.197 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -128.19 115.19 17.99 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.05 -1.886 . . . . 0.0 108.098 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.1 p-80 35.69 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.3 m-85 -142.86 137.95 29.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.013 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -88.19 111.07 21.22 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 60' ' ' VAL . 65.8 t -112.22 126.8 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.306 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -132.55 138.8 47.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 125.08 1.488 . . . . 0.0 107.632 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.17 156.31 43.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.715 -1.594 . . . . 0.0 112.223 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.2 ptm180 -134.88 163.54 29.6 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.892 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -120.71 -168.25 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.773 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.5 tp -93.28 40.54 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.825 170.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.8 -61.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.572 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.59 157.78 30.0 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.231 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -109.69 156.21 20.54 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.594 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.532 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.1 m95 34.42 83.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.108 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.2 mmtt -70.45 161.54 75.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.203 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.8 Cg_exo -43.2 107.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.982 1.788 . . . . 0.0 111.556 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -55.18 161.27 1.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.729 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.281 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttp85 -112.43 118.06 34.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.2 mm? -60.12 165.9 4.43 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.036 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.1 Cg_exo -61.47 141.67 92.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.37 1.38 . . . . 0.0 109.483 172.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -59.15 88.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.568 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.453 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 106.52 58.9 0.6 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -97.12 -173.49 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.449 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.97 -25.48 3.59 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.536 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 15.4 p-80 -160.07 167.51 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.394 -1.323 . . . . 0.0 112.574 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -130.73 150.27 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.671 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -134.92 147.74 49.89 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.777 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -140.46 142.86 35.31 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.226 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 178.68 6.68 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.536 -175.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m 49.06 56.89 7.1 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.687 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 10.2 mt -91.99 164.34 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.527 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 4.4 m-20 -61.36 129.78 42.9 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.832 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -71.8 147.84 46.84 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.16 51.09 13.54 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.623 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -129.52 151.62 49.94 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.264 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 36.3 mt-10 -89.2 146.74 24.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 m-85 -133.97 140.84 47.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.531 -176.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -122.11 123.4 41.46 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.585 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -113.79 122.57 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 39.7 m-85 -112.29 124.06 51.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.49 120.6 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.86 0.725 . . . . 0.0 110.702 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 86' ' ' ALA . 1.9 t -103.78 164.45 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 154.08 49.85 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.679 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.79 156.37 22.98 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.789 -1.165 . . . . 0.0 107.88 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -144.97 152.33 40.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -40.83 -40.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.144 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -105.65 35.83 2.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.91 -151.32 20.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.98 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -128.41 161.59 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.573 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -126.76 128.24 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.881 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -46.14 173.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 125.608 1.817 . . . . 0.0 112.906 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -93.63 145.34 24.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.31 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.81 146.61 28.38 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 171.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 90' ' ' VAL . 11.0 t-160 -115.69 129.8 56.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.457 -174.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 51.7 t80 -119.95 131.95 55.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.6 t -129.69 144.18 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.209 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 47.6 p90 -159.83 -177.97 6.72 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.977 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -129.64 145.66 51.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.471 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 169.22 18.23 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -84.43 -169.94 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.305 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.53 142.02 36.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.008 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 116.542 -1.694 . . . . 0.0 110.685 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HG3' HD22 ' A' ' 79' ' ' ASN . 3.1 Cg_exo -61.77 169.25 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.824 . . . . 0.0 112.169 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 m -91.09 152.95 20.42 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.66 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 143.53 93.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.165 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.88 167.63 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.329 1.353 . . . . 0.0 110.45 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -103.4 132.69 49.45 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.1 mt -104.6 113.85 27.7 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.158 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -95.66 143.18 27.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 127.38 8.76 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.586 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -123.3 121.12 35.04 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.1 ttm -105.14 132.55 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.658 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.37 149.73 21.45 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.318 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -65.75 14.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.907 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.1 m-20 -80.01 -24.59 40.72 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.549 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.16 -42.73 1.87 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.41 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -131.84 10.02 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.18 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -77.98 112.81 15.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.256 -0.977 . . . . 0.0 108.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.521 HD11 ' CE2' ' A' ' 91' ' ' PHE . 9.5 mm -116.34 126.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.972 -172.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.38 127.11 56.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.4 t -108.01 116.55 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -97.28 129.4 44.58 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.424 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 44.7 mt -99.2 106.39 18.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.758 0.661 . . . . 0.0 109.491 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -96.29 129.82 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -105.55 153.33 21.9 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.506 -177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.68 0.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.191 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.93 116.47 10.74 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.724 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.3 m-20 -126.66 -44.6 1.66 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.872 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.8 65.28 0.26 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.33 64.15 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -174.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.61 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.4 t 44.03 60.63 11.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 114.58 -0.81 . . . . 0.0 113.008 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 31' ' ' SER . 19.6 Cg_endo -91.24 52.28 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.782 1.655 . . . . 0.0 109.337 174.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.67 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.842 0.829 . . . . 0.0 111.423 -174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -131.41 118.91 20.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.034 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.4 p-80 36.1 -172.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.539 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.4 m-85 -140.26 151.07 44.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.754 176.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.96 111.61 23.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 60' ' ' VAL . 61.8 t -114.8 124.45 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.324 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.7 141.33 46.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.789 1.306 . . . . 0.0 107.911 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.34 157.7 43.69 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.731 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -132.01 162.87 29.7 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.032 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -113.2 -169.13 1.43 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.2 tp -94.22 40.76 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.263 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.81 -59.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.504 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -114.02 147.94 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.197 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.5 pt-20 -107.83 157.53 18.09 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.762 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.508 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.7 m95 31.51 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.185 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 69.3 mmtt -72.57 162.04 76.11 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.111 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.4 Cg_exo -45.13 100.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.837 1.691 . . . . 0.0 110.614 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.34 173.06 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.617 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 tt -138.52 155.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.133 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -114.15 127.41 55.89 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.03 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -73.36 166.46 43.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.562 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.62 165.69 11.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.836 1.691 . . . . 0.0 110.635 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -75.43 79.5 2.48 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.071 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.69 57.96 0.34 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -97.04 170.19 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.546 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -120.32 -3.5 9.98 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.606 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.16 164.2 33.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.83 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.2 p -138.76 154.27 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.732 172.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptp -138.2 152.74 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.738 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.4 pp -144.64 146.35 32.22 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.783 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -141.87 173.29 11.65 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.532 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t 58.65 60.77 2.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.455 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 62' ' ' LEU . 14.6 mt -98.76 178.58 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.442 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 5.0 m-20 -71.3 128.52 36.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.147 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 82.3 m95 -71.78 151.31 43.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.459 -1.296 . . . . 0.0 109.999 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.86 50.37 11.21 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.687 -175.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -127.92 151.57 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.024 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -89.73 145.29 25.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.9 m-85 -132.68 141.52 48.64 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.568 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.6 119.39 29.74 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.54 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -112.59 124.81 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.7 m-85 -112.71 125.49 54.37 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.74 121.99 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.406 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.4 158.26 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.5 158.42 37.45 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.634 -1.226 . . . . 0.0 109.235 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 26.6 tt0 -112.86 157.41 21.44 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.289 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.489 HD22 ' HG3' ' A' ' 3' ' ' PRO . 15.3 t-20 -139.42 148.03 42.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.696 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -35.61 -44.06 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.796 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -114.89 41.87 2.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.575 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.51 -155.15 25.95 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.563 -1.303 . . . . 0.0 111.188 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -122.28 167.44 13.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.671 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 2.2 t -123.93 116.97 23.75 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -40.71 162.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.554 1.784 . . . . 0.0 113.284 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.87 136.33 35.36 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.356 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.58 146.28 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.54 130.56 56.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.596 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -116.57 126.81 53.83 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.961 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -124.37 136.68 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.561 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CE2' HD11 ' A' ' 19' ' ' ILE . 40.4 p90 -157.33 -178.93 7.72 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.012 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -129.55 146.48 51.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.486 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -79.92 168.97 18.55 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.734 -0.787 . . . . 0.0 108.885 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.93 -169.97 2.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.656 -0.817 . . . . 0.0 110.184 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.89 140.57 39.5 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 116.551 -1.69 . . . . 0.0 110.808 -178.606 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 4.2 Cg_exo -59.86 165.28 10.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.427 2.085 . . . . 0.0 113.269 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -86.29 169.77 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.559 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.41 139.02 63.51 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.746 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -69.58 169.04 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.561 1.507 . . . . 0.0 110.411 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.12 138.44 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.3 107.18 17.98 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.789 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 20.8 tt0 -86.71 140.8 29.42 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.455 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.52 119.56 6.3 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.89 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -120.31 117.54 28.07 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.452 ' CE ' HD11 ' A' ' 19' ' ' ILE . 55.4 tpp -100.44 132.33 45.88 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.156 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.08 149.01 20.52 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.456 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -65.38 13.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.08 -0.56 . . . . 0.0 112.047 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.91 -25.21 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.448 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.08 -48.8 0.91 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.575 -1.298 . . . . 0.0 111.388 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -128.44 0.08 5.63 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.104 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -67.84 117.98 10.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.339 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.524 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.03 128.71 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.307 -172.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -114.26 127.3 55.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 123.981 0.801 . . . . 0.0 108.926 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 53.9 t -107.95 117.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 5.9 t-20 -90.9 124.55 35.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.899 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -98.51 96.89 8.29 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.91 106.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.612 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -77.06 151.43 35.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -148.06 -63.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.296 -172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.21 93.51 3.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.344 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 2.5 m-20 -122.08 -34.51 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.054 0.846 . . . . 0.0 109.944 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.48 55.16 0.33 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.62 46.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -175.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.581 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 66.2 m 41.95 61.9 7.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.5 Cg_endo -86.7 46.6 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.715 1.61 . . . . 0.0 108.503 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.7 mm -82.58 152.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.468 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 35' ' ' HIS . 49.9 mtt180 -129.6 114.26 15.83 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.544 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.596 ' H ' ' H ' ' A' ' 56' ' ' GLY . 9.1 p-80 35.46 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.0 m-85 -142.2 151.74 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.744 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.78 109.56 21.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 60' ' ' VAL . 57.3 t -115.31 123.32 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.341 -172.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.84 140.37 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.613 1.196 . . . . 0.0 108.028 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.36 154.06 41.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.971 -1.492 . . . . 0.0 112.492 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.2 ptm180 -131.52 165.0 24.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.916 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -121.48 174.64 6.64 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.153 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -79.45 42.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.045 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.52 -59.02 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.288 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.8 m -124.7 152.99 43.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.056 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -101.98 162.68 12.72 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.808 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.496 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 25.16 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.575 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.5 mttp -74.91 163.37 68.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.843 175.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.95 99.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.916 1.744 . . . . 0.0 110.917 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.55 175.97 3.17 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.352 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.74 154.99 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.207 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -116.68 129.79 56.35 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.842 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -75.25 163.49 67.48 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.09 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.79 144.34 48.27 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.775 1.65 . . . . 0.0 109.677 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -51.95 110.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.935 0.772 . . . . 0.0 111.842 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.596 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 94.33 58.99 1.18 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.865 -1.16 . . . . 0.0 110.581 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -97.19 -177.27 3.79 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.135 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -134.4 -33.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.918 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -143.96 163.17 34.22 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.811 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.557 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -131.3 152.05 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.279 173.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.418 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -137.73 156.03 48.44 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.086 -176.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -144.22 140.98 29.61 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.121 174.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -140.61 158.62 43.72 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.276 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t 72.01 51.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.443 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.7 mm? -100.6 -176.8 3.3 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.626 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.47 131.17 40.81 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -73.3 155.77 39.12 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.985 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 48.37 45.68 20.47 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.55 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.01 152.9 49.82 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.357 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -95.22 148.7 22.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.8 m-85 -133.44 143.8 49.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.706 -178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.63 119.64 34.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.521 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.72 124.28 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.8 m-85 -111.75 125.33 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.14 120.53 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.909 0.756 . . . . 0.0 110.595 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.37 155.68 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.01 154.67 40.88 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.335 -1.346 . . . . 0.0 109.513 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.7 tt0 -111.08 161.02 16.33 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.33 -1.348 . . . . 0.0 107.652 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.1 t-20 -148.84 153.36 37.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.125 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -39.5 -39.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.61 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -79.7 -44.89 19.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.59 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.77 -127.1 0.89 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.676 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -124.41 159.07 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.07 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.0 t -124.44 124.39 42.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.37 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -41.49 163.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 125.629 1.831 . . . . 0.0 113.304 -175.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.83 141.05 30.74 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.65 -174.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.89 144.88 30.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 171.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -114.58 129.15 56.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.114 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.59 127.99 54.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.163 -1.381 . . . . 0.0 108.141 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.67 136.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.149 -177.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.9 p90 -153.58 177.22 11.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.98 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.31 144.06 51.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.814 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.2 p -82.8 163.48 21.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -174.14 4.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.142 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 149.81 21.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.205 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.546 -178.931 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.6 Cg_exo -58.86 171.37 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 113.299 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 m -98.53 166.59 11.28 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.61 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 141.91 83.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.122 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.84 171.39 15.74 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.596 1.53 . . . . 0.0 110.6 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.82 140.03 32.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -109.61 110.86 22.04 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.202 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.8 142.69 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.44 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.94 136.79 11.51 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 118.912 -1.613 . . . . 0.0 113.468 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.01 136.46 52.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.397 -0.902 . . . . 0.0 109.185 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.2 ttm -108.1 130.96 55.07 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.462 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.59 152.16 27.32 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.14 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.89 12.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.248 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.95 -23.9 41.35 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.57 175.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.24 -39.28 2.96 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.755 -1.212 . . . . 0.0 111.315 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.55 9.49 3.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.468 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 m -78.92 113.47 17.05 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.776 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.9 mm -114.92 126.94 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -172.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -113.94 123.61 50.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.087 0.867 . . . . 0.0 108.885 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.8 t -111.25 122.58 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -98.04 132.27 43.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.634 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 20.6 mt -100.46 101.8 12.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 124.091 0.869 . . . . 0.0 108.805 -175.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.7 mm -87.11 105.43 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.666 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -74.77 149.79 39.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.36 -56.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.19 -172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.2 100.75 5.51 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.557 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.5 m-20 -129.73 -36.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.087 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.81 53.45 0.37 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 21.35 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.592 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.1 t 41.6 62.65 7.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 114.784 -0.708 . . . . 0.0 112.823 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 31' ' ' SER . 7.4 Cg_endo -86.02 43.46 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.603 1.535 . . . . 0.0 108.392 171.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.24 150.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.581 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.8 mtt180 -129.71 116.0 18.15 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.634 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.69 -172.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.556 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.7 m-85 -139.5 148.88 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.671 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.8 mt -104.77 110.08 22.28 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 60' ' ' VAL . 52.8 t -111.98 126.33 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.651 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.85 140.75 47.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 125.056 1.472 . . . . 0.0 107.767 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 151.86 35.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.592 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.8 ptt180 -125.62 162.31 25.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.247 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.615 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -125.45 174.44 8.19 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.391 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.05 43.92 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.993 171.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -150.41 -61.65 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.5 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -129.28 163.0 26.61 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.562 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 21.2 mt-10 -109.73 156.78 19.85 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.945 -1.102 . . . . 0.0 113.197 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 41' ' ' ARG . 3.6 m95 34.72 79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.795 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 73.7 mmtt -62.53 160.74 31.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.193 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.71 101.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.884 1.722 . . . . 0.0 111.06 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -49.13 158.58 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.957 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.3 147.22 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.196 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -114.75 123.91 50.44 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -70.34 165.42 44.59 Favored Pre-proline 0 N--CA 1.488 1.462 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.237 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.98 164.55 9.88 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.823 1.682 . . . . 0.0 110.451 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -73.65 79.88 1.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.67 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.63 60.67 0.43 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -96.98 -174.69 3.04 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.856 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.66 -12.05 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.512 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.7 p-80 -154.16 163.64 39.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.275 -176.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -136.92 151.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.946 173.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.5 ptp -135.22 148.06 49.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.106 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.547 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.6 pp -141.52 143.24 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.354 173.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -141.63 173.04 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.716 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 t 59.43 57.21 3.42 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.433 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 15.0 mt -94.35 179.95 5.12 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.62 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.11 135.28 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.037 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.428 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 75.6 m95 -76.17 152.33 36.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.593 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.21 49.29 15.45 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.521 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 153.71 47.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.33 147.75 22.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.213 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.6 m-85 -133.94 137.29 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 123.947 0.779 . . . . 0.0 111.865 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -118.5 115.82 25.38 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.908 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.15 122.97 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 39.2 m-85 -112.53 124.74 53.19 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.38 121.22 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.666 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.12 157.27 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 118.422 -1.311 . . . . 0.0 109.686 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.2 tt0 -111.57 160.28 17.34 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.49 -1.284 . . . . 0.0 107.795 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -145.79 151.47 37.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.852 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -36.77 -43.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.649 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -109.1 37.41 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.79 -152.45 22.16 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.771 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -129.04 163.71 24.81 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.734 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -126.18 125.93 43.26 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.964 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -43.27 167.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.707 1.879 . . . . 0.0 113.378 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.85 141.03 28.84 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.793 -173.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.68 147.13 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -116.71 130.3 56.65 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.544 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 81.3 t80 -117.95 127.64 54.04 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.239 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -123.87 134.39 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.611 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.0 p90 -156.29 176.78 12.24 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.263 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.74 147.39 49.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.511 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -79.9 168.49 19.18 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.92 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.11 -170.91 3.12 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.223 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.78 141.41 36.55 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.017 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.531 -178.643 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -58.76 170.91 2.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.518 2.146 . . . . 0.0 112.797 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 t -93.63 171.04 9.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.64 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.29 141.3 73.63 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.685 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.16 168.16 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 121.47 1.446 . . . . 0.0 110.904 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -101.63 130.81 48.05 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 mt -104.71 111.52 24.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.118 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -95.45 142.79 27.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -113.71 133.17 11.04 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.23 -1.462 . . . . 0.0 112.978 -170.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -127.75 129.3 46.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.6 ttm -107.66 134.08 51.16 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.699 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.33 153.73 24.58 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.779 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.56 10.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.985 -0.607 . . . . 0.0 112.292 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.92 -22.39 42.78 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.866 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.14 -37.47 3.54 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.559 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.5 p30 -137.48 46.82 2.11 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -120.58 114.93 22.46 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -118.56 128.34 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.501 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -113.6 125.34 54.06 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.1 t -109.86 118.5 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -98.73 128.5 45.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.48 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 18.7 mt -100.38 105.18 16.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mm -94.65 128.58 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.876 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -103.54 147.64 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.311 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.42 -54.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.197 -174.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 18.9 m-20 -132.82 107.34 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.627 -175.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.6 m-20 -131.98 -35.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.035 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.91 52.22 0.35 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.19 20.96 34.05 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 67.1 m 41.92 61.34 8.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.5 Cg_endo -87.74 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.631 1.554 . . . . 0.0 108.787 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.81 151.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.449 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.0 mtt180 -130.67 115.1 16.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.69 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.531 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.8 p-80 37.43 -171.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.582 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -141.17 151.49 43.89 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.021 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.6 mt -105.19 108.81 20.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 60' ' ' VAL . 55.3 t -114.42 122.37 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.95 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.64 142.23 46.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 124.536 1.147 . . . . 0.0 108.222 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -146.82 153.3 40.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.994 -1.482 . . . . 0.0 112.575 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.3 ptm180 -129.0 164.53 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.563 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -118.25 -169.17 1.65 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.314 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 9.7 tp -93.32 41.27 1.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.403 172.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.93 -59.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.719 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -121.97 156.54 33.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.544 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -105.48 157.26 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.839 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.528 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 32.83 88.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.495 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -71.84 166.01 44.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.002 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.4 Cg_exo -46.38 96.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.816 1.677 . . . . 0.0 110.578 177.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.73 174.97 4.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.244 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.83 155.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.642 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -115.83 127.94 55.44 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.034 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -74.57 164.71 59.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.091 -177.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -71.21 143.89 45.1 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.747 1.631 . . . . 0.0 109.461 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.46 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.5 m -56.69 105.33 0.2 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.931 0.769 . . . . 0.0 111.906 -176.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 107.22 52.15 0.74 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -97.15 169.24 9.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.844 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.18 -32.25 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.391 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.415 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 24.9 p-80 -148.05 167.3 25.3 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.523 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.4 p -134.22 153.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.865 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 ptp -136.54 152.69 50.78 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.513 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -137.59 141.7 41.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.728 172.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 64' ' ' SER . 10.0 ttpp -144.51 135.39 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.891 -173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 91.49 46.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.332 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -93.62 -178.98 4.87 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.829 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.73 135.46 40.34 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.401 -173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.59 156.4 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.297 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.48 48.77 10.87 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.888 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.12 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.086 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.2 mt-10 -94.44 146.18 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.954 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.652 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.8 m-85 -131.04 140.48 50.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.31 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.86 117.29 28.45 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.195 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.05 121.89 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 37.7 m-85 -110.81 123.73 50.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.5 t -120.21 121.07 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.946 0.778 . . . . 0.0 110.349 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.37 158.34 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.63 156.21 42.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.606 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 18.8 tt0 -111.69 160.68 17.04 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.486 HD21 ' HG2' ' A' ' 32' ' ' PRO . 14.2 t-20 -145.37 151.15 37.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.839 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -36.42 -43.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.719 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -110.5 38.03 2.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.17 -153.53 23.44 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.839 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -128.09 163.36 24.78 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.765 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.6 t -126.54 125.19 41.61 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.037 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -43.14 167.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 125.582 1.801 . . . . 0.0 113.513 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.76 141.27 28.64 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.679 -174.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.83 147.0 28.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.04 129.35 56.32 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.609 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.6 t80 -117.25 127.83 54.48 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.239 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -125.43 139.12 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.921 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 42.2 p90 -157.91 178.31 10.37 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.733 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -129.12 146.56 51.04 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.957 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.2 p -79.94 171.58 14.92 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.419 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -84.36 -176.04 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.092 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.85 147.99 24.92 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.08 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.436 -1.745 . . . . 0.0 110.568 -178.529 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 37.6 Cg_endo -73.01 179.46 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.919 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -98.34 159.42 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.182 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.87 147.95 92.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.617 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.59 169.47 15.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.296 1.331 . . . . 0.0 110.626 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -104.06 134.6 47.05 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.99 110.86 21.92 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.405 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.34 148.22 22.3 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.487 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -115.49 128.91 8.27 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.959 -172.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.77 128.1 50.03 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.514 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.8 tpp -103.62 128.99 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.21 151.14 25.45 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.256 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.87 8.92 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -80.0 -21.13 43.97 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.246 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.9 -35.19 5.19 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.573 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 6.1 p30 -133.12 0.47 3.43 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.17 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -72.97 113.83 10.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.227 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.523 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.3 mm -114.97 126.17 72.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.831 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.69 125.36 54.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.928 0.767 . . . . 0.0 109.227 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.4 t -109.43 122.3 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.73 129.04 41.8 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.324 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 43.2 mt -99.06 98.52 9.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.96 133.43 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.648 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' C ' HE21 ' A' ' 26' ' ' GLN . 40.9 mtmt -92.32 171.38 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.865 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -161.1 -64.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.757 -173.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.99 91.23 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.2 m-20 -128.43 -16.11 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.061 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.65 49.82 2.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.52 47.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.52 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 42.6 t 44.2 68.04 3.45 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.379 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -89.49 43.91 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.764 1.642 . . . . 0.0 107.956 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.27 146.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.853 -171.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 89.8 mtt-85 -126.04 123.78 39.18 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.464 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.4 p-80 37.16 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -138.08 156.07 48.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.026 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.52 110.82 22.02 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 60' ' ' VAL . 49.0 t -114.35 123.56 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.024 -1.07 . . . . 0.0 109.94 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -136.01 139.22 42.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.682 1.239 . . . . 0.0 107.927 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.06 155.2 43.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.933 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.0 ptt85 -130.63 164.34 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.016 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -124.88 169.85 11.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.683 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.68 43.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.9 -56.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.041 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.5 m -130.54 157.18 43.4 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.197 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -101.65 165.25 11.32 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.82 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.8 m95 21.9 91.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.047 -1.433 . . . . 0.0 114.019 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.0 mptm? -74.45 165.23 55.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.109 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.3 Cg_exo -45.13 99.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.856 1.704 . . . . 0.0 110.716 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 175.24 3.5 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.451 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.1 tt -140.18 154.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -115.29 136.42 53.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.0 mt -87.99 164.64 32.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.32 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.3 Cg_exo -62.24 165.68 14.42 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.812 1.674 . . . . 0.0 110.389 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -74.93 80.89 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.13 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.04 58.2 0.26 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.721 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -97.06 167.16 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.375 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.24 -8.94 12.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.651 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.7 p-80 -160.09 165.23 32.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.053 -1.459 . . . . 0.0 112.943 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.6 p -137.72 153.52 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.978 172.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 ptp -136.53 151.02 48.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.341 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.84 146.14 35.49 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.366 173.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -141.52 -177.25 5.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.416 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.4 t 55.19 51.87 12.54 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 17' ' ' ASN . 31.6 mt -85.49 165.68 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.812 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -78.31 8.19 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.412 -171.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 60.52 162.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.167 0.508 . . . . 0.0 111.861 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 36.23 43.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.03 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.77 156.16 48.88 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.061 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -98.23 147.86 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.144 0.903 . . . . 0.0 108.629 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 33.2 m-85 -131.95 142.92 49.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.972 0.795 . . . . 0.0 111.783 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -118.55 118.15 30.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.646 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -110.52 122.75 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 54.2 m-85 -111.45 125.88 54.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.1 t -121.0 122.29 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.626 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.35 155.51 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.15 159.2 35.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.955 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -109.37 149.77 29.02 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.469 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -130.88 143.96 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.267 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -43.39 -37.17 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.81 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -117.07 46.26 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.793 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -153.72 22.62 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.371 174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -125.17 160.59 28.8 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.882 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.8 t -113.13 109.64 19.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -39.25 158.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 125.497 1.748 . . . . 0.0 112.698 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.56 127.88 33.23 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.828 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.76 145.21 26.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.53 129.26 56.65 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.608 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.5 t80 -115.84 127.22 54.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.37 134.55 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.358 -175.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 39.7 p90 -155.74 174.75 14.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.473 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.52 148.46 48.88 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.803 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -79.88 172.58 13.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 m -87.14 -172.94 4.19 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.727 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.23 144.21 27.26 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.283 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.566 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.522 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.9 Cg_exo -60.3 168.08 6.86 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.551 2.167 . . . . 0.0 113.046 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.82 158.46 18.74 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.828 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.06 146.2 92.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.173 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.32 167.93 19.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.458 1.439 . . . . 0.0 110.749 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 44.9 mtmt -103.59 128.75 50.81 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.6 114.34 28.5 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.494 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -103.18 140.74 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.552 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -123.31 140.8 13.27 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.724 -170.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -131.39 143.3 50.37 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.2 -1.0 . . . . 0.0 109.645 170.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.661 -0.816 . . . . 0.0 108.969 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -81.89 153.8 33.15 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.808 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.27 8.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.374 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' GLY . 17.5 m-20 -79.92 -25.16 40.62 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.533 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.1 -37.03 4.03 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.727 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 13.4 m-20 -123.08 -12.0 7.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.9 m -65.73 112.04 3.51 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.638 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 91' ' ' PHE . 6.8 mm -112.21 126.7 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -114.7 121.35 43.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 124.044 0.84 . . . . 0.0 108.865 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.5 t -109.98 118.02 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -95.44 133.78 39.02 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.341 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 52.0 mt -102.58 101.12 11.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 124.049 0.843 . . . . 0.0 108.885 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 7' ' ' LYS . 23.8 mm -89.51 134.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.025 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -101.52 148.61 25.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.006 0.816 . . . . 0.0 109.333 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.66 -72.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.81 -175.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 29.9 m-20 -130.34 107.29 9.15 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.931 -176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.0 m-20 -126.44 -35.73 2.35 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.655 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.43 54.6 0.26 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 32' ' ' PRO . . . 89.06 28.63 20.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 77.8 p 32.21 63.37 1.26 Allowed Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -87.39 46.31 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.758 1.638 . . . . 0.0 108.755 173.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.08 149.87 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.462 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' HIS . 62.1 mtt85 -130.45 117.59 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.13 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.8 p-80 36.1 -175.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.549 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.1 m-85 -137.55 142.84 41.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.944 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.28 105.7 17.74 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 60' ' ' VAL . 60.7 t -108.81 125.57 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.088 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -131.8 134.02 45.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 125.0 1.438 . . . . 0.0 107.681 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.59 158.63 43.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 117.711 -1.595 . . . . 0.0 112.185 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 22.5 ptt85 -142.71 168.37 19.89 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.458 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -131.43 171.63 13.15 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.38 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -71.06 26.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.153 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -131.22 -59.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -124.82 154.91 40.27 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -108.98 166.74 10.6 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.314 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.473 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 22.67 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.188 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.81 165.67 39.66 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.085 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -48.81 107.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.867 1.711 . . . . 0.0 110.711 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.81 159.59 2.22 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.86 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -130.09 147.82 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.018 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -114.77 113.33 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.334 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.549 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mm? -58.55 167.44 1.78 Allowed Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.604 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.62 171.37 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.736 1.624 . . . . 0.0 110.502 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.3 m -76.29 77.29 3.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.736 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 70.1 0.68 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -93.31 -171.94 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.187 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.89 -20.22 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.006 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 20.4 p-80 -160.0 173.46 15.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.025 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -135.23 150.8 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 124.856 1.347 . . . . 0.0 108.416 173.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptp -134.12 147.59 50.85 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.002 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.9 pp -142.13 147.35 36.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.885 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -141.09 175.44 9.63 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.942 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t 49.36 66.94 0.97 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.226 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 12.3 mt -100.0 -174.69 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.075 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 6.4 m-20 -70.0 126.42 29.63 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.761 172.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -76.38 151.4 36.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.177 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.04 49.06 15.26 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.032 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB1' ' CD2' ' A' ' 43' ' ' LEU . . . -127.45 150.72 49.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.45 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' H ' HD13 ' A' ' 43' ' ' LEU . 31.2 mt-10 -91.8 140.64 29.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -129.9 143.38 50.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.002 0.814 . . . . 0.0 112.431 -173.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.46 125.18 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.804 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.88 125.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 49.1 m-85 -114.49 127.66 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.54 119.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.59 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.34 156.98 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.42 155.4 43.73 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.185 -1.406 . . . . 0.0 109.862 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.2 tt0 -111.25 157.93 19.56 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.869 175.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.522 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.6 t-20 -145.43 152.87 40.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.09 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -33.61 -45.82 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.908 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -109.85 37.68 2.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.56 -153.52 22.09 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.227 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -120.25 158.76 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.835 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -121.79 124.76 44.93 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.29 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -40.85 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 125.75 1.906 . . . . 0.0 113.505 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.83 137.93 32.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.223 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.81 145.94 28.48 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -117.03 131.85 56.84 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.648 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.9 t80 -121.5 134.39 55.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.236 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -131.07 142.8 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.818 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 19' ' ' ILE . 49.0 p90 -158.97 -178.78 7.49 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.282 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -129.32 144.41 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.661 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -79.82 169.38 18.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -85.75 -168.11 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.076 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.13 140.55 37.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.433 -178.729 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.2 Cg_endo -62.8 176.79 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.476 2.117 . . . . 0.0 112.767 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -96.81 162.1 13.57 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.906 173.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 145.63 99.02 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.316 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.11 170.27 12.12 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.391 1.394 . . . . 0.0 111.177 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -104.59 132.92 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.09 111.84 23.68 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.254 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.92 145.19 24.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.95 130.3 9.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.332 -1.413 . . . . 0.0 112.868 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.09 125.82 45.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 ttm -107.13 128.93 54.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.468 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.04 150.55 24.02 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.811 -1.185 . . . . 0.0 111.472 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.46 13.97 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.833 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 13.5 m-20 -79.96 -23.14 41.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.669 174.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.51 -39.63 2.83 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.397 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.443 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 17.6 p30 -133.6 12.78 4.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.94 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -80.0 109.89 14.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.2 mm -115.14 126.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.272 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -113.28 126.5 55.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 123.943 0.777 . . . . 0.0 109.058 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 55.7 t -108.74 115.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.96 128.58 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.459 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.52 107.62 19.84 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.772 -172.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.1 mm -100.71 135.22 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.458 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -101.71 152.1 21.24 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.652 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.95 -50.41 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.129 -176.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 12.7 m-20 -141.15 106.78 5.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.9 m-20 -132.06 -34.26 1.28 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.234 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.63 53.85 0.37 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.05 21.01 34.3 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.574 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 39.52 64.15 4.28 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 114.927 -0.637 . . . . 0.0 112.64 -176.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.6 Cg_endo -86.28 44.41 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.621 1.547 . . . . 0.0 108.556 172.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -86.66 148.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.468 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 47.1 mtt180 -129.68 120.09 24.59 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.616 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 36.89 -174.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.1 m-85 -139.2 151.65 46.72 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.036 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.21 109.73 21.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.39 123.12 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.055 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -134.48 140.92 46.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.552 1.158 . . . . 0.0 107.922 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -146.04 156.15 43.28 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.694 -1.602 . . . . 0.0 112.378 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.2 ptm180 -125.89 160.49 29.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.49 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.55 -169.63 1.53 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.4 tp -96.19 39.91 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.116 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.45 -59.41 0.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.2 m -118.41 148.6 42.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.009 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.0 pt-20 -107.05 151.62 25.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.816 -1.153 . . . . 0.0 112.181 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.536 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 42.0 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.41 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.3 mttt -73.54 165.17 55.38 Favored Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.483 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.89 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.767 1.645 . . . . 0.0 110.479 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.12 174.38 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.675 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -137.76 154.23 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.043 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.74 128.69 56.05 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.093 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.17 165.13 56.39 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.149 -177.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.75 166.58 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.858 1.705 . . . . 0.0 110.237 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.3 m -76.27 79.67 3.05 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.874 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.69 60.75 0.41 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -97.08 -175.61 3.3 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.769 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -117.82 -39.89 3.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.571 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -148.22 168.44 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.21 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -128.07 152.09 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.289 174.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptp -136.44 154.11 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.528 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.7 OUTLIER -137.9 142.79 40.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.552 173.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -131.6 165.72 23.02 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.455 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m 53.58 62.56 2.58 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.189 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.3 mt -92.36 178.19 5.91 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.029 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -73.59 128.98 37.0 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.188 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.51 150.1 45.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.584 -1.246 . . . . 0.0 109.883 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.61 49.15 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.478 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.55 153.1 48.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.963 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 26.8 tt0 -94.04 147.96 22.63 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.009 175.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.9 m-85 -132.67 140.88 48.34 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.419 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.95 116.24 24.73 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.024 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.53 123.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 40.5 m-85 -112.18 125.56 54.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.29 121.84 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 124.035 0.834 . . . . 0.0 110.188 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -107.7 158.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.69 160.98 31.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.333 -1.347 . . . . 0.0 109.106 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -112.22 157.46 20.87 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.091 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -139.92 147.99 41.36 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.105 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -36.83 -43.39 0.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.41 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -114.41 42.73 2.04 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.669 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.9 -154.25 24.27 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.192 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -121.33 161.34 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.961 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.566 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.2 t -116.0 115.45 26.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -40.44 160.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 125.512 1.757 . . . . 0.0 112.661 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.65 138.35 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.532 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.21 146.27 29.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.494 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -116.97 130.86 56.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.465 -173.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -118.49 128.44 54.59 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.116 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.39 138.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.818 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.519 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.48 -179.78 8.22 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.973 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.08 147.48 50.94 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.768 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -80.02 170.06 16.99 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.784 -0.767 . . . . 0.0 109.292 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.7 m -81.41 -175.98 5.77 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.154 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.42 147.38 26.41 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.123 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.521 -1.704 . . . . 0.0 110.692 -178.203 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.0 Cg_endo -64.24 174.29 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.548 2.165 . . . . 0.0 112.603 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -87.92 145.59 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.286 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.77 78.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.571 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.41 165.74 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.218 1.279 . . . . 0.0 110.569 -176.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' N ' HE22 ' A' ' 26' ' ' GLN . 25.3 ttpt -103.42 133.29 48.72 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.3 112.24 25.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.959 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -93.4 141.89 27.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.29 131.28 10.55 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.341 -1.409 . . . . 0.0 112.587 -171.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -128.85 126.97 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 ttm -106.2 132.69 51.96 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.77 152.42 23.95 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.571 -176.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.99 12.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.311 -0.556 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.95 -24.26 41.12 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.645 175.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.06 -40.77 2.43 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.434 177.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -132.15 10.06 4.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.076 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -81.78 116.25 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.953 176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.529 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.3 mm -116.97 128.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.324 -172.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -113.47 126.3 55.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.988 0.805 . . . . 0.0 108.982 173.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -108.78 113.27 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -95.05 129.83 41.98 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.401 -176.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -98.71 106.45 18.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.715 -173.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.3 mm -97.66 131.76 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.994 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -107.49 156.26 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.366 -177.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.45 HE22 ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -132.32 -65.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.516 -174.091 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -135.23 128.4 31.86 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.325 177.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -133.53 -36.27 0.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 123.901 0.751 . . . . 0.0 109.899 177.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.63 54.22 0.3 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.44 18.86 37.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -175.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 42.56 61.27 9.25 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 114.907 -0.646 . . . . 0.0 112.648 -176.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.0 Cg_endo -88.46 37.99 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.558 1.506 . . . . 0.0 109.583 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 79' ' ' ASN . 23.6 mm -77.54 150.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.901 0.858 . . . . 0.0 111.78 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 9.0 mmt180 -127.85 113.32 15.77 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.367 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.2 p-80 36.2 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 174.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.535 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.0 m-85 -137.98 152.3 48.78 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.115 177.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.404 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.1 mt -108.56 110.72 22.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 60' ' ' VAL . 52.4 t -115.45 124.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.289 -174.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -135.52 140.15 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.62 1.2 . . . . 0.0 108.291 177.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.78 155.98 44.34 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.202 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.3 ptm180 -129.56 164.67 23.32 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.988 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -113.83 -177.95 3.26 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 tp -87.03 41.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.111 173.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.11 -60.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.522 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 p -119.11 151.3 38.53 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.439 177.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.8 pt-20 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.858 -173.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.572 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 42.29 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.35 175.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -69.83 168.3 18.55 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.695 173.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -52.26 95.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.656 1.57 . . . . 0.0 109.819 174.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.65 172.61 2.05 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.486 -173.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.11 154.63 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.392 -177.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -114.74 129.24 56.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.09 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -76.1 165.93 49.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.133 -177.968 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.45 168.24 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.787 1.658 . . . . 0.0 110.211 172.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.4 t -77.87 78.97 4.35 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.566 -177.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.0 60.72 0.34 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -97.18 -174.51 2.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.688 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -119.5 -40.52 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.707 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -148.06 169.12 20.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.11 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.0 p -127.46 152.48 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.422 173.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.8 ptp -136.25 150.42 48.95 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.599 -1.241 . . . . 0.0 112.908 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -140.47 139.21 35.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.097 172.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -140.39 162.76 34.54 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.606 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t 66.93 50.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.605 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -96.43 -174.52 3.07 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.665 176.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -83.3 142.6 30.97 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.095 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.412 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 74.3 m95 -77.75 155.17 31.37 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.366 -178.037 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.35 48.66 10.49 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.604 -176.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.09 47.33 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.837 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -97.94 149.92 21.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.532 177.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 31.6 m-85 -135.47 145.27 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.423 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -121.08 118.56 30.08 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.347 -1.751 . . . . 0.0 108.328 177.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.68 124.55 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 45.0 m-85 -112.69 126.18 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -121.29 122.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.13 158.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.98 156.54 41.41 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.261 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 27.6 tt0 -111.97 159.77 18.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.585 175.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -144.88 148.94 34.5 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.985 178.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -37.91 -42.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.481 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -112.32 42.12 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.465 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.45 -153.97 22.76 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.46 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -125.35 162.52 24.59 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.877 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -119.77 117.13 27.39 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -40.96 163.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 125.482 1.739 . . . . 0.0 113.206 -174.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.15 134.72 34.98 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.126 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.87 145.58 29.58 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.25 131.06 57.05 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.627 -173.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -118.13 127.27 53.61 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.008 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -125.32 139.31 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.64 -176.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 38.5 p90 -159.17 176.98 11.55 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.24 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -127.63 147.9 50.37 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.756 175.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.3 p -79.84 170.83 15.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.248 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.57 -170.81 3.24 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.143 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.19 141.88 36.81 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.156 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.54 -1.695 . . . . 0.0 110.741 -179.193 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -60.99 173.83 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.493 2.129 . . . . 0.0 112.917 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -95.39 155.51 16.71 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.036 174.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.26 143.09 97.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.075 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.65 165.9 23.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.343 1.362 . . . . 0.0 110.75 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.61 132.53 48.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.082 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.6 mt -104.72 113.78 27.58 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.224 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.02 138.78 31.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.441 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.75 124.56 7.91 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.492 -1.337 . . . . 0.0 112.469 -172.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.81 120.88 35.85 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.4 ttm -106.39 131.69 53.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.73 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.73 149.27 23.26 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.689 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.84 11.63 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.074 -0.563 . . . . 0.0 112.255 -177.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.5 m-20 -79.93 -22.36 42.8 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.876 176.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.8 -37.8 3.61 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.957 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.0 p-10 -140.27 47.52 1.79 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m -120.57 114.33 21.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.533 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.9 mm -117.41 128.54 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.633 -170.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -114.94 126.6 54.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.575 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.9 t -109.01 111.5 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -94.33 130.9 40.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.623 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 19.6 mt -100.05 108.51 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.949 -172.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.79 127.12 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -104.06 156.16 18.09 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.471 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 -53.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.146 -172.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.15 118.91 16.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.294 -178.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.27 -41.43 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 177.577 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.13 54.54 0.25 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -177.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.53 42.88 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 14.4 t 42.3 60.38 9.59 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -88.65 46.87 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.658 1.572 . . . . 0.0 108.962 173.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.67 152.32 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.602 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 35' ' ' HIS . 11.0 mtt180 -130.37 119.9 23.47 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.331 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.636 ' H ' ' HA ' ' A' ' 55' ' ' SER . 7.2 p-80 31.87 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.129 -1.851 . . . . 0.0 115.988 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 81.9 m-85 -137.47 153.1 50.13 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.9 175.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.9 mt -110.82 112.2 23.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 60' ' ' VAL . 42.4 t -115.86 128.16 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.215 -174.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.3 139.4 46.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.905 1.378 . . . . 0.0 108.104 175.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.9 p90 -147.38 154.57 41.04 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.581 177.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -133.39 160.81 36.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.775 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.47 -172.75 2.12 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -93.43 39.34 1.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.585 171.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.66 -60.67 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.348 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.5 m -118.94 141.12 48.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.8 pt-20 -105.02 171.93 7.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.093 -171.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 7.4 m95 18.28 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.591 -1.641 . . . . 0.0 114.123 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 9.4 mptt -67.57 164.34 39.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.689 174.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -47.17 104.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.844 1.696 . . . . 0.0 110.881 177.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 156.66 0.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.261 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 tt -131.12 146.92 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.359 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -115.21 132.14 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -82.69 164.69 45.84 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.875 -177.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.25 155.58 68.84 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.599 1.533 . . . . 0.0 109.454 172.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.636 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.5 t -73.36 103.1 3.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.373 -177.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.25 0.74 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.07 172.84 7.58 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.155 -175.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.3 -43.7 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.565 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.5 p-80 -148.86 168.4 23.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.614 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -123.15 150.74 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.035 174.146 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -135.92 149.19 48.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.506 -1.277 . . . . 0.0 112.833 -175.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -138.65 135.31 34.73 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.68 173.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' SER . 84.1 mttt -142.9 142.11 31.66 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.778 -178.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.9 m 91.07 43.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.892 176.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.9 mm? -95.37 -176.47 3.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.369 -177.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.43 130.95 42.6 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.877 -172.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.6 155.99 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 43.3 48.42 5.8 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.792 -177.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.9 151.88 49.98 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.802 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.86 149.54 21.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.775 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 7.6 m-85 -133.74 140.92 47.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.657 -177.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.17 119.72 34.1 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.518 -1.673 . . . . 0.0 108.234 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.62 125.41 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m-85 -113.52 125.39 54.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.463 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.2 123.75 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.893 0.746 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -108.72 158.01 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.72 157.02 41.46 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.413 -1.315 . . . . 0.0 109.547 178.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.2 tt0 -112.15 161.88 16.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.731 -1.188 . . . . 0.0 108.009 175.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.9 t-20 -143.78 149.8 37.6 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.546 177.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -41.21 -39.47 1.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.172 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -113.05 39.06 2.64 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.92 -150.88 22.39 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.681 175.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -134.31 168.52 18.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.227 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 9.1 t -127.97 123.06 33.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.215 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.15 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 125.557 1.786 . . . . 0.0 113.253 -174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.02 138.84 31.15 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.63 -174.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.79 145.8 29.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.04 130.72 57.0 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.6 -173.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -118.5 129.26 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.017 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.5 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.7 140.64 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.936 -176.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.2 p90 -158.84 -178.65 7.41 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.739 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -130.85 146.76 52.38 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.91 175.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -79.88 171.5 15.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.332 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.86 -170.88 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.072 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.07 140.85 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.052 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.459 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 10.9 Cg_endo -68.23 174.34 8.22 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.658 2.239 . . . . 0.0 112.427 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -101.54 158.78 15.83 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.925 172.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.31 149.58 68.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.349 -174.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -71.82 172.02 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.589 1.526 . . . . 0.0 110.766 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -106.07 134.1 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.47 112.43 24.82 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.399 -176.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 23.1 tt0 -92.48 141.45 28.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.76 121.83 7.29 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.869 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -122.16 121.58 37.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.4 ttm -104.76 134.2 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.701 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.63 150.86 22.01 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.735 -176.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.76 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.085 -0.557 . . . . 0.0 112.294 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 15.5 m-20 -79.82 -22.2 43.31 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.017 176.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.97 -50.97 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.541 176.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -128.15 7.62 6.02 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.807 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.5 t -73.11 117.32 14.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.865 176.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.04 128.63 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.869 -171.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -113.8 125.85 54.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.008 0.817 . . . . 0.0 108.976 171.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 59.4 t -105.9 110.19 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 11.5 t-20 -88.03 129.06 35.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.95 -175.441 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 75' ' ' VAL . 33.4 mt -99.69 100.95 11.99 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.265 -175.024 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -93.05 128.84 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -101.17 147.57 26.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 123.951 0.782 . . . . 0.0 109.672 -176.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.18 -86.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.937 -175.189 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -107.59 109.5 21.16 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.659 -174.952 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.1 m-20 -133.62 -34.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.127 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.92 53.51 0.36 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.72 21.04 35.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -175.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.0 m 42.85 61.47 9.4 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.745 -176.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 14.3 Cg_endo -86.54 45.61 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.792 1.662 . . . . 0.0 108.75 173.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 79' ' ' ASN . 23.0 mm -82.35 148.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.278 -173.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.0 mtt180 -125.35 111.43 15.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.89 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 33.97 -171.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.07 156.23 49.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.83 176.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.2 mt -112.82 111.45 22.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.061 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 60' ' ' VAL . 48.5 t -115.82 124.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.447 -174.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -136.75 138.1 40.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.487 1.117 . . . . 0.0 108.328 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.85 156.88 45.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.0 -1.48 . . . . 0.0 112.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 27.0 ptt180 -134.69 168.81 18.33 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.39 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.25 172.17 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.797 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.471 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -71.8 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.952 174.706 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -136.53 -58.75 0.73 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.742 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.7 m -126.48 158.79 35.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.581 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.7 pt-20 -101.43 166.98 10.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.751 -177.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.9 m95 17.94 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.966 -1.47 . . . . 0.0 114.514 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.68 167.27 36.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.322 173.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -48.06 98.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.76 1.64 . . . . 0.0 110.39 176.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.77 174.44 5.16 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.349 -173.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -139.19 154.89 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.499 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.35 137.06 52.07 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.783 173.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.5 mt -87.49 166.45 25.28 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.306 -177.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -81.33 140.04 11.94 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.92 1.747 . . . . 0.0 108.063 167.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -62.53 135.31 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.742 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.61 41.81 4.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -97.03 168.62 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.505 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -114.59 -45.81 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.44 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -147.86 167.43 24.8 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.361 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.0 p -119.07 149.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.778 173.353 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -132.55 148.41 52.37 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.874 -174.074 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.98 140.41 38.21 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.202 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -140.59 162.35 35.57 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.357 -177.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 m 71.69 46.4 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.403 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -95.27 -176.06 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 177.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -84.98 146.33 27.27 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.816 -175.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.451 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 71.0 m95 -80.25 155.33 27.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.545 -177.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 44.91 46.77 9.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.458 -175.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 149.94 47.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.712 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' H ' HD13 ' A' ' 43' ' ' LEU . 18.8 tt0 -98.83 143.09 29.55 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.327 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 39.4 m-85 -131.51 144.32 51.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 123.995 0.809 . . . . 0.0 112.057 -177.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.12 119.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.428 -1.715 . . . . 0.0 108.06 176.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.55 124.53 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 59.8 m-85 -111.35 126.96 55.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 23' ' ' LEU . 75.8 t -120.92 121.82 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -109.5 158.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.72 160.21 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.516 -1.274 . . . . 0.0 109.36 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.6 tt0 -111.1 164.76 12.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 20.1 t-20 -152.19 151.89 31.57 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -41.63 -41.41 2.2 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.327 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -79.7 -47.62 15.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.503 -177.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.63 -108.79 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.995 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -140.72 173.23 11.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.895 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -125.77 119.27 27.47 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -42.49 162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.307 1.629 . . . . 0.0 112.664 -176.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.51 134.49 35.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.202 -176.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.3 143.07 32.54 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.469 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.21 130.74 56.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.397 -174.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -116.88 126.85 53.61 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.984 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -123.63 135.44 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.298 -176.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 p90 -156.93 174.03 16.12 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.34 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -127.3 148.2 50.23 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.544 175.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -79.83 168.5 19.19 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.002 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 m -81.25 -173.17 4.18 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.356 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.04 150.55 21.28 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.109 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 116.247 -1.835 . . . . 0.0 110.392 -178.802 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 7.2 Cg_exo -59.35 176.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.634 2.223 . . . . 0.0 112.909 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -93.0 161.53 14.41 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.224 171.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.36 143.73 92.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.422 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.37 172.8 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.484 1.456 . . . . 0.0 110.915 -177.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -106.6 132.25 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.1 mt -109.04 112.12 24.13 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.352 -176.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.33 144.2 25.62 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.41 131.52 10.56 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.422 -173.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -129.16 129.4 45.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.249 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.8 ttm -106.86 134.64 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.652 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.41 144.03 21.29 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.591 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.48 9.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.95 -27.22 39.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.858 175.566 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.26 -40.05 1.95 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.931 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -130.64 -15.1 3.56 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.801 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -52.88 115.72 1.98 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.332 174.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 91' ' ' PHE . 5.9 mm -117.33 128.79 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.122 -175.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -114.94 126.66 55.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 47.6 t -109.27 118.94 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.77 124.02 39.6 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.81 -178.334 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.62 104.29 15.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -173.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -97.96 133.06 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.204 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -101.1 146.58 27.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.896 0.747 . . . . 0.0 109.434 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.07 -89.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.413 -175.781 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 20.8 t70 -95.45 105.69 17.68 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.125 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.75 -35.12 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.66 51.27 0.42 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.96 17.61 40.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -175.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.615 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 64.3 m 43.35 59.84 11.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.475 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.4 Cg_endo -88.53 50.9 1.67 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.842 1.695 . . . . 0.0 108.513 172.317 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mm -78.86 151.34 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.027 0.918 . . . . 0.0 111.68 -172.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 32.8 mmm-85 -126.13 108.01 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.536 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.536 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.0 p-80 36.17 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 76.5 m-85 -138.73 151.92 47.54 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.131 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.5 mt -107.87 108.78 20.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.08 122.23 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.02 -173.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -132.58 135.65 46.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.664 1.228 . . . . 0.0 108.1 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -140.8 158.69 43.6 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 117.941 -1.504 . . . . 0.0 112.162 179.172 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.6 ptm180 -138.32 170.36 16.15 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.305 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.62 179.5 4.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.514 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 40.83 0.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.535 172.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.28 -60.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -116.45 149.5 39.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.104 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -100.11 160.84 14.01 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.175 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.471 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 24.8 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.402 -1.272 . . . . 0.0 114.028 178.286 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 67.5 mmtt -76.19 162.16 72.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.8 Cg_exo -45.12 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.765 1.643 . . . . 0.0 110.611 177.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.87 175.45 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.571 -173.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -137.97 155.19 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.354 -177.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -115.89 130.25 56.75 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.214 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -78.33 165.09 52.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.239 -177.472 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.12 161.0 27.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.832 1.688 . . . . 0.0 110.87 172.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 t -68.24 95.55 0.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 95.57 65.38 0.97 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -97.14 -169.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.231 -176.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -129.54 -38.88 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.646 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -144.69 164.65 30.35 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.569 -1.252 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -131.77 153.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.492 174.02 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptp -137.45 152.13 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.981 -174.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -142.04 138.61 31.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.172 172.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -137.94 161.23 37.22 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.745 -177.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t 66.51 49.91 1.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.543 177.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -174.63 3.31 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.653 177.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.55 137.32 36.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.708 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.521 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 73.1 m95 -75.62 156.04 35.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.168 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 49.53 44.82 24.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.111 -178.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.71 156.06 44.89 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.546 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.76 149.33 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 19.8 m-85 -135.22 144.63 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.78 -178.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.58 121.45 38.4 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.273 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.0 t -114.06 123.11 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.9 m-85 -110.92 125.64 53.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.67 121.21 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 123.881 0.738 . . . . 0.0 110.446 -178.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -106.54 158.04 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.448 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.81 157.53 41.24 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.381 -1.327 . . . . 0.0 109.868 178.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.9 tt0 -112.11 164.27 13.35 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.491 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.3 t-20 -148.24 151.99 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.949 178.127 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -34.14 -45.81 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.757 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.95 39.78 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.5 -152.81 23.66 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.636 174.208 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -129.86 166.25 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.779 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.1 t -128.71 125.68 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.957 -176.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -43.39 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.52 1.762 . . . . 0.0 113.298 -175.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.25 139.7 30.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.61 -175.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.52 145.54 30.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.2 130.11 56.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.382 -174.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -117.86 129.72 55.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.883 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -127.38 141.1 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.694 -176.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.5 p90 -157.99 177.92 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.066 178.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 146.5 50.78 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.69 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.0 p -83.34 163.36 20.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.379 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 m -74.86 178.75 5.31 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.164 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.5 144.79 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 116.252 -1.832 . . . . 0.0 110.328 -178.926 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 8.3 Cg_exo -59.4 177.26 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.798 2.332 . . . . 0.0 112.944 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -80.17 -154.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.23 150.18 39.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.97 166.28 28.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.377 1.385 . . . . 0.0 110.755 -177.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.48 128.94 52.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 mt -102.91 110.73 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.018 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -91.49 143.09 26.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.431 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.27 125.17 7.76 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.337 -1.411 . . . . 0.0 112.486 -173.388 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.55 122.47 39.76 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.5 ttm -107.17 130.9 54.65 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.745 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.8 149.09 24.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.307 -177.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.55 16.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.85 -24.48 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.332 174.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -40.61 2.45 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.715 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.9 p30 -137.49 49.1 2.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.139 0.495 . . . . 0.0 110.0 177.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.2 m -122.16 113.5 19.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.554 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.07 128.53 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.604 -169.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.94 125.75 53.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.082 0.864 . . . . 0.0 108.748 173.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.5 t -107.12 116.47 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.178 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -93.88 129.01 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.913 -177.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 39.4 mt -100.56 99.41 10.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -175.317 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.9 mm -95.99 130.36 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -104.15 150.85 23.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.711 0.632 . . . . 0.0 109.803 -175.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -79.64 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.037 -174.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.55 102.43 11.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.177 -175.532 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -131.91 -35.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 178.535 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.07 51.04 0.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.77 22.48 25.86 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -175.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.585 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.0 m 39.09 62.44 4.86 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.065 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -88.25 50.69 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.729 1.62 . . . . 0.0 108.722 173.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.402 HD13 HD22 ' A' ' 79' ' ' ASN . 41.0 mm -86.45 151.59 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.068 -174.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.7 mtt85 -131.69 121.69 24.69 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.821 178.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.609 ' H ' ' N ' ' A' ' 56' ' ' GLY . 9.2 p-80 35.44 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.19 158.37 43.81 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.972 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.407 HD23 ' HG3' ' A' ' 52' ' ' ARG . 4.4 mt -112.45 109.86 19.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 60' ' ' VAL . 48.0 t -115.48 124.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.652 -173.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -134.72 140.57 46.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.683 1.24 . . . . 0.0 108.422 177.018 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.1 p90 -144.07 154.83 43.62 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.924 -1.51 . . . . 0.0 112.706 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 12.0 ptm180 -126.14 163.68 22.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.556 179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.81 -168.08 1.3 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' LEU . 12.1 tp -95.9 41.49 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.447 173.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.77 -56.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.611 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -106.76 142.83 35.76 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.6 pt-20 -107.87 144.06 35.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.792 -176.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.551 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.6 m95 47.45 84.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.454 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.0 mmtt -77.54 161.17 73.11 Favored Pre-proline 0 N--CA 1.491 1.603 0 CA-C-N 114.346 -1.297 . . . . 0.0 107.824 174.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.4 Cg_exo -43.37 103.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.909 1.739 . . . . 0.0 110.838 179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 14.2 pt-20 -73.76 175.87 6.82 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.503 -173.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.7 157.54 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.757 -177.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HG3' HD23 ' A' ' 37' ' ' LEU . 14.5 ttp85 -114.39 140.98 48.23 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.911 172.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.0 mt -90.18 165.56 23.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.667 -176.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.9 Cg_exo -61.58 157.91 39.45 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.71 1.607 . . . . 0.0 110.39 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -64.58 86.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.171 -176.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.609 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 106.15 62.91 0.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -93.84 179.59 5.3 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.24 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -18.91 7.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.236 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.462 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 19.1 p-80 -160.16 168.94 24.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.435 -1.306 . . . . 0.0 112.245 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.5 p -134.6 153.64 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.924 172.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.2 ptp -138.34 153.69 48.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.314 -1.354 . . . . 0.0 112.763 -176.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.97 140.17 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.142 173.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.9 tppt? -137.98 137.82 38.29 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.821 -174.177 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 8.2 m 85.86 50.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.784 171.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -95.2 -177.55 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.833 -179.289 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.2 134.21 39.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.687 0.756 . . . . 0.0 111.079 -172.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -72.34 154.65 40.82 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 47.5 47.37 17.36 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.911 -177.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.07 50.11 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.821 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.61 149.96 22.24 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.278 177.047 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.627 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -133.29 144.25 49.59 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.62 -176.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.35 118.25 28.0 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.82 123.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 39.3 m-85 -111.64 125.16 53.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 23' ' ' LEU . 68.1 t -121.32 122.14 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 123.935 0.772 . . . . 0.0 110.314 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.32 155.4 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.4 163.81 22.48 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.5 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -117.59 156.34 28.27 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.461 -1.295 . . . . 0.0 107.961 172.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 6.5 t-20 -141.76 152.12 43.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.665 178.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 34.3 tt0 -29.34 -47.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.501 179.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -111.85 36.09 3.44 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.5 -161.27 27.37 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.786 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -110.3 158.76 18.06 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.031 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.49 114.47 24.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.569 -175.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -39.98 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.368 1.668 . . . . 0.0 112.794 -176.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -80.53 140.06 36.04 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.769 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.46 147.27 29.53 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 172.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -116.93 131.48 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.667 -173.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.9 t80 -118.22 131.53 56.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.25 140.16 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.897 -176.533 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.75 178.79 9.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.016 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.5 52.06 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.279 177.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.4 p -81.0 165.9 21.3 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.711 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 m -79.9 -175.78 5.11 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.096 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.49 149.28 23.38 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.106 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 116.488 -1.72 . . . . 0.0 110.63 -178.685 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 1.6 Cg_endo -62.32 170.96 5.86 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.471 2.114 . . . . 0.0 112.924 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.6 p -87.42 150.36 23.84 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.909 171.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.45 160.12 1.42 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.173 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.5 162.47 27.66 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.206 1.27 . . . . 0.0 110.193 176.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 132.54 48.47 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.65 113.45 27.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.577 -174.005 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -92.7 141.19 28.74 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.597 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.42 121.37 7.08 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.129 -174.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -117.55 114.57 23.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.097 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.443 ' CE ' HD11 ' A' ' 19' ' ' ILE . 50.9 tpp -101.87 130.14 48.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.148 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.01 146.36 21.19 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.481 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.23 14.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.916 -177.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.8 -25.56 40.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.572 175.312 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.54 -48.34 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.924 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -131.92 51.38 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.167 0.508 . . . . 0.0 109.967 176.183 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -121.69 112.21 18.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 173.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -116.27 128.54 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.656 -171.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -114.98 126.07 54.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.05 0.844 . . . . 0.0 108.859 171.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.1 t -105.6 111.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -89.0 127.83 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.5 -175.439 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.31 103.54 15.49 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.352 -174.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.7 mm -96.52 134.78 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -104.48 154.53 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.257 -176.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -66.56 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.627 -175.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -131.41 117.79 19.35 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 5.0 m-20 -130.06 -35.25 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.98 177.344 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.51 52.76 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.94 23.25 28.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -175.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 24.7 m 43.51 61.38 10.25 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -88.9 39.58 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.464 1.443 . . . . 0.0 109.058 173.005 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.1 151.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.927 0.87 . . . . 0.0 111.258 -174.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.8 mtt180 -128.75 115.52 18.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.825 -179.841 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 31.9 -174.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 71.7 m-85 -132.57 153.34 51.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.077 174.254 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.0 mt -112.86 113.27 25.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 60' ' ' VAL . 43.1 t -115.89 128.98 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.043 -174.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.82 138.03 45.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.839 1.337 . . . . 0.0 108.122 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.63 157.15 44.33 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.805 -1.558 . . . . 0.0 112.007 176.137 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -134.73 163.93 28.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.448 -177.081 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.33 166.18 15.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.727 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.04 43.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.966 172.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -147.69 -56.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.742 176.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 p -132.05 157.99 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.198 175.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 16.0 pt-20 -105.09 165.34 11.16 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.711 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.8 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.614 178.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -69.52 163.44 58.96 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.45 172.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.0 Cg_exo -49.59 105.72 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.726 1.618 . . . . 0.0 110.622 176.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.36 160.67 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -175.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.27 148.84 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.181 174.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -115.07 135.56 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -88.1 164.19 34.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.159 -177.033 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.26 161.19 41.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.694 1.596 . . . . 0.0 109.08 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -84.38 99.65 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.188 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.38 48.75 0.51 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -177.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -97.05 178.3 5.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.551 -177.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.21 -42.02 3.09 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.058 -179.761 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -150.72 168.32 24.72 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.106 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.6 p -120.73 148.19 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.719 172.141 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 ptp -133.09 149.95 52.1 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.604 -1.238 . . . . 0.0 112.79 -174.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -139.15 134.84 33.36 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.402 173.573 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -133.96 138.56 45.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.42 -176.025 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 5.9 t 88.81 49.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.836 172.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -96.32 -179.88 4.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.852 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -71.62 133.45 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.587 0.708 . . . . 0.0 111.127 -174.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -73.76 155.72 38.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 45.18 47.1 10.02 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.859 -177.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.27 156.04 45.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.014 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.29 148.94 22.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 12.2 m-85 -134.02 144.38 48.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.525 -178.43 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 9.3 mp0 -120.52 123.33 42.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.421 176.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.05 124.76 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 40.3 m-85 -113.43 125.66 54.48 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -120.63 124.36 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.536 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -110.99 157.05 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.54 158.84 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.459 177.223 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.8 tt0 -113.22 163.91 14.2 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.627 -1.229 . . . . 0.0 107.786 174.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.8 t-20 -148.93 152.37 36.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.987 177.217 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -36.81 -44.08 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.516 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -109.99 40.21 1.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.59 -153.78 22.23 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.271 172.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -122.29 161.81 22.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.733 179.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.7 t -120.94 117.64 27.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -40.95 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 125.592 1.808 . . . . 0.0 113.378 -174.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.18 136.51 33.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.194 -176.26 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.03 145.45 30.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.493 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -114.83 131.02 56.96 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.718 -173.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -118.58 130.48 55.91 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.019 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.55 141.01 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.386 -177.169 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.47 177.28 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.068 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 147.01 50.73 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.927 176.537 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.92 163.45 20.01 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.586 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -80.77 -168.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.213 -179.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.57 143.16 33.43 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.044 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.235 -1.84 . . . . 0.0 110.463 -179.361 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 9.3 Cg_endo -67.41 174.39 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.573 2.182 . . . . 0.0 113.054 -178.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -94.36 -178.01 4.45 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.706 172.043 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.65 149.34 64.06 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.988 177.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.83 174.68 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.377 1.385 . . . . 0.0 109.954 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -105.78 141.0 37.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.75 115.16 29.35 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.29 -177.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.04 138.41 39.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.592 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -126.64 143.65 14.5 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.277 -1.916 . . . . 0.0 113.815 -171.509 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -128.14 138.53 52.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.084 171.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.473 ' CE ' HD11 ' A' ' 19' ' ' ILE . 21.5 mtp -108.31 128.2 54.54 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.9 178.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -80.88 151.46 32.04 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.81 -175.023 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.87 11.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.037 -0.581 . . . . 0.0 112.311 -178.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.8 -24.62 41.29 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.727 176.155 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.29 -41.65 2.16 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.86 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.6 p30 -138.87 50.44 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.116 177.275 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.3 m -122.31 114.65 21.07 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.5 mm -116.2 128.86 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.684 -170.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 123.04 47.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.12 0.887 . . . . 0.0 109.214 175.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 44.4 t -112.79 120.28 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -176.753 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -97.42 134.2 40.99 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.772 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD22 HG11 ' A' ' 75' ' ' VAL . 16.9 mt -101.4 105.9 16.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.048 0.843 . . . . 0.0 109.039 -175.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.18 107.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.165 -176.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -76.92 156.84 31.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -154.57 -83.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.389 -173.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.42 98.65 8.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.66 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -131.62 -34.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.498 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.79 56.72 0.43 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.86 19.07 41.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.578 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.8 m 42.1 61.56 8.45 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.744 -176.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -86.92 45.51 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.727 1.618 . . . . 0.0 108.701 173.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.436 HD13 HD22 ' A' ' 79' ' ' ASN . 23.4 mm -82.15 150.8 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.203 -173.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' HIS . 63.4 mtp85 -128.26 112.41 14.46 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.799 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.4 p-80 38.66 -173.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 175.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.53 153.88 51.57 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.28 177.173 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.2 mt -110.89 110.51 21.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 175.366 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG11 HG21 ' A' ' 60' ' ' VAL . 47.3 t -114.55 124.92 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.281 -173.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -135.56 139.97 44.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.647 1.217 . . . . 0.0 108.151 177.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.38 154.87 42.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.299 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 16.0 ptt180 -132.23 164.87 25.41 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.381 -178.058 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.53 169.77 13.33 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.272 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -74.16 42.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.783 173.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -145.49 -56.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.731 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -137.05 164.25 28.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.521 175.728 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -100.98 169.13 9.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.398 -174.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 6.5 m95 17.81 95.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.788 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.5 mmtt -69.0 165.48 37.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.99 172.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 13.1 Cg_exo -50.71 97.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.538 1.492 . . . . 0.0 109.849 175.063 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.0 172.23 1.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.566 -173.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.3 tt -138.24 154.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.956 -179.07 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -115.5 135.57 53.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.94 174.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -85.41 165.1 37.73 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.002 -177.383 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 9.9 Cg_endo -73.31 146.41 40.17 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.725 1.616 . . . . 0.0 109.783 172.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 37.3 p -58.17 113.85 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.931 0.769 . . . . 0.0 111.285 -178.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.41 56.29 1.05 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -97.04 177.04 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 -45.48 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.813 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -144.27 170.22 16.4 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.128 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.5 p -129.03 151.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.348 175.334 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ptp -138.09 150.91 47.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.67 -1.212 . . . . 0.0 112.193 -177.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.52 140.51 41.15 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.983 174.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.8 ttpt -140.47 136.42 32.96 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.811 -173.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.3 t 90.31 48.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.763 172.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -95.4 179.49 5.14 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.321 -178.228 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.03 134.69 48.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.661 0.743 . . . . 0.0 111.441 -173.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -74.47 154.21 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.86 48.06 12.1 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.618 -177.163 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.29 151.86 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.2 148.77 21.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 8.6 m-85 -133.62 141.25 47.56 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.398 -178.16 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.47 117.83 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.753 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.07 122.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 41.8 m-85 -112.21 125.88 54.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.409 HG11 HD22 ' A' ' 23' ' ' LEU . 95.4 t -120.33 122.71 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.888 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.7 t -109.15 158.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.99 159.67 33.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.049 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -112.74 164.66 13.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.448 -1.301 . . . . 0.0 107.582 174.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -149.6 153.2 36.72 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.872 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -40.74 -40.89 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.318 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -79.75 -52.5 7.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.01 -119.37 0.57 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.114 -177.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -125.34 163.93 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.427 -179.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.66 119.35 30.47 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -40.59 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 125.357 1.661 . . . . 0.0 113.447 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.62 139.24 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.387 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.87 144.78 34.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.39 131.59 56.9 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.633 -173.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 85.6 t80 -117.72 128.16 54.62 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.083 -179.175 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -124.89 137.89 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.58 -176.788 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.1 p90 -157.8 178.3 10.4 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.276 178.471 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.13 145.98 51.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.78 175.502 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -80.0 172.6 13.55 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.283 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -86.28 -174.96 5.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.166 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.91 147.51 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.312 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.471 -1.728 . . . . 0.0 110.551 -179.09 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 14.9 Cg_endo -71.2 178.02 5.92 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -84.93 152.71 23.32 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.479 170.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 162.7 0.92 Allowed Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.335 174.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.71 167.38 20.69 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.219 1.28 . . . . 0.0 110.522 176.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -104.24 127.42 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -98.31 112.32 24.35 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.983 -177.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.62 93.99 4.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -104.46 152.24 17.51 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.946 -172.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.64 157.82 43.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.953 -1.124 . . . . 0.0 109.232 178.643 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.3 ttm -111.12 139.45 46.47 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.359 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.15 154.85 25.76 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.121 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.45 11.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.267 -176.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' GLY . 20.4 m-20 -79.89 -22.87 42.29 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.152 175.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.58 -37.09 3.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.939 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 10.1 p-10 -140.12 46.22 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.112 177.017 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.4 m -120.77 115.23 22.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.529 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 8.0 mm -116.08 130.85 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.132 -170.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.77 122.48 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.8 t -108.88 116.44 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -93.44 134.34 35.78 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.17 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 32.7 mt -101.41 103.74 14.68 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.286 -176.138 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mm -95.2 136.71 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.13 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -104.36 152.6 22.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.45 -69.88 0.54 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.916 -175.636 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 25.7 m-20 -127.45 110.78 13.11 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.3 m-20 -131.48 -33.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.399 178.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.12 52.09 0.5 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.22 24.81 25.77 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 39.26 64.34 4.0 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.853 -0.674 . . . . 0.0 112.489 -176.162 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.9 44.61 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.665 1.577 . . . . 0.0 108.705 173.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.479 HD13 HD22 ' A' ' 79' ' ' ASN . 21.2 mm -90.69 148.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.163 -174.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' HIS . 74.6 mtm-85 -131.8 125.6 32.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.829 175.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.7 p-80 36.34 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 176.233 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 94.7 m-85 -138.57 150.56 46.45 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.518 178.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -105.27 110.32 22.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -112.47 126.31 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 118.959 -1.097 . . . . 0.0 110.607 -174.264 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -132.41 135.31 46.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 125.035 1.46 . . . . 0.0 107.804 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.47 151.69 41.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.659 -1.616 . . . . 0.0 112.128 176.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.3 ptm180 -124.15 160.53 27.64 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.433 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -109.17 -168.84 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -96.85 39.78 1.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.541 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.54 -60.97 0.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.03 150.26 39.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.505 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.9 pt-20 -106.79 144.02 34.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.746 -177.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.517 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.4 m95 48.45 82.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.107 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -68.71 161.26 72.48 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.926 174.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.6 Cg_exo -43.63 104.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.96 1.773 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -52.21 161.63 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.902 -175.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.3 147.7 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.412 174.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -114.04 129.69 56.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.4 mt -78.35 164.68 54.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.663 -178.259 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 6.0 Cg_exo -63.03 149.84 90.4 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.646 1.564 . . . . 0.0 110.009 174.192 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.416 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 20.5 m -64.23 87.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.68 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 113.7 56.61 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.7 t -97.02 -175.07 3.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.162 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.86 -24.01 3.01 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.974 -178.537 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p-80 -160.26 167.52 27.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.988 -177.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.8 p -130.4 152.32 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.579 174.504 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ptp -137.86 148.91 45.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.235 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -138.58 135.75 35.31 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.719 174.556 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.9 mtmt -141.63 143.07 33.45 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.871 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.5 m 90.82 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.999 175.036 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -92.6 -177.81 4.69 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.813 -178.556 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.29 133.94 41.19 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.635 0.731 . . . . 0.0 111.229 -172.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.59 155.8 39.66 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.125 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.6 t30 44.63 47.02 8.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.084 -177.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.41 154.58 46.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.824 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.9 mt-10 -97.42 148.31 23.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.684 177.455 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 21.4 m-85 -133.76 142.1 47.78 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.502 -177.511 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -122.86 118.42 27.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.184 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.68 123.42 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 50.3 m-85 -112.2 126.04 54.79 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.08 122.42 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.925 0.766 . . . . 0.0 110.705 -178.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.23 159.71 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.017 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.61 159.93 35.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.016 177.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.6 tt0 -113.14 151.99 30.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.361 -1.336 . . . . 0.0 108.283 175.553 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -142.55 150.77 40.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.62 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -37.81 -39.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.711 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.63 -49.86 11.53 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.085 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 -125.2 0.75 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.513 -179.491 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -119.78 157.87 27.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.088 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -116.68 118.05 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -41.53 162.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 125.538 1.774 . . . . 0.0 112.873 -175.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.78 135.36 34.57 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.235 -175.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.99 148.05 25.83 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.533 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -117.4 130.64 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.783 -172.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.3 t80 -119.17 130.37 55.48 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.939 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.533 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.7 t -128.48 142.85 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.311 -175.307 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 49.6 p90 -162.52 179.08 8.03 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.334 177.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -129.28 147.91 51.16 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.49 175.023 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.6 p -79.87 170.95 15.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.344 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -83.23 -173.02 4.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.967 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 138.9 39.83 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.02 -178.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 116.447 -1.739 . . . . 0.0 110.654 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.3 Cg_exo -60.09 173.26 1.92 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.549 2.166 . . . . 0.0 113.177 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -98.62 162.61 13.04 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 144.27 94.98 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.168 -177.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.54 174.01 8.02 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.392 1.395 . . . . 0.0 110.495 -178.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -109.09 132.08 54.45 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.37 114.68 29.0 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.876 -1.129 . . . . 0.0 110.035 -176.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -95.09 141.27 28.92 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.715 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -105.73 127.44 8.97 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.634 -171.541 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -121.82 113.28 19.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.433 ' CE ' HD11 ' A' ' 19' ' ' ILE . 25.0 mtp -103.63 127.2 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.348 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.79 147.16 21.0 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.722 -1.228 . . . . 0.0 112.25 -174.185 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.27 13.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.918 -0.641 . . . . 0.0 112.141 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.23 41.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.449 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.67 -46.18 1.21 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.55 176.372 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -134.54 35.37 3.18 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.315 177.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -104.59 113.88 27.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 12.1 mm -118.43 126.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.492 -171.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -113.66 127.38 56.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.006 0.816 . . . . 0.0 108.822 172.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.1 t -108.53 116.31 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -97.65 129.64 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.54 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.2 mt -99.37 109.64 22.22 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.756 -172.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.9 mm -100.6 135.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.94 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -101.58 150.42 23.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.828 0.705 . . . . 0.0 109.265 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -135.34 -49.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.744 -175.922 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 27.5 m-20 -140.01 104.27 4.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.69 -177.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -132.57 -33.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.256 178.695 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.64 51.66 0.49 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.64 23.94 29.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.598 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.6 t 42.76 62.13 8.64 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.734 -0.733 . . . . 0.0 112.816 -176.026 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.83 41.68 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.582 1.521 . . . . 0.0 108.813 171.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.65 150.83 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.488 -173.004 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 53.4 mtt-85 -130.69 117.52 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.47 -1.695 . . . . 0.0 108.598 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.3 p-80 36.76 -175.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 176.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.7 m-85 -137.21 153.96 50.29 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.012 176.446 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -108.65 110.21 21.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' VAL . 44.7 t -114.17 123.81 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.137 -173.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -134.49 137.85 44.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.661 1.225 . . . . 0.0 108.113 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.21 158.71 43.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.968 -1.493 . . . . 0.0 112.505 179.475 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.0 ptm180 -138.28 170.72 15.52 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.983 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.09 -168.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.155 -175.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.24 41.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.484 174.351 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.23 -57.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.701 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -122.95 157.61 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.926 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.1 pt-20 -97.68 178.22 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.462 -177.431 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.5 m95 3.38 100.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.42 167.87 32.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.307 172.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -48.61 98.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.711 1.607 . . . . 0.0 110.365 176.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.37 174.32 4.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.353 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.12 155.51 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.389 -177.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -113.68 134.08 54.95 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.974 173.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -82.28 163.55 52.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.933 -177.64 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.7 Cg_exo -59.59 167.29 6.76 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.84 1.693 . . . . 0.0 110.51 174.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -74.76 79.82 2.07 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.657 -176.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 63.02 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -97.05 -175.81 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.808 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.03 -16.53 3.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.274 -179.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.9 p-80 -160.07 164.52 33.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.496 -176.073 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 38' ' ' VAL . 14.7 p -134.9 152.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.614 173.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -137.42 152.86 50.06 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.708 -176.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -138.88 140.57 38.45 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.52 173.043 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.32 156.2 47.01 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.617 -174.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.1 t 62.68 59.13 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.378 175.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -100.68 -175.14 2.81 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.653 176.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.84 140.33 36.85 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.677 0.751 . . . . 0.0 111.462 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.409 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 80.4 m95 -76.73 154.15 34.37 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.602 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.49 48.34 8.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 -177.064 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.34 152.79 47.75 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.676 179.503 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.58 147.66 24.57 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.601 176.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -132.2 143.39 49.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.36 -176.421 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -120.82 118.26 29.52 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.785 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -112.91 120.63 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 47.6 m-85 -110.08 125.4 52.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.83 120.69 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.429 -178.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.98 158.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.98 156.48 43.71 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.612 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.24 159.24 18.1 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.742 174.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 20.0 t-20 -143.64 151.87 40.66 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.512 178.228 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -40.03 -39.1 0.81 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.006 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -107.99 35.43 3.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.01 -151.44 20.45 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.942 173.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -121.79 160.08 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.933 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -122.54 122.85 39.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.338 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -41.88 165.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.664 1.852 . . . . 0.0 113.468 -174.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.57 137.23 33.01 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.34 146.01 28.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.09 128.16 55.45 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.687 -174.039 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 82.7 t80 -112.73 124.97 53.78 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.88 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -124.29 137.46 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.324 -176.475 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 46.3 p90 -161.34 179.09 8.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.821 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -128.53 153.36 47.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.364 173.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.1 p -79.92 177.72 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.074 177.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -90.45 -174.01 3.98 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.333 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.46 149.18 23.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.083 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.538 -1.696 . . . . 0.0 110.621 -178.571 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.4 Cg_exo -60.62 169.48 5.46 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.407 2.072 . . . . 0.0 113.08 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -98.0 163.39 12.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.347 172.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.44 142.28 91.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.269 -176.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -70.65 163.24 39.7 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.551 1.501 . . . . 0.0 110.087 -178.55 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -91.98 137.05 32.68 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.7 mt -105.77 109.81 21.9 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.56 -179.011 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 27.6 tt0 -94.34 137.92 32.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.34 -178.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.85 125.85 8.48 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.593 -1.289 . . . . 0.0 112.384 -171.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -120.84 117.74 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.448 ' CE ' HD11 ' A' ' 19' ' ' ILE . 51.2 tpp -99.92 127.43 46.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.78 150.34 24.12 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.191 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 4.8 mp0 -66.69 14.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.798 -176.781 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.75 41.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.461 174.559 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.21 -43.5 1.7 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.337 177.72 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -130.81 6.89 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.205 178.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -75.06 112.27 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.819 176.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 9.4 mm -114.36 125.04 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.862 -173.356 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.63 125.85 54.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.415 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.0 t -108.38 113.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -178.624 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 56.4 t30 -93.46 129.26 39.7 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.353 -177.44 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -97.37 106.14 18.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.393 -173.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.94 105.55 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.803 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -76.23 148.04 37.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -146.01 -55.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.26 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.68 101.58 5.54 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.682 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.1 m-20 -129.07 -37.41 1.69 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.109 178.252 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.02 54.69 0.38 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.54 20.24 38.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -175.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.595 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.1 m 42.47 61.87 8.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.524 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -86.68 43.0 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.695 1.597 . . . . 0.0 108.493 172.058 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -80.79 151.09 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.536 -172.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.1 mtt180 -127.85 111.7 13.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.696 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.8 p-80 37.46 -176.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 175.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 80.9 m-85 -134.34 151.35 51.18 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.847 175.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.9 mt -107.68 110.68 22.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.003 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -115.7 125.98 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.413 -174.352 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -137.53 142.2 41.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.637 1.21 . . . . 0.0 107.924 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.19 157.78 43.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.802 -1.559 . . . . 0.0 112.187 179.239 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.5 ptm180 -132.32 163.19 29.22 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.305 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.98 175.65 5.95 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.62 42.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.125 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.97 -59.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.244 178.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -125.41 154.89 41.24 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.156 176.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -106.47 158.16 17.11 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.992 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.533 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 33.03 86.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.204 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.8 mmtt -72.52 164.16 62.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.387 175.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.46 98.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.83 1.687 . . . . 0.0 110.537 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.64 173.6 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.506 -174.032 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.02 155.0 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.09 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -115.96 133.45 56.01 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.884 173.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.6 mt -82.63 162.94 54.03 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.294 -176.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.7 Cg_exo -60.33 168.85 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.932 1.755 . . . . 0.0 111.016 173.123 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 p -80.9 81.44 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.956 -177.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 58.47 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 m -97.13 178.94 5.09 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.898 -178.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.75 -37.68 2.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.545 -178.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -148.93 168.43 23.07 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.018 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -126.89 150.49 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.48 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ptp -134.39 148.12 50.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.52 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.5 pp -141.85 141.74 33.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.008 173.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -141.51 174.06 10.91 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.901 -1.119 . . . . 0.0 111.309 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 m 59.02 56.79 3.81 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.424 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD11 ' CD1' ' A' ' 62' ' ' LEU . 17.2 mt -94.33 -178.1 4.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.18 131.95 38.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.229 175.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.3 m95 -72.71 152.61 41.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.556 -1.258 . . . . 0.0 110.251 -178.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.77 46.79 18.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.853 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.88 154.28 45.68 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.889 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.28 149.9 20.83 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.216 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.3 m-85 -135.5 141.9 45.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.269 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.14 118.28 30.96 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.422 177.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.64 124.2 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.59 125.71 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.233 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.5 t -121.49 122.51 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.023 0.827 . . . . 0.0 110.482 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.16 158.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.09 156.77 43.35 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.408 -1.317 . . . . 0.0 109.797 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.4 tt0 -112.05 162.52 15.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -147.26 150.86 35.67 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.099 177.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -39.05 -43.04 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.307 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -111.52 40.37 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.599 -175.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.12 -152.12 22.58 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.82 174.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -132.67 167.88 19.29 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.701 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.2 t -127.34 121.01 29.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.3 -178.345 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -43.41 166.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 125.5 1.75 . . . . 0.0 112.987 -175.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.82 135.87 34.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.37 -175.57 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.9 144.32 29.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.592 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.96 129.25 56.62 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.336 -174.265 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -116.8 125.05 51.02 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.785 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -124.28 137.73 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.501 -176.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.1 p90 -156.85 177.93 10.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.07 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -126.31 147.72 49.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.475 174.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.88 167.97 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 m -78.16 -177.25 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.362 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.22 146.65 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.891 179.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 116.466 -1.731 . . . . 0.0 110.531 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.79 -176.35 17.11 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.489 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.49 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.7 Cg_exo -56.53 173.7 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.509 2.14 . . . . 0.0 113.095 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m -95.15 159.51 14.98 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.536 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.91 144.4 98.99 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.129 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.9 Cg_endo -66.02 163.63 30.52 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.417 1.411 . . . . 0.0 110.822 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 128.1 48.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -102.91 115.72 31.15 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.45 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.42 141.68 30.2 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -106.92 125.66 8.15 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.448 -1.358 . . . . 0.0 112.51 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -121.27 119.68 32.95 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.0 ttm -105.89 132.2 52.28 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.727 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.31 147.49 22.41 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.458 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.07 13.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.907 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.88 -22.76 42.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.828 175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -40.65 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.102 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.409 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 8.4 p30 -137.65 49.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.278 0.561 . . . . 0.0 109.876 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -121.12 112.95 19.33 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.9 127.92 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.751 -170.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -114.18 127.25 55.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -107.83 113.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.81 131.88 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.544 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 30.3 mt -101.33 107.07 18.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.787 -172.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.56 132.59 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.095 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -99.1 155.29 17.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.845 0.715 . . . . 0.0 109.729 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.493 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.99 -48.2 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.02 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -143.89 109.11 5.04 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.134 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.0 m-20 -130.77 -37.59 1.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.035 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.82 54.71 0.39 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.42 33.16 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 11.4 m 43.62 61.3 10.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -88.75 40.0 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.418 1.412 . . . . 0.0 108.943 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.24 150.21 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.897 0.856 . . . . 0.0 111.336 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.1 mtt180 -130.95 116.67 18.17 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.793 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 35.66 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.566 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 82.7 m-85 -139.16 151.3 46.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.792 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.8 mt -106.89 109.83 21.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 54.9 t -113.92 122.9 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.035 -174.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.74 135.43 46.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.614 1.196 . . . . 0.0 107.927 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -141.51 161.6 37.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.876 -1.53 . . . . 0.0 112.063 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 7.8 ptm180 -144.35 170.1 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.763 -1.562 . . . . 0.0 110.166 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -122.63 179.65 4.54 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.714 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 tp -82.43 42.68 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.102 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.56 -56.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.344 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.3 m -124.31 151.95 43.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.409 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -98.07 175.03 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.606 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.8 m95 10.5 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.581 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 27.7 mmmt -80.53 163.0 58.77 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.049 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.4 Cg_exo -44.89 102.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.907 1.738 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.45 175.09 4.26 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.577 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.52 153.12 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.014 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 39.1 ttm105 -114.39 127.51 55.88 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.019 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -73.26 164.77 58.56 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.263 -177.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.77 169.99 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.749 1.633 . . . . 0.0 110.272 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.5 t -76.9 77.55 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.554 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.09 64.67 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 t -96.99 -174.47 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.14 -25.33 4.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 12.3 p-80 -160.22 167.68 27.06 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.778 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -129.56 153.66 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.125 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ptp -139.81 154.54 47.38 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.37 -1.332 . . . . 0.0 113.157 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -140.38 139.77 35.4 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.563 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -135.78 136.55 40.8 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.616 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 86.97 51.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.0 170.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.1 mm? -97.96 -177.85 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.923 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 134.73 42.58 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.685 0.755 . . . . 0.0 111.328 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -73.21 155.32 39.69 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.207 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.14 49.12 7.64 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.869 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 153.8 49.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.732 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -95.14 150.26 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.888 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.4 m-85 -134.23 143.4 47.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.451 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.7 123.06 43.98 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.891 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.51 121.82 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 35.2 m-85 -110.39 125.43 53.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -120.76 122.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.87 0.732 . . . . 0.0 110.835 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -107.11 157.99 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.51 155.53 43.6 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.43 -1.308 . . . . 0.0 109.534 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.7 tt0 -111.35 158.84 18.58 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.838 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.7 t-20 -144.58 151.34 38.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.716 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -35.7 -44.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.585 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.14 38.14 2.5 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.74 -155.06 23.49 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.317 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -121.76 159.32 26.91 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.794 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.5 t -121.86 125.59 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.294 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -41.38 165.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.718 1.886 . . . . 0.0 113.737 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.09 136.08 33.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.19 147.01 27.56 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.56 129.66 56.6 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.702 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 80.3 t80 -115.09 128.58 56.31 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.986 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -125.85 138.66 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.421 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 39.6 p90 -158.09 178.19 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.028 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -129.7 147.07 51.45 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.912 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -79.85 171.7 14.76 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.67 -171.07 3.36 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.051 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.65 141.24 36.4 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.068 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 116.245 -1.836 . . . . 0.0 110.431 -179.226 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.017 0.437 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.27 176.5 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.557 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -55.22 170.09 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.699 2.266 . . . . 0.0 113.748 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -94.27 174.17 7.27 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.191 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.36 142.2 58.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.744 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -69.55 169.53 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.588 1.525 . . . . 0.0 110.289 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -99.23 137.61 37.5 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 mt -108.38 109.32 20.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.834 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.07 145.38 24.57 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.94 127.96 7.91 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.68 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.39 126.81 48.77 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.484 ' CE ' HD11 ' A' ' 19' ' ' ILE . 47.5 tpp -104.46 129.7 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.913 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -82.82 150.17 27.65 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.31 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.73 12.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.061 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.3 m-20 -79.86 -23.31 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.967 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.27 -41.99 2.03 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.883 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -136.53 48.31 2.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.131 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 m -121.22 116.03 24.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -116.19 128.59 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.469 -170.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.5 124.42 52.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.071 0.857 . . . . 0.0 108.961 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -109.12 120.62 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -94.19 130.7 40.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.283 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.33 98.54 9.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mm -89.42 107.88 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.242 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -68.69 170.03 10.13 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 4.5 pt20 -170.31 -67.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.652 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.4 m-20 -117.94 86.52 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.218 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.4 m-20 -129.31 -17.41 3.79 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.57 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.82 23.43 49.75 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.1 m 43.84 64.9 6.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.763 -0.718 . . . . 0.0 112.797 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -86.93 46.44 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 N-CA-C 107.26 -1.862 . . . . 0.0 107.26 170.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.02 152.11 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.008 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -127.63 113.91 16.68 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.221 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.8 p-80 36.86 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.9 m-85 -137.25 152.09 49.43 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.461 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.8 109.26 21.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 60' ' ' VAL . 49.7 t -113.12 121.15 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.797 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.82 137.54 48.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 124.69 1.244 . . . . 0.0 107.874 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 155.16 44.87 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.906 -1.518 . . . . 0.0 112.173 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.2 ptm180 -131.23 164.66 25.07 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.018 -1.447 . . . . 0.0 110.098 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.61 170.48 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.02 43.09 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.506 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.73 -58.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.074 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.3 m -127.21 154.81 44.36 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.194 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -101.41 163.6 12.19 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.144 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.469 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 24.81 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.258 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 39.9 mmtm -71.49 165.93 44.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.116 174.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -49.17 96.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.723 1.615 . . . . 0.0 110.046 175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.01 174.34 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.534 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.91 154.4 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.368 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -113.99 130.12 56.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.789 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mt -78.18 164.02 58.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.798 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.8 Cg_exo -60.33 168.08 6.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.666 1.577 . . . . 0.0 110.318 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.2 t -75.92 78.1 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.724 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 63.66 0.36 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.1 t -97.09 -172.12 2.37 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.689 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -131.96 -15.82 2.95 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.214 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.2 p-80 -159.71 165.39 32.65 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.556 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.3 p -135.0 152.18 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.66 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptp -137.78 150.58 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.418 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -139.6 138.21 35.99 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.954 174.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 53.1 mtmt -142.41 141.7 32.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.849 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.2 t 93.32 44.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.291 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -178.65 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.028 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.72 135.17 43.62 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 0.0 111.241 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -74.19 156.49 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.291 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 45.24 47.07 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.729 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.48 154.95 47.24 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.002 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -97.24 149.04 22.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.8 m-85 -133.8 144.47 49.02 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.614 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.72 121.0 37.29 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.619 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.73 123.38 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.16 127.12 55.84 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.48 120.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 123.914 0.759 . . . . 0.0 110.731 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.08 158.88 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.58 45.26 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.219 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.97 157.48 21.44 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.317 -1.353 . . . . 0.0 107.9 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.5 t-20 -144.37 153.29 41.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.527 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -37.21 -41.95 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.496 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -107.64 36.38 2.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.79 -153.51 21.11 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.041 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -120.08 158.92 25.85 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 t -124.04 128.02 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.97 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -42.09 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 125.751 1.907 . . . . 0.0 113.303 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -90.17 140.89 29.24 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.443 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.8 145.08 29.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.466 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -115.25 129.87 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.418 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 78.1 t80 -117.73 130.1 56.11 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.095 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.61 139.7 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.541 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.7 p90 -157.38 177.43 11.45 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.154 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.52 146.57 51.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.951 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.31 164.98 19.7 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.539 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -81.61 -169.84 2.52 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.1 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.94 141.7 36.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.154 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.708 -179.524 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -113.91 172.35 14.31 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.539 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 28.2 Cg_endo -71.33 179.99 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.849 2.366 . . . . 0.0 112.737 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -103.95 160.32 14.91 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.177 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.69 148.99 98.56 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.812 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -71.85 171.85 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.307 1.338 . . . . 0.0 110.335 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.16 146.57 26.68 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.9 mt -115.09 114.04 24.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.195 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -95.42 144.81 25.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.79 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -111.33 127.09 8.03 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.48 -1.343 . . . . 0.0 112.554 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -122.73 124.58 43.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 47.9 ttm -105.25 133.13 50.52 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.595 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.94 153.88 25.09 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.543 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.07 10.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.082 -0.559 . . . . 0.0 112.234 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -80.0 -23.17 41.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.878 176.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.57 -37.03 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.36 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -132.53 2.46 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.123 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -75.67 116.5 16.45 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.974 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.0 127.67 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.182 -172.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.85 125.45 54.08 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.2 t -108.91 119.78 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -97.28 128.72 44.38 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.102 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 47.3 mt -96.72 110.34 22.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 123.855 0.722 . . . . 0.0 109.695 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -97.42 108.18 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.686 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -72.4 168.43 18.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.753 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.458 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.6 pt20 -166.27 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.555 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 18.7 t70 -111.8 89.87 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.075 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 18.1 m-20 -131.97 -17.81 2.73 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.255 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.18 54.03 1.31 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.42 31.65 58.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 t 36.8 79.07 0.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 114.637 -0.782 . . . . 0.0 112.949 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 79' ' ' ASN . 6.0 Cg_endo -87.55 35.46 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 N-CA-C 107.169 -1.896 . . . . 0.0 107.169 165.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.99 144.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 122.091 0.948 . . . . 0.0 111.863 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 27.6 mtt180 -128.19 128.65 45.15 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.109 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 11.9 p-80 34.44 -173.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -139.93 153.5 46.97 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.555 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -106.29 112.16 25.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 60' ' ' VAL . 45.9 t -114.11 128.22 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.928 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -134.43 140.25 46.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 125.039 1.462 . . . . 0.0 108.011 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.62 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.99 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.477 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 24.5 ptt85 -126.41 158.8 35.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.354 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.78 169.43 10.43 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.551 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.95 43.6 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.868 173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.49 -57.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.826 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.3 m -130.95 152.28 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.003 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 38.2 mt-10 -105.89 142.02 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.655 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.2 m95 58.81 84.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.837 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mptp? -70.67 161.89 74.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.123 173.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.66 105.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.88 1.72 . . . . 0.0 111.073 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.81 161.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.842 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.5 tt -134.12 149.91 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.459 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -114.29 132.41 56.17 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 60' ' ' VAL . 1.5 mt -82.79 165.25 42.75 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.129 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.5 Cg_exo -63.1 156.13 56.92 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.784 1.656 . . . . 0.0 110.324 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -73.66 83.26 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.183 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.62 47.61 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.63 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -97.13 167.44 11.05 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.04 -2.62 9.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.643 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.459 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.05 163.5 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.191 -1.403 . . . . 0.0 112.86 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -135.43 152.29 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.867 173.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptp -137.67 150.63 47.51 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.641 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -141.74 140.78 33.19 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.24 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.41 162.1 35.84 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.011 -1.075 . . . . 0.0 111.728 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 m 65.96 54.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.705 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -100.18 -175.43 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.046 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.51 136.64 37.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.084 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -75.16 155.72 36.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 43.28 48.61 5.77 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.567 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.47 152.83 47.79 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.128 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -91.63 146.14 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 17.1 m-85 -134.45 138.72 44.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.245 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.61 118.3 28.88 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.457 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -112.29 126.85 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 51.5 m-85 -115.69 125.76 53.24 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.44 121.88 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 123.96 0.787 . . . . 0.0 110.708 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -106.81 156.26 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.38 155.74 41.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.955 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -110.08 149.13 30.47 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.126 -1.43 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.56 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -129.34 141.68 51.02 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.806 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -42.59 -33.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.229 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -126.61 50.44 1.93 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -160.36 27.06 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.097 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -125.97 159.18 33.35 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.827 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -113.18 111.32 21.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -39.59 159.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 125.442 1.714 . . . . 0.0 112.527 -176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.0 128.75 35.07 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.951 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.58 145.06 25.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.7 t-160 -116.12 130.94 57.04 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.781 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.6 t80 -120.07 128.86 53.88 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.314 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -126.23 135.67 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.627 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 19' ' ' ILE . 38.7 p90 -157.49 177.65 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.169 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -128.25 147.9 50.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.425 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.8 p -79.87 170.59 16.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.178 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -84.48 -171.29 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.222 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 140.88 36.92 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.092 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.386 -179.074 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.72 169.87 15.22 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.569 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.492 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.0 Cg_exo -58.05 172.23 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.561 2.174 . . . . 0.0 113.34 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -98.66 163.35 12.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.567 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.75 143.7 98.21 Favored Pre-proline 0 N--CA 1.491 1.594 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.372 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -71.63 172.51 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.66 1.573 . . . . 0.0 110.582 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -99.06 142.21 30.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -112.29 111.37 22.2 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.037 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -92.05 144.03 25.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.0 131.45 10.46 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.22 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -128.07 125.83 40.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.1 ttm -107.65 131.52 54.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.89 151.97 28.09 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.429 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.18 10.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.157 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -79.97 -22.46 42.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.123 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.74 -37.16 3.84 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.051 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.1 p-10 -138.56 46.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -121.48 113.25 19.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 mm -116.35 129.16 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.688 -169.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -114.21 127.38 55.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.8 t -110.69 118.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -95.75 130.63 42.6 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.62 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 55.6 mt -99.6 109.43 21.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 123.678 0.611 . . . . 0.0 109.978 -174.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -94.69 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.74 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -79.01 140.41 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -136.87 -70.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.329 -171.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -115.88 101.29 8.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.004 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.02 -34.54 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.31 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.94 52.1 0.35 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.19 18.78 35.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.604 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 68.6 m 40.75 61.85 6.73 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.9 Cg_endo -87.08 51.36 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.709 1.606 . . . . 0.0 108.694 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.6 mm -88.2 149.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 122.046 0.927 . . . . 0.0 111.446 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.9 mtp85 -132.05 123.61 27.58 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.943 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.59 ' H ' ' N ' ' A' ' 56' ' ' GLY . 6.0 p-80 33.65 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.6 m-85 -142.02 156.46 45.43 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.862 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.57 109.91 21.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 60' ' ' VAL . 46.8 t -114.11 123.67 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.068 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.23 137.87 46.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.804 1.315 . . . . 0.0 108.057 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.39 157.53 44.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 117.966 -1.494 . . . . 0.0 112.294 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.3 ptm180 -134.23 166.54 22.55 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.941 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.02 -170.72 2.01 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.91 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.0 tp -91.83 40.17 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.089 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.44 -58.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.597 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.55 37.1 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.417 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.6 pt-20 -101.3 162.57 12.8 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.282 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.467 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 25.24 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.838 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 70.6 mmtt -75.83 162.99 69.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -44.28 100.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.747 1.632 . . . . 0.0 110.869 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.66 175.65 4.07 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.42 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.34 155.64 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.384 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -113.96 135.36 54.08 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.861 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.1 mt -85.18 167.06 27.9 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.415 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.4 Cg_exo -65.12 154.65 72.47 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.729 1.619 . . . . 0.0 109.91 172.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.453 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 9.0 t -65.62 85.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.588 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 113.4 61.9 0.42 Allowed Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.327 -0.939 . . . . 0.0 110.94 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 t -97.08 164.78 12.37 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.582 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.3 -18.69 14.76 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.87 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.0 p-80 -160.03 172.86 16.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.898 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.2 p -134.8 155.0 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.232 171.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -139.06 151.46 46.77 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.863 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -139.37 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.574 173.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -134.85 137.56 43.38 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.764 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 90.07 48.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.843 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -96.72 -177.47 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.986 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 133.5 40.88 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.752 0.787 . . . . 0.0 111.46 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.66 156.13 39.72 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.254 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.3 t30 46.37 46.04 13.63 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.199 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.8 154.65 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.077 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 45.0 mt-10 -97.61 147.58 24.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.528 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 18.2 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.476 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -120.24 119.78 34.19 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.956 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.69 121.41 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 32.9 m-85 -110.92 124.27 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.9 t -121.08 122.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.856 0.722 . . . . 0.0 110.725 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.27 155.41 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -125.52 157.28 37.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.408 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 29.9 tt0 -111.79 156.33 22.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.712 -1.195 . . . . 0.0 107.801 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.5 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.9 t-20 -137.04 150.03 47.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -37.69 -35.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.145 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -125.73 48.35 2.08 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.732 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.25 -162.18 27.22 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.323 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -119.08 159.15 24.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.85 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.6 t -121.02 119.35 32.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -40.75 164.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.639 1.837 . . . . 0.0 113.231 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.92 140.09 31.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.519 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.6 146.63 28.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.64 129.85 56.39 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.021 -1.071 . . . . 0.0 111.469 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -117.97 130.63 56.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.163 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -127.64 141.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.75 -176.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 40.0 p90 -160.09 178.11 10.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.971 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -127.86 147.74 50.45 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.775 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -80.04 170.31 16.64 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.133 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -80.43 -179.63 7.25 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.892 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.67 144.1 28.32 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.382 -179.263 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.9 172.32 15.86 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.603 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.1 Cg_exo -61.22 172.43 3.23 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.566 2.177 . . . . 0.0 112.936 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -97.56 152.49 18.98 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.548 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.74 144.73 72.91 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.49 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.19 164.27 30.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.251 1.301 . . . . 0.0 110.212 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -102.35 129.29 48.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.3 mt -102.79 110.86 22.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.073 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -89.73 139.6 30.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.16 118.37 6.16 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.488 -1.339 . . . . 0.0 112.033 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.73 105.63 13.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.438 ' CE ' HD11 ' A' ' 19' ' ' ILE . 23.6 mtp -103.8 127.66 51.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.016 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -79.91 118.03 4.63 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.845 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.45 13.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.786 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.7 m-20 -79.85 -24.25 41.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.984 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 156.58 -69.96 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.493 -1.813 . . . . 0.0 112.891 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -143.46 18.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.736 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -75.81 115.12 15.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.981 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.501 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 15.6 mm -117.03 123.84 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.716 -173.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.4 124.48 52.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.903 0.752 . . . . 0.0 109.345 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.8 t -104.37 109.41 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -88.87 128.59 35.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.563 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.12 102.37 14.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.434 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.73 132.55 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -107.01 148.25 28.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.283 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -130.61 -63.76 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.055 -173.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 5.1 m-20 -132.86 116.52 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.162 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.1 m-20 -133.42 -35.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.04 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.4 53.65 0.42 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 20.81 37.09 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.612 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.1 t 44.08 61.15 11.18 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.83 -176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -87.86 44.24 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.518 1.478 . . . . 0.0 109.013 172.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.78 148.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.398 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.5 mtt180 -130.82 126.04 35.26 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.185 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.3 p-80 31.95 169.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 54.1 m-85 -123.5 138.88 54.48 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.32 172.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.4 mt -100.27 100.6 11.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 51' ' ' ILE . 48.2 t -109.1 121.97 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.4 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -133.33 140.54 47.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.727 1.267 . . . . 0.0 107.749 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.49 155.42 43.09 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 8.8 ptt180 -131.48 163.08 28.76 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.404 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.14 169.52 11.15 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.458 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -74.13 43.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.733 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.98 -57.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.186 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -128.44 156.42 43.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -104.78 160.59 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.774 -1.171 . . . . 0.0 112.21 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.5 m95 28.36 89.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.101 -1.409 . . . . 0.0 113.749 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 61.5 mttm -76.24 163.4 66.62 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.323 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.31 105.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.832 1.688 . . . . 0.0 110.551 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -78.17 174.49 11.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.849 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.92 136.25 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.099 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.656 ' N ' HD13 ' A' ' 51' ' ' ILE . 18.5 ttp85 -105.52 110.62 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.895 169.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 51' ' ' ILE . 2.8 mt -69.09 162.14 67.54 Favored Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.606 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -79.18 147.53 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.12 1.88 . . . . 0.0 109.173 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 m -61.47 127.33 30.97 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.671 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.91 43.17 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -97.03 167.04 11.31 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.939 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.58 -47.22 3.0 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.654 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -148.17 167.62 24.59 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.962 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.1 p -119.36 145.06 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.479 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -131.31 148.69 52.71 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.831 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.2 pp -140.7 136.72 32.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.425 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -142.7 158.61 43.48 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.846 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t 75.9 45.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -92.9 -175.02 3.77 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.45 141.46 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.128 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.578 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.8 m95 -77.89 153.42 32.64 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.376 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.2 47.22 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.342 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.78 153.07 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.26 149.07 22.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 20.7 m-85 -133.45 141.7 47.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.393 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -119.76 118.1 29.97 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.576 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.98 123.67 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 56.6 m-85 -111.96 126.34 55.03 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.67 119.38 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 124.021 0.826 . . . . 0.0 110.462 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -110.22 157.42 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.35 158.1 40.74 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.37 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.8 tt0 -112.54 160.62 17.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.53 -1.268 . . . . 0.0 107.924 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -144.76 151.46 38.88 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.08 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -37.28 -44.03 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.315 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.99 41.79 1.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.42 -154.15 22.32 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.325 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -123.35 162.02 23.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.868 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 5.7 t -119.67 115.42 23.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -40.34 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 125.646 1.841 . . . . 0.0 113.458 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.37 131.65 35.04 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.944 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.24 143.0 30.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.74 129.08 56.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.45 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -114.89 123.88 50.28 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.669 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -122.71 134.05 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.11 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 43.3 p90 -156.41 178.68 10.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.501 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.94 51.71 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.137 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 p -84.98 165.26 17.73 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -80.18 -172.78 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.158 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.33 140.51 39.15 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.01 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 116.586 -1.673 . . . . 0.0 110.707 -178.699 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.024 0.44 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.41 173.87 15.22 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.452 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -59.86 172.41 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.541 2.161 . . . . 0.0 112.984 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 m -93.8 159.58 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.603 172.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.79 146.72 90.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.5 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.5 169.0 18.16 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.428 1.419 . . . . 0.0 110.642 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -104.38 130.94 52.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -105.8 113.46 27.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.396 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -95.55 139.41 31.85 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.562 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.44 123.34 7.83 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.442 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.55 119.75 33.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.77 131.04 51.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.477 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.61 153.16 24.73 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.718 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 8.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-20 -79.84 -22.34 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.969 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.39 -36.38 4.43 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.318 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -131.35 -1.36 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.984 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -68.05 113.39 5.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.321 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.541 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.8 mm -115.75 127.17 73.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.1 -175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -115.74 124.63 51.28 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 63.3 t -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 114.446 -1.252 . . . . 0.0 107.941 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -88.27 128.47 35.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.091 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.51 106.43 18.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.908 0.755 . . . . 0.0 109.704 -171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.07 131.04 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.637 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -102.0 145.86 28.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.946 0.779 . . . . 0.0 109.586 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.4 -90.26 0.38 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.934 -175.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 24.1 m-20 -104.46 111.36 23.99 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.799 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -134.35 -33.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.196 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.81 51.94 0.33 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.11 19.62 38.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.603 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 43.46 60.78 10.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 114.781 -0.71 . . . . 0.0 112.802 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -87.8 43.65 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.594 1.529 . . . . 0.0 108.815 172.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mm -76.58 152.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.272 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.3 mtt180 -127.74 114.43 17.27 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.2 p-80 31.83 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 77.8 m-85 -135.43 152.14 51.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.551 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.5 mt -111.17 112.02 23.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 60' ' ' VAL . 49.1 t -114.95 129.59 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.054 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HD3' ' CG ' ' A' ' 47' ' ' TRP . 40.2 ttmt -134.58 134.6 41.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.895 1.372 . . . . 0.0 108.086 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.76 159.83 41.81 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.791 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 12.6 ptt180 -142.99 172.32 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -126.65 169.55 13.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.989 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.9 44.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.734 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.16 -54.33 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.94 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 p -133.6 156.63 47.49 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.53 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -86.63 -163.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.982 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.443 ' CG ' ' HD3' ' A' ' 39' ' ' LYS . 9.7 m95 -23.22 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -77.9 167.01 39.42 Favored Pre-proline 0 N--CA 1.489 1.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.687 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -50.62 108.57 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.843 1.695 . . . . 0.0 110.528 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -53.25 161.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.755 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.79 149.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.078 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -114.32 131.38 56.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.233 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -79.64 167.88 30.67 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.817 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.43 154.85 55.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.79 1.66 . . . . 0.0 108.867 169.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -80.18 113.31 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.973 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 46.51 3.7 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.3 p -96.8 -178.01 4.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.892 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.35 -56.77 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.315 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -146.04 164.87 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.669 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 7.1 p -109.88 144.01 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.66 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.13 147.22 50.96 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.019 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.9 OUTLIER -138.76 138.28 37.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.001 173.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -137.17 163.18 31.49 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.494 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m 63.59 53.41 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.664 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -96.21 -176.25 3.61 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.849 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.94 132.47 39.07 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.639 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -72.98 154.52 40.49 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.013 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 46.32 47.92 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.657 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.78 153.45 48.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.935 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.74 145.93 25.87 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.227 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.2 m-85 -132.14 145.14 51.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 123.918 0.761 . . . . 0.0 112.526 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.37 122.83 40.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.433 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.1 125.49 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.0 m-85 -112.85 127.23 56.12 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.63 124.19 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -109.27 157.21 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.59 155.83 44.31 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.467 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.0 tt0 -110.6 164.62 12.55 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.782 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 32' ' ' PRO . 16.3 t-20 -146.27 149.68 34.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.021 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -38.22 -42.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.447 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -115.54 43.01 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.533 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.67 -158.49 27.68 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.986 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 157.92 40.78 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 28.4 t -123.32 119.25 29.55 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.586 -175.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -43.39 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.602 1.814 . . . . 0.0 113.23 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.66 140.45 29.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.804 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.57 29.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -114.68 131.61 56.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.545 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -118.56 129.62 55.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.897 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.75 139.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.496 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.541 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.4 p90 -158.84 175.9 13.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.167 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.44 147.19 49.83 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.654 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -79.91 169.64 17.61 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.238 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -80.51 -176.37 5.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.154 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.22 147.74 25.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.107 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.69 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.51 155.03 6.36 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.548 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.8 Cg_exo -68.3 170.79 13.96 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.4 m -82.69 -157.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.824 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.35 35.86 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 9.7 Cg_endo -67.52 160.75 46.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.188 1.258 . . . . 0.0 110.661 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.77 126.05 47.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -100.72 113.63 26.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.317 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -98.42 144.22 28.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.427 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.47 132.31 10.38 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.14 -171.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -125.13 128.67 48.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.06 133.84 51.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.678 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.55 150.6 21.31 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.785 -1.198 . . . . 0.0 111.789 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.79 10.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.973 -0.613 . . . . 0.0 112.429 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.2 m-20 -79.8 -21.83 43.83 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.996 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.0 -43.02 1.76 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.194 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.09 40.02 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.981 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -112.34 116.71 30.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.557 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.7 mm -120.47 127.87 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 120.091 -0.643 . . . . 0.0 110.648 -170.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -112.8 125.4 54.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.152 0.907 . . . . 0.0 108.599 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.8 t -109.09 117.88 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.3 129.34 45.0 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.379 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -98.58 102.56 14.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.274 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 7' ' ' LYS . 29.1 mm -90.74 129.99 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.013 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -97.86 156.6 16.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.787 0.68 . . . . 0.0 109.723 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -144.61 -50.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.356 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.9 m-20 -141.51 109.15 5.64 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.211 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.6 m-20 -131.06 -31.72 1.67 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.66 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.38 50.99 0.59 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.83 27.29 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.616 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 8.4 m 45.77 59.1 15.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.2 Cg_endo -89.01 42.41 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.438 1.425 . . . . 0.0 109.547 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.54 HD13 HD22 ' A' ' 79' ' ' ASN . 22.7 mm -82.42 151.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.916 0.865 . . . . 0.0 111.255 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -130.25 115.06 16.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.677 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.5 p-80 37.38 -172.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.2 m-85 -139.94 154.05 47.1 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.187 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.92 109.9 20.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' VAL . 47.7 t -113.73 121.26 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.88 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -132.42 140.24 48.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.607 1.192 . . . . 0.0 108.132 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.409 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -145.36 156.22 43.65 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.808 -1.557 . . . . 0.0 112.389 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.603 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 5.0 ptm180 -129.17 160.34 33.2 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.598 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -114.14 -172.88 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.146 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 11.5 tp -91.31 41.69 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.448 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.48 -58.86 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -120.02 151.29 39.21 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.387 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -106.68 153.77 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.825 -176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.603 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 38.83 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.652 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 65.2 mttm -77.28 162.75 68.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.255 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.2 Cg_exo -43.39 99.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.946 1.764 . . . . 0.0 110.814 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.67 175.71 6.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.268 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.96 153.91 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.301 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -113.49 135.85 53.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.929 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -84.71 162.68 49.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.824 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -69.16 145.7 61.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.716 1.611 . . . . 0.0 109.755 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.428 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.4 m -59.8 102.6 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 123.934 0.771 . . . . 0.0 111.479 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 52.68 0.56 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -97.13 -179.49 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.563 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.98 -34.59 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.515 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -148.51 167.7 24.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.204 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.1 p -133.4 153.97 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.746 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -138.76 151.68 47.3 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.568 -1.253 . . . . 0.0 112.515 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.25 142.7 42.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.74 173.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -142.94 153.14 42.76 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.081 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t 72.25 42.98 0.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.589 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.2 mm? -87.62 -172.31 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.666 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.29 143.33 28.77 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.637 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -76.46 154.69 34.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.744 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 43.59 49.41 6.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.768 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.92 49.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.575 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 29.2 tt0 -97.51 147.91 23.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.407 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 30.8 m-85 -133.0 142.72 48.99 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.515 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 4.6 mp0 -119.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.78 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.91 122.7 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.0 m-85 -111.1 124.2 51.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.34 120.8 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.863 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.4 t -105.76 158.05 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.17 164.9 22.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.658 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.2 tt0 -118.71 162.48 18.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.222 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.548 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.5 t-20 -151.16 154.47 36.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.356 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -41.99 -34.02 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.61 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -79.41 -45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.891 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.76 -118.71 0.51 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -118.46 163.2 17.11 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.613 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.92 116.03 22.93 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.869 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -39.05 158.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.297 1.623 . . . . 0.0 112.784 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.04 139.71 32.33 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.544 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.37 146.29 30.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -116.47 130.87 56.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.785 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 74.6 t80 -118.01 130.22 56.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.21 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.58 140.52 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.971 -176.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.557 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 36.6 p90 -161.57 179.04 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -130.63 148.48 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.836 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -79.91 172.3 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.522 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -85.54 -171.22 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.099 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.96 142.77 35.1 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.081 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 116.199 -1.858 . . . . 0.0 110.443 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.33 13.57 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.434 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.1 Cg_endo -63.77 166.65 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.36 2.04 . . . . 0.0 112.586 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.15 165.79 15.47 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.468 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.79 142.85 88.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.11 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.42 167.22 23.0 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.412 1.408 . . . . 0.0 110.54 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -101.7 131.83 47.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.02 113.74 27.52 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.844 -1.142 . . . . 0.0 110.277 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.36 142.29 32.04 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.257 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -118.51 136.46 12.21 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 118.877 -1.63 . . . . 0.0 113.82 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -128.43 137.91 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.647 -0.777 . . . . 0.0 109.464 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.5 ttm -109.33 134.42 51.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.502 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.62 146.15 22.26 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.855 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.87 8.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.89 -30.11 40.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.783 175.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.54 -39.43 2.06 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.407 -1.378 . . . . 0.0 113.174 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -130.27 -14.75 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.697 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -54.17 113.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.214 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.3 mm -116.78 130.71 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.076 -174.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -116.98 124.77 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.859 0.724 . . . . 0.0 109.084 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -110.23 120.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -97.09 133.22 42.04 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.343 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 41.0 mt -101.55 101.45 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -93.78 131.01 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -101.74 157.66 16.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.738 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -51.44 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.649 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -145.4 103.93 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.428 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.6 m-20 -117.25 -40.21 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.738 0.649 . . . . 0.0 109.714 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.57 52.95 0.21 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.29 20.56 29.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 19.5 m 42.16 60.84 9.12 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.9 Cg_endo -90.44 42.85 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.553 1.502 . . . . 0.0 109.112 172.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 79' ' ' ASN . 23.2 mm -81.44 151.42 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.989 0.899 . . . . 0.0 111.367 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.4 mtt180 -130.52 114.37 15.41 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.835 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.7 p-80 35.77 -170.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.4 m-85 -139.99 150.64 44.71 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.006 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.07 110.86 23.26 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.52 127.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.812 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -132.49 140.7 48.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.012 1.445 . . . . 0.0 107.834 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.17 157.01 43.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.56 -1.656 . . . . 0.0 112.591 177.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.8 ptm180 -134.41 165.3 25.48 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.354 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -127.53 177.74 6.56 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.303 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.56 40.96 0.53 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.838 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -142.34 -62.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.904 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -129.7 171.23 12.87 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.267 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -116.46 160.87 19.96 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.211 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.9 m95 28.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.347 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 52.0 mttp -72.63 160.08 83.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.351 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.7 Cg_exo -41.77 107.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.1 1.866 . . . . 0.0 111.579 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.16 160.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.623 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -131.35 147.95 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.156 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -113.71 125.03 53.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -69.88 164.23 53.4 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.271 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.63 172.21 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.804 1.669 . . . . 0.0 110.635 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -74.5 76.92 1.95 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.974 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.47 64.78 0.59 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.526 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -89.63 -176.99 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.851 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -126.63 -14.11 5.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.503 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 42.2 p-80 -159.18 170.34 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.753 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p -136.87 150.81 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 124.864 1.353 . . . . 0.0 108.582 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -133.72 150.0 51.5 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.152 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.584 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.3 pp -143.85 144.88 31.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.539 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -140.27 172.17 13.12 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.789 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.7 m 57.84 59.66 3.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.631 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.6 mt -95.21 177.9 5.71 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.353 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.51 124.15 22.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.252 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 77.1 m95 -70.74 148.49 47.9 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.77 49.77 20.32 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.671 -175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.27 152.27 50.69 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.27 151.78 22.41 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.698 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.7 m-85 -137.04 141.28 42.47 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.6 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.65 121.08 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.721 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.26 123.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.438 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 43.9 m-85 -113.03 125.51 54.48 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.46 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.534 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.2 159.41 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.07 155.38 44.46 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.548 -1.261 . . . . 0.0 109.805 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.8 tt0 -110.81 163.85 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.86 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.483 HD22 HD13 ' A' ' 33' ' ' ILE . 18.6 t-20 -153.69 154.21 33.7 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.577 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -40.45 -43.48 1.82 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.327 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -101.84 37.05 1.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.33 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.23 -134.02 8.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.22 -179.99 6.86 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.585 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -130.05 124.31 32.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -45.79 171.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 125.516 1.76 . . . . 0.0 111.686 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.55 145.96 25.42 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.605 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.72 147.96 27.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.908 -1.497 . . . . 0.0 106.982 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.522 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.8 t-160 -116.14 130.96 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.592 -173.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.4 t80 -118.65 130.56 55.92 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.737 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.522 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.95 140.44 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.854 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 19' ' ' ILE . 48.3 p90 -157.44 -178.76 7.58 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.849 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -128.97 145.07 51.34 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.353 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.93 168.42 19.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.901 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.1 m -81.78 -176.47 6.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.291 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.23 144.16 30.43 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.321 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.219 -1.848 . . . . 0.0 110.505 -178.088 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.032 0.444 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.4 178.54 29.95 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.402 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.6 Cg_exo -57.93 171.85 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.417 2.078 . . . . 0.0 113.011 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -95.43 159.66 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.682 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.32 141.86 98.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.896 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.09 167.52 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.28 1.32 . . . . 0.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -100.64 127.77 46.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.38 109.79 21.54 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.922 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.13 137.81 37.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.49 142.87 16.16 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.489 -1.815 . . . . 0.0 113.791 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -129.4 138.79 51.68 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.093 -1.053 . . . . 0.0 109.361 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.487 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.2 tpp -104.72 131.52 52.07 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.42 150.31 23.43 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.525 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.72 8.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.0 m-20 -79.87 -23.03 42.2 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.125 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.8 -50.87 0.76 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.649 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 9.8 p30 -123.87 1.36 8.7 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.33 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.6 m -69.56 116.75 10.32 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.301 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -115.41 127.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.776 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -115.07 124.78 52.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.023 0.827 . . . . 0.0 109.072 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.5 t -112.45 120.69 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -98.2 130.48 44.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.04 100.88 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.27 130.7 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.868 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -104.16 153.04 21.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.842 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.05 -49.89 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.915 -174.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.6 m-20 -139.76 111.63 7.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.008 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -130.02 -37.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.123 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.51 55.05 0.36 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 20.42 35.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.628 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.7 t 44.15 60.61 11.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 114.8 -0.7 . . . . 0.0 112.728 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -89.42 43.39 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.393 1.395 . . . . 0.0 109.214 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mm -88.54 149.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.877 0.846 . . . . 0.0 111.266 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 69.2 mtt85 -131.46 123.55 28.34 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.867 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.9 p-80 36.69 -173.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.7 m-85 -139.74 153.57 47.22 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.784 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.49 109.42 21.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 48.2 t -113.32 125.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.204 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -136.45 141.1 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.56 158.06 43.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.069 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.614 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 9.0 ptm85 -133.96 159.36 40.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.645 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -116.81 -177.8 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.92 41.58 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.792 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.65 -61.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.335 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -118.99 149.68 41.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.528 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 23.9 pt-20 -117.53 144.73 44.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.588 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.614 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 56.87 77.48 0.26 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.027 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 25.9 mmmt -72.57 163.27 69.15 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.541 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -46.57 99.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.823 1.682 . . . . 0.0 110.444 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.32 172.7 2.99 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.529 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.17 153.81 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.951 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -112.84 131.77 55.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.949 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.455 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.8 mt -81.84 163.76 52.06 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.861 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.26 152.43 76.46 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.771 1.647 . . . . 0.0 110.438 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 33.7 m -68.61 93.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.885 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.91 52.71 0.46 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -97.22 170.13 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.394 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.93 -36.66 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.996 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -146.56 169.48 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.579 -1.248 . . . . 0.0 112.124 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -132.76 151.79 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.885 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ptp -135.65 148.31 48.91 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.894 -1.123 . . . . 0.0 112.022 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 65' ' ' LEU . 1.5 pp -141.32 144.2 34.46 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.458 174.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -140.16 170.36 15.98 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.663 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 m 61.19 57.03 2.56 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.042 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 62' ' ' LEU . 10.6 mp -94.95 178.52 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -71.99 133.06 45.1 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.248 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.403 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.4 m95 -72.93 151.47 41.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.837 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.97 49.08 15.05 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.54 152.08 48.7 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.051 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -92.66 148.72 21.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.1 m-85 -136.05 143.33 44.62 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.692 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 3.7 mp0 -119.2 122.66 42.49 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.139 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.96 123.4 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.7 m-85 -112.57 125.98 54.85 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.6 t -122.45 121.8 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 124.047 0.842 . . . . 0.0 110.677 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.33 159.07 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.34 156.68 42.7 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.751 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.41 153.82 25.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.392 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.2 t-20 -141.25 150.83 43.13 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.143 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -36.12 -43.82 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.846 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -108.33 35.9 3.0 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -152.31 21.5 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.072 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -120.97 158.15 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.32 120.43 37.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -40.05 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 125.81 1.944 . . . . 0.0 113.492 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.0 136.41 34.06 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.051 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.94 145.68 28.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.486 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.49 129.43 56.54 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.574 -174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 71.6 t80 -117.5 129.75 56.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.34 140.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.749 -176.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.2 p90 -158.63 -179.34 7.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.071 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -129.55 147.63 51.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.568 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.4 p -79.88 166.83 21.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -82.44 -172.01 3.78 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.66 148.28 24.51 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.325 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 116.474 -1.727 . . . . 0.0 110.652 -178.799 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.54 169.53 14.14 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.9 Cg_exo -61.3 172.84 2.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.6 2.2 . . . . 0.0 112.99 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -97.06 163.45 12.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.479 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.0 99.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.164 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.91 172.14 12.31 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.451 1.434 . . . . 0.0 110.463 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -107.04 133.48 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.1 mt -106.46 115.9 31.01 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.262 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.39 140.49 31.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.45 129.05 9.37 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.656 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -124.53 124.73 42.9 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.9 ttm -106.96 133.76 51.13 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.8 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.25 150.55 22.83 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.596 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.35 14.01 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.074 -0.563 . . . . 0.0 111.936 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.86 -24.31 41.33 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.684 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 -40.53 2.45 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.706 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 9.4 p30 -138.18 48.68 1.96 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.92 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -120.82 115.11 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.552 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.05 129.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -114.01 125.16 53.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.3 t -107.7 115.0 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -96.73 130.41 43.98 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.313 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.84 109.66 22.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.637 -173.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.29 132.5 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -104.4 148.0 26.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.82 0.7 . . . . 0.0 109.408 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.56 -66.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.135 -174.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.7 m-20 -127.77 110.92 13.09 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.27 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.7 m-20 -128.83 -37.09 1.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.986 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 56.87 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 18.65 43.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 45.16 60.15 13.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.791 -0.704 . . . . 0.0 112.87 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -88.89 42.52 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.458 1.438 . . . . 0.0 109.365 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 79' ' ' ASN . 22.6 mm -83.43 151.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.878 0.847 . . . . 0.0 111.446 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 78.4 mtt-85 -131.05 117.31 18.95 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.886 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.57 -173.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 82.2 m-85 -137.85 154.26 49.51 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.052 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.5 mt -110.33 111.49 22.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 60' ' ' VAL . 46.4 t -115.12 123.98 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.146 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -132.35 138.56 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.688 1.242 . . . . 0.0 107.938 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.2 p90 -144.05 158.43 43.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.916 -1.514 . . . . 0.0 112.45 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.4 ptm180 -141.88 169.79 16.94 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.442 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -128.14 168.87 14.8 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.767 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.92 43.53 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.724 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -153.4 -51.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.931 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 p -125.87 148.06 49.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.111 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -103.1 167.23 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.865 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.7 m95 18.33 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.952 -1.476 . . . . 0.0 114.226 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.7 mttp -77.18 163.55 64.17 Favored Pre-proline 0 N--CA 1.49 1.525 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.072 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.7 Cg_exo -44.68 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.803 1.668 . . . . 0.0 110.908 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.02 175.27 3.84 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.394 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.04 154.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.362 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 42.7 ttm180 -114.95 134.06 55.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.812 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.2 mt -82.42 162.99 54.33 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.027 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 3.9 Cg_exo -59.88 169.86 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.773 1.649 . . . . 0.0 110.633 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -74.64 77.82 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.935 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.5 65.82 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 t -97.01 -174.54 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.71 -23.02 4.43 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.618 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.6 p-80 -160.23 168.31 25.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.994 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.5 p -131.87 151.4 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.268 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -137.3 152.07 49.36 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.827 -176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.14 139.1 33.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.43 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 64' ' ' SER . 51.8 mtmt -142.5 141.43 32.11 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.85 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.5 t 93.51 45.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.345 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.7 mm? -96.56 178.51 5.31 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.391 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -68.17 133.44 48.9 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.612 0.72 . . . . 0.0 111.493 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.73 154.25 39.69 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.227 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.42 48.9 8.23 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.565 -177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.63 49.82 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.802 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.37 144.05 26.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 6.0 m-85 -129.74 144.84 51.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.912 0.758 . . . . 0.0 112.463 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -119.79 124.01 45.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.409 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.2 t -116.07 123.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 38.9 m-85 -111.49 124.92 53.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -120.02 122.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 123.876 0.735 . . . . 0.0 110.567 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -106.94 157.8 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 155.63 42.86 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.58 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.67 158.87 18.78 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.233 -1.387 . . . . 0.0 107.73 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.6 t-20 -146.45 153.28 40.26 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.543 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -42.4 -37.68 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.466 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -103.01 29.77 5.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.5 -148.04 19.35 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.849 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -122.23 158.82 28.62 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.967 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.7 t -121.86 124.13 43.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.35 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -40.92 165.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.735 1.897 . . . . 0.0 113.59 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.45 140.97 28.92 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.45 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.53 30.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.19 129.45 56.65 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.408 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 67.5 t80 -116.87 130.23 56.57 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.033 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.63 140.74 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.593 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.31 178.09 10.72 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.777 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -128.12 145.21 51.08 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.894 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.8 p -79.88 171.37 15.2 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.154 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -86.53 -170.47 3.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.134 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.72 141.19 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.242 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.536 -1.697 . . . . 0.0 110.672 -179.366 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.08 0.467 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.42 179.82 15.87 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 12.4 Cg_exo -56.89 173.26 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.601 2.201 . . . . 0.0 113.1 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -95.76 163.04 13.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.239 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.73 142.07 95.53 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.173 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.48 171.21 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.606 1.538 . . . . 0.0 110.686 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -98.03 139.92 33.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.4 mt -111.29 110.21 20.59 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.15 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.04 141.51 28.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.793 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.8 123.32 7.29 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.17 -173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -120.88 123.09 41.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.3 ttm -104.14 131.86 50.99 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.19 146.25 23.75 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.719 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.14 9.53 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.76 -30.25 40.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.858 175.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.29 -41.47 1.68 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.062 177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.91 -15.05 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.676 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.0 m -55.37 116.5 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.552 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.0 mm -117.55 130.35 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.552 -173.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.1 125.68 52.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.939 0.774 . . . . 0.0 108.996 172.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.584 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 60.2 t -107.33 113.47 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 126.69 37.0 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.212 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.7 mt -99.11 107.22 19.54 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.899 -172.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.2 mm -92.44 106.27 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.524 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.73 140.89 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.446 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.2 pt20 -138.17 -78.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.355 -172.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.1 m-20 -106.14 100.82 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.962 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -132.36 -35.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.277 -179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 51.45 0.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.01 17.75 36.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.602 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 41.39 61.09 7.99 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -86.48 51.58 2.6 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.685 1.59 . . . . 0.0 108.73 172.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.5 mm -87.41 150.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.031 0.92 . . . . 0.0 111.622 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.8 mtt180 -129.94 119.38 23.14 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.413 -1.722 . . . . 0.0 108.543 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.53 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.7 p-80 34.73 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.516 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.2 m-85 -139.52 151.18 45.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.009 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mt -107.48 110.78 22.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.2 128.2 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.913 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.73 140.23 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 125.036 1.46 . . . . 0.0 107.979 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.56 156.52 43.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.726 -1.59 . . . . 0.0 112.657 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -131.58 156.99 44.8 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.073 -177.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.629 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -119.33 168.56 10.8 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 tp -73.59 42.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.795 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.93 -57.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.083 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.3 m -128.62 153.06 47.65 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.141 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -104.99 165.49 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.044 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.62 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.448 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.9 mttm -77.03 159.99 77.2 Favored Pre-proline 0 N--CA 1.491 1.618 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.334 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 24.3 Cg_exo -40.45 111.65 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.188 1.926 . . . . 0.0 111.895 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.71 164.87 4.29 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.809 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -136.4 151.18 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.365 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -117.34 132.24 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.241 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -79.07 165.13 51.02 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.508 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.33 159.79 29.72 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.808 1.672 . . . . 0.0 110.682 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 95.34 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.94 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 96.92 65.35 0.92 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -97.14 -172.57 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.469 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -122.16 -43.81 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.741 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 22.6 p-80 -147.13 167.44 24.13 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.061 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.5 p -122.48 149.54 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.375 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -132.87 147.12 52.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.606 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -139.48 137.76 35.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.991 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -139.55 158.16 44.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.463 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t 71.88 49.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.203 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -97.82 -174.22 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.233 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.6 133.51 38.44 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.666 0.746 . . . . 0.0 111.081 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.51 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 72.1 m95 -75.17 156.95 35.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.074 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 45.53 46.3 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.769 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.7 154.66 46.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.11 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -96.69 147.65 23.69 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.629 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.5 m-85 -134.0 140.85 46.98 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.471 -178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 119.48 34.26 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.205 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.6 t -113.77 127.65 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 55.0 m-85 -114.82 126.58 54.98 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.58 121.54 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.627 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -105.84 156.06 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.91 156.01 42.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.523 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -109.96 156.24 20.72 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.821 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 13.2 t-20 -140.53 149.88 43.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.958 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -34.14 -45.34 0.21 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.758 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -113.97 40.15 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.82 -156.85 26.11 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.378 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -120.33 159.6 24.71 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.725 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 24.8 t -120.59 120.64 36.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -41.0 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.633 1.833 . . . . 0.0 113.189 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.95 136.16 34.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.338 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.93 144.42 29.01 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.8 t-160 -114.81 130.08 56.8 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.284 -174.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.192 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.86 137.98 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.571 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.6 p90 -156.04 177.47 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.163 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.27 146.17 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.623 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -83.76 164.59 19.48 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -80.48 -171.13 2.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.273 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.15 139.18 39.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.208 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.461 -1.733 . . . . 0.0 110.801 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.48 175.42 18.74 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.2 Cg_exo -58.04 172.83 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.621 2.214 . . . . 0.0 113.31 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -101.6 162.54 12.82 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.407 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.92 142.27 85.26 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.364 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.82 154.12 67.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.501 1.468 . . . . 0.0 109.962 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -83.39 139.66 32.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 mt -109.03 108.98 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.313 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -93.89 144.71 25.19 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.462 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -112.93 130.58 9.57 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.302 -1.427 . . . . 0.0 112.889 -171.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -125.37 129.87 50.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.0 ttm -107.28 134.49 50.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.55 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -90.52 151.53 21.42 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.679 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.91 9.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.11 -0.545 . . . . 0.0 112.353 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.92 -20.55 45.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.009 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 108.54 -41.98 2.07 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.633 -1.27 . . . . 0.0 111.163 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 12.9 p30 -127.86 2.15 6.01 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.915 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -65.42 111.92 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.248 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.56 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.5 mm -116.34 126.36 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.968 -176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -114.71 124.93 53.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 123.933 0.771 . . . . 0.0 108.949 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.4 t -108.87 118.58 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.7 128.42 42.56 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.6 mt -97.95 102.27 13.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 123.914 0.759 . . . . 0.0 109.079 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.31 103.04 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.715 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -77.6 149.95 34.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.75 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -147.31 -51.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.946 -1.101 . . . . 0.0 112.406 -172.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 106.11 7.06 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.098 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.4 m-20 -129.42 -39.33 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.22 57.16 0.38 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.65 18.42 41.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.627 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.8 t 44.76 60.47 12.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -89.15 43.98 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.476 1.451 . . . . 0.0 109.071 172.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.67 150.95 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.883 0.849 . . . . 0.0 111.543 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.8 mtt85 -129.22 117.56 20.93 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.07 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.9 p-80 32.02 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.506 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 69.4 m-85 -134.62 152.35 51.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.173 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.62 113.36 26.28 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 60' ' ' VAL . 52.9 t -115.79 128.55 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.209 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -135.41 139.68 44.35 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.24 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.35 154.54 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.161 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.6 ptm180 -126.49 160.74 29.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.671 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.64 -169.27 1.47 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.8 tp -96.97 41.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.587 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.22 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 p -121.65 150.02 42.35 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.999 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -113.27 150.04 33.01 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.22 -172.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.5 m95 47.79 83.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.562 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 46.1 mmtm -66.29 161.49 56.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.368 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -47.22 105.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.77 1.647 . . . . 0.0 110.81 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.25 154.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.464 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -129.55 148.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.269 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -114.26 128.59 56.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.753 -0.779 . . . . 0.0 108.899 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.58 163.97 63.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.712 -176.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -78.23 132.39 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.879 1.719 . . . . 0.0 107.74 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -56.58 131.95 50.24 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.44 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.26 34.26 5.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 m -96.98 152.47 18.69 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.961 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.07 -28.08 10.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.033 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -145.49 165.72 27.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.36 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 10.6 p -128.58 150.12 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.269 174.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -134.74 149.85 50.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.741 -1.184 . . . . 0.0 112.509 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.1 pp -141.61 146.48 36.28 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.765 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -139.2 178.57 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.867 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.1 m 54.34 55.24 8.35 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.733 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 62' ' ' LEU . 25.1 mt -91.49 176.55 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.867 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -73.45 128.22 34.89 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.828 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.416 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 81.7 m95 -71.06 149.92 46.06 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.951 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.05 50.33 16.12 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.604 -175.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.43 154.51 47.65 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.792 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.94 147.83 23.27 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.285 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 13.5 m-85 -133.23 143.88 49.43 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.521 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.04 119.24 29.76 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.16 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.39 124.57 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 53.8 m-85 -114.21 125.78 54.31 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.36 123.46 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 123.991 0.807 . . . . 0.0 110.416 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.72 157.18 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.26 156.4 40.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.079 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -110.12 160.25 16.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.823 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.529 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -146.46 151.81 38.0 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.372 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -34.89 -46.15 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.644 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -109.19 38.81 2.2 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.99 -150.55 20.65 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.147 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -123.23 159.58 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.04 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.99 118.06 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -39.32 163.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.849 1.968 . . . . 0.0 113.725 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.44 137.49 32.88 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.15 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.34 29.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.03 130.39 56.93 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.534 -174.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.9 t80 -118.33 130.56 56.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.117 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.61 139.11 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.647 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.5 p90 -159.88 179.36 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.266 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -128.04 147.46 50.51 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.642 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.4 p -79.92 168.39 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.81 -170.45 3.0 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.172 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.25 141.61 36.47 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.16 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 116.143 -1.884 . . . . 0.0 110.398 -178.742 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.992 0.425 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.25 169.07 12.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.0 Cg_exo -59.15 169.85 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.372 2.048 . . . . 0.0 113.639 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -94.89 177.51 5.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.16 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.34 144.97 58.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.139 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -71.68 164.99 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.691 1.594 . . . . 0.0 110.531 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -93.43 132.62 37.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.04 108.83 20.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.795 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.49 135.28 42.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.75 143.59 16.44 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.455 -1.831 . . . . 0.0 113.151 -171.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -131.14 139.56 49.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 108.942 172.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -108.88 132.77 53.72 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.708 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.39 150.74 27.47 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.326 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.19 13.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.931 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.94 -25.28 40.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.664 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.01 -44.63 1.46 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.066 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.568 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 10.8 p30 -134.41 44.8 2.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.321 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -112.9 110.63 20.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.7 mm -114.13 128.48 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.421 -170.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.38 124.82 51.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.3 t -111.84 120.13 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -96.65 130.7 43.82 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.524 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 36' ' ' TYR . 40.2 mt -99.99 103.43 14.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.943 0.777 . . . . 0.0 109.114 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.67 108.4 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.554 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -70.13 169.43 13.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 4.3 pt20 -170.25 -69.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.689 -1.204 . . . . 0.0 111.399 -175.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 16.9 t70 -115.23 89.39 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.019 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -130.85 -17.63 3.14 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.776 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.34 52.35 1.6 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.417 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.27 22.75 50.71 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 44.26 64.37 7.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 114.78 -0.71 . . . . 0.0 112.736 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.7 Cg_endo -88.13 46.22 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 171.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 mm -92.55 151.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.197 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -128.19 115.19 17.99 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.05 -1.886 . . . . 0.0 108.098 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.1 p-80 35.69 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.3 m-85 -142.86 137.95 29.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.013 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -88.19 111.07 21.22 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 60' ' ' VAL . 65.8 t -112.22 126.8 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.306 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -132.55 138.8 47.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 125.08 1.488 . . . . 0.0 107.632 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.17 156.31 43.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.715 -1.594 . . . . 0.0 112.223 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.2 ptm180 -134.88 163.54 29.6 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.892 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -120.71 -168.25 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.773 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.5 tp -93.28 40.54 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.825 170.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.8 -61.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.572 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.59 157.78 30.0 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.231 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -109.69 156.21 20.54 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.594 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.532 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.1 m95 34.42 83.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.108 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.2 mmtt -70.45 161.54 75.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.203 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.8 Cg_exo -43.2 107.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.982 1.788 . . . . 0.0 111.556 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -55.18 161.27 1.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.729 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.281 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttp85 -112.43 118.06 34.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.2 mm? -60.12 165.9 4.43 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.036 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.1 Cg_exo -61.47 141.67 92.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.37 1.38 . . . . 0.0 109.483 172.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -59.15 88.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.568 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.453 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 106.52 58.9 0.6 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -97.12 -173.49 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.449 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.97 -25.48 3.59 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.536 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 15.4 p-80 -160.07 167.51 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.394 -1.323 . . . . 0.0 112.574 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -130.73 150.27 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.671 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -134.92 147.74 49.89 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.777 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -140.46 142.86 35.31 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.226 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 178.68 6.68 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.536 -175.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m 49.06 56.89 7.1 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.687 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 10.2 mt -91.99 164.34 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.527 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 4.4 m-20 -61.36 129.78 42.9 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.832 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -71.8 147.84 46.84 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.16 51.09 13.54 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.623 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -129.52 151.62 49.94 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.264 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 36.3 mt-10 -89.2 146.74 24.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 m-85 -133.97 140.84 47.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.531 -176.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -122.11 123.4 41.46 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.585 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -113.79 122.57 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 39.7 m-85 -112.29 124.06 51.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.49 120.6 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.86 0.725 . . . . 0.0 110.702 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 86' ' ' ALA . 1.9 t -103.78 164.45 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 154.08 49.85 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.679 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.79 156.37 22.98 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.789 -1.165 . . . . 0.0 107.88 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -144.97 152.33 40.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -40.83 -40.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.144 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -105.65 35.83 2.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.91 -151.32 20.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.98 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -128.41 161.59 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.573 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -126.76 128.24 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.881 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -46.14 173.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 125.608 1.817 . . . . 0.0 112.906 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -93.63 145.34 24.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.31 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.81 146.61 28.38 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 171.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 90' ' ' VAL . 11.0 t-160 -115.69 129.8 56.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.457 -174.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 51.7 t80 -119.95 131.95 55.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.6 t -129.69 144.18 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.209 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 47.6 p90 -159.83 -177.97 6.72 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.977 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -129.64 145.66 51.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.471 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 169.22 18.23 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -84.43 -169.94 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.305 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.53 142.02 36.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.008 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 116.542 -1.694 . . . . 0.0 110.685 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.995 0.426 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.85 -87.85 1.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HG3' HD22 ' A' ' 79' ' ' ASN . 3.1 Cg_exo -61.77 169.25 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.824 . . . . 0.0 112.169 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 m -91.09 152.95 20.42 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.66 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 143.53 93.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.165 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.88 167.63 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.329 1.353 . . . . 0.0 110.45 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -103.4 132.69 49.45 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.1 mt -104.6 113.85 27.7 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.158 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -95.66 143.18 27.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 127.38 8.76 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.586 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -123.3 121.12 35.04 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.1 ttm -105.14 132.55 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.658 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.37 149.73 21.45 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.318 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -65.75 14.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.907 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.1 m-20 -80.01 -24.59 40.72 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.549 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.16 -42.73 1.87 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.41 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -131.84 10.02 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.18 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -77.98 112.81 15.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.256 -0.977 . . . . 0.0 108.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.521 HD11 ' CE2' ' A' ' 91' ' ' PHE . 9.5 mm -116.34 126.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.972 -172.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.38 127.11 56.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.4 t -108.01 116.55 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -97.28 129.4 44.58 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.424 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 44.7 mt -99.2 106.39 18.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.758 0.661 . . . . 0.0 109.491 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -96.29 129.82 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -105.55 153.33 21.9 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.506 -177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.68 0.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.191 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.93 116.47 10.74 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.724 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.3 m-20 -126.66 -44.6 1.66 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.872 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.8 65.28 0.26 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.33 64.15 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -174.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.61 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.4 t 44.03 60.63 11.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 114.58 -0.81 . . . . 0.0 113.008 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 31' ' ' SER . 19.6 Cg_endo -91.24 52.28 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.782 1.655 . . . . 0.0 109.337 174.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.67 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.842 0.829 . . . . 0.0 111.423 -174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -131.41 118.91 20.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.034 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.4 p-80 36.1 -172.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.539 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.4 m-85 -140.26 151.07 44.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.754 176.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.96 111.61 23.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 60' ' ' VAL . 61.8 t -114.8 124.45 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.324 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.7 141.33 46.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.789 1.306 . . . . 0.0 107.911 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.34 157.7 43.69 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.731 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -132.01 162.87 29.7 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.032 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -113.2 -169.13 1.43 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.2 tp -94.22 40.76 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.263 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.81 -59.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.504 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -114.02 147.94 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.197 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.5 pt-20 -107.83 157.53 18.09 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.762 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.508 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.7 m95 31.51 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.185 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 69.3 mmtt -72.57 162.04 76.11 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.111 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.4 Cg_exo -45.13 100.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.837 1.691 . . . . 0.0 110.614 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.34 173.06 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.617 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 tt -138.52 155.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.133 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -114.15 127.41 55.89 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.03 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -73.36 166.46 43.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.562 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.62 165.69 11.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.836 1.691 . . . . 0.0 110.635 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -75.43 79.5 2.48 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.071 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.69 57.96 0.34 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -97.04 170.19 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.546 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -120.32 -3.5 9.98 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.606 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.16 164.2 33.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.83 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.2 p -138.76 154.27 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.732 172.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptp -138.2 152.74 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.738 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.4 pp -144.64 146.35 32.22 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.783 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -141.87 173.29 11.65 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.532 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t 58.65 60.77 2.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.455 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 62' ' ' LEU . 14.6 mt -98.76 178.58 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.442 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 5.0 m-20 -71.3 128.52 36.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.147 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 82.3 m95 -71.78 151.31 43.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.459 -1.296 . . . . 0.0 109.999 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.86 50.37 11.21 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.687 -175.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -127.92 151.57 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.024 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -89.73 145.29 25.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.9 m-85 -132.68 141.52 48.64 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.568 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.6 119.39 29.74 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.54 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -112.59 124.81 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.7 m-85 -112.71 125.49 54.37 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.74 121.99 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.406 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.4 158.26 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.5 158.42 37.45 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.634 -1.226 . . . . 0.0 109.235 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 26.6 tt0 -112.86 157.41 21.44 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.289 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.489 HD22 ' HG3' ' A' ' 3' ' ' PRO . 15.3 t-20 -139.42 148.03 42.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.696 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -35.61 -44.06 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.796 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -114.89 41.87 2.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.575 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.51 -155.15 25.95 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.563 -1.303 . . . . 0.0 111.188 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -122.28 167.44 13.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.671 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 2.2 t -123.93 116.97 23.75 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -40.71 162.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.554 1.784 . . . . 0.0 113.284 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.87 136.33 35.36 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.356 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.58 146.28 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.54 130.56 56.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.596 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -116.57 126.81 53.83 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.961 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -124.37 136.68 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.561 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CE2' HD11 ' A' ' 19' ' ' ILE . 40.4 p90 -157.33 -178.93 7.72 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.012 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -129.55 146.48 51.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.486 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -79.92 168.97 18.55 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.734 -0.787 . . . . 0.0 108.885 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.93 -169.97 2.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.656 -0.817 . . . . 0.0 110.184 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.89 140.57 39.5 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 116.551 -1.69 . . . . 0.0 110.808 -178.606 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.977 0.418 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.71 173.06 15.19 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 4.2 Cg_exo -59.86 165.28 10.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.427 2.085 . . . . 0.0 113.269 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -86.29 169.77 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.559 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.41 139.02 63.51 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.746 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -69.58 169.04 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.561 1.507 . . . . 0.0 110.411 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.12 138.44 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.3 107.18 17.98 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.789 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 20.8 tt0 -86.71 140.8 29.42 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.455 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.52 119.56 6.3 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.89 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -120.31 117.54 28.07 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.452 ' CE ' HD11 ' A' ' 19' ' ' ILE . 55.4 tpp -100.44 132.33 45.88 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.156 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.08 149.01 20.52 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.456 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -65.38 13.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.08 -0.56 . . . . 0.0 112.047 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.91 -25.21 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.448 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.08 -48.8 0.91 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.575 -1.298 . . . . 0.0 111.388 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -128.44 0.08 5.63 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.104 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -67.84 117.98 10.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.339 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.524 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.03 128.71 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.307 -172.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -114.26 127.3 55.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 123.981 0.801 . . . . 0.0 108.926 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 53.9 t -107.95 117.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 5.9 t-20 -90.9 124.55 35.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.899 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -98.51 96.89 8.29 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.91 106.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.612 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -77.06 151.43 35.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -148.06 -63.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.296 -172.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.21 93.51 3.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.344 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 2.5 m-20 -122.08 -34.51 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.054 0.846 . . . . 0.0 109.944 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.48 55.16 0.33 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.62 46.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -175.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.581 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 66.2 m 41.95 61.9 7.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.5 Cg_endo -86.7 46.6 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.715 1.61 . . . . 0.0 108.503 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.7 mm -82.58 152.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.468 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 35' ' ' HIS . 49.9 mtt180 -129.6 114.26 15.83 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.544 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.596 ' H ' ' H ' ' A' ' 56' ' ' GLY . 9.1 p-80 35.46 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.0 m-85 -142.2 151.74 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.744 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.78 109.56 21.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 60' ' ' VAL . 57.3 t -115.31 123.32 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.341 -172.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.84 140.37 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.613 1.196 . . . . 0.0 108.028 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.36 154.06 41.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.971 -1.492 . . . . 0.0 112.492 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.2 ptm180 -131.52 165.0 24.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.916 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -121.48 174.64 6.64 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.153 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -79.45 42.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.045 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.52 -59.02 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.288 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.8 m -124.7 152.99 43.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.056 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -101.98 162.68 12.72 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.808 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.496 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 25.16 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.575 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.5 mttp -74.91 163.37 68.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.843 175.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.95 99.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.916 1.744 . . . . 0.0 110.917 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.55 175.97 3.17 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.352 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.74 154.99 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.207 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -116.68 129.79 56.35 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.842 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -75.25 163.49 67.48 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.09 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.79 144.34 48.27 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.775 1.65 . . . . 0.0 109.677 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -51.95 110.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.935 0.772 . . . . 0.0 111.842 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.596 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 94.33 58.99 1.18 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.865 -1.16 . . . . 0.0 110.581 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -97.19 -177.27 3.79 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.135 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -134.4 -33.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.918 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -143.96 163.17 34.22 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.811 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.557 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -131.3 152.05 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.279 173.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.418 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -137.73 156.03 48.44 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.086 -176.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -144.22 140.98 29.61 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.121 174.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -140.61 158.62 43.72 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.276 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t 72.01 51.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.443 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.7 mm? -100.6 -176.8 3.3 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.626 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.47 131.17 40.81 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -73.3 155.77 39.12 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.985 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 48.37 45.68 20.47 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.55 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.01 152.9 49.82 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.357 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -95.22 148.7 22.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.8 m-85 -133.44 143.8 49.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.706 -178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.63 119.64 34.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.521 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.72 124.28 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.8 m-85 -111.75 125.33 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.14 120.53 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.909 0.756 . . . . 0.0 110.595 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.37 155.68 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.01 154.67 40.88 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.335 -1.346 . . . . 0.0 109.513 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.7 tt0 -111.08 161.02 16.33 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.33 -1.348 . . . . 0.0 107.652 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.1 t-20 -148.84 153.36 37.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.125 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -39.5 -39.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.61 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -79.7 -44.89 19.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.59 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.77 -127.1 0.89 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.676 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -124.41 159.07 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.07 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.0 t -124.44 124.39 42.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.37 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -41.49 163.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 125.629 1.831 . . . . 0.0 113.304 -175.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.83 141.05 30.74 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.65 -174.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.89 144.88 30.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 171.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -114.58 129.15 56.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.114 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.59 127.99 54.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.163 -1.381 . . . . 0.0 108.141 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.67 136.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.149 -177.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.9 p90 -153.58 177.22 11.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.98 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.31 144.06 51.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.814 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.2 p -82.8 163.48 21.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -174.14 4.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.142 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 149.81 21.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.205 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.546 -178.931 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.034 0.445 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.1 173.2 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.455 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.6 Cg_exo -58.86 171.37 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 113.299 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 m -98.53 166.59 11.28 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.61 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 141.91 83.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.122 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.84 171.39 15.74 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.596 1.53 . . . . 0.0 110.6 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.82 140.03 32.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -109.61 110.86 22.04 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.202 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.8 142.69 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.44 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.94 136.79 11.51 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 118.912 -1.613 . . . . 0.0 113.468 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.01 136.46 52.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.397 -0.902 . . . . 0.0 109.185 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.2 ttm -108.1 130.96 55.07 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.462 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.59 152.16 27.32 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.14 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.89 12.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.248 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.95 -23.9 41.35 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.57 175.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.24 -39.28 2.96 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.755 -1.212 . . . . 0.0 111.315 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.55 9.49 3.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.468 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 m -78.92 113.47 17.05 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.776 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.9 mm -114.92 126.94 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -172.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -113.94 123.61 50.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.087 0.867 . . . . 0.0 108.885 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.8 t -111.25 122.58 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -98.04 132.27 43.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.634 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 20.6 mt -100.46 101.8 12.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 124.091 0.869 . . . . 0.0 108.805 -175.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.7 mm -87.11 105.43 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.666 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -74.77 149.79 39.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.36 -56.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.19 -172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.2 100.75 5.51 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.557 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.5 m-20 -129.73 -36.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.087 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.81 53.45 0.37 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 21.35 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.592 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.1 t 41.6 62.65 7.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 114.784 -0.708 . . . . 0.0 112.823 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 31' ' ' SER . 7.4 Cg_endo -86.02 43.46 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.603 1.535 . . . . 0.0 108.392 171.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.24 150.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.581 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.8 mtt180 -129.71 116.0 18.15 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.634 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.69 -172.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.556 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.7 m-85 -139.5 148.88 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.671 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.8 mt -104.77 110.08 22.28 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 60' ' ' VAL . 52.8 t -111.98 126.33 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.651 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.85 140.75 47.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 125.056 1.472 . . . . 0.0 107.767 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 151.86 35.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.592 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.8 ptt180 -125.62 162.31 25.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.247 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.615 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -125.45 174.44 8.19 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.391 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.05 43.92 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.993 171.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -150.41 -61.65 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.5 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -129.28 163.0 26.61 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.562 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 21.2 mt-10 -109.73 156.78 19.85 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.945 -1.102 . . . . 0.0 113.197 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 41' ' ' ARG . 3.6 m95 34.72 79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.795 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 73.7 mmtt -62.53 160.74 31.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.193 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.71 101.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.884 1.722 . . . . 0.0 111.06 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -49.13 158.58 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.957 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.3 147.22 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.196 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -114.75 123.91 50.44 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -70.34 165.42 44.59 Favored Pre-proline 0 N--CA 1.488 1.462 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.237 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.98 164.55 9.88 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.823 1.682 . . . . 0.0 110.451 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -73.65 79.88 1.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.67 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.63 60.67 0.43 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -96.98 -174.69 3.04 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.856 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.66 -12.05 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.512 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.7 p-80 -154.16 163.64 39.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.275 -176.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -136.92 151.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.946 173.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.5 ptp -135.22 148.06 49.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.106 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.6 pp -141.52 143.24 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.354 173.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -141.63 173.04 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.716 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 t 59.43 57.21 3.42 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.433 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 15.0 mt -94.35 179.95 5.12 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.62 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.11 135.28 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.037 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.428 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 75.6 m95 -76.17 152.33 36.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.593 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.21 49.29 15.45 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.521 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 153.71 47.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.33 147.75 22.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.213 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.6 m-85 -133.94 137.29 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 123.947 0.779 . . . . 0.0 111.865 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -118.5 115.82 25.38 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.908 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.15 122.97 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 39.2 m-85 -112.53 124.74 53.19 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.38 121.22 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.666 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.12 157.27 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 118.422 -1.311 . . . . 0.0 109.686 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.2 tt0 -111.57 160.28 17.34 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.49 -1.284 . . . . 0.0 107.795 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -145.79 151.47 37.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.852 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -36.77 -43.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.649 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -109.1 37.41 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.79 -152.45 22.16 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.771 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -129.04 163.71 24.81 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.734 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -126.18 125.93 43.26 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.964 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -43.27 167.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.707 1.879 . . . . 0.0 113.378 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.85 141.03 28.84 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.793 -173.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.68 147.13 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -116.71 130.3 56.65 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.544 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 81.3 t80 -117.95 127.64 54.04 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.239 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -123.87 134.39 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.611 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.0 p90 -156.29 176.78 12.24 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.263 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.74 147.39 49.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.511 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -79.9 168.49 19.18 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.92 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.11 -170.91 3.12 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.223 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.78 141.41 36.55 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.017 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.531 -178.643 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.64 177.66 15.87 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -58.76 170.91 2.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.518 2.146 . . . . 0.0 112.797 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 t -93.63 171.04 9.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.64 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.29 141.3 73.63 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.685 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.16 168.16 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 121.47 1.446 . . . . 0.0 110.904 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -101.63 130.81 48.05 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 mt -104.71 111.52 24.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.118 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -95.45 142.79 27.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -113.71 133.17 11.04 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.23 -1.462 . . . . 0.0 112.978 -170.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -127.75 129.3 46.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.6 ttm -107.66 134.08 51.16 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.699 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.33 153.73 24.58 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.779 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.56 10.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.985 -0.607 . . . . 0.0 112.292 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.92 -22.39 42.78 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.866 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.14 -37.47 3.54 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.559 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.5 p30 -137.48 46.82 2.11 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -120.58 114.93 22.46 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -118.56 128.34 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.501 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -113.6 125.34 54.06 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.1 t -109.86 118.5 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -98.73 128.5 45.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.48 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 18.7 mt -100.38 105.18 16.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mm -94.65 128.58 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.876 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -103.54 147.64 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.311 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.42 -54.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.197 -174.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 18.9 m-20 -132.82 107.34 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.627 -175.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.6 m-20 -131.98 -35.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.035 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.91 52.22 0.35 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.19 20.96 34.05 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 67.1 m 41.92 61.34 8.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.5 Cg_endo -87.74 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.631 1.554 . . . . 0.0 108.787 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.81 151.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.449 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.0 mtt180 -130.67 115.1 16.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.69 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.531 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.8 p-80 37.43 -171.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.582 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -141.17 151.49 43.89 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.021 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.6 mt -105.19 108.81 20.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 60' ' ' VAL . 55.3 t -114.42 122.37 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.95 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.64 142.23 46.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 124.536 1.147 . . . . 0.0 108.222 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -146.82 153.3 40.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.994 -1.482 . . . . 0.0 112.575 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.3 ptm180 -129.0 164.53 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.563 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -118.25 -169.17 1.65 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.314 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 9.7 tp -93.32 41.27 1.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.403 172.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.93 -59.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.719 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -121.97 156.54 33.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.544 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -105.48 157.26 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.839 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.528 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 32.83 88.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.495 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -71.84 166.01 44.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.002 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.4 Cg_exo -46.38 96.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.816 1.677 . . . . 0.0 110.578 177.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.73 174.97 4.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.244 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.83 155.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.642 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -115.83 127.94 55.44 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.034 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -74.57 164.71 59.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.091 -177.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -71.21 143.89 45.1 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.747 1.631 . . . . 0.0 109.461 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.46 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.5 m -56.69 105.33 0.2 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.931 0.769 . . . . 0.0 111.906 -176.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 107.22 52.15 0.74 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -97.15 169.24 9.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.844 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.18 -32.25 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.391 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 24.9 p-80 -148.05 167.3 25.3 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.523 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.4 p -134.22 153.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.865 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 ptp -136.54 152.69 50.78 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.513 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -137.59 141.7 41.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.728 172.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 64' ' ' SER . 10.0 ttpp -144.51 135.39 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.891 -173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 91.49 46.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.332 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -93.62 -178.98 4.87 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.829 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.73 135.46 40.34 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.401 -173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.59 156.4 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.297 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.48 48.77 10.87 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.888 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.12 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.086 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.2 mt-10 -94.44 146.18 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.954 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.652 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.8 m-85 -131.04 140.48 50.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.31 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.86 117.29 28.45 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.195 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.05 121.89 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 37.7 m-85 -110.81 123.73 50.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.5 t -120.21 121.07 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.946 0.778 . . . . 0.0 110.349 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.37 158.34 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.63 156.21 42.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.606 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 18.8 tt0 -111.69 160.68 17.04 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.486 HD21 ' HG2' ' A' ' 32' ' ' PRO . 14.2 t-20 -145.37 151.15 37.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.839 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -36.42 -43.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.719 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -110.5 38.03 2.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.17 -153.53 23.44 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.839 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -128.09 163.36 24.78 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.765 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.6 t -126.54 125.19 41.61 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.037 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -43.14 167.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 125.582 1.801 . . . . 0.0 113.513 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.76 141.27 28.64 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.679 -174.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.83 147.0 28.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.04 129.35 56.32 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.609 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.6 t80 -117.25 127.83 54.48 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.239 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -125.43 139.12 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.921 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 42.2 p90 -157.91 178.31 10.37 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.733 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -129.12 146.56 51.04 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.957 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.2 p -79.94 171.58 14.92 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.419 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -84.36 -176.04 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.092 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.85 147.99 24.92 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.08 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.436 -1.745 . . . . 0.0 110.568 -178.529 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.69 179.95 19.01 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.498 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 37.6 Cg_endo -73.01 179.46 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.919 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -98.34 159.42 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.182 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.87 147.95 92.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.617 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.59 169.47 15.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.296 1.331 . . . . 0.0 110.626 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -104.06 134.6 47.05 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.99 110.86 21.92 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.405 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.34 148.22 22.3 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.487 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -115.49 128.91 8.27 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.959 -172.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.77 128.1 50.03 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.514 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.8 tpp -103.62 128.99 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.21 151.14 25.45 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.256 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.87 8.92 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -80.0 -21.13 43.97 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.246 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.9 -35.19 5.19 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.573 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 6.1 p30 -133.12 0.47 3.43 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.17 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -72.97 113.83 10.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.227 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.523 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.3 mm -114.97 126.17 72.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.831 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.69 125.36 54.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.928 0.767 . . . . 0.0 109.227 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.4 t -109.43 122.3 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.73 129.04 41.8 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.324 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 43.2 mt -99.06 98.52 9.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.96 133.43 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.648 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' C ' HE21 ' A' ' 26' ' ' GLN . 40.9 mtmt -92.32 171.38 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.865 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -161.1 -64.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.757 -173.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.99 91.23 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.2 m-20 -128.43 -16.11 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.061 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.65 49.82 2.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.52 47.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.52 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 42.6 t 44.2 68.04 3.45 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.379 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -89.49 43.91 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.764 1.642 . . . . 0.0 107.956 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.27 146.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.853 -171.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 89.8 mtt-85 -126.04 123.78 39.18 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.464 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.4 p-80 37.16 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -138.08 156.07 48.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.026 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.52 110.82 22.02 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 60' ' ' VAL . 49.0 t -114.35 123.56 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.024 -1.07 . . . . 0.0 109.94 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -136.01 139.22 42.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.682 1.239 . . . . 0.0 107.927 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.06 155.2 43.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.933 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.0 ptt85 -130.63 164.34 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.016 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -124.88 169.85 11.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.683 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.68 43.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.9 -56.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.041 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.5 m -130.54 157.18 43.4 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.197 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -101.65 165.25 11.32 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.82 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.8 m95 21.9 91.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.047 -1.433 . . . . 0.0 114.019 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.0 mptm? -74.45 165.23 55.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.109 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.3 Cg_exo -45.13 99.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.856 1.704 . . . . 0.0 110.716 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 175.24 3.5 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.451 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.1 tt -140.18 154.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -115.29 136.42 53.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.0 mt -87.99 164.64 32.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.32 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.3 Cg_exo -62.24 165.68 14.42 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.812 1.674 . . . . 0.0 110.389 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -74.93 80.89 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.13 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.04 58.2 0.26 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.721 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -97.06 167.16 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.375 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.24 -8.94 12.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.651 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.7 p-80 -160.09 165.23 32.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.053 -1.459 . . . . 0.0 112.943 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.6 p -137.72 153.52 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.978 172.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 ptp -136.53 151.02 48.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.341 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.84 146.14 35.49 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.366 173.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -141.52 -177.25 5.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.416 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.4 t 55.19 51.87 12.54 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 17' ' ' ASN . 31.6 mt -85.49 165.68 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.812 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -78.31 8.19 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.412 -171.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 60.52 162.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.167 0.508 . . . . 0.0 111.861 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 36.23 43.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.03 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.77 156.16 48.88 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.061 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -98.23 147.86 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.144 0.903 . . . . 0.0 108.629 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 33.2 m-85 -131.95 142.92 49.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.972 0.795 . . . . 0.0 111.783 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -118.55 118.15 30.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.646 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -110.52 122.75 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 54.2 m-85 -111.45 125.88 54.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.1 t -121.0 122.29 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.626 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.35 155.51 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.15 159.2 35.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.955 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -109.37 149.77 29.02 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.469 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -130.88 143.96 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.267 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -43.39 -37.17 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.81 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -117.07 46.26 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.793 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -153.72 22.62 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.371 174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -125.17 160.59 28.8 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.882 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.8 t -113.13 109.64 19.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -39.25 158.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 125.497 1.748 . . . . 0.0 112.698 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.56 127.88 33.23 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.828 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.76 145.21 26.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.53 129.26 56.65 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.608 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.5 t80 -115.84 127.22 54.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.37 134.55 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.358 -175.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 39.7 p90 -155.74 174.75 14.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.473 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.52 148.46 48.88 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.803 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -79.88 172.58 13.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 m -87.14 -172.94 4.19 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.727 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.23 144.21 27.26 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.283 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.566 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.2 173.83 14.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.522 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.9 Cg_exo -60.3 168.08 6.86 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.551 2.167 . . . . 0.0 113.046 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.82 158.46 18.74 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.828 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.06 146.2 92.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.173 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.32 167.93 19.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.458 1.439 . . . . 0.0 110.749 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 44.9 mtmt -103.59 128.75 50.81 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.6 114.34 28.5 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.494 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -103.18 140.74 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.552 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -123.31 140.8 13.27 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.724 -170.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -131.39 143.3 50.37 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.2 -1.0 . . . . 0.0 109.645 170.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.661 -0.816 . . . . 0.0 108.969 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -81.89 153.8 33.15 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.808 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.27 8.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.374 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' GLY . 17.5 m-20 -79.92 -25.16 40.62 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.533 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.1 -37.03 4.03 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.727 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 13.4 m-20 -123.08 -12.0 7.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.9 m -65.73 112.04 3.51 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.638 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 91' ' ' PHE . 6.8 mm -112.21 126.7 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -114.7 121.35 43.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 124.044 0.84 . . . . 0.0 108.865 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.5 t -109.98 118.02 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -95.44 133.78 39.02 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.341 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 52.0 mt -102.58 101.12 11.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 124.049 0.843 . . . . 0.0 108.885 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 7' ' ' LYS . 23.8 mm -89.51 134.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.025 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -101.52 148.61 25.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.006 0.816 . . . . 0.0 109.333 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.66 -72.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.81 -175.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 29.9 m-20 -130.34 107.29 9.15 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.931 -176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.0 m-20 -126.44 -35.73 2.35 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.655 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.43 54.6 0.26 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 32' ' ' PRO . . . 89.06 28.63 20.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 77.8 p 32.21 63.37 1.26 Allowed Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -87.39 46.31 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.758 1.638 . . . . 0.0 108.755 173.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.08 149.87 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.462 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' HIS . 62.1 mtt85 -130.45 117.59 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.13 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.8 p-80 36.1 -175.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.549 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.1 m-85 -137.55 142.84 41.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.944 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.28 105.7 17.74 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 60' ' ' VAL . 60.7 t -108.81 125.57 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.088 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -131.8 134.02 45.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 125.0 1.438 . . . . 0.0 107.681 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.59 158.63 43.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 117.711 -1.595 . . . . 0.0 112.185 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 22.5 ptt85 -142.71 168.37 19.89 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.458 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -131.43 171.63 13.15 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.38 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -71.06 26.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.153 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -131.22 -59.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -124.82 154.91 40.27 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -108.98 166.74 10.6 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.314 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.473 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 22.67 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.188 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.81 165.67 39.66 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.085 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -48.81 107.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.867 1.711 . . . . 0.0 110.711 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.81 159.59 2.22 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.86 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -130.09 147.82 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.018 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -114.77 113.33 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.334 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.549 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mm? -58.55 167.44 1.78 Allowed Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.604 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.62 171.37 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.736 1.624 . . . . 0.0 110.502 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.3 m -76.29 77.29 3.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.736 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 70.1 0.68 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -93.31 -171.94 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.187 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.89 -20.22 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.006 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 20.4 p-80 -160.0 173.46 15.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.025 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -135.23 150.8 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 124.856 1.347 . . . . 0.0 108.416 173.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptp -134.12 147.59 50.85 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.002 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.9 pp -142.13 147.35 36.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.885 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -141.09 175.44 9.63 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.942 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t 49.36 66.94 0.97 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.226 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 12.3 mt -100.0 -174.69 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.075 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 6.4 m-20 -70.0 126.42 29.63 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.761 172.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -76.38 151.4 36.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.177 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.04 49.06 15.26 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.032 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB1' ' CD2' ' A' ' 43' ' ' LEU . . . -127.45 150.72 49.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.45 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' H ' HD13 ' A' ' 43' ' ' LEU . 31.2 mt-10 -91.8 140.64 29.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -129.9 143.38 50.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.002 0.814 . . . . 0.0 112.431 -173.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.46 125.18 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.804 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.88 125.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 49.1 m-85 -114.49 127.66 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.54 119.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.59 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.34 156.98 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.42 155.4 43.73 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.185 -1.406 . . . . 0.0 109.862 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.2 tt0 -111.25 157.93 19.56 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.869 175.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.522 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.6 t-20 -145.43 152.87 40.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.09 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -33.61 -45.82 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.908 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -109.85 37.68 2.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.56 -153.52 22.09 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.227 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -120.25 158.76 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.835 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -121.79 124.76 44.93 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.29 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -40.85 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 125.75 1.906 . . . . 0.0 113.505 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.83 137.93 32.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.223 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.81 145.94 28.48 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -117.03 131.85 56.84 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.648 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.9 t80 -121.5 134.39 55.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.236 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -131.07 142.8 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.818 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 19' ' ' ILE . 49.0 p90 -158.97 -178.78 7.49 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.282 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -129.32 144.41 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.661 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -79.82 169.38 18.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -85.75 -168.11 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.076 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.13 140.55 37.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.433 -178.729 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.063 0.459 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.48 173.31 14.22 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.2 Cg_endo -62.8 176.79 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.476 2.117 . . . . 0.0 112.767 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -96.81 162.1 13.57 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.906 173.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 145.63 99.02 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.316 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.11 170.27 12.12 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.391 1.394 . . . . 0.0 111.177 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -104.59 132.92 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.09 111.84 23.68 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.254 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.92 145.19 24.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.95 130.3 9.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.332 -1.413 . . . . 0.0 112.868 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -123.09 125.82 45.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 ttm -107.13 128.93 54.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.468 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.04 150.55 24.02 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.811 -1.185 . . . . 0.0 111.472 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.46 13.97 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.833 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 13.5 m-20 -79.96 -23.14 41.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.669 174.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.51 -39.63 2.83 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.397 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.443 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 17.6 p30 -133.6 12.78 4.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.94 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -80.0 109.89 14.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.2 mm -115.14 126.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.272 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -113.28 126.5 55.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 123.943 0.777 . . . . 0.0 109.058 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 55.7 t -108.74 115.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.96 128.58 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.459 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.52 107.62 19.84 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.772 -172.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.1 mm -100.71 135.22 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.458 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -101.71 152.1 21.24 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.652 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.95 -50.41 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.129 -176.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 12.7 m-20 -141.15 106.78 5.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.9 m-20 -132.06 -34.26 1.28 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.234 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.63 53.85 0.37 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.05 21.01 34.3 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.574 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 39.52 64.15 4.28 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 114.927 -0.637 . . . . 0.0 112.64 -176.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.6 Cg_endo -86.28 44.41 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.621 1.547 . . . . 0.0 108.556 172.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -86.66 148.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.468 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 47.1 mtt180 -129.68 120.09 24.59 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.616 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 36.89 -174.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.1 m-85 -139.2 151.65 46.72 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.036 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.21 109.73 21.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.39 123.12 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.055 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -134.48 140.92 46.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.552 1.158 . . . . 0.0 107.922 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -146.04 156.15 43.28 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.694 -1.602 . . . . 0.0 112.378 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.2 ptm180 -125.89 160.49 29.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.49 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.55 -169.63 1.53 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.4 tp -96.19 39.91 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.116 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.45 -59.41 0.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.2 m -118.41 148.6 42.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.009 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.0 pt-20 -107.05 151.62 25.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.816 -1.153 . . . . 0.0 112.181 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.536 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 42.0 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.41 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.3 mttt -73.54 165.17 55.38 Favored Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.483 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.89 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.767 1.645 . . . . 0.0 110.479 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.12 174.38 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.675 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -137.76 154.23 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.043 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.74 128.69 56.05 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.093 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.17 165.13 56.39 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.149 -177.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.75 166.58 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.858 1.705 . . . . 0.0 110.237 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.3 m -76.27 79.67 3.05 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.874 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.69 60.75 0.41 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -97.08 -175.61 3.3 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.769 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -117.82 -39.89 3.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.571 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -148.22 168.44 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.21 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -128.07 152.09 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.289 174.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptp -136.44 154.11 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.528 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.7 OUTLIER -137.9 142.79 40.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.552 173.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -131.6 165.72 23.02 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.455 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m 53.58 62.56 2.58 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.189 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.3 mt -92.36 178.19 5.91 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.029 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -73.59 128.98 37.0 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.188 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.51 150.1 45.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.584 -1.246 . . . . 0.0 109.883 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.61 49.15 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.478 -175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.55 153.1 48.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.963 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 26.8 tt0 -94.04 147.96 22.63 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.009 175.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.9 m-85 -132.67 140.88 48.34 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.419 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.95 116.24 24.73 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.024 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.53 123.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 40.5 m-85 -112.18 125.56 54.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.29 121.84 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 124.035 0.834 . . . . 0.0 110.188 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -107.7 158.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.69 160.98 31.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.333 -1.347 . . . . 0.0 109.106 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -112.22 157.46 20.87 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.091 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -139.92 147.99 41.36 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.105 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -36.83 -43.39 0.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.41 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -114.41 42.73 2.04 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.669 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.9 -154.25 24.27 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.192 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -121.33 161.34 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.961 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.566 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.2 t -116.0 115.45 26.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -40.44 160.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 125.512 1.757 . . . . 0.0 112.661 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.65 138.35 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.532 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.21 146.27 29.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.494 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -116.97 130.86 56.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.465 -173.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -118.49 128.44 54.59 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.116 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.39 138.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.818 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.519 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.48 -179.78 8.22 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.973 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.08 147.48 50.94 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.768 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -80.02 170.06 16.99 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.784 -0.767 . . . . 0.0 109.292 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.7 m -81.41 -175.98 5.77 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.154 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.42 147.38 26.41 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.123 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.521 -1.704 . . . . 0.0 110.692 -178.203 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.913 0.387 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.74 176.05 16.79 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.598 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.0 Cg_endo -64.24 174.29 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.548 2.165 . . . . 0.0 112.603 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -87.92 145.59 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.286 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.77 78.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.571 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.41 165.74 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.218 1.279 . . . . 0.0 110.569 -176.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' N ' HE22 ' A' ' 26' ' ' GLN . 25.3 ttpt -103.42 133.29 48.72 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.3 112.24 25.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.959 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -93.4 141.89 27.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.29 131.28 10.55 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.341 -1.409 . . . . 0.0 112.587 -171.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -128.85 126.97 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 ttm -106.2 132.69 51.96 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.77 152.42 23.95 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.571 -176.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.99 12.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.311 -0.556 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.95 -24.26 41.12 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.645 175.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.06 -40.77 2.43 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.434 177.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -132.15 10.06 4.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.076 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -81.78 116.25 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.953 176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.529 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.3 mm -116.97 128.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.324 -172.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -113.47 126.3 55.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.988 0.805 . . . . 0.0 108.982 173.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -108.78 113.27 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -95.05 129.83 41.98 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.401 -176.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -98.71 106.45 18.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.715 -173.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.3 mm -97.66 131.76 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.994 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -107.49 156.26 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.366 -177.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.45 HE22 ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -132.32 -65.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.516 -174.091 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -135.23 128.4 31.86 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.325 177.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -133.53 -36.27 0.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 123.901 0.751 . . . . 0.0 109.899 177.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.63 54.22 0.3 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.44 18.86 37.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -175.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 42.56 61.27 9.25 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 114.907 -0.646 . . . . 0.0 112.648 -176.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.0 Cg_endo -88.46 37.99 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.558 1.506 . . . . 0.0 109.583 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 79' ' ' ASN . 23.6 mm -77.54 150.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.901 0.858 . . . . 0.0 111.78 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 9.0 mmt180 -127.85 113.32 15.77 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.367 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.2 p-80 36.2 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 174.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.0 m-85 -137.98 152.3 48.78 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.115 177.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.404 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.1 mt -108.56 110.72 22.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 60' ' ' VAL . 52.4 t -115.45 124.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.289 -174.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -135.52 140.15 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.62 1.2 . . . . 0.0 108.291 177.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.78 155.98 44.34 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.202 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.3 ptm180 -129.56 164.67 23.32 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.988 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -113.83 -177.95 3.26 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 tp -87.03 41.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.111 173.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.11 -60.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.522 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 p -119.11 151.3 38.53 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.439 177.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.8 pt-20 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.858 -173.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.572 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 42.29 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.35 175.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -69.83 168.3 18.55 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.695 173.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -52.26 95.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.656 1.57 . . . . 0.0 109.819 174.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.65 172.61 2.05 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.486 -173.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.11 154.63 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.392 -177.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -114.74 129.24 56.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.09 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -76.1 165.93 49.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.133 -177.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.45 168.24 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.787 1.658 . . . . 0.0 110.211 172.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.4 t -77.87 78.97 4.35 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.566 -177.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.0 60.72 0.34 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -97.18 -174.51 2.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.688 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -119.5 -40.52 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.707 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -148.06 169.12 20.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.11 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.0 p -127.46 152.48 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.422 173.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.8 ptp -136.25 150.42 48.95 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.599 -1.241 . . . . 0.0 112.908 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -140.47 139.21 35.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.097 172.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -140.39 162.76 34.54 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.606 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t 66.93 50.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.605 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -96.43 -174.52 3.07 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.665 176.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -83.3 142.6 30.97 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.095 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.412 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 74.3 m95 -77.75 155.17 31.37 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.366 -178.037 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.35 48.66 10.49 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.604 -176.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.09 47.33 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.837 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -97.94 149.92 21.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.532 177.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 31.6 m-85 -135.47 145.27 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.423 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -121.08 118.56 30.08 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.347 -1.751 . . . . 0.0 108.328 177.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.68 124.55 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 45.0 m-85 -112.69 126.18 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -121.29 122.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.13 158.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.98 156.54 41.41 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.261 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 27.6 tt0 -111.97 159.77 18.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.585 175.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -144.88 148.94 34.5 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.985 178.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -37.91 -42.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.481 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -112.32 42.12 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.465 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.45 -153.97 22.76 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.46 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -125.35 162.52 24.59 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.877 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -119.77 117.13 27.39 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -40.96 163.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 125.482 1.739 . . . . 0.0 113.206 -174.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.15 134.72 34.98 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.126 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.87 145.58 29.58 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.25 131.06 57.05 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.627 -173.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -118.13 127.27 53.61 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.008 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -125.32 139.31 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.64 -176.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 38.5 p90 -159.17 176.98 11.55 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.24 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -127.63 147.9 50.37 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.756 175.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.3 p -79.84 170.83 15.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.248 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.57 -170.81 3.24 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.143 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.19 141.88 36.81 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.156 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.54 -1.695 . . . . 0.0 110.741 -179.193 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.003 0.43 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.8 170.83 14.56 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.97 -1.109 . . . . 0.0 110.556 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -60.99 173.83 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.493 2.129 . . . . 0.0 112.917 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -95.39 155.51 16.71 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.036 174.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.26 143.09 97.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.075 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.65 165.9 23.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.343 1.362 . . . . 0.0 110.75 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.61 132.53 48.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.6 mt -104.72 113.78 27.58 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.224 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.02 138.78 31.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.441 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.75 124.56 7.91 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.492 -1.337 . . . . 0.0 112.469 -172.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.81 120.88 35.85 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.4 ttm -106.39 131.69 53.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.73 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.73 149.27 23.26 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.689 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.84 11.63 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.074 -0.563 . . . . 0.0 112.255 -177.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.5 m-20 -79.93 -22.36 42.8 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.876 176.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.8 -37.8 3.61 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.957 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.0 p-10 -140.27 47.52 1.79 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m -120.57 114.33 21.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.533 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.9 mm -117.41 128.54 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.633 -170.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -114.94 126.6 54.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.575 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.9 t -109.01 111.5 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -94.33 130.9 40.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.623 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 19.6 mt -100.05 108.51 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.949 -172.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.79 127.12 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -104.06 156.16 18.09 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.471 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 -53.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.146 -172.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.15 118.91 16.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.294 -178.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.27 -41.43 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 177.577 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.13 54.54 0.25 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -177.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.53 42.88 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 14.4 t 42.3 60.38 9.59 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -88.65 46.87 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.658 1.572 . . . . 0.0 108.962 173.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.67 152.32 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.602 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 35' ' ' HIS . 11.0 mtt180 -130.37 119.9 23.47 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.331 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.636 ' H ' ' HA ' ' A' ' 55' ' ' SER . 7.2 p-80 31.87 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.129 -1.851 . . . . 0.0 115.988 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 81.9 m-85 -137.47 153.1 50.13 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.9 175.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.9 mt -110.82 112.2 23.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 60' ' ' VAL . 42.4 t -115.86 128.16 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.215 -174.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.3 139.4 46.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.905 1.378 . . . . 0.0 108.104 175.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.9 p90 -147.38 154.57 41.04 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.581 177.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -133.39 160.81 36.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.775 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.47 -172.75 2.12 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -93.43 39.34 1.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.585 171.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.66 -60.67 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.348 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.5 m -118.94 141.12 48.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.8 pt-20 -105.02 171.93 7.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.093 -171.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 7.4 m95 18.28 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.591 -1.641 . . . . 0.0 114.123 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 9.4 mptt -67.57 164.34 39.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.689 174.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -47.17 104.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.844 1.696 . . . . 0.0 110.881 177.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 156.66 0.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.261 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 tt -131.12 146.92 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.359 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -115.21 132.14 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -82.69 164.69 45.84 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.875 -177.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.25 155.58 68.84 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.599 1.533 . . . . 0.0 109.454 172.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.636 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.5 t -73.36 103.1 3.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.373 -177.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.25 0.74 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.07 172.84 7.58 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.155 -175.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.3 -43.7 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.565 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.5 p-80 -148.86 168.4 23.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.614 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -123.15 150.74 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.035 174.146 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -135.92 149.19 48.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.506 -1.277 . . . . 0.0 112.833 -175.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -138.65 135.31 34.73 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.68 173.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' SER . 84.1 mttt -142.9 142.11 31.66 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.778 -178.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.9 m 91.07 43.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.892 176.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.9 mm? -95.37 -176.47 3.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.369 -177.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.43 130.95 42.6 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.877 -172.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.6 155.99 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 43.3 48.42 5.8 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.792 -177.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.9 151.88 49.98 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.802 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.86 149.54 21.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.775 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 7.6 m-85 -133.74 140.92 47.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.657 -177.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.17 119.72 34.1 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.518 -1.673 . . . . 0.0 108.234 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.62 125.41 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m-85 -113.52 125.39 54.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.2 123.75 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.893 0.746 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -108.72 158.01 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.72 157.02 41.46 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.413 -1.315 . . . . 0.0 109.547 178.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.2 tt0 -112.15 161.88 16.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.731 -1.188 . . . . 0.0 108.009 175.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.9 t-20 -143.78 149.8 37.6 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.546 177.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -41.21 -39.47 1.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.172 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -113.05 39.06 2.64 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.92 -150.88 22.39 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.681 175.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -134.31 168.52 18.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.227 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 9.1 t -127.97 123.06 33.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.215 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.15 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 125.557 1.786 . . . . 0.0 113.253 -174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.02 138.84 31.15 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.63 -174.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.79 145.8 29.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.04 130.72 57.0 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.6 -173.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -118.5 129.26 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.017 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.5 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.7 140.64 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.936 -176.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.2 p90 -158.84 -178.65 7.41 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.739 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -130.85 146.76 52.38 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.91 175.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -79.88 171.5 15.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.332 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.86 -170.88 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.072 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.07 140.85 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.052 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.459 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -113.66 172.89 14.65 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.657 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 10.9 Cg_endo -68.23 174.34 8.22 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.658 2.239 . . . . 0.0 112.427 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -101.54 158.78 15.83 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.925 172.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.31 149.58 68.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.349 -174.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -71.82 172.02 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.589 1.526 . . . . 0.0 110.766 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -106.07 134.1 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.47 112.43 24.82 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.399 -176.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 23.1 tt0 -92.48 141.45 28.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.76 121.83 7.29 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.869 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -122.16 121.58 37.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.4 ttm -104.76 134.2 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.701 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.63 150.86 22.01 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.735 -176.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.76 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.085 -0.557 . . . . 0.0 112.294 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 15.5 m-20 -79.82 -22.2 43.31 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.017 176.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.97 -50.97 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.541 176.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -128.15 7.62 6.02 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.807 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.5 t -73.11 117.32 14.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.865 176.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.04 128.63 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.869 -171.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -113.8 125.85 54.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.008 0.817 . . . . 0.0 108.976 171.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 59.4 t -105.9 110.19 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 11.5 t-20 -88.03 129.06 35.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.95 -175.441 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 75' ' ' VAL . 33.4 mt -99.69 100.95 11.99 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.265 -175.024 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -93.05 128.84 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -101.17 147.57 26.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 123.951 0.782 . . . . 0.0 109.672 -176.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.18 -86.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.937 -175.189 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -107.59 109.5 21.16 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.659 -174.952 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.1 m-20 -133.62 -34.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.127 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.92 53.51 0.36 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.72 21.04 35.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -175.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.0 m 42.85 61.47 9.4 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.745 -176.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 14.3 Cg_endo -86.54 45.61 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.792 1.662 . . . . 0.0 108.75 173.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 79' ' ' ASN . 23.0 mm -82.35 148.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.278 -173.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.0 mtt180 -125.35 111.43 15.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.89 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 33.97 -171.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.07 156.23 49.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.83 176.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.2 mt -112.82 111.45 22.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.061 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 60' ' ' VAL . 48.5 t -115.82 124.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.447 -174.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -136.75 138.1 40.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.487 1.117 . . . . 0.0 108.328 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.85 156.88 45.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.0 -1.48 . . . . 0.0 112.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 27.0 ptt180 -134.69 168.81 18.33 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.39 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.25 172.17 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.797 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.471 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -71.8 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.952 174.706 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -136.53 -58.75 0.73 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.742 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.7 m -126.48 158.79 35.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.581 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.7 pt-20 -101.43 166.98 10.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.751 -177.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.9 m95 17.94 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.966 -1.47 . . . . 0.0 114.514 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.68 167.27 36.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.322 173.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -48.06 98.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.76 1.64 . . . . 0.0 110.39 176.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.77 174.44 5.16 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.349 -173.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -139.19 154.89 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.499 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.35 137.06 52.07 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.783 173.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.5 mt -87.49 166.45 25.28 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.306 -177.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -81.33 140.04 11.94 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.92 1.747 . . . . 0.0 108.063 167.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -62.53 135.31 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.742 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.61 41.81 4.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -97.03 168.62 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.505 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -114.59 -45.81 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.44 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -147.86 167.43 24.8 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.361 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.0 p -119.07 149.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.778 173.353 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -132.55 148.41 52.37 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.874 -174.074 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.98 140.41 38.21 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.202 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -140.59 162.35 35.57 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.357 -177.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 m 71.69 46.4 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.403 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -95.27 -176.06 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 177.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -84.98 146.33 27.27 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.816 -175.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.451 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 71.0 m95 -80.25 155.33 27.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.545 -177.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 44.91 46.77 9.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.458 -175.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 149.94 47.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.712 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' H ' HD13 ' A' ' 43' ' ' LEU . 18.8 tt0 -98.83 143.09 29.55 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.327 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 39.4 m-85 -131.51 144.32 51.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 123.995 0.809 . . . . 0.0 112.057 -177.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.12 119.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.428 -1.715 . . . . 0.0 108.06 176.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.55 124.53 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 59.8 m-85 -111.35 126.96 55.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 23' ' ' LEU . 75.8 t -120.92 121.82 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -109.5 158.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.72 160.21 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.516 -1.274 . . . . 0.0 109.36 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.6 tt0 -111.1 164.76 12.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 20.1 t-20 -152.19 151.89 31.57 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -41.63 -41.41 2.2 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.327 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -79.7 -47.62 15.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.503 -177.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.63 -108.79 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.995 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -140.72 173.23 11.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.895 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -125.77 119.27 27.47 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -42.49 162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.307 1.629 . . . . 0.0 112.664 -176.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.51 134.49 35.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.202 -176.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.3 143.07 32.54 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.469 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.21 130.74 56.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.397 -174.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -116.88 126.85 53.61 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.984 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -123.63 135.44 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.298 -176.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 p90 -156.93 174.03 16.12 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.34 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -127.3 148.2 50.23 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.544 175.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -79.83 168.5 19.19 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.002 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 m -81.25 -173.17 4.18 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.356 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.04 150.55 21.28 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.109 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 116.247 -1.835 . . . . 0.0 110.392 -178.802 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.37 174.9 15.6 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 7.2 Cg_exo -59.35 176.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.634 2.223 . . . . 0.0 112.909 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -93.0 161.53 14.41 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.224 171.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.36 143.73 92.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.422 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.37 172.8 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.484 1.456 . . . . 0.0 110.915 -177.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -106.6 132.25 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.1 mt -109.04 112.12 24.13 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.352 -176.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.33 144.2 25.62 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.41 131.52 10.56 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.422 -173.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -129.16 129.4 45.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.8 ttm -106.86 134.64 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.652 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.41 144.03 21.29 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.591 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.48 9.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.95 -27.22 39.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.858 175.566 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.26 -40.05 1.95 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.931 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -130.64 -15.1 3.56 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.801 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -52.88 115.72 1.98 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.332 174.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 91' ' ' PHE . 5.9 mm -117.33 128.79 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.122 -175.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -114.94 126.66 55.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 47.6 t -109.27 118.94 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.77 124.02 39.6 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.81 -178.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.62 104.29 15.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -173.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -97.96 133.06 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.204 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -101.1 146.58 27.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.896 0.747 . . . . 0.0 109.434 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.07 -89.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.413 -175.781 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 20.8 t70 -95.45 105.69 17.68 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.125 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.75 -35.12 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.66 51.27 0.42 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.96 17.61 40.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -175.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.615 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 64.3 m 43.35 59.84 11.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.475 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.4 Cg_endo -88.53 50.9 1.67 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.842 1.695 . . . . 0.0 108.513 172.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mm -78.86 151.34 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.027 0.918 . . . . 0.0 111.68 -172.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 32.8 mmm-85 -126.13 108.01 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.536 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.536 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.0 p-80 36.17 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 76.5 m-85 -138.73 151.92 47.54 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.131 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.5 mt -107.87 108.78 20.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.08 122.23 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.02 -173.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -132.58 135.65 46.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.664 1.228 . . . . 0.0 108.1 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -140.8 158.69 43.6 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 117.941 -1.504 . . . . 0.0 112.162 179.172 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.6 ptm180 -138.32 170.36 16.15 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.305 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.62 179.5 4.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.514 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 40.83 0.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.535 172.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.28 -60.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -116.45 149.5 39.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.104 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -100.11 160.84 14.01 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.175 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.471 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 24.8 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.402 -1.272 . . . . 0.0 114.028 178.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 67.5 mmtt -76.19 162.16 72.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.8 Cg_exo -45.12 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.765 1.643 . . . . 0.0 110.611 177.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.87 175.45 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.571 -173.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -137.97 155.19 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.354 -177.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -115.89 130.25 56.75 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.214 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -78.33 165.09 52.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.239 -177.472 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.12 161.0 27.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.832 1.688 . . . . 0.0 110.87 172.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 t -68.24 95.55 0.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 95.57 65.38 0.97 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -97.14 -169.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.231 -176.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -129.54 -38.88 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.646 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -144.69 164.65 30.35 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.569 -1.252 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -131.77 153.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.492 174.02 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptp -137.45 152.13 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.981 -174.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -142.04 138.61 31.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.172 172.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -137.94 161.23 37.22 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.745 -177.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t 66.51 49.91 1.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.543 177.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -174.63 3.31 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.653 177.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.55 137.32 36.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.708 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.521 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 73.1 m95 -75.62 156.04 35.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.168 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 49.53 44.82 24.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.111 -178.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.71 156.06 44.89 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.546 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.76 149.33 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 19.8 m-85 -135.22 144.63 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.78 -178.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.58 121.45 38.4 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.273 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.0 t -114.06 123.11 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.9 m-85 -110.92 125.64 53.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.67 121.21 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 123.881 0.738 . . . . 0.0 110.446 -178.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -106.54 158.04 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.448 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.81 157.53 41.24 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.381 -1.327 . . . . 0.0 109.868 178.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.9 tt0 -112.11 164.27 13.35 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.491 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.3 t-20 -148.24 151.99 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.949 178.127 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -34.14 -45.81 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.757 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.95 39.78 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.5 -152.81 23.66 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.636 174.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -129.86 166.25 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.779 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.1 t -128.71 125.68 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.957 -176.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -43.39 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.52 1.762 . . . . 0.0 113.298 -175.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.25 139.7 30.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.61 -175.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.52 145.54 30.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.2 130.11 56.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.382 -174.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -117.86 129.72 55.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.883 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -127.38 141.1 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.694 -176.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.5 p90 -157.99 177.92 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.066 178.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 146.5 50.78 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.69 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.0 p -83.34 163.36 20.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.379 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 m -74.86 178.75 5.31 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.164 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.5 144.79 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 116.252 -1.832 . . . . 0.0 110.328 -178.926 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.01 179.03 18.26 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.937 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 8.3 Cg_exo -59.4 177.26 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.798 2.332 . . . . 0.0 112.944 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -80.17 -154.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.23 150.18 39.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.97 166.28 28.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.377 1.385 . . . . 0.0 110.755 -177.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.48 128.94 52.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 mt -102.91 110.73 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.018 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -91.49 143.09 26.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.431 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.27 125.17 7.76 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.337 -1.411 . . . . 0.0 112.486 -173.388 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.55 122.47 39.76 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.5 ttm -107.17 130.9 54.65 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.745 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.8 149.09 24.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.307 -177.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.55 16.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.85 -24.48 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.332 174.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -40.61 2.45 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.715 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.9 p30 -137.49 49.1 2.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.139 0.495 . . . . 0.0 110.0 177.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.2 m -122.16 113.5 19.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.554 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.07 128.53 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.604 -169.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.94 125.75 53.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.082 0.864 . . . . 0.0 108.748 173.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.5 t -107.12 116.47 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.178 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -93.88 129.01 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.913 -177.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 39.4 mt -100.56 99.41 10.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -175.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.9 mm -95.99 130.36 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -104.15 150.85 23.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.711 0.632 . . . . 0.0 109.803 -175.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -79.64 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.037 -174.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.55 102.43 11.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.177 -175.532 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -131.91 -35.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 178.535 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.07 51.04 0.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.77 22.48 25.86 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -175.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.585 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.0 m 39.09 62.44 4.86 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.065 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -88.25 50.69 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.729 1.62 . . . . 0.0 108.722 173.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.402 HD13 HD22 ' A' ' 79' ' ' ASN . 41.0 mm -86.45 151.59 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.068 -174.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.7 mtt85 -131.69 121.69 24.69 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.821 178.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.609 ' H ' ' N ' ' A' ' 56' ' ' GLY . 9.2 p-80 35.44 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.19 158.37 43.81 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.972 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.407 HD23 ' HG3' ' A' ' 52' ' ' ARG . 4.4 mt -112.45 109.86 19.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 60' ' ' VAL . 48.0 t -115.48 124.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.652 -173.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -134.72 140.57 46.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.683 1.24 . . . . 0.0 108.422 177.018 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.1 p90 -144.07 154.83 43.62 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.924 -1.51 . . . . 0.0 112.706 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 12.0 ptm180 -126.14 163.68 22.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.556 179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.81 -168.08 1.3 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' LEU . 12.1 tp -95.9 41.49 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.447 173.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.77 -56.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.611 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -106.76 142.83 35.76 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.6 pt-20 -107.87 144.06 35.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.792 -176.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.551 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.6 m95 47.45 84.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.454 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.0 mmtt -77.54 161.17 73.11 Favored Pre-proline 0 N--CA 1.491 1.603 0 CA-C-N 114.346 -1.297 . . . . 0.0 107.824 174.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.4 Cg_exo -43.37 103.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.909 1.739 . . . . 0.0 110.838 179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 14.2 pt-20 -73.76 175.87 6.82 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.503 -173.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.7 157.54 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.757 -177.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HG3' HD23 ' A' ' 37' ' ' LEU . 14.5 ttp85 -114.39 140.98 48.23 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.911 172.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.0 mt -90.18 165.56 23.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.667 -176.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.9 Cg_exo -61.58 157.91 39.45 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.71 1.607 . . . . 0.0 110.39 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -64.58 86.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.171 -176.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.609 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 106.15 62.91 0.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -93.84 179.59 5.3 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.24 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -18.91 7.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.236 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.462 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 19.1 p-80 -160.16 168.94 24.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.435 -1.306 . . . . 0.0 112.245 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.5 p -134.6 153.64 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.924 172.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.2 ptp -138.34 153.69 48.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.314 -1.354 . . . . 0.0 112.763 -176.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.97 140.17 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.142 173.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.9 tppt? -137.98 137.82 38.29 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.821 -174.177 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 8.2 m 85.86 50.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.784 171.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -95.2 -177.55 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.833 -179.289 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.2 134.21 39.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.687 0.756 . . . . 0.0 111.079 -172.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -72.34 154.65 40.82 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 47.5 47.37 17.36 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.911 -177.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.07 50.11 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.821 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.61 149.96 22.24 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.278 177.047 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.627 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -133.29 144.25 49.59 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.62 -176.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.35 118.25 28.0 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.82 123.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 39.3 m-85 -111.64 125.16 53.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 23' ' ' LEU . 68.1 t -121.32 122.14 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 123.935 0.772 . . . . 0.0 110.314 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.32 155.4 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.4 163.81 22.48 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.5 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -117.59 156.34 28.27 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.461 -1.295 . . . . 0.0 107.961 172.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 6.5 t-20 -141.76 152.12 43.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.665 178.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 34.3 tt0 -29.34 -47.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.501 179.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -111.85 36.09 3.44 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.5 -161.27 27.37 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.786 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -110.3 158.76 18.06 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.031 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.49 114.47 24.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.569 -175.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -39.98 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.368 1.668 . . . . 0.0 112.794 -176.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -80.53 140.06 36.04 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.769 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.46 147.27 29.53 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 172.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -116.93 131.48 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.667 -173.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.9 t80 -118.22 131.53 56.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.25 140.16 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.897 -176.533 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.75 178.79 9.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.016 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.5 52.06 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.279 177.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.4 p -81.0 165.9 21.3 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.711 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 m -79.9 -175.78 5.11 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.096 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.49 149.28 23.38 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.106 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 116.488 -1.72 . . . . 0.0 110.63 -178.685 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.973 0.415 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.23 172.95 16.87 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.501 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 1.6 Cg_endo -62.32 170.96 5.86 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.471 2.114 . . . . 0.0 112.924 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.6 p -87.42 150.36 23.84 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.909 171.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.45 160.12 1.42 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.173 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.5 162.47 27.66 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.206 1.27 . . . . 0.0 110.193 176.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 132.54 48.47 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.65 113.45 27.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.577 -174.005 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -92.7 141.19 28.74 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.597 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.42 121.37 7.08 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.129 -174.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -117.55 114.57 23.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.097 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.443 ' CE ' HD11 ' A' ' 19' ' ' ILE . 50.9 tpp -101.87 130.14 48.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.148 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.01 146.36 21.19 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.481 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.23 14.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.916 -177.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.8 -25.56 40.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.572 175.312 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.54 -48.34 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.924 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -131.92 51.38 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.167 0.508 . . . . 0.0 109.967 176.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -121.69 112.21 18.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 173.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -116.27 128.54 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.656 -171.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -114.98 126.07 54.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.05 0.844 . . . . 0.0 108.859 171.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.1 t -105.6 111.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -89.0 127.83 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.5 -175.439 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.31 103.54 15.49 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.352 -174.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.7 mm -96.52 134.78 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -104.48 154.53 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.257 -176.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -66.56 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.627 -175.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -131.41 117.79 19.35 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 5.0 m-20 -130.06 -35.25 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.98 177.344 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.51 52.76 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.94 23.25 28.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -175.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 24.7 m 43.51 61.38 10.25 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -88.9 39.58 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.464 1.443 . . . . 0.0 109.058 173.005 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.1 151.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.927 0.87 . . . . 0.0 111.258 -174.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.8 mtt180 -128.75 115.52 18.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.825 -179.841 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 31.9 -174.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 71.7 m-85 -132.57 153.34 51.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.077 174.254 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.0 mt -112.86 113.27 25.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 60' ' ' VAL . 43.1 t -115.89 128.98 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.043 -174.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.82 138.03 45.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.839 1.337 . . . . 0.0 108.122 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.63 157.15 44.33 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.805 -1.558 . . . . 0.0 112.007 176.137 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -134.73 163.93 28.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.448 -177.081 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.33 166.18 15.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.727 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.04 43.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.966 172.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -147.69 -56.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.742 176.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 p -132.05 157.99 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.198 175.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 16.0 pt-20 -105.09 165.34 11.16 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.711 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.8 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.614 178.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -69.52 163.44 58.96 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.45 172.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.0 Cg_exo -49.59 105.72 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.726 1.618 . . . . 0.0 110.622 176.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.36 160.67 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -175.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.27 148.84 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.181 174.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -115.07 135.56 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -88.1 164.19 34.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.159 -177.033 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.26 161.19 41.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.694 1.596 . . . . 0.0 109.08 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -84.38 99.65 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.188 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.38 48.75 0.51 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -177.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -97.05 178.3 5.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.551 -177.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.21 -42.02 3.09 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.058 -179.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -150.72 168.32 24.72 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.106 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.6 p -120.73 148.19 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.719 172.141 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 ptp -133.09 149.95 52.1 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.604 -1.238 . . . . 0.0 112.79 -174.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -139.15 134.84 33.36 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.402 173.573 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -133.96 138.56 45.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.42 -176.025 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 5.9 t 88.81 49.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.836 172.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.0 mm? -96.32 -179.88 4.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.852 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -71.62 133.45 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.587 0.708 . . . . 0.0 111.127 -174.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -73.76 155.72 38.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 45.18 47.1 10.02 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.859 -177.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.27 156.04 45.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.014 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.29 148.94 22.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 12.2 m-85 -134.02 144.38 48.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.525 -178.43 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 9.3 mp0 -120.52 123.33 42.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.421 176.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.05 124.76 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 40.3 m-85 -113.43 125.66 54.48 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -120.63 124.36 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.536 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -110.99 157.05 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.54 158.84 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.459 177.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.8 tt0 -113.22 163.91 14.2 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.627 -1.229 . . . . 0.0 107.786 174.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.8 t-20 -148.93 152.37 36.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.987 177.217 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -36.81 -44.08 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.516 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -109.99 40.21 1.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.59 -153.78 22.23 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.271 172.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -122.29 161.81 22.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.733 179.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.7 t -120.94 117.64 27.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -40.95 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 125.592 1.808 . . . . 0.0 113.378 -174.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.18 136.51 33.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.194 -176.26 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.03 145.45 30.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.493 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -114.83 131.02 56.96 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.718 -173.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -118.58 130.48 55.91 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.019 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.55 141.01 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.386 -177.169 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.47 177.28 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.068 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 147.01 50.73 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.927 176.537 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.92 163.45 20.01 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.586 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -80.77 -168.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.213 -179.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.57 143.16 33.43 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.044 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.235 -1.84 . . . . 0.0 110.463 -179.361 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.907 0.384 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.18 171.84 13.53 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.644 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 9.3 Cg_endo -67.41 174.39 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.573 2.182 . . . . 0.0 113.054 -178.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -94.36 -178.01 4.45 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.706 172.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.65 149.34 64.06 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.988 177.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.83 174.68 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.377 1.385 . . . . 0.0 109.954 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -105.78 141.0 37.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.75 115.16 29.35 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.29 -177.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.04 138.41 39.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -126.64 143.65 14.5 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.277 -1.916 . . . . 0.0 113.815 -171.509 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -128.14 138.53 52.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.084 171.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.473 ' CE ' HD11 ' A' ' 19' ' ' ILE . 21.5 mtp -108.31 128.2 54.54 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.9 178.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -80.88 151.46 32.04 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.81 -175.023 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.87 11.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.037 -0.581 . . . . 0.0 112.311 -178.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.8 -24.62 41.29 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.727 176.155 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.29 -41.65 2.16 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.86 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.6 p30 -138.87 50.44 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.116 177.275 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.3 m -122.31 114.65 21.07 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.5 mm -116.2 128.86 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.684 -170.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 123.04 47.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.12 0.887 . . . . 0.0 109.214 175.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 44.4 t -112.79 120.28 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -176.753 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -97.42 134.2 40.99 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.772 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.409 HD22 HG11 ' A' ' 75' ' ' VAL . 16.9 mt -101.4 105.9 16.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.048 0.843 . . . . 0.0 109.039 -175.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.18 107.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.165 -176.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -76.92 156.84 31.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -154.57 -83.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.389 -173.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.42 98.65 8.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.66 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -131.62 -34.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.498 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.79 56.72 0.43 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.86 19.07 41.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.578 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.8 m 42.1 61.56 8.45 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.744 -176.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -86.92 45.51 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.727 1.618 . . . . 0.0 108.701 173.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.436 HD13 HD22 ' A' ' 79' ' ' ASN . 23.4 mm -82.15 150.8 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.203 -173.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' HIS . 63.4 mtp85 -128.26 112.41 14.46 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.799 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.4 p-80 38.66 -173.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 175.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.53 153.88 51.57 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.28 177.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.2 mt -110.89 110.51 21.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 175.366 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG11 HG21 ' A' ' 60' ' ' VAL . 47.3 t -114.55 124.92 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.281 -173.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -135.56 139.97 44.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.647 1.217 . . . . 0.0 108.151 177.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.38 154.87 42.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.299 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 16.0 ptt180 -132.23 164.87 25.41 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.381 -178.058 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.53 169.77 13.33 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.272 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -74.16 42.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.783 173.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -145.49 -56.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.731 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -137.05 164.25 28.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.521 175.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -100.98 169.13 9.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.398 -174.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 6.5 m95 17.81 95.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.788 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.5 mmtt -69.0 165.48 37.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.99 172.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 13.1 Cg_exo -50.71 97.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.538 1.492 . . . . 0.0 109.849 175.063 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.0 172.23 1.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.566 -173.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.3 tt -138.24 154.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.956 -179.07 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -115.5 135.57 53.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.94 174.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -85.41 165.1 37.73 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.002 -177.383 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 9.9 Cg_endo -73.31 146.41 40.17 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.725 1.616 . . . . 0.0 109.783 172.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 37.3 p -58.17 113.85 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.931 0.769 . . . . 0.0 111.285 -178.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.41 56.29 1.05 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -97.04 177.04 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 -45.48 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.813 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -144.27 170.22 16.4 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.128 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.5 p -129.03 151.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.348 175.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ptp -138.09 150.91 47.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.67 -1.212 . . . . 0.0 112.193 -177.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.52 140.51 41.15 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.983 174.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.8 ttpt -140.47 136.42 32.96 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.811 -173.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.3 t 90.31 48.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.763 172.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.8 mm? -95.4 179.49 5.14 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.321 -178.228 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.03 134.69 48.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.661 0.743 . . . . 0.0 111.441 -173.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -74.47 154.21 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.86 48.06 12.1 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.618 -177.163 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.29 151.86 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.2 148.77 21.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 8.6 m-85 -133.62 141.25 47.56 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.398 -178.16 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.47 117.83 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.753 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.07 122.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 41.8 m-85 -112.21 125.88 54.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.409 HG11 HD22 ' A' ' 23' ' ' LEU . 95.4 t -120.33 122.71 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.888 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.7 t -109.15 158.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.99 159.67 33.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.049 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -112.74 164.66 13.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.448 -1.301 . . . . 0.0 107.582 174.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -149.6 153.2 36.72 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.872 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -40.74 -40.89 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.318 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -79.75 -52.5 7.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.01 -119.37 0.57 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.114 -177.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -125.34 163.93 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.427 -179.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.66 119.35 30.47 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -40.59 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 125.357 1.661 . . . . 0.0 113.447 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.62 139.24 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.387 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.87 144.78 34.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.39 131.59 56.9 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.633 -173.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 85.6 t80 -117.72 128.16 54.62 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.083 -179.175 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -124.89 137.89 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.58 -176.788 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.1 p90 -157.8 178.3 10.4 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.276 178.471 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.13 145.98 51.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.78 175.502 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -80.0 172.6 13.55 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.283 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -86.28 -174.96 5.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.166 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.91 147.51 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.312 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.471 -1.728 . . . . 0.0 110.551 -179.09 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.78 172.97 13.4 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.692 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 14.9 Cg_endo -71.2 178.02 5.92 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -84.93 152.71 23.32 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.479 170.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 162.7 0.92 Allowed Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.335 174.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.71 167.38 20.69 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.219 1.28 . . . . 0.0 110.522 176.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -104.24 127.42 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -98.31 112.32 24.35 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.983 -177.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.62 93.99 4.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -104.46 152.24 17.51 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.946 -172.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.64 157.82 43.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.953 -1.124 . . . . 0.0 109.232 178.643 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.3 ttm -111.12 139.45 46.47 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.359 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.15 154.85 25.76 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.121 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.45 11.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.267 -176.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' GLY . 20.4 m-20 -79.89 -22.87 42.29 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.152 175.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.58 -37.09 3.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.939 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 10.1 p-10 -140.12 46.22 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.112 177.017 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.4 m -120.77 115.23 22.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.529 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 8.0 mm -116.08 130.85 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.132 -170.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.77 122.48 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.8 t -108.88 116.44 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -93.44 134.34 35.78 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.17 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 32.7 mt -101.41 103.74 14.68 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.286 -176.138 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mm -95.2 136.71 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.13 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -104.36 152.6 22.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.45 -69.88 0.54 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.916 -175.636 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 25.7 m-20 -127.45 110.78 13.11 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.3 m-20 -131.48 -33.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.399 178.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.12 52.09 0.5 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.22 24.81 25.77 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 39.26 64.34 4.0 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.853 -0.674 . . . . 0.0 112.489 -176.162 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.9 44.61 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.665 1.577 . . . . 0.0 108.705 173.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.479 HD13 HD22 ' A' ' 79' ' ' ASN . 21.2 mm -90.69 148.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.163 -174.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' HIS . 74.6 mtm-85 -131.8 125.6 32.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.829 175.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.7 p-80 36.34 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 176.233 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 94.7 m-85 -138.57 150.56 46.45 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.518 178.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -105.27 110.32 22.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -112.47 126.31 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 118.959 -1.097 . . . . 0.0 110.607 -174.264 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -132.41 135.31 46.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 125.035 1.46 . . . . 0.0 107.804 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.47 151.69 41.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.659 -1.616 . . . . 0.0 112.128 176.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.3 ptm180 -124.15 160.53 27.64 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.433 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -109.17 -168.84 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -96.85 39.78 1.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.541 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.54 -60.97 0.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.03 150.26 39.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.505 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.9 pt-20 -106.79 144.02 34.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.746 -177.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.517 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.4 m95 48.45 82.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.107 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -68.71 161.26 72.48 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.926 174.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.6 Cg_exo -43.63 104.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.96 1.773 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -52.21 161.63 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.902 -175.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.3 147.7 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.412 174.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -114.04 129.69 56.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.4 mt -78.35 164.68 54.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.663 -178.259 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 6.0 Cg_exo -63.03 149.84 90.4 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.646 1.564 . . . . 0.0 110.009 174.192 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.416 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 20.5 m -64.23 87.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.68 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 113.7 56.61 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.7 t -97.02 -175.07 3.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.162 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.86 -24.01 3.01 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.974 -178.537 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p-80 -160.26 167.52 27.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.988 -177.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.8 p -130.4 152.32 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.579 174.504 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ptp -137.86 148.91 45.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.235 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -138.58 135.75 35.31 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.719 174.556 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.9 mtmt -141.63 143.07 33.45 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.871 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.5 m 90.82 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.999 175.036 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 65' ' ' LEU . 4.2 mm? -92.6 -177.81 4.69 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.813 -178.556 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.29 133.94 41.19 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.635 0.731 . . . . 0.0 111.229 -172.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.59 155.8 39.66 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.125 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.6 t30 44.63 47.02 8.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.084 -177.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.41 154.58 46.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.824 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.9 mt-10 -97.42 148.31 23.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.684 177.455 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 21.4 m-85 -133.76 142.1 47.78 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.502 -177.511 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -122.86 118.42 27.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.184 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.68 123.42 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 50.3 m-85 -112.2 126.04 54.79 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.08 122.42 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.925 0.766 . . . . 0.0 110.705 -178.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.23 159.71 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.017 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.61 159.93 35.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.016 177.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.6 tt0 -113.14 151.99 30.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.361 -1.336 . . . . 0.0 108.283 175.553 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -142.55 150.77 40.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.62 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -37.81 -39.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.711 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.63 -49.86 11.53 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.085 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 -125.2 0.75 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.513 -179.491 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -119.78 157.87 27.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.088 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -116.68 118.05 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -41.53 162.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 125.538 1.774 . . . . 0.0 112.873 -175.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.78 135.36 34.57 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.235 -175.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.99 148.05 25.83 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.533 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -117.4 130.64 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.783 -172.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.3 t80 -119.17 130.37 55.48 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.939 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.533 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.7 t -128.48 142.85 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.311 -175.307 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 49.6 p90 -162.52 179.08 8.03 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.334 177.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -129.28 147.91 51.16 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.49 175.023 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.6 p -79.87 170.95 15.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.344 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -83.23 -173.02 4.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.967 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 138.9 39.83 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.02 -178.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 116.447 -1.739 . . . . 0.0 110.654 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.965 0.412 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.69 176.59 14.54 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.044 -1.074 . . . . 0.0 110.588 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.3 Cg_exo -60.09 173.26 1.92 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.549 2.166 . . . . 0.0 113.177 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -98.62 162.61 13.04 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 144.27 94.98 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.168 -177.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.54 174.01 8.02 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.392 1.395 . . . . 0.0 110.495 -178.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -109.09 132.08 54.45 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.37 114.68 29.0 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.876 -1.129 . . . . 0.0 110.035 -176.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -95.09 141.27 28.92 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -105.73 127.44 8.97 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.634 -171.541 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -121.82 113.28 19.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.433 ' CE ' HD11 ' A' ' 19' ' ' ILE . 25.0 mtp -103.63 127.2 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.348 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.79 147.16 21.0 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.722 -1.228 . . . . 0.0 112.25 -174.185 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.27 13.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.918 -0.641 . . . . 0.0 112.141 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.23 41.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.449 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.67 -46.18 1.21 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.55 176.372 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -134.54 35.37 3.18 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.315 177.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -104.59 113.88 27.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 12.1 mm -118.43 126.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.492 -171.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -113.66 127.38 56.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.006 0.816 . . . . 0.0 108.822 172.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.1 t -108.53 116.31 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -97.65 129.64 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.54 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.2 mt -99.37 109.64 22.22 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.756 -172.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.9 mm -100.6 135.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.94 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -101.58 150.42 23.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.828 0.705 . . . . 0.0 109.265 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -135.34 -49.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.744 -175.922 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 27.5 m-20 -140.01 104.27 4.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.69 -177.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -132.57 -33.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.256 178.695 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.64 51.66 0.49 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.64 23.94 29.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.598 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.6 t 42.76 62.13 8.64 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.734 -0.733 . . . . 0.0 112.816 -176.026 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.83 41.68 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.582 1.521 . . . . 0.0 108.813 171.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.65 150.83 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.488 -173.004 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 53.4 mtt-85 -130.69 117.52 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.47 -1.695 . . . . 0.0 108.598 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.3 p-80 36.76 -175.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 176.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.7 m-85 -137.21 153.96 50.29 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.012 176.446 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -108.65 110.21 21.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' VAL . 44.7 t -114.17 123.81 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.137 -173.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -134.49 137.85 44.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.661 1.225 . . . . 0.0 108.113 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.21 158.71 43.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.968 -1.493 . . . . 0.0 112.505 179.475 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.0 ptm180 -138.28 170.72 15.52 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.983 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.09 -168.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.155 -175.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.24 41.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.484 174.351 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.23 -57.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.701 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -122.95 157.61 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.926 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.1 pt-20 -97.68 178.22 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.462 -177.431 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.5 m95 3.38 100.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.42 167.87 32.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.307 172.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -48.61 98.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.711 1.607 . . . . 0.0 110.365 176.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.37 174.32 4.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.353 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.12 155.51 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.389 -177.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -113.68 134.08 54.95 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.974 173.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -82.28 163.55 52.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.933 -177.64 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.7 Cg_exo -59.59 167.29 6.76 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.84 1.693 . . . . 0.0 110.51 174.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -74.76 79.82 2.07 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.657 -176.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 63.02 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -97.05 -175.81 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.808 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.03 -16.53 3.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.274 -179.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.9 p-80 -160.07 164.52 33.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.496 -176.073 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 38' ' ' VAL . 14.7 p -134.9 152.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.614 173.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -137.42 152.86 50.06 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.708 -176.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -138.88 140.57 38.45 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.52 173.043 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.32 156.2 47.01 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.617 -174.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.1 t 62.68 59.13 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.378 175.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -100.68 -175.14 2.81 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.653 176.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.84 140.33 36.85 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.677 0.751 . . . . 0.0 111.462 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.409 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 80.4 m95 -76.73 154.15 34.37 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.602 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.49 48.34 8.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 -177.064 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.34 152.79 47.75 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.676 179.503 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.58 147.66 24.57 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.601 176.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -132.2 143.39 49.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.36 -176.421 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -120.82 118.26 29.52 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.785 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -112.91 120.63 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 47.6 m-85 -110.08 125.4 52.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.83 120.69 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.429 -178.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.98 158.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.98 156.48 43.71 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.612 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.24 159.24 18.1 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.742 174.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 20.0 t-20 -143.64 151.87 40.66 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.512 178.228 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -40.03 -39.1 0.81 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.006 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -107.99 35.43 3.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.01 -151.44 20.45 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.942 173.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -121.79 160.08 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.933 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -122.54 122.85 39.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -41.88 165.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.664 1.852 . . . . 0.0 113.468 -174.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.57 137.23 33.01 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.34 146.01 28.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.09 128.16 55.45 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.687 -174.039 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 82.7 t80 -112.73 124.97 53.78 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.88 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -124.29 137.46 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.324 -176.475 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 46.3 p90 -161.34 179.09 8.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.821 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -128.53 153.36 47.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.364 173.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.1 p -79.92 177.72 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.074 177.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -90.45 -174.01 3.98 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.333 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.46 149.18 23.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.083 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.538 -1.696 . . . . 0.0 110.621 -178.571 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.56 169.45 17.5 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.467 179.25 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.4 Cg_exo -60.62 169.48 5.46 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.407 2.072 . . . . 0.0 113.08 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -98.0 163.39 12.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.347 172.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.44 142.28 91.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.269 -176.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -70.65 163.24 39.7 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.551 1.501 . . . . 0.0 110.087 -178.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -91.98 137.05 32.68 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.7 mt -105.77 109.81 21.9 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.56 -179.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 27.6 tt0 -94.34 137.92 32.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.34 -178.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.85 125.85 8.48 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.593 -1.289 . . . . 0.0 112.384 -171.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -120.84 117.74 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.448 ' CE ' HD11 ' A' ' 19' ' ' ILE . 51.2 tpp -99.92 127.43 46.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.78 150.34 24.12 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.191 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 4.8 mp0 -66.69 14.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.798 -176.781 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.75 41.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.461 174.559 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.21 -43.5 1.7 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.337 177.72 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -130.81 6.89 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.205 178.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -75.06 112.27 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.819 176.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 9.4 mm -114.36 125.04 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.862 -173.356 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.63 125.85 54.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.0 t -108.38 113.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -178.624 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 56.4 t30 -93.46 129.26 39.7 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.353 -177.44 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -97.37 106.14 18.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.393 -173.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.94 105.55 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.803 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -76.23 148.04 37.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -146.01 -55.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.26 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.68 101.58 5.54 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.682 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.1 m-20 -129.07 -37.41 1.69 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.109 178.252 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.02 54.69 0.38 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.54 20.24 38.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -175.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.595 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.1 m 42.47 61.87 8.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.524 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -86.68 43.0 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.695 1.597 . . . . 0.0 108.493 172.058 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -80.79 151.09 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.536 -172.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.1 mtt180 -127.85 111.7 13.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.696 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.8 p-80 37.46 -176.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 175.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 80.9 m-85 -134.34 151.35 51.18 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.847 175.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.9 mt -107.68 110.68 22.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.003 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -115.7 125.98 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.413 -174.352 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -137.53 142.2 41.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.637 1.21 . . . . 0.0 107.924 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.19 157.78 43.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.802 -1.559 . . . . 0.0 112.187 179.239 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.5 ptm180 -132.32 163.19 29.22 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.305 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.98 175.65 5.95 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.62 42.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.125 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.97 -59.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.244 178.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -125.41 154.89 41.24 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.156 176.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -106.47 158.16 17.11 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.992 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.533 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 33.03 86.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.204 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.8 mmtt -72.52 164.16 62.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.387 175.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.46 98.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.83 1.687 . . . . 0.0 110.537 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.64 173.6 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.506 -174.032 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.02 155.0 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.09 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -115.96 133.45 56.01 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.884 173.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.6 mt -82.63 162.94 54.03 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.294 -176.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.7 Cg_exo -60.33 168.85 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.932 1.755 . . . . 0.0 111.016 173.123 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 p -80.9 81.44 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.956 -177.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 58.47 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 m -97.13 178.94 5.09 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.898 -178.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.75 -37.68 2.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.545 -178.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -148.93 168.43 23.07 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.018 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -126.89 150.49 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.48 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ptp -134.39 148.12 50.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.52 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.5 pp -141.85 141.74 33.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.008 173.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -141.51 174.06 10.91 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.901 -1.119 . . . . 0.0 111.309 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 m 59.02 56.79 3.81 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.424 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD11 ' CD1' ' A' ' 62' ' ' LEU . 17.2 mt -94.33 -178.1 4.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.18 131.95 38.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.229 175.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.3 m95 -72.71 152.61 41.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.556 -1.258 . . . . 0.0 110.251 -178.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.77 46.79 18.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.853 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.88 154.28 45.68 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.889 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.28 149.9 20.83 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.216 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.3 m-85 -135.5 141.9 45.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.269 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.14 118.28 30.96 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.422 177.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.64 124.2 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.59 125.71 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.233 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.5 t -121.49 122.51 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.023 0.827 . . . . 0.0 110.482 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.16 158.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.09 156.77 43.35 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.408 -1.317 . . . . 0.0 109.797 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.4 tt0 -112.05 162.52 15.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -147.26 150.86 35.67 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.099 177.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -39.05 -43.04 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.307 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -111.52 40.37 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.599 -175.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.12 -152.12 22.58 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.82 174.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -132.67 167.88 19.29 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.701 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.2 t -127.34 121.01 29.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.3 -178.345 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -43.41 166.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 125.5 1.75 . . . . 0.0 112.987 -175.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.82 135.87 34.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.37 -175.57 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.9 144.32 29.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.96 129.25 56.62 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.336 -174.265 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -116.8 125.05 51.02 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.785 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -124.28 137.73 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.501 -176.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.1 p90 -156.85 177.93 10.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.07 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -126.31 147.72 49.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.475 174.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.88 167.97 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 m -78.16 -177.25 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.362 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.22 146.65 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.891 179.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 116.466 -1.731 . . . . 0.0 110.531 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.49 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.7 Cg_exo -56.53 173.7 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.509 2.14 . . . . 0.0 113.095 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m -95.15 159.51 14.98 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.536 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.91 144.4 98.99 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.129 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.9 Cg_endo -66.02 163.63 30.52 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.417 1.411 . . . . 0.0 110.822 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 128.1 48.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -102.91 115.72 31.15 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.45 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.42 141.68 30.2 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -106.92 125.66 8.15 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.448 -1.358 . . . . 0.0 112.51 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -121.27 119.68 32.95 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.0 ttm -105.89 132.2 52.28 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.727 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.31 147.49 22.41 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.458 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.07 13.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.907 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.88 -22.76 42.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.828 175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -40.65 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.102 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.409 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 8.4 p30 -137.65 49.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.278 0.561 . . . . 0.0 109.876 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -121.12 112.95 19.33 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.9 127.92 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.751 -170.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -114.18 127.25 55.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -107.83 113.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.81 131.88 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.544 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 30.3 mt -101.33 107.07 18.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.787 -172.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.56 132.59 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.095 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -99.1 155.29 17.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.845 0.715 . . . . 0.0 109.729 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.493 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.99 -48.2 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.02 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -143.89 109.11 5.04 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.134 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.0 m-20 -130.77 -37.59 1.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.035 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.82 54.71 0.39 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.42 33.16 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 11.4 m 43.62 61.3 10.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -88.75 40.0 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.418 1.412 . . . . 0.0 108.943 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.24 150.21 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.897 0.856 . . . . 0.0 111.336 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.1 mtt180 -130.95 116.67 18.17 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.793 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 35.66 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.566 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 82.7 m-85 -139.16 151.3 46.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.792 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.401 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.8 mt -106.89 109.83 21.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 54.9 t -113.92 122.9 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.035 -174.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.74 135.43 46.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.614 1.196 . . . . 0.0 107.927 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -141.51 161.6 37.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.876 -1.53 . . . . 0.0 112.063 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 7.8 ptm180 -144.35 170.1 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.763 -1.562 . . . . 0.0 110.166 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -122.63 179.65 4.54 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.714 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 tp -82.43 42.68 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.102 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.56 -56.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.344 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.3 m -124.31 151.95 43.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.409 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -98.07 175.03 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.606 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.8 m95 10.5 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.581 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 27.7 mmmt -80.53 163.0 58.77 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.049 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.4 Cg_exo -44.89 102.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.907 1.738 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.45 175.09 4.26 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.577 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.52 153.12 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.014 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 39.1 ttm105 -114.39 127.51 55.88 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.019 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -73.26 164.77 58.56 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.263 -177.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.77 169.99 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.749 1.633 . . . . 0.0 110.272 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.5 t -76.9 77.55 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.554 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.09 64.67 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 t -96.99 -174.47 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.14 -25.33 4.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 12.3 p-80 -160.22 167.68 27.06 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.778 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -129.56 153.66 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.125 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ptp -139.81 154.54 47.38 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.37 -1.332 . . . . 0.0 113.157 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -140.38 139.77 35.4 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.563 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -135.78 136.55 40.8 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.616 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 86.97 51.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.0 170.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.1 mm? -97.96 -177.85 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.923 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 134.73 42.58 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.685 0.755 . . . . 0.0 111.328 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -73.21 155.32 39.69 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.207 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.14 49.12 7.64 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.869 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 153.8 49.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.732 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -95.14 150.26 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.888 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.4 m-85 -134.23 143.4 47.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.451 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.7 123.06 43.98 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.891 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.51 121.82 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 35.2 m-85 -110.39 125.43 53.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -120.76 122.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.87 0.732 . . . . 0.0 110.835 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -107.11 157.99 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.51 155.53 43.6 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.43 -1.308 . . . . 0.0 109.534 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.7 tt0 -111.35 158.84 18.58 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.838 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.7 t-20 -144.58 151.34 38.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.716 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -35.7 -44.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.585 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.14 38.14 2.5 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.74 -155.06 23.49 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.317 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -121.76 159.32 26.91 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.794 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.5 t -121.86 125.59 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.294 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -41.38 165.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.718 1.886 . . . . 0.0 113.737 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.09 136.08 33.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.19 147.01 27.56 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.56 129.66 56.6 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.702 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 80.3 t80 -115.09 128.58 56.31 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.986 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -125.85 138.66 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.421 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 39.6 p90 -158.09 178.19 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.028 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -129.7 147.07 51.45 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.912 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -79.85 171.7 14.76 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.67 -171.07 3.36 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.051 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.65 141.24 36.4 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.068 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 116.245 -1.836 . . . . 0.0 110.431 -179.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -55.22 170.09 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.699 2.266 . . . . 0.0 113.748 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -94.27 174.17 7.27 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.191 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.36 142.2 58.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.744 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -69.55 169.53 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.588 1.525 . . . . 0.0 110.289 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' HB2' HE22 ' A' ' 26' ' ' GLN . 34.0 ttpt -99.23 137.61 37.5 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 172.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 mt -108.38 109.32 20.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.834 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.07 145.38 24.57 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.94 127.96 7.91 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.68 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.39 126.81 48.77 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.484 ' CE ' HD11 ' A' ' 19' ' ' ILE . 47.5 tpp -104.46 129.7 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.913 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -82.82 150.17 27.65 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.31 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.73 12.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.061 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.3 m-20 -79.86 -23.31 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.967 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.27 -41.99 2.03 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.883 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -136.53 48.31 2.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.131 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 m -121.22 116.03 24.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -116.19 128.59 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.469 -170.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.5 124.42 52.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.071 0.857 . . . . 0.0 108.961 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -109.12 120.62 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -94.19 130.7 40.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.283 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.33 98.54 9.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mm -89.42 107.88 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.242 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -68.69 170.03 10.13 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.5 HE22 ' HB2' ' A' ' 7' ' ' LYS . 3.5 pt20 -170.31 -67.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.652 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.4 m-20 -117.94 86.52 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.218 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.4 m-20 -129.31 -17.41 3.79 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.57 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.82 23.43 49.75 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.1 m 43.84 64.9 6.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.763 -0.718 . . . . 0.0 112.797 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -86.93 46.44 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 N-CA-C 107.26 -1.862 . . . . 0.0 107.26 170.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.02 152.11 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.008 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -127.63 113.91 16.68 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.221 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.8 p-80 36.86 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.9 m-85 -137.25 152.09 49.43 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.461 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.8 109.26 21.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 60' ' ' VAL . 49.7 t -113.12 121.15 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.797 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.82 137.54 48.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 124.69 1.244 . . . . 0.0 107.874 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 155.16 44.87 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.906 -1.518 . . . . 0.0 112.173 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.2 ptm180 -131.23 164.66 25.07 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.018 -1.447 . . . . 0.0 110.098 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.61 170.48 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.02 43.09 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.506 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.73 -58.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.074 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.3 m -127.21 154.81 44.36 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.194 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -101.41 163.6 12.19 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.144 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.469 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 24.81 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.258 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 39.9 mmtm -71.49 165.93 44.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.116 174.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -49.17 96.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.723 1.615 . . . . 0.0 110.046 175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.01 174.34 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.534 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.91 154.4 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.368 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -113.99 130.12 56.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.789 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mt -78.18 164.02 58.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.798 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.8 Cg_exo -60.33 168.08 6.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.666 1.577 . . . . 0.0 110.318 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.2 t -75.92 78.1 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.724 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 63.66 0.36 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.1 t -97.09 -172.12 2.37 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.689 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -131.96 -15.82 2.95 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.214 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.2 p-80 -159.71 165.39 32.65 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.556 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.3 p -135.0 152.18 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.66 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptp -137.78 150.58 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.418 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -139.6 138.21 35.99 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.954 174.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 53.1 mtmt -142.41 141.7 32.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.849 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.2 t 93.32 44.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.291 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -178.65 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.028 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.72 135.17 43.62 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 0.0 111.241 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -74.19 156.49 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.291 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 45.24 47.07 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.729 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.48 154.95 47.24 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.002 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -97.24 149.04 22.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.8 m-85 -133.8 144.47 49.02 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.614 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.72 121.0 37.29 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.619 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.73 123.38 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.16 127.12 55.84 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.48 120.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 123.914 0.759 . . . . 0.0 110.731 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.08 158.88 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.58 45.26 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.219 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.97 157.48 21.44 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.317 -1.353 . . . . 0.0 107.9 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.5 t-20 -144.37 153.29 41.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.527 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -37.21 -41.95 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.496 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -107.64 36.38 2.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.79 -153.51 21.11 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.041 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -120.08 158.92 25.85 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 t -124.04 128.02 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.97 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -42.09 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 125.751 1.907 . . . . 0.0 113.303 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -90.17 140.89 29.24 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.443 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.8 145.08 29.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.466 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -115.25 129.87 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.418 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 78.1 t80 -117.73 130.1 56.11 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.095 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.61 139.7 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.541 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.7 p90 -157.38 177.43 11.45 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.154 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.52 146.57 51.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.951 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.31 164.98 19.7 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.539 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -81.61 -169.84 2.52 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.1 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.94 141.7 36.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.154 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.708 -179.524 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.453 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 28.2 Cg_endo -71.33 179.99 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.849 2.366 . . . . 0.0 112.737 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -103.95 160.32 14.91 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.177 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.69 148.99 98.56 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.812 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -71.85 171.85 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.307 1.338 . . . . 0.0 110.335 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.46 ' HG3' HE22 ' A' ' 26' ' ' GLN . 32.9 mtmt -100.16 146.57 26.68 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 171.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.9 mt -115.09 114.04 24.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.195 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -95.42 144.81 25.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.79 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -111.33 127.09 8.03 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.48 -1.343 . . . . 0.0 112.554 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -122.73 124.58 43.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 47.9 ttm -105.25 133.13 50.52 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.595 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.94 153.88 25.09 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.543 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.07 10.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.082 -0.559 . . . . 0.0 112.234 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -80.0 -23.17 41.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.878 176.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.57 -37.03 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.36 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -132.53 2.46 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.123 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -75.67 116.5 16.45 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.974 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.0 127.67 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.182 -172.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.85 125.45 54.08 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.2 t -108.91 119.78 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -97.28 128.72 44.38 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.102 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 47.3 mt -96.72 110.34 22.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 123.855 0.722 . . . . 0.0 109.695 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -97.42 108.18 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.686 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -72.4 168.43 18.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.753 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.46 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.6 pt20 -166.27 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.555 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 18.7 t70 -111.8 89.87 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.075 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 18.1 m-20 -131.97 -17.81 2.73 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.255 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.18 54.03 1.31 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.42 31.65 58.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 t 36.8 79.07 0.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 114.637 -0.782 . . . . 0.0 112.949 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 79' ' ' ASN . 6.0 Cg_endo -87.55 35.46 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 N-CA-C 107.169 -1.896 . . . . 0.0 107.169 165.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.99 144.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 122.091 0.948 . . . . 0.0 111.863 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 27.6 mtt180 -128.19 128.65 45.15 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.109 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 11.9 p-80 34.44 -173.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.475 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -139.93 153.5 46.97 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.555 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -106.29 112.16 25.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 60' ' ' VAL . 45.9 t -114.11 128.22 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.928 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -134.43 140.25 46.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 125.039 1.462 . . . . 0.0 108.011 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.62 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.99 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.477 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 24.5 ptt85 -126.41 158.8 35.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.354 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.78 169.43 10.43 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.551 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.95 43.6 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.868 173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.49 -57.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.826 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.3 m -130.95 152.28 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.003 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 38.2 mt-10 -105.89 142.02 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.655 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.2 m95 58.81 84.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.837 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mptp? -70.67 161.89 74.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.123 173.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.66 105.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.88 1.72 . . . . 0.0 111.073 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.81 161.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.842 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.5 tt -134.12 149.91 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.459 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -114.29 132.41 56.17 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 60' ' ' VAL . 1.5 mt -82.79 165.25 42.75 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.129 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.5 Cg_exo -63.1 156.13 56.92 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.784 1.656 . . . . 0.0 110.324 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -73.66 83.26 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.183 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.62 47.61 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.63 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -97.13 167.44 11.05 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.04 -2.62 9.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.643 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.459 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.05 163.5 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.191 -1.403 . . . . 0.0 112.86 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -135.43 152.29 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.867 173.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptp -137.67 150.63 47.51 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.641 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -141.74 140.78 33.19 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.24 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.41 162.1 35.84 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.011 -1.075 . . . . 0.0 111.728 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 m 65.96 54.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.705 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -100.18 -175.43 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.046 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.51 136.64 37.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.084 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -75.16 155.72 36.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 43.28 48.61 5.77 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.567 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.47 152.83 47.79 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.128 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -91.63 146.14 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 17.1 m-85 -134.45 138.72 44.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.245 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.61 118.3 28.88 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.457 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -112.29 126.85 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 51.5 m-85 -115.69 125.76 53.24 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.44 121.88 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 123.96 0.787 . . . . 0.0 110.708 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -106.81 156.26 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.38 155.74 41.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.955 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -110.08 149.13 30.47 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.126 -1.43 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.56 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -129.34 141.68 51.02 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.806 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -42.59 -33.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.229 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -126.61 50.44 1.93 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -160.36 27.06 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.097 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -125.97 159.18 33.35 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.827 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -113.18 111.32 21.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -39.59 159.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 125.442 1.714 . . . . 0.0 112.527 -176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.0 128.75 35.07 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.951 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.58 145.06 25.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.7 t-160 -116.12 130.94 57.04 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.781 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.6 t80 -120.07 128.86 53.88 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.314 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -126.23 135.67 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.627 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 19' ' ' ILE . 38.7 p90 -157.49 177.65 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.169 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -128.25 147.9 50.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.425 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.8 p -79.87 170.59 16.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.178 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -84.48 -171.29 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.222 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 140.88 36.92 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.092 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.386 -179.074 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.492 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.0 Cg_exo -58.05 172.23 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.561 2.174 . . . . 0.0 113.34 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -98.66 163.35 12.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.567 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.75 143.7 98.21 Favored Pre-proline 0 N--CA 1.491 1.594 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.372 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -71.63 172.51 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.66 1.573 . . . . 0.0 110.582 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' N ' ' NE2' ' A' ' 26' ' ' GLN . 28.1 mtmt -99.06 142.21 30.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -112.29 111.37 22.2 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.037 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -92.05 144.03 25.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.0 131.45 10.46 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.22 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -128.07 125.83 40.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.1 ttm -107.65 131.52 54.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.89 151.97 28.09 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.429 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.18 10.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.157 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -79.97 -22.46 42.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.123 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.74 -37.16 3.84 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.051 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.1 p-10 -138.56 46.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -121.48 113.25 19.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 mm -116.35 129.16 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.688 -169.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -114.21 127.38 55.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.8 t -110.69 118.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -95.75 130.63 42.6 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.62 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 55.6 mt -99.6 109.43 21.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 123.678 0.611 . . . . 0.0 109.978 -174.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -94.69 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.74 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -79.01 140.41 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' N ' ' A' ' 7' ' ' LYS . 2.2 pt20 -136.87 -70.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.329 -171.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -115.88 101.29 8.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.004 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.02 -34.54 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.31 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.94 52.1 0.35 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.19 18.78 35.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.604 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 68.6 m 40.75 61.85 6.73 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.9 Cg_endo -87.08 51.36 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.709 1.606 . . . . 0.0 108.694 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.6 mm -88.2 149.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 122.046 0.927 . . . . 0.0 111.446 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.9 mtp85 -132.05 123.61 27.58 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.943 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.59 ' H ' ' N ' ' A' ' 56' ' ' GLY . 6.0 p-80 33.65 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.6 m-85 -142.02 156.46 45.43 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.862 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.57 109.91 21.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 60' ' ' VAL . 46.8 t -114.11 123.67 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.068 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.23 137.87 46.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.804 1.315 . . . . 0.0 108.057 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.39 157.53 44.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 117.966 -1.494 . . . . 0.0 112.294 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.3 ptm180 -134.23 166.54 22.55 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.941 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.02 -170.72 2.01 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.91 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.0 tp -91.83 40.17 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.089 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.44 -58.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.597 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.55 37.1 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.417 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.6 pt-20 -101.3 162.57 12.8 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.282 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.467 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 25.24 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.838 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 70.6 mmtt -75.83 162.99 69.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -44.28 100.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.747 1.632 . . . . 0.0 110.869 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.66 175.65 4.07 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.42 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.34 155.64 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.384 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -113.96 135.36 54.08 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.861 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.1 mt -85.18 167.06 27.9 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.415 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.4 Cg_exo -65.12 154.65 72.47 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.729 1.619 . . . . 0.0 109.91 172.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.453 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 9.0 t -65.62 85.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.588 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 113.4 61.9 0.42 Allowed Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.327 -0.939 . . . . 0.0 110.94 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 t -97.08 164.78 12.37 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.582 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.3 -18.69 14.76 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.87 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.0 p-80 -160.03 172.86 16.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.898 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.2 p -134.8 155.0 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.232 171.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -139.06 151.46 46.77 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.863 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -139.37 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.574 173.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -134.85 137.56 43.38 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.764 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 90.07 48.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.843 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.496 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mm? -96.72 -177.47 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.986 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 133.5 40.88 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.752 0.787 . . . . 0.0 111.46 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.66 156.13 39.72 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.254 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.3 t30 46.37 46.04 13.63 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.199 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.8 154.65 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.077 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 45.0 mt-10 -97.61 147.58 24.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.528 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 18.2 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.476 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -120.24 119.78 34.19 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.956 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.69 121.41 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 32.9 m-85 -110.92 124.27 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.9 t -121.08 122.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.856 0.722 . . . . 0.0 110.725 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.27 155.41 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -125.52 157.28 37.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.408 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 29.9 tt0 -111.79 156.33 22.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.712 -1.195 . . . . 0.0 107.801 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.5 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.9 t-20 -137.04 150.03 47.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -37.69 -35.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.145 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -125.73 48.35 2.08 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.732 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.25 -162.18 27.22 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.323 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -119.08 159.15 24.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.85 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.6 t -121.02 119.35 32.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -40.75 164.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.639 1.837 . . . . 0.0 113.231 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.92 140.09 31.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.519 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.6 146.63 28.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.64 129.85 56.39 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.021 -1.071 . . . . 0.0 111.469 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -117.97 130.63 56.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.163 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -127.64 141.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.75 -176.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 40.0 p90 -160.09 178.11 10.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.971 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -127.86 147.74 50.45 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.775 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -80.04 170.31 16.64 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.133 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -80.43 -179.63 7.25 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.892 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.67 144.1 28.32 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.382 -179.263 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.1 Cg_exo -61.22 172.43 3.23 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.566 2.177 . . . . 0.0 112.936 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -97.56 152.49 18.98 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.548 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.74 144.73 72.91 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.49 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.19 164.27 30.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.251 1.301 . . . . 0.0 110.212 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -102.35 129.29 48.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.3 mt -102.79 110.86 22.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.073 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -89.73 139.6 30.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.16 118.37 6.16 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.488 -1.339 . . . . 0.0 112.033 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 75.6 mt-30 -112.73 105.63 13.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.438 ' CE ' HD11 ' A' ' 19' ' ' ILE . 23.6 mtp -103.8 127.66 51.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.016 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -79.91 118.03 4.63 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.845 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.45 13.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.786 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.7 m-20 -79.85 -24.25 41.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.984 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 156.58 -69.96 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.493 -1.813 . . . . 0.0 112.891 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -143.46 18.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.736 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -75.81 115.12 15.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.981 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.501 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 15.6 mm -117.03 123.84 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.716 -173.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.4 124.48 52.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.903 0.752 . . . . 0.0 109.345 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.8 t -104.37 109.41 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.0 t-20 -88.87 128.59 35.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.563 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.12 102.37 14.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.434 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.73 132.55 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -107.01 148.25 28.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.283 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -130.61 -63.76 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.055 -173.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 5.1 m-20 -132.86 116.52 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.162 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.1 m-20 -133.42 -35.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.04 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.4 53.65 0.42 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 20.81 37.09 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.612 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.1 t 44.08 61.15 11.18 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.83 -176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -87.86 44.24 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.518 1.478 . . . . 0.0 109.013 172.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.78 148.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.398 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.5 mtt180 -130.82 126.04 35.26 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.185 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.3 p-80 31.95 169.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 54.1 m-85 -123.5 138.88 54.48 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.32 172.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.4 mt -100.27 100.6 11.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 51' ' ' ILE . 48.2 t -109.1 121.97 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.4 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -133.33 140.54 47.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.727 1.267 . . . . 0.0 107.749 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.49 155.42 43.09 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 8.8 ptt180 -131.48 163.08 28.76 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.404 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.14 169.52 11.15 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.458 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -74.13 43.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.733 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.98 -57.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.186 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -128.44 156.42 43.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -104.78 160.59 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.774 -1.171 . . . . 0.0 112.21 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.5 m95 28.36 89.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.101 -1.409 . . . . 0.0 113.749 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 61.5 mttm -76.24 163.4 66.62 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.323 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.31 105.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.832 1.688 . . . . 0.0 110.551 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -78.17 174.49 11.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.849 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.92 136.25 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.099 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.656 ' N ' HD13 ' A' ' 51' ' ' ILE . 18.5 ttp85 -105.52 110.62 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.895 169.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 51' ' ' ILE . 2.8 mt -69.09 162.14 67.54 Favored Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.606 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -79.18 147.53 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.12 1.88 . . . . 0.0 109.173 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 m -61.47 127.33 30.97 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.671 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.91 43.17 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -97.03 167.04 11.31 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.939 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.58 -47.22 3.0 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.654 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -148.17 167.62 24.59 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.962 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.1 p -119.36 145.06 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.479 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -131.31 148.69 52.71 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.831 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.2 pp -140.7 136.72 32.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.425 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -142.7 158.61 43.48 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.846 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t 75.9 45.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -92.9 -175.02 3.77 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.45 141.46 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.128 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.578 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.8 m95 -77.89 153.42 32.64 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.376 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.2 47.22 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.342 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.78 153.07 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.26 149.07 22.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 20.7 m-85 -133.45 141.7 47.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.393 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -119.76 118.1 29.97 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.576 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.98 123.67 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 56.6 m-85 -111.96 126.34 55.03 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.67 119.38 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 124.021 0.826 . . . . 0.0 110.462 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -110.22 157.42 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.35 158.1 40.74 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.37 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.8 tt0 -112.54 160.62 17.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.53 -1.268 . . . . 0.0 107.924 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -144.76 151.46 38.88 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.08 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -37.28 -44.03 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.315 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.99 41.79 1.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.42 -154.15 22.32 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.325 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -123.35 162.02 23.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.868 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 5.7 t -119.67 115.42 23.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -40.34 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 125.646 1.841 . . . . 0.0 113.458 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.37 131.65 35.04 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.944 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.24 143.0 30.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.74 129.08 56.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.45 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -114.89 123.88 50.28 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.669 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -122.71 134.05 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.11 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 43.3 p90 -156.41 178.68 10.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.501 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.94 51.71 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.137 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 p -84.98 165.26 17.73 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -80.18 -172.78 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.158 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.33 140.51 39.15 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.01 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 116.586 -1.673 . . . . 0.0 110.707 -178.699 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -59.86 172.41 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.541 2.161 . . . . 0.0 112.984 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 m -93.8 159.58 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.603 172.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.79 146.72 90.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.5 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.5 169.0 18.16 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.428 1.419 . . . . 0.0 110.642 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -104.38 130.94 52.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -105.8 113.46 27.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.396 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -95.55 139.41 31.85 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.562 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.44 123.34 7.83 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.442 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.55 119.75 33.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.77 131.04 51.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.477 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.61 153.16 24.73 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.718 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 8.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-20 -79.84 -22.34 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.969 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.39 -36.38 4.43 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.318 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -131.35 -1.36 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.984 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -68.05 113.39 5.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.321 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.541 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.8 mm -115.75 127.17 73.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.1 -175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -115.74 124.63 51.28 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 63.3 t -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 114.446 -1.252 . . . . 0.0 107.941 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -88.27 128.47 35.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.091 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.51 106.43 18.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.908 0.755 . . . . 0.0 109.704 -171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.07 131.04 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.637 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -102.0 145.86 28.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.946 0.779 . . . . 0.0 109.586 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.4 -90.26 0.38 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.934 -175.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 24.1 m-20 -104.46 111.36 23.99 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.799 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -134.35 -33.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.196 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.81 51.94 0.33 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.11 19.62 38.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.603 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 43.46 60.78 10.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 114.781 -0.71 . . . . 0.0 112.802 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -87.8 43.65 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.594 1.529 . . . . 0.0 108.815 172.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mm -76.58 152.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.272 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.3 mtt180 -127.74 114.43 17.27 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.2 p-80 31.83 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 77.8 m-85 -135.43 152.14 51.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.551 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.5 mt -111.17 112.02 23.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 60' ' ' VAL . 49.1 t -114.95 129.59 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.054 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HD3' ' CG ' ' A' ' 47' ' ' TRP . 40.2 ttmt -134.58 134.6 41.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.895 1.372 . . . . 0.0 108.086 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.76 159.83 41.81 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.791 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 12.6 ptt180 -142.99 172.32 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -126.65 169.55 13.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.989 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.9 44.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.734 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.16 -54.33 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.94 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 p -133.6 156.63 47.49 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.53 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -86.63 -163.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.982 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.443 ' CG ' ' HD3' ' A' ' 39' ' ' LYS . 9.7 m95 -23.22 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -77.9 167.01 39.42 Favored Pre-proline 0 N--CA 1.489 1.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.687 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -50.62 108.57 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.843 1.695 . . . . 0.0 110.528 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -53.25 161.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.755 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.79 149.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.078 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -114.32 131.38 56.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.233 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -79.64 167.88 30.67 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.817 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.43 154.85 55.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.79 1.66 . . . . 0.0 108.867 169.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -80.18 113.31 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.973 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 46.51 3.7 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.3 p -96.8 -178.01 4.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.892 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.35 -56.77 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.315 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -146.04 164.87 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.669 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 7.1 p -109.88 144.01 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.66 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.13 147.22 50.96 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.019 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.9 OUTLIER -138.76 138.28 37.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.001 173.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -137.17 163.18 31.49 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.494 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m 63.59 53.41 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.664 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -96.21 -176.25 3.61 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.849 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.94 132.47 39.07 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.639 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -72.98 154.52 40.49 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.013 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 46.32 47.92 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.657 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.78 153.45 48.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.935 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.74 145.93 25.87 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.227 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.2 m-85 -132.14 145.14 51.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 123.918 0.761 . . . . 0.0 112.526 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.37 122.83 40.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.433 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.1 125.49 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.0 m-85 -112.85 127.23 56.12 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.63 124.19 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -109.27 157.21 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.59 155.83 44.31 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.467 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.0 tt0 -110.6 164.62 12.55 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.782 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 32' ' ' PRO . 16.3 t-20 -146.27 149.68 34.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.021 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -38.22 -42.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.447 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -115.54 43.01 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.533 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.67 -158.49 27.68 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.986 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 157.92 40.78 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 28.4 t -123.32 119.25 29.55 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.586 -175.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -43.39 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.602 1.814 . . . . 0.0 113.23 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.66 140.45 29.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.804 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.57 29.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -114.68 131.61 56.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.545 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -118.56 129.62 55.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.897 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.75 139.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.496 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.541 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.4 p90 -158.84 175.9 13.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.167 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.44 147.19 49.83 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.654 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -79.91 169.64 17.61 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.238 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -80.51 -176.37 5.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.154 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.22 147.74 25.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.107 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.69 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.548 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.8 Cg_exo -68.3 170.79 13.96 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.4 m -82.69 -157.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.824 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.35 35.86 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 9.7 Cg_endo -67.52 160.75 46.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.188 1.258 . . . . 0.0 110.661 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.77 126.05 47.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -100.72 113.63 26.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.317 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -98.42 144.22 28.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.427 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.47 132.31 10.38 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.14 -171.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.482 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.7 mt-30 -125.13 128.67 48.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.06 133.84 51.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.678 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.55 150.6 21.31 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.785 -1.198 . . . . 0.0 111.789 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.79 10.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.973 -0.613 . . . . 0.0 112.429 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.2 m-20 -79.8 -21.83 43.83 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.996 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.0 -43.02 1.76 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.194 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.09 40.02 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.981 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -112.34 116.71 30.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.557 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.7 mm -120.47 127.87 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 120.091 -0.643 . . . . 0.0 110.648 -170.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -112.8 125.4 54.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.152 0.907 . . . . 0.0 108.599 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.8 t -109.09 117.88 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' ND2' HE21 ' A' ' 11' ' ' GLN . 6.3 m-80 -98.3 129.34 45.0 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.379 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -98.58 102.56 14.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.274 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 7' ' ' LYS . 29.1 mm -90.74 129.99 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.013 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -97.86 156.6 16.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.787 0.68 . . . . 0.0 109.723 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -144.61 -50.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.356 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.9 m-20 -141.51 109.15 5.64 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.211 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.6 m-20 -131.06 -31.72 1.67 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.66 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.38 50.99 0.59 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.83 27.29 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.616 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 8.4 m 45.77 59.1 15.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.2 Cg_endo -89.01 42.41 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.438 1.425 . . . . 0.0 109.547 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.54 HD13 HD22 ' A' ' 79' ' ' ASN . 22.7 mm -82.42 151.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.916 0.865 . . . . 0.0 111.255 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -130.25 115.06 16.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.677 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.5 p-80 37.38 -172.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.2 m-85 -139.94 154.05 47.1 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.187 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.92 109.9 20.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' VAL . 47.7 t -113.73 121.26 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.88 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -132.42 140.24 48.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.607 1.192 . . . . 0.0 108.132 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.409 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -145.36 156.22 43.65 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.808 -1.557 . . . . 0.0 112.389 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.603 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 5.0 ptm180 -129.17 160.34 33.2 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.598 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -114.14 -172.88 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.146 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 11.5 tp -91.31 41.69 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.448 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.48 -58.86 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -120.02 151.29 39.21 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.387 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -106.68 153.77 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.825 -176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.603 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 38.83 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.652 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 65.2 mttm -77.28 162.75 68.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.255 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.2 Cg_exo -43.39 99.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.946 1.764 . . . . 0.0 110.814 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.67 175.71 6.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.268 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.96 153.91 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.301 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -113.49 135.85 53.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.929 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -84.71 162.68 49.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.824 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -69.16 145.7 61.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.716 1.611 . . . . 0.0 109.755 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.428 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.4 m -59.8 102.6 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 123.934 0.771 . . . . 0.0 111.479 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 52.68 0.56 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -97.13 -179.49 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.563 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.98 -34.59 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.515 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -148.51 167.7 24.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.204 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.1 p -133.4 153.97 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.746 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -138.76 151.68 47.3 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.568 -1.253 . . . . 0.0 112.515 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.25 142.7 42.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.74 173.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -142.94 153.14 42.76 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.081 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t 72.25 42.98 0.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.589 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.2 mm? -87.62 -172.31 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.666 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.29 143.33 28.77 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.637 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -76.46 154.69 34.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.744 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.59 49.41 6.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.768 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.92 49.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.575 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 29.2 tt0 -97.51 147.91 23.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.407 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 30.8 m-85 -133.0 142.72 48.99 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.515 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 4.6 mp0 -119.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.78 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.91 122.7 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.0 m-85 -111.1 124.2 51.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.34 120.8 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.863 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.4 t -105.76 158.05 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.17 164.9 22.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.658 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.2 tt0 -118.71 162.48 18.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.222 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.548 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.5 t-20 -151.16 154.47 36.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.356 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -41.99 -34.02 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.61 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -79.41 -45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.891 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.76 -118.71 0.51 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -118.46 163.2 17.11 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.613 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.92 116.03 22.93 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.869 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -39.05 158.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.297 1.623 . . . . 0.0 112.784 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.04 139.71 32.33 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.544 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.37 146.29 30.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -116.47 130.87 56.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.785 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 74.6 t80 -118.01 130.22 56.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.21 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.58 140.52 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.971 -176.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.557 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 36.6 p90 -161.57 179.04 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -130.63 148.48 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.836 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -79.91 172.3 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.522 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -85.54 -171.22 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.099 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.96 142.77 35.1 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.081 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 116.199 -1.858 . . . . 0.0 110.443 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.1 Cg_endo -63.77 166.65 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.36 2.04 . . . . 0.0 112.586 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.15 165.79 15.47 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.468 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.79 142.85 88.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.11 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.42 167.22 23.0 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.412 1.408 . . . . 0.0 110.54 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -101.7 131.83 47.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.02 113.74 27.52 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.844 -1.142 . . . . 0.0 110.277 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.36 142.29 32.04 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.257 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -118.51 136.46 12.21 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 118.877 -1.63 . . . . 0.0 113.82 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -128.43 137.91 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.647 -0.777 . . . . 0.0 109.464 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.5 ttm -109.33 134.42 51.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.502 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.62 146.15 22.26 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.855 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.87 8.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.89 -30.11 40.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.783 175.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.54 -39.43 2.06 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.407 -1.378 . . . . 0.0 113.174 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -130.27 -14.75 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.697 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -54.17 113.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.214 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.3 mm -116.78 130.71 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.076 -174.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -116.98 124.77 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.859 0.724 . . . . 0.0 109.084 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -110.23 120.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -97.09 133.22 42.04 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.343 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 41.0 mt -101.55 101.45 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -93.78 131.01 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -101.74 157.66 16.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.738 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -51.44 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.649 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -145.4 103.93 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.428 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.6 m-20 -117.25 -40.21 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.738 0.649 . . . . 0.0 109.714 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.57 52.95 0.21 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.29 20.56 29.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 19.5 m 42.16 60.84 9.12 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.9 Cg_endo -90.44 42.85 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.553 1.502 . . . . 0.0 109.112 172.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 79' ' ' ASN . 23.2 mm -81.44 151.42 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.989 0.899 . . . . 0.0 111.367 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.4 mtt180 -130.52 114.37 15.41 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.835 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.7 p-80 35.77 -170.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.4 m-85 -139.99 150.64 44.71 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.006 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.07 110.86 23.26 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.52 127.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.812 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -132.49 140.7 48.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.012 1.445 . . . . 0.0 107.834 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.17 157.01 43.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.56 -1.656 . . . . 0.0 112.591 177.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.8 ptm180 -134.41 165.3 25.48 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.354 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -127.53 177.74 6.56 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.303 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.56 40.96 0.53 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.838 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -142.34 -62.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.904 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -129.7 171.23 12.87 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.267 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -116.46 160.87 19.96 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.211 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.9 m95 28.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.347 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 52.0 mttp -72.63 160.08 83.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.351 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.7 Cg_exo -41.77 107.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.1 1.866 . . . . 0.0 111.579 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.16 160.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.623 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -131.35 147.95 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.156 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -113.71 125.03 53.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -69.88 164.23 53.4 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.271 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.63 172.21 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.804 1.669 . . . . 0.0 110.635 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -74.5 76.92 1.95 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.974 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.47 64.78 0.59 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.526 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -89.63 -176.99 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.851 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -126.63 -14.11 5.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.503 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 42.2 p-80 -159.18 170.34 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.753 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p -136.87 150.81 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 124.864 1.353 . . . . 0.0 108.582 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -133.72 150.0 51.5 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.152 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.584 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.3 pp -143.85 144.88 31.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.539 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -140.27 172.17 13.12 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.789 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.7 m 57.84 59.66 3.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.631 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.6 mt -95.21 177.9 5.71 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.353 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.51 124.15 22.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.252 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 77.1 m95 -70.74 148.49 47.9 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 50.77 49.77 20.32 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.671 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.27 152.27 50.69 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.27 151.78 22.41 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.698 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.7 m-85 -137.04 141.28 42.47 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.6 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.65 121.08 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.721 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.26 123.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.438 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 43.9 m-85 -113.03 125.51 54.48 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.46 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.534 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.2 159.41 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.07 155.38 44.46 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.548 -1.261 . . . . 0.0 109.805 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.8 tt0 -110.81 163.85 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.86 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.483 HD22 HD13 ' A' ' 33' ' ' ILE . 18.6 t-20 -153.69 154.21 33.7 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.577 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -40.45 -43.48 1.82 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.327 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -101.84 37.05 1.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.33 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.23 -134.02 8.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.22 -179.99 6.86 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.585 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -130.05 124.31 32.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -45.79 171.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 125.516 1.76 . . . . 0.0 111.686 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.55 145.96 25.42 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.605 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.72 147.96 27.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.908 -1.497 . . . . 0.0 106.982 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.522 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.8 t-160 -116.14 130.96 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.592 -173.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.4 t80 -118.65 130.56 55.92 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.737 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.522 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.95 140.44 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.854 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 19' ' ' ILE . 48.3 p90 -157.44 -178.76 7.58 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.849 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -128.97 145.07 51.34 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.353 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.93 168.42 19.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.901 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.1 m -81.78 -176.47 6.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.291 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.23 144.16 30.43 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.321 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.219 -1.848 . . . . 0.0 110.505 -178.088 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.6 Cg_exo -57.93 171.85 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.417 2.078 . . . . 0.0 113.011 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -95.43 159.66 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.682 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.32 141.86 98.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.896 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.09 167.52 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.28 1.32 . . . . 0.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -100.64 127.77 46.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.38 109.79 21.54 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.922 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.13 137.81 37.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.49 142.87 16.16 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.489 -1.815 . . . . 0.0 113.791 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -129.4 138.79 51.68 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.093 -1.053 . . . . 0.0 109.361 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.487 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.2 tpp -104.72 131.52 52.07 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.42 150.31 23.43 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.525 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.72 8.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.0 m-20 -79.87 -23.03 42.2 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.125 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.8 -50.87 0.76 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.649 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 9.8 p30 -123.87 1.36 8.7 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.33 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.6 m -69.56 116.75 10.32 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.301 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -115.41 127.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.776 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -115.07 124.78 52.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.023 0.827 . . . . 0.0 109.072 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.5 t -112.45 120.69 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -98.2 130.48 44.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.04 100.88 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.27 130.7 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.868 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -104.16 153.04 21.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.842 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.05 -49.89 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.915 -174.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.6 m-20 -139.76 111.63 7.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.008 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -130.02 -37.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.123 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.51 55.05 0.36 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 20.42 35.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.628 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.7 t 44.15 60.61 11.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 114.8 -0.7 . . . . 0.0 112.728 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -89.42 43.39 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.393 1.395 . . . . 0.0 109.214 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mm -88.54 149.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.877 0.846 . . . . 0.0 111.266 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 69.2 mtt85 -131.46 123.55 28.34 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.867 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.9 p-80 36.69 -173.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.7 m-85 -139.74 153.57 47.22 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.784 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.49 109.42 21.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 48.2 t -113.32 125.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.204 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -136.45 141.1 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.56 158.06 43.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.069 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.614 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 9.0 ptm85 -133.96 159.36 40.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.645 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -116.81 -177.8 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.92 41.58 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.792 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.65 -61.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.335 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -118.99 149.68 41.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.528 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 23.9 pt-20 -117.53 144.73 44.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.588 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.614 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 56.87 77.48 0.26 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.027 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 25.9 mmmt -72.57 163.27 69.15 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.541 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -46.57 99.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.823 1.682 . . . . 0.0 110.444 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.32 172.7 2.99 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.529 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.17 153.81 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.951 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -112.84 131.77 55.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.949 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.455 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.8 mt -81.84 163.76 52.06 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.861 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.26 152.43 76.46 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.771 1.647 . . . . 0.0 110.438 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 33.7 m -68.61 93.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.885 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.91 52.71 0.46 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -97.22 170.13 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.394 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.93 -36.66 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.996 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -146.56 169.48 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.579 -1.248 . . . . 0.0 112.124 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -132.76 151.79 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.885 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ptp -135.65 148.31 48.91 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.894 -1.123 . . . . 0.0 112.022 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 65' ' ' LEU . 1.5 pp -141.32 144.2 34.46 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.458 174.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -140.16 170.36 15.98 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.663 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 m 61.19 57.03 2.56 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.042 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 62' ' ' LEU . 10.6 mp -94.95 178.52 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -71.99 133.06 45.1 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.248 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.403 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.4 m95 -72.93 151.47 41.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.837 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 46.97 49.08 15.05 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.54 152.08 48.7 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.051 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -92.66 148.72 21.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.1 m-85 -136.05 143.33 44.62 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.692 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 3.7 mp0 -119.2 122.66 42.49 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.139 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.96 123.4 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.7 m-85 -112.57 125.98 54.85 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.6 t -122.45 121.8 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 124.047 0.842 . . . . 0.0 110.677 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.33 159.07 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.34 156.68 42.7 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.751 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.41 153.82 25.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.392 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.2 t-20 -141.25 150.83 43.13 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.143 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -36.12 -43.82 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.846 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -108.33 35.9 3.0 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -152.31 21.5 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.072 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -120.97 158.15 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.32 120.43 37.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -40.05 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 125.81 1.944 . . . . 0.0 113.492 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.0 136.41 34.06 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.051 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.94 145.68 28.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.486 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.49 129.43 56.54 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.574 -174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 71.6 t80 -117.5 129.75 56.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.34 140.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.749 -176.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.2 p90 -158.63 -179.34 7.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.071 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -129.55 147.63 51.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.568 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.4 p -79.88 166.83 21.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -82.44 -172.01 3.78 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.66 148.28 24.51 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.325 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 116.474 -1.727 . . . . 0.0 110.652 -178.799 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.9 Cg_exo -61.3 172.84 2.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.6 2.2 . . . . 0.0 112.99 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -97.06 163.45 12.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.479 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.0 99.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.164 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.91 172.14 12.31 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.451 1.434 . . . . 0.0 110.463 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -107.04 133.48 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.1 mt -106.46 115.9 31.01 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.262 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.39 140.49 31.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.45 129.05 9.37 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.656 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -124.53 124.73 42.9 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.9 ttm -106.96 133.76 51.13 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.8 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.25 150.55 22.83 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.596 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.35 14.01 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.074 -0.563 . . . . 0.0 111.936 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.86 -24.31 41.33 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.684 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 -40.53 2.45 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.706 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 9.4 p30 -138.18 48.68 1.96 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.92 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -120.82 115.11 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.552 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.9 mm -117.05 129.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -114.01 125.16 53.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.3 t -107.7 115.0 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -96.73 130.41 43.98 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.313 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.84 109.66 22.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.637 -173.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.29 132.5 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -104.4 148.0 26.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.82 0.7 . . . . 0.0 109.408 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.56 -66.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.135 -174.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.7 m-20 -127.77 110.92 13.09 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.27 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.7 m-20 -128.83 -37.09 1.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.986 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 56.87 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 18.65 43.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 45.16 60.15 13.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.791 -0.704 . . . . 0.0 112.87 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -88.89 42.52 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.458 1.438 . . . . 0.0 109.365 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 79' ' ' ASN . 22.6 mm -83.43 151.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.878 0.847 . . . . 0.0 111.446 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 78.4 mtt-85 -131.05 117.31 18.95 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.886 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.57 -173.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 82.2 m-85 -137.85 154.26 49.51 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.052 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.5 mt -110.33 111.49 22.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 60' ' ' VAL . 46.4 t -115.12 123.98 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.146 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -132.35 138.56 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.688 1.242 . . . . 0.0 107.938 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.2 p90 -144.05 158.43 43.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.916 -1.514 . . . . 0.0 112.45 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.4 ptm180 -141.88 169.79 16.94 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.442 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -128.14 168.87 14.8 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.767 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.92 43.53 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.724 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -153.4 -51.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.931 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 p -125.87 148.06 49.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.111 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -103.1 167.23 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.865 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.7 m95 18.33 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.952 -1.476 . . . . 0.0 114.226 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.7 mttp -77.18 163.55 64.17 Favored Pre-proline 0 N--CA 1.49 1.525 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.072 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.7 Cg_exo -44.68 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.803 1.668 . . . . 0.0 110.908 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.02 175.27 3.84 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.394 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.04 154.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.362 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 42.7 ttm180 -114.95 134.06 55.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.812 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.2 mt -82.42 162.99 54.33 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.027 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 3.9 Cg_exo -59.88 169.86 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.773 1.649 . . . . 0.0 110.633 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -74.64 77.82 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.935 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.5 65.82 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 t -97.01 -174.54 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.71 -23.02 4.43 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.618 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.6 p-80 -160.23 168.31 25.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.994 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.5 p -131.87 151.4 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.268 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -137.3 152.07 49.36 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.827 -176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.14 139.1 33.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.43 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 64' ' ' SER . 51.8 mtmt -142.5 141.43 32.11 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.85 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.5 t 93.51 45.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.345 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.7 mm? -96.56 178.51 5.31 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.391 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -68.17 133.44 48.9 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.612 0.72 . . . . 0.0 111.493 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.73 154.25 39.69 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.227 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.42 48.9 8.23 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.565 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.63 49.82 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.802 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.37 144.05 26.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 6.0 m-85 -129.74 144.84 51.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.912 0.758 . . . . 0.0 112.463 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -119.79 124.01 45.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.409 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.2 t -116.07 123.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 38.9 m-85 -111.49 124.92 53.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -120.02 122.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 123.876 0.735 . . . . 0.0 110.567 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -106.94 157.8 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 155.63 42.86 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.58 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.67 158.87 18.78 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.233 -1.387 . . . . 0.0 107.73 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.6 t-20 -146.45 153.28 40.26 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.543 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -42.4 -37.68 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.466 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -103.01 29.77 5.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.5 -148.04 19.35 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.849 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -122.23 158.82 28.62 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.967 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.7 t -121.86 124.13 43.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.35 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -40.92 165.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.735 1.897 . . . . 0.0 113.59 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.45 140.97 28.92 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.45 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.53 30.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.19 129.45 56.65 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.408 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 67.5 t80 -116.87 130.23 56.57 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.033 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.63 140.74 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.593 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.31 178.09 10.72 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.777 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -128.12 145.21 51.08 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.894 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.8 p -79.88 171.37 15.2 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.154 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -86.53 -170.47 3.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.134 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.72 141.19 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.242 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.536 -1.697 . . . . 0.0 110.672 -179.366 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.46 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 12.4 Cg_exo -56.89 173.26 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.601 2.201 . . . . 0.0 113.1 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -95.76 163.04 13.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.239 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.73 142.07 95.53 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.173 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.48 171.21 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.606 1.538 . . . . 0.0 110.686 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.509 ' CG ' HE22 ' A' ' 26' ' ' GLN . 38.1 mtpt -98.03 139.92 33.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.4 mt -111.29 110.21 20.59 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.15 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.04 141.51 28.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.793 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.8 123.32 7.29 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.17 -173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -120.88 123.09 41.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.3 ttm -104.14 131.86 50.99 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.19 146.25 23.75 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.719 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.14 9.53 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.76 -30.25 40.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.858 175.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.29 -41.47 1.68 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.062 177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.91 -15.05 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.676 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.0 m -55.37 116.5 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.552 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.0 mm -117.55 130.35 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.552 -173.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.1 125.68 52.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.939 0.774 . . . . 0.0 108.996 172.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.584 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 60.2 t -107.33 113.47 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 126.69 37.0 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.212 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.7 mt -99.11 107.22 19.54 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.899 -172.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.2 mm -92.44 106.27 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.524 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.73 140.89 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.509 HE22 ' CG ' ' A' ' 7' ' ' LYS . 2.4 pt20 -138.17 -78.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.355 -172.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.1 m-20 -106.14 100.82 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.962 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -132.36 -35.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.277 -179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 51.45 0.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.01 17.75 36.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.602 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 41.39 61.09 7.99 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -86.48 51.58 2.6 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.685 1.59 . . . . 0.0 108.73 172.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.5 mm -87.41 150.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.031 0.92 . . . . 0.0 111.622 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.8 mtt180 -129.94 119.38 23.14 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.413 -1.722 . . . . 0.0 108.543 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.53 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.7 p-80 34.73 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.516 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.2 m-85 -139.52 151.18 45.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.009 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mt -107.48 110.78 22.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.2 128.2 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.913 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.73 140.23 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 125.036 1.46 . . . . 0.0 107.979 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.56 156.52 43.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.726 -1.59 . . . . 0.0 112.657 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -131.58 156.99 44.8 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.073 -177.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.629 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -119.33 168.56 10.8 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 tp -73.59 42.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.795 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.93 -57.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.083 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.3 m -128.62 153.06 47.65 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.141 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -104.99 165.49 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.044 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.62 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.448 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.9 mttm -77.03 159.99 77.2 Favored Pre-proline 0 N--CA 1.491 1.618 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.334 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 24.3 Cg_exo -40.45 111.65 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.188 1.926 . . . . 0.0 111.895 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.71 164.87 4.29 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.809 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -136.4 151.18 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.365 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -117.34 132.24 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.241 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -79.07 165.13 51.02 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.508 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.33 159.79 29.72 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.808 1.672 . . . . 0.0 110.682 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 95.34 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.94 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 96.92 65.35 0.92 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -97.14 -172.57 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.469 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -122.16 -43.81 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.741 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 22.6 p-80 -147.13 167.44 24.13 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.061 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.5 p -122.48 149.54 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.375 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -132.87 147.12 52.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.606 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -139.48 137.76 35.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.991 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -139.55 158.16 44.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.463 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t 71.88 49.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.203 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -97.82 -174.22 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.233 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.6 133.51 38.44 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.666 0.746 . . . . 0.0 111.081 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.51 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 72.1 m95 -75.17 156.95 35.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.074 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 45.53 46.3 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.769 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.7 154.66 46.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.11 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -96.69 147.65 23.69 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.629 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.5 m-85 -134.0 140.85 46.98 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.471 -178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 119.48 34.26 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.205 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.6 t -113.77 127.65 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 55.0 m-85 -114.82 126.58 54.98 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.58 121.54 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.627 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -105.84 156.06 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.91 156.01 42.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.523 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -109.96 156.24 20.72 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.821 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 13.2 t-20 -140.53 149.88 43.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.958 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -34.14 -45.34 0.21 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.758 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -113.97 40.15 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.82 -156.85 26.11 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.378 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -120.33 159.6 24.71 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.725 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 24.8 t -120.59 120.64 36.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -41.0 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.633 1.833 . . . . 0.0 113.189 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.95 136.16 34.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.338 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.93 144.42 29.01 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.8 t-160 -114.81 130.08 56.8 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.284 -174.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.192 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.86 137.98 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.571 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.6 p90 -156.04 177.47 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.163 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.27 146.17 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.623 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -83.76 164.59 19.48 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -80.48 -171.13 2.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.273 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.15 139.18 39.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.208 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.461 -1.733 . . . . 0.0 110.801 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.2 Cg_exo -58.04 172.83 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.621 2.214 . . . . 0.0 113.31 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -101.6 162.54 12.82 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.407 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.92 142.27 85.26 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.364 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.82 154.12 67.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.501 1.468 . . . . 0.0 109.962 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HG3' HE22 ' A' ' 26' ' ' GLN . 31.0 mtmt -83.39 139.66 32.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 mt -109.03 108.98 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.313 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -93.89 144.71 25.19 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.462 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -112.93 130.58 9.57 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.302 -1.427 . . . . 0.0 112.889 -171.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -125.37 129.87 50.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.0 ttm -107.28 134.49 50.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.55 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -90.52 151.53 21.42 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.679 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.91 9.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.11 -0.545 . . . . 0.0 112.353 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.92 -20.55 45.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.009 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 108.54 -41.98 2.07 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.633 -1.27 . . . . 0.0 111.163 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 12.9 p30 -127.86 2.15 6.01 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.915 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -65.42 111.92 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.248 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.56 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.5 mm -116.34 126.36 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.968 -176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -114.71 124.93 53.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 123.933 0.771 . . . . 0.0 108.949 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.4 t -108.87 118.58 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.7 128.42 42.56 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.6 mt -97.95 102.27 13.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 123.914 0.759 . . . . 0.0 109.079 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.31 103.04 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.715 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -77.6 149.95 34.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.75 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.405 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.7 pt20 -147.31 -51.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.946 -1.101 . . . . 0.0 112.406 -172.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 106.11 7.06 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.098 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.4 m-20 -129.42 -39.33 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.22 57.16 0.38 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.65 18.42 41.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.627 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.8 t 44.76 60.47 12.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -89.15 43.98 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.476 1.451 . . . . 0.0 109.071 172.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.67 150.95 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.883 0.849 . . . . 0.0 111.543 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.8 mtt85 -129.22 117.56 20.93 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.07 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.9 p-80 32.02 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.506 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 69.4 m-85 -134.62 152.35 51.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.173 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.62 113.36 26.28 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 60' ' ' VAL . 52.9 t -115.79 128.55 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.209 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -135.41 139.68 44.35 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.24 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.35 154.54 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.161 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.6 ptm180 -126.49 160.74 29.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.671 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.64 -169.27 1.47 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.8 tp -96.97 41.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.587 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.22 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 p -121.65 150.02 42.35 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.999 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -113.27 150.04 33.01 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.22 -172.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.5 m95 47.79 83.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.562 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 46.1 mmtm -66.29 161.49 56.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.368 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -47.22 105.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.77 1.647 . . . . 0.0 110.81 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.25 154.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.464 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -129.55 148.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.269 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -114.26 128.59 56.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.753 -0.779 . . . . 0.0 108.899 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.58 163.97 63.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.712 -176.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -78.23 132.39 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.879 1.719 . . . . 0.0 107.74 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -56.58 131.95 50.24 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.44 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.26 34.26 5.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 m -96.98 152.47 18.69 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.961 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.07 -28.08 10.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.033 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -145.49 165.72 27.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.36 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 10.6 p -128.58 150.12 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.269 174.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -134.74 149.85 50.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.741 -1.184 . . . . 0.0 112.509 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.1 pp -141.61 146.48 36.28 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.765 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -139.2 178.57 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.867 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.1 m 54.34 55.24 8.35 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.733 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 62' ' ' LEU . 25.1 mt -91.49 176.55 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.867 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -73.45 128.22 34.89 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.828 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.416 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 81.7 m95 -71.06 149.92 46.06 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.951 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 48.05 50.33 16.12 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.604 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.43 154.51 47.65 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.792 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.94 147.83 23.27 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.285 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 13.5 m-85 -133.23 143.88 49.43 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.521 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.04 119.24 29.76 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.16 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.39 124.57 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 53.8 m-85 -114.21 125.78 54.31 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.36 123.46 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 123.991 0.807 . . . . 0.0 110.416 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.72 157.18 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.26 156.4 40.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.079 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -110.12 160.25 16.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.823 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.529 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -146.46 151.81 38.0 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.372 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -34.89 -46.15 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.644 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -109.19 38.81 2.2 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.99 -150.55 20.65 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.147 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -123.23 159.58 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.04 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.99 118.06 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -39.32 163.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.849 1.968 . . . . 0.0 113.725 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.44 137.49 32.88 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.15 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.34 29.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.03 130.39 56.93 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.534 -174.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.9 t80 -118.33 130.56 56.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.117 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.61 139.11 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.647 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.5 p90 -159.88 179.36 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.266 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -128.04 147.46 50.51 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.642 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.4 p -79.92 168.39 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.81 -170.45 3.0 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.172 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.25 141.61 36.47 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.16 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 116.143 -1.884 . . . . 0.0 110.398 -178.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.0 Cg_exo -59.15 169.85 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.372 2.048 . . . . 0.0 113.639 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -94.89 177.51 5.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.16 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.34 144.97 58.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.139 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -71.68 164.99 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.691 1.594 . . . . 0.0 110.531 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' CB ' HE22 ' A' ' 26' ' ' GLN . 10.3 mtpp -93.43 132.62 37.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.04 108.83 20.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.795 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.49 135.28 42.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.75 143.59 16.44 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.455 -1.831 . . . . 0.0 113.151 -171.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.412 HE21 HD21 ' A' ' 22' ' ' ASN . 71.5 mt-30 -131.14 139.56 49.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 108.942 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -108.88 132.77 53.72 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.708 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.39 150.74 27.47 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.326 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.19 13.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.931 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.94 -25.28 40.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.664 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.01 -44.63 1.46 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.066 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.568 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 10.8 p30 -134.41 44.8 2.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.321 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -112.9 110.63 20.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.7 mm -114.13 128.48 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.421 -170.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.38 124.82 51.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.3 t -111.84 120.13 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.412 HD21 HE21 ' A' ' 11' ' ' GLN . 14.7 m-20 -96.65 130.7 43.82 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.524 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 36' ' ' TYR . 40.2 mt -99.99 103.43 14.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.943 0.777 . . . . 0.0 109.114 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.67 108.4 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.554 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -70.13 169.43 13.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.2 pt20 -170.25 -69.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.689 -1.204 . . . . 0.0 111.399 -175.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 16.9 t70 -115.23 89.39 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.019 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -130.85 -17.63 3.14 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.776 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.34 52.35 1.6 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.417 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.27 22.75 50.71 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 44.26 64.37 7.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 114.78 -0.71 . . . . 0.0 112.736 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.7 Cg_endo -88.13 46.22 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 171.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 mm -92.55 151.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.197 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -128.19 115.19 17.99 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.05 -1.886 . . . . 0.0 108.098 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.1 p-80 35.69 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.3 m-85 -142.86 137.95 29.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.013 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -88.19 111.07 21.22 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 60' ' ' VAL . 65.8 t -112.22 126.8 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.306 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -132.55 138.8 47.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 125.08 1.488 . . . . 0.0 107.632 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.17 156.31 43.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.715 -1.594 . . . . 0.0 112.223 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.2 ptm180 -134.88 163.54 29.6 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.892 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -120.71 -168.25 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.773 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.5 tp -93.28 40.54 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.825 170.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.8 -61.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.572 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.59 157.78 30.0 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.231 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -109.69 156.21 20.54 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.594 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.532 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.1 m95 34.42 83.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.108 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.2 mmtt -70.45 161.54 75.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.203 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.8 Cg_exo -43.2 107.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.982 1.788 . . . . 0.0 111.556 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -55.18 161.27 1.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.729 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.281 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttp85 -112.43 118.06 34.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.2 mm? -60.12 165.9 4.43 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.036 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.1 Cg_exo -61.47 141.67 92.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.37 1.38 . . . . 0.0 109.483 172.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -59.15 88.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.568 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.453 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 106.52 58.9 0.6 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -97.12 -173.49 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.449 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.97 -25.48 3.59 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.536 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 15.4 p-80 -160.07 167.51 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.394 -1.323 . . . . 0.0 112.574 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -130.73 150.27 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.671 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -134.92 147.74 49.89 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.777 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -140.46 142.86 35.31 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.226 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 178.68 6.68 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.536 -175.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m 49.06 56.89 7.1 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.687 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 10.2 mt -91.99 164.34 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.527 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 4.4 m-20 -61.36 129.78 42.9 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.832 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -71.8 147.84 46.84 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 47.16 51.09 13.54 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.623 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -129.52 151.62 49.94 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.264 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 36.3 mt-10 -89.2 146.74 24.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 m-85 -133.97 140.84 47.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.531 -176.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -122.11 123.4 41.46 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.585 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -113.79 122.57 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 39.7 m-85 -112.29 124.06 51.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.49 120.6 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.86 0.725 . . . . 0.0 110.702 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 86' ' ' ALA . 1.9 t -103.78 164.45 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 154.08 49.85 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.679 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.79 156.37 22.98 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.789 -1.165 . . . . 0.0 107.88 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -144.97 152.33 40.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -40.83 -40.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.144 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.65 35.83 2.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.91 -151.32 20.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.98 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -128.41 161.59 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.573 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -126.76 128.24 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.881 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -46.14 173.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 125.608 1.817 . . . . 0.0 112.906 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -93.63 145.34 24.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.31 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.81 146.61 28.38 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 171.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 90' ' ' VAL . 11.0 t-160 -115.69 129.8 56.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.457 -174.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 51.7 t80 -119.95 131.95 55.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.6 t -129.69 144.18 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.209 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 47.6 p90 -159.83 -177.97 6.72 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.977 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -129.64 145.66 51.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.471 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 169.22 18.23 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -84.43 -169.94 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.305 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.53 142.02 36.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.008 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 116.542 -1.694 . . . . 0.0 110.685 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HG3' HD22 ' A' ' 79' ' ' ASN . 3.1 Cg_exo -61.77 169.25 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.824 . . . . 0.0 112.169 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 m -91.09 152.95 20.42 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.66 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 143.53 93.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.165 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.88 167.63 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.329 1.353 . . . . 0.0 110.45 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -103.4 132.69 49.45 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.1 mt -104.6 113.85 27.7 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.158 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -95.66 143.18 27.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 127.38 8.76 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.586 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -123.3 121.12 35.04 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.1 ttm -105.14 132.55 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.658 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.37 149.73 21.45 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.318 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -65.75 14.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.907 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.1 m-20 -80.01 -24.59 40.72 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.549 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.16 -42.73 1.87 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.41 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -131.84 10.02 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.18 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -77.98 112.81 15.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.256 -0.977 . . . . 0.0 108.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.521 HD11 ' CE2' ' A' ' 91' ' ' PHE . 9.5 mm -116.34 126.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.972 -172.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.38 127.11 56.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.4 t -108.01 116.55 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -97.28 129.4 44.58 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.424 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 44.7 mt -99.2 106.39 18.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.758 0.661 . . . . 0.0 109.491 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -96.29 129.82 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -105.55 153.33 21.9 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.506 -177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.68 0.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.191 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.93 116.47 10.74 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.724 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.3 m-20 -126.66 -44.6 1.66 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.872 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.8 65.28 0.26 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.33 64.15 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -174.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.61 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.4 t 44.03 60.63 11.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 114.58 -0.81 . . . . 0.0 113.008 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 31' ' ' SER . 19.6 Cg_endo -91.24 52.28 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.782 1.655 . . . . 0.0 109.337 174.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.67 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.842 0.829 . . . . 0.0 111.423 -174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -131.41 118.91 20.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.034 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.4 p-80 36.1 -172.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.539 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.4 m-85 -140.26 151.07 44.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.754 176.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.96 111.61 23.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 60' ' ' VAL . 61.8 t -114.8 124.45 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.324 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.7 141.33 46.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.789 1.306 . . . . 0.0 107.911 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.34 157.7 43.69 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.731 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -132.01 162.87 29.7 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.032 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -113.2 -169.13 1.43 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.2 tp -94.22 40.76 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.263 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.81 -59.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.504 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -114.02 147.94 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.197 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.5 pt-20 -107.83 157.53 18.09 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.762 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.508 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.7 m95 31.51 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.185 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 69.3 mmtt -72.57 162.04 76.11 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.111 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.4 Cg_exo -45.13 100.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.837 1.691 . . . . 0.0 110.614 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.34 173.06 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.617 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 tt -138.52 155.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.133 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -114.15 127.41 55.89 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.03 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -73.36 166.46 43.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.562 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.62 165.69 11.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.836 1.691 . . . . 0.0 110.635 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -75.43 79.5 2.48 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.071 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.69 57.96 0.34 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -97.04 170.19 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.546 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -120.32 -3.5 9.98 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.606 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.16 164.2 33.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.83 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.2 p -138.76 154.27 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.732 172.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptp -138.2 152.74 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.738 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.4 pp -144.64 146.35 32.22 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.783 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -141.87 173.29 11.65 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.532 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t 58.65 60.77 2.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.455 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 62' ' ' LEU . 14.6 mt -98.76 178.58 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.442 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 5.0 m-20 -71.3 128.52 36.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.147 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 82.3 m95 -71.78 151.31 43.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.459 -1.296 . . . . 0.0 109.999 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.86 50.37 11.21 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.687 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -127.92 151.57 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.024 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -89.73 145.29 25.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.9 m-85 -132.68 141.52 48.64 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.568 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.6 119.39 29.74 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.54 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -112.59 124.81 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.7 m-85 -112.71 125.49 54.37 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.74 121.99 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.406 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.4 158.26 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.5 158.42 37.45 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.634 -1.226 . . . . 0.0 109.235 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 26.6 tt0 -112.86 157.41 21.44 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.289 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.489 HD22 ' HG3' ' A' ' 3' ' ' PRO . 15.3 t-20 -139.42 148.03 42.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.696 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -35.61 -44.06 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.796 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -114.89 41.87 2.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.575 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.51 -155.15 25.95 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.563 -1.303 . . . . 0.0 111.188 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -122.28 167.44 13.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.671 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 2.2 t -123.93 116.97 23.75 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -40.71 162.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.554 1.784 . . . . 0.0 113.284 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.87 136.33 35.36 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.356 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.58 146.28 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.54 130.56 56.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.596 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -116.57 126.81 53.83 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.961 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -124.37 136.68 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.561 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CE2' HD11 ' A' ' 19' ' ' ILE . 40.4 p90 -157.33 -178.93 7.72 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.012 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -129.55 146.48 51.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.486 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -79.92 168.97 18.55 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.734 -0.787 . . . . 0.0 108.885 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.93 -169.97 2.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.656 -0.817 . . . . 0.0 110.184 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.89 140.57 39.5 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 116.551 -1.69 . . . . 0.0 110.808 -178.606 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 4.2 Cg_exo -59.86 165.28 10.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.427 2.085 . . . . 0.0 113.269 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -86.29 169.77 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.559 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.41 139.02 63.51 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.746 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -69.58 169.04 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.561 1.507 . . . . 0.0 110.411 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' HB2' HE22 ' A' ' 26' ' ' GLN . 1.1 tmmt? -96.12 138.44 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.3 107.18 17.98 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.789 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 20.8 tt0 -86.71 140.8 29.42 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.455 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.52 119.56 6.3 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.89 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -120.31 117.54 28.07 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.452 ' CE ' HD11 ' A' ' 19' ' ' ILE . 55.4 tpp -100.44 132.33 45.88 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.156 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.08 149.01 20.52 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.456 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -65.38 13.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.08 -0.56 . . . . 0.0 112.047 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.91 -25.21 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.448 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.08 -48.8 0.91 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.575 -1.298 . . . . 0.0 111.388 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -128.44 0.08 5.63 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.104 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -67.84 117.98 10.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.339 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.524 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.03 128.71 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.307 -172.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -114.26 127.3 55.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 123.981 0.801 . . . . 0.0 108.926 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 53.9 t -107.95 117.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 5.9 t-20 -90.9 124.55 35.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.899 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -98.51 96.89 8.29 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.91 106.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.612 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -77.06 151.43 35.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.515 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.8 pt20 -148.06 -63.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.296 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.21 93.51 3.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.344 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 2.5 m-20 -122.08 -34.51 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.054 0.846 . . . . 0.0 109.944 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.48 55.16 0.33 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.62 46.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -175.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.581 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 66.2 m 41.95 61.9 7.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.5 Cg_endo -86.7 46.6 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.715 1.61 . . . . 0.0 108.503 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.7 mm -82.58 152.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.468 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 35' ' ' HIS . 49.9 mtt180 -129.6 114.26 15.83 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.544 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.596 ' H ' ' H ' ' A' ' 56' ' ' GLY . 9.1 p-80 35.46 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.0 m-85 -142.2 151.74 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.744 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.78 109.56 21.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 60' ' ' VAL . 57.3 t -115.31 123.32 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.341 -172.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.84 140.37 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.613 1.196 . . . . 0.0 108.028 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.36 154.06 41.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.971 -1.492 . . . . 0.0 112.492 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.2 ptm180 -131.52 165.0 24.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.916 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -121.48 174.64 6.64 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.153 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -79.45 42.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.045 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.52 -59.02 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.288 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.8 m -124.7 152.99 43.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.056 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -101.98 162.68 12.72 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.808 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.496 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 25.16 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.575 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.5 mttp -74.91 163.37 68.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.843 175.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.95 99.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.916 1.744 . . . . 0.0 110.917 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.55 175.97 3.17 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.352 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.74 154.99 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.207 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -116.68 129.79 56.35 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.842 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -75.25 163.49 67.48 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.09 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.79 144.34 48.27 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.775 1.65 . . . . 0.0 109.677 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -51.95 110.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.935 0.772 . . . . 0.0 111.842 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.596 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 94.33 58.99 1.18 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.865 -1.16 . . . . 0.0 110.581 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -97.19 -177.27 3.79 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.135 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -134.4 -33.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.918 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -143.96 163.17 34.22 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.811 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.557 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -131.3 152.05 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.279 173.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.418 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -137.73 156.03 48.44 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.086 -176.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -144.22 140.98 29.61 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.121 174.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -140.61 158.62 43.72 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.276 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t 72.01 51.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.443 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.7 mm? -100.6 -176.8 3.3 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.626 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.47 131.17 40.81 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -73.3 155.77 39.12 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.985 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 48.37 45.68 20.47 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.55 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.01 152.9 49.82 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.357 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -95.22 148.7 22.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.8 m-85 -133.44 143.8 49.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.706 -178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.63 119.64 34.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.521 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.72 124.28 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.8 m-85 -111.75 125.33 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.14 120.53 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.909 0.756 . . . . 0.0 110.595 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.37 155.68 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.01 154.67 40.88 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.335 -1.346 . . . . 0.0 109.513 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.7 tt0 -111.08 161.02 16.33 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.33 -1.348 . . . . 0.0 107.652 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.1 t-20 -148.84 153.36 37.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.125 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -39.5 -39.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.61 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.7 -44.89 19.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.59 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.77 -127.1 0.89 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.676 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -124.41 159.07 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.07 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.0 t -124.44 124.39 42.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.37 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -41.49 163.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 125.629 1.831 . . . . 0.0 113.304 -175.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.83 141.05 30.74 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.65 -174.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.89 144.88 30.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 171.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -114.58 129.15 56.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.114 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.59 127.99 54.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.163 -1.381 . . . . 0.0 108.141 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.67 136.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.149 -177.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.9 p90 -153.58 177.22 11.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.98 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.31 144.06 51.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.814 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.2 p -82.8 163.48 21.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -174.14 4.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.142 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 149.81 21.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.205 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.546 -178.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.6 Cg_exo -58.86 171.37 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 113.299 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 m -98.53 166.59 11.28 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.61 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 141.91 83.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.122 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.84 171.39 15.74 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.596 1.53 . . . . 0.0 110.6 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HG3' HE22 ' A' ' 26' ' ' GLN . 30.2 mtmt -97.82 140.03 32.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -109.61 110.86 22.04 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.202 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.8 142.69 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.44 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.94 136.79 11.51 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 118.912 -1.613 . . . . 0.0 113.468 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.01 136.46 52.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.397 -0.902 . . . . 0.0 109.185 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.2 ttm -108.1 130.96 55.07 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.462 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.59 152.16 27.32 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.14 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.89 12.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.248 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.95 -23.9 41.35 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.57 175.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.24 -39.28 2.96 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.755 -1.212 . . . . 0.0 111.315 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.55 9.49 3.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.468 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 m -78.92 113.47 17.05 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.776 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.9 mm -114.92 126.94 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -172.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -113.94 123.61 50.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.087 0.867 . . . . 0.0 108.885 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.8 t -111.25 122.58 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -98.04 132.27 43.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.634 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 20.6 mt -100.46 101.8 12.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 124.091 0.869 . . . . 0.0 108.805 -175.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.7 mm -87.11 105.43 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.666 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -74.77 149.79 39.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.428 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.8 pt20 -147.36 -56.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.19 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.2 100.75 5.51 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.557 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.5 m-20 -129.73 -36.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.087 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.81 53.45 0.37 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 21.35 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.592 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.1 t 41.6 62.65 7.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 114.784 -0.708 . . . . 0.0 112.823 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 31' ' ' SER . 7.4 Cg_endo -86.02 43.46 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.603 1.535 . . . . 0.0 108.392 171.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.24 150.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.581 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.8 mtt180 -129.71 116.0 18.15 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.634 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.69 -172.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.556 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.7 m-85 -139.5 148.88 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.671 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.8 mt -104.77 110.08 22.28 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 60' ' ' VAL . 52.8 t -111.98 126.33 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.651 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.85 140.75 47.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 125.056 1.472 . . . . 0.0 107.767 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 151.86 35.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.592 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.8 ptt180 -125.62 162.31 25.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.247 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.615 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -125.45 174.44 8.19 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.391 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.05 43.92 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.993 171.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -150.41 -61.65 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.5 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -129.28 163.0 26.61 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.562 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 21.2 mt-10 -109.73 156.78 19.85 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.945 -1.102 . . . . 0.0 113.197 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 41' ' ' ARG . 3.6 m95 34.72 79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.795 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 73.7 mmtt -62.53 160.74 31.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.193 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.71 101.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.884 1.722 . . . . 0.0 111.06 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -49.13 158.58 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.957 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.3 147.22 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.196 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -114.75 123.91 50.44 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -70.34 165.42 44.59 Favored Pre-proline 0 N--CA 1.488 1.462 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.237 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.98 164.55 9.88 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.823 1.682 . . . . 0.0 110.451 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -73.65 79.88 1.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.67 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.63 60.67 0.43 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -96.98 -174.69 3.04 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.856 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.66 -12.05 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.512 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.7 p-80 -154.16 163.64 39.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.275 -176.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -136.92 151.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.946 173.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.5 ptp -135.22 148.06 49.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.106 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.547 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.6 pp -141.52 143.24 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.354 173.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -141.63 173.04 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.716 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 t 59.43 57.21 3.42 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.433 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 15.0 mt -94.35 179.95 5.12 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.62 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.11 135.28 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.037 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.428 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 75.6 m95 -76.17 152.33 36.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.593 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.21 49.29 15.45 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.521 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 153.71 47.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.33 147.75 22.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.213 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.6 m-85 -133.94 137.29 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 123.947 0.779 . . . . 0.0 111.865 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -118.5 115.82 25.38 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.908 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.15 122.97 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 39.2 m-85 -112.53 124.74 53.19 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.38 121.22 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.666 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.12 157.27 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 118.422 -1.311 . . . . 0.0 109.686 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.2 tt0 -111.57 160.28 17.34 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.49 -1.284 . . . . 0.0 107.795 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -145.79 151.47 37.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.852 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -36.77 -43.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.649 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -109.1 37.41 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.79 -152.45 22.16 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.771 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -129.04 163.71 24.81 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.734 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -126.18 125.93 43.26 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.964 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -43.27 167.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.707 1.879 . . . . 0.0 113.378 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.85 141.03 28.84 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.793 -173.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.68 147.13 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -116.71 130.3 56.65 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.544 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 81.3 t80 -117.95 127.64 54.04 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.239 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -123.87 134.39 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.611 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.0 p90 -156.29 176.78 12.24 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.263 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.74 147.39 49.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.511 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -79.9 168.49 19.18 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.92 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.11 -170.91 3.12 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.223 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.78 141.41 36.55 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.017 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.531 -178.643 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -58.76 170.91 2.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.518 2.146 . . . . 0.0 112.797 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 t -93.63 171.04 9.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.64 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.29 141.3 73.63 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.685 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.16 168.16 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 121.47 1.446 . . . . 0.0 110.904 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -101.63 130.81 48.05 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 mt -104.71 111.52 24.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.118 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -95.45 142.79 27.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -113.71 133.17 11.04 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.23 -1.462 . . . . 0.0 112.978 -170.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -127.75 129.3 46.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.6 ttm -107.66 134.08 51.16 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.699 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.33 153.73 24.58 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.779 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.56 10.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.985 -0.607 . . . . 0.0 112.292 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.92 -22.39 42.78 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.866 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.14 -37.47 3.54 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.559 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.5 p30 -137.48 46.82 2.11 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -120.58 114.93 22.46 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -118.56 128.34 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.501 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -113.6 125.34 54.06 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.1 t -109.86 118.5 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -98.73 128.5 45.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.48 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 18.7 mt -100.38 105.18 16.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mm -94.65 128.58 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.876 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -103.54 147.64 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.311 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.42 -54.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.197 -174.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 18.9 m-20 -132.82 107.34 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.627 -175.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.6 m-20 -131.98 -35.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.035 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.91 52.22 0.35 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.19 20.96 34.05 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 67.1 m 41.92 61.34 8.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.5 Cg_endo -87.74 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.631 1.554 . . . . 0.0 108.787 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.81 151.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.449 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.0 mtt180 -130.67 115.1 16.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.69 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.531 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.8 p-80 37.43 -171.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.582 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -141.17 151.49 43.89 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.021 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.6 mt -105.19 108.81 20.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 60' ' ' VAL . 55.3 t -114.42 122.37 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.95 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.64 142.23 46.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 124.536 1.147 . . . . 0.0 108.222 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -146.82 153.3 40.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.994 -1.482 . . . . 0.0 112.575 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.3 ptm180 -129.0 164.53 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.563 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -118.25 -169.17 1.65 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.314 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 9.7 tp -93.32 41.27 1.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.403 172.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.93 -59.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.719 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -121.97 156.54 33.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.544 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -105.48 157.26 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.839 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.528 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 32.83 88.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.495 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -71.84 166.01 44.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.002 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.4 Cg_exo -46.38 96.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.816 1.677 . . . . 0.0 110.578 177.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.73 174.97 4.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.244 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.83 155.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.642 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -115.83 127.94 55.44 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.034 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -74.57 164.71 59.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.091 -177.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -71.21 143.89 45.1 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.747 1.631 . . . . 0.0 109.461 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.46 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.5 m -56.69 105.33 0.2 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.931 0.769 . . . . 0.0 111.906 -176.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 107.22 52.15 0.74 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -97.15 169.24 9.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.844 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.18 -32.25 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.391 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.415 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 24.9 p-80 -148.05 167.3 25.3 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.523 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.4 p -134.22 153.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.865 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 ptp -136.54 152.69 50.78 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.513 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -137.59 141.7 41.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.728 172.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 64' ' ' SER . 10.0 ttpp -144.51 135.39 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.891 -173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 91.49 46.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.332 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -93.62 -178.98 4.87 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.829 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.73 135.46 40.34 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.401 -173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.59 156.4 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.297 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.48 48.77 10.87 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.888 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.12 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.086 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.2 mt-10 -94.44 146.18 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.954 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.652 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.8 m-85 -131.04 140.48 50.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.31 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.86 117.29 28.45 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.195 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.05 121.89 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 37.7 m-85 -110.81 123.73 50.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.5 t -120.21 121.07 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.946 0.778 . . . . 0.0 110.349 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.37 158.34 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.63 156.21 42.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.606 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 18.8 tt0 -111.69 160.68 17.04 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.486 HD21 ' HG2' ' A' ' 32' ' ' PRO . 14.2 t-20 -145.37 151.15 37.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.839 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -36.42 -43.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.719 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -110.5 38.03 2.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.17 -153.53 23.44 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.839 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -128.09 163.36 24.78 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.765 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.6 t -126.54 125.19 41.61 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.037 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -43.14 167.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 125.582 1.801 . . . . 0.0 113.513 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.76 141.27 28.64 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.679 -174.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.83 147.0 28.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.04 129.35 56.32 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.609 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.6 t80 -117.25 127.83 54.48 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.239 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -125.43 139.12 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.921 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 42.2 p90 -157.91 178.31 10.37 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.733 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -129.12 146.56 51.04 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.957 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.2 p -79.94 171.58 14.92 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.419 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -84.36 -176.04 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.092 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.85 147.99 24.92 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.08 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.436 -1.745 . . . . 0.0 110.568 -178.529 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 37.6 Cg_endo -73.01 179.46 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.919 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -98.34 159.42 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.182 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.87 147.95 92.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.617 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.59 169.47 15.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.296 1.331 . . . . 0.0 110.626 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -104.06 134.6 47.05 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.99 110.86 21.92 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.405 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.34 148.22 22.3 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.487 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -115.49 128.91 8.27 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.959 -172.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.77 128.1 50.03 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.514 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.8 tpp -103.62 128.99 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.21 151.14 25.45 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.256 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.87 8.92 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -80.0 -21.13 43.97 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.246 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.9 -35.19 5.19 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.573 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 6.1 p30 -133.12 0.47 3.43 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.17 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -72.97 113.83 10.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.227 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.523 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.3 mm -114.97 126.17 72.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.831 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.69 125.36 54.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.928 0.767 . . . . 0.0 109.227 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.4 t -109.43 122.3 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.73 129.04 41.8 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.324 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 43.2 mt -99.06 98.52 9.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.96 133.43 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.648 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' C ' HE21 ' A' ' 26' ' ' GLN . 40.9 mtmt -92.32 171.38 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.865 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -161.1 -64.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.757 -173.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.99 91.23 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.2 m-20 -128.43 -16.11 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.061 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.65 49.82 2.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.52 47.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.52 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 42.6 t 44.2 68.04 3.45 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.379 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -89.49 43.91 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.764 1.642 . . . . 0.0 107.956 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.27 146.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.853 -171.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 89.8 mtt-85 -126.04 123.78 39.18 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.464 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.4 p-80 37.16 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -138.08 156.07 48.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.026 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.52 110.82 22.02 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 60' ' ' VAL . 49.0 t -114.35 123.56 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.024 -1.07 . . . . 0.0 109.94 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -136.01 139.22 42.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.682 1.239 . . . . 0.0 107.927 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.06 155.2 43.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.933 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.0 ptt85 -130.63 164.34 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.016 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -124.88 169.85 11.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.683 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.68 43.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.9 -56.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.041 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.5 m -130.54 157.18 43.4 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.197 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -101.65 165.25 11.32 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.82 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.8 m95 21.9 91.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.047 -1.433 . . . . 0.0 114.019 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.0 mptm? -74.45 165.23 55.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.109 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.3 Cg_exo -45.13 99.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.856 1.704 . . . . 0.0 110.716 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 175.24 3.5 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.451 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.1 tt -140.18 154.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -115.29 136.42 53.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.0 mt -87.99 164.64 32.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.32 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.3 Cg_exo -62.24 165.68 14.42 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.812 1.674 . . . . 0.0 110.389 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -74.93 80.89 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.13 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.04 58.2 0.26 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.721 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -97.06 167.16 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.375 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.24 -8.94 12.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.651 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.7 p-80 -160.09 165.23 32.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.053 -1.459 . . . . 0.0 112.943 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.6 p -137.72 153.52 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.978 172.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 ptp -136.53 151.02 48.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.341 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.84 146.14 35.49 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.366 173.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -141.52 -177.25 5.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.416 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.4 t 55.19 51.87 12.54 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 17' ' ' ASN . 31.6 mt -85.49 165.68 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.812 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -78.31 8.19 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.412 -171.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 60.52 162.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.167 0.508 . . . . 0.0 111.861 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 36.23 43.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.03 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.77 156.16 48.88 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.061 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -98.23 147.86 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.144 0.903 . . . . 0.0 108.629 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 33.2 m-85 -131.95 142.92 49.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.972 0.795 . . . . 0.0 111.783 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -118.55 118.15 30.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.646 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -110.52 122.75 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 54.2 m-85 -111.45 125.88 54.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.1 t -121.0 122.29 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.626 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.35 155.51 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.15 159.2 35.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.955 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -109.37 149.77 29.02 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.469 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -130.88 143.96 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.267 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -43.39 -37.17 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.81 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -117.07 46.26 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.793 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -153.72 22.62 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.371 174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -125.17 160.59 28.8 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.882 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.8 t -113.13 109.64 19.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -39.25 158.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 125.497 1.748 . . . . 0.0 112.698 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.56 127.88 33.23 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.828 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.76 145.21 26.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.53 129.26 56.65 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.608 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.5 t80 -115.84 127.22 54.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.37 134.55 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.358 -175.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 39.7 p90 -155.74 174.75 14.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.473 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.52 148.46 48.88 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.803 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -79.88 172.58 13.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 m -87.14 -172.94 4.19 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.727 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.23 144.21 27.26 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.283 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.566 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.522 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.9 Cg_exo -60.3 168.08 6.86 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.551 2.167 . . . . 0.0 113.046 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.82 158.46 18.74 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.828 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.06 146.2 92.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.173 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.32 167.93 19.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.458 1.439 . . . . 0.0 110.749 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 44.9 mtmt -103.59 128.75 50.81 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.6 114.34 28.5 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.494 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -103.18 140.74 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.552 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -123.31 140.8 13.27 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.724 -170.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -131.39 143.3 50.37 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.2 -1.0 . . . . 0.0 109.645 170.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.661 -0.816 . . . . 0.0 108.969 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -81.89 153.8 33.15 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.808 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.27 8.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.374 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' GLY . 17.5 m-20 -79.92 -25.16 40.62 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.533 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.1 -37.03 4.03 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.727 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 13.4 m-20 -123.08 -12.0 7.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.9 m -65.73 112.04 3.51 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.638 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 91' ' ' PHE . 6.8 mm -112.21 126.7 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -114.7 121.35 43.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 124.044 0.84 . . . . 0.0 108.865 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.5 t -109.98 118.02 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -95.44 133.78 39.02 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.341 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 52.0 mt -102.58 101.12 11.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 124.049 0.843 . . . . 0.0 108.885 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 7' ' ' LYS . 23.8 mm -89.51 134.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.025 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -101.52 148.61 25.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.006 0.816 . . . . 0.0 109.333 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.66 -72.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.81 -175.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 29.9 m-20 -130.34 107.29 9.15 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.931 -176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.0 m-20 -126.44 -35.73 2.35 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.655 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.43 54.6 0.26 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 32' ' ' PRO . . . 89.06 28.63 20.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 77.8 p 32.21 63.37 1.26 Allowed Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -87.39 46.31 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.758 1.638 . . . . 0.0 108.755 173.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.08 149.87 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.462 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' HIS . 62.1 mtt85 -130.45 117.59 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.13 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.8 p-80 36.1 -175.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.549 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.1 m-85 -137.55 142.84 41.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.944 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.28 105.7 17.74 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 60' ' ' VAL . 60.7 t -108.81 125.57 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.088 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -131.8 134.02 45.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 125.0 1.438 . . . . 0.0 107.681 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.59 158.63 43.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 117.711 -1.595 . . . . 0.0 112.185 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 22.5 ptt85 -142.71 168.37 19.89 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.458 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -131.43 171.63 13.15 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.38 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -71.06 26.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.153 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -131.22 -59.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -124.82 154.91 40.27 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -108.98 166.74 10.6 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.314 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.473 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 22.67 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.188 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.81 165.67 39.66 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.085 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -48.81 107.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.867 1.711 . . . . 0.0 110.711 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.81 159.59 2.22 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.86 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -130.09 147.82 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.018 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -114.77 113.33 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.334 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.549 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mm? -58.55 167.44 1.78 Allowed Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.604 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.62 171.37 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.736 1.624 . . . . 0.0 110.502 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.3 m -76.29 77.29 3.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.736 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 70.1 0.68 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -93.31 -171.94 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.187 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.89 -20.22 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.006 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 20.4 p-80 -160.0 173.46 15.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.025 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -135.23 150.8 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 124.856 1.347 . . . . 0.0 108.416 173.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptp -134.12 147.59 50.85 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.002 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.9 pp -142.13 147.35 36.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.885 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -141.09 175.44 9.63 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.942 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t 49.36 66.94 0.97 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.226 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 12.3 mt -100.0 -174.69 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.075 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 6.4 m-20 -70.0 126.42 29.63 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.761 172.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -76.38 151.4 36.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.177 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 47.04 49.06 15.26 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.032 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB1' ' CD2' ' A' ' 43' ' ' LEU . . . -127.45 150.72 49.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.45 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' H ' HD13 ' A' ' 43' ' ' LEU . 31.2 mt-10 -91.8 140.64 29.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -129.9 143.38 50.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.002 0.814 . . . . 0.0 112.431 -173.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.46 125.18 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.804 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.88 125.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 49.1 m-85 -114.49 127.66 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.54 119.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.59 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.34 156.98 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.42 155.4 43.73 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.185 -1.406 . . . . 0.0 109.862 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.2 tt0 -111.25 157.93 19.56 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.869 175.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.522 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.6 t-20 -145.43 152.87 40.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.09 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -33.61 -45.82 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.908 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -109.85 37.68 2.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.56 -153.52 22.09 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.227 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -120.25 158.76 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.835 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -121.79 124.76 44.93 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.29 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -40.85 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 125.75 1.906 . . . . 0.0 113.505 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.83 137.93 32.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.223 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.81 145.94 28.48 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -117.03 131.85 56.84 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.648 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.9 t80 -121.5 134.39 55.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.236 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -131.07 142.8 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.818 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 19' ' ' ILE . 49.0 p90 -158.97 -178.78 7.49 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.282 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -129.32 144.41 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.661 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -79.82 169.38 18.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -85.75 -168.11 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.076 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.13 140.55 37.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.433 -178.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.2 Cg_endo -62.8 176.79 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.476 2.117 . . . . 0.0 112.767 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -96.81 162.1 13.57 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.906 173.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 145.63 99.02 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.316 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.11 170.27 12.12 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.391 1.394 . . . . 0.0 111.177 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -104.59 132.92 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.09 111.84 23.68 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.254 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.92 145.19 24.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.95 130.3 9.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.332 -1.413 . . . . 0.0 112.868 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.449 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.5 mt-30 -123.09 125.82 45.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 170.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 ttm -107.13 128.93 54.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.468 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.04 150.55 24.02 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.811 -1.185 . . . . 0.0 111.472 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.46 13.97 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.833 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 13.5 m-20 -79.96 -23.14 41.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.669 174.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.51 -39.63 2.83 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.397 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.443 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 17.6 p30 -133.6 12.78 4.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.94 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -80.0 109.89 14.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.2 mm -115.14 126.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.272 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -113.28 126.5 55.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 123.943 0.777 . . . . 0.0 109.058 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 55.7 t -108.74 115.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' ND2' HE21 ' A' ' 11' ' ' GLN . 3.5 m-80 -95.96 128.58 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.459 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.52 107.62 19.84 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.772 -172.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.1 mm -100.71 135.22 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.458 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -101.71 152.1 21.24 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.652 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.95 -50.41 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.129 -176.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 12.7 m-20 -141.15 106.78 5.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.9 m-20 -132.06 -34.26 1.28 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.234 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.63 53.85 0.37 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.05 21.01 34.3 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.574 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 39.52 64.15 4.28 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 114.927 -0.637 . . . . 0.0 112.64 -176.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.6 Cg_endo -86.28 44.41 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.621 1.547 . . . . 0.0 108.556 172.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -86.66 148.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.468 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 47.1 mtt180 -129.68 120.09 24.59 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.616 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 36.89 -174.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.1 m-85 -139.2 151.65 46.72 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.036 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.21 109.73 21.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.39 123.12 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.055 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -134.48 140.92 46.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.552 1.158 . . . . 0.0 107.922 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -146.04 156.15 43.28 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.694 -1.602 . . . . 0.0 112.378 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.2 ptm180 -125.89 160.49 29.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.49 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.55 -169.63 1.53 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.4 tp -96.19 39.91 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.116 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.45 -59.41 0.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.2 m -118.41 148.6 42.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.009 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.0 pt-20 -107.05 151.62 25.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.816 -1.153 . . . . 0.0 112.181 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.536 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 42.0 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.41 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.3 mttt -73.54 165.17 55.38 Favored Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.483 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.89 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.767 1.645 . . . . 0.0 110.479 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.12 174.38 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.675 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -137.76 154.23 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.043 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.74 128.69 56.05 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.093 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.17 165.13 56.39 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.149 -177.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.75 166.58 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.858 1.705 . . . . 0.0 110.237 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.3 m -76.27 79.67 3.05 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.874 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.69 60.75 0.41 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -97.08 -175.61 3.3 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.769 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -117.82 -39.89 3.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.571 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -148.22 168.44 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.21 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -128.07 152.09 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.289 174.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptp -136.44 154.11 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.528 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.7 OUTLIER -137.9 142.79 40.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.552 173.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -131.6 165.72 23.02 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.455 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m 53.58 62.56 2.58 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.189 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.3 mt -92.36 178.19 5.91 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.029 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -73.59 128.98 37.0 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.188 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.51 150.1 45.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.584 -1.246 . . . . 0.0 109.883 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 48.61 49.15 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.478 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.55 153.1 48.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.963 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 26.8 tt0 -94.04 147.96 22.63 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.009 175.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.9 m-85 -132.67 140.88 48.34 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.419 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.95 116.24 24.73 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.024 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.53 123.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 40.5 m-85 -112.18 125.56 54.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.29 121.84 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 124.035 0.834 . . . . 0.0 110.188 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -107.7 158.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.69 160.98 31.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.333 -1.347 . . . . 0.0 109.106 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -112.22 157.46 20.87 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.091 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -139.92 147.99 41.36 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.105 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -36.83 -43.39 0.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.41 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -114.41 42.73 2.04 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.669 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.9 -154.25 24.27 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.192 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -121.33 161.34 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.961 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.566 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.2 t -116.0 115.45 26.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -40.44 160.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 125.512 1.757 . . . . 0.0 112.661 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.65 138.35 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.532 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.21 146.27 29.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.494 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -116.97 130.86 56.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.465 -173.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -118.49 128.44 54.59 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.116 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.39 138.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.818 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.519 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.48 -179.78 8.22 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.973 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.08 147.48 50.94 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.768 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -80.02 170.06 16.99 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.784 -0.767 . . . . 0.0 109.292 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.7 m -81.41 -175.98 5.77 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.154 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.42 147.38 26.41 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.123 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.521 -1.704 . . . . 0.0 110.692 -178.203 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.0 Cg_endo -64.24 174.29 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.548 2.165 . . . . 0.0 112.603 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -87.92 145.59 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.286 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.77 78.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.571 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.41 165.74 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.218 1.279 . . . . 0.0 110.569 -176.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -103.42 133.29 48.72 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.3 112.24 25.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.959 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -93.4 141.89 27.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.29 131.28 10.55 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.341 -1.409 . . . . 0.0 112.587 -171.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -128.85 126.97 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 ttm -106.2 132.69 51.96 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.77 152.42 23.95 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.571 -176.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.99 12.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.311 -0.556 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.95 -24.26 41.12 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.645 175.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.06 -40.77 2.43 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.434 177.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -132.15 10.06 4.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.076 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -81.78 116.25 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.953 176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.529 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.3 mm -116.97 128.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.324 -172.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -113.47 126.3 55.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.988 0.805 . . . . 0.0 108.982 173.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -108.78 113.27 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -95.05 129.83 41.98 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.401 -176.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -98.71 106.45 18.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.715 -173.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.3 mm -97.66 131.76 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.994 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -107.49 156.26 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.366 -177.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.32 -65.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.516 -174.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -135.23 128.4 31.86 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.325 177.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -133.53 -36.27 0.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 123.901 0.751 . . . . 0.0 109.899 177.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.63 54.22 0.3 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.44 18.86 37.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -175.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 42.56 61.27 9.25 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 114.907 -0.646 . . . . 0.0 112.648 -176.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.0 Cg_endo -88.46 37.99 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.558 1.506 . . . . 0.0 109.583 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 79' ' ' ASN . 23.6 mm -77.54 150.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.901 0.858 . . . . 0.0 111.78 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 9.0 mmt180 -127.85 113.32 15.77 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.367 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.2 p-80 36.2 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 174.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.535 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.0 m-85 -137.98 152.3 48.78 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.115 177.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.404 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.1 mt -108.56 110.72 22.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 60' ' ' VAL . 52.4 t -115.45 124.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.289 -174.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -135.52 140.15 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.62 1.2 . . . . 0.0 108.291 177.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.78 155.98 44.34 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.202 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.3 ptm180 -129.56 164.67 23.32 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.988 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -113.83 -177.95 3.26 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 tp -87.03 41.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.111 173.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.11 -60.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.522 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 p -119.11 151.3 38.53 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.439 177.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.8 pt-20 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.858 -173.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.572 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 42.29 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.35 175.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -69.83 168.3 18.55 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.695 173.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -52.26 95.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.656 1.57 . . . . 0.0 109.819 174.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.65 172.61 2.05 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.486 -173.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.11 154.63 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.392 -177.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -114.74 129.24 56.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.09 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -76.1 165.93 49.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.133 -177.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.45 168.24 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.787 1.658 . . . . 0.0 110.211 172.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.4 t -77.87 78.97 4.35 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.566 -177.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.0 60.72 0.34 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -97.18 -174.51 2.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.688 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -119.5 -40.52 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.707 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -148.06 169.12 20.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.11 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.0 p -127.46 152.48 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.422 173.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.8 ptp -136.25 150.42 48.95 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.599 -1.241 . . . . 0.0 112.908 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -140.47 139.21 35.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.097 172.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -140.39 162.76 34.54 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.606 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t 66.93 50.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.605 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -96.43 -174.52 3.07 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.665 176.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -83.3 142.6 30.97 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.095 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.412 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 74.3 m95 -77.75 155.17 31.37 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.366 -178.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.35 48.66 10.49 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.604 -176.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.09 47.33 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.837 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -97.94 149.92 21.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.532 177.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 31.6 m-85 -135.47 145.27 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.423 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -121.08 118.56 30.08 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.347 -1.751 . . . . 0.0 108.328 177.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.68 124.55 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 45.0 m-85 -112.69 126.18 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -121.29 122.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.13 158.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.98 156.54 41.41 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.261 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 27.6 tt0 -111.97 159.77 18.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.585 175.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -144.88 148.94 34.5 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.985 178.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -37.91 -42.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.481 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -112.32 42.12 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.465 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.45 -153.97 22.76 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.46 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -125.35 162.52 24.59 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.877 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -119.77 117.13 27.39 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -40.96 163.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 125.482 1.739 . . . . 0.0 113.206 -174.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.15 134.72 34.98 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.126 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.87 145.58 29.58 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.25 131.06 57.05 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.627 -173.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -118.13 127.27 53.61 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.008 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -125.32 139.31 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.64 -176.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 38.5 p90 -159.17 176.98 11.55 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.24 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -127.63 147.9 50.37 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.756 175.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.3 p -79.84 170.83 15.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.248 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.57 -170.81 3.24 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.143 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.19 141.88 36.81 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.156 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.54 -1.695 . . . . 0.0 110.741 -179.193 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -60.99 173.83 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.493 2.129 . . . . 0.0 112.917 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -95.39 155.51 16.71 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.036 174.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.26 143.09 97.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.075 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.65 165.9 23.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.343 1.362 . . . . 0.0 110.75 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.61 132.53 48.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.6 mt -104.72 113.78 27.58 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.224 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.02 138.78 31.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.441 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.75 124.56 7.91 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.492 -1.337 . . . . 0.0 112.469 -172.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.81 120.88 35.85 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.4 ttm -106.39 131.69 53.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.73 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.73 149.27 23.26 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.689 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.84 11.63 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.074 -0.563 . . . . 0.0 112.255 -177.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.5 m-20 -79.93 -22.36 42.8 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.876 176.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.8 -37.8 3.61 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.957 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.0 p-10 -140.27 47.52 1.79 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m -120.57 114.33 21.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.533 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.9 mm -117.41 128.54 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.633 -170.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -114.94 126.6 54.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.575 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.9 t -109.01 111.5 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -94.33 130.9 40.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.623 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 19.6 mt -100.05 108.51 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.949 -172.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.79 127.12 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -104.06 156.16 18.09 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.471 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 -53.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.146 -172.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.15 118.91 16.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.294 -178.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.27 -41.43 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 177.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.13 54.54 0.25 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -177.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.53 42.88 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 14.4 t 42.3 60.38 9.59 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -88.65 46.87 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.658 1.572 . . . . 0.0 108.962 173.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.67 152.32 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.602 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 35' ' ' HIS . 11.0 mtt180 -130.37 119.9 23.47 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.331 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.636 ' H ' ' HA ' ' A' ' 55' ' ' SER . 7.2 p-80 31.87 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.129 -1.851 . . . . 0.0 115.988 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 81.9 m-85 -137.47 153.1 50.13 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.9 175.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.9 mt -110.82 112.2 23.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 60' ' ' VAL . 42.4 t -115.86 128.16 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.215 -174.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.3 139.4 46.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.905 1.378 . . . . 0.0 108.104 175.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.9 p90 -147.38 154.57 41.04 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.581 177.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -133.39 160.81 36.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.775 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.47 -172.75 2.12 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -93.43 39.34 1.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.585 171.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.66 -60.67 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.348 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.5 m -118.94 141.12 48.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.8 pt-20 -105.02 171.93 7.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.093 -171.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 7.4 m95 18.28 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.591 -1.641 . . . . 0.0 114.123 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 9.4 mptt -67.57 164.34 39.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.689 174.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -47.17 104.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.844 1.696 . . . . 0.0 110.881 177.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 156.66 0.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.261 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 tt -131.12 146.92 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.359 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -115.21 132.14 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -82.69 164.69 45.84 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.875 -177.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.25 155.58 68.84 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.599 1.533 . . . . 0.0 109.454 172.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.636 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.5 t -73.36 103.1 3.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.373 -177.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.25 0.74 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.07 172.84 7.58 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.155 -175.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.3 -43.7 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.565 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.5 p-80 -148.86 168.4 23.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.614 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -123.15 150.74 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.035 174.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -135.92 149.19 48.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.506 -1.277 . . . . 0.0 112.833 -175.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -138.65 135.31 34.73 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.68 173.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' SER . 84.1 mttt -142.9 142.11 31.66 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.778 -178.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.9 m 91.07 43.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.892 176.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.9 mm? -95.37 -176.47 3.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.369 -177.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.43 130.95 42.6 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.877 -172.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.6 155.99 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 43.3 48.42 5.8 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.792 -177.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.9 151.88 49.98 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.802 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.86 149.54 21.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.775 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 7.6 m-85 -133.74 140.92 47.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.657 -177.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.17 119.72 34.1 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.518 -1.673 . . . . 0.0 108.234 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.62 125.41 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m-85 -113.52 125.39 54.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.2 123.75 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.893 0.746 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -108.72 158.01 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.72 157.02 41.46 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.413 -1.315 . . . . 0.0 109.547 178.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.2 tt0 -112.15 161.88 16.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.731 -1.188 . . . . 0.0 108.009 175.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.9 t-20 -143.78 149.8 37.6 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.546 177.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -41.21 -39.47 1.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.172 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -113.05 39.06 2.64 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.92 -150.88 22.39 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.681 175.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -134.31 168.52 18.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.227 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 9.1 t -127.97 123.06 33.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.215 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.15 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 125.557 1.786 . . . . 0.0 113.253 -174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.02 138.84 31.15 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.63 -174.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.79 145.8 29.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.04 130.72 57.0 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.6 -173.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -118.5 129.26 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.017 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.5 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.7 140.64 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.936 -176.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.2 p90 -158.84 -178.65 7.41 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.739 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -130.85 146.76 52.38 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.91 175.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -79.88 171.5 15.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.332 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.86 -170.88 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.072 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.07 140.85 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.052 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.459 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 10.9 Cg_endo -68.23 174.34 8.22 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.658 2.239 . . . . 0.0 112.427 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -101.54 158.78 15.83 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.925 172.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.31 149.58 68.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.349 -174.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -71.82 172.02 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.589 1.526 . . . . 0.0 110.766 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -106.07 134.1 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.47 112.43 24.82 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.399 -176.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 23.1 tt0 -92.48 141.45 28.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.76 121.83 7.29 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.869 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -122.16 121.58 37.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.4 ttm -104.76 134.2 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.701 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.63 150.86 22.01 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.735 -176.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.76 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.085 -0.557 . . . . 0.0 112.294 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 15.5 m-20 -79.82 -22.2 43.31 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.017 176.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.97 -50.97 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.541 176.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -128.15 7.62 6.02 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.807 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.5 t -73.11 117.32 14.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.865 176.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.04 128.63 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.869 -171.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -113.8 125.85 54.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.008 0.817 . . . . 0.0 108.976 171.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.583 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 59.4 t -105.9 110.19 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 11.5 t-20 -88.03 129.06 35.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.95 -175.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 75' ' ' VAL . 33.4 mt -99.69 100.95 11.99 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.265 -175.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -93.05 128.84 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -101.17 147.57 26.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 123.951 0.782 . . . . 0.0 109.672 -176.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.18 -86.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.937 -175.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -107.59 109.5 21.16 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.659 -174.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.1 m-20 -133.62 -34.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.127 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.92 53.51 0.36 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.72 21.04 35.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -175.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.0 m 42.85 61.47 9.4 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.745 -176.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 14.3 Cg_endo -86.54 45.61 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.792 1.662 . . . . 0.0 108.75 173.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 79' ' ' ASN . 23.0 mm -82.35 148.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.278 -173.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.0 mtt180 -125.35 111.43 15.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.89 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 33.97 -171.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.07 156.23 49.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.83 176.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.2 mt -112.82 111.45 22.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 60' ' ' VAL . 48.5 t -115.82 124.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.447 -174.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -136.75 138.1 40.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.487 1.117 . . . . 0.0 108.328 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.85 156.88 45.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.0 -1.48 . . . . 0.0 112.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 27.0 ptt180 -134.69 168.81 18.33 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.39 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.25 172.17 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.797 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.471 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -71.8 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.952 174.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -136.53 -58.75 0.73 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.742 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.7 m -126.48 158.79 35.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.581 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.7 pt-20 -101.43 166.98 10.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.751 -177.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.9 m95 17.94 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.966 -1.47 . . . . 0.0 114.514 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.68 167.27 36.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.322 173.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -48.06 98.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.76 1.64 . . . . 0.0 110.39 176.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.77 174.44 5.16 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.349 -173.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -139.19 154.89 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.499 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.35 137.06 52.07 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.783 173.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.5 mt -87.49 166.45 25.28 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.306 -177.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -81.33 140.04 11.94 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.92 1.747 . . . . 0.0 108.063 167.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -62.53 135.31 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.742 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.61 41.81 4.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -97.03 168.62 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.505 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -114.59 -45.81 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.44 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -147.86 167.43 24.8 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.361 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.0 p -119.07 149.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.778 173.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -132.55 148.41 52.37 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.874 -174.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.98 140.41 38.21 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.202 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -140.59 162.35 35.57 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.357 -177.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 m 71.69 46.4 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.403 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -95.27 -176.06 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 177.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -84.98 146.33 27.27 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.816 -175.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.451 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 71.0 m95 -80.25 155.33 27.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.545 -177.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 44.91 46.77 9.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.458 -175.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 149.94 47.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.712 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' H ' HD13 ' A' ' 43' ' ' LEU . 18.8 tt0 -98.83 143.09 29.55 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.327 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 39.4 m-85 -131.51 144.32 51.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 123.995 0.809 . . . . 0.0 112.057 -177.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.12 119.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.428 -1.715 . . . . 0.0 108.06 176.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.55 124.53 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 59.8 m-85 -111.35 126.96 55.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 23' ' ' LEU . 75.8 t -120.92 121.82 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -109.5 158.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.72 160.21 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.516 -1.274 . . . . 0.0 109.36 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.6 tt0 -111.1 164.76 12.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 20.1 t-20 -152.19 151.89 31.57 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -41.63 -41.41 2.2 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.327 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -79.7 -47.62 15.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.503 -177.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.63 -108.79 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.995 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -140.72 173.23 11.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.895 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -125.77 119.27 27.47 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -42.49 162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.307 1.629 . . . . 0.0 112.664 -176.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.51 134.49 35.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.202 -176.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.3 143.07 32.54 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.469 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.21 130.74 56.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.397 -174.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -116.88 126.85 53.61 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.984 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -123.63 135.44 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.298 -176.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 p90 -156.93 174.03 16.12 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.34 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -127.3 148.2 50.23 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.544 175.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -79.83 168.5 19.19 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.002 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 m -81.25 -173.17 4.18 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.356 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.04 150.55 21.28 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.109 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 116.247 -1.835 . . . . 0.0 110.392 -178.802 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 7.2 Cg_exo -59.35 176.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.634 2.223 . . . . 0.0 112.909 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -93.0 161.53 14.41 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.224 171.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.36 143.73 92.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.422 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.37 172.8 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.484 1.456 . . . . 0.0 110.915 -177.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -106.6 132.25 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.1 mt -109.04 112.12 24.13 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.352 -176.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.33 144.2 25.62 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.41 131.52 10.56 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.422 -173.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -129.16 129.4 45.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.8 ttm -106.86 134.64 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.652 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.41 144.03 21.29 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.591 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.48 9.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.95 -27.22 39.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.858 175.566 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.26 -40.05 1.95 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.931 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -130.64 -15.1 3.56 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.801 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -52.88 115.72 1.98 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.332 174.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 91' ' ' PHE . 5.9 mm -117.33 128.79 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.122 -175.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -114.94 126.66 55.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 47.6 t -109.27 118.94 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.77 124.02 39.6 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.81 -178.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.62 104.29 15.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -173.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -97.96 133.06 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.204 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -101.1 146.58 27.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.896 0.747 . . . . 0.0 109.434 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.07 -89.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.413 -175.781 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 20.8 t70 -95.45 105.69 17.68 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.125 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.75 -35.12 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.66 51.27 0.42 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.96 17.61 40.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -175.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.615 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 64.3 m 43.35 59.84 11.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.4 Cg_endo -88.53 50.9 1.67 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.842 1.695 . . . . 0.0 108.513 172.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mm -78.86 151.34 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.027 0.918 . . . . 0.0 111.68 -172.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 32.8 mmm-85 -126.13 108.01 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.536 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.536 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.0 p-80 36.17 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 76.5 m-85 -138.73 151.92 47.54 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.131 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.5 mt -107.87 108.78 20.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.08 122.23 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.02 -173.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -132.58 135.65 46.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.664 1.228 . . . . 0.0 108.1 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -140.8 158.69 43.6 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 117.941 -1.504 . . . . 0.0 112.162 179.172 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.6 ptm180 -138.32 170.36 16.15 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.305 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.62 179.5 4.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.514 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 40.83 0.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.535 172.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.28 -60.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -116.45 149.5 39.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.104 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -100.11 160.84 14.01 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.175 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.471 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 24.8 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.402 -1.272 . . . . 0.0 114.028 178.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 67.5 mmtt -76.19 162.16 72.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.8 Cg_exo -45.12 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.765 1.643 . . . . 0.0 110.611 177.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.87 175.45 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.571 -173.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -137.97 155.19 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.354 -177.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -115.89 130.25 56.75 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.214 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -78.33 165.09 52.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.239 -177.472 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.12 161.0 27.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.832 1.688 . . . . 0.0 110.87 172.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 t -68.24 95.55 0.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 95.57 65.38 0.97 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -97.14 -169.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.231 -176.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -129.54 -38.88 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.646 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -144.69 164.65 30.35 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.569 -1.252 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -131.77 153.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.492 174.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptp -137.45 152.13 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.981 -174.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -142.04 138.61 31.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.172 172.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -137.94 161.23 37.22 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.745 -177.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t 66.51 49.91 1.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.543 177.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -174.63 3.31 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.653 177.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.55 137.32 36.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.708 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.521 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 73.1 m95 -75.62 156.04 35.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.168 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 49.53 44.82 24.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.111 -178.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.71 156.06 44.89 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.546 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.76 149.33 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 19.8 m-85 -135.22 144.63 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.78 -178.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.58 121.45 38.4 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.273 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.0 t -114.06 123.11 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.9 m-85 -110.92 125.64 53.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.67 121.21 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 123.881 0.738 . . . . 0.0 110.446 -178.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -106.54 158.04 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.81 157.53 41.24 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.381 -1.327 . . . . 0.0 109.868 178.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.9 tt0 -112.11 164.27 13.35 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.491 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.3 t-20 -148.24 151.99 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.949 178.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -34.14 -45.81 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.757 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.95 39.78 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.5 -152.81 23.66 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.636 174.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -129.86 166.25 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.779 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.1 t -128.71 125.68 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.957 -176.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -43.39 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.52 1.762 . . . . 0.0 113.298 -175.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.25 139.7 30.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.61 -175.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.52 145.54 30.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.2 130.11 56.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.382 -174.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -117.86 129.72 55.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.883 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -127.38 141.1 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.694 -176.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.5 p90 -157.99 177.92 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.066 178.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 146.5 50.78 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.69 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.0 p -83.34 163.36 20.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.379 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 m -74.86 178.75 5.31 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.164 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.5 144.79 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 116.252 -1.832 . . . . 0.0 110.328 -178.926 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 8.3 Cg_exo -59.4 177.26 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.798 2.332 . . . . 0.0 112.944 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -80.17 -154.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.23 150.18 39.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.97 166.28 28.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.377 1.385 . . . . 0.0 110.755 -177.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.48 128.94 52.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 mt -102.91 110.73 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.018 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -91.49 143.09 26.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.431 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.27 125.17 7.76 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.337 -1.411 . . . . 0.0 112.486 -173.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.444 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 77.9 mt-30 -121.55 122.47 39.76 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.5 ttm -107.17 130.9 54.65 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.745 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.8 149.09 24.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.307 -177.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.55 16.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.85 -24.48 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.332 174.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -40.61 2.45 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.715 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.9 p30 -137.49 49.1 2.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.139 0.495 . . . . 0.0 110.0 177.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.2 m -122.16 113.5 19.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.554 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.07 128.53 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.604 -169.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.94 125.75 53.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.082 0.864 . . . . 0.0 108.748 173.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.5 t -107.12 116.47 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.6 m-20 -93.88 129.01 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.913 -177.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 39.4 mt -100.56 99.41 10.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -175.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.9 mm -95.99 130.36 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -104.15 150.85 23.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.711 0.632 . . . . 0.0 109.803 -175.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -79.64 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.037 -174.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.55 102.43 11.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.177 -175.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -131.91 -35.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 178.535 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.07 51.04 0.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.77 22.48 25.86 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -175.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.585 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.0 m 39.09 62.44 4.86 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -88.25 50.69 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.729 1.62 . . . . 0.0 108.722 173.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.402 HD13 HD22 ' A' ' 79' ' ' ASN . 41.0 mm -86.45 151.59 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.068 -174.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.7 mtt85 -131.69 121.69 24.69 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.821 178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.609 ' H ' ' N ' ' A' ' 56' ' ' GLY . 9.2 p-80 35.44 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.19 158.37 43.81 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.972 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.407 HD23 ' HG3' ' A' ' 52' ' ' ARG . 4.4 mt -112.45 109.86 19.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 60' ' ' VAL . 48.0 t -115.48 124.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.652 -173.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -134.72 140.57 46.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.683 1.24 . . . . 0.0 108.422 177.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.1 p90 -144.07 154.83 43.62 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.924 -1.51 . . . . 0.0 112.706 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 12.0 ptm180 -126.14 163.68 22.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.556 179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.81 -168.08 1.3 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' LEU . 12.1 tp -95.9 41.49 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.447 173.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.77 -56.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.611 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -106.76 142.83 35.76 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.6 pt-20 -107.87 144.06 35.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.792 -176.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.551 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.6 m95 47.45 84.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.454 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.0 mmtt -77.54 161.17 73.11 Favored Pre-proline 0 N--CA 1.491 1.603 0 CA-C-N 114.346 -1.297 . . . . 0.0 107.824 174.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.4 Cg_exo -43.37 103.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.909 1.739 . . . . 0.0 110.838 179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 14.2 pt-20 -73.76 175.87 6.82 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.503 -173.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.7 157.54 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.757 -177.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HG3' HD23 ' A' ' 37' ' ' LEU . 14.5 ttp85 -114.39 140.98 48.23 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.911 172.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.0 mt -90.18 165.56 23.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.667 -176.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.9 Cg_exo -61.58 157.91 39.45 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.71 1.607 . . . . 0.0 110.39 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -64.58 86.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.171 -176.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.609 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 106.15 62.91 0.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -93.84 179.59 5.3 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.24 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -18.91 7.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.236 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.462 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 19.1 p-80 -160.16 168.94 24.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.435 -1.306 . . . . 0.0 112.245 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.5 p -134.6 153.64 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.924 172.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.2 ptp -138.34 153.69 48.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.314 -1.354 . . . . 0.0 112.763 -176.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.97 140.17 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.142 173.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.9 tppt? -137.98 137.82 38.29 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.821 -174.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 8.2 m 85.86 50.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.784 171.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mm? -95.2 -177.55 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.833 -179.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.2 134.21 39.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.687 0.756 . . . . 0.0 111.079 -172.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -72.34 154.65 40.82 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 47.5 47.37 17.36 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.911 -177.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.07 50.11 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.821 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.61 149.96 22.24 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.278 177.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.627 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -133.29 144.25 49.59 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.62 -176.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.35 118.25 28.0 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.82 123.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 39.3 m-85 -111.64 125.16 53.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 23' ' ' LEU . 68.1 t -121.32 122.14 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 123.935 0.772 . . . . 0.0 110.314 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.32 155.4 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.4 163.81 22.48 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.5 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -117.59 156.34 28.27 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.461 -1.295 . . . . 0.0 107.961 172.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 6.5 t-20 -141.76 152.12 43.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.665 178.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 34.3 tt0 -29.34 -47.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.501 179.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -111.85 36.09 3.44 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.5 -161.27 27.37 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.786 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -110.3 158.76 18.06 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.031 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.49 114.47 24.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.569 -175.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -39.98 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.368 1.668 . . . . 0.0 112.794 -176.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -80.53 140.06 36.04 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.769 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.46 147.27 29.53 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 172.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -116.93 131.48 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.667 -173.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.9 t80 -118.22 131.53 56.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.25 140.16 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.897 -176.533 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.75 178.79 9.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.016 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.5 52.06 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.279 177.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.4 p -81.0 165.9 21.3 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.711 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 m -79.9 -175.78 5.11 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.096 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.49 149.28 23.38 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.106 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 116.488 -1.72 . . . . 0.0 110.63 -178.685 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 1.6 Cg_endo -62.32 170.96 5.86 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.471 2.114 . . . . 0.0 112.924 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.6 p -87.42 150.36 23.84 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.909 171.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.45 160.12 1.42 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.173 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.5 162.47 27.66 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.206 1.27 . . . . 0.0 110.193 176.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 132.54 48.47 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.65 113.45 27.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.577 -174.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -92.7 141.19 28.74 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.597 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.42 121.37 7.08 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.129 -174.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 79.4 mt-30 -117.55 114.57 23.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.443 ' CE ' HD11 ' A' ' 19' ' ' ILE . 50.9 tpp -101.87 130.14 48.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.148 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.01 146.36 21.19 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.481 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.23 14.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.916 -177.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.8 -25.56 40.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.572 175.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.54 -48.34 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.924 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -131.92 51.38 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.167 0.508 . . . . 0.0 109.967 176.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -121.69 112.21 18.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 173.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -116.27 128.54 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.656 -171.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -114.98 126.07 54.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.05 0.844 . . . . 0.0 108.859 171.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.1 t -105.6 111.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 1.4 t-20 -89.0 127.83 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.5 -175.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.31 103.54 15.49 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.352 -174.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.7 mm -96.52 134.78 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -104.48 154.53 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.257 -176.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -66.56 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.627 -175.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -131.41 117.79 19.35 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 5.0 m-20 -130.06 -35.25 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.98 177.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.51 52.76 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.94 23.25 28.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -175.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 24.7 m 43.51 61.38 10.25 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -88.9 39.58 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.464 1.443 . . . . 0.0 109.058 173.005 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.1 151.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.927 0.87 . . . . 0.0 111.258 -174.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.8 mtt180 -128.75 115.52 18.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.825 -179.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 31.9 -174.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 71.7 m-85 -132.57 153.34 51.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.077 174.254 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.0 mt -112.86 113.27 25.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 60' ' ' VAL . 43.1 t -115.89 128.98 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.043 -174.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.82 138.03 45.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.839 1.337 . . . . 0.0 108.122 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.63 157.15 44.33 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.805 -1.558 . . . . 0.0 112.007 176.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -134.73 163.93 28.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.448 -177.081 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.33 166.18 15.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.727 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.04 43.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.966 172.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -147.69 -56.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.742 176.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 p -132.05 157.99 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.198 175.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 16.0 pt-20 -105.09 165.34 11.16 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.711 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.8 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.614 178.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -69.52 163.44 58.96 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.45 172.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.0 Cg_exo -49.59 105.72 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.726 1.618 . . . . 0.0 110.622 176.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.36 160.67 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -175.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.27 148.84 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.181 174.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -115.07 135.56 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -88.1 164.19 34.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.159 -177.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.26 161.19 41.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.694 1.596 . . . . 0.0 109.08 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -84.38 99.65 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.188 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.38 48.75 0.51 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -177.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -97.05 178.3 5.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.551 -177.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.21 -42.02 3.09 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.058 -179.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -150.72 168.32 24.72 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.106 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.6 p -120.73 148.19 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.719 172.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 ptp -133.09 149.95 52.1 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.604 -1.238 . . . . 0.0 112.79 -174.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -139.15 134.84 33.36 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.402 173.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -133.96 138.56 45.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.42 -176.025 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 5.9 t 88.81 49.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.836 172.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -96.32 -179.88 4.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.852 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -71.62 133.45 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.587 0.708 . . . . 0.0 111.127 -174.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -73.76 155.72 38.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 45.18 47.1 10.02 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.859 -177.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.27 156.04 45.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.014 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.29 148.94 22.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 12.2 m-85 -134.02 144.38 48.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.525 -178.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 9.3 mp0 -120.52 123.33 42.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.421 176.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.05 124.76 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 40.3 m-85 -113.43 125.66 54.48 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -120.63 124.36 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.536 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -110.99 157.05 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.54 158.84 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.459 177.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.8 tt0 -113.22 163.91 14.2 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.627 -1.229 . . . . 0.0 107.786 174.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.8 t-20 -148.93 152.37 36.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.987 177.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -36.81 -44.08 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.516 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -109.99 40.21 1.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.59 -153.78 22.23 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.271 172.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -122.29 161.81 22.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.733 179.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.7 t -120.94 117.64 27.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -40.95 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 125.592 1.808 . . . . 0.0 113.378 -174.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.18 136.51 33.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.194 -176.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.03 145.45 30.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.493 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -114.83 131.02 56.96 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.718 -173.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -118.58 130.48 55.91 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.019 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.55 141.01 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.386 -177.169 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.47 177.28 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.068 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 147.01 50.73 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.927 176.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.92 163.45 20.01 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.586 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -80.77 -168.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.213 -179.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.57 143.16 33.43 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.044 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.235 -1.84 . . . . 0.0 110.463 -179.361 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 9.3 Cg_endo -67.41 174.39 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.573 2.182 . . . . 0.0 113.054 -178.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -94.36 -178.01 4.45 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.706 172.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.65 149.34 64.06 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.988 177.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.83 174.68 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.377 1.385 . . . . 0.0 109.954 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' HB2' HE22 ' A' ' 26' ' ' GLN . 20.9 ttpt -105.78 141.0 37.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.75 115.16 29.35 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.29 -177.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.04 138.41 39.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.592 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -126.64 143.65 14.5 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.277 -1.916 . . . . 0.0 113.815 -171.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -128.14 138.53 52.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.084 171.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.473 ' CE ' HD11 ' A' ' 19' ' ' ILE . 21.5 mtp -108.31 128.2 54.54 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.9 178.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -80.88 151.46 32.04 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.81 -175.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.87 11.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.037 -0.581 . . . . 0.0 112.311 -178.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.8 -24.62 41.29 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.727 176.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.29 -41.65 2.16 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.86 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.408 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 7.6 p30 -138.87 50.44 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.116 177.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.3 m -122.31 114.65 21.07 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.5 mm -116.2 128.86 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.684 -170.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 123.04 47.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.12 0.887 . . . . 0.0 109.214 175.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 44.4 t -112.79 120.28 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -176.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -97.42 134.2 40.99 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.772 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD22 HG11 ' A' ' 75' ' ' VAL . 16.9 mt -101.4 105.9 16.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.048 0.843 . . . . 0.0 109.039 -175.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.18 107.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.165 -176.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -76.92 156.84 31.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.49 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.7 pt20 -154.57 -83.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.389 -173.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.42 98.65 8.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.66 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -131.62 -34.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.498 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.79 56.72 0.43 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.86 19.07 41.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.578 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.8 m 42.1 61.56 8.45 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.744 -176.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -86.92 45.51 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.727 1.618 . . . . 0.0 108.701 173.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.436 HD13 HD22 ' A' ' 79' ' ' ASN . 23.4 mm -82.15 150.8 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.203 -173.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' HIS . 63.4 mtp85 -128.26 112.41 14.46 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.799 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.4 p-80 38.66 -173.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 175.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.53 153.88 51.57 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.28 177.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.2 mt -110.89 110.51 21.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 175.366 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG11 HG21 ' A' ' 60' ' ' VAL . 47.3 t -114.55 124.92 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.281 -173.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -135.56 139.97 44.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.647 1.217 . . . . 0.0 108.151 177.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.38 154.87 42.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.299 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 16.0 ptt180 -132.23 164.87 25.41 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.381 -178.058 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.53 169.77 13.33 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.272 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -74.16 42.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.783 173.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -145.49 -56.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.731 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -137.05 164.25 28.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.521 175.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -100.98 169.13 9.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.398 -174.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 6.5 m95 17.81 95.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.788 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.5 mmtt -69.0 165.48 37.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.99 172.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 13.1 Cg_exo -50.71 97.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.538 1.492 . . . . 0.0 109.849 175.063 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.0 172.23 1.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.566 -173.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.3 tt -138.24 154.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.956 -179.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -115.5 135.57 53.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.94 174.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -85.41 165.1 37.73 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.002 -177.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 9.9 Cg_endo -73.31 146.41 40.17 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.725 1.616 . . . . 0.0 109.783 172.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 37.3 p -58.17 113.85 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.931 0.769 . . . . 0.0 111.285 -178.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.41 56.29 1.05 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -97.04 177.04 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 -45.48 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.813 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -144.27 170.22 16.4 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.128 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.5 p -129.03 151.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.348 175.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ptp -138.09 150.91 47.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.67 -1.212 . . . . 0.0 112.193 -177.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.52 140.51 41.15 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.983 174.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.8 ttpt -140.47 136.42 32.96 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.811 -173.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.3 t 90.31 48.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.763 172.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -95.4 179.49 5.14 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.321 -178.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.03 134.69 48.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.661 0.743 . . . . 0.0 111.441 -173.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -74.47 154.21 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 45.86 48.06 12.1 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.618 -177.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.29 151.86 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.2 148.77 21.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 8.6 m-85 -133.62 141.25 47.56 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.398 -178.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.47 117.83 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.753 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.07 122.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 41.8 m-85 -112.21 125.88 54.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.409 HG11 HD22 ' A' ' 23' ' ' LEU . 95.4 t -120.33 122.71 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.888 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.7 t -109.15 158.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.99 159.67 33.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.049 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -112.74 164.66 13.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.448 -1.301 . . . . 0.0 107.582 174.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -149.6 153.2 36.72 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.872 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -40.74 -40.89 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.318 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -79.75 -52.5 7.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.01 -119.37 0.57 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.114 -177.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -125.34 163.93 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.427 -179.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.66 119.35 30.47 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -40.59 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 125.357 1.661 . . . . 0.0 113.447 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.62 139.24 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.387 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.87 144.78 34.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.39 131.59 56.9 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.633 -173.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 85.6 t80 -117.72 128.16 54.62 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.083 -179.175 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -124.89 137.89 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.58 -176.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.1 p90 -157.8 178.3 10.4 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.276 178.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.13 145.98 51.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.78 175.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -80.0 172.6 13.55 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.283 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -86.28 -174.96 5.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.166 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.91 147.51 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.312 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.471 -1.728 . . . . 0.0 110.551 -179.09 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 14.9 Cg_endo -71.2 178.02 5.92 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -84.93 152.71 23.32 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.479 170.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 162.7 0.92 Allowed Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.335 174.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.71 167.38 20.69 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.219 1.28 . . . . 0.0 110.522 176.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -104.24 127.42 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -98.31 112.32 24.35 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.983 -177.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.62 93.99 4.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -104.46 152.24 17.51 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.946 -172.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.64 157.82 43.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.953 -1.124 . . . . 0.0 109.232 178.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.3 ttm -111.12 139.45 46.47 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.359 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.15 154.85 25.76 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.121 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.45 11.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.267 -176.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' GLY . 20.4 m-20 -79.89 -22.87 42.29 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.152 175.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.58 -37.09 3.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.939 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 10.1 p-10 -140.12 46.22 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.112 177.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.4 m -120.77 115.23 22.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.529 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 8.0 mm -116.08 130.85 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.132 -170.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.77 122.48 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.8 t -108.88 116.44 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -93.44 134.34 35.78 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.17 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 32.7 mt -101.41 103.74 14.68 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.286 -176.138 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mm -95.2 136.71 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.13 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -104.36 152.6 22.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.45 -69.88 0.54 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.916 -175.636 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 25.7 m-20 -127.45 110.78 13.11 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.3 m-20 -131.48 -33.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.399 178.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.12 52.09 0.5 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.22 24.81 25.77 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 39.26 64.34 4.0 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.853 -0.674 . . . . 0.0 112.489 -176.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.9 44.61 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.665 1.577 . . . . 0.0 108.705 173.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.479 HD13 HD22 ' A' ' 79' ' ' ASN . 21.2 mm -90.69 148.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.163 -174.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' HIS . 74.6 mtm-85 -131.8 125.6 32.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.829 175.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.7 p-80 36.34 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 176.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 94.7 m-85 -138.57 150.56 46.45 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.518 178.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -105.27 110.32 22.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -112.47 126.31 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 118.959 -1.097 . . . . 0.0 110.607 -174.264 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -132.41 135.31 46.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 125.035 1.46 . . . . 0.0 107.804 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.47 151.69 41.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.659 -1.616 . . . . 0.0 112.128 176.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.3 ptm180 -124.15 160.53 27.64 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.433 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -109.17 -168.84 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -96.85 39.78 1.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.541 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.54 -60.97 0.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.03 150.26 39.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.9 pt-20 -106.79 144.02 34.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.746 -177.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.517 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.4 m95 48.45 82.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.107 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -68.71 161.26 72.48 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.926 174.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.6 Cg_exo -43.63 104.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.96 1.773 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -52.21 161.63 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.902 -175.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.3 147.7 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.412 174.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -114.04 129.69 56.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.4 mt -78.35 164.68 54.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.663 -178.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 6.0 Cg_exo -63.03 149.84 90.4 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.646 1.564 . . . . 0.0 110.009 174.192 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.416 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 20.5 m -64.23 87.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.68 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 113.7 56.61 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.7 t -97.02 -175.07 3.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.162 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.86 -24.01 3.01 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.974 -178.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p-80 -160.26 167.52 27.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.988 -177.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.8 p -130.4 152.32 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.579 174.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ptp -137.86 148.91 45.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.235 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -138.58 135.75 35.31 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.719 174.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.9 mtmt -141.63 143.07 33.45 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.871 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.5 m 90.82 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.999 175.036 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mm? -92.6 -177.81 4.69 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.813 -178.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.29 133.94 41.19 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.635 0.731 . . . . 0.0 111.229 -172.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.59 155.8 39.66 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.125 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.6 t30 44.63 47.02 8.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.084 -177.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.41 154.58 46.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.824 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.9 mt-10 -97.42 148.31 23.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.684 177.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 21.4 m-85 -133.76 142.1 47.78 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.502 -177.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -122.86 118.42 27.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.184 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.68 123.42 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 50.3 m-85 -112.2 126.04 54.79 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.08 122.42 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.925 0.766 . . . . 0.0 110.705 -178.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.23 159.71 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.61 159.93 35.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.016 177.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.6 tt0 -113.14 151.99 30.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.361 -1.336 . . . . 0.0 108.283 175.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -142.55 150.77 40.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.62 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -37.81 -39.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.711 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.63 -49.86 11.53 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.085 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 -125.2 0.75 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.513 -179.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -119.78 157.87 27.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.088 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -116.68 118.05 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -41.53 162.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 125.538 1.774 . . . . 0.0 112.873 -175.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.78 135.36 34.57 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.235 -175.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.99 148.05 25.83 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.533 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -117.4 130.64 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.783 -172.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.3 t80 -119.17 130.37 55.48 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.939 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.533 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.7 t -128.48 142.85 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.311 -175.307 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 49.6 p90 -162.52 179.08 8.03 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.334 177.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -129.28 147.91 51.16 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.49 175.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.6 p -79.87 170.95 15.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.344 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -83.23 -173.02 4.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.967 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 138.9 39.83 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.02 -178.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 116.447 -1.739 . . . . 0.0 110.654 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.3 Cg_exo -60.09 173.26 1.92 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.549 2.166 . . . . 0.0 113.177 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -98.62 162.61 13.04 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 144.27 94.98 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.168 -177.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.54 174.01 8.02 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.392 1.395 . . . . 0.0 110.495 -178.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -109.09 132.08 54.45 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.37 114.68 29.0 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.876 -1.129 . . . . 0.0 110.035 -176.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -95.09 141.27 28.92 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -105.73 127.44 8.97 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.634 -171.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -121.82 113.28 19.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.433 ' CE ' HD11 ' A' ' 19' ' ' ILE . 25.0 mtp -103.63 127.2 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.348 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.79 147.16 21.0 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.722 -1.228 . . . . 0.0 112.25 -174.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.27 13.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.918 -0.641 . . . . 0.0 112.141 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.23 41.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.449 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.67 -46.18 1.21 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.55 176.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -134.54 35.37 3.18 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.315 177.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -104.59 113.88 27.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 12.1 mm -118.43 126.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.492 -171.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -113.66 127.38 56.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.006 0.816 . . . . 0.0 108.822 172.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.1 t -108.53 116.31 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -97.65 129.64 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.54 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.2 mt -99.37 109.64 22.22 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.756 -172.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.9 mm -100.6 135.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.94 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -101.58 150.42 23.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.828 0.705 . . . . 0.0 109.265 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -135.34 -49.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.744 -175.922 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 27.5 m-20 -140.01 104.27 4.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.69 -177.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -132.57 -33.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.256 178.695 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.64 51.66 0.49 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.64 23.94 29.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.598 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.6 t 42.76 62.13 8.64 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.734 -0.733 . . . . 0.0 112.816 -176.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.83 41.68 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.582 1.521 . . . . 0.0 108.813 171.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.65 150.83 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.488 -173.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 53.4 mtt-85 -130.69 117.52 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.47 -1.695 . . . . 0.0 108.598 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.3 p-80 36.76 -175.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 176.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.7 m-85 -137.21 153.96 50.29 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.012 176.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -108.65 110.21 21.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' VAL . 44.7 t -114.17 123.81 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.137 -173.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -134.49 137.85 44.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.661 1.225 . . . . 0.0 108.113 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.21 158.71 43.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.968 -1.493 . . . . 0.0 112.505 179.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.0 ptm180 -138.28 170.72 15.52 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.983 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.09 -168.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.155 -175.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.24 41.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.484 174.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.23 -57.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.701 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -122.95 157.61 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.926 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.1 pt-20 -97.68 178.22 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.462 -177.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.5 m95 3.38 100.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.42 167.87 32.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.307 172.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -48.61 98.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.711 1.607 . . . . 0.0 110.365 176.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.37 174.32 4.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.353 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.12 155.51 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.389 -177.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -113.68 134.08 54.95 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.974 173.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -82.28 163.55 52.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.933 -177.64 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.7 Cg_exo -59.59 167.29 6.76 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.84 1.693 . . . . 0.0 110.51 174.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -74.76 79.82 2.07 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.657 -176.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 63.02 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -97.05 -175.81 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.808 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.03 -16.53 3.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.274 -179.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.9 p-80 -160.07 164.52 33.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.496 -176.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 38' ' ' VAL . 14.7 p -134.9 152.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.614 173.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -137.42 152.86 50.06 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.708 -176.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -138.88 140.57 38.45 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.52 173.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.32 156.2 47.01 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.617 -174.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.1 t 62.68 59.13 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.378 175.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -100.68 -175.14 2.81 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.653 176.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.84 140.33 36.85 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.677 0.751 . . . . 0.0 111.462 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.409 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 80.4 m95 -76.73 154.15 34.37 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.602 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 44.49 48.34 8.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 -177.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.34 152.79 47.75 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.676 179.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.58 147.66 24.57 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.601 176.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -132.2 143.39 49.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.36 -176.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -120.82 118.26 29.52 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.785 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -112.91 120.63 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 47.6 m-85 -110.08 125.4 52.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.83 120.69 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.429 -178.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.98 158.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.98 156.48 43.71 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.612 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.24 159.24 18.1 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.742 174.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 20.0 t-20 -143.64 151.87 40.66 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.512 178.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -40.03 -39.1 0.81 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.006 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -107.99 35.43 3.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.01 -151.44 20.45 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.942 173.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -121.79 160.08 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.933 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -122.54 122.85 39.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -41.88 165.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.664 1.852 . . . . 0.0 113.468 -174.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.57 137.23 33.01 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.34 146.01 28.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.09 128.16 55.45 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.687 -174.039 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 82.7 t80 -112.73 124.97 53.78 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.88 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -124.29 137.46 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.324 -176.475 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 46.3 p90 -161.34 179.09 8.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.821 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -128.53 153.36 47.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.364 173.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.1 p -79.92 177.72 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.074 177.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -90.45 -174.01 3.98 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.333 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.46 149.18 23.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.083 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.538 -1.696 . . . . 0.0 110.621 -178.571 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.4 Cg_exo -60.62 169.48 5.46 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.407 2.072 . . . . 0.0 113.08 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -98.0 163.39 12.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.347 172.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.44 142.28 91.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.269 -176.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -70.65 163.24 39.7 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.551 1.501 . . . . 0.0 110.087 -178.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG3' HE22 ' A' ' 26' ' ' GLN . 29.5 mtmt -91.98 137.05 32.68 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.7 mt -105.77 109.81 21.9 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.56 -179.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 27.6 tt0 -94.34 137.92 32.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.34 -178.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.85 125.85 8.48 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.593 -1.289 . . . . 0.0 112.384 -171.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -120.84 117.74 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.448 ' CE ' HD11 ' A' ' 19' ' ' ILE . 51.2 tpp -99.92 127.43 46.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.78 150.34 24.12 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.191 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 4.8 mp0 -66.69 14.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.798 -176.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.75 41.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.461 174.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.21 -43.5 1.7 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.337 177.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -130.81 6.89 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.205 178.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -75.06 112.27 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.819 176.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 9.4 mm -114.36 125.04 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.862 -173.356 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.63 125.85 54.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.0 t -108.38 113.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -178.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 56.4 t30 -93.46 129.26 39.7 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.353 -177.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -97.37 106.14 18.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.393 -173.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.94 105.55 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.803 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -76.23 148.04 37.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.417 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.7 pt20 -146.01 -55.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.26 -173.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.68 101.58 5.54 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.682 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.1 m-20 -129.07 -37.41 1.69 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.109 178.252 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.02 54.69 0.38 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.54 20.24 38.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -175.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.595 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.1 m 42.47 61.87 8.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -86.68 43.0 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.695 1.597 . . . . 0.0 108.493 172.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -80.79 151.09 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.536 -172.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.1 mtt180 -127.85 111.7 13.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.696 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.8 p-80 37.46 -176.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 175.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 80.9 m-85 -134.34 151.35 51.18 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.847 175.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.9 mt -107.68 110.68 22.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.003 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -115.7 125.98 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.413 -174.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -137.53 142.2 41.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.637 1.21 . . . . 0.0 107.924 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.19 157.78 43.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.802 -1.559 . . . . 0.0 112.187 179.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.5 ptm180 -132.32 163.19 29.22 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.305 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.98 175.65 5.95 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.62 42.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.125 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.97 -59.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.244 178.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -125.41 154.89 41.24 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.156 176.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -106.47 158.16 17.11 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.992 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.533 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 33.03 86.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.204 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.8 mmtt -72.52 164.16 62.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.387 175.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.46 98.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.83 1.687 . . . . 0.0 110.537 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.64 173.6 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.506 -174.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.02 155.0 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.09 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -115.96 133.45 56.01 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.884 173.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.6 mt -82.63 162.94 54.03 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.294 -176.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.7 Cg_exo -60.33 168.85 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.932 1.755 . . . . 0.0 111.016 173.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 p -80.9 81.44 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.956 -177.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 58.47 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 m -97.13 178.94 5.09 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.898 -178.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.75 -37.68 2.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.545 -178.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -148.93 168.43 23.07 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.018 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -126.89 150.49 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.48 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ptp -134.39 148.12 50.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.52 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.5 pp -141.85 141.74 33.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.008 173.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -141.51 174.06 10.91 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.901 -1.119 . . . . 0.0 111.309 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 m 59.02 56.79 3.81 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.424 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD11 ' CD1' ' A' ' 62' ' ' LEU . 17.2 mt -94.33 -178.1 4.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.18 131.95 38.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.229 175.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.3 m95 -72.71 152.61 41.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.556 -1.258 . . . . 0.0 110.251 -178.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.77 46.79 18.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.853 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.88 154.28 45.68 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.889 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.28 149.9 20.83 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.216 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.3 m-85 -135.5 141.9 45.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.269 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.14 118.28 30.96 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.422 177.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.64 124.2 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.59 125.71 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.5 t -121.49 122.51 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.023 0.827 . . . . 0.0 110.482 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.16 158.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.09 156.77 43.35 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.408 -1.317 . . . . 0.0 109.797 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.4 tt0 -112.05 162.52 15.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -147.26 150.86 35.67 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.099 177.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -39.05 -43.04 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.307 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -111.52 40.37 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.599 -175.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.12 -152.12 22.58 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.82 174.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -132.67 167.88 19.29 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.701 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.2 t -127.34 121.01 29.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.3 -178.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -43.41 166.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 125.5 1.75 . . . . 0.0 112.987 -175.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.82 135.87 34.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.37 -175.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.9 144.32 29.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.96 129.25 56.62 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.336 -174.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -116.8 125.05 51.02 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.785 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -124.28 137.73 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.501 -176.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.1 p90 -156.85 177.93 10.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.07 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -126.31 147.72 49.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.475 174.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.88 167.97 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 m -78.16 -177.25 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.362 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.22 146.65 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.891 179.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 116.466 -1.731 . . . . 0.0 110.531 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.79 -176.35 17.11 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.489 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.49 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.7 Cg_exo -56.53 173.7 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.509 2.14 . . . . 0.0 113.095 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m -95.15 159.51 14.98 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.536 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.91 144.4 98.99 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.129 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 7.9 Cg_endo -66.02 163.63 30.52 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.417 1.411 . . . . 0.0 110.822 -177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 128.1 48.94 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -102.91 115.72 31.15 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.45 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.42 141.68 30.2 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -106.92 125.66 8.15 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.448 -1.358 . . . . 0.0 112.51 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -121.27 119.68 32.95 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.0 ttm -105.89 132.2 52.28 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.727 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.31 147.49 22.41 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.458 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.07 13.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.907 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.88 -22.76 42.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.828 175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.03 -40.65 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.102 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.409 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 8.4 p30 -137.65 49.06 1.99 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.278 0.561 . . . . 0.0 109.876 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.3 m -121.12 112.95 19.33 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.532 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.9 127.92 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.751 -170.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -114.18 127.25 55.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -107.83 113.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -95.81 131.88 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.544 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 30.3 mt -101.33 107.07 18.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.787 -172.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.56 132.59 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.095 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -99.1 155.29 17.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 123.845 0.715 . . . . 0.0 109.729 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.493 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.99 -48.2 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.02 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -143.89 109.11 5.04 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.134 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.0 m-20 -130.77 -37.59 1.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.035 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.82 54.71 0.39 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.42 33.16 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 11.4 m 43.62 61.3 10.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -88.75 40.0 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.418 1.412 . . . . 0.0 108.943 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.24 150.21 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.897 0.856 . . . . 0.0 111.336 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.1 mtt180 -130.95 116.67 18.17 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.793 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 35.66 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.566 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 82.7 m-85 -139.16 151.3 46.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.792 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.8 mt -106.89 109.83 21.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 54.9 t -113.92 122.9 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.035 -174.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.74 135.43 46.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.614 1.196 . . . . 0.0 107.927 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CD2' HD22 ' A' ' 62' ' ' LEU . 0.8 OUTLIER -141.51 161.6 37.52 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.876 -1.53 . . . . 0.0 112.063 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 7.8 ptm180 -144.35 170.1 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.763 -1.562 . . . . 0.0 110.166 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -122.63 179.65 4.54 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.714 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 tp -82.43 42.68 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.102 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.56 -56.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.344 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.3 m -124.31 151.95 43.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.409 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -98.07 175.03 6.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.606 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.8 m95 10.5 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.581 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 27.7 mmmt -80.53 163.0 58.77 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.049 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.4 Cg_exo -44.89 102.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.907 1.738 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.45 175.09 4.26 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.577 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.52 153.12 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.014 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 39.1 ttm105 -114.39 127.51 55.88 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.019 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -73.26 164.77 58.56 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.263 -177.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.77 169.99 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.749 1.633 . . . . 0.0 110.272 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.5 t -76.9 77.55 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.554 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.09 64.67 0.46 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.9 t -96.99 -174.47 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.14 -25.33 4.92 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 12.3 p-80 -160.22 167.68 27.06 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.778 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -129.56 153.66 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.125 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ptp -139.81 154.54 47.38 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.37 -1.332 . . . . 0.0 113.157 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -140.38 139.77 35.4 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.563 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -135.78 136.55 40.8 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.616 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 86.97 51.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.0 170.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.1 mm? -97.96 -177.85 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.923 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 134.73 42.58 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.685 0.755 . . . . 0.0 111.328 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -73.21 155.32 39.69 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.207 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.14 49.12 7.64 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.869 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.15 153.8 49.03 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.732 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -95.14 150.26 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.888 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.4 m-85 -134.23 143.4 47.8 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.451 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.7 123.06 43.98 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.403 -1.726 . . . . 0.0 107.891 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.51 121.82 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 35.2 m-85 -110.39 125.43 53.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.0 t -120.76 122.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 123.87 0.732 . . . . 0.0 110.835 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -107.11 157.99 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.51 155.53 43.6 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.43 -1.308 . . . . 0.0 109.534 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.7 tt0 -111.35 158.84 18.58 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.838 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 14.7 t-20 -144.58 151.34 38.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.716 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -35.7 -44.13 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.585 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.14 38.14 2.5 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.74 -155.06 23.49 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.317 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -121.76 159.32 26.91 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.794 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.5 t -121.86 125.59 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.294 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -41.38 165.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.718 1.886 . . . . 0.0 113.737 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.09 136.08 33.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.19 147.01 27.56 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.56 129.66 56.6 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.702 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 80.3 t80 -115.09 128.58 56.31 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.986 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -125.85 138.66 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.421 -176.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 39.6 p90 -158.09 178.19 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.028 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -129.7 147.07 51.45 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.912 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -79.85 171.7 14.76 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.201 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.67 -171.07 3.36 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.051 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.65 141.24 36.4 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.068 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 116.245 -1.836 . . . . 0.0 110.431 -179.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.017 0.437 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.27 176.5 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.036 -1.078 . . . . 0.0 110.557 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -55.22 170.09 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.699 2.266 . . . . 0.0 113.748 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -94.27 174.17 7.27 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.191 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.36 142.2 58.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.744 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -69.55 169.53 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.588 1.525 . . . . 0.0 110.289 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' HB2' HE22 ' A' ' 26' ' ' GLN . 34.0 ttpt -99.23 137.61 37.5 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 172.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 mt -108.38 109.32 20.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.834 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.07 145.38 24.57 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.94 127.96 7.91 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.68 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.39 126.81 48.77 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.484 ' CE ' HD11 ' A' ' 19' ' ' ILE . 47.5 tpp -104.46 129.7 52.43 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.913 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -82.82 150.17 27.65 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.31 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.73 12.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.061 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.3 m-20 -79.86 -23.31 42.02 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.967 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.27 -41.99 2.03 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.883 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.4 p30 -136.53 48.31 2.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.131 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 m -121.22 116.03 24.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.5 mm -116.19 128.59 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.469 -170.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.5 124.42 52.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.071 0.857 . . . . 0.0 108.961 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.6 t -109.12 120.62 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -94.19 130.7 40.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.283 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.33 98.54 9.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mm -89.42 107.88 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.242 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -68.69 170.03 10.13 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.5 HE22 ' HB2' ' A' ' 7' ' ' LYS . 3.5 pt20 -170.31 -67.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.652 -175.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.4 m-20 -117.94 86.52 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.218 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.4 m-20 -129.31 -17.41 3.79 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.57 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.82 23.43 49.75 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.1 m 43.84 64.9 6.36 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.763 -0.718 . . . . 0.0 112.797 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -86.93 46.44 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 N-CA-C 107.26 -1.862 . . . . 0.0 107.26 170.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.02 152.11 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.008 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -127.63 113.91 16.68 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.221 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.8 p-80 36.86 -176.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.9 m-85 -137.25 152.09 49.43 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.461 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.8 109.26 21.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 60' ' ' VAL . 49.7 t -113.12 121.15 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.797 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.82 137.54 48.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 124.69 1.244 . . . . 0.0 107.874 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 155.16 44.87 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.906 -1.518 . . . . 0.0 112.173 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.2 ptm180 -131.23 164.66 25.07 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.018 -1.447 . . . . 0.0 110.098 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.61 170.48 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.02 43.09 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.506 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.73 -58.05 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.074 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.3 m -127.21 154.81 44.36 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.194 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -101.41 163.6 12.19 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.144 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.469 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 24.81 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.999 -1.455 . . . . 0.0 114.258 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 39.9 mmtm -71.49 165.93 44.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.116 174.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -49.17 96.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.723 1.615 . . . . 0.0 110.046 175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.01 174.34 2.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.534 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.91 154.4 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.368 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -113.99 130.12 56.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.789 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mt -78.18 164.02 58.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.798 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.8 Cg_exo -60.33 168.08 6.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.666 1.577 . . . . 0.0 110.318 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.2 t -75.92 78.1 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.724 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.93 63.66 0.36 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.1 t -97.09 -172.12 2.37 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.689 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -131.96 -15.82 2.95 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.214 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.2 p-80 -159.71 165.39 32.65 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.556 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.3 p -135.0 152.18 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.66 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptp -137.78 150.58 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.418 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -139.6 138.21 35.99 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.954 174.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 53.1 mtmt -142.41 141.7 32.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.849 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.2 t 93.32 44.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.291 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -178.65 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.028 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.72 135.17 43.62 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.704 0.764 . . . . 0.0 111.241 -173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -74.19 156.49 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.291 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 45.24 47.07 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.729 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.48 154.95 47.24 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.002 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -97.24 149.04 22.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.8 m-85 -133.8 144.47 49.02 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.614 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.72 121.0 37.29 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.619 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.73 123.38 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.16 127.12 55.84 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.48 120.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 123.914 0.759 . . . . 0.0 110.731 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.08 158.88 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.58 45.26 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.219 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -112.97 157.48 21.44 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.317 -1.353 . . . . 0.0 107.9 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.5 t-20 -144.37 153.29 41.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.527 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -37.21 -41.95 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.496 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -107.64 36.38 2.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.79 -153.51 21.11 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.441 -1.361 . . . . 0.0 111.041 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -120.08 158.92 25.85 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 t -124.04 128.02 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.97 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -42.09 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 125.751 1.907 . . . . 0.0 113.303 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -90.17 140.89 29.24 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.443 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.8 145.08 29.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.466 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -115.25 129.87 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.418 -175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 78.1 t80 -117.73 130.1 56.11 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.095 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.61 139.7 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.541 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.7 p90 -157.38 177.43 11.45 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.154 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.52 146.57 51.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.951 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.31 164.98 19.7 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.539 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -81.61 -169.84 2.52 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.1 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.94 141.7 36.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.154 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.708 -179.524 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -113.91 172.35 14.31 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.539 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 28.2 Cg_endo -71.33 179.99 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.849 2.366 . . . . 0.0 112.737 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -103.95 160.32 14.91 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.177 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.69 148.99 98.56 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.812 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -71.85 171.85 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.307 1.338 . . . . 0.0 110.335 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.46 ' HG3' HE22 ' A' ' 26' ' ' GLN . 32.9 mtmt -100.16 146.57 26.68 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 171.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.9 mt -115.09 114.04 24.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.195 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -95.42 144.81 25.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.79 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -111.33 127.09 8.03 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.48 -1.343 . . . . 0.0 112.554 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -122.73 124.58 43.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 171.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 47.9 ttm -105.25 133.13 50.52 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.595 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.94 153.88 25.09 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.543 -176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.07 10.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.082 -0.559 . . . . 0.0 112.234 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -80.0 -23.17 41.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.878 176.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.57 -37.03 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.36 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -132.53 2.46 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.123 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.4 m -75.67 116.5 16.45 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.974 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.0 127.67 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.182 -172.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.85 125.45 54.08 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.2 t -108.91 119.78 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -97.28 128.72 44.38 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.102 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 47.3 mt -96.72 110.34 22.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 123.855 0.722 . . . . 0.0 109.695 -174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -97.42 108.18 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.686 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -72.4 168.43 18.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.753 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.46 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.6 pt20 -166.27 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.555 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 18.7 t70 -111.8 89.87 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.075 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 18.1 m-20 -131.97 -17.81 2.73 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.255 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.18 54.03 1.31 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.42 31.65 58.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 t 36.8 79.07 0.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 114.637 -0.782 . . . . 0.0 112.949 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 79' ' ' ASN . 6.0 Cg_endo -87.55 35.46 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 N-CA-C 107.169 -1.896 . . . . 0.0 107.169 165.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.99 144.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-O 122.091 0.948 . . . . 0.0 111.863 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 27.6 mtt180 -128.19 128.65 45.15 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.109 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 11.9 p-80 34.44 -173.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.996 1.851 . . . . 0.0 115.996 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -139.93 153.5 46.97 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.555 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -106.29 112.16 25.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 60' ' ' VAL . 45.9 t -114.11 128.22 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.928 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -134.43 140.25 46.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 125.039 1.462 . . . . 0.0 108.011 176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.62 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.99 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.477 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 24.5 ptt85 -126.41 158.8 35.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.354 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.78 169.43 10.43 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.551 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.95 43.6 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.868 173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.49 -57.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.826 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.3 m -130.95 152.28 50.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.003 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 38.2 mt-10 -105.89 142.02 36.31 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.655 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.2 m95 58.81 84.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.837 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mptp? -70.67 161.89 74.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.123 173.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.66 105.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.88 1.72 . . . . 0.0 111.073 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.81 161.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.842 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.5 tt -134.12 149.91 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.459 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -114.29 132.41 56.17 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 60' ' ' VAL . 1.5 mt -82.79 165.25 42.75 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.129 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.5 Cg_exo -63.1 156.13 56.92 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.784 1.656 . . . . 0.0 110.324 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -73.66 83.26 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.183 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.62 47.61 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.63 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -97.13 167.44 11.05 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.04 -2.62 9.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.643 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.459 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.05 163.5 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.191 -1.403 . . . . 0.0 112.86 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -135.43 152.29 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.867 173.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptp -137.67 150.63 47.51 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.641 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -141.74 140.78 33.19 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.24 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.41 162.1 35.84 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.011 -1.075 . . . . 0.0 111.728 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 m 65.96 54.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.705 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -100.18 -175.43 2.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.046 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.51 136.64 37.62 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.084 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -75.16 155.72 36.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 43.28 48.61 5.77 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.567 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.47 152.83 47.79 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.128 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -91.63 146.14 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 17.1 m-85 -134.45 138.72 44.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.245 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.61 118.3 28.88 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.457 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -112.29 126.85 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 51.5 m-85 -115.69 125.76 53.24 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.44 121.88 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 123.96 0.787 . . . . 0.0 110.708 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -106.81 156.26 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.38 155.74 41.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.955 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -110.08 149.13 30.47 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.126 -1.43 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.56 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -129.34 141.68 51.02 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.806 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -42.59 -33.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.229 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -126.61 50.44 1.93 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.546 -0.862 . . . . 0.0 111.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.89 -160.36 27.06 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.097 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -125.97 159.18 33.35 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.827 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -113.18 111.32 21.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -39.59 159.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 125.442 1.714 . . . . 0.0 112.527 -176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.0 128.75 35.07 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.951 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.58 145.06 25.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.7 t-160 -116.12 130.94 57.04 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.781 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.6 t80 -120.07 128.86 53.88 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.314 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -126.23 135.67 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.627 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 19' ' ' ILE . 38.7 p90 -157.49 177.65 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.169 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -128.25 147.9 50.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.425 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.8 p -79.87 170.59 16.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.178 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -84.48 -171.29 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.222 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 140.88 36.92 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.092 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.386 -179.074 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.72 169.87 15.22 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.569 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.492 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.0 Cg_exo -58.05 172.23 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.561 2.174 . . . . 0.0 113.34 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -98.66 163.35 12.68 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.567 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.75 143.7 98.21 Favored Pre-proline 0 N--CA 1.491 1.594 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.372 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -71.63 172.51 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.66 1.573 . . . . 0.0 110.582 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' N ' ' NE2' ' A' ' 26' ' ' GLN . 28.1 mtmt -99.06 142.21 30.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -112.29 111.37 22.2 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.037 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -92.05 144.03 25.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.0 131.45 10.46 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.394 -1.384 . . . . 0.0 112.22 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -128.07 125.83 40.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.1 ttm -107.65 131.52 54.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.89 151.97 28.09 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.429 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -64.18 10.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.157 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -79.97 -22.46 42.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.123 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.74 -37.16 3.84 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.664 -1.255 . . . . 0.0 111.051 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.1 p-10 -138.56 46.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -121.48 113.25 19.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.2 mm -116.35 129.16 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.688 -169.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -114.21 127.38 55.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.8 t -110.69 118.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -95.75 130.63 42.6 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.62 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 55.6 mt -99.6 109.43 21.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 123.678 0.611 . . . . 0.0 109.978 -174.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mm -94.69 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.74 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -79.01 140.41 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' N ' ' A' ' 7' ' ' LYS . 2.2 pt20 -136.87 -70.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.329 -171.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -115.88 101.29 8.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.004 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.02 -34.54 0.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.31 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.94 52.1 0.35 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.19 18.78 35.33 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.604 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 68.6 m 40.75 61.85 6.73 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.9 Cg_endo -87.08 51.36 2.32 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.709 1.606 . . . . 0.0 108.694 172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.6 mm -88.2 149.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 122.046 0.927 . . . . 0.0 111.446 -173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.9 mtp85 -132.05 123.61 27.58 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.943 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.59 ' H ' ' N ' ' A' ' 56' ' ' GLY . 6.0 p-80 33.65 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.6 m-85 -142.02 156.46 45.43 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.862 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.57 109.91 21.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 60' ' ' VAL . 46.8 t -114.11 123.67 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.068 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.23 137.87 46.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.804 1.315 . . . . 0.0 108.057 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.39 157.53 44.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 117.966 -1.494 . . . . 0.0 112.294 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.3 ptm180 -134.23 166.54 22.55 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.941 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.02 -170.72 2.01 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.91 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.0 tp -91.83 40.17 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.089 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.44 -58.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.597 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 157.55 37.1 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.417 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.6 pt-20 -101.3 162.57 12.8 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.282 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.467 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 25.24 89.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.838 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 70.6 mmtt -75.83 162.99 69.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -44.28 100.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.747 1.632 . . . . 0.0 110.869 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.66 175.65 4.07 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.42 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.34 155.64 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.384 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -113.96 135.36 54.08 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.861 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.1 mt -85.18 167.06 27.9 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.415 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 5.4 Cg_exo -65.12 154.65 72.47 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.729 1.619 . . . . 0.0 109.91 172.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.453 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 9.0 t -65.62 85.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.588 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 113.4 61.9 0.42 Allowed Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.327 -0.939 . . . . 0.0 110.94 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 t -97.08 164.78 12.37 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.582 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.3 -18.69 14.76 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.87 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.0 p-80 -160.03 172.86 16.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.487 -1.285 . . . . 0.0 111.898 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.2 p -134.8 155.0 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.232 171.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -139.06 151.46 46.77 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.593 -1.243 . . . . 0.0 112.863 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -139.37 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.574 173.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -134.85 137.56 43.38 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.764 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 90.07 48.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.843 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mm? -96.72 -177.47 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.986 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 133.5 40.88 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.752 0.787 . . . . 0.0 111.46 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.66 156.13 39.72 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.254 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.3 t30 46.37 46.04 13.63 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.199 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.8 154.65 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.077 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 45.0 mt-10 -97.61 147.58 24.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.528 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 18.2 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.476 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -120.24 119.78 34.19 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.956 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.69 121.41 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 32.9 m-85 -110.92 124.27 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.9 t -121.08 122.25 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.856 0.722 . . . . 0.0 110.725 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.27 155.41 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -125.52 157.28 37.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.408 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 29.9 tt0 -111.79 156.33 22.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.712 -1.195 . . . . 0.0 107.801 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.5 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.9 t-20 -137.04 150.03 47.81 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.911 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -37.69 -35.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.145 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -125.73 48.35 2.08 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.732 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.25 -162.18 27.22 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.323 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -119.08 159.15 24.46 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.85 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 26.6 t -121.02 119.35 32.26 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -40.75 164.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.639 1.837 . . . . 0.0 113.231 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.92 140.09 31.37 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.519 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.6 146.63 28.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.64 129.85 56.39 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.021 -1.071 . . . . 0.0 111.469 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -117.97 130.63 56.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.163 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -127.64 141.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.75 -176.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 40.0 p90 -160.09 178.11 10.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.971 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -127.86 147.74 50.45 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.775 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -80.04 170.31 16.64 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.133 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -80.43 -179.63 7.25 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.892 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.67 144.1 28.32 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 116.187 -1.863 . . . . 0.0 110.382 -179.263 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.9 172.32 15.86 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.603 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.1 Cg_exo -61.22 172.43 3.23 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.566 2.177 . . . . 0.0 112.936 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -97.56 152.49 18.98 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.548 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.74 144.73 72.91 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.49 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.19 164.27 30.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.251 1.301 . . . . 0.0 110.212 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -102.35 129.29 48.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.3 mt -102.79 110.86 22.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.073 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -89.73 139.6 30.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.16 118.37 6.16 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.488 -1.339 . . . . 0.0 112.033 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 75.6 mt-30 -112.73 105.63 13.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.438 ' CE ' HD11 ' A' ' 19' ' ' ILE . 23.6 mtp -103.8 127.66 51.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.016 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -79.91 118.03 4.63 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.845 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.45 13.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.786 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.7 m-20 -79.85 -24.25 41.4 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.984 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 156.58 -69.96 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 118.493 -1.813 . . . . 0.0 112.891 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -143.46 18.92 1.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.736 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -75.81 115.12 15.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.981 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.501 ' CD1' ' CE2' ' A' ' 91' ' ' PHE . 15.6 mm -117.03 123.84 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.716 -173.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -114.4 124.48 52.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 123.903 0.752 . . . . 0.0 109.345 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.8 t -104.37 109.41 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.0 t-20 -88.87 128.59 35.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.563 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.12 102.37 14.11 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.434 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.73 132.55 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -107.01 148.25 28.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.283 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -130.61 -63.76 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.055 -173.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 5.1 m-20 -132.86 116.52 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.162 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.1 m-20 -133.42 -35.42 1.01 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.04 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.4 53.65 0.42 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 20.81 37.09 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.612 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.1 t 44.08 61.15 11.18 Favored Pre-proline 0 N--CA 1.491 1.6 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.83 -176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -87.86 44.24 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.518 1.478 . . . . 0.0 109.013 172.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.78 148.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.398 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.5 mtt180 -130.82 126.04 35.26 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.185 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.3 p-80 31.95 169.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 54.1 m-85 -123.5 138.88 54.48 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.32 172.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.4 mt -100.27 100.6 11.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 51' ' ' ILE . 48.2 t -109.1 121.97 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.4 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -133.33 140.54 47.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.727 1.267 . . . . 0.0 107.749 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.49 155.42 43.09 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 8.8 ptt180 -131.48 163.08 28.76 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.404 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.14 169.52 11.15 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.458 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -74.13 43.39 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.733 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.98 -57.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.186 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.9 m -128.44 156.42 43.22 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -104.78 160.59 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.774 -1.171 . . . . 0.0 112.21 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.5 m95 28.36 89.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.101 -1.409 . . . . 0.0 113.749 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 61.5 mttm -76.24 163.4 66.62 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.323 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.5 Cg_exo -44.31 105.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.832 1.688 . . . . 0.0 110.551 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -78.17 174.49 11.12 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.849 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -130.92 136.25 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.099 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.656 ' N ' HD13 ' A' ' 51' ' ' ILE . 18.5 ttp85 -105.52 110.62 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.895 169.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 51' ' ' ILE . 2.8 mt -69.09 162.14 67.54 Favored Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.606 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -79.18 147.53 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.12 1.88 . . . . 0.0 109.173 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 m -61.47 127.33 30.97 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.671 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.91 43.17 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 m -97.03 167.04 11.31 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.939 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.58 -47.22 3.0 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.654 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -148.17 167.62 24.59 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.536 -1.266 . . . . 0.0 111.962 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.1 p -119.36 145.06 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.479 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -131.31 148.69 52.71 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.831 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.2 pp -140.7 136.72 32.9 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.425 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -142.7 158.61 43.48 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.846 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t 75.9 45.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -92.9 -175.02 3.77 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.45 141.46 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.128 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.578 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.8 m95 -77.89 153.42 32.64 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.376 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 50.2 47.22 23.96 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.342 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.78 153.07 49.44 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.26 149.07 22.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 20.7 m-85 -133.45 141.7 47.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.393 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -119.76 118.1 29.97 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.576 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.98 123.67 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 56.6 m-85 -111.96 126.34 55.03 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.67 119.38 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 124.021 0.826 . . . . 0.0 110.462 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -110.22 157.42 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.35 158.1 40.74 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.37 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.8 tt0 -112.54 160.62 17.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.53 -1.268 . . . . 0.0 107.924 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -144.76 151.46 38.88 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.08 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -37.28 -44.03 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.315 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.99 41.79 1.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.42 -154.15 22.32 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.325 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -123.35 162.02 23.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.868 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 5.7 t -119.67 115.42 23.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -40.34 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 125.646 1.841 . . . . 0.0 113.458 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.37 131.65 35.04 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.944 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.24 143.0 30.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.74 129.08 56.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.45 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -114.89 123.88 50.28 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.152 -1.386 . . . . 0.0 107.669 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -122.71 134.05 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.11 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 43.3 p90 -156.41 178.68 10.04 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.501 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.94 51.71 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.137 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 p -84.98 165.26 17.73 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -80.18 -172.78 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.158 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.33 140.51 39.15 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.01 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 116.586 -1.673 . . . . 0.0 110.707 -178.699 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.024 0.44 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.41 173.87 15.22 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.452 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -59.86 172.41 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.541 2.161 . . . . 0.0 112.984 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.7 m -93.8 159.58 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.603 172.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.79 146.72 90.46 Favored Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.5 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.5 169.0 18.16 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.428 1.419 . . . . 0.0 110.642 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -104.38 130.94 52.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -105.8 113.46 27.03 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.396 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -95.55 139.41 31.85 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.562 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.44 123.34 7.83 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.442 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.55 119.75 33.84 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.77 131.04 51.32 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.477 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.61 153.16 24.73 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.718 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 8.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 13' ' ' GLY . 3.9 m-20 -79.84 -22.34 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.969 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.39 -36.38 4.43 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.318 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -131.35 -1.36 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.984 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -68.05 113.39 5.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.321 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.541 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.8 mm -115.75 127.17 73.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.1 -175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -115.74 124.63 51.28 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 171.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 63.3 t -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 114.446 -1.252 . . . . 0.0 107.941 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -88.27 128.47 35.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.091 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.51 106.43 18.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.908 0.755 . . . . 0.0 109.704 -171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.07 131.04 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.637 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -102.0 145.86 28.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 123.946 0.779 . . . . 0.0 109.586 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.4 -90.26 0.38 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.934 -175.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 24.1 m-20 -104.46 111.36 23.99 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.799 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -134.35 -33.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.196 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.81 51.94 0.33 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.11 19.62 38.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.603 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 43.46 60.78 10.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 114.781 -0.71 . . . . 0.0 112.802 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -87.8 43.65 0.89 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.594 1.529 . . . . 0.0 108.815 172.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mm -76.58 152.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.272 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.3 mtt180 -127.74 114.43 17.27 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.868 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.504 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.2 p-80 31.83 -171.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 77.8 m-85 -135.43 152.14 51.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.551 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.5 mt -111.17 112.02 23.51 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 60' ' ' VAL . 49.1 t -114.95 129.59 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.054 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HD3' ' CG ' ' A' ' 47' ' ' TRP . 40.2 ttmt -134.58 134.6 41.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.895 1.372 . . . . 0.0 108.086 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.76 159.83 41.81 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.791 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 12.6 ptt180 -142.99 172.32 12.85 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -126.65 169.55 13.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.989 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.9 tp -73.9 44.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.734 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.16 -54.33 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.94 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 p -133.6 156.63 47.49 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.53 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -86.63 -163.92 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.982 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.443 ' CG ' ' HD3' ' A' ' 39' ' ' LYS . 9.7 m95 -23.22 115.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -77.9 167.01 39.42 Favored Pre-proline 0 N--CA 1.489 1.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.687 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -50.62 108.57 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.843 1.695 . . . . 0.0 110.528 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -53.25 161.25 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.755 -175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.6 tt -132.79 149.59 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.078 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -114.32 131.38 56.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.233 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -79.64 167.88 30.67 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.817 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.43 154.85 55.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.79 1.66 . . . . 0.0 108.867 169.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -80.18 113.31 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.973 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 46.51 3.7 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.3 p -96.8 -178.01 4.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.892 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.35 -56.77 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.315 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -146.04 164.87 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.382 -1.327 . . . . 0.0 112.669 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 7.1 p -109.88 144.01 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.253 -1.339 . . . . 0.0 107.66 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.13 147.22 50.96 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.019 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.9 OUTLIER -138.76 138.28 37.49 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.001 173.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -137.17 163.18 31.49 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.494 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m 63.59 53.41 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.664 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -96.21 -176.25 3.61 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.849 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.94 132.47 39.07 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.639 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -72.98 154.52 40.49 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.013 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 46.32 47.92 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.657 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.78 153.45 48.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.935 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.74 145.93 25.87 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.227 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.2 m-85 -132.14 145.14 51.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 123.918 0.761 . . . . 0.0 112.526 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.37 122.83 40.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.433 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.1 125.49 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.0 m-85 -112.85 127.23 56.12 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.63 124.19 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -109.27 157.21 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.59 155.83 44.31 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.467 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.0 tt0 -110.6 164.62 12.55 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.782 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.47 HD21 ' HG2' ' A' ' 32' ' ' PRO . 16.3 t-20 -146.27 149.68 34.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.021 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -38.22 -42.96 0.73 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.447 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -115.54 43.01 2.15 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.533 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.67 -158.49 27.68 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.986 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 157.92 40.78 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 28.4 t -123.32 119.25 29.55 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.586 -175.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -43.39 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.602 1.814 . . . . 0.0 113.23 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.66 140.45 29.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.804 -174.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.57 29.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -114.68 131.61 56.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.545 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -118.56 129.62 55.44 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.897 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -126.75 139.89 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.496 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.541 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.4 p90 -158.84 175.9 13.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.167 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.44 147.19 49.83 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.654 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -79.91 169.64 17.61 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.238 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -80.51 -176.37 5.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.154 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.22 147.74 25.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.107 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.69 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.51 155.03 6.36 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.548 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.8 Cg_exo -68.3 170.79 13.96 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.4 m -82.69 -157.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.824 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.35 35.86 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HA ' ' OE1' ' A' ' 26' ' ' GLN . 9.7 Cg_endo -67.52 160.75 46.52 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.188 1.258 . . . . 0.0 110.661 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -100.77 126.05 47.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -100.72 113.63 26.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.867 -1.133 . . . . 0.0 110.317 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -98.42 144.22 28.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.427 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -114.47 132.31 10.38 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.263 -1.446 . . . . 0.0 113.14 -171.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.482 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.7 mt-30 -125.13 128.67 48.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.06 133.84 51.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.678 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.55 150.6 21.31 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.785 -1.198 . . . . 0.0 111.789 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.79 10.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.973 -0.613 . . . . 0.0 112.429 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.2 m-20 -79.8 -21.83 43.83 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.996 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.0 -43.02 1.76 Allowed Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.194 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.09 40.02 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.981 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -112.34 116.71 30.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.557 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.7 mm -120.47 127.87 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 120.091 -0.643 . . . . 0.0 110.648 -170.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -112.8 125.4 54.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.152 0.907 . . . . 0.0 108.599 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.8 t -109.09 117.88 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' ND2' HE21 ' A' ' 11' ' ' GLN . 6.3 m-80 -98.3 129.34 45.0 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.379 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -98.58 102.56 14.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.274 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 7' ' ' LYS . 29.1 mm -90.74 129.99 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.013 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -97.86 156.6 16.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.787 0.68 . . . . 0.0 109.723 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -144.61 -50.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.356 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.9 m-20 -141.51 109.15 5.64 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.211 -177.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.6 m-20 -131.06 -31.72 1.67 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.66 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.38 50.99 0.59 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.83 27.29 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.616 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 8.4 m 45.77 59.1 15.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.2 Cg_endo -89.01 42.41 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 121.438 1.425 . . . . 0.0 109.547 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.54 HD13 HD22 ' A' ' 79' ' ' ASN . 22.7 mm -82.42 151.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.916 0.865 . . . . 0.0 111.255 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -130.25 115.06 16.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.677 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.5 p-80 37.38 -172.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.2 m-85 -139.94 154.05 47.1 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.187 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.92 109.9 20.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' VAL . 47.7 t -113.73 121.26 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.88 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -132.42 140.24 48.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.607 1.192 . . . . 0.0 108.132 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.409 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -145.36 156.22 43.65 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.808 -1.557 . . . . 0.0 112.389 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.603 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 5.0 ptm180 -129.17 160.34 33.2 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.598 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -114.14 -172.88 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.146 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 11.5 tp -91.31 41.69 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.448 173.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.48 -58.86 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.515 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -120.02 151.29 39.21 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.387 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.7 pt-20 -106.68 153.77 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.825 -176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.603 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 38.83 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.652 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 65.2 mttm -77.28 162.75 68.13 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.255 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.2 Cg_exo -43.39 99.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.946 1.764 . . . . 0.0 110.814 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -73.67 175.71 6.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.268 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.96 153.91 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.301 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -113.49 135.85 53.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.929 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -84.71 162.68 49.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.824 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -69.16 145.7 61.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.716 1.611 . . . . 0.0 109.755 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.428 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.4 m -59.8 102.6 0.16 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 123.934 0.771 . . . . 0.0 111.479 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 52.68 0.56 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -97.13 -179.49 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.563 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.98 -34.59 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.515 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -148.51 167.7 24.67 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.204 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.1 p -133.4 153.97 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.746 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -138.76 151.68 47.3 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.568 -1.253 . . . . 0.0 112.515 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.25 142.7 42.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.74 173.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -142.94 153.14 42.76 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.081 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t 72.25 42.98 0.53 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.589 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.2 mm? -87.62 -172.31 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.666 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.29 143.33 28.77 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.637 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -76.46 154.69 34.51 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.744 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 43.59 49.41 6.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.768 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.92 49.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.575 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 29.2 tt0 -97.51 147.91 23.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.407 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 30.8 m-85 -133.0 142.72 48.99 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.515 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 4.6 mp0 -119.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.78 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.91 122.7 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.0 m-85 -111.1 124.2 51.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.34 120.8 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.863 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.4 t -105.76 158.05 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.17 164.9 22.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.658 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.2 tt0 -118.71 162.48 18.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.222 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.548 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.5 t-20 -151.16 154.47 36.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.356 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -41.99 -34.02 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.61 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -79.41 -45.34 19.67 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.891 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.76 -118.71 0.51 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -118.46 163.2 17.11 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.613 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.92 116.03 22.93 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.869 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -39.05 158.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.297 1.623 . . . . 0.0 112.784 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.04 139.71 32.33 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.544 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.37 146.29 30.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -116.47 130.87 56.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.785 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 74.6 t80 -118.01 130.22 56.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.21 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.58 140.52 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.971 -176.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.557 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 36.6 p90 -161.57 179.04 8.51 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -130.63 148.48 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.836 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -79.91 172.3 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.522 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -85.54 -171.22 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.099 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.96 142.77 35.1 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.081 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 116.199 -1.858 . . . . 0.0 110.443 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.33 13.57 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.434 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.1 Cg_endo -63.77 166.65 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.36 2.04 . . . . 0.0 112.586 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.15 165.79 15.47 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.468 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.79 142.85 88.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.11 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.42 167.22 23.0 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.412 1.408 . . . . 0.0 110.54 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -101.7 131.83 47.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.02 113.74 27.52 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.844 -1.142 . . . . 0.0 110.277 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -100.36 142.29 32.04 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.257 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -118.51 136.46 12.21 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 118.877 -1.63 . . . . 0.0 113.82 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -128.43 137.91 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.647 -0.777 . . . . 0.0 109.464 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.5 ttm -109.33 134.42 51.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.502 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.62 146.15 22.26 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.855 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.87 8.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.89 -30.11 40.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.783 175.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.54 -39.43 2.06 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.407 -1.378 . . . . 0.0 113.174 176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -130.27 -14.75 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.697 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.0 m -54.17 113.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.214 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.3 mm -116.78 130.71 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.076 -174.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -116.98 124.77 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.859 0.724 . . . . 0.0 109.084 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -110.23 120.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -97.09 133.22 42.04 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.343 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 41.0 mt -101.55 101.45 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -93.78 131.01 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -101.74 157.66 16.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.738 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -51.44 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.649 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -145.4 103.93 3.87 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.428 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.6 m-20 -117.25 -40.21 3.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.738 0.649 . . . . 0.0 109.714 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.57 52.95 0.21 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.29 20.56 29.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 19.5 m 42.16 60.84 9.12 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.9 Cg_endo -90.44 42.85 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.553 1.502 . . . . 0.0 109.112 172.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.483 HD13 HD22 ' A' ' 79' ' ' ASN . 23.2 mm -81.44 151.42 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.989 0.899 . . . . 0.0 111.367 -173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.4 mtt180 -130.52 114.37 15.41 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.647 -1.615 . . . . 0.0 108.835 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.7 p-80 35.77 -170.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.4 m-85 -139.99 150.64 44.71 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.006 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.07 110.86 23.26 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -113.52 127.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.812 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -132.49 140.7 48.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 125.012 1.445 . . . . 0.0 107.834 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.17 157.01 43.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.56 -1.656 . . . . 0.0 112.591 177.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.8 ptm180 -134.41 165.3 25.48 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.354 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -127.53 177.74 6.56 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.303 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.56 40.96 0.53 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.838 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -142.34 -62.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.904 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -129.7 171.23 12.87 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.267 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -116.46 160.87 19.96 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.211 -174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.9 m95 28.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.347 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 52.0 mttp -72.63 160.08 83.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.351 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.7 Cg_exo -41.77 107.3 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.1 1.866 . . . . 0.0 111.579 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.16 160.82 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.623 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -131.35 147.95 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.156 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -113.71 125.03 53.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -69.88 164.23 53.4 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.271 -177.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.63 172.21 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.804 1.669 . . . . 0.0 110.635 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -74.5 76.92 1.95 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.974 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.47 64.78 0.59 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.526 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -89.63 -176.99 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.851 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -126.63 -14.11 5.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.503 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 42.2 p-80 -159.18 170.34 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.753 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p -136.87 150.81 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 124.864 1.353 . . . . 0.0 108.582 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -133.72 150.0 51.5 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.152 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.584 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.3 pp -143.85 144.88 31.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.539 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -140.27 172.17 13.12 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.789 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.7 m 57.84 59.66 3.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.631 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.6 mt -95.21 177.9 5.71 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.353 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.51 124.15 22.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.252 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.498 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 77.1 m95 -70.74 148.49 47.9 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 50.77 49.77 20.32 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.671 -175.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.27 152.27 50.69 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.27 151.78 22.41 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.698 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.7 m-85 -137.04 141.28 42.47 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.6 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -121.65 121.08 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.721 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.1 t -113.26 123.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.438 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 43.9 m-85 -113.03 125.51 54.48 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.46 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.534 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.2 159.41 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.07 155.38 44.46 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.548 -1.261 . . . . 0.0 109.805 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 33.8 tt0 -110.81 163.85 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.734 -1.186 . . . . 0.0 107.86 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.483 HD22 HD13 ' A' ' 33' ' ' ILE . 18.6 t-20 -153.69 154.21 33.7 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.577 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -40.45 -43.48 1.82 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.327 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -101.84 37.05 1.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.33 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.23 -134.02 8.43 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.22 -179.99 6.86 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.585 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -130.05 124.31 32.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -45.79 171.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 125.516 1.76 . . . . 0.0 111.686 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.55 145.96 25.42 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.605 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.72 147.96 27.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.908 -1.497 . . . . 0.0 106.982 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.522 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.8 t-160 -116.14 130.96 57.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.592 -173.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.4 t80 -118.65 130.56 55.92 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.737 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.522 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.95 140.44 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.854 -176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 19' ' ' ILE . 48.3 p90 -157.44 -178.76 7.58 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.849 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -128.97 145.07 51.34 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.353 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.93 168.42 19.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.901 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.1 m -81.78 -176.47 6.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.291 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.23 144.16 30.43 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.321 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.219 -1.848 . . . . 0.0 110.505 -178.088 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.032 0.444 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.4 178.54 29.95 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.402 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 7.6 Cg_exo -57.93 171.85 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.417 2.078 . . . . 0.0 113.011 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -95.43 159.66 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.682 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.32 141.86 98.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.896 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.09 167.52 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.28 1.32 . . . . 0.0 110.846 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -100.64 127.77 46.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.38 109.79 21.54 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.922 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.13 137.81 37.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.49 142.87 16.16 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.489 -1.815 . . . . 0.0 113.791 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -129.4 138.79 51.68 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.093 -1.053 . . . . 0.0 109.361 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.487 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.2 tpp -104.72 131.52 52.07 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.42 150.31 23.43 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.525 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.72 8.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.0 m-20 -79.87 -23.03 42.2 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.125 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.8 -50.87 0.76 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.649 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 9.8 p30 -123.87 1.36 8.7 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.33 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.6 m -69.56 116.75 10.32 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.301 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.525 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -115.41 127.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.776 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -115.07 124.78 52.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.023 0.827 . . . . 0.0 109.072 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.5 t -112.45 120.69 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -98.2 130.48 44.93 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.04 100.88 12.09 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.27 130.7 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.868 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -104.16 153.04 21.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.842 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.05 -49.89 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.915 -174.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 11.6 m-20 -139.76 111.63 7.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.008 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -130.02 -37.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.123 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.51 55.05 0.36 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.4 20.42 35.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.628 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.7 t 44.15 60.61 11.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 114.8 -0.7 . . . . 0.0 112.728 -176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.2 Cg_endo -89.42 43.39 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.393 1.395 . . . . 0.0 109.214 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mm -88.54 149.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.877 0.846 . . . . 0.0 111.266 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 69.2 mtt85 -131.46 123.55 28.34 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.669 -1.605 . . . . 0.0 108.867 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.9 p-80 36.69 -173.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 86.7 m-85 -139.74 153.57 47.22 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.784 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.49 109.42 21.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 60' ' ' VAL . 48.2 t -113.32 125.07 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.204 -173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -136.45 141.1 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.56 158.06 43.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.74 -1.584 . . . . 0.0 112.069 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.614 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 9.0 ptm85 -133.96 159.36 40.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.645 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -116.81 -177.8 3.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.107 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.92 41.58 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.792 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.65 -61.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.335 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.1 m -118.99 149.68 41.23 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.528 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 23.9 pt-20 -117.53 144.73 44.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.588 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.614 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 56.87 77.48 0.26 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.027 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 25.9 mmmt -72.57 163.27 69.15 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.541 176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -46.57 99.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.823 1.682 . . . . 0.0 110.444 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.32 172.7 2.99 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.529 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -137.17 153.81 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.951 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -112.84 131.77 55.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.949 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.455 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.8 mt -81.84 163.76 52.06 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.861 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.26 152.43 76.46 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.771 1.647 . . . . 0.0 110.438 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 33.7 m -68.61 93.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.885 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.91 52.71 0.46 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -97.22 170.13 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.394 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.93 -36.66 4.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.996 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -146.56 169.48 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.579 -1.248 . . . . 0.0 112.124 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.7 p -132.76 151.79 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.885 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ptp -135.65 148.31 48.91 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.894 -1.123 . . . . 0.0 112.022 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' CD1' HD21 ' A' ' 65' ' ' LEU . 1.5 pp -141.32 144.2 34.46 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.458 174.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -140.16 170.36 15.98 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.663 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 m 61.19 57.03 2.56 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.042 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 62' ' ' LEU . 10.6 mp -94.95 178.52 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.217 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -71.99 133.06 45.1 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.248 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.403 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.4 m95 -72.93 151.47 41.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.837 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 46.97 49.08 15.05 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.54 152.08 48.7 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.051 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -92.66 148.72 21.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.1 m-85 -136.05 143.33 44.62 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.692 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB2' ' CG ' ' A' ' 41' ' ' ARG . 3.7 mp0 -119.2 122.66 42.49 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 113.588 -1.642 . . . . 0.0 108.139 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.96 123.4 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.7 m-85 -112.57 125.98 54.85 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.6 t -122.45 121.8 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 124.047 0.842 . . . . 0.0 110.677 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.33 159.07 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.34 156.68 42.7 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.751 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.41 153.82 25.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.392 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.2 t-20 -141.25 150.83 43.13 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.143 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -36.12 -43.82 0.36 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.846 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -108.33 35.9 3.0 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -152.31 21.5 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.072 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -120.97 158.15 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.32 120.43 37.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -40.05 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 125.81 1.944 . . . . 0.0 113.492 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.0 136.41 34.06 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.051 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.94 145.68 28.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.486 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.49 129.43 56.54 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.574 -174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 71.6 t80 -117.5 129.75 56.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.052 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.34 140.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.749 -176.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.2 p90 -158.63 -179.34 7.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.071 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -129.55 147.63 51.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.568 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.4 p -79.88 166.83 21.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -82.44 -172.01 3.78 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.66 148.28 24.51 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.325 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 116.474 -1.727 . . . . 0.0 110.652 -178.799 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.54 169.53 14.14 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.9 Cg_exo -61.3 172.84 2.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.6 2.2 . . . . 0.0 112.99 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.0 m -97.06 163.45 12.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.479 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.0 99.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.164 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.91 172.14 12.31 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.451 1.434 . . . . 0.0 110.463 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -107.04 133.48 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.1 mt -106.46 115.9 31.01 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.262 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.39 140.49 31.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.45 129.05 9.37 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.356 -1.402 . . . . 0.0 112.656 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -124.53 124.73 42.9 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.9 ttm -106.96 133.76 51.13 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.8 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.25 150.55 22.83 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.596 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.35 14.01 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.074 -0.563 . . . . 0.0 111.936 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.86 -24.31 41.33 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.684 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 -40.53 2.45 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.706 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 9.4 p30 -138.18 48.68 1.96 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.92 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 m -120.82 115.11 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.552 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.9 mm -117.05 129.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -114.01 125.16 53.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 50.3 t -107.7 115.0 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -96.73 130.41 43.98 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.313 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 31.2 mt -99.84 109.66 22.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.637 -173.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.29 132.5 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -104.4 148.0 26.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.82 0.7 . . . . 0.0 109.408 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.56 -66.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.135 -174.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.7 m-20 -127.77 110.92 13.09 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.27 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.7 m-20 -128.83 -37.09 1.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.986 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.08 56.87 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 18.65 43.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.62 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 45.16 60.15 13.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.791 -0.704 . . . . 0.0 112.87 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -88.89 42.52 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.458 1.438 . . . . 0.0 109.365 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 79' ' ' ASN . 22.6 mm -83.43 151.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.878 0.847 . . . . 0.0 111.446 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 78.4 mtt-85 -131.05 117.31 18.95 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.886 178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.57 -173.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 82.2 m-85 -137.85 154.26 49.51 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.052 176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD2' ' HE ' ' A' ' 52' ' ' ARG . 6.5 mt -110.33 111.49 22.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 60' ' ' VAL . 46.4 t -115.12 123.98 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.146 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -132.35 138.56 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.688 1.242 . . . . 0.0 107.938 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.2 p90 -144.05 158.43 43.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.916 -1.514 . . . . 0.0 112.45 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 5.4 ptm180 -141.88 169.79 16.94 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.442 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -128.14 168.87 14.8 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.767 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.92 43.53 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.724 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -153.4 -51.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.931 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 p -125.87 148.06 49.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.111 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -103.1 167.23 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.865 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.7 m95 18.33 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.952 -1.476 . . . . 0.0 114.226 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.7 mttp -77.18 163.55 64.17 Favored Pre-proline 0 N--CA 1.49 1.525 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.072 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.7 Cg_exo -44.68 100.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.803 1.668 . . . . 0.0 110.908 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.02 175.27 3.84 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.394 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.04 154.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.362 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 37' ' ' LEU . 42.7 ttm180 -114.95 134.06 55.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.812 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.2 mt -82.42 162.99 54.33 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.027 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 3.9 Cg_exo -59.88 169.86 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.773 1.649 . . . . 0.0 110.633 174.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -74.64 77.82 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.935 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.5 65.82 0.49 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 t -97.01 -174.54 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.71 -23.02 4.43 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.618 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.6 p-80 -160.23 168.31 25.67 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.189 -1.405 . . . . 0.0 112.994 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.5 p -131.87 151.4 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.268 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.2 ptp -137.3 152.07 49.36 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.827 -176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -141.14 139.1 33.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.43 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 64' ' ' SER . 51.8 mtmt -142.5 141.43 32.11 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.85 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.5 t 93.51 45.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.345 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.7 mm? -96.56 178.51 5.31 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.391 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -68.17 133.44 48.9 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.612 0.72 . . . . 0.0 111.493 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.73 154.25 39.69 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.227 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 44.42 48.9 8.23 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.565 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.63 49.82 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.802 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.37 144.05 26.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.71 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 6.0 m-85 -129.74 144.84 51.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.912 0.758 . . . . 0.0 112.463 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -119.79 124.01 45.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.409 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.2 t -116.07 123.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 38.9 m-85 -111.49 124.92 53.26 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -120.02 122.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 123.876 0.735 . . . . 0.0 110.567 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -106.94 157.8 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.98 155.63 42.86 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.58 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.67 158.87 18.78 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.233 -1.387 . . . . 0.0 107.73 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.6 t-20 -146.45 153.28 40.26 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.543 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -42.4 -37.68 1.65 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.466 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -103.01 29.77 5.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.5 -148.04 19.35 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.849 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -122.23 158.82 28.62 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.967 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.7 t -121.86 124.13 43.39 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.35 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -40.92 165.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.735 1.897 . . . . 0.0 113.59 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.45 140.97 28.92 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.45 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.53 30.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.19 129.45 56.65 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.408 -174.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 67.5 t80 -116.87 130.23 56.57 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.033 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.63 140.74 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.593 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.31 178.09 10.72 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.777 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -128.12 145.21 51.08 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.894 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.8 p -79.88 171.37 15.2 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.154 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -86.53 -170.47 3.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.134 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.72 141.19 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.242 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.536 -1.697 . . . . 0.0 110.672 -179.366 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.08 0.467 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.42 179.82 15.87 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 12.4 Cg_exo -56.89 173.26 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.601 2.201 . . . . 0.0 113.1 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -95.76 163.04 13.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.239 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.73 142.07 95.53 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.173 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.48 171.21 13.39 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.606 1.538 . . . . 0.0 110.686 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' CG ' HE22 ' A' ' 26' ' ' GLN . 38.1 mtpt -98.03 139.92 33.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.4 mt -111.29 110.21 20.59 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.15 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.04 141.51 28.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.793 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.8 123.32 7.29 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.17 -173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -120.88 123.09 41.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.3 ttm -104.14 131.86 50.99 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.434 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.19 146.25 23.75 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.719 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.14 9.53 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.76 -30.25 40.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.858 175.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.29 -41.47 1.68 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.451 -1.357 . . . . 0.0 113.062 177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.91 -15.05 4.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.676 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.0 m -55.37 116.5 2.88 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.552 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.558 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.0 mm -117.55 130.35 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.552 -173.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.1 125.68 52.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.939 0.774 . . . . 0.0 108.996 172.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.584 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 60.2 t -107.33 113.47 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 126.69 37.0 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.212 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.7 mt -99.11 107.22 19.54 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.899 -172.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.2 mm -92.44 106.27 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.524 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -77.73 140.89 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.509 HE22 ' CG ' ' A' ' 7' ' ' LYS . 2.4 pt20 -138.17 -78.51 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.355 -172.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 6.1 m-20 -106.14 100.82 10.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.962 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -132.36 -35.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.277 -179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 51.45 0.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.01 17.75 36.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.602 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 13.1 t 41.39 61.09 7.99 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -86.48 51.58 2.6 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.685 1.59 . . . . 0.0 108.73 172.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.5 mm -87.41 150.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.031 0.92 . . . . 0.0 111.622 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.8 mtt180 -129.94 119.38 23.14 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.413 -1.722 . . . . 0.0 108.543 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.53 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.7 p-80 34.73 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.516 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.2 m-85 -139.52 151.18 45.92 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.009 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 mt -107.48 110.78 22.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.2 128.2 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.913 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.73 140.23 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 125.036 1.46 . . . . 0.0 107.979 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.56 156.52 43.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.726 -1.59 . . . . 0.0 112.657 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -131.58 156.99 44.8 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.073 -177.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.629 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -119.33 168.56 10.8 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 tp -73.59 42.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.795 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.93 -57.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.083 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.3 m -128.62 153.06 47.65 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.141 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -104.99 165.49 11.03 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.044 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.62 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.448 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.9 mttm -77.03 159.99 77.2 Favored Pre-proline 0 N--CA 1.491 1.618 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.334 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 24.3 Cg_exo -40.45 111.65 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.188 1.926 . . . . 0.0 111.895 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.71 164.87 4.29 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.809 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -136.4 151.18 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.365 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -117.34 132.24 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.241 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -79.07 165.13 51.02 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.508 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.33 159.79 29.72 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.808 1.672 . . . . 0.0 110.682 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 95.34 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.94 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 96.92 65.35 0.92 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -97.14 -172.57 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.469 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -122.16 -43.81 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.741 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 22.6 p-80 -147.13 167.44 24.13 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.061 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 8.5 p -122.48 149.54 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.375 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.4 ptp -132.87 147.12 52.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.606 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -139.48 137.76 35.82 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.991 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -139.55 158.16 44.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.463 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t 71.88 49.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.203 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -97.82 -174.22 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.233 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -77.6 133.51 38.44 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.666 0.746 . . . . 0.0 111.081 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.51 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 72.1 m95 -75.17 156.95 35.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.074 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 45.53 46.3 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.769 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.7 154.66 46.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.11 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -96.69 147.65 23.69 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.629 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 14.5 m-85 -134.0 140.85 46.98 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.471 -178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 119.48 34.26 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.205 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.6 t -113.77 127.65 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 55.0 m-85 -114.82 126.58 54.98 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.58 121.54 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.627 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -105.84 156.06 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.91 156.01 42.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.523 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -109.96 156.24 20.72 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.821 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 13.2 t-20 -140.53 149.88 43.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.958 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -34.14 -45.34 0.21 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.758 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -113.97 40.15 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.82 -156.85 26.11 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.378 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -120.33 159.6 24.71 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.725 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 24.8 t -120.59 120.64 36.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -41.0 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.633 1.833 . . . . 0.0 113.189 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.95 136.16 34.18 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.338 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.93 144.42 29.01 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.508 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.8 t-160 -114.81 130.08 56.8 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.284 -174.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -119.8 130.34 54.88 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.192 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.86 137.98 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.571 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.6 p90 -156.04 177.47 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.163 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.27 146.17 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.623 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -83.76 164.59 19.48 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -80.48 -171.13 2.9 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.273 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.15 139.18 39.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.208 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 116.461 -1.733 . . . . 0.0 110.801 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.48 175.42 18.74 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.2 Cg_exo -58.04 172.83 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.621 2.214 . . . . 0.0 113.31 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -101.6 162.54 12.82 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.407 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.92 142.27 85.26 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.364 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.82 154.12 67.87 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.501 1.468 . . . . 0.0 109.962 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HG3' HE22 ' A' ' 26' ' ' GLN . 31.0 mtmt -83.39 139.66 32.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 mt -109.03 108.98 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.313 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -93.89 144.71 25.19 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.462 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -112.93 130.58 9.57 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.302 -1.427 . . . . 0.0 112.889 -171.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -125.37 129.87 50.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.0 ttm -107.28 134.49 50.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.55 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -90.52 151.53 21.42 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.679 -176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.91 9.27 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.11 -0.545 . . . . 0.0 112.353 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 13' ' ' GLY . 16.6 m-20 -79.92 -20.55 45.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.009 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 108.54 -41.98 2.07 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.633 -1.27 . . . . 0.0 111.163 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 12.9 p30 -127.86 2.15 6.01 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.915 177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -65.42 111.92 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.248 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.56 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.5 mm -116.34 126.36 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.968 -176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -114.71 124.93 53.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 123.933 0.771 . . . . 0.0 108.949 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 57.4 t -108.87 118.58 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -95.7 128.42 42.56 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.633 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.6 mt -97.95 102.27 13.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 123.914 0.759 . . . . 0.0 109.079 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.31 103.04 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.715 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -77.6 149.95 34.72 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.75 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.405 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.7 pt20 -147.31 -51.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.946 -1.101 . . . . 0.0 112.406 -172.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 106.11 7.06 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.098 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.4 m-20 -129.42 -39.33 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.22 57.16 0.38 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.65 18.42 41.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.627 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 25.8 t 44.76 60.47 12.71 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -89.15 43.98 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.476 1.451 . . . . 0.0 109.071 172.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.67 150.95 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.883 0.849 . . . . 0.0 111.543 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.8 mtt85 -129.22 117.56 20.93 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.07 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.9 p-80 32.02 -171.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.506 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 69.4 m-85 -134.62 152.35 51.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.173 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -108.62 113.36 26.28 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 60' ' ' VAL . 52.9 t -115.79 128.55 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.209 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -135.41 139.68 44.35 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.24 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -147.35 154.54 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 117.843 -1.543 . . . . 0.0 112.161 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.6 ptm180 -126.49 160.74 29.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.671 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.64 -169.27 1.47 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.8 tp -96.97 41.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.587 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.22 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 p -121.65 150.02 42.35 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.999 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -113.27 150.04 33.01 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.577 -1.249 . . . . 0.0 113.22 -172.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.5 m95 47.79 83.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.562 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 46.1 mmtm -66.29 161.49 56.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.368 173.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.6 Cg_exo -47.22 105.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.77 1.647 . . . . 0.0 110.81 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.25 154.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.464 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -129.55 148.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.269 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -114.26 128.59 56.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.753 -0.779 . . . . 0.0 108.899 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.58 163.97 63.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.712 -176.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -78.23 132.39 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.879 1.719 . . . . 0.0 107.74 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -56.58 131.95 50.24 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.44 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.26 34.26 5.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 m -96.98 152.47 18.69 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.961 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -107.07 -28.08 10.22 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.033 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -145.49 165.72 27.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.36 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 10.6 p -128.58 150.12 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.269 174.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -134.74 149.85 50.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.741 -1.184 . . . . 0.0 112.509 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.1 pp -141.61 146.48 36.28 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.765 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -139.2 178.57 7.08 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.867 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.1 m 54.34 55.24 8.35 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.733 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 62' ' ' LEU . 25.1 mt -91.49 176.55 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.867 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -73.45 128.22 34.89 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.828 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.416 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 81.7 m95 -71.06 149.92 46.06 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.951 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 48.05 50.33 16.12 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.604 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.43 154.51 47.65 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.792 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -95.94 147.83 23.27 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.285 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 13.5 m-85 -133.23 143.88 49.43 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.521 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.04 119.24 29.76 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.16 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.39 124.57 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 53.8 m-85 -114.21 125.78 54.31 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.36 123.46 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 123.991 0.807 . . . . 0.0 110.416 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.72 157.18 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.26 156.4 40.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.079 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -110.12 160.25 16.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.823 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.529 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -146.46 151.81 38.0 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.372 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -34.89 -46.15 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.644 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -109.19 38.81 2.2 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.99 -150.55 20.65 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.147 173.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -123.23 159.58 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.04 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 23.1 t -118.99 118.06 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -39.32 163.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 125.849 1.968 . . . . 0.0 113.725 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.44 137.49 32.88 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.15 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.34 29.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 10.5 t-160 -115.03 130.39 56.93 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.534 -174.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.9 t80 -118.33 130.56 56.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.156 -1.383 . . . . 0.0 108.117 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.61 139.11 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.647 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 19' ' ' ILE . 37.5 p90 -159.88 179.36 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.266 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -128.04 147.46 50.51 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.642 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.4 p -79.92 168.39 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.81 -170.45 3.0 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.172 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.25 141.61 36.47 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.16 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 116.143 -1.884 . . . . 0.0 110.398 -178.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.992 0.425 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.25 169.07 12.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.0 Cg_exo -59.15 169.85 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.372 2.048 . . . . 0.0 113.639 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.6 m -94.89 177.51 5.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.16 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.34 144.97 58.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.139 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -71.68 164.99 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.691 1.594 . . . . 0.0 110.531 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' CB ' HE22 ' A' ' 26' ' ' GLN . 10.3 mtpp -93.43 132.62 37.52 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.04 108.83 20.56 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.795 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.49 135.28 42.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.75 143.59 16.44 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 118.455 -1.831 . . . . 0.0 113.151 -171.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.412 HE21 HD21 ' A' ' 22' ' ' ASN . 71.5 mt-30 -131.14 139.56 49.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.063 -1.069 . . . . 0.0 108.942 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.6 ttm -108.88 132.77 53.72 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.708 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -83.39 150.74 27.47 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.326 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.19 13.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.931 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.94 -25.28 40.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.664 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.01 -44.63 1.46 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.066 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.568 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 10.8 p30 -134.41 44.8 2.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.321 175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 m -112.9 110.63 20.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.7 mm -114.13 128.48 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.421 -170.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.38 124.82 51.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.3 t -111.84 120.13 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.412 HD21 HE21 ' A' ' 11' ' ' GLN . 14.7 m-20 -96.65 130.7 43.82 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.524 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 36' ' ' TYR . 40.2 mt -99.99 103.43 14.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.943 0.777 . . . . 0.0 109.114 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.67 108.4 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.554 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -70.13 169.43 13.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 27' ' ' ASP . 3.2 pt20 -170.25 -69.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.689 -1.204 . . . . 0.0 111.399 -175.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 26' ' ' GLN . 16.9 t70 -115.23 89.39 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.019 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -130.85 -17.63 3.14 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.776 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.34 52.35 1.6 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.417 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.27 22.75 50.71 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 44.26 64.37 7.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 114.78 -0.71 . . . . 0.0 112.736 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.7 Cg_endo -88.13 46.22 1.15 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 N-CA-C 107.601 -1.73 . . . . 0.0 107.601 171.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 mm -92.55 151.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.197 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' HIS . 45.8 mtt180 -128.19 115.19 17.99 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.05 -1.886 . . . . 0.0 108.098 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.1 p-80 35.69 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 175.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.3 m-85 -142.86 137.95 29.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.013 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 mt -88.19 111.07 21.22 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 60' ' ' VAL . 65.8 t -112.22 126.8 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.306 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -132.55 138.8 47.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 125.08 1.488 . . . . 0.0 107.632 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.17 156.31 43.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 117.715 -1.594 . . . . 0.0 112.223 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.2 ptm180 -134.88 163.54 29.6 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.892 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -120.71 -168.25 1.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.773 -177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 10.5 tp -93.28 40.54 1.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.825 170.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.8 -61.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.572 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.59 157.78 30.0 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.231 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.4 pt-20 -109.69 156.21 20.54 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.594 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.532 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.1 m95 34.42 83.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.108 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.2 mmtt -70.45 161.54 75.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.203 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.8 Cg_exo -43.2 107.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.982 1.788 . . . . 0.0 111.556 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -55.18 161.27 1.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.729 -175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.281 174.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttp85 -112.43 118.06 34.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.2 mm? -60.12 165.9 4.43 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.036 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.1 Cg_exo -61.47 141.67 92.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.37 1.38 . . . . 0.0 109.483 172.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -59.15 88.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.568 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.453 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 106.52 58.9 0.6 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -97.12 -173.49 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.449 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.97 -25.48 3.59 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.536 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 15.4 p-80 -160.07 167.51 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.394 -1.323 . . . . 0.0 112.574 -177.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -130.73 150.27 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.671 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.7 ptp -134.92 147.74 49.89 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.777 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -140.46 142.86 35.31 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.226 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 178.68 6.68 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.536 -175.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m 49.06 56.89 7.1 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.687 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 10.2 mt -91.99 164.34 13.66 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.527 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 4.4 m-20 -61.36 129.78 42.9 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.832 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -71.8 147.84 46.84 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 47.16 51.09 13.54 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.623 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -129.52 151.62 49.94 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.264 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 36.3 mt-10 -89.2 146.74 24.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 m-85 -133.97 140.84 47.0 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.531 -176.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -122.11 123.4 41.46 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.585 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.2 t -113.79 122.57 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 39.7 m-85 -112.29 124.06 51.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.49 120.6 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 123.86 0.725 . . . . 0.0 110.702 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 86' ' ' ALA . 1.9 t -103.78 164.45 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 154.08 49.85 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.679 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.79 156.37 22.98 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.789 -1.165 . . . . 0.0 107.88 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -144.97 152.33 40.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -40.83 -40.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.144 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.65 35.83 2.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.91 -151.32 20.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.98 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -128.41 161.59 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.573 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -126.76 128.24 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.881 -176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -46.14 173.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 125.608 1.817 . . . . 0.0 112.906 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -93.63 145.34 24.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.31 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.81 146.61 28.38 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 171.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.524 ' CE1' HG22 ' A' ' 90' ' ' VAL . 11.0 t-160 -115.69 129.8 56.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.457 -174.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 51.7 t80 -119.95 131.95 55.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.31 -1.314 . . . . 0.0 107.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.6 t -129.69 144.18 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.209 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 47.6 p90 -159.83 -177.97 6.72 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.977 177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -129.64 145.66 51.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.471 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 169.22 18.23 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -84.43 -169.94 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.305 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.53 142.02 36.87 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.008 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 116.542 -1.694 . . . . 0.0 110.685 -179.044 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.995 0.426 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.85 -87.85 1.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HG3' HD22 ' A' ' 79' ' ' ASN . 3.1 Cg_exo -61.77 169.25 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.824 . . . . 0.0 112.169 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 m -91.09 152.95 20.42 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.66 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.63 143.53 93.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.165 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.88 167.63 19.12 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.329 1.353 . . . . 0.0 110.45 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -103.4 132.69 49.45 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.1 mt -104.6 113.85 27.7 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.158 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -95.66 143.18 27.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 127.38 8.76 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.586 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -123.3 121.12 35.04 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.1 ttm -105.14 132.55 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.658 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.37 149.73 21.45 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.318 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -65.75 14.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.907 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.1 m-20 -80.01 -24.59 40.72 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.549 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.16 -42.73 1.87 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.41 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -131.84 10.02 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.18 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -77.98 112.81 15.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.256 -0.977 . . . . 0.0 108.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.521 HD11 ' CE2' ' A' ' 91' ' ' PHE . 9.5 mm -116.34 126.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.972 -172.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -113.38 127.11 56.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.4 t -108.01 116.55 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -97.28 129.4 44.58 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.424 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 44.7 mt -99.2 106.39 18.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.758 0.661 . . . . 0.0 109.491 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -96.29 129.82 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -105.55 153.33 21.9 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.506 -177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.68 0.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.355 -0.938 . . . . 0.0 112.191 -173.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.93 116.47 10.74 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.724 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.3 m-20 -126.66 -44.6 1.66 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.872 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.8 65.28 0.26 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.33 64.15 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -174.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.61 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.4 t 44.03 60.63 11.63 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 114.58 -0.81 . . . . 0.0 113.008 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 31' ' ' SER . 19.6 Cg_endo -91.24 52.28 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.782 1.655 . . . . 0.0 109.337 174.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.67 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.842 0.829 . . . . 0.0 111.423 -174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' HIS . 46.2 mtt180 -131.41 118.91 20.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.034 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ARG . 6.4 p-80 36.1 -172.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.539 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.4 m-85 -140.26 151.07 44.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.754 176.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.96 111.61 23.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 60' ' ' VAL . 61.8 t -114.8 124.45 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.324 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.7 141.33 46.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 124.789 1.306 . . . . 0.0 107.911 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.34 157.7 43.69 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.731 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.2 ptm180 -132.01 162.87 29.7 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.032 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.72 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -113.2 -169.13 1.43 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.2 tp -94.22 40.76 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.263 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.81 -59.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.504 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -114.02 147.94 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.197 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.5 pt-20 -107.83 157.53 18.09 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.762 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.508 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.7 m95 31.51 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.185 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 69.3 mmtt -72.57 162.04 76.11 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.111 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.4 Cg_exo -45.13 100.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.837 1.691 . . . . 0.0 110.614 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.34 173.06 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.617 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 tt -138.52 155.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.133 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -114.15 127.41 55.89 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.03 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -73.36 166.46 43.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.562 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.62 165.69 11.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.836 1.691 . . . . 0.0 110.635 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -75.43 79.5 2.48 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.071 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.69 57.96 0.34 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -97.04 170.19 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.546 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -120.32 -3.5 9.98 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.606 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 29.2 p-80 -160.16 164.2 33.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.83 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.2 p -138.76 154.27 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.732 172.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptp -138.2 152.74 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.623 -1.231 . . . . 0.0 112.738 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.4 pp -144.64 146.35 32.22 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.783 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -141.87 173.29 11.65 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.532 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t 58.65 60.77 2.42 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.455 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 62' ' ' LEU . 14.6 mt -98.76 178.58 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.442 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 5.0 m-20 -71.3 128.52 36.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.147 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.4 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 82.3 m95 -71.78 151.31 43.61 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.459 -1.296 . . . . 0.0 109.999 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.86 50.37 11.21 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.687 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 66' ' ' ASP . . . -127.92 151.57 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.024 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -89.73 145.29 25.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.72 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 1.9 m-85 -132.68 141.52 48.64 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.568 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.6 119.39 29.74 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.54 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -112.59 124.81 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 47.7 m-85 -112.71 125.49 54.37 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.74 121.99 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.406 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.4 158.26 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.5 158.42 37.45 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.634 -1.226 . . . . 0.0 109.235 176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 26.6 tt0 -112.86 157.41 21.44 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.289 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.489 HD22 ' HG3' ' A' ' 3' ' ' PRO . 15.3 t-20 -139.42 148.03 42.22 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.696 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -35.61 -44.06 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.796 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -114.89 41.87 2.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.575 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.51 -155.15 25.95 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.563 -1.303 . . . . 0.0 111.188 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -122.28 167.44 13.23 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.671 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.493 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 2.2 t -123.93 116.97 23.75 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -40.71 162.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.554 1.784 . . . . 0.0 113.284 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.476 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.87 136.33 35.36 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.356 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.58 146.28 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.54 130.56 56.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.596 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -116.57 126.81 53.83 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.961 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -124.37 136.68 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.561 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' CE2' HD11 ' A' ' 19' ' ' ILE . 40.4 p90 -157.33 -178.93 7.72 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.012 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -129.55 146.48 51.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.486 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -79.92 168.97 18.55 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.734 -0.787 . . . . 0.0 108.885 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.93 -169.97 2.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.656 -0.817 . . . . 0.0 110.184 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.89 140.57 39.5 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 116.551 -1.69 . . . . 0.0 110.808 -178.606 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.977 0.418 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.71 173.06 15.19 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 4.2 Cg_exo -59.86 165.28 10.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.427 2.085 . . . . 0.0 113.269 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -86.29 169.77 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.231 -1.349 . . . . 0.0 108.559 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.41 139.02 63.51 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.746 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -69.58 169.04 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.561 1.507 . . . . 0.0 110.411 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' HB2' HE22 ' A' ' 26' ' ' GLN . 1.1 tmmt? -96.12 138.44 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.3 107.18 17.98 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.789 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 20.8 tt0 -86.71 140.8 29.42 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.455 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.52 119.56 6.3 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.89 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -120.31 117.54 28.07 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.452 ' CE ' HD11 ' A' ' 19' ' ' ILE . 55.4 tpp -100.44 132.33 45.88 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.156 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -89.08 149.01 20.52 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.456 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -65.38 13.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.08 -0.56 . . . . 0.0 112.047 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.91 -25.21 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.448 175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.08 -48.8 0.91 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.575 -1.298 . . . . 0.0 111.388 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -128.44 0.08 5.63 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.104 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -67.84 117.98 10.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.339 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.524 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -117.03 128.71 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.307 -172.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -114.26 127.3 55.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 123.981 0.801 . . . . 0.0 108.926 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 53.9 t -107.95 117.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 5.9 t-20 -90.9 124.55 35.27 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.899 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -98.51 96.89 8.29 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mm -87.91 106.36 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.612 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -77.06 151.43 35.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.515 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.8 pt20 -148.06 -63.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.296 -172.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.21 93.51 3.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.344 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 2.5 m-20 -122.08 -34.51 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 124.054 0.846 . . . . 0.0 109.944 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.48 55.16 0.33 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.62 46.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -175.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.581 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 66.2 m 41.95 61.9 7.99 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 31' ' ' SER . 10.5 Cg_endo -86.7 46.6 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.715 1.61 . . . . 0.0 108.503 172.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.7 mm -82.58 152.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.468 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 35' ' ' HIS . 49.9 mtt180 -129.6 114.26 15.83 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.544 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.596 ' H ' ' H ' ' A' ' 56' ' ' GLY . 9.1 p-80 35.46 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 85.0 m-85 -142.2 151.74 42.45 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.744 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.78 109.56 21.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 60' ' ' VAL . 57.3 t -115.31 123.32 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.341 -172.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -133.84 140.37 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.613 1.196 . . . . 0.0 108.028 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.36 154.06 41.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.971 -1.492 . . . . 0.0 112.492 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.2 ptm180 -131.52 165.0 24.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.916 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -121.48 174.64 6.64 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.153 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -79.45 42.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.045 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -149.52 -59.02 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.288 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.8 m -124.7 152.99 43.03 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.056 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -101.98 162.68 12.72 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.808 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.496 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m95 25.16 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.575 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 50.5 mttp -74.91 163.37 68.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.843 175.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.95 99.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.916 1.744 . . . . 0.0 110.917 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.55 175.97 3.17 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.352 -174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.0 tt -142.74 154.99 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.207 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -116.68 129.79 56.35 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.842 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -75.25 163.49 67.48 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.09 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -70.79 144.34 48.27 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.775 1.65 . . . . 0.0 109.677 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.0 p -51.95 110.39 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 123.935 0.772 . . . . 0.0 111.842 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.596 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 94.33 58.99 1.18 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.865 -1.16 . . . . 0.0 110.581 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -97.19 -177.27 3.79 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.135 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -134.4 -33.25 1.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.918 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -143.96 163.17 34.22 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.811 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.557 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -131.3 152.05 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.279 173.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.418 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -137.73 156.03 48.44 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.086 -176.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.3 pp -144.22 140.98 29.61 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.121 174.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -140.61 158.62 43.72 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.276 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t 72.01 51.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.443 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.7 mm? -100.6 -176.8 3.3 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.626 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.47 131.17 40.81 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -73.3 155.77 39.12 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.985 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 48.37 45.68 20.47 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.55 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.01 152.9 49.82 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.357 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -95.22 148.7 22.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.8 m-85 -133.44 143.8 49.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.706 -178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.63 119.64 34.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.521 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.6 t -112.72 124.28 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.8 m-85 -111.75 125.33 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.14 120.53 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 123.909 0.756 . . . . 0.0 110.595 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.37 155.68 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.01 154.67 40.88 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.335 -1.346 . . . . 0.0 109.513 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.7 tt0 -111.08 161.02 16.33 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.33 -1.348 . . . . 0.0 107.652 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 16.1 t-20 -148.84 153.36 37.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.125 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -39.5 -39.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.61 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.7 -44.89 19.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.59 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.77 -127.1 0.89 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.676 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -124.41 159.07 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.07 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.0 t -124.44 124.39 42.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.37 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -41.49 163.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 125.629 1.831 . . . . 0.0 113.304 -175.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.83 141.05 30.74 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.65 -174.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.89 144.88 30.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 171.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -114.58 129.15 56.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.094 -1.042 . . . . 0.0 111.114 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.59 127.99 54.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.163 -1.381 . . . . 0.0 108.141 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.67 136.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.149 -177.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.9 p90 -153.58 177.22 11.18 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.98 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.31 144.06 51.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.814 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.2 p -82.8 163.48 21.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -174.14 4.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.142 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.43 149.81 21.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.205 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 116.483 -1.722 . . . . 0.0 110.546 -178.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.034 0.445 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.1 173.2 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.455 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 2.6 Cg_exo -58.86 171.37 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.524 2.149 . . . . 0.0 113.299 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 m -98.53 166.59 11.28 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.61 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 141.91 83.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.122 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.84 171.39 15.74 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.596 1.53 . . . . 0.0 110.6 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HG3' HE22 ' A' ' 26' ' ' GLN . 30.2 mtmt -97.82 140.03 32.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 172.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.2 mt -109.61 110.86 22.04 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.202 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.8 142.69 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.44 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -120.94 136.79 11.51 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 118.912 -1.613 . . . . 0.0 113.468 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.01 136.46 52.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.397 -0.902 . . . . 0.0 109.185 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 46.2 ttm -108.1 130.96 55.07 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.462 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.59 152.16 27.32 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.14 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.89 12.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.248 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.95 -23.9 41.35 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.57 175.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.24 -39.28 2.96 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.755 -1.212 . . . . 0.0 111.315 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.55 9.49 3.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.468 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 m -78.92 113.47 17.05 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.776 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.9 mm -114.92 126.94 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -172.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -113.94 123.61 50.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.087 0.867 . . . . 0.0 108.885 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.563 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.8 t -111.25 122.58 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -98.04 132.27 43.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.634 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 20.6 mt -100.46 101.8 12.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 124.091 0.869 . . . . 0.0 108.805 -175.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.7 mm -87.11 105.43 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.666 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -74.77 149.79 39.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.428 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.8 pt20 -147.36 -56.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.882 -1.127 . . . . 0.0 112.19 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.2 100.75 5.51 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.557 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.5 m-20 -129.73 -36.8 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.087 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.81 53.45 0.37 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 21.35 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.592 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.1 t 41.6 62.65 7.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 114.784 -0.708 . . . . 0.0 112.823 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 31' ' ' SER . 7.4 Cg_endo -86.02 43.46 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.603 1.535 . . . . 0.0 108.392 171.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.24 150.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.581 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 35' ' ' HIS . 50.8 mtt180 -129.71 116.0 18.15 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.634 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.5 p-80 35.69 -172.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.556 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.7 m-85 -139.5 148.88 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.671 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.8 mt -104.77 110.08 22.28 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 60' ' ' VAL . 52.8 t -111.98 126.33 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.651 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.85 140.75 47.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 125.056 1.472 . . . . 0.0 107.767 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 151.86 35.03 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 117.651 -1.619 . . . . 0.0 112.592 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 11.8 ptt180 -125.62 162.31 25.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.247 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.615 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -125.45 174.44 8.19 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.391 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.05 43.92 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.993 171.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -150.41 -61.65 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.5 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.6 m -129.28 163.0 26.61 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.562 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 21.2 mt-10 -109.73 156.78 19.85 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.945 -1.102 . . . . 0.0 113.197 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 41' ' ' ARG . 3.6 m95 34.72 79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.571 -1.649 . . . . 0.0 112.795 174.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 73.7 mmtt -62.53 160.74 31.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.193 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 20.9 Cg_exo -42.71 101.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.884 1.722 . . . . 0.0 111.06 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -49.13 158.58 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.957 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.3 147.22 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.196 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -114.75 123.91 50.44 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -70.34 165.42 44.59 Favored Pre-proline 0 N--CA 1.488 1.462 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.237 -177.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.98 164.55 9.88 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.823 1.682 . . . . 0.0 110.451 174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -73.65 79.88 1.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.67 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.63 60.67 0.43 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -96.98 -174.69 3.04 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.856 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.66 -12.05 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.512 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.7 p-80 -154.16 163.64 39.79 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.275 -176.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -136.92 151.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.946 173.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.5 ptp -135.22 148.06 49.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.106 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.6 pp -141.52 143.24 33.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.354 173.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -141.63 173.04 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.716 -176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 t 59.43 57.21 3.42 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.433 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 71' ' ' TYR . 15.0 mt -94.35 179.95 5.12 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.62 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.11 135.28 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.037 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.428 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 75.6 m95 -76.17 152.33 36.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.669 -1.213 . . . . 0.0 110.593 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 47.21 49.29 15.45 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.521 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.39 153.71 47.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.33 147.75 22.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.213 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 15.6 m-85 -133.94 137.29 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 123.947 0.779 . . . . 0.0 111.865 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -118.5 115.82 25.38 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.908 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.15 122.97 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 39.2 m-85 -112.53 124.74 53.19 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.38 121.22 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.666 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.12 157.27 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 118.422 -1.311 . . . . 0.0 109.686 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.2 tt0 -111.57 160.28 17.34 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.49 -1.284 . . . . 0.0 107.795 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.1 t-20 -145.79 151.47 37.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.852 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -36.77 -43.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.649 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -109.1 37.41 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.79 -152.45 22.16 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.771 174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -129.04 163.71 24.81 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.734 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -126.18 125.93 43.26 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.964 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -43.27 167.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.707 1.879 . . . . 0.0 113.378 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.85 141.03 28.84 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.793 -173.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.68 147.13 27.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 74' ' ' TYR . 11.0 t-160 -116.71 130.3 56.65 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.544 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 81.3 t80 -117.95 127.64 54.04 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.239 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.3 t -123.87 134.39 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.611 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 38.0 p90 -156.29 176.78 12.24 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.263 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -126.74 147.39 49.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.511 175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -79.9 168.49 19.18 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.92 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 t -82.11 -170.91 3.12 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.223 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.78 141.41 36.55 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.017 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.531 -178.643 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.64 177.66 15.87 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.0 Cg_exo -58.76 170.91 2.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.518 2.146 . . . . 0.0 112.797 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 t -93.63 171.04 9.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.64 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.29 141.3 73.63 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.685 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.16 168.16 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 121.47 1.446 . . . . 0.0 110.904 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -101.63 130.81 48.05 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.2 mt -104.71 111.52 24.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.118 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -95.45 142.79 27.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -113.71 133.17 11.04 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.23 -1.462 . . . . 0.0 112.978 -170.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -127.75 129.3 46.84 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.6 ttm -107.66 134.08 51.16 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.699 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.33 153.73 24.58 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.779 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.56 10.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.985 -0.607 . . . . 0.0 112.292 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.92 -22.39 42.78 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.866 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.14 -37.47 3.54 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.559 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 8.5 p30 -137.48 46.82 2.11 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 176.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -120.58 114.93 22.46 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.5 mm -118.56 128.34 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.501 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -113.6 125.34 54.06 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.1 t -109.86 118.5 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -98.73 128.5 45.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.532 -0.867 . . . . 0.0 109.48 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 18.7 mt -100.38 105.18 16.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mm -94.65 128.58 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.876 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -103.54 147.64 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.311 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -132.42 -54.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.197 -174.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 18.9 m-20 -132.82 107.34 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.627 -175.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 2.6 m-20 -131.98 -35.04 1.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.035 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.91 52.22 0.35 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.19 20.96 34.05 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.605 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 67.1 m 41.92 61.34 8.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.5 Cg_endo -87.74 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.631 1.554 . . . . 0.0 108.787 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.81 151.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.449 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 35' ' ' HIS . 51.0 mtt180 -130.67 115.1 16.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.69 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.531 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.8 p-80 37.43 -171.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.582 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.8 m-85 -141.17 151.49 43.89 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.021 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 76' ' ' VAL . 10.6 mt -105.19 108.81 20.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.455 HG11 HG21 ' A' ' 60' ' ' VAL . 55.3 t -114.42 122.37 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.95 -172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -134.64 142.23 46.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 124.536 1.147 . . . . 0.0 108.222 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -146.82 153.3 40.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 117.994 -1.482 . . . . 0.0 112.575 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 2.3 ptm180 -129.0 164.53 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.563 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.652 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -118.25 -169.17 1.65 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.314 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 9.7 tp -93.32 41.27 1.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.403 172.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.93 -59.38 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.719 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -121.97 156.54 33.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.544 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.8 pt-20 -105.48 157.26 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.839 -177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.528 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.5 m95 32.83 88.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.495 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -71.84 166.01 44.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.002 173.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.4 Cg_exo -46.38 96.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.816 1.677 . . . . 0.0 110.578 177.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.73 174.97 4.56 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.244 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.83 155.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.642 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -115.83 127.94 55.44 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.034 173.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -74.57 164.71 59.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.091 -177.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -71.21 143.89 45.1 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.747 1.631 . . . . 0.0 109.461 171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.46 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 58.5 m -56.69 105.33 0.2 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.931 0.769 . . . . 0.0 111.906 -176.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 107.22 52.15 0.74 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 m -97.15 169.24 9.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.844 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -120.18 -32.25 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.391 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 24.9 p-80 -148.05 167.3 25.3 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.523 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.4 p -134.22 153.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.865 175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 ptp -136.54 152.69 50.78 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.513 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -137.59 141.7 41.29 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.728 172.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 64' ' ' SER . 10.0 ttpp -144.51 135.39 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.891 -173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.0 t 91.49 46.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.332 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -93.62 -178.98 4.87 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.829 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.73 135.46 40.34 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.401 -173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -73.59 156.4 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.297 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 45.48 48.77 10.87 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.888 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.12 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.086 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.2 mt-10 -94.44 146.18 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.954 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.652 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 11.8 m-85 -131.04 140.48 50.08 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.31 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.86 117.29 28.45 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.195 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.05 121.89 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 37.7 m-85 -110.81 123.73 50.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.5 t -120.21 121.07 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.946 0.778 . . . . 0.0 110.349 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.37 158.34 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.63 156.21 42.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.606 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 18.8 tt0 -111.69 160.68 17.04 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.486 HD21 ' HG2' ' A' ' 32' ' ' PRO . 14.2 t-20 -145.37 151.15 37.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.839 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -36.42 -43.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 112.719 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -110.5 38.03 2.58 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.17 -153.53 23.44 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.839 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -128.09 163.36 24.78 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.765 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.6 t -126.54 125.19 41.61 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.037 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -43.14 167.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 125.582 1.801 . . . . 0.0 113.513 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.76 141.27 28.64 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.679 -174.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.83 147.0 28.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.49 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.04 129.35 56.32 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.609 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.6 t80 -117.25 127.83 54.48 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.139 -1.392 . . . . 0.0 108.239 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -125.43 139.12 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.921 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 42.2 p90 -157.91 178.31 10.37 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.733 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -129.12 146.56 51.04 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.957 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.2 p -79.94 171.58 14.92 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.419 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -84.36 -176.04 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.092 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.85 147.99 24.92 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.08 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 116.436 -1.745 . . . . 0.0 110.568 -178.529 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.69 179.95 19.01 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.498 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 37.6 Cg_endo -73.01 179.46 5.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.919 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -98.34 159.42 14.96 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.182 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.87 147.95 92.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.617 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.59 169.47 15.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.296 1.331 . . . . 0.0 110.626 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -104.06 134.6 47.05 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.99 110.86 21.92 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.405 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.34 148.22 22.3 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.261 -0.976 . . . . 0.0 108.487 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -115.49 128.91 8.27 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.327 -1.416 . . . . 0.0 112.959 -172.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.77 128.1 50.03 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.514 ' CE ' HD11 ' A' ' 19' ' ' ILE . 52.8 tpp -103.62 128.99 50.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.21 151.14 25.45 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.706 -1.235 . . . . 0.0 111.256 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.87 8.92 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.1 m-20 -80.0 -21.13 43.97 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.246 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.9 -35.19 5.19 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.573 176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 6.1 p30 -133.12 0.47 3.43 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.17 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.5 m -72.97 113.83 10.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.227 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.523 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 8.3 mm -114.97 126.17 72.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.831 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.69 125.36 54.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.928 0.767 . . . . 0.0 109.227 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.4 t -109.43 122.3 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.73 129.04 41.8 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.324 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 43.2 mt -99.06 98.52 9.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.96 133.43 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.648 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' C ' HE21 ' A' ' 26' ' ' GLN . 40.9 mtmt -92.32 171.38 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.865 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -161.1 -64.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.757 -173.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.99 91.23 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 7.2 m-20 -128.43 -16.11 4.44 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.061 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.65 49.82 2.08 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.52 47.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.52 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 42.6 t 44.2 68.04 3.45 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.379 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.2 Cg_endo -89.49 43.91 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.764 1.642 . . . . 0.0 107.956 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.27 146.58 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.853 -171.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 35' ' ' HIS . 89.8 mtt-85 -126.04 123.78 39.18 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.324 -1.762 . . . . 0.0 108.464 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.4 p-80 37.16 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -138.08 156.07 48.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.026 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.52 110.82 22.02 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 60' ' ' VAL . 49.0 t -114.35 123.56 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.024 -1.07 . . . . 0.0 109.94 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -136.01 139.22 42.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.682 1.239 . . . . 0.0 107.927 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.06 155.2 43.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.933 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.0 ptt85 -130.63 164.34 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.016 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -124.88 169.85 11.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.683 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.68 43.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.9 -56.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.041 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.5 m -130.54 157.18 43.4 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.197 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.0 pt-20 -101.65 165.25 11.32 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.82 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.8 m95 21.9 91.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.047 -1.433 . . . . 0.0 114.019 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.0 mptm? -74.45 165.23 55.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.109 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 17.3 Cg_exo -45.13 99.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.856 1.704 . . . . 0.0 110.716 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 175.24 3.5 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.451 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.1 tt -140.18 154.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -115.29 136.42 53.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.0 mt -87.99 164.64 32.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.32 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.3 Cg_exo -62.24 165.68 14.42 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.812 1.674 . . . . 0.0 110.389 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -74.93 80.89 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.13 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.04 58.2 0.26 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.721 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -97.06 167.16 11.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.375 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -115.24 -8.94 12.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.651 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 33.7 p-80 -160.09 165.23 32.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.053 -1.459 . . . . 0.0 112.943 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 14.6 p -137.72 153.52 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.978 172.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 ptp -136.53 151.02 48.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.341 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.6 pp -141.84 146.14 35.49 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.366 173.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -141.52 -177.25 5.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.416 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.4 t 55.19 51.87 12.54 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 17' ' ' ASN . 31.6 mt -85.49 165.68 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.812 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -78.31 8.19 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.412 -171.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 60.52 162.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.167 0.508 . . . . 0.0 111.861 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 36.23 43.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.03 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.77 156.16 48.88 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.061 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -98.23 147.86 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 124.144 0.903 . . . . 0.0 108.629 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 33.2 m-85 -131.95 142.92 49.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.972 0.795 . . . . 0.0 111.783 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -118.55 118.15 30.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.646 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -110.52 122.75 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 54.2 m-85 -111.45 125.88 54.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.1 t -121.0 122.29 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.626 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -109.35 155.51 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.15 159.2 35.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.955 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -109.37 149.77 29.02 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.469 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 22.9 t-20 -130.88 143.96 51.11 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.267 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -43.39 -37.17 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.81 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -117.07 46.26 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.793 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -153.72 22.62 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.371 174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -125.17 160.59 28.8 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.882 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.8 t -113.13 109.64 19.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -39.25 158.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 125.497 1.748 . . . . 0.0 112.698 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -77.56 127.88 33.23 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.828 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.76 145.21 26.03 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.454 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.3 t-160 -114.53 129.26 56.65 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.608 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.451 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.5 t80 -115.84 127.22 54.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -123.37 134.55 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.358 -175.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 39.7 p90 -155.74 174.75 14.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.473 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.52 148.46 48.88 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.803 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -79.88 172.58 13.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 m -87.14 -172.94 4.19 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.727 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.23 144.21 27.26 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.283 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.566 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.2 173.83 14.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.522 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.9 Cg_exo -60.3 168.08 6.86 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.551 2.167 . . . . 0.0 113.046 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.82 158.46 18.74 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.828 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.06 146.2 92.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.173 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.32 167.93 19.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.458 1.439 . . . . 0.0 110.749 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 44.9 mtmt -103.59 128.75 50.81 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 173.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.6 114.34 28.5 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.494 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -103.18 140.74 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.552 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -123.31 140.8 13.27 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.639 -1.743 . . . . 0.0 113.724 -170.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -131.39 143.3 50.37 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.2 -1.0 . . . . 0.0 109.645 170.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.661 -0.816 . . . . 0.0 108.969 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -81.89 153.8 33.15 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.808 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.27 8.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.336 -0.545 . . . . 0.0 112.374 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' GLY . 17.5 m-20 -79.92 -25.16 40.62 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.533 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.1 -37.03 4.03 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.727 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 13.4 m-20 -123.08 -12.0 7.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.9 m -65.73 112.04 3.51 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.638 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 91' ' ' PHE . 6.8 mm -112.21 126.7 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -114.7 121.35 43.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 124.044 0.84 . . . . 0.0 108.865 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 46.5 t -109.98 118.02 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -95.44 133.78 39.02 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.341 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 52.0 mt -102.58 101.12 11.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 124.049 0.843 . . . . 0.0 108.885 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 7' ' ' LYS . 23.8 mm -89.51 134.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.025 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -101.52 148.61 25.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.006 0.816 . . . . 0.0 109.333 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.66 -72.78 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.81 -175.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 29.9 m-20 -130.34 107.29 9.15 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.931 -176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.0 m-20 -126.44 -35.73 2.35 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.655 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.43 54.6 0.26 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 32' ' ' PRO . . . 89.06 28.63 20.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 77.8 p 32.21 63.37 1.26 Allowed Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.9 Cg_endo -87.39 46.31 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.758 1.638 . . . . 0.0 108.755 173.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.08 149.87 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.462 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' HIS . 62.1 mtt85 -130.45 117.59 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.13 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.8 p-80 36.1 -175.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.549 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 81.1 m-85 -137.55 142.84 41.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.944 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.28 105.7 17.74 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 60' ' ' VAL . 60.7 t -108.81 125.57 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.088 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -131.8 134.02 45.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 125.0 1.438 . . . . 0.0 107.681 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.59 158.63 43.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 117.711 -1.595 . . . . 0.0 112.185 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 22.5 ptt85 -142.71 168.37 19.89 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.458 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -131.43 171.63 13.15 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.38 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -71.06 26.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.153 176.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -131.22 -59.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.369 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -124.82 154.91 40.27 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.07 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.9 pt-20 -108.98 166.74 10.6 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.314 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.473 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 22.67 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.188 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.81 165.67 39.66 Favored Pre-proline 0 N--CA 1.49 1.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.085 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -48.81 107.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.867 1.711 . . . . 0.0 110.711 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.81 159.59 2.22 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.86 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 tt -130.09 147.82 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.018 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -114.77 113.33 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.334 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.549 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.1 mm? -58.55 167.44 1.78 Allowed Pre-proline 0 N--CA 1.492 1.633 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.604 -177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.62 171.37 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.736 1.624 . . . . 0.0 110.502 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.3 m -76.29 77.29 3.07 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.736 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 70.1 0.68 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -93.31 -171.94 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.187 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.89 -20.22 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.006 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 20.4 p-80 -160.0 173.46 15.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.025 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -135.23 150.8 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 124.856 1.347 . . . . 0.0 108.416 173.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptp -134.12 147.59 50.85 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.002 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.9 pp -142.13 147.35 36.53 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.885 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -141.09 175.44 9.63 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.942 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t 49.36 66.94 0.97 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.226 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 12.3 mt -100.0 -174.69 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.075 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 6.4 m-20 -70.0 126.42 29.63 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.761 172.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -76.38 151.4 36.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.177 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 47.04 49.06 15.26 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.032 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.432 ' HB1' ' CD2' ' A' ' 43' ' ' LEU . . . -127.45 150.72 49.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.45 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' H ' HD13 ' A' ' 43' ' ' LEU . 31.2 mt-10 -91.8 140.64 29.49 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -129.9 143.38 50.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.002 0.814 . . . . 0.0 112.431 -173.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.46 125.18 44.45 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.804 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.88 125.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 49.1 m-85 -114.49 127.66 55.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.54 119.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.59 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -104.34 156.98 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.42 155.4 43.73 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.185 -1.406 . . . . 0.0 109.862 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 23.2 tt0 -111.25 157.93 19.56 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.869 175.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.522 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 11.6 t-20 -145.43 152.87 40.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.09 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -33.61 -45.82 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.908 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -109.85 37.68 2.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.56 -153.52 22.09 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.227 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -120.25 158.76 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.835 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.1 t -121.79 124.76 44.93 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.29 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -40.85 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 125.75 1.906 . . . . 0.0 113.505 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.83 137.93 32.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.223 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.81 145.94 28.48 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.491 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -117.03 131.85 56.84 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.648 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 76.9 t80 -121.5 134.39 55.05 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.236 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -131.07 142.8 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.818 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 19' ' ' ILE . 49.0 p90 -158.97 -178.78 7.49 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.282 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -129.32 144.41 51.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.661 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -79.82 169.38 18.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.179 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -85.75 -168.11 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.076 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.13 140.55 37.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.433 -178.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.063 0.459 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.48 173.31 14.22 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.106 -1.045 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.2 Cg_endo -62.8 176.79 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.476 2.117 . . . . 0.0 112.767 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.6 m -96.81 162.1 13.57 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.906 173.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 145.63 99.02 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.316 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.11 170.27 12.12 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.391 1.394 . . . . 0.0 111.177 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -104.59 132.92 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.09 111.84 23.68 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.254 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -93.92 145.19 24.81 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.95 130.3 9.41 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.332 -1.413 . . . . 0.0 112.868 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.449 HE21 ' ND2' ' A' ' 22' ' ' ASN . 71.5 mt-30 -123.09 125.82 45.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 170.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 ttm -107.13 128.93 54.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.468 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.04 150.55 24.02 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.811 -1.185 . . . . 0.0 111.472 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.46 13.97 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.833 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 13.5 m-20 -79.96 -23.14 41.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.669 174.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.51 -39.63 2.83 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.397 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.443 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 17.6 p30 -133.6 12.78 4.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.94 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -80.0 109.89 14.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 8.2 mm -115.14 126.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.272 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -113.28 126.5 55.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 123.943 0.777 . . . . 0.0 109.058 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 55.7 t -108.74 115.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' ND2' HE21 ' A' ' 11' ' ' GLN . 3.5 m-80 -95.96 128.58 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.459 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 23.9 mt -99.52 107.62 19.84 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.772 -172.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.1 mm -100.71 135.22 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.458 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -101.71 152.1 21.24 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.652 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.467 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -136.95 -50.41 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.129 -176.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 12.7 m-20 -141.15 106.78 5.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.9 m-20 -132.06 -34.26 1.28 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.234 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.63 53.85 0.37 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.05 21.01 34.3 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.574 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 39.52 64.15 4.28 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 114.927 -0.637 . . . . 0.0 112.64 -176.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 31' ' ' SER . 8.6 Cg_endo -86.28 44.41 1.25 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.621 1.547 . . . . 0.0 108.556 172.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mm -86.66 148.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.468 -173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' HIS . 47.1 mtt180 -129.68 120.09 24.59 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.616 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 36.89 -174.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 90.1 m-85 -139.2 151.65 46.72 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.036 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.21 109.73 21.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.39 123.12 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.055 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -134.48 140.92 46.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.552 1.158 . . . . 0.0 107.922 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -146.04 156.15 43.28 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.694 -1.602 . . . . 0.0 112.378 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.2 ptm180 -125.89 160.49 29.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.49 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.55 -169.63 1.53 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 43' ' ' LEU . 11.4 tp -96.19 39.91 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.116 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.45 -59.41 0.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.446 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.2 m -118.41 148.6 42.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.009 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.0 pt-20 -107.05 151.62 25.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.816 -1.153 . . . . 0.0 112.181 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.536 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 42.0 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.41 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.3 mttt -73.54 165.17 55.38 Favored Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.483 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.89 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.767 1.645 . . . . 0.0 110.479 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.12 174.38 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.675 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -137.76 154.23 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.043 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -115.74 128.69 56.05 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.093 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -75.17 165.13 56.39 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.149 -177.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.75 166.58 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.858 1.705 . . . . 0.0 110.237 173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.3 m -76.27 79.67 3.05 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.874 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.69 60.75 0.41 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -97.08 -175.61 3.3 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.769 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -117.82 -39.89 3.07 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.571 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -148.22 168.44 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.21 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.8 p -128.07 152.09 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.289 174.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptp -136.44 154.11 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.528 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 0.7 OUTLIER -137.9 142.79 40.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.552 173.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -131.6 165.72 23.02 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.455 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m 53.58 62.56 2.58 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.189 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 62' ' ' LEU . 19.3 mt -92.36 178.19 5.91 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.029 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -73.59 128.98 37.0 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.188 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -71.51 150.1 45.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.584 -1.246 . . . . 0.0 109.883 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 48.61 49.15 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.478 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.55 153.1 48.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.963 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 26.8 tt0 -94.04 147.96 22.63 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.009 175.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 10.9 m-85 -132.67 140.88 48.34 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.419 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.95 116.24 24.73 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.024 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.53 123.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 40.5 m-85 -112.18 125.56 54.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.29 121.84 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 124.035 0.834 . . . . 0.0 110.188 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -107.7 158.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.69 160.98 31.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.333 -1.347 . . . . 0.0 109.106 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -112.22 157.46 20.87 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.293 -1.363 . . . . 0.0 108.091 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -139.92 147.99 41.36 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.105 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -36.83 -43.39 0.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.41 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -114.41 42.73 2.04 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.669 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.9 -154.25 24.27 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.192 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -121.33 161.34 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.961 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.566 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.2 t -116.0 115.45 26.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -40.44 160.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 125.512 1.757 . . . . 0.0 112.661 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.65 138.35 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.532 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.21 146.27 29.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.494 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -116.97 130.86 56.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.465 -173.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -118.49 128.44 54.59 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.116 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -126.39 138.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.818 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.519 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.48 -179.78 8.22 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.973 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.08 147.48 50.94 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.768 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -80.02 170.06 16.99 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.784 -0.767 . . . . 0.0 109.292 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.7 m -81.41 -175.98 5.77 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.154 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.42 147.38 26.41 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.123 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.521 -1.704 . . . . 0.0 110.692 -178.203 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.913 0.387 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.74 176.05 16.79 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.598 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 5.0 Cg_endo -64.24 174.29 4.29 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.548 2.165 . . . . 0.0 112.603 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -87.92 145.59 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.286 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.77 78.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.174 -1.011 . . . . 0.0 108.571 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.41 165.74 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.218 1.279 . . . . 0.0 110.569 -176.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -103.42 133.29 48.72 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.3 112.24 25.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.844 -1.142 . . . . 0.0 109.959 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -93.4 141.89 27.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.29 131.28 10.55 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.341 -1.409 . . . . 0.0 112.587 -171.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -128.85 126.97 40.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 ttm -106.2 132.69 51.96 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -87.77 152.42 23.95 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.571 -176.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.99 12.46 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.311 -0.556 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.95 -24.26 41.12 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.645 175.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 110.06 -40.77 2.43 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.434 177.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -132.15 10.06 4.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.076 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 m -81.78 116.25 21.38 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.953 176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.529 HD11 ' CE2' ' A' ' 91' ' ' PHE . 7.3 mm -116.97 128.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.324 -172.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -113.47 126.3 55.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 123.988 0.805 . . . . 0.0 108.982 173.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 48.3 t -108.78 113.27 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -95.05 129.83 41.98 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.401 -176.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.2 mt -98.71 106.45 18.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.715 -173.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.3 mm -97.66 131.76 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.994 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -107.49 156.26 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.366 -177.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.32 -65.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.516 -174.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -135.23 128.4 31.86 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.325 177.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.4 m-20 -133.53 -36.27 0.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 123.901 0.751 . . . . 0.0 109.899 177.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.63 54.22 0.3 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -178.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.44 18.86 37.18 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -175.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.6 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 22.9 t 42.56 61.27 9.25 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 114.907 -0.646 . . . . 0.0 112.648 -176.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 31' ' ' SER . 11.0 Cg_endo -88.46 37.99 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.558 1.506 . . . . 0.0 109.583 174.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 79' ' ' ASN . 23.6 mm -77.54 150.58 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.901 0.858 . . . . 0.0 111.78 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 35' ' ' HIS . 9.0 mmt180 -127.85 113.32 15.77 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.367 178.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.2 p-80 36.2 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 174.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 74.0 m-85 -137.98 152.3 48.78 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.115 177.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.404 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.1 mt -108.56 110.72 22.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 60' ' ' VAL . 52.4 t -115.45 124.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.289 -174.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -135.52 140.15 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.62 1.2 . . . . 0.0 108.291 177.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.78 155.98 44.34 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.202 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.3 ptm180 -129.56 164.67 23.32 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.988 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -113.83 -177.95 3.26 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 tp -87.03 41.66 0.98 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.111 173.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.11 -60.11 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.522 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 p -119.11 151.3 38.53 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.439 177.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.8 pt-20 -106.96 151.45 25.27 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.858 -173.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.572 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.3 m95 42.29 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.35 175.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -69.83 168.3 18.55 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.695 173.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -52.26 95.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.656 1.57 . . . . 0.0 109.819 174.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.65 172.61 2.05 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.486 -173.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.11 154.63 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.392 -177.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -114.74 129.24 56.66 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.09 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -76.1 165.93 49.1 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.133 -177.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.45 168.24 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.787 1.658 . . . . 0.0 110.211 172.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.4 t -77.87 78.97 4.35 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.566 -177.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.0 60.72 0.34 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -97.18 -174.51 2.97 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.688 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -119.5 -40.52 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.707 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -148.06 169.12 20.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.11 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.0 p -127.46 152.48 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.422 173.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.8 ptp -136.25 150.42 48.95 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.599 -1.241 . . . . 0.0 112.908 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -140.47 139.21 35.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.097 172.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -140.39 162.76 34.54 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.606 -177.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t 66.93 50.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.605 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -96.43 -174.52 3.07 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.665 176.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -83.3 142.6 30.97 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.095 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.412 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 74.3 m95 -77.75 155.17 31.37 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.366 -178.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.35 48.66 10.49 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.604 -176.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.09 47.33 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.837 178.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -97.94 149.92 21.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.532 177.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 31.6 m-85 -135.47 145.27 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.423 -179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -121.08 118.56 30.08 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.347 -1.751 . . . . 0.0 108.328 177.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.68 124.55 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 45.0 m-85 -112.69 126.18 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -121.29 122.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.492 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.13 158.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -126.98 156.54 41.41 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.261 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 27.6 tt0 -111.97 159.77 18.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.585 175.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.0 t-20 -144.88 148.94 34.5 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.985 178.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -37.91 -42.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.481 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -112.32 42.12 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.751 -0.78 . . . . 0.0 112.465 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.45 -153.97 22.76 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.46 173.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -125.35 162.52 24.59 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.877 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -119.77 117.13 27.39 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -40.96 163.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 125.482 1.739 . . . . 0.0 113.206 -174.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.15 134.72 34.98 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.126 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.87 145.58 29.58 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.489 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.25 131.06 57.05 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.627 -173.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -118.13 127.27 53.61 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.008 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -125.32 139.31 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.64 -176.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 38.5 p90 -159.17 176.98 11.55 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.24 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -127.63 147.9 50.37 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.756 175.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.3 p -79.84 170.83 15.94 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.248 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -83.57 -170.81 3.24 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.143 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.19 141.88 36.81 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.156 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.54 -1.695 . . . . 0.0 110.741 -179.193 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.003 0.43 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.8 170.83 14.56 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.97 -1.109 . . . . 0.0 110.556 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 3.8 Cg_exo -60.99 173.83 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.493 2.129 . . . . 0.0 112.917 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -95.39 155.51 16.71 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.036 174.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.26 143.09 97.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.075 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.65 165.9 23.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.343 1.362 . . . . 0.0 110.75 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.61 132.53 48.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.6 mt -104.72 113.78 27.58 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.224 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.02 138.78 31.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.441 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.75 124.56 7.91 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.492 -1.337 . . . . 0.0 112.469 -172.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -121.81 120.88 35.85 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.4 ttm -106.39 131.69 53.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.73 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.73 149.27 23.26 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.689 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.84 11.63 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.074 -0.563 . . . . 0.0 112.255 -177.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLY . 18.5 m-20 -79.93 -22.36 42.8 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.876 176.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.8 -37.8 3.61 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.957 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 11.0 p-10 -140.27 47.52 1.79 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m -120.57 114.33 21.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.533 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 7.9 mm -117.41 128.54 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.633 -170.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -114.94 126.6 54.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.575 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.9 t -109.01 111.5 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -94.33 130.9 40.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.623 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 19.6 mt -100.05 108.51 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.949 -172.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.79 127.12 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -104.06 156.16 18.09 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.471 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.33 -53.31 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.146 -172.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -136.15 118.91 16.11 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.294 -178.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -134.27 -41.43 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 177.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.13 54.54 0.25 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -177.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.53 42.88 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 14.4 t 42.3 60.38 9.59 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -88.65 46.87 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.658 1.572 . . . . 0.0 108.962 173.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.67 152.32 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.602 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 35' ' ' HIS . 11.0 mtt180 -130.37 119.9 23.47 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.629 -1.623 . . . . 0.0 109.331 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.636 ' H ' ' HA ' ' A' ' 55' ' ' SER . 7.2 p-80 31.87 -171.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.129 -1.851 . . . . 0.0 115.988 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 81.9 m-85 -137.47 153.1 50.13 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.9 175.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 76' ' ' VAL . 4.9 mt -110.82 112.2 23.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 60' ' ' VAL . 42.4 t -115.86 128.16 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.215 -174.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.3 139.4 46.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.905 1.378 . . . . 0.0 108.104 175.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.9 p90 -147.38 154.57 41.04 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 117.807 -1.557 . . . . 0.0 112.581 177.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 10.5 ptm180 -133.39 160.81 36.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.157 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.775 ' HB2' ' CZ ' ' A' ' 71' ' ' TYR . . . -108.47 -172.75 2.12 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -93.43 39.34 1.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.585 171.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.66 -60.67 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.348 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.5 m -118.94 141.12 48.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.8 pt-20 -105.02 171.93 7.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.6 -1.24 . . . . 0.0 113.093 -171.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 7.4 m95 18.28 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.591 -1.641 . . . . 0.0 114.123 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 9.4 mptt -67.57 164.34 39.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.689 174.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.3 Cg_exo -47.17 104.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.844 1.696 . . . . 0.0 110.881 177.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 156.66 0.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.261 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 tt -131.12 146.92 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.359 175.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -115.21 132.14 56.7 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.4 mt -82.69 164.69 45.84 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.875 -177.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.25 155.58 68.84 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.599 1.533 . . . . 0.0 109.454 172.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.636 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 8.5 t -73.36 103.1 3.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.204 -0.999 . . . . 0.0 110.373 -177.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.25 0.74 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.07 172.84 7.58 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.155 -175.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.3 -43.7 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.565 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 18.5 p-80 -148.86 168.4 23.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.614 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.4 p -123.15 150.74 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.035 174.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.2 ptp -135.92 149.19 48.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.506 -1.277 . . . . 0.0 112.833 -175.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.7 pp -138.65 135.31 34.73 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.68 173.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' SER . 84.1 mttt -142.9 142.11 31.66 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.778 -178.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.9 m 91.07 43.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.892 176.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.9 mm? -95.37 -176.47 3.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.369 -177.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.43 130.95 42.6 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.877 -172.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.6 155.99 39.46 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.213 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 43.3 48.42 5.8 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.792 -177.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.9 151.88 49.98 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.802 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.86 149.54 21.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.775 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 7.6 m-85 -133.74 140.92 47.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.657 -177.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.17 119.72 34.1 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.518 -1.673 . . . . 0.0 108.234 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.1 t -113.62 125.41 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m-85 -113.52 125.39 54.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.2 123.75 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 123.893 0.746 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -108.72 158.01 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -127.72 157.02 41.46 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.413 -1.315 . . . . 0.0 109.547 178.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.2 tt0 -112.15 161.88 16.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.731 -1.188 . . . . 0.0 108.009 175.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.9 t-20 -143.78 149.8 37.6 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.546 177.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -41.21 -39.47 1.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.172 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -113.05 39.06 2.64 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.92 -150.88 22.39 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.681 175.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -134.31 168.52 18.75 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.227 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 9.1 t -127.97 123.06 33.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.215 -178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.15 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 125.557 1.786 . . . . 0.0 113.253 -174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -87.02 138.84 31.15 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.63 -174.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.79 145.8 29.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.5 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.2 t-160 -115.04 130.72 57.0 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.6 -173.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -118.5 129.26 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.017 -179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.5 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -127.7 140.64 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.936 -176.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.2 p90 -158.84 -178.65 7.41 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.739 178.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -130.85 146.76 52.38 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.91 175.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.1 p -79.88 171.5 15.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.332 178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -86.86 -170.88 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.072 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.07 140.85 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.052 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.459 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -113.66 172.89 14.65 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.657 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 10.9 Cg_endo -68.23 174.34 8.22 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.658 2.239 . . . . 0.0 112.427 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.8 m -101.54 158.78 15.83 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.925 172.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.31 149.58 68.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.349 -174.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -71.82 172.02 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.589 1.526 . . . . 0.0 110.766 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -106.07 134.1 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.47 112.43 24.82 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.399 -176.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 23.1 tt0 -92.48 141.45 28.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.76 121.83 7.29 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.744 -1.217 . . . . 0.0 111.869 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -122.16 121.58 37.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.4 ttm -104.76 134.2 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.701 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.63 150.86 22.01 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.735 -176.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.76 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.085 -0.557 . . . . 0.0 112.294 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLY . 15.5 m-20 -79.82 -22.2 43.31 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.017 176.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 116.97 -50.97 0.75 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.541 176.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -128.15 7.62 6.02 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.807 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.5 t -73.11 117.32 14.71 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.865 176.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.548 HD11 ' CE2' ' A' ' 91' ' ' PHE . 8.4 mm -117.04 128.63 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.869 -171.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -113.8 125.85 54.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 124.008 0.817 . . . . 0.0 108.976 171.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.583 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 59.4 t -105.9 110.19 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 11.5 t-20 -88.03 129.06 35.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.95 -175.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 75' ' ' VAL . 33.4 mt -99.69 100.95 11.99 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.265 -175.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -93.05 128.84 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.3 mtmt -101.17 147.57 26.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 123.951 0.782 . . . . 0.0 109.672 -176.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -134.18 -86.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.937 -175.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -107.59 109.5 21.16 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.659 -174.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 6.1 m-20 -133.62 -34.51 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.127 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.92 53.51 0.36 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.72 21.04 35.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -175.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.579 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.0 m 42.85 61.47 9.4 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.745 -176.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 31' ' ' SER . 14.3 Cg_endo -86.54 45.61 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.792 1.662 . . . . 0.0 108.75 173.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 79' ' ' ASN . 23.0 mm -82.35 148.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.278 -173.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.0 mtt180 -125.35 111.43 15.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.89 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ARG . 5.9 p-80 33.97 -171.45 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.07 156.23 49.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.83 176.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.2 mt -112.82 111.45 22.24 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 60' ' ' VAL . 48.5 t -115.82 124.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.447 -174.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -136.75 138.1 40.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.487 1.117 . . . . 0.0 108.328 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.85 156.88 45.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.0 -1.48 . . . . 0.0 112.533 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 27.0 ptt180 -134.69 168.81 18.33 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.39 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.25 172.17 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.797 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.471 HD13 ' H ' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -71.8 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.952 174.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -136.53 -58.75 0.73 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.742 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.7 m -126.48 158.79 35.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.581 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.7 pt-20 -101.43 166.98 10.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.751 -177.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.435 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 5.9 m95 17.94 93.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 113.966 -1.47 . . . . 0.0 114.514 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -73.68 167.27 36.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.322 173.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -48.06 98.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.76 1.64 . . . . 0.0 110.39 176.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.77 174.44 5.16 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.349 -173.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -139.19 154.89 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.499 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.35 137.06 52.07 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.783 173.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.5 mt -87.49 166.45 25.28 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.306 -177.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -81.33 140.04 11.94 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.92 1.747 . . . . 0.0 108.063 167.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.6 t -62.53 135.31 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.742 -177.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.61 41.81 4.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -97.03 168.62 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.505 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -114.59 -45.81 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.44 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -147.86 167.43 24.8 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.361 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.0 p -119.07 149.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.196 -1.365 . . . . 0.0 107.778 173.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.9 ptp -132.55 148.41 52.37 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.874 -174.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.98 140.41 38.21 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.202 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -140.59 162.35 35.57 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.357 -177.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.0 m 71.69 46.4 0.39 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.403 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -95.27 -176.06 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.571 177.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -84.98 146.33 27.27 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.816 -175.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.451 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 71.0 m95 -80.25 155.33 27.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.545 -177.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 44.91 46.77 9.13 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.458 -175.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.43 149.94 47.75 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.712 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' H ' HD13 ' A' ' 43' ' ' LEU . 18.8 tt0 -98.83 143.09 29.55 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.327 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 39.4 m-85 -131.51 144.32 51.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 123.995 0.809 . . . . 0.0 112.057 -177.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.12 119.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 113.428 -1.715 . . . . 0.0 108.06 176.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.55 124.53 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 59.8 m-85 -111.35 126.96 55.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 23' ' ' LEU . 75.8 t -120.92 121.82 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.944 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.5 t -109.5 158.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.72 160.21 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.516 -1.274 . . . . 0.0 109.36 177.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.6 tt0 -111.1 164.76 12.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 20.1 t-20 -152.19 151.89 31.57 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.659 -1.217 . . . . 0.0 111.115 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -41.63 -41.41 2.2 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.327 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -79.7 -47.62 15.03 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.503 -177.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.63 -108.79 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.621 -1.276 . . . . 0.0 109.995 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -140.72 173.23 11.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.895 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -125.77 119.27 27.47 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -42.49 162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 125.307 1.629 . . . . 0.0 112.664 -176.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -81.51 134.49 35.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.202 -176.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.3 143.07 32.54 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.469 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.21 130.74 56.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.397 -174.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -116.88 126.85 53.61 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.984 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.1 t -123.63 135.44 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.298 -176.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 p90 -156.93 174.03 16.12 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.684 -1.206 . . . . 0.0 111.34 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -127.3 148.2 50.23 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.544 175.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -79.83 168.5 19.19 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.002 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 m -81.25 -173.17 4.18 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.356 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.04 150.55 21.28 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.109 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 116.247 -1.835 . . . . 0.0 110.392 -178.802 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.37 174.9 15.6 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 7.2 Cg_exo -59.35 176.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.634 2.223 . . . . 0.0 112.909 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -93.0 161.53 14.41 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.224 171.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.36 143.73 92.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.422 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.37 172.8 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.484 1.456 . . . . 0.0 110.915 -177.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -106.6 132.25 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.1 mt -109.04 112.12 24.13 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.352 -176.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.33 144.2 25.62 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.41 131.52 10.56 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.411 -1.376 . . . . 0.0 112.422 -173.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -129.16 129.4 45.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.8 ttm -106.86 134.64 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.652 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.41 144.03 21.29 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.591 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.48 9.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -174.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -79.95 -27.22 39.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.858 175.566 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 125.26 -40.05 1.95 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.931 175.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -130.64 -15.1 3.56 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.801 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.2 m -52.88 115.72 1.98 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.332 174.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' A' ' 91' ' ' PHE . 5.9 mm -117.33 128.79 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.122 -175.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -114.94 126.66 55.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 47.6 t -109.27 118.94 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.77 124.02 39.6 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.81 -178.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.62 104.29 15.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -173.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -97.96 133.06 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.204 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -101.1 146.58 27.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.896 0.747 . . . . 0.0 109.434 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.07 -89.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.413 -175.781 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 26' ' ' GLN . 20.8 t70 -95.45 105.69 17.68 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.125 -177.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.75 -35.12 0.99 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.18 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.66 51.27 0.42 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.96 17.61 40.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -175.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.615 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 64.3 m 43.35 59.84 11.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 31' ' ' SER . 12.4 Cg_endo -88.53 50.9 1.67 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.842 1.695 . . . . 0.0 108.513 172.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mm -78.86 151.34 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.027 0.918 . . . . 0.0 111.68 -172.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' HIS . 32.8 mmm-85 -126.13 108.01 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 113.391 -1.731 . . . . 0.0 108.536 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.536 ' H ' ' H ' ' A' ' 56' ' ' GLY . 8.0 p-80 36.17 -170.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 76.5 m-85 -138.73 151.92 47.54 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.131 178.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 76' ' ' VAL . 6.5 mt -107.87 108.78 20.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 174.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 60' ' ' VAL . 54.7 t -114.08 122.23 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.116 -1.033 . . . . 0.0 110.02 -173.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -132.58 135.65 46.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 124.664 1.228 . . . . 0.0 108.1 178.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -140.8 158.69 43.6 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 117.941 -1.504 . . . . 0.0 112.162 179.172 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 9.6 ptm180 -138.32 170.36 16.15 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.305 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.62 179.5 4.31 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.514 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 40.83 0.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.535 172.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.28 -60.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -116.45 149.5 39.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.104 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.6 pt-20 -100.11 160.84 14.01 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.175 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.471 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.8 m95 24.8 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.402 -1.272 . . . . 0.0 114.028 178.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 67.5 mmtt -76.19 162.16 72.42 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 18.8 Cg_exo -45.12 101.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.765 1.643 . . . . 0.0 110.611 177.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.87 175.45 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.571 -173.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -137.97 155.19 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.354 -177.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -115.89 130.25 56.75 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.214 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -78.33 165.09 52.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.239 -177.472 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.12 161.0 27.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.832 1.688 . . . . 0.0 110.87 172.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 t -68.24 95.55 0.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -176.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 95.57 65.38 0.97 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 m -97.14 -169.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.231 -176.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -129.54 -38.88 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.646 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -144.69 164.65 30.35 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.569 -1.252 . . . . 0.0 112.406 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 12.2 p -131.77 153.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.492 174.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptp -137.45 152.13 49.24 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.981 -174.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.54 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -142.04 138.61 31.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.172 172.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -137.94 161.23 37.22 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.745 -177.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t 66.51 49.91 1.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.543 177.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -94.96 -174.63 3.31 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.653 177.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.55 137.32 36.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.708 -175.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.521 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 73.1 m95 -75.62 156.04 35.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.168 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 49.53 44.82 24.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.111 -178.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.71 156.06 44.89 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.546 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.76 149.33 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 19.8 m-85 -135.22 144.63 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.78 -178.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -120.58 121.45 38.4 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.273 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 88.0 t -114.06 123.11 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 46.9 m-85 -110.92 125.64 53.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.67 121.21 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 123.881 0.738 . . . . 0.0 110.446 -178.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -106.54 158.04 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.81 157.53 41.24 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.381 -1.327 . . . . 0.0 109.868 178.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.9 tt0 -112.11 164.27 13.35 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.491 HD21 ' HG2' ' A' ' 32' ' ' PRO . 11.3 t-20 -148.24 151.99 36.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.949 178.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -34.14 -45.81 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.757 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.95 39.78 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.5 -152.81 23.66 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.636 174.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -129.86 166.25 20.36 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.779 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.1 t -128.71 125.68 38.48 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.957 -176.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -43.39 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.52 1.762 . . . . 0.0 113.298 -175.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -88.25 139.7 30.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.61 -175.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.52 145.54 30.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 171.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.511 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -115.2 130.11 56.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.382 -174.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -117.86 129.72 55.82 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.883 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.4 t -127.38 141.1 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.694 -176.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' A' ' 19' ' ' ILE . 44.5 p90 -157.99 177.92 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.066 178.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 146.5 50.78 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.69 175.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.0 p -83.34 163.36 20.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.379 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.6 m -74.86 178.75 5.31 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.164 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.5 144.79 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 116.252 -1.832 . . . . 0.0 110.328 -178.926 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.01 179.03 18.26 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.937 178.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 8.3 Cg_exo -59.4 177.26 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.798 2.332 . . . . 0.0 112.944 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -80.17 -154.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.23 150.18 39.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.97 166.28 28.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.377 1.385 . . . . 0.0 110.755 -177.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.48 128.94 52.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 mt -102.91 110.73 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.018 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -91.49 143.09 26.96 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.431 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -108.27 125.17 7.76 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.337 -1.411 . . . . 0.0 112.486 -173.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.444 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 77.9 mt-30 -121.55 122.47 39.76 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.5 ttm -107.17 130.9 54.65 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.745 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -84.8 149.09 24.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.307 -177.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.55 16.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.587 -177.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.85 -24.48 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.332 174.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -40.61 2.45 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.715 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 7.9 p30 -137.49 49.1 2.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.139 0.495 . . . . 0.0 110.0 177.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.2 m -122.16 113.5 19.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.554 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 6.9 mm -117.07 128.53 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.604 -169.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -114.94 125.75 53.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 124.082 0.864 . . . . 0.0 108.748 173.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.559 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 54.5 t -107.12 116.47 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 2.6 m-20 -93.88 129.01 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.913 -177.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 39.4 mt -100.56 99.41 10.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -175.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.9 mm -95.99 130.36 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -104.15 150.85 23.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.711 0.632 . . . . 0.0 109.803 -175.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -79.64 0.41 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.037 -174.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.55 102.43 11.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.177 -175.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -131.91 -35.01 1.26 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.13 178.535 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.07 51.04 0.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.77 22.48 25.86 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -175.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.585 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 73.0 m 39.09 62.44 4.86 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.6 Cg_endo -88.25 50.69 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.729 1.62 . . . . 0.0 108.722 173.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.402 HD13 HD22 ' A' ' 79' ' ' ASN . 41.0 mm -86.45 151.59 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.068 -174.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' HIS . 61.7 mtt85 -131.69 121.69 24.69 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.821 178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.609 ' H ' ' N ' ' A' ' 56' ' ' GLY . 9.2 p-80 35.44 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.19 158.37 43.81 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.972 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.407 HD23 ' HG3' ' A' ' 52' ' ' ARG . 4.4 mt -112.45 109.86 19.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 174.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 60' ' ' VAL . 48.0 t -115.48 124.74 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.652 -173.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -134.72 140.57 46.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.683 1.24 . . . . 0.0 108.422 177.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CD2' HD22 ' A' ' 62' ' ' LEU . 1.1 p90 -144.07 154.83 43.62 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.924 -1.51 . . . . 0.0 112.706 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 12.0 ptm180 -126.14 163.68 22.58 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.556 179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -108.81 -168.08 1.3 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' LEU . 12.1 tp -95.9 41.49 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.447 173.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.77 -56.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.611 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.8 m -106.76 142.83 35.76 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.6 pt-20 -107.87 144.06 35.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.792 -176.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.551 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.6 m95 47.45 84.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.454 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.0 mmtt -77.54 161.17 73.11 Favored Pre-proline 0 N--CA 1.491 1.603 0 CA-C-N 114.346 -1.297 . . . . 0.0 107.824 174.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 22.4 Cg_exo -43.37 103.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.909 1.739 . . . . 0.0 110.838 179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 14.2 pt-20 -73.76 175.87 6.82 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.503 -173.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.7 157.54 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.757 -177.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HG3' HD23 ' A' ' 37' ' ' LEU . 14.5 ttp85 -114.39 140.98 48.23 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.911 172.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD11 ' HB ' ' A' ' 60' ' ' VAL . 2.0 mt -90.18 165.56 23.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.667 -176.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.9 Cg_exo -61.58 157.91 39.45 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.71 1.607 . . . . 0.0 110.39 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 t -64.58 86.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.171 -176.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.609 ' N ' ' H ' ' A' ' 35' ' ' HIS . . . 106.15 62.91 0.61 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -93.84 179.59 5.3 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.24 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.32 -18.91 7.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.236 -177.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.462 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 19.1 p-80 -160.16 168.94 24.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.435 -1.306 . . . . 0.0 112.245 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.5 p -134.6 153.64 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 113.738 -1.573 . . . . 0.0 107.924 172.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.2 ptp -138.34 153.69 48.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.314 -1.354 . . . . 0.0 112.763 -176.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -138.97 140.17 38.15 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.142 173.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.9 tppt? -137.98 137.82 38.29 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.821 -174.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 8.2 m 85.86 50.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.784 171.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mm? -95.2 -177.55 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.833 -179.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.2 134.21 39.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.687 0.756 . . . . 0.0 111.079 -172.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -72.34 154.65 40.82 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 47.5 47.37 17.36 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.911 -177.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.44 153.07 50.11 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.821 178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.61 149.96 22.24 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.278 177.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.627 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -133.29 144.25 49.59 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.62 -176.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.35 118.25 28.0 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.134 -1.848 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.82 123.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 39.3 m-85 -111.64 125.16 53.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 23' ' ' LEU . 68.1 t -121.32 122.14 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 123.935 0.772 . . . . 0.0 110.314 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.1 t -106.32 155.4 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.4 163.81 22.48 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.5 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -117.59 156.34 28.27 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.461 -1.295 . . . . 0.0 107.961 172.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 6.5 t-20 -141.76 152.12 43.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.665 178.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 34.3 tt0 -29.34 -47.69 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.501 179.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -111.85 36.09 3.44 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.5 -161.27 27.37 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.786 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -110.3 158.76 18.06 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.031 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.49 114.47 24.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.569 -175.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -39.98 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 125.368 1.668 . . . . 0.0 112.794 -176.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -80.53 140.06 36.04 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.769 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.46 147.27 29.53 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 172.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CD2' ' CE1' ' A' ' 74' ' ' TYR . 10.6 t-160 -116.93 131.48 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.667 -173.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 77.9 t80 -118.22 131.53 56.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -127.25 140.16 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.897 -176.533 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.554 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 37.1 p90 -159.75 178.79 9.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.016 178.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 146.5 52.06 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.279 177.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.4 p -81.0 165.9 21.3 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.711 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 m -79.9 -175.78 5.11 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.096 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.49 149.28 23.38 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.106 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 116.488 -1.72 . . . . 0.0 110.63 -178.685 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.973 0.415 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.23 172.95 16.87 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.501 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 1.6 Cg_endo -62.32 170.96 5.86 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.471 2.114 . . . . 0.0 112.924 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.6 p -87.42 150.36 23.84 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.909 171.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.45 160.12 1.42 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.173 174.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.5 162.47 27.66 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.206 1.27 . . . . 0.0 110.193 176.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 132.54 48.47 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.65 113.45 27.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.577 -174.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -92.7 141.19 28.74 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.597 177.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.42 121.37 7.08 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.129 -174.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' NE2' ' ND2' ' A' ' 22' ' ' ASN . 79.4 mt-30 -117.55 114.57 23.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.443 ' CE ' HD11 ' A' ' 19' ' ' ILE . 50.9 tpp -101.87 130.14 48.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.148 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.01 146.36 21.19 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.481 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.23 14.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.916 -177.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.3 m-20 -79.8 -25.56 40.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.572 175.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.54 -48.34 0.95 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.924 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -131.92 51.38 2.15 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.167 0.508 . . . . 0.0 109.967 176.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -121.69 112.21 18.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 173.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 7.9 mm -116.27 128.54 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.656 -171.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -114.98 126.07 54.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.05 0.844 . . . . 0.0 108.859 171.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.1 t -105.6 111.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.437 ' ND2' ' NE2' ' A' ' 11' ' ' GLN . 1.4 t-20 -89.0 127.83 35.68 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.5 -175.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.31 103.54 15.49 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.352 -174.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.7 mm -96.52 134.78 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -104.48 154.53 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.257 -176.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -66.56 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.627 -175.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -131.41 117.79 19.35 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.806 178.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 5.0 m-20 -130.06 -35.25 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.98 177.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.51 52.76 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.94 23.25 28.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -175.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.614 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 24.7 m 43.51 61.38 10.25 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.2 Cg_endo -88.9 39.58 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.464 1.443 . . . . 0.0 109.058 173.005 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.1 151.93 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.927 0.87 . . . . 0.0 111.258 -174.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.507 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.8 mtt180 -128.75 115.52 18.1 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.825 -179.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.7 p-80 31.9 -174.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 71.7 m-85 -132.57 153.34 51.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.077 174.254 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.0 mt -112.86 113.27 25.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 60' ' ' VAL . 43.1 t -115.89 128.98 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.043 -174.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -133.82 138.03 45.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.839 1.337 . . . . 0.0 108.122 176.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.63 157.15 44.33 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.805 -1.558 . . . . 0.0 112.007 176.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -134.73 163.93 28.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.448 -177.081 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -123.33 166.18 15.73 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.727 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.04 43.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.966 172.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -147.69 -56.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.742 176.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 p -132.05 157.99 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.198 175.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 16.0 pt-20 -105.09 165.34 11.16 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.711 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.481 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.4 m95 25.8 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.614 178.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -69.52 163.44 58.96 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.45 172.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 15.0 Cg_exo -49.59 105.72 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.726 1.618 . . . . 0.0 110.622 176.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.36 160.67 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -175.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.4 tt -132.27 148.84 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.181 174.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -115.07 135.56 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' HB2' ' A' ' 36' ' ' TYR . 1.3 mt -88.1 164.19 34.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.159 -177.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.26 161.19 41.56 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.694 1.596 . . . . 0.0 109.08 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 t -84.38 99.65 10.78 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.188 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.38 48.75 0.51 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -177.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -97.05 178.3 5.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.551 -177.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.21 -42.02 3.09 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.058 -179.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -150.72 168.32 24.72 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.106 -179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 9.6 p -120.73 148.19 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.719 172.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 ptp -133.09 149.95 52.1 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.604 -1.238 . . . . 0.0 112.79 -174.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.4 pp -139.15 134.84 33.36 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.402 173.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -133.96 138.56 45.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.42 -176.025 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 5.9 t 88.81 49.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.836 172.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.0 mm? -96.32 -179.88 4.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.852 -178.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -71.62 133.45 45.72 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.587 0.708 . . . . 0.0 111.127 -174.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -73.76 155.72 38.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 45.18 47.1 10.02 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.859 -177.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.27 156.04 45.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.014 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -97.29 148.94 22.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 12.2 m-85 -134.02 144.38 48.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.525 -178.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 9.3 mp0 -120.52 123.33 42.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.421 176.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.05 124.76 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 40.3 m-85 -113.43 125.66 54.48 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -120.63 124.36 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.536 -178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.3 t -110.99 157.05 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -128.54 158.84 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.493 -1.283 . . . . 0.0 109.459 177.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 32.8 tt0 -113.22 163.91 14.2 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.627 -1.229 . . . . 0.0 107.786 174.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 15.8 t-20 -148.93 152.37 36.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.987 177.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -36.81 -44.08 0.47 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.516 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -109.99 40.21 1.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.59 -153.78 22.23 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.271 172.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -122.29 161.81 22.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.733 179.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 1.7 t -120.94 117.64 27.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -40.95 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 125.592 1.808 . . . . 0.0 113.378 -174.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -84.18 136.51 33.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.194 -176.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.03 145.45 30.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 173.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.493 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.3 t-160 -114.83 131.02 56.96 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.718 -173.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -118.58 130.48 55.91 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.019 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -126.55 141.01 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.386 -177.169 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 43.1 p90 -157.47 177.28 11.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.068 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 147.01 50.73 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.927 176.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.1 p -83.92 163.45 20.01 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.586 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -80.77 -168.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.213 -179.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.57 143.16 33.43 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.044 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 116.235 -1.84 . . . . 0.0 110.463 -179.361 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.907 0.384 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.18 171.84 13.53 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.644 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 9.3 Cg_endo -67.41 174.39 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.573 2.182 . . . . 0.0 113.054 -178.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -94.36 -178.01 4.45 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.706 172.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.65 149.34 64.06 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.988 177.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.83 174.68 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.377 1.385 . . . . 0.0 109.954 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' HB2' HE22 ' A' ' 26' ' ' GLN . 20.9 ttpt -105.78 141.0 37.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.75 115.16 29.35 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.29 -177.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.04 138.41 39.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -126.64 143.65 14.5 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.277 -1.916 . . . . 0.0 113.815 -171.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -128.14 138.53 52.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.084 171.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.473 ' CE ' HD11 ' A' ' 19' ' ' ILE . 21.5 mtp -108.31 128.2 54.54 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.9 178.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -80.88 151.46 32.04 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.81 -175.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -63.87 11.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.037 -0.581 . . . . 0.0 112.311 -178.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.5 m-20 -79.8 -24.62 41.29 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.727 176.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.29 -41.65 2.16 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.86 178.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' HB2' ' H ' ' A' ' 65' ' ' LEU . 7.6 p30 -138.87 50.44 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.116 177.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.3 m -122.31 114.65 21.07 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.555 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 5.5 mm -116.2 128.86 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.684 -170.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 123.04 47.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.12 0.887 . . . . 0.0 109.214 175.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 44.4 t -112.79 120.28 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -176.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -97.42 134.2 40.99 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.772 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.409 HD22 HG11 ' A' ' 75' ' ' VAL . 16.9 mt -101.4 105.9 16.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.048 0.843 . . . . 0.0 109.039 -175.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.18 107.74 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.165 -176.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -76.92 156.84 31.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.49 HE22 ' HB2' ' A' ' 7' ' ' LYS . 1.7 pt20 -154.57 -83.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.389 -173.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.42 98.65 8.52 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.66 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 m-20 -131.62 -34.57 1.34 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.498 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.79 56.72 0.43 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.86 19.07 41.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.578 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.8 m 42.1 61.56 8.45 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.744 -176.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 31' ' ' SER . 13.0 Cg_endo -86.92 45.51 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.727 1.618 . . . . 0.0 108.701 173.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.436 HD13 HD22 ' A' ' 79' ' ' ASN . 23.4 mm -82.15 150.8 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.203 -173.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' HIS . 63.4 mtp85 -128.26 112.41 14.46 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.799 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.4 p-80 38.66 -173.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 175.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 84.6 m-85 -135.53 153.88 51.57 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.28 177.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD12 ' HB ' ' A' ' 76' ' ' VAL . 3.2 mt -110.89 110.51 21.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 175.366 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG11 HG21 ' A' ' 60' ' ' VAL . 47.3 t -114.55 124.92 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.281 -173.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -135.56 139.97 44.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.647 1.217 . . . . 0.0 108.151 177.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.38 154.87 42.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.299 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 16.0 ptt180 -132.23 164.87 25.41 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.381 -178.058 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -127.53 169.77 13.33 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.272 -177.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -74.16 42.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.783 173.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -145.49 -56.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.731 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -137.05 164.25 28.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.521 175.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 12.9 pt-20 -100.98 169.13 9.16 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.398 -174.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CH2' ' HD3' ' A' ' 41' ' ' ARG . 6.5 m95 17.81 95.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.788 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 71.5 mmtt -69.0 165.48 37.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.99 172.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 13.1 Cg_exo -50.71 97.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.538 1.492 . . . . 0.0 109.849 175.063 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.0 172.23 1.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.566 -173.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.3 tt -138.24 154.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.956 -179.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 ttp85 -115.5 135.57 53.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.94 174.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -85.41 165.1 37.73 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.002 -177.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 9.9 Cg_endo -73.31 146.41 40.17 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.725 1.616 . . . . 0.0 109.783 172.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' A' ' 35' ' ' HIS . 37.3 p -58.17 113.85 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.931 0.769 . . . . 0.0 111.285 -178.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.41 56.29 1.05 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -97.04 177.04 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 -45.48 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.813 -179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -144.27 170.22 16.4 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.128 177.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.5 p -129.03 151.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.348 175.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ptp -138.09 150.91 47.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.67 -1.212 . . . . 0.0 112.193 -177.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.5 pp -137.52 140.51 41.15 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.983 174.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' SER . 2.8 ttpt -140.47 136.42 32.96 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.811 -173.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 6.3 t 90.31 48.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.763 172.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.8 mm? -95.4 179.49 5.14 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.321 -178.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.03 134.69 48.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.661 0.743 . . . . 0.0 111.441 -173.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -74.47 154.21 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 45.86 48.06 12.1 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.618 -177.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.29 151.86 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.187 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.2 148.77 21.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 8.6 m-85 -133.62 141.25 47.56 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.398 -178.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.47 117.83 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.753 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.07 122.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 41.8 m-85 -112.21 125.88 54.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.409 HG11 HD22 ' A' ' 23' ' ' LEU . 95.4 t -120.33 122.71 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.888 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.7 t -109.15 158.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.99 159.67 33.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.049 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -112.74 164.66 13.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.448 -1.301 . . . . 0.0 107.582 174.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 19.2 t-20 -149.6 153.2 36.72 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.872 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -40.74 -40.89 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.318 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -79.75 -52.5 7.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.984 -178.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.01 -119.37 0.57 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.481 -1.343 . . . . 0.0 111.114 -177.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -125.34 163.93 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.427 -179.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.66 119.35 30.47 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -40.59 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 125.357 1.661 . . . . 0.0 113.447 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.62 139.24 31.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.387 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -107.87 144.78 34.62 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.477 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.4 t-160 -116.39 131.59 56.9 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.633 -173.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 85.6 t80 -117.72 128.16 54.62 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.083 -179.175 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.477 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.0 OUTLIER -124.89 137.89 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.58 -176.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 46.1 p90 -157.8 178.3 10.4 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.276 178.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -129.13 145.98 51.18 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.78 175.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -80.0 172.6 13.55 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.283 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -86.28 -174.96 5.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.166 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.91 147.51 24.89 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.312 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.471 -1.728 . . . . 0.0 110.551 -179.09 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.78 172.97 13.4 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.692 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 14.9 Cg_endo -71.2 178.02 5.92 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.7 p -84.93 152.71 23.32 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.479 170.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 162.7 0.92 Allowed Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 119.12 -1.032 . . . . 0.0 108.335 174.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -79.71 167.38 20.69 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.219 1.28 . . . . 0.0 110.522 176.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -104.24 127.42 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -98.31 112.32 24.35 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.613 -1.235 . . . . 0.0 109.983 -177.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.62 93.99 4.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -104.46 152.24 17.51 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.946 -172.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.64 157.82 43.83 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.953 -1.124 . . . . 0.0 109.232 178.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.3 ttm -111.12 139.45 46.47 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.359 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -88.15 154.85 25.76 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.846 -1.169 . . . . 0.0 111.121 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.45 11.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.267 -176.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' GLY . 20.4 m-20 -79.89 -22.87 42.29 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.152 175.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.58 -37.09 3.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.939 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 17' ' ' ASN . 10.1 p-10 -140.12 46.22 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.112 177.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.4 m -120.77 115.23 22.91 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.529 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 8.0 mm -116.08 130.85 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.132 -170.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.77 122.48 41.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 52.8 t -108.88 116.44 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -93.44 134.34 35.78 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.17 -178.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 32.7 mt -101.41 103.74 14.68 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.286 -176.138 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mm -95.2 136.71 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.13 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -104.36 152.6 22.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -133.45 -69.88 0.54 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.916 -175.636 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 25.7 m-20 -127.45 110.78 13.11 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.235 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 8.3 m-20 -131.48 -33.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.399 178.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.12 52.09 0.5 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.22 24.81 25.77 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 23.0 t 39.26 64.34 4.0 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 114.853 -0.674 . . . . 0.0 112.489 -176.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.9 44.61 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.665 1.577 . . . . 0.0 108.705 173.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.479 HD13 HD22 ' A' ' 79' ' ' ASN . 21.2 mm -90.69 148.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.163 -174.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' HIS . 74.6 mtm-85 -131.8 125.6 32.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.829 175.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 34' ' ' ARG . 9.7 p-80 36.34 -177.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 176.233 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 94.7 m-85 -138.57 150.56 46.45 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.518 178.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mt -105.27 110.32 22.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -112.47 126.31 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 118.959 -1.097 . . . . 0.0 110.607 -174.264 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -132.41 135.31 46.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 125.035 1.46 . . . . 0.0 107.804 176.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.47 151.69 41.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.659 -1.616 . . . . 0.0 112.128 176.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 11.3 ptm180 -124.15 160.53 27.64 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.433 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -109.17 -168.84 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' ' H ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -96.85 39.78 1.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.541 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.54 -60.97 0.34 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.03 150.26 39.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 14.9 pt-20 -106.79 144.02 34.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.746 -177.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.517 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 5.4 m95 48.45 82.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.107 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 72.6 mmtt -68.71 161.26 72.48 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.926 174.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 21.6 Cg_exo -43.63 104.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.96 1.773 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -52.21 161.63 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.902 -175.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.3 147.7 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.412 174.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -114.04 129.69 56.6 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 36' ' ' TYR . 1.4 mt -78.35 164.68 54.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.663 -178.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 6.0 Cg_exo -63.03 149.84 90.4 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.646 1.564 . . . . 0.0 110.009 174.192 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.416 ' HA ' ' N ' ' A' ' 35' ' ' HIS . 20.5 m -64.23 87.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.68 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 35' ' ' HIS . . . 113.7 56.61 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.7 t -97.02 -175.07 3.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.162 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.86 -24.01 3.01 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.974 -178.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p-80 -160.26 167.52 27.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.288 -1.365 . . . . 0.0 112.988 -177.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 13.8 p -130.4 152.32 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.579 174.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ptp -137.86 148.91 45.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.235 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 19' ' ' ILE . 1.9 pp -138.58 135.75 35.31 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.719 174.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.9 mtmt -141.63 143.07 33.45 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.871 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 63' ' ' LYS . 9.5 m 90.82 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.999 175.036 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mm? -92.6 -177.81 4.69 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.813 -178.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.29 133.94 41.19 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.635 0.731 . . . . 0.0 111.229 -172.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.59 155.8 39.66 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.125 179.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.6 t30 44.63 47.02 8.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.084 -177.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.41 154.58 46.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.824 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' H ' ' HB2' ' A' ' 43' ' ' LEU . 41.9 mt-10 -97.42 148.31 23.32 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.684 177.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 21.4 m-85 -133.76 142.1 47.78 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.502 -177.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -122.86 118.42 27.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.184 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.2 t -110.68 123.42 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CZ ' ' CD2' ' A' ' 88' ' ' HIS . 50.3 m-85 -112.2 126.04 54.79 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.08 122.42 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 123.925 0.766 . . . . 0.0 110.705 -178.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.0 t -107.23 159.71 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -130.61 159.93 35.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.016 177.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 17.6 tt0 -113.14 151.99 30.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.361 -1.336 . . . . 0.0 108.283 175.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' PRO . 18.6 t-20 -142.55 150.77 40.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.62 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -37.81 -39.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.711 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.63 -49.86 11.53 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.085 -177.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 -125.2 0.75 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.513 -179.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -119.78 157.87 27.72 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.088 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -116.68 118.05 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -41.53 162.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 125.538 1.774 . . . . 0.0 112.873 -175.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.78 135.36 34.57 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.235 -175.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.99 148.05 25.83 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.533 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.5 t-160 -117.4 130.64 56.62 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.783 -172.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 10' ' ' GLY . 79.3 t80 -119.17 130.37 55.48 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.939 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.533 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.7 t -128.48 142.85 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.311 -175.307 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 49.6 p90 -162.52 179.08 8.03 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.334 177.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -129.28 147.91 51.16 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.49 175.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.6 p -79.87 170.95 15.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.344 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 t -83.23 -173.02 4.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.967 -179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.91 138.9 39.83 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.02 -178.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 116.447 -1.739 . . . . 0.0 110.654 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.965 0.412 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.69 176.59 14.54 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 120.044 -1.074 . . . . 0.0 110.588 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 6.3 Cg_exo -60.09 173.26 1.92 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.549 2.166 . . . . 0.0 113.177 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -98.62 162.61 13.04 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 144.27 94.98 Favored Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.168 -177.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.54 174.01 8.02 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.392 1.395 . . . . 0.0 110.495 -178.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -109.09 132.08 54.45 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.37 114.68 29.0 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.876 -1.129 . . . . 0.0 110.035 -176.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -95.09 141.27 28.92 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 89' ' ' PHE . . . -105.73 127.44 8.97 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.634 -171.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -121.82 113.28 19.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.433 ' CE ' HD11 ' A' ' 19' ' ' ILE . 25.0 mtp -103.63 127.2 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.348 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -86.79 147.16 21.0 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.722 -1.228 . . . . 0.0 112.25 -174.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.27 13.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.918 -0.641 . . . . 0.0 112.141 -178.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.23 41.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.449 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.67 -46.18 1.21 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.6 -1.286 . . . . 0.0 111.55 176.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -134.54 35.37 3.18 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.315 177.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.4 m -104.59 113.88 27.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 12.1 mm -118.43 126.1 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.492 -171.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -113.66 127.38 56.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.006 0.816 . . . . 0.0 108.822 172.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 49.1 t -108.53 116.31 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -97.65 129.64 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.54 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 59' ' ' HIS . 25.2 mt -99.37 109.64 22.22 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.756 -172.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.9 mm -100.6 135.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.94 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -101.58 150.42 23.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.828 0.705 . . . . 0.0 109.265 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -135.34 -49.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.744 -175.922 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 27.5 m-20 -140.01 104.27 4.81 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.69 -177.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -132.57 -33.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.256 178.695 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.64 51.66 0.49 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.64 23.94 29.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.598 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 20.6 t 42.76 62.13 8.64 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 114.734 -0.733 . . . . 0.0 112.816 -176.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.4 Cg_endo -85.83 41.68 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.582 1.521 . . . . 0.0 108.813 171.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.65 150.83 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.488 -173.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 35' ' ' HIS . 53.4 mtt-85 -130.69 117.52 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.47 -1.695 . . . . 0.0 108.598 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 34' ' ' ARG . 8.3 p-80 36.76 -175.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 176.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 53' ' ' LEU . 91.7 m-85 -137.21 153.96 50.29 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.012 176.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -108.65 110.21 21.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 175.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' VAL . 44.7 t -114.17 123.81 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.137 -173.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -134.49 137.85 44.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.661 1.225 . . . . 0.0 108.113 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.21 158.71 43.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.968 -1.493 . . . . 0.0 112.505 179.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 2.0 ptm180 -138.28 170.72 15.52 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.983 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.09 -168.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.155 -175.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.24 41.82 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.484 174.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.23 -57.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.701 179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -122.95 157.61 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.926 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 13.1 pt-20 -97.68 178.22 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.462 -177.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 6.5 m95 3.38 100.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.42 167.87 32.71 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.307 172.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -48.61 98.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.711 1.607 . . . . 0.0 110.365 176.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.37 174.32 4.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.353 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.8 tt -140.12 155.51 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.389 -177.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -113.68 134.08 54.95 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.974 173.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 mt -82.28 163.55 52.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.933 -177.64 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 2.7 Cg_exo -59.59 167.29 6.76 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.84 1.693 . . . . 0.0 110.51 174.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -74.76 79.82 2.07 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.657 -176.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 63.02 0.39 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -97.05 -175.81 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.808 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -130.03 -16.53 3.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.274 -179.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . 30.9 p-80 -160.07 164.52 33.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 118.255 -1.378 . . . . 0.0 112.496 -176.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 38' ' ' VAL . 14.7 p -134.9 152.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.614 173.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.3 ptp -137.42 152.86 50.06 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.64 -1.224 . . . . 0.0 112.708 -176.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 19' ' ' ILE . 1.1 pp -138.88 140.57 38.45 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.52 173.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.32 156.2 47.01 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.617 -174.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.1 t 62.68 59.13 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.378 175.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 65' ' ' LEU . 3.9 mm? -100.68 -175.14 2.81 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.653 176.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.84 140.33 36.85 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.677 0.751 . . . . 0.0 111.462 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.409 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 80.4 m95 -76.73 154.15 34.37 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.602 -178.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 44.49 48.34 8.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 -177.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.34 152.79 47.75 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.676 179.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.58 147.66 24.57 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.601 176.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 23.1 m-85 -132.2 143.39 49.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.36 -176.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -120.82 118.26 29.52 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.785 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -112.91 120.63 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 88' ' ' HIS . 47.6 m-85 -110.08 125.4 52.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -120.83 120.69 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.429 -178.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -104.98 158.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -128.98 156.48 43.71 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.612 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.24 159.24 18.1 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.742 174.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 20.0 t-20 -143.64 151.87 40.66 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.512 178.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -40.03 -39.1 0.81 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.006 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -107.99 35.43 3.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.01 -151.44 20.45 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.942 173.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -121.79 160.08 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.933 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -122.54 122.85 39.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -41.88 165.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.664 1.852 . . . . 0.0 113.468 -174.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -85.57 137.23 33.01 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.34 146.01 28.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 172.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -116.09 128.16 55.45 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.687 -174.039 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 82.7 t80 -112.73 124.97 53.78 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.168 -1.378 . . . . 0.0 107.88 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG22 ' CE1' ' A' ' 88' ' ' HIS . 0.6 OUTLIER -124.29 137.46 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.324 -176.475 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 19' ' ' ILE . 46.3 p90 -161.34 179.09 8.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.821 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -128.53 153.36 47.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.364 173.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.1 p -79.92 177.72 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.074 177.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -90.45 -174.01 3.98 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.333 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.46 149.18 23.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.083 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.538 -1.696 . . . . 0.0 110.621 -178.571 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.56 169.45 17.5 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.467 179.25 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' HG3' ' ND2' ' A' ' 79' ' ' ASN . 5.4 Cg_exo -60.62 169.48 5.46 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.407 2.072 . . . . 0.0 113.08 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -98.0 163.39 12.79 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.347 172.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.44 142.28 91.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.269 -176.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -70.65 163.24 39.7 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.551 1.501 . . . . 0.0 110.087 -178.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG3' HE22 ' A' ' 26' ' ' GLN . 29.5 mtmt -91.98 137.05 32.68 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.7 mt -105.77 109.81 21.9 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.56 -179.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 27.6 tt0 -94.34 137.92 32.93 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.34 -178.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.85 125.85 8.48 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.593 -1.289 . . . . 0.0 112.384 -171.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -120.84 117.74 28.17 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.448 ' CE ' HD11 ' A' ' 19' ' ' ILE . 51.2 tpp -99.92 127.43 46.11 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 15' ' ' ASP . . . -85.78 150.34 24.12 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.191 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 4.8 mp0 -66.69 14.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.798 -176.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 13' ' ' GLY . 4.4 m-20 -79.84 -24.75 41.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.461 174.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' CH2' ' A' ' 67' ' ' TRP . . . 113.21 -43.5 1.7 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.337 177.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -130.81 6.89 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.205 178.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.9 t -75.06 112.27 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.819 176.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 9.4 mm -114.36 125.04 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.862 -173.356 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.63 125.85 54.73 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 61.0 t -108.38 113.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -178.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 56.4 t30 -93.46 129.26 39.7 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.353 -177.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -97.37 106.14 18.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.393 -173.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.94 105.55 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.803 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -76.23 148.04 37.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.417 HE22 ' HG3' ' A' ' 7' ' ' LYS . 2.7 pt20 -146.01 -55.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.26 -173.228 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.68 101.58 5.54 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.682 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 3' ' ' PRO . 3.1 m-20 -129.07 -37.41 1.69 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.109 178.252 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.02 54.69 0.38 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.54 20.24 38.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -175.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.595 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 69.1 m 42.47 61.87 8.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 31' ' ' SER . 9.3 Cg_endo -86.68 43.0 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.695 1.597 . . . . 0.0 108.493 172.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.9 mm -80.79 151.09 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.536 -172.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 35' ' ' HIS . 52.1 mtt180 -127.85 111.7 13.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.696 179.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ARG . 7.8 p-80 37.46 -176.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 175.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 80.9 m-85 -134.34 151.35 51.18 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.847 175.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD12 ' HB ' ' A' ' 76' ' ' VAL . 5.9 mt -107.68 110.68 22.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.003 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG11 HG21 ' A' ' 60' ' ' VAL . 43.4 t -115.7 125.98 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.413 -174.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -137.53 142.2 41.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.637 1.21 . . . . 0.0 107.924 176.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.19 157.78 43.72 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.802 -1.559 . . . . 0.0 112.187 179.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HB3' ' H ' ' A' ' 47' ' ' TRP . 10.5 ptm180 -132.32 163.19 29.22 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.305 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 71' ' ' TYR . . . -120.98 175.65 5.95 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.62 42.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.125 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . . . -148.97 -59.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.244 178.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -125.41 154.89 41.24 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.156 176.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 15.2 pt-20 -106.47 158.16 17.11 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.854 -1.139 . . . . 0.0 111.992 -176.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.533 ' H ' ' HB3' ' A' ' 41' ' ' ARG . 6.1 m95 33.03 86.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.204 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 66.8 mmtt -72.52 164.16 62.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.387 175.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 48' ' ' LYS . 16.7 Cg_exo -46.46 98.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.83 1.687 . . . . 0.0 110.537 177.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.64 173.6 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.506 -174.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.02 155.0 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.09 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -115.96 133.45 56.01 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.884 173.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.6 mt -82.63 162.94 54.03 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.294 -176.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 53' ' ' LEU . 4.7 Cg_exo -60.33 168.85 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.932 1.755 . . . . 0.0 111.016 173.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 p -80.9 81.44 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.956 -177.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 58.47 0.22 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 m -97.13 178.94 5.09 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.898 -178.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.75 -37.68 2.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.545 -178.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -148.93 168.43 23.07 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.018 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 21' ' ' VAL . 11.8 p -126.89 150.49 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.48 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.6 ptp -134.39 148.12 50.62 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.52 -175.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 65' ' ' LEU . 1.5 pp -141.85 141.74 33.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.008 173.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -141.51 174.06 10.91 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.901 -1.119 . . . . 0.0 111.309 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 m 59.02 56.79 3.81 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.424 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD11 ' CD1' ' A' ' 62' ' ' LEU . 17.2 mt -94.33 -178.1 4.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.18 131.95 38.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.229 175.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.411 ' CH2' ' HA3' ' A' ' 16' ' ' GLY . 79.3 m95 -72.71 152.61 41.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.556 -1.258 . . . . 0.0 110.251 -178.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.77 46.79 18.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.853 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -127.88 154.28 45.68 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.889 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.28 149.9 20.83 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.216 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 16.3 m-85 -135.5 141.9 45.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.269 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.14 118.28 30.96 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.422 177.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.64 124.2 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE1' ' CD2' ' A' ' 88' ' ' HIS . 46.2 m-85 -112.59 125.71 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.5 t -121.49 122.51 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.023 0.827 . . . . 0.0 110.482 -179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 86' ' ' ALA . 2.2 t -109.16 158.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 84' ' ' SER . . . -129.09 156.77 43.35 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.408 -1.317 . . . . 0.0 109.797 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 34.4 tt0 -112.05 162.52 15.3 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HG3' ' A' ' 3' ' ' PRO . 17.2 t-20 -147.26 150.86 35.67 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.099 177.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -39.05 -43.04 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.307 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -111.52 40.37 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.599 -175.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.12 -152.12 22.58 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.82 174.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -132.67 167.88 19.29 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.701 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.2 t -127.34 121.01 29.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.3 -178.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -43.41 166.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 125.5 1.75 . . . . 0.0 112.987 -175.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 76' ' ' VAL . . . -83.82 135.87 34.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.37 -175.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.9 144.32 29.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.52 ' CE1' HG22 ' A' ' 90' ' ' VAL . 10.6 t-160 -113.96 129.25 56.62 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.336 -174.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -116.8 125.05 51.02 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.785 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 88' ' ' HIS . 1.5 t -124.28 137.73 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.501 -176.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 19' ' ' ILE . 44.1 p90 -156.85 177.93 10.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.916 -1.114 . . . . 0.0 111.07 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -126.31 147.72 49.67 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.475 174.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -79.88 167.97 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.2 m -78.16 -177.25 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.362 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.22 146.65 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.891 179.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 116.466 -1.731 . . . . 0.0 110.531 -179.133 . . . . . . . . 0 0 . 1 stop_ save_